data_2jwp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jwp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.547 ' HG ' HD11 ' A' ' 27' ' ' ILE . 25.8 tp . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.241 0.543 . . . . 1.2 109.879 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -63.25 -23.02 67.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.204 -0.907 . . . . 1.1699999999999999 111.686 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.581 ' HB3' ' HE3' ' A' ' 9' ' ' LYS . 22.6 t70 -83.0 -35.27 25.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.91 -0.587 . . . . 2.1800000000000002 111.404 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.581 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 10.6 mmtp -94.26 -19.33 20.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.893 -0.323 . . . . 2.2599999999999998 111.593 -171.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.501 HG21 ' HE1' ' A' ' 171' ' ' PHE . 7.2 p -56.01 134.78 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.018 0.437 . . . . 1.1100000000000001 111.424 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 pt -110.88 -22.56 4.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.209 -0.45 . . . . 1.51 110.581 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.551 ' HB3' ' CG2' ' A' ' 172' ' ' ILE . 77.1 t90 -170.54 146.07 2.69 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.696 -0.483 . . . . 0.42999999999999999 109.696 -173.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' A' ' 30' ' ' ARG . . . -163.01 138.28 6.71 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.32 -0.238 . . . . 1.0700000000000001 111.003 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.781 HG23 ' HB2' ' A' ' 30' ' ' ARG . 84.4 t -146.84 121.78 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 122.574 0.35 . . . . 1.45 111.568 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.601 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 46.5 t30 -102.61 99.58 9.59 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.703 -0.48 . . . . 1.6100000000000001 109.703 167.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.07 105.44 1.06 Allowed 'General case' 0 C--O 1.243 0.747 0 N-CA-C 109.414 -0.587 . . . . 1.1599999999999999 109.414 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.562 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 158.24 -47.1 0.45 Allowed Glycine 0 N--CA 1.447 -0.601 0 O-C-N 124.248 0.968 . . . . 0.76000000000000001 113.337 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.07 -132.77 7.76 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.853 -0.689 . . . . 0.82999999999999996 112.727 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 16.9 mt-10 -156.87 120.27 4.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 119.679 -0.2 . . . . 1.8400000000000001 111.237 174.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 4.0 p 35.31 90.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.644 1.215 . . . . 1.75 113.499 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.683 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 79.6 t60 -131.16 133.75 45.86 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.574 -0.851 . . . . 0.52000000000000002 111.687 -174.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.17 116.22 36.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.724 -0.671 . . . . 1.6100000000000001 110.038 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.82 155.99 39.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.991 -0.55 . . . . 0.77000000000000002 109.768 176.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.45 -13.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 113.422 0.897 . . . . 1.29 113.422 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -93.57 -0.66 56.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.421 0.629 . . . . 1.02 109.357 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 93.71 31.13 8.43 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 114.826 -1.079 . . . . 0.37 112.811 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.547 HD11 ' HG ' ' A' ' 6' ' ' LEU . 21.6 mm -103.93 109.3 26.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.14 0.495 . . . . 1.0900000000000001 110.907 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -92.11 114.03 26.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 1.1200000000000001 111.431 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.61 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -78.45 131.18 36.79 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.995 -0.548 . . . . 1.9199999999999999 110.881 176.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.781 ' HB2' HG23 ' A' ' 14' ' ' VAL . 8.2 mpt_? -69.9 102.5 1.99 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 125.018 1.449 . . . . 3.4399999999999999 111.565 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 20' ' ' SER . 14.7 ttmm -38.96 96.33 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.953 1.094 . . . . 3.23 113.953 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.604 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 75.0 m-20 30.22 78.25 0.29 Allowed Pre-proline 0 N--CA 1.476 0.859 0 C-N-CA 124.6 1.16 . . . . 2.4100000000000001 113.297 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 16.4 Cg_endo . . . . . 0 N--CA 1.456 -0.72 0 C-N-CA 122.985 2.456 . . . . 1.8700000000000001 114.347 -170.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.6 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.0 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.803 0.811 . . . . 1.5900000000000001 109.407 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.7 tp 69.26 -52.99 0.59 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.282 -1.326 . . . . 2.48 112.594 174.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -68.64 -21.88 64.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.449 -0.341 . . . . 3.7200000000000002 111.764 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.426 ' HB3' ' CA ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -113.67 146.49 39.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.993 0.738 . . . . 0.96999999999999997 112.993 -170.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.579 HD22 ' HG2' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -69.16 146.04 96.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 114.485 -1.234 . . . . 1.9199999999999999 109.312 175.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.553 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 52.9 Cg_exo -38.24 -43.56 1.81 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.162 3.241 . . . . 0.95999999999999996 116.161 -165.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.586 ' HB2' ' HE1' ' A' ' 21' ' ' HIS . 10.7 pt-20 -78.56 -50.1 12.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.203 0.525 . . . . 2.71 111.039 -173.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -74.88 -19.86 59.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.165 0.507 . . . . 1.6299999999999999 109.695 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.426 ' CA ' ' HB3' ' A' ' 53' ' ' SER . 27.8 tt0 -59.69 -43.29 94.11 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.725 -0.67 . . . . 2.1200000000000001 109.948 168.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 55' ' ' PRO . 91.4 t -54.18 -43.8 61.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.593 -0.521 . . . . 1.9099999999999999 109.593 173.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.683 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 26.5 tp -67.53 -14.03 62.58 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.148 -0.933 . . . . 1.77 111.653 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.685 ' CE2' ' HE3' ' A' ' 88' ' ' LYS . 12.0 m-30 -118.39 7.74 12.0 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 111.833 0.309 . . . . 1.3799999999999999 111.833 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.473 ' HB2' HD12 ' A' ' 50' ' ' ILE . 4.5 tt0 -127.2 -43.01 1.66 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.75 0.648 . . . . 1.97 112.75 -172.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.542 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 18.7 p -67.37 130.82 44.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.276 0.473 . . . . 1.54 112.276 -174.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.804 ' HB3' HG21 ' A' ' 167' ' ' VAL . 8.7 pt-20 -114.94 156.65 24.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.048 0.452 . . . . 1.96 111.59 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.604 ' HD2' ' CG ' ' A' ' 32' ' ' ASP . 37.8 mtp85 . . . . . 0 CA--C 1.531 0.237 0 CA-C-N 115.948 -0.569 . . . . 4.0700000000000003 111.461 173.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.3 t . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.701 0.286 . . . . 1.78 110.345 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.552 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 11.5 p90 -124.52 140.18 53.19 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.116 -0.698 . . . . 2.2999999999999998 109.116 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -136.77 161.81 25.12 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.133 -1.032 . . . . 1.1599999999999999 114.8 -167.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.494 ' HB3' ' CH2' ' A' ' 12' ' ' TRP . 60.1 m-85 -100.43 152.85 19.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.854 -0.673 . . . . 1.6200000000000001 111.847 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.549 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 9.4 t0 -116.24 103.61 10.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.067 -0.97 . . . . 2.4700000000000002 108.646 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.86 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.7 mp -103.87 89.87 2.6 Favored Pre-proline 0 N--CA 1.464 0.246 0 N-CA-C 110.121 -0.325 . . . . 1.1899999999999999 110.121 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.587 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 38.6 Cg_exo -57.59 117.53 4.25 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.194 1.929 . . . . 0.89000000000000001 112.733 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.663 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 67.9 mt -117.12 136.29 54.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.937 -0.574 . . . . 1.1699999999999999 110.237 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -130.45 10.16 5.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.405 -0.361 . . . . 3.7000000000000002 110.988 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.594 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 23.3 tt0 -139.09 -176.89 4.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.148 -0.316 . . . . 2.1600000000000001 110.148 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.638 ' HG3' ' O ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -130.32 157.51 42.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.559 -0.534 . . . . 1.2 109.559 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.08 -162.85 28.84 Favored Glycine 0 C--O 1.234 0.154 0 N-CA-C 110.354 -1.098 . . . . 0.35999999999999999 110.354 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 27.7 mt-10 -99.68 102.66 14.21 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 118.281 1.04 . . . . 1.96 110.198 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.637 ' HB2' HG12 ' A' ' 133' ' ' ILE . 79.1 m-85 -94.68 124.27 38.62 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.243 -1.021 . . . . 1.1399999999999999 108.243 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.809 HG22 ' HA ' ' A' ' 177' ' ' ALA . 52.9 t -104.8 105.68 19.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.64 0.734 . . . . 1.0700000000000001 109.902 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.778 HD13 ' HB ' ' A' ' 172' ' ' ILE . 7.5 tp -89.48 101.41 14.09 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.348 -1.297 . . . . 2.0600000000000001 108.548 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.57 104.61 17.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.778 0.799 . . . . 1.72 108.848 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.635 ' CD1' ' HB2' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -104.55 134.53 47.57 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.405 -0.816 . . . . 2.0600000000000001 109.959 -178.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.799 ' HD2' ' HB3' ' A' ' 126' ' ' ALA . 10.9 tppt? -96.05 120.08 35.69 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.941 -0.703 . . . . 4.1900000000000004 109.4 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.686 ' CD2' HD11 ' A' ' 115' ' ' LEU . 13.8 m-85 -106.26 141.81 36.99 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.781 -0.645 . . . . 0.54000000000000004 110.374 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.446 ' HB2' ' CG2' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.891 0 CA-C-N 115.72 -0.673 . . . . 1.1599999999999999 109.661 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.3 m . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 122.134 0.969 . . . . 1.8200000000000001 110.316 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.719 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 11.8 m-85 -87.74 164.12 16.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.173 -1.376 . . . . 1.1699999999999999 111.682 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.65 137.8 41.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.566 -0.902 . . . . 1.53 108.566 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.635 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 2.5 t -131.91 113.09 21.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.902 -0.59 . . . . 1.3500000000000001 109.51 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.722 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 62.9 mtt180 -122.6 130.15 52.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 2.3100000000000001 111.471 -173.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.865 HG11 HD12 ' A' ' 153' ' ' LEU . 21.8 t -105.62 99.88 9.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.154 -0.93 . . . . 2.0899999999999999 109.413 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.799 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 4.1 t-20 57.87 51.81 8.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.219 1.009 . . . . 2.0899999999999999 109.022 -170.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.5 -20.18 19.64 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 114.544 -1.207 . . . . 0.41999999999999998 113.163 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.541 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 95.4 m-70 -79.25 107.33 11.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.01 0.374 . . . . 0.81999999999999995 112.01 -172.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.53 HG23 ' HG2' ' A' ' 105' ' ' ARG . 3.1 p -68.52 96.61 0.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.19 0.519 . . . . 1.3500000000000001 111.198 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.83 HG11 HD11 ' A' ' 131' ' ' ILE . 22.3 t -85.32 -46.14 17.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.832 -0.622 . . . . 1.6000000000000001 109.568 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.635 ' HB ' ' HB ' ' A' ' 104' ' ' VAL . 10.2 t -119.2 88.35 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.441 0.639 . . . . 1.1200000000000001 109.645 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 51.9 tptt -103.85 76.5 1.38 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.211 -1.033 . . . . 4.4000000000000004 108.211 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.559 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 4.8 p-10 162.43 14.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.154 -1.384 . . . . 1.96 110.457 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.719 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -66.47 98.29 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.867 0.365 . . . . 1.78 111.37 -169.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -112.87 94.58 4.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.066 0.936 . . . . 1.9299999999999999 109.641 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.553 ' O ' HG23 ' A' ' 121' ' ' VAL . 56.2 mt -61.03 -46.8 95.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.713 -1.13 . . . . 1.4199999999999999 111.829 -170.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -53.64 -37.17 62.85 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.092 0.404 . . . . 1.2 112.092 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.73 -39.54 70.02 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.719 -0.392 . . . . 0.95999999999999996 110.806 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -74.2 -43.72 56.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.89 -0.595 . . . . 2.1800000000000002 111.607 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 117' ' ' ILE . 29.7 m -92.71 -32.66 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.87 -0.332 . . . . 2.0899999999999999 111.829 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.1 -69.89 3.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 1.3999999999999999 111.789 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -114.92 169.47 9.06 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.032 -0.359 . . . . 4.9100000000000001 110.032 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.6 m -59.92 97.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.245 0.545 . . . . 2.1499999999999999 112.142 -173.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 36.8 p -144.75 -166.44 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.391 -0.822 . . . . 1.3999999999999999 109.004 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.799 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . . . -100.58 118.21 36.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.765 0.317 . . . . 1.21 111.69 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.456 ' HB2' ' CG1' ' A' ' 121' ' ' VAL . 83.8 t60 -95.57 136.98 35.26 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.206 -0.664 . . . . 0.57999999999999996 109.206 175.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.2 132.31 43.01 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.871 -0.732 . . . . 1.6399999999999999 112.167 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.635 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 77.0 mm-40 -110.95 114.09 27.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.12 -0.945 . . . . 1.6799999999999999 108.673 170.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.44 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 46.0 mt -96.34 109.8 23.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.084 -0.71 . . . . 1.3899999999999999 109.084 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.83 HD11 HG11 ' A' ' 111' ' ' VAL . 31.2 mm -118.43 88.14 32.8 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.612 -0.267 . . . . 1.8500000000000001 110.908 -171.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 130' ' ' ILE . 8.3 Cg_exo -74.57 127.47 11.02 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.593 2.196 . . . . 0.33000000000000002 111.796 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.637 HG12 ' HB2' ' A' ' 83' ' ' TYR . 3.4 pt -110.13 144.73 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.857 -0.794 . . . . 1.1000000000000001 108.857 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 p -116.34 107.67 15.12 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.205 0.526 . . . . 1.8200000000000001 110.44 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.638 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 3.9 mt -98.68 131.71 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.194 -0.669 . . . . 1.1399999999999999 109.194 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.44 ' HD3' ' HG3' ' A' ' 80' ' ' GLU . 71.6 mmtt -148.38 129.73 14.74 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 123.641 0.588 . . . . 2.4300000000000002 109.896 174.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 60.61 24.95 14.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.828 -0.624 . . . . 3.6000000000000001 111.526 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.05 8.43 66.89 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.557 -0.83 . . . . 0.45000000000000001 112.857 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.633 ' HG3' HG21 ' A' ' 148' ' ' THR . 8.9 mptt -111.69 139.65 46.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.682 -0.488 . . . . 2.7000000000000002 109.682 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.4 tt -115.08 115.73 27.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.981 -0.554 . . . . 1.1100000000000001 109.738 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.1 m -109.07 115.04 29.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 1.8100000000000001 110.837 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.81 104.92 17.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 O-C-N 122.282 -0.261 . . . . 1.5700000000000001 110.337 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 64.17 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.816 0.697 . . . . 1.8799999999999999 110.928 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.51 1.68 5.66 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.944 -0.646 . . . . 1.25 112.27 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -99.14 112.8 24.85 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.0 -0.37 . . . . 1.95 110.0 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 p -115.02 119.23 61.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.385 0.612 . . . . 1.49 111.482 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.8 m -145.94 156.16 43.33 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.928 -0.767 . . . . 1.75 108.928 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.633 HG21 ' HG3' ' A' ' 139' ' ' LYS . 41.6 p -63.17 140.58 58.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.835 0.35 . . . . 1.8700000000000001 110.536 176.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.663 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 18.0 t80 -79.48 142.8 35.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.618 . . . . 0.56999999999999995 109.489 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -137.95 102.71 4.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.274 0.559 . . . . 2.2400000000000002 111.798 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.65 -64.27 3.31 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.693 -0.685 . . . . 0.77000000000000002 113.979 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.675 ' HE2' ' HB3' ' A' ' 154' ' ' SER . 0.0 OUTLIER -155.92 170.65 21.62 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 117.137 0.469 . . . . 1.8 110.723 -178.332 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.865 HD12 HG11 ' A' ' 106' ' ' VAL . 22.7 tp -81.21 131.19 35.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.047 -1.094 . . . . 1.8300000000000001 108.047 174.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.799 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 p -123.51 102.35 7.83 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.6 -0.84 . . . . 1.72 111.85 -171.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.722 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 48.4 t -93.01 95.97 5.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.231 -0.588 . . . . 1.1699999999999999 110.146 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -98.72 119.83 38.12 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.203 -0.666 . . . . 1.98 109.203 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.552 ' CE2' ' CE1' ' A' ' 71' ' ' PHE . 1.9 p90 -115.92 126.57 54.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.047 0.927 . . . . 2.9100000000000001 110.535 175.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.45 144.59 16.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.791 -1.549 . . . . 1.3 110.87 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.8 pttm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.593 -0.73 . . . . 2.6699999999999999 111.364 -176.684 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.804 HG21 ' HB3' ' A' ' 64' ' ' GLU . 61.7 t . . . . . 0 CA--C 1.506 -0.715 0 N-CA-C 108.353 -0.981 . . . . 1.8700000000000001 108.353 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 38.8 t -134.46 88.12 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.812 -0.755 . . . . 1.9099999999999999 112.133 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -80.0 36.49 0.34 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 124.466 1.106 . . . . 1.05 112.658 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.7 HD13 HD11 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -35.92 120.48 0.61 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.412 0.685 . . . . 1.3500000000000001 111.507 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 4.1 t80 -136.18 109.7 7.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.497 -0.32 . . . . 0.60999999999999999 110.317 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.778 ' HB ' HD13 ' A' ' 85' ' ' LEU . 6.7 tt -104.17 121.46 55.83 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 121.899 0.857 . . . . 1.1000000000000001 110.583 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.672 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.2 ppp? -119.07 152.53 36.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.435 -0.802 . . . . 1.1399999999999999 109.705 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.533 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 72.6 tttt -97.87 139.4 33.78 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 114.895 1.443 . . . . 1.74 114.895 -169.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.87 -28.89 12.97 Favored Glycine 0 C--N 1.317 -0.473 0 CA-C-N 113.196 -1.82 . . . . 0.31 115.61 155.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.81 155.0 3.77 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.28 1.04 . . . . 1.3 113.439 -174.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.809 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -84.78 -21.2 30.06 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.19 -0.914 . . . . 1.3500000000000001 110.973 173.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.113 0.482 . . . . 2.1600000000000001 111.582 -175.608 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.592 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.3 tp . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.062 0.458 . . . . 1.2 110.618 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 25' ' ' HIS . . . -63.03 -23.79 67.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.628 -0.714 . . . . 1.1699999999999999 111.811 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.9 -43.94 14.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.285 -0.416 . . . . 2.1800000000000002 110.885 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.692 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 32.2 mmtp -87.24 -10.74 51.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.489 0.552 . . . . 2.2599999999999998 112.489 -172.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.569 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 14.1 p -57.28 135.77 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.323 0.583 . . . . 1.1100000000000001 111.111 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.471 HG22 ' HZ2' ' A' ' 174' ' ' LYS . 42.2 pt -119.35 -28.18 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.909 -0.587 . . . . 1.51 110.829 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.596 ' CH2' ' HB3' ' A' ' 73' ' ' TYR . 59.5 t90 -166.4 119.97 1.08 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.038 -0.528 . . . . 0.42999999999999999 109.908 -170.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -135.49 140.1 44.53 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.114 -0.328 . . . . 1.0700000000000001 110.114 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.89 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 55.0 t -140.5 105.71 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 112.615 0.598 . . . . 1.45 112.615 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.654 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 14.0 t-20 -81.53 89.3 6.17 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.082 -1.081 . . . . 1.6100000000000001 108.082 164.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.52 101.14 0.42 Allowed 'General case' 0 C--O 1.248 1.026 0 N-CA-C 109.268 -0.642 . . . . 1.1599999999999999 109.268 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.728 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 155.17 -44.08 0.56 Allowed Glycine 0 N--CA 1.441 -1.018 0 O-C-N 125.66 1.85 . . . . 0.76000000000000001 110.865 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' C ' ' HE2' ' A' ' 29' ' ' TYR . . . -102.42 -150.63 23.01 Favored Glycine 0 C--O 1.225 -0.409 0 CA-C-N 115.193 -0.504 . . . . 0.82999999999999996 112.958 -172.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.069 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 3.9 tm-20 -149.34 121.06 8.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.929 0.365 . . . . 1.8400000000000001 111.248 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.753 ' HB2' ' HB2' ' A' ' 31' ' ' LYS . 5.9 t 34.61 86.96 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.846 1.341 . . . . 1.75 112.839 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.875 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 67.4 t60 -129.42 132.01 46.9 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 119.75 -0.78 . . . . 0.52000000000000002 111.541 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.4 120.75 45.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.597 -0.729 . . . . 1.6100000000000001 110.338 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.86 154.36 31.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.754 -0.657 . . . . 0.77000000000000002 109.383 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.1 m -61.52 -10.22 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 113.871 1.063 . . . . 1.29 113.871 -171.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.522 ' HB2' HD21 ' A' ' 6' ' ' LEU . 66.7 m-70 -95.35 -0.82 52.28 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.213 -0.662 . . . . 1.02 109.213 175.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.05 30.4 8.34 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.128 -0.942 . . . . 0.37 112.923 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.592 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.9 mm -104.08 115.46 46.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.08 0.466 . . . . 1.0900000000000001 111.037 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -102.43 122.11 43.65 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.008 0.373 . . . . 1.1200000000000001 112.008 -171.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.89 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -86.4 139.47 30.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.222 -0.444 . . . . 1.9199999999999999 111.164 175.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.426 ' HG2' HG22 ' A' ' 14' ' ' VAL . 11.2 mmm180 -72.61 -7.89 52.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.527 1.677 . . . . 3.4399999999999999 115.527 -161.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 1.069 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 25.3 ttmt 70.18 103.92 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.434 0.531 . . . . 3.23 112.434 -176.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 2.3 m-20 60.13 58.27 4.39 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.849 1.055 . . . . 2.4100000000000001 113.849 165.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 30.0 Cg_endo . . . . . 0 CA--C 1.541 0.839 0 C-N-CA 123.639 2.893 . . . . 1.8700000000000001 113.492 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.562 HG23 ' HB3' ' A' ' 126' ' ' ALA . 1.4 mp . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 121.552 0.691 . . . . 1.5900000000000001 110.087 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -68.17 -23.25 64.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.409 -0.814 . . . . 2.48 112.52 -171.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -100.54 36.33 1.93 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.759 0.314 . . . . 3.7200000000000002 111.331 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.536 ' HB3' HG21 ' A' ' 50' ' ' ILE . 42.2 t -154.36 153.54 31.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.172 -0.467 . . . . 0.96999999999999997 111.142 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.9 140.93 50.54 Favored Pre-proline 0 C--O 1.219 -0.506 0 N-CA-C 109.087 -0.709 . . . . 1.9199999999999999 109.087 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.481 ' O ' HG21 ' A' ' 59' ' ' VAL . 5.1 Cg_exo -39.22 -39.54 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.537 3.491 . . . . 0.95999999999999996 115.992 -167.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.53 -55.09 6.78 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.484 1.135 . . . . 2.71 110.068 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.58 -15.11 60.4 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.048 -0.978 . . . . 1.6299999999999999 109.655 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -60.73 -43.09 98.34 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.464 -0.789 . . . . 2.1200000000000001 109.294 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 55' ' ' PRO . 58.3 t -58.52 -40.86 80.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.154 -0.476 . . . . 1.9099999999999999 109.848 174.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.875 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 23.6 tp -68.87 -22.78 64.18 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.583 -0.447 . . . . 1.77 111.573 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.441 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 9.1 m-30 -101.06 1.93 39.91 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.278 0.561 . . . . 1.3799999999999999 109.667 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.564 ' O ' HG11 ' A' ' 167' ' ' VAL . 11.5 tt0 -124.44 -124.55 0.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.034 -0.984 . . . . 1.97 109.301 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.728 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.7 OUTLIER 29.04 104.05 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.751 1.22 . . . . 1.54 114.143 -173.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.82 148.16 29.0 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.086 0.469 . . . . 1.96 112.027 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.606 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.1 ttm180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.533 -0.303 . . . . 4.0700000000000003 111.433 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.794 0.807 . . . . 1.78 110.574 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -111.24 138.37 47.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.911 -1.041 . . . . 2.2999999999999998 111.296 -167.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -129.57 146.37 17.19 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.661 -0.78 . . . . 1.1599999999999999 113.658 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.596 ' HB3' ' CH2' ' A' ' 12' ' ' TRP . 57.7 m-85 -103.44 136.43 43.2 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.42 -0.39 . . . . 1.6200000000000001 110.769 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -99.51 115.63 29.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.034 -0.53 . . . . 2.4700000000000002 110.937 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.836 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.3 mp -110.01 89.86 8.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.602 -0.726 . . . . 1.1899999999999999 109.358 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.661 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 21.8 Cg_exo -63.66 121.19 8.85 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 C-N-CA 121.992 1.795 . . . . 0.89000000000000001 111.727 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.896 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 64.9 mt -121.47 143.05 35.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.715 0.293 . . . . 1.1699999999999999 111.019 -174.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -127.05 -12.25 5.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.262 -0.426 . . . . 3.7000000000000002 111.443 173.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -112.03 168.15 9.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 2.1600000000000001 111.387 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -106.5 -178.37 3.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.799 -0.637 . . . . 1.2 110.6 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.36 -169.58 15.6 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.144 -0.782 . . . . 0.35999999999999999 111.144 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 5.1 mm-40 -98.87 103.28 15.22 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.083 -0.71 . . . . 1.96 109.083 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.668 ' HB2' HG12 ' A' ' 133' ' ' ILE . 2.4 m-85 -92.37 124.37 36.37 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 119.225 -0.99 . . . . 1.1399999999999999 108.8 -173.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.559 HG22 ' CA ' ' A' ' 177' ' ' ALA . 49.0 t -107.3 105.6 19.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.22 -0.9 . . . . 1.0700000000000001 109.937 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' A' ' 172' ' ' ILE . 17.0 tp -90.37 104.6 17.16 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.286 -1.325 . . . . 2.0600000000000001 109.764 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 44.8 t -114.01 104.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.841 -0.8 . . . . 1.72 108.841 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.38 135.68 46.32 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.968 -0.693 . . . . 2.0600000000000001 110.616 178.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.697 ' HD2' ' HB3' ' A' ' 128' ' ' ASP . 16.2 tptt -98.7 120.63 39.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.302 -0.408 . . . . 4.1900000000000004 110.494 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CE2' HD12 ' A' ' 115' ' ' LEU . 26.4 m-85 -107.35 142.11 37.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.911 0.386 . . . . 0.54000000000000004 111.253 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.48 ' HB2' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.424 -0.807 . . . . 1.1599999999999999 110.387 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.894 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 23.6 m . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.321 0.581 . . . . 1.8200000000000001 110.063 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.492 ' HD1' ' HA ' ' A' ' 159' ' ' LYS . 61.7 m-85 -104.12 163.53 12.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.512 -0.767 . . . . 1.1699999999999999 111.722 -173.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 24.6 m-20 -109.59 140.61 43.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.579 -0.282 . . . . 1.53 110.48 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.612 HG22 ' HD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -143.32 127.89 14.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.048 0.451 . . . . 1.3500000000000001 110.735 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.673 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -121.39 144.89 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.676 -0.693 . . . . 2.3100000000000001 112.189 -175.326 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.794 HG23 HD21 ' A' ' 153' ' ' LEU . 3.0 p -108.2 105.36 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.691 . . . . 2.0899999999999999 109.722 171.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.4 t30 57.67 44.22 21.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.882 0.848 . . . . 2.0899999999999999 109.149 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.95 -15.79 61.97 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 114.994 -1.003 . . . . 0.41999999999999998 113.017 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 94.6 m-70 -89.39 98.86 12.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.564 0.579 . . . . 0.81999999999999995 112.564 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 2.3 p -66.64 98.98 0.55 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.208 0.528 . . . . 1.3500000000000001 111.706 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.683 HG22 HG22 ' A' ' 131' ' ' ILE . 6.4 t -80.47 -47.79 20.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.636 -0.711 . . . . 1.6000000000000001 109.53 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.579 HG13 ' HG ' ' A' ' 115' ' ' LEU . 10.8 t -113.3 90.03 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.556 0.694 . . . . 1.1200000000000001 109.364 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -113.16 71.74 0.75 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 122.332 1.063 . . . . 4.4000000000000004 108.871 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.894 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.7 p30 162.66 30.2 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.186 -1.825 . . . . 1.96 107.218 -169.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.663 HD13 ' HE2' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -74.1 78.65 1.74 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.862 -1.063 . . . . 1.78 111.095 -172.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.411 ' HB2' HG11 ' A' ' 101' ' ' VAL . 10.9 t70 -101.95 103.74 14.4 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.727 -1.212 . . . . 1.9299999999999999 107.727 172.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 66.7 mt -55.0 -40.9 55.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.893 -0.594 . . . . 1.4199999999999999 111.173 -174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.563 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 2.3 t80 -64.12 -45.61 87.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.7 -0.682 . . . . 1.2 110.558 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.8 -32.86 68.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.31 -0.405 . . . . 0.95999999999999996 111.471 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.49 ' HB3' ' CE1' ' A' ' 127' ' ' HIS . 15.4 mmt180 -77.03 -50.1 13.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.276 -0.42 . . . . 2.1800000000000002 111.792 -173.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.9 p -118.79 -27.59 2.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.49 -0.484 . . . . 2.0899999999999999 112.295 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 123.6 -161.49 17.91 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.316 -1.114 . . . . 1.3999999999999999 110.316 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.4 ' C ' ' HG ' ' A' ' 124' ' ' SER . 38.6 t-80 -78.79 122.24 25.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.532 0.666 . . . . 4.9100000000000001 111.027 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.4 ' HG ' ' C ' ' A' ' 123' ' ' HIS . 78.2 p 51.77 -121.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.163 -0.926 . . . . 2.1499999999999999 112.516 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.7 p 52.32 -161.41 0.1 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.469 0.707 . . . . 1.3999999999999999 110.796 -173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.622 ' HB1' ' HE3' ' A' ' 88' ' ' LYS . . . -98.95 109.08 21.89 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.67 -0.412 . . . . 1.21 110.304 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.559 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 18.9 t60 -93.84 133.05 37.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.247 -0.649 . . . . 0.57999999999999996 109.247 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.697 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.5 p30 -133.22 135.77 45.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.132 0.492 . . . . 1.6399999999999999 111.108 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.453 ' HB2' HD21 ' A' ' 87' ' ' LEU . 17.1 mm-40 -112.25 111.78 22.9 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.211 -1.033 . . . . 1.6799999999999999 108.211 171.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.414 HG22 HG22 ' A' ' 86' ' ' VAL . 65.5 mt -96.04 113.48 30.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.934 -0.575 . . . . 1.3899999999999999 109.668 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.683 HG22 HG22 ' A' ' 111' ' ' VAL . 47.2 mt -124.0 93.47 47.01 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.36 -0.382 . . . . 1.8500000000000001 111.293 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -72.42 122.07 7.99 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.317 2.011 . . . . 0.33000000000000002 112.648 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.668 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -109.74 160.61 8.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 106.959 -1.497 . . . . 1.1000000000000001 106.959 174.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.5 p -127.29 111.99 14.55 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.036 0.446 . . . . 1.8200000000000001 110.377 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 36.9 mt -99.87 122.41 51.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.191 -0.67 . . . . 1.1399999999999999 109.191 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -149.06 135.32 19.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.87 -0.418 . . . . 2.4300000000000002 109.87 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 61.28 25.04 15.07 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.606 0.566 . . . . 3.6000000000000001 110.586 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.16 14.46 81.74 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.73 -0.668 . . . . 0.45000000000000001 112.27 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 56.5 mtpt -111.9 150.53 30.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.583 -0.525 . . . . 2.7000000000000002 109.583 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.0 tt -121.25 116.31 24.63 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.701 -0.481 . . . . 1.1100000000000001 109.701 -175.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -116.65 111.04 19.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.61 -0.515 . . . . 1.8100000000000001 109.61 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.698 HG22 HG13 ' A' ' 106' ' ' VAL . 5.5 p -100.76 113.95 38.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.175 -0.306 . . . . 1.5700000000000001 110.175 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 58.77 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.015 -0.539 . . . . 1.8799999999999999 112.02 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.19 1.98 7.76 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.945 -0.645 . . . . 1.25 112.685 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -106.14 148.49 27.79 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.488 -0.56 . . . . 1.95 109.488 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.09 133.59 60.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.247 0.546 . . . . 1.49 111.616 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m -152.94 179.06 9.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.897 -0.779 . . . . 1.75 108.897 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 7.9 t -99.36 143.05 30.06 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.847 -0.798 . . . . 1.8700000000000001 108.847 168.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.896 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 51.6 t80 -79.62 121.98 25.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.264 -0.425 . . . . 0.56999999999999995 110.46 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 p -118.46 95.59 4.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.248 0.546 . . . . 2.2400000000000002 112.295 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.54 -71.6 2.87 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.77000000000000002 114.167 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.661 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -151.5 156.75 41.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.355 0.577 . . . . 1.8 111.015 -176.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.836 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 7.0 tt -82.13 140.42 33.81 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.67 -0.863 . . . . 1.8300000000000001 108.67 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.458 ' N ' HD22 ' A' ' 153' ' ' LEU . 5.5 t -124.29 109.17 13.04 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.876 -0.73 . . . . 1.72 110.241 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.736 HG12 HD21 ' A' ' 170' ' ' LEU . 49.1 t -91.51 96.03 5.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.029 -1.1 . . . . 1.1699999999999999 108.029 174.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.573 ' HB3' ' HG3' ' A' ' 105' ' ' ARG . 4.5 tt0 -99.57 120.53 39.81 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.074 -0.966 . . . . 1.98 109.766 -175.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.663 ' HE2' HD13 ' A' ' 115' ' ' LEU . 62.1 t80 -108.36 116.38 31.86 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.332 0.587 . . . . 2.9100000000000001 109.928 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 44.6 t -106.82 112.86 41.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.241 -0.89 . . . . 1.3 110.502 -176.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.492 ' HA ' ' HD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.577 -0.738 . . . . 2.6699999999999999 110.066 172.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 62' ' ' GLN . 38.8 t . . . . . 0 C--O 1.242 0.66 0 CA-C-O 119.658 -0.21 . . . . 1.8700000000000001 110.832 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.1 t -141.74 94.47 2.68 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 120.062 -0.655 . . . . 1.9099999999999999 112.32 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.673 ' HB2' ' CB ' ' A' ' 88' ' ' LYS . . . -87.64 38.59 0.84 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.841 1.256 . . . . 1.05 113.473 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.736 HD21 HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -31.0 131.91 0.09 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.58 0.752 . . . . 1.3500000000000001 112.137 177.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 5.4 t80 -144.97 115.65 7.71 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.242 -0.286 . . . . 0.60999999999999999 110.449 171.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 75' ' ' ILE . 7.0 tt -113.89 125.72 71.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 122.268 1.032 . . . . 1.1000000000000001 111.007 172.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 9.7 ptm -117.58 163.55 16.27 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.58 -1.191 . . . . 1.1399999999999999 109.099 176.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.692 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -120.74 149.62 42.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.131 0.967 . . . . 1.74 112.635 -174.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.15 -29.63 12.03 Favored Glycine 0 C--N 1.306 -1.099 0 CA-C-N 114.105 -1.407 . . . . 0.31 114.34 162.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.494 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.0 OUTLIER -176.31 160.06 2.09 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.253 1.027 . . . . 1.3 112.115 179.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.559 ' CA ' HG22 ' A' ' 84' ' ' VAL . . . -85.48 -9.64 57.18 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.496 -0.775 . . . . 1.3500000000000001 110.048 168.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.494 ' H ' ' HB ' ' A' ' 176' ' ' THR . 2.4 m-20 . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.901 -0.59 . . . . 2.1600000000000001 111.618 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.573 ' HG ' HD11 ' A' ' 27' ' ' ILE . 27.2 tp . . . . . 0 N--CA 1.45 -0.454 0 CA-C-O 121.113 0.482 . . . . 1.2 109.975 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.434 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . . . -66.5 -24.91 66.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.487 -0.779 . . . . 1.1699999999999999 111.288 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -75.33 -32.79 61.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.008 -0.542 . . . . 2.1800000000000002 110.606 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.679 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 30.6 mmtp -93.4 -28.82 15.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.09 -0.504 . . . . 2.2599999999999998 111.853 -171.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 9.6 p -57.63 119.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.627 0.727 . . . . 1.1100000000000001 111.901 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.2 pt -101.82 -24.62 4.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.784 -0.644 . . . . 1.51 110.181 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.786 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 35.5 t90 -159.24 135.25 8.85 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.53 -0.759 . . . . 0.42999999999999999 109.449 -172.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.76 131.34 10.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.722 0.296 . . . . 1.0700000000000001 110.76 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.48 ' HB ' ' CH2' ' A' ' 12' ' ' TRP . 4.1 t -140.33 125.16 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.514 0.673 . . . . 1.45 111.598 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.548 ' HB2' HD23 ' A' ' 60' ' ' LEU . 3.2 t-20 -97.49 90.48 5.06 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.751 -1.203 . . . . 1.6100000000000001 107.751 167.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.55 ' C ' ' HB2' ' A' ' 65' ' ' ARG . . . -62.38 102.2 0.29 Allowed 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.584 -0.734 . . . . 1.1599999999999999 109.446 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 150.56 -20.12 1.03 Allowed Glycine 0 N--CA 1.442 -0.938 0 O-C-N 125.398 1.686 . . . . 0.76000000000000001 112.333 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.64 -166.08 10.72 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.036 -1.078 . . . . 0.82999999999999996 112.924 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 31.7 tt0 -120.78 118.2 29.4 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.814 0.302 . . . . 1.8400000000000001 111.814 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.747 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 18.4 m 36.31 109.27 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 115.639 1.718 . . . . 1.75 115.639 166.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.841 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 71.4 t60 -147.02 143.42 28.39 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 121.668 -0.645 . . . . 0.52000000000000002 110.958 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.6 t -104.21 117.48 49.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.33 -0.85 . . . . 1.6100000000000001 109.934 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.763 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -70.98 148.63 47.47 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.236 -0.653 . . . . 0.77000000000000002 109.236 174.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.32 -17.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 114.219 1.192 . . . . 1.29 114.219 -173.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.52 ' HB2' HD21 ' A' ' 6' ' ' LEU . 63.9 m-70 -87.74 -11.52 47.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.255 -0.646 . . . . 1.02 109.255 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 7' ' ' ALA . . . 108.64 33.89 2.77 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.053 -0.976 . . . . 0.37 113.246 175.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.573 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.5 mm -103.32 105.53 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.043 -0.663 . . . . 1.0900000000000001 110.355 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -90.41 105.75 18.03 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.024 -0.534 . . . . 1.1200000000000001 110.604 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.841 ' CE2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -83.7 138.77 33.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.686 -0.688 . . . . 1.9199999999999999 109.269 175.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -95.23 149.29 21.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.861 0.362 . . . . 3.4399999999999999 110.557 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 76.6 tttt -43.24 143.38 0.85 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.802 -1.09 . . . . 3.23 112.28 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.568 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 13.3 p-10 -45.8 106.09 0.53 Allowed Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 124.763 1.29 . . . . 2.4100000000000001 113.387 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 N--CA 1.455 -0.774 0 C-N-CA 123.967 3.111 . . . . 1.8700000000000001 113.717 174.845 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.671 ' CG2' ' HB3' ' A' ' 126' ' ' ALA . 1.4 mp . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 121.649 0.738 . . . . 1.5900000000000001 110.335 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.53 ' HB2' HG21 ' A' ' 125' ' ' THR . 2.7 mm? -74.8 -2.83 28.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.389 -0.823 . . . . 2.48 112.744 -171.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.569 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 7.5 mmm180 -112.67 23.33 13.62 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.845 -0.342 . . . . 3.7200000000000002 111.166 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.7 t -142.81 157.55 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.371 0.605 . . . . 0.96999999999999997 112.346 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 22.6 t30 -63.75 129.25 93.66 Favored Pre-proline 0 C--O 1.213 -0.858 0 CA-C-N 114.983 -1.008 . . . . 1.9199999999999999 109.258 172.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.522 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 3.2 Cg_exo -40.19 -44.75 4.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.192 3.261 . . . . 0.95999999999999996 115.058 -170.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -64.31 -51.82 61.55 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 123.149 1.452 . . . . 2.71 109.407 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.763 ' OD1' ' HA ' ' A' ' 23' ' ' ASP . 31.6 m-20 -82.26 -6.87 59.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.231 -1.804 . . . . 1.6299999999999999 109.645 -174.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.522 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 22.4 tt0 -67.41 -41.37 85.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 2.1200000000000001 108.354 169.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.03 -50.4 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.311 -0.859 . . . . 1.9099999999999999 109.064 170.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.751 ' HG ' ' HD2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -55.9 -34.41 65.52 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.484 -0.78 . . . . 1.77 110.39 178.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' HA ' ' CB ' ' A' ' 169' ' ' ALA . 10.9 m-30 -94.58 1.51 55.64 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.952 -0.567 . . . . 1.3799999999999999 111.263 -174.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.688 ' HA ' HG21 ' A' ' 167' ' ' VAL . 2.1 tt0 -128.32 -110.05 0.28 Allowed 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 116.567 -0.288 . . . . 1.97 111.413 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.695 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 29.58 108.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.38 1.472 . . . . 1.54 114.584 -172.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.682 ' HB3' HG12 ' A' ' 167' ' ' VAL . 8.1 pt-20 -80.63 136.53 36.24 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.031 0.752 . . . . 1.96 113.031 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.568 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.265 0 CA-C-N 116.011 -0.54 . . . . 4.0700000000000003 110.034 170.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 C--O 1.234 0.269 0 CA-C-O 121.237 0.541 . . . . 1.78 110.741 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.635 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 1.5 p90 -126.77 137.41 53.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.836 -0.431 . . . . 2.2999999999999998 109.836 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.08 -153.07 7.93 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.618 -0.801 . . . . 1.1599999999999999 112.873 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -143.96 168.16 20.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.196 0.522 . . . . 1.6200000000000001 111.589 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.435 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.6 m-20 -122.75 125.14 44.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.305 -0.861 . . . . 2.4700000000000002 109.129 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.0 mp -104.69 95.96 9.66 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.439 -0.578 . . . . 1.1899999999999999 109.439 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 32.0 Cg_exo -57.04 120.82 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.936 1.757 . . . . 0.89000000000000001 112.013 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.78 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 66.3 mt -126.67 133.03 69.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.436 -0.347 . . . . 1.1699999999999999 110.393 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -132.77 16.07 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.345 -0.389 . . . . 3.7000000000000002 110.825 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -135.43 174.29 10.77 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.725 -0.39 . . . . 2.1600000000000001 110.447 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.545 ' HG2' HG21 ' A' ' 135' ' ' ILE . 10.9 mt-10 -122.61 163.44 20.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.118 -0.492 . . . . 1.2 110.718 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.98 -173.99 21.89 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.644 -0.982 . . . . 0.35999999999999999 110.644 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -92.4 104.74 17.04 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 117.878 0.839 . . . . 1.96 109.267 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.661 ' HB2' HG12 ' A' ' 133' ' ' ILE . 92.9 m-85 -92.59 123.4 35.86 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.491 -0.929 . . . . 1.1399999999999999 108.491 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.496 HG23 ' CA ' ' A' ' 177' ' ' ALA . 88.8 t -116.14 106.65 20.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.633 -0.712 . . . . 1.0700000000000001 110.268 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.516 ' HG ' ' HB ' ' A' ' 172' ' ' ILE . 5.7 mp -86.77 104.69 16.38 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.955 -1.021 . . . . 2.0600000000000001 109.302 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 130' ' ' ILE . 53.3 t -102.87 102.64 13.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.694 -1.224 . . . . 1.72 107.694 172.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.598 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -113.26 133.33 55.15 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.55 -0.46 . . . . 2.0600000000000001 110.513 -176.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 5.3 mptp? -91.74 124.68 36.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.278 0.561 . . . . 4.1900000000000004 110.097 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CD2' HD11 ' A' ' 115' ' ' LEU . 2.8 m-85 -108.95 141.78 40.54 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.486 -0.779 . . . . 0.54000000000000004 110.121 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.588 ' HB3' ' CG2' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.313 -0.995 0 CA-C-N 115.736 -0.665 . . . . 1.1599999999999999 109.901 174.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.839 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 13.3 m . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 121.602 0.715 . . . . 1.8200000000000001 110.273 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.597 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 22.5 m-85 -90.41 156.96 17.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.133 -0.94 . . . . 1.1699999999999999 111.469 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 6.7 t70 -107.57 136.33 47.51 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.507 -0.553 . . . . 1.53 109.507 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.68 122.41 23.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 1.3500000000000001 111.042 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.2 mtt180 -124.7 140.29 53.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.154 -0.93 . . . . 2.3100000000000001 111.258 -174.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.596 HG22 HD12 ' A' ' 153' ' ' LEU . 7.7 p -117.59 104.93 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 2.0899999999999999 109.611 173.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.918 ' HB2' HD11 ' A' ' 153' ' ' LEU . 28.4 t-20 61.3 41.54 13.02 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.52 1.152 . . . . 2.0899999999999999 108.193 -171.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.62 -21.29 26.78 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.747 -1.115 . . . . 0.41999999999999998 112.698 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 78.1 m-70 -74.08 105.35 5.26 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 122.631 0.373 . . . . 0.81999999999999995 111.717 -174.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.548 ' CG2' ' HG2' ' A' ' 105' ' ' ARG . 2.4 p -70.2 92.64 0.78 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.041 0.448 . . . . 1.3500000000000001 111.511 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.415 HG23 HG12 ' A' ' 106' ' ' VAL . 21.4 t -76.62 -41.76 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.917 -0.583 . . . . 1.6000000000000001 109.804 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.418 HG13 ' HG ' ' A' ' 115' ' ' LEU . 11.1 t -132.55 90.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.098 -0.501 . . . . 1.1200000000000001 110.148 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -105.08 72.49 1.0 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.655 0.741 . . . . 4.4000000000000004 109.777 175.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.839 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 7.8 p-10 161.24 32.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.587 -1.642 . . . . 1.96 108.226 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -69.65 85.43 0.46 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.91 -1.041 . . . . 1.78 111.093 -174.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.57 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 19.3 p-10 -98.0 88.69 4.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.574 -0.739 . . . . 1.9299999999999999 109.52 172.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.8 mt -59.62 -39.86 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.578 -0.737 . . . . 1.4199999999999999 111.166 -173.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.4 ' O ' ' HA2' ' A' ' 122' ' ' GLY . 84.0 t80 -52.64 -37.15 57.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 1.2 111.585 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.88 -37.21 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.896 -0.503 . . . . 0.95999999999999996 111.108 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 7.6 mmt180 -73.11 -51.91 16.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.721 -0.672 . . . . 2.1800000000000002 110.945 -170.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.93 -23.18 4.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.351 -0.386 . . . . 2.0899999999999999 111.813 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 118' ' ' PHE . . . 86.78 -83.34 1.6 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.186 -1.006 . . . . 1.3999999999999999 112.144 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -114.92 107.82 15.91 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.88 -0.328 . . . . 4.9100000000000001 111.043 -176.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.6 p 44.71 -123.73 0.98 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.775 -0.648 . . . . 2.1499999999999999 111.961 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.569 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 60.4 p 53.76 -169.27 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.859 0.863 . . . . 1.3999999999999999 112.425 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.671 ' HB3' ' CG2' ' A' ' 50' ' ' ILE . . . -100.02 129.15 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.315 0.487 . . . . 1.21 112.315 -177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.429 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 38.4 t60 -101.82 147.41 26.53 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.584 -1.265 . . . . 0.57999999999999996 107.584 169.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.594 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.5 p30 -142.78 127.65 18.29 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.145 -0.622 . . . . 1.6399999999999999 111.911 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.95 115.27 28.52 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.895 -1.048 . . . . 1.6799999999999999 108.793 172.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.405 HG23 HG23 ' A' ' 86' ' ' VAL . 64.2 mt -101.5 106.67 19.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.229 -0.656 . . . . 1.3899999999999999 109.229 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 54.3 mt -116.84 90.73 33.13 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.377 -0.374 . . . . 1.8500000000000001 110.956 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HB3' HG22 ' A' ' 84' ' ' VAL . 8.9 Cg_exo -77.43 119.69 5.0 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.568 2.179 . . . . 0.33000000000000002 112.237 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.661 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -109.68 144.59 17.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.875 -1.157 . . . . 1.1000000000000001 107.875 175.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -113.92 107.33 15.54 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 120.34 -0.544 . . . . 1.8200000000000001 110.503 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.568 HG12 ' HG ' ' A' ' 140' ' ' LEU . 33.5 mt -99.62 120.89 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.786 -0.45 . . . . 1.1399999999999999 109.786 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -149.8 137.76 20.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.563 -0.532 . . . . 2.4300000000000002 109.563 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.565 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 8.3 mptt 61.23 30.35 19.18 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.646 0.736 . . . . 3.6000000000000001 110.185 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.31 11.44 84.18 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 114.805 -1.089 . . . . 0.45000000000000001 112.607 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.733 ' HG2' HG22 ' A' ' 148' ' ' THR . 90.2 mttt -113.33 142.45 45.84 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.646 -0.326 . . . . 2.7000000000000002 110.159 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 5.8 tt -112.61 119.46 38.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.037 -0.529 . . . . 1.1100000000000001 110.096 -173.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 17.3 m -111.97 109.45 19.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.688 0.28 . . . . 1.8100000000000001 110.94 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' A' ' 140' ' ' LEU . 66.9 t -94.24 94.58 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.563 -0.903 . . . . 1.5700000000000001 108.563 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 59.27 -88.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.115 -0.948 . . . . 1.8799999999999999 111.068 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -107.23 -13.0 22.33 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.541 -0.838 . . . . 1.25 113.091 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 141' ' ' SER . 51.6 mt-10 -90.14 112.88 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.535 -0.391 . . . . 1.95 110.863 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.8 p -105.65 113.48 42.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.418 0.627 . . . . 1.49 110.378 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.3 t -147.42 137.46 23.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.689 . . . . 1.75 109.19 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.733 HG22 ' HG2' ' A' ' 139' ' ' LYS . 41.0 p -56.81 139.36 51.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.116 0.484 . . . . 1.8700000000000001 111.878 -175.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.78 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 22.8 t80 -79.91 129.09 34.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.497 -0.774 . . . . 0.56999999999999995 109.785 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 t -122.64 99.19 6.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 2.2400000000000002 111.971 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.37 -67.36 3.33 Favored Glycine 0 C--N 1.329 0.194 0 CA-C-N 115.742 -0.663 . . . . 0.77000000000000002 113.939 171.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -158.83 167.55 29.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.205 0.526 . . . . 1.8 110.08 -177.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.918 HD11 ' HB2' ' A' ' 107' ' ' ASN . 14.5 tp -81.87 144.02 31.29 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.574 -0.899 . . . . 1.8300000000000001 108.574 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.7 t -132.74 108.7 9.18 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.146 -1.022 . . . . 1.72 110.777 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 96.0 t -94.18 108.61 20.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.373 -0.376 . . . . 1.1699999999999999 110.19 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -114.46 138.41 50.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.782 -0.644 . . . . 1.98 110.121 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.647 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -129.21 128.31 43.07 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.511 0.672 . . . . 2.9100000000000001 110.705 168.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 44.5 t -106.47 144.63 15.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.423 -1.262 . . . . 1.3 111.085 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt . . . . . 0 C--O 1.233 0.217 0 CA-C-N 115.377 -0.828 . . . . 2.6699999999999999 111.794 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 62' ' ' GLN . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 N-CA-C 109.516 -0.55 . . . . 1.8700000000000001 109.516 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 38.3 t -132.53 101.61 5.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.725 0.774 . . . . 1.9099999999999999 111.84 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.752 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -88.34 36.79 0.79 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.629 1.172 . . . . 1.05 112.094 -177.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.786 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 13.6 tp -61.64 116.59 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.798 0.666 . . . . 1.3500000000000001 112.798 -170.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 173' ' ' MET . 0.1 OUTLIER -124.22 123.47 40.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.652 -0.703 . . . . 0.60999999999999999 110.25 176.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.592 ' CG2' ' HB3' ' A' ' 12' ' ' TRP . 2.7 tt -113.0 123.41 68.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 122.001 0.905 . . . . 1.1000000000000001 111.366 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.584 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 12.3 ptm -111.4 164.57 12.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.997 -1.001 . . . . 1.1399999999999999 109.914 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.679 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 19.2 ptmt -115.66 141.16 48.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.371 1.081 . . . . 1.74 112.726 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.71 -28.84 13.72 Favored Glycine 0 C--N 1.304 -1.227 0 CA-C-N 113.853 -1.521 . . . . 0.31 114.827 161.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.419 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.2 OUTLIER -169.52 153.67 5.25 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.642 1.221 . . . . 1.3 113.023 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.496 ' CA ' HG23 ' A' ' 84' ' ' VAL . . . -86.43 -9.89 55.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.057 -0.974 . . . . 1.3500000000000001 109.981 168.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.419 ' H ' ' HB ' ' A' ' 176' ' ' THR . 10.9 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.524 -0.762 . . . . 2.1600000000000001 111.528 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.855 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 34.6 tp . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 121.319 0.58 . . . . 1.2 110.789 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -55.23 -43.08 74.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.878 -1.055 . . . . 1.1699999999999999 112.533 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.73 -17.76 34.99 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.441 -0.504 . . . . 2.1800000000000002 112.256 -173.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.609 ' HB2' ' HE1' ' A' ' 173' ' ' MET . 23.1 mmtm -91.55 -16.6 26.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.163 -0.615 . . . . 2.2599999999999998 111.409 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 7' ' ' ALA . 12.3 p -55.2 128.57 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.546 0.689 . . . . 1.1100000000000001 111.197 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.605 HG22 HG21 ' A' ' 172' ' ' ILE . 0.3 OUTLIER -96.63 -31.39 3.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.345 -0.843 . . . . 1.51 109.912 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.689 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 74.8 t90 -172.95 132.62 0.53 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.321 -0.854 . . . . 0.42999999999999999 109.396 -169.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.57 137.82 18.41 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.864 -0.522 . . . . 1.0700000000000001 110.827 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.655 HG21 ' O ' ' A' ' 30' ' ' ARG . 7.3 p -148.37 138.86 16.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 122.196 0.998 . . . . 1.45 112.57 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.529 ' HB2' HD11 ' A' ' 60' ' ' LEU . 10.9 t-20 -98.35 104.12 16.12 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.403 -1.271 . . . . 1.6100000000000001 107.623 167.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.3 89.14 0.13 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.002 -1.111 . . . . 1.1599999999999999 108.002 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.861 ' HA2' ' N ' ' A' ' 65' ' ' ARG . . . 179.1 -41.24 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.56 0 O-C-N 125.059 1.474 . . . . 0.76000000000000001 112.023 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.556 ' C ' ' HH ' ' A' ' 29' ' ' TYR . . . -144.66 -157.55 7.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.18 -1.009 . . . . 0.82999999999999996 112.937 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.547 ' HB3' ' HG2' ' A' ' 31' ' ' LYS . 44.1 mt-10 -119.35 120.09 35.88 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 111.528 0.196 . . . . 1.8400000000000001 111.528 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.844 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 67.2 m 39.1 112.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.504 2.039 . . . . 1.75 116.504 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.982 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 8.4 t60 -145.94 130.07 17.48 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.252 0.549 . . . . 0.52000000000000002 111.334 171.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -87.75 115.91 28.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.043 -0.981 . . . . 1.6100000000000001 109.646 174.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -82.42 164.53 20.94 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.769 -0.456 . . . . 0.77000000000000002 109.769 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 m -62.63 -17.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 O-C-N 124.16 0.913 . . . . 1.29 111.791 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.493 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 88.3 m-70 -84.64 -1.84 56.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.3 0.571 . . . . 1.02 109.966 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.48 25.94 34.51 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.166 -0.924 . . . . 0.37 111.81 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.593 HD13 ' HG ' ' A' ' 6' ' ' LEU . 26.1 mm -103.95 113.23 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.394 0.616 . . . . 1.0900000000000001 111.145 -175.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -92.96 110.83 22.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.42 -0.809 . . . . 1.1200000000000001 110.823 -173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.982 ' CE2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -85.7 145.4 27.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.5 0.191 . . . . 1.9199999999999999 110.59 179.119 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.655 ' O ' HG21 ' A' ' 14' ' ' VAL . 66.2 mtt180 -94.97 170.19 9.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.979 -0.555 . . . . 3.4399999999999999 111.689 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 61.1 mttp -84.7 82.49 8.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.017 0.747 . . . . 3.23 113.017 -169.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 1.041 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 39.45 45.9 1.05 Allowed Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 114.737 1.384 . . . . 2.4100000000000001 114.737 167.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.609 ' CD ' HG23 ' A' ' 14' ' ' VAL . 28.0 Cg_endo . . . . . 0 N--CA 1.456 -0.699 0 C-N-CA 124.15 3.234 . . . . 1.8700000000000001 113.76 -161.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.885 HD12 ' HA ' ' A' ' 62' ' ' GLN . 1.7 mp . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.661 0.743 . . . . 1.5900000000000001 109.811 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.515 ' HB2' HG21 ' A' ' 125' ' ' THR . 3.6 mm? -65.29 -18.36 65.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.878 -1.055 . . . . 2.48 112.962 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HD3' ' HB ' ' A' ' 125' ' ' THR . 4.3 mpt_? -91.91 -9.83 41.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.481 -0.487 . . . . 3.7200000000000002 111.985 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.667 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 57.9 m -108.83 160.06 16.29 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.285 0.564 . . . . 0.96999999999999997 112.323 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.513 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -90.88 143.44 28.71 Favored Pre-proline 0 C--O 1.214 -0.798 0 CA-C-N 115.305 -0.861 . . . . 1.9199999999999999 109.26 -176.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.513 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 46.8 Cg_exo -37.48 -48.92 1.85 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.989 3.126 . . . . 0.95999999999999996 115.841 -164.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HB3' ' HE1' ' A' ' 21' ' ' HIS . 25.5 mm-40 -64.22 -54.58 31.24 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.442 1.115 . . . . 2.71 109.659 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 3.3 p30 -77.85 -15.8 58.78 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.538 -1.21 . . . . 1.6299999999999999 110.577 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.708 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 9.4 tt0 -58.12 -50.5 73.26 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.556 -0.535 . . . . 2.1200000000000001 109.556 172.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.4 t -55.25 -47.94 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.445 0.641 . . . . 1.9099999999999999 109.859 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.717 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 50.1 tp -56.78 -19.42 16.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.799 -1.091 . . . . 1.77 111.425 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.667 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 23.1 m-30 -120.51 5.34 10.63 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.072 -0.513 . . . . 1.3799999999999999 111.722 -173.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.885 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.7 OUTLIER -120.78 -38.25 2.88 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.812 -0.555 . . . . 1.97 112.453 -170.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.4 ' HB ' ' OD1' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -67.56 139.41 56.92 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.477 -0.783 . . . . 1.54 110.479 -175.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.953 ' HB3' HG12 ' A' ' 167' ' ' VAL . 0.0 OUTLIER -122.87 -4.01 8.62 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.298 1.592 . . . . 1.96 115.298 -166.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 1.041 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 2.1 mtp-105 . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 121.377 0.608 . . . . 4.0700000000000003 112.179 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 121.076 0.465 . . . . 1.78 109.808 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 71.4 m-85 -77.91 108.49 11.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.403 -0.962 . . . . 2.2999999999999998 108.403 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.11 144.63 16.5 Favored Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 115.361 -0.836 . . . . 1.1599999999999999 113.234 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.639 ' HH ' ' HG ' ' A' ' 168' ' ' CYS . 54.2 m-85 -132.42 129.26 39.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.344 -0.428 . . . . 1.6200000000000001 110.487 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.563 ' OD2' ' HE2' ' A' ' 152' ' ' LYS . 10.3 t70 -100.6 102.34 13.47 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.151 -0.685 . . . . 2.4700000000000002 109.151 177.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.624 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 6.1 mt -102.6 90.06 2.05 Favored Pre-proline 0 CA--C 1.513 -0.46 0 N-CA-C 109.158 -0.682 . . . . 1.1899999999999999 109.158 174.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 33.4 Cg_endo -66.12 116.58 4.09 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.305 1.337 . . . . 0.89000000000000001 111.751 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.844 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 43.6 mt -110.32 139.75 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.98 -0.554 . . . . 1.1699999999999999 111.113 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.29 16.29 4.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 3.7000000000000002 109.979 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 9.1 mm-40 -129.09 158.13 39.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.585 0.231 . . . . 2.1600000000000001 110.891 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG2' HG21 ' A' ' 135' ' ' ILE . 4.5 mt-10 -111.64 170.6 8.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.062 -0.517 . . . . 1.2 110.374 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.26 -162.98 24.02 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.447 -1.061 . . . . 0.35999999999999999 110.447 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -102.61 111.45 23.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.854 0.827 . . . . 1.96 109.83 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.661 ' HB2' HG12 ' A' ' 133' ' ' ILE . 73.6 m-85 -94.12 123.87 37.77 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 108.434 -0.95 . . . . 1.1399999999999999 108.434 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.59 HG22 ' CA ' ' A' ' 177' ' ' ALA . 86.1 t -113.63 106.15 20.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.646 0.736 . . . . 1.0700000000000001 110.289 -174.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.37 104.0 16.02 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.602 -1.181 . . . . 2.0600000000000001 109.127 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 130' ' ' ILE . 50.3 t -106.02 103.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.754 -1.202 . . . . 1.72 107.754 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 1.1 pt? -116.0 132.01 56.77 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.076 -0.65 . . . . 2.0600000000000001 110.18 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.638 ' HG3' ' HB3' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -86.26 120.29 27.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.116 -0.698 . . . . 4.1900000000000004 109.116 178.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -106.29 140.47 39.18 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.099 -0.955 . . . . 0.54000000000000004 110.508 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.511 ' HB3' HG23 ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.792 0 N-CA-C 109.129 -0.693 . . . . 1.1599999999999999 109.129 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.818 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.6 m . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.325 0.584 . . . . 1.8200000000000001 111.0 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -96.79 165.49 12.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.172 -0.922 . . . . 1.1699999999999999 110.727 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.62 ' OD2' ' HB ' ' A' ' 158' ' ' VAL . 0.0 OUTLIER -106.54 136.94 45.43 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.786 -0.766 . . . . 1.53 109.905 173.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 1.8 t -121.55 119.19 58.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.844 -0.616 . . . . 1.3500000000000001 109.522 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.574 ' HG2' HG22 ' A' ' 110' ' ' THR . 24.5 mtt180 -121.38 139.42 53.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.088 0.471 . . . . 2.3100000000000001 111.447 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.862 HG11 HD11 ' A' ' 153' ' ' LEU . 79.9 t -122.39 100.07 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.24 -0.891 . . . . 2.0899999999999999 109.469 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.828 ' HB2' HD23 ' A' ' 153' ' ' LEU . 29.1 t-20 63.28 43.66 6.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.46 1.124 . . . . 2.0899999999999999 108.686 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.59 -5.4 78.32 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.941 -1.027 . . . . 0.41999999999999998 112.704 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 92.9 m-70 -92.35 106.64 18.6 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 122.017 0.127 . . . . 0.81999999999999995 111.15 -174.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.574 HG22 ' HG2' ' A' ' 105' ' ' ARG . 2.9 p -70.18 88.67 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.968 0.413 . . . . 1.3500000000000001 111.362 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.53 HG22 HG11 ' A' ' 142' ' ' VAL . 37.2 t -69.01 -51.46 43.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 1.6000000000000001 109.799 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 104' ' ' VAL . 35.6 t -120.88 88.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.938 -0.574 . . . . 1.1200000000000001 110.144 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.614 ' HG2' ' HB3' ' A' ' 103' ' ' ASP . 0.2 OUTLIER -102.57 76.88 1.57 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.515 -1.291 . . . . 4.4000000000000004 107.515 173.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.818 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 9.2 p-10 166.05 26.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.99 -1.459 . . . . 1.96 109.634 -172.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.73 101.11 3.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 1.78 111.499 -172.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 27.5 p-10 -118.16 85.88 2.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.288 1.042 . . . . 1.9299999999999999 109.72 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 60.0 mt -54.21 -37.43 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.84 -1.073 . . . . 1.4199999999999999 112.167 -172.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -58.44 -38.63 77.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.691 0.282 . . . . 1.2 111.579 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.15 -33.93 72.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.329 0.585 . . . . 0.95999999999999996 110.422 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 7.4 mmt180 -74.42 -51.38 15.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.531 -0.759 . . . . 2.1800000000000002 111.117 -173.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 m -115.18 -29.51 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 113.109 0.781 . . . . 2.0899999999999999 113.109 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.1 -73.97 2.58 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.517 -0.849 . . . . 1.3999999999999999 112.003 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -77.28 151.21 35.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.251 -0.277 . . . . 4.9100000000000001 110.251 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.6 t -68.55 80.22 0.27 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.785 0.802 . . . . 2.1499999999999999 109.762 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.515 HG21 ' HB2' ' A' ' 51' ' ' LEU . 41.5 p -125.38 -137.95 0.27 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.958 -1.019 . . . . 1.3999999999999999 109.188 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.585 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . . . -102.5 116.54 32.82 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.492 -0.483 . . . . 1.21 111.427 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 48.4 t60 -112.88 106.75 15.11 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 108.704 -0.85 . . . . 0.57999999999999996 108.704 170.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.53 ' OD1' ' HG2' ' A' ' 88' ' ' LYS . 13.6 m-20 -105.03 117.12 33.2 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.319 -0.552 . . . . 1.6399999999999999 111.384 -169.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -89.09 111.97 22.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.682 -0.69 . . . . 1.6799999999999999 109.546 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.517 HG22 HG21 ' A' ' 86' ' ' VAL . 61.3 mt -103.18 110.15 28.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.411 -0.588 . . . . 1.3899999999999999 109.411 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.461 HG23 HG21 ' A' ' 106' ' ' VAL . 65.5 mt -122.69 94.41 47.56 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.283 -0.417 . . . . 1.8500000000000001 111.099 -173.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.405 ' HB3' HG21 ' A' ' 84' ' ' VAL . 3.7 Cg_exo -80.83 121.81 4.19 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.728 2.285 . . . . 0.33000000000000002 111.988 172.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.661 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.6 OUTLIER -110.58 155.62 11.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.646 -0.872 . . . . 1.1000000000000001 108.646 177.057 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.515 ' OG ' ' HB2' ' A' ' 141' ' ' SER . 2.9 p -120.22 106.94 12.4 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.694 -0.402 . . . . 1.8200000000000001 110.799 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 34.1 mt -100.66 119.6 49.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.326 -0.62 . . . . 1.1399999999999999 109.326 176.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 27.5 mmtp -151.4 136.79 17.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.705 -0.48 . . . . 2.4300000000000002 109.705 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt 65.52 22.91 11.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.68 -0.691 . . . . 3.6000000000000001 110.47 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.64 9.47 86.37 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.844 -0.693 . . . . 0.45000000000000001 112.084 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 52.8 mtpt -106.61 166.51 10.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.687 -0.486 . . . . 2.7000000000000002 109.687 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.2 tt -140.73 116.35 10.2 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.636 -0.505 . . . . 1.1100000000000001 109.636 -174.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.515 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 40.6 m -110.73 131.07 55.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.26 -0.427 . . . . 1.8100000000000001 111.041 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.53 HG11 HG22 ' A' ' 111' ' ' VAL . 74.6 t -129.37 109.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 1.5700000000000001 111.136 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 50.79 37.5 17.13 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.82 -0.627 . . . . 1.8799999999999999 112.665 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.97 -24.33 25.37 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.783 -0.723 . . . . 1.25 112.576 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -85.06 112.12 20.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.02 -0.733 . . . . 1.95 109.02 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.6 p -105.57 125.67 60.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.771 -0.65 . . . . 1.49 110.611 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.3 m -144.51 -166.65 2.44 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.926 -0.768 . . . . 1.75 108.926 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 59.8 p -98.75 148.39 23.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.001 0.429 . . . . 1.8700000000000001 110.847 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.844 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 39.6 t80 -81.41 120.95 25.63 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.736 -1.209 . . . . 0.56999999999999995 107.736 168.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 m -130.51 95.92 4.0 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.122 0.487 . . . . 2.2400000000000002 110.75 -174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.13 -82.41 1.18 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.598 -0.728 . . . . 0.77000000000000002 113.781 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.563 ' HE2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -145.04 158.69 43.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.331 0.565 . . . . 1.8 111.004 -175.187 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.862 HD11 HG11 ' A' ' 106' ' ' VAL . 1.4 tm? -80.96 118.56 22.54 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.174 -1.417 . . . . 1.8300000000000001 107.174 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.502 ' CB ' ' HZ2' ' A' ' 152' ' ' LYS . 5.3 t -114.23 107.06 15.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.951 -0.699 . . . . 1.72 110.161 -171.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.516 ' O ' ' HD1' ' A' ' 73' ' ' TYR . 38.2 t -92.62 108.02 19.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.98 -0.748 . . . . 1.1699999999999999 108.98 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 25.4 mt-10 -130.33 108.91 10.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.174 -0.466 . . . . 1.98 110.156 -177.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.581 ' CE1' ' HE1' ' A' ' 73' ' ' TYR . 2.9 p90 -104.58 115.85 31.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.722 0.772 . . . . 2.9100000000000001 110.676 174.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.62 ' HB ' ' OD2' ' A' ' 103' ' ' ASP . 59.3 t -87.63 143.43 11.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 114.347 -1.297 . . . . 1.3 111.01 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 N--CA 1.454 -0.231 0 CA-C-N 114.739 -1.119 . . . . 2.6699999999999999 111.585 -175.877 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.953 HG12 ' HB3' ' A' ' 64' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 120.859 0.361 . . . . 1.8700000000000001 110.169 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.639 ' HG ' ' HH ' ' A' ' 73' ' ' TYR . 47.7 t -125.81 135.35 51.89 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.672 0.749 . . . . 1.9099999999999999 110.313 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.579 ' HB2' ' HD1' ' A' ' 61' ' ' TYR . . . -123.05 36.76 4.57 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.615 -1.175 . . . . 1.05 109.869 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.689 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 9.9 tp -57.98 112.17 1.41 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.627 -1.17 . . . . 1.3500000000000001 112.715 -170.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.855 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -122.27 120.45 34.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.619 -0.719 . . . . 0.60999999999999999 110.243 176.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.605 HG21 HG22 ' A' ' 11' ' ' ILE . 6.9 tt -113.09 132.16 62.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.697 0.76 . . . . 1.1000000000000001 110.357 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.614 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 4.1 ppp? -127.02 164.09 22.29 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.562 -0.744 . . . . 1.1399999999999999 109.412 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.9 ptmt -112.61 142.16 45.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.565 1.174 . . . . 1.74 113.32 -173.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.504 ' O ' HG22 ' A' ' 176' ' ' THR . . . 105.37 -30.0 10.6 Favored Glycine 0 C--N 1.31 -0.865 0 CA-C-N 113.161 -1.836 . . . . 0.31 115.058 161.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 175' ' ' GLY . 0.6 OUTLIER -176.75 153.07 1.04 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.467 1.133 . . . . 1.3 113.238 -177.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.59 ' CA ' HG22 ' A' ' 84' ' ' VAL . . . -84.59 -14.61 48.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.755 -0.657 . . . . 1.3500000000000001 109.596 168.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.418 ' H ' ' HB ' ' A' ' 176' ' ' THR . 38.9 t70 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 114.937 -1.029 . . . . 2.1600000000000001 111.807 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.743 HD21 ' HB3' ' A' ' 25' ' ' HIS . 27.6 tp . . . . . 0 C--O 1.233 0.221 0 CA-C-O 121.099 0.476 . . . . 1.2 110.425 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.433 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -61.32 -25.86 67.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.368 -0.833 . . . . 1.1699999999999999 111.91 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.73 -36.72 23.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.375 -0.375 . . . . 2.1800000000000002 111.358 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.638 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -90.15 -11.04 42.35 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.542 -0.463 . . . . 2.2599999999999998 111.582 -171.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.728 HG23 ' HE1' ' A' ' 171' ' ' PHE . 14.7 p -59.31 132.8 24.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.035 -0.666 . . . . 1.1100000000000001 111.546 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.659 HG22 HG23 ' A' ' 172' ' ' ILE . 0.6 OUTLIER -107.79 -38.4 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.051 -0.522 . . . . 1.51 110.563 176.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.739 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 49.6 t90 -165.33 143.63 6.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.825 -0.625 . . . . 0.42999999999999999 109.32 -172.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.85 135.75 11.76 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.66 -0.416 . . . . 1.0700000000000001 111.347 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.0 t -137.15 106.58 4.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.686 0.755 . . . . 1.45 110.922 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 3.2 t-20 -81.25 86.55 6.21 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.265 -1.383 . . . . 1.6100000000000001 107.265 163.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.575 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . . . -66.61 103.85 1.16 Allowed 'General case' 0 C--O 1.255 1.362 0 CA-C-N 115.386 -0.824 . . . . 1.1599999999999999 109.813 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 172.93 -38.69 0.15 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 113.073 -1.876 . . . . 0.76000000000000001 112.279 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.88 -141.26 4.58 Favored Glycine 0 N--CA 1.459 0.205 0 C-N-CA 120.702 -0.761 . . . . 0.82999999999999996 112.427 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -118.17 157.63 26.58 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.589 -0.359 . . . . 1.8400000000000001 110.893 175.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.684 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 23.2 m -19.03 122.44 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.307 1.595 . . . . 1.75 115.307 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.684 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 42.9 t60 -138.16 121.67 17.27 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.218 -0.901 . . . . 0.52000000000000002 111.271 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 28' ' ' HIS . 64.1 t -85.3 123.3 39.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.077 -0.965 . . . . 1.6100000000000001 109.019 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.543 ' OD1' ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -101.7 171.26 7.65 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.525 -0.47 . . . . 0.77000000000000002 110.715 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -56.53 -22.95 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 124.708 1.255 . . . . 1.29 112.808 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.743 ' HB3' HD21 ' A' ' 6' ' ' LEU . 34.0 m-70 -77.12 -10.61 59.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.35 0.595 . . . . 1.02 109.672 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 87.76 28.21 24.54 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.135 -0.939 . . . . 0.37 110.763 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.583 ' CD1' ' HB ' ' A' ' 10' ' ' VAL . 12.6 mm -102.14 112.49 35.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.136 0.493 . . . . 1.0900000000000001 110.1 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.568 ' HB2' HG22 ' A' ' 22' ' ' VAL . 29.9 t60 -93.63 113.09 25.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.973 -0.558 . . . . 1.1200000000000001 110.076 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.684 ' CD2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -90.5 142.38 27.8 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.643 -0.503 . . . . 1.9199999999999999 109.643 175.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.429 ' H ' ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -100.78 69.29 1.35 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.012 0.745 . . . . 3.4399999999999999 113.012 -169.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.736 ' HG2' ' H ' ' A' ' 32' ' ' ASP . 14.5 ttpp 60.83 -169.34 0.16 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.477 -0.783 . . . . 3.23 111.723 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.749 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 9.4 p-10 -103.09 88.93 1.71 Allowed Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-O 121.984 0.897 . . . . 2.4100000000000001 110.106 173.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.621 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 31.7 Cg_endo . . . . . 0 N--CA 1.446 -1.279 0 C-N-CA 122.158 1.905 . . . . 1.8700000000000001 112.313 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.571 ' CG2' ' HB1' ' A' ' 126' ' ' ALA . 1.3 mp . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 121.891 0.853 . . . . 1.5900000000000001 110.462 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.542 HD11 ' H ' ' A' ' 51' ' ' LEU . 4.6 mp -68.86 -14.38 63.0 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.809 -1.087 . . . . 2.48 111.73 -172.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HB2' ' HB3' ' A' ' 126' ' ' ALA . 27.4 mmm180 -98.97 23.01 9.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.22 -0.445 . . . . 3.7200000000000002 111.423 -175.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -150.31 167.76 26.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 0.96999999999999997 112.186 -176.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.408 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 3.0 t30 -95.51 139.17 21.84 Favored Pre-proline 0 C--O 1.215 -0.744 0 CA-C-N 115.013 -0.994 . . . . 1.9199999999999999 108.83 177.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 3.7 Cg_exo -36.69 -54.7 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.512 3.475 . . . . 0.95999999999999996 116.246 -162.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -77.08 -28.71 54.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.172 0.896 . . . . 2.71 112.012 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -10.98 43.8 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 120.912 -1.117 . . . . 1.6299999999999999 109.026 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 19.7 tt0 -67.07 -46.38 74.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.722 -1.126 . . . . 2.1200000000000001 110.002 170.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.72 -39.98 86.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 109.684 -0.487 . . . . 1.9099999999999999 109.684 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.646 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 45.3 tp -60.69 -21.58 63.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.183 0.516 . . . . 1.77 111.153 173.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.573 ' CD2' ' HE3' ' A' ' 88' ' ' LYS . 8.6 m-30 -102.64 -2.21 28.75 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.937 -0.574 . . . . 1.3799999999999999 111.542 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.833 ' HA ' HG13 ' A' ' 167' ' ' VAL . 4.1 tt0 -121.67 -110.4 0.33 Allowed 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.637 -0.425 . . . . 1.97 110.147 174.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.62 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.6 OUTLIER 35.01 102.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.446 0.906 . . . . 1.54 113.446 -173.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -88.84 136.98 32.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.465 -0.334 . . . . 1.96 111.824 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.749 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 4.0700000000000003 110.469 173.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.059 0.457 . . . . 1.78 109.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.49 ' CG ' ' CE2' ' A' ' 157' ' ' PHE . 38.2 m-85 -71.24 94.82 1.21 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.945 -1.132 . . . . 2.2999999999999998 107.945 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.72 111.67 3.73 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.662 -0.78 . . . . 1.1599999999999999 112.495 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.689 ' HE1' ' CE1' ' A' ' 157' ' ' PHE . 35.0 m-85 -102.59 151.29 22.51 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.568 0.347 . . . . 1.6200000000000001 110.643 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -115.28 112.97 23.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.342 0.591 . . . . 2.4700000000000002 110.609 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.813 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.3 mp -103.55 93.42 4.97 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.611 -0.722 . . . . 1.1899999999999999 110.067 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.535 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 25.2 Cg_endo -65.8 119.33 6.34 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.683 1.588 . . . . 0.89000000000000001 112.108 -175.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.824 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 69.3 mt -117.97 132.2 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.658 -0.701 . . . . 1.1699999999999999 110.114 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.89 6.7 4.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.039 -0.528 . . . . 3.7000000000000002 111.134 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -134.92 176.66 8.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.836 0.35 . . . . 2.1600000000000001 110.625 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.552 ' HG2' HG22 ' A' ' 135' ' ' ILE . 5.5 mt-10 -122.12 159.06 27.94 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.807 -0.633 . . . . 1.2 110.108 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.97 -155.22 26.35 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.805 -0.918 . . . . 0.35999999999999999 110.805 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 47.0 mt-10 -110.92 106.48 15.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.265 0.532 . . . . 1.96 109.781 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.674 ' HB2' HG12 ' A' ' 133' ' ' ILE . 88.8 m-85 -94.76 125.4 39.39 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 119.735 -0.786 . . . . 1.1399999999999999 109.219 -176.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.649 HG21 ' CA ' ' A' ' 177' ' ' ALA . 52.8 t -108.67 106.02 19.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.165 0.983 . . . . 1.0700000000000001 110.039 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.574 HD12 HG21 ' A' ' 155' ' ' VAL . 9.1 tt -97.84 104.98 17.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.875 -1.511 . . . . 2.0600000000000001 109.141 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 129' ' ' GLU . 2.2 p -115.01 105.94 19.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 109.013 -0.736 . . . . 1.72 109.013 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -101.48 134.94 43.81 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.115 0.483 . . . . 2.0600000000000001 110.114 -177.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 1.048 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 10.9 tppt? -98.69 114.92 27.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.327 0.584 . . . . 4.1900000000000004 109.873 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.458 ' CD2' HD11 ' A' ' 115' ' ' LEU . 4.0 m-85 -106.53 146.79 30.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.455 -0.793 . . . . 0.54000000000000004 109.9 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.852 ' HB1' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 116.201 -0.454 . . . . 1.1599999999999999 110.159 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 16.7 m . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.44 0.638 . . . . 1.8200000000000001 110.466 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -114.65 168.66 9.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.335 -0.848 . . . . 1.1699999999999999 111.752 -173.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.625 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 11.3 m-20 -107.21 138.01 44.2 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 109.091 -0.707 . . . . 1.53 109.091 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 157' ' ' PHE . 7.4 t -136.3 113.33 13.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 117.699 0.227 . . . . 1.3500000000000001 111.525 -175.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.638 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 84.2 mtt180 -110.94 141.41 44.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.225 0.454 . . . . 2.3100000000000001 112.225 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.404 HG22 ' HB2' ' A' ' 109' ' ' HIS . 12.0 m -110.65 96.71 4.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.44 -0.8 . . . . 2.0899999999999999 109.662 168.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.742 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 3.7 t-20 55.05 58.52 4.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.013 -0.994 . . . . 2.0899999999999999 109.834 -172.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.25 -25.85 7.55 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.738 -1.119 . . . . 0.41999999999999998 112.895 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.404 ' HB2' HG22 ' A' ' 106' ' ' VAL . 90.1 m-70 -83.71 95.04 8.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.915 0.339 . . . . 0.81999999999999995 111.915 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -68.69 92.71 0.48 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.196 0.522 . . . . 1.3500000000000001 111.063 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 112' ' ' VAL . 6.5 m -74.6 -37.58 43.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.978 -0.556 . . . . 1.6000000000000001 110.904 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.582 HG23 HG22 ' A' ' 111' ' ' VAL . 5.6 t -120.88 89.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.986 0.422 . . . . 1.1200000000000001 109.963 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 11.6 tmtt? -106.98 73.9 0.96 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.733 -1.21 . . . . 4.4000000000000004 107.733 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 7.2 p-10 161.16 28.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.441 -1.709 . . . . 1.96 108.807 -172.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -71.09 80.4 0.68 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.074 -0.512 . . . . 1.78 111.76 -170.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -90.48 99.4 12.43 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.051 -1.092 . . . . 1.9299999999999999 108.051 169.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.0 mt -63.64 -36.33 76.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.092 -0.504 . . . . 1.4199999999999999 111.494 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -67.13 -34.94 78.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.056 0.455 . . . . 1.2 110.343 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -67.51 -37.9 83.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.001 0.429 . . . . 0.95999999999999996 111.405 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 120' ' ' ARG . 14.1 mmt85 -77.15 -46.76 22.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.307 0.484 . . . . 2.1800000000000002 112.307 -169.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.682 HG13 ' HD1' ' A' ' 127' ' ' HIS . 4.6 m -113.54 -17.02 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.484 0.549 . . . . 2.0899999999999999 112.484 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.86 -146.66 16.71 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.261 -0.971 . . . . 1.3999999999999999 111.723 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -80.24 116.1 20.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.676 0.274 . . . . 4.9100000000000001 111.385 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.5 t 64.55 -146.74 0.27 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.792 -0.64 . . . . 2.1499999999999999 110.693 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 42.6 p 63.06 178.87 0.15 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.48 1.112 . . . . 1.3999999999999999 111.724 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.675 ' HB2' ' HD2' ' A' ' 88' ' ' LYS . . . -94.23 128.27 40.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.356 -0.384 . . . . 1.21 111.315 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.682 ' HD1' HG13 ' A' ' 121' ' ' VAL . 66.9 t60 -101.65 146.78 27.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.139 -0.689 . . . . 0.57999999999999996 109.139 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 1.1 p30 -143.91 137.62 27.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.301 0.572 . . . . 1.6399999999999999 111.305 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 81.6 mm-40 -110.03 114.63 28.31 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.267 -1.012 . . . . 1.6799999999999999 108.267 172.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.13 107.61 20.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.672 -0.492 . . . . 1.3899999999999999 109.672 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.4 mm -116.47 101.06 53.81 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.394 -0.367 . . . . 1.8500000000000001 111.017 -173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.6 121.56 3.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.815 2.343 . . . . 0.33000000000000002 111.616 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.2 pt -110.58 158.63 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.363 -0.606 . . . . 1.1000000000000001 109.363 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.7 p -124.67 107.09 10.63 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.014 0.435 . . . . 1.8200000000000001 110.773 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 35.0 mt -103.8 124.11 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.262 -0.426 . . . . 1.1399999999999999 110.138 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 53.0 mmtt -151.46 138.49 19.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.646 0.592 . . . . 2.4300000000000002 110.331 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt 62.42 31.62 17.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.45 0.643 . . . . 3.6000000000000001 110.507 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.09 22.01 77.15 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.015 -0.993 . . . . 0.45000000000000001 111.923 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.622 ' HG2' HG21 ' A' ' 148' ' ' THR . 58.1 mtpt -118.71 137.58 53.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.014 -0.365 . . . . 2.7000000000000002 110.014 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 7.1 tt -113.91 116.32 29.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.178 -0.464 . . . . 1.1100000000000001 109.777 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.6 t -111.26 132.95 53.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.407 -0.36 . . . . 1.8100000000000001 110.375 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 88.7 t -125.66 103.97 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.298 -0.41 . . . . 1.5700000000000001 110.246 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 57.41 -91.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.68 0.612 . . . . 1.8799999999999999 112.005 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -113.7 14.47 22.23 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.866 -0.683 . . . . 1.25 112.905 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -129.27 116.38 19.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.861 0.331 . . . . 1.95 111.201 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.21 129.85 57.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.071 0.462 . . . . 1.49 109.961 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m -144.03 -177.63 5.54 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.574 -0.528 . . . . 1.75 109.574 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.622 HG21 ' HG2' ' A' ' 139' ' ' LYS . 39.0 p -98.07 138.98 34.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.745 0.307 . . . . 1.8700000000000001 110.284 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.824 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 58.6 t80 -79.57 135.44 36.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.996 -0.547 . . . . 0.56999999999999995 109.966 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.7 t -132.17 102.31 5.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.526 0.679 . . . . 2.2400000000000002 111.949 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.31 -68.46 2.91 Favored Glycine 0 CA--C 1.508 -0.344 0 CA-C-N 115.421 -0.809 . . . . 0.77000000000000002 113.678 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -158.63 167.01 30.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.864 0.364 . . . . 1.8 110.452 -177.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.813 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 6.0 tt -80.92 127.55 32.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.539 -0.911 . . . . 1.8300000000000001 108.539 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.742 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 5.7 p -112.45 102.9 10.98 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.346 -0.542 . . . . 1.72 112.333 -172.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.574 HG21 HD12 ' A' ' 85' ' ' LEU . 97.1 t -91.72 109.35 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.783 -0.451 . . . . 1.1699999999999999 109.783 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.563 ' HB2' ' HD2' ' A' ' 105' ' ' ARG . 39.9 mt-10 -120.3 112.05 18.55 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.533 -0.758 . . . . 1.98 109.609 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.689 ' CE1' ' HE1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -99.71 114.47 27.59 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 118.569 -1.253 . . . . 2.9100000000000001 110.344 166.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 20.8 t -83.77 144.69 9.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 113.758 -1.565 . . . . 1.3 110.828 -169.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? . . . . . 0 C--O 1.234 0.256 0 CA-C-N 115.064 -0.971 . . . . 2.6699999999999999 112.03 -172.002 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.852 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 2.4 t . . . . . 0 C--O 1.238 0.475 0 CA-C-O 119.727 -0.178 . . . . 1.8700000000000001 110.699 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -129.95 74.42 1.59 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 119.623 -0.831 . . . . 1.9099999999999999 113.133 -172.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 1.048 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -80.12 36.08 0.34 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.708 1.203 . . . . 1.05 113.576 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.739 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 18.9 tp -53.76 117.37 3.11 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.688 0.625 . . . . 1.3500000000000001 112.688 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.728 ' HE1' HG23 ' A' ' 10' ' ' VAL . 8.4 t80 -123.89 127.79 48.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.963 0.505 . . . . 0.60999999999999999 110.555 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 11' ' ' ILE . 8.7 tt -119.13 131.65 71.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 121.811 0.815 . . . . 1.1000000000000001 111.05 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 9.4 ptm -121.33 159.93 25.05 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.846 -0.616 . . . . 1.1399999999999999 109.534 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 16.2 ptmt -113.18 149.98 32.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.424 1.107 . . . . 1.74 113.063 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 176' ' ' THR . . . 103.58 -32.47 7.53 Favored Glycine 0 C--N 1.309 -0.917 0 CA-C-N 113.231 -1.804 . . . . 0.31 114.337 161.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.608 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.2 OUTLIER -177.49 162.22 1.82 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.052 0.926 . . . . 1.3 112.511 176.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.649 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -85.49 -10.36 56.18 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.22 -0.9 . . . . 1.3500000000000001 109.891 168.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.608 ' H ' ' HB ' ' A' ' 176' ' ' THR . 22.2 m-20 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.416 -0.811 . . . . 2.1600000000000001 111.616 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.584 ' HG ' HD11 ' A' ' 27' ' ' ILE . 47.6 tp . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 121.159 0.504 . . . . 1.2 110.111 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -61.23 -22.87 65.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.204 -0.907 . . . . 1.1699999999999999 111.781 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -82.46 -34.3 28.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.41 -0.359 . . . . 2.1800000000000002 111.373 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.546 ' HB2' ' HE1' ' A' ' 173' ' ' MET . 57.8 mmtt -93.54 -15.39 25.52 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.59 -0.444 . . . . 2.2599999999999998 112.02 -171.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.73 HG23 ' HE1' ' A' ' 171' ' ' PHE . 7.1 p -54.02 132.53 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.027 0.441 . . . . 1.1100000000000001 111.775 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 pt -115.78 -32.28 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.226 -0.443 . . . . 1.51 110.705 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.724 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 42.0 t90 -159.63 133.0 7.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.046 -0.724 . . . . 0.42999999999999999 109.046 -172.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.84 131.45 13.09 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.848 -0.341 . . . . 1.0700000000000001 111.059 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.836 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 52.3 t -140.42 120.59 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.66 0.743 . . . . 1.45 111.357 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 51.4 t30 -98.15 101.63 13.15 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.109 -1.071 . . . . 1.6100000000000001 108.109 167.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.401 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -60.36 95.7 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 116.051 -0.522 . . . . 1.1599999999999999 110.036 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 175.94 -90.17 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 O-C-N 124.812 1.32 . . . . 0.76000000000000001 113.068 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.37 -130.11 0.26 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.562 -0.352 . . . . 0.82999999999999996 113.751 -172.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HG3' ' HD3' ' A' ' 31' ' ' LYS . 31.6 tt0 -144.95 119.44 9.68 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.572 -0.369 . . . . 1.8400000000000001 111.528 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.71 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 50.0 m 31.45 99.0 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.726 1.38 . . . . 1.75 114.726 172.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.869 ' HD2' ' HB2' ' A' ' 60' ' ' LEU . 76.2 t60 -135.33 134.97 40.4 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.786 -0.572 . . . . 0.52000000000000002 111.855 -177.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.409 ' CG2' ' HD1' ' A' ' 28' ' ' HIS . 83.7 t -88.45 115.48 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.46 -0.791 . . . . 1.6100000000000001 110.225 175.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.47 159.47 33.91 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.442 -0.577 . . . . 0.77000000000000002 109.442 176.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 57' ' ' ASP . 28.8 m -66.2 -6.96 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.999 0.74 . . . . 1.29 112.999 -171.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -99.0 7.35 46.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.856 -0.794 . . . . 1.02 108.856 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 87.3 30.8 18.44 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.877 -1.056 . . . . 0.37 112.706 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.584 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.7 mm -104.45 106.27 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 1.0900000000000001 111.34 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.409 ' HD1' ' CG2' ' A' ' 22' ' ' VAL . 30.3 t60 -86.33 109.43 18.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.289 0.566 . . . . 1.1200000000000001 111.459 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.836 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -77.12 138.82 39.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.498 -0.774 . . . . 1.9199999999999999 109.994 172.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -99.5 116.2 31.1 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.016 0.436 . . . . 3.4399999999999999 110.677 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.535 ' HG2' ' N ' ' A' ' 32' ' ' ASP . 8.9 ttpp -34.25 146.98 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.914 1.286 . . . . 3.23 114.371 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.535 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 7.7 p-10 -24.21 92.72 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 125.961 1.705 . . . . 2.4100000000000001 114.639 -173.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.451 -1.015 0 C-N-CA 123.879 3.053 . . . . 1.8700000000000001 113.507 176.138 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.548 HD12 ' HG3' ' A' ' 62' ' ' GLN . 1.5 mp . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 121.294 0.569 . . . . 1.5900000000000001 110.389 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.89 -17.54 62.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 2.48 111.595 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.521 ' HD3' ' HB ' ' A' ' 125' ' ' THR . 10.6 mpt_? -97.48 25.7 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.245 0.461 . . . . 3.7200000000000002 112.245 -175.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -153.46 165.87 34.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 0.96999999999999997 111.373 177.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 1.3 t30 -89.25 140.64 28.75 Favored Pre-proline 0 C--O 1.217 -0.655 0 CA-C-N 115.469 -0.787 . . . . 1.9199999999999999 109.901 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 38.2 Cg_exo -37.78 -53.04 1.59 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 124.681 3.587 . . . . 0.95999999999999996 117.339 -161.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -73.07 -45.97 54.27 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 119.419 1.008 . . . . 2.71 110.708 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.401 ' HB3' HG13 ' A' ' 24' ' ' VAL . 2.7 p30 -77.37 -20.8 54.24 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.004 -0.544 . . . . 1.6299999999999999 109.563 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.475 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 24.5 tt0 -54.19 -48.07 71.38 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.563 -0.744 . . . . 2.1200000000000001 109.378 169.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.79 -37.9 42.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.987 -0.551 . . . . 1.9099999999999999 110.576 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.869 ' HB2' ' HD2' ' A' ' 21' ' ' HIS . 0.4 OUTLIER -74.92 -10.53 59.57 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.932 0.396 . . . . 1.77 111.758 178.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.541 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . 62.2 m-85 -115.78 12.66 15.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.276 1.036 . . . . 1.3799999999999999 108.756 175.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.548 ' HG3' HD12 ' A' ' 50' ' ' ILE . 8.3 tt0 -126.88 -130.6 0.23 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.401 -1.727 . . . . 1.97 108.716 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.653 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 40.7 p 39.03 106.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.956 1.465 . . . . 1.54 114.956 -176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.926 ' HB3' HG12 ' A' ' 167' ' ' VAL . 12.5 pt-20 -97.27 151.83 19.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.991 -1.114 . . . . 1.96 107.991 168.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.633 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 22.8 ptt180 . . . . . 0 C--N 1.328 -0.364 0 N-CA-C 112.353 0.501 . . . . 4.0700000000000003 112.353 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.465 0.281 0 N-CA-C 109.308 -0.626 . . . . 1.78 109.308 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.829 ' HB2' ' HD1' ' A' ' 157' ' ' PHE . 15.3 m-85 -66.63 104.99 1.41 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.74 -0.664 . . . . 2.2999999999999998 109.484 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.43 95.04 0.86 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 119.75 -1.214 . . . . 1.1599999999999999 114.193 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.62 ' HH ' HH22 ' A' ' 65' ' ' ARG . 51.6 m-85 -84.4 148.33 26.66 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.305 -0.447 . . . . 1.6200000000000001 110.77 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -127.68 127.02 43.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.742 0.782 . . . . 2.4700000000000002 109.934 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.87 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.0 mp -110.6 92.46 14.21 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 114.664 -1.153 . . . . 1.1899999999999999 109.028 -176.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.56 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 34.5 Cg_exo -57.71 117.12 3.76 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.085 1.857 . . . . 0.89000000000000001 111.609 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.761 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 56.4 mt -115.6 130.43 70.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.165 0.507 . . . . 1.1699999999999999 111.634 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.52 -24.59 9.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.848 -0.615 . . . . 3.7000000000000002 110.789 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.725 ' HB2' ' HH ' ' A' ' 83' ' ' TYR . 7.4 mm-40 -99.06 176.06 5.7 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.864 0.364 . . . . 2.1600000000000001 110.575 -168.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 136' ' ' LYS . 2.3 tt0 -126.59 160.71 29.88 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.83 -0.623 . . . . 1.2 109.817 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.583 ' N ' ' HG2' ' A' ' 80' ' ' GLU . . . 139.45 -163.84 26.03 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 115.576 -0.738 . . . . 0.35999999999999999 111.534 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 27.4 mt-10 -98.75 109.77 22.47 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 120.373 -0.531 . . . . 1.96 109.857 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.725 ' HH ' ' HB2' ' A' ' 79' ' ' GLU . 74.8 m-85 -94.34 124.66 38.5 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.583 -0.895 . . . . 1.1399999999999999 108.583 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.663 HG21 ' HA ' ' A' ' 177' ' ' ALA . 52.9 t -104.74 106.13 19.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-O 121.909 0.862 . . . . 1.0700000000000001 109.902 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.735 HD12 HD11 ' A' ' 170' ' ' LEU . 10.9 tp -89.66 103.32 15.98 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.2 -1.364 . . . . 2.0600000000000001 109.291 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.13 107.72 23.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.64 0.734 . . . . 1.72 109.364 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 1.3 pp -113.23 140.73 47.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.601 -0.727 . . . . 2.0600000000000001 111.035 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.799 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 12.8 mptt -99.55 134.24 42.71 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.374 -0.53 . . . . 4.1900000000000004 110.203 173.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.527 ' CE2' HD12 ' A' ' 87' ' ' LEU . 11.3 m-85 -117.17 138.01 51.96 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.696 -0.684 . . . . 0.54000000000000004 110.372 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.516 ' HB3' ' CG2' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.977 0 C-N-CA 120.78 -0.368 . . . . 1.1599999999999999 111.252 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.646 0 CA-C-O 121.26 0.552 . . . . 1.8200000000000001 110.809 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.642 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 33.9 m-85 -77.36 158.19 30.24 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.532 -0.758 . . . . 1.1699999999999999 109.804 176.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.729 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 50.9 m-20 -112.23 135.15 53.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.439 -0.949 . . . . 1.53 108.439 172.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.881 HG22 ' HD2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -125.79 119.81 55.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.164 0.506 . . . . 1.3500000000000001 109.95 -177.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.704 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 79.6 mtt180 -116.83 141.87 47.66 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.017 -0.992 . . . . 2.3100000000000001 111.456 -171.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.653 HG11 HD13 ' A' ' 153' ' ' LEU . 41.8 t -116.5 102.25 13.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.663 -0.699 . . . . 2.0899999999999999 109.153 174.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.876 ' HB2' HD12 ' A' ' 153' ' ' LEU . 23.3 t-20 57.26 46.45 18.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.227 1.013 . . . . 2.0899999999999999 108.421 -170.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.79 -21.97 30.64 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.945 -1.025 . . . . 0.41999999999999998 113.315 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 93.0 m-70 -78.12 108.57 11.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.268 0.47 . . . . 0.81999999999999995 112.268 -173.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.496 ' CG2' ' HG2' ' A' ' 105' ' ' ARG . 5.9 p -69.35 87.81 0.45 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.779 0.323 . . . . 1.3500000000000001 111.029 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.6 t -67.78 -55.55 16.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.154 -0.684 . . . . 1.6000000000000001 109.154 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.573 HG23 ' HG2' ' A' ' 129' ' ' GLU . 17.3 t -112.53 90.52 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.874 -0.603 . . . . 1.1200000000000001 109.72 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -107.9 73.25 0.89 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.757 0.789 . . . . 4.4000000000000004 109.781 177.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 9.2 p-10 164.94 32.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.063 -1.426 . . . . 1.96 108.536 -172.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -78.11 71.08 4.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.217 -0.901 . . . . 1.78 112.042 -170.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.513 ' HB2' ' HB3' ' A' ' 119' ' ' ASP . 31.0 m-20 -77.16 93.57 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.937 -1.134 . . . . 1.9299999999999999 107.937 167.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.7 mt -54.01 -39.78 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.996 0.427 . . . . 1.4199999999999999 110.211 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 56.7 t80 -64.71 -39.53 93.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.417 -0.81 . . . . 1.2 110.987 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 12.1 t70 -71.98 -36.41 69.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.987 0.422 . . . . 0.95999999999999996 111.431 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -77.9 -49.56 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 2.1800000000000002 111.807 -171.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.676 HG11 ' HD1' ' A' ' 127' ' ' HIS . 15.9 m -110.5 -24.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.379 -0.529 . . . . 2.0899999999999999 112.284 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 112.81 -142.86 17.54 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.423 -0.894 . . . . 1.3999999999999999 111.961 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -89.14 110.29 21.04 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.173 -0.306 . . . . 4.9100000000000001 110.173 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.4 t 68.15 -150.71 0.16 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.621 -0.718 . . . . 2.1499999999999999 110.909 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.521 ' HB ' ' HD3' ' A' ' 52' ' ' ARG . 20.8 p 66.57 177.85 0.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.531 1.132 . . . . 1.3999999999999999 111.176 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.492 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -91.94 119.1 31.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.826 0.346 . . . . 1.21 111.574 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.676 ' HD1' HG11 ' A' ' 121' ' ' VAL . 84.0 t60 -89.37 130.04 35.8 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.714 -0.847 . . . . 0.57999999999999996 108.714 172.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -121.58 113.26 19.53 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.494 -0.321 . . . . 1.6399999999999999 110.912 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.573 ' HG2' HG23 ' A' ' 112' ' ' VAL . 2.6 tp10 -116.53 113.62 23.02 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.696 -0.483 . . . . 1.6799999999999999 109.696 177.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.4 mt -98.75 119.83 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.232 -0.44 . . . . 1.3899999999999999 109.828 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.538 HG21 HG21 ' A' ' 106' ' ' VAL . 58.2 mt -125.23 89.58 52.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.233 -0.44 . . . . 1.8500000000000001 110.63 -173.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -75.83 126.61 9.55 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.61 2.207 . . . . 0.33000000000000002 112.019 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.648 HG12 ' HB2' ' A' ' 83' ' ' TYR . 6.0 pt -110.38 157.16 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.043 -0.725 . . . . 1.1000000000000001 109.043 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 t -123.93 106.67 10.61 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.808 -0.442 . . . . 1.8200000000000001 109.808 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.735 HG12 ' HG ' ' A' ' 140' ' ' LEU . 5.2 mt -104.73 137.14 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 109.021 -0.733 . . . . 1.1399999999999999 109.021 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 53.1 mttm -152.77 131.13 12.08 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 123.699 0.625 . . . . 2.4300000000000002 111.104 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.674 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER 56.22 27.66 12.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.147 -0.933 . . . . 3.6000000000000001 111.239 177.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.62 13.62 62.75 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.792 -0.718 . . . . 0.45000000000000001 113.085 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 59.2 mtpt -115.17 137.54 51.91 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.391 -0.476 . . . . 2.7000000000000002 109.904 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.735 ' HG ' HG12 ' A' ' 135' ' ' ILE . 3.8 tt -115.51 121.44 42.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.314 -0.403 . . . . 1.1100000000000001 110.185 -172.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -117.47 114.17 23.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.32 -0.4 . . . . 1.8100000000000001 109.942 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 142' ' ' VAL . 5.5 m -90.73 111.07 23.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.97 -0.752 . . . . 1.5700000000000001 108.97 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 63.55 -85.41 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.128 -0.487 . . . . 1.8799999999999999 110.43 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -139.71 17.65 3.03 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.826 -0.625 . . . . 1.25 111.626 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -108.49 121.42 44.94 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.829 -0.804 . . . . 1.95 108.829 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.8 p -103.46 146.78 10.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.315 0.578 . . . . 1.49 111.943 -168.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.4 p -163.25 176.51 9.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.224 -0.898 . . . . 1.75 109.046 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.426 HG21 ' HG2' ' A' ' 139' ' ' LYS . 70.3 p -100.27 138.13 37.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.711 0.291 . . . . 1.8700000000000001 110.316 175.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.761 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 39.3 t80 -79.81 131.35 35.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.026 -0.361 . . . . 0.56999999999999995 110.026 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.3 t -131.39 111.06 11.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.464 0.649 . . . . 2.2400000000000002 111.473 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.37 -72.8 1.88 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.387 -0.824 . . . . 0.77000000000000002 113.678 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.56 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -155.75 169.11 25.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.973 0.416 . . . . 1.8 110.62 -175.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.876 HD12 ' HB2' ' A' ' 107' ' ' ASN . 22.7 tp -80.99 150.72 28.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.707 -0.849 . . . . 1.8300000000000001 108.707 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.6 t -132.53 104.11 6.51 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 118.994 -1.082 . . . . 1.72 110.353 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 15.5 t -92.91 96.44 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 108.401 -0.963 . . . . 1.1699999999999999 108.401 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HB3' ' HD2' ' A' ' 105' ' ' ARG . 4.3 tt0 -107.7 121.82 45.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.495 -1.229 . . . . 1.98 109.582 -173.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.881 ' HD2' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -113.32 115.52 28.27 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.178 -0.609 . . . . 2.9100000000000001 110.116 176.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 52.9 t -82.81 140.82 15.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.971 -1.013 . . . . 1.3 110.766 -173.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.3 pttm . . . . . 0 N--CA 1.454 -0.259 0 CA-C-N 114.999 -1.0 . . . . 2.6699999999999999 112.336 -173.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.926 HG12 ' HB3' ' A' ' 64' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.802 0 N-CA-C 108.341 -0.985 . . . . 1.8700000000000001 108.341 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 33.9 t -137.41 89.03 2.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.04 0.755 . . . . 1.9099999999999999 113.04 -168.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.799 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -75.39 38.4 0.14 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 124.479 1.112 . . . . 1.05 113.273 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.735 HD11 HD12 ' A' ' 85' ' ' LEU . 40.7 tp -54.12 104.42 0.11 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.769 0.655 . . . . 1.3500000000000001 112.769 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.772 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 4.3 t80 -117.99 124.62 48.62 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.489 -0.323 . . . . 0.60999999999999999 110.925 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.676 ' HB ' HD11 ' A' ' 85' ' ' LEU . 5.0 tt -114.53 123.7 70.46 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-O 122.226 1.012 . . . . 1.1000000000000001 111.359 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.772 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.6 ppp? -115.68 159.88 20.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.884 -1.053 . . . . 1.1399999999999999 109.99 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.569 ' HZ1' ' HG3' ' A' ' 79' ' ' GLU . 53.8 tttt -105.87 133.23 50.93 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 114.1 1.148 . . . . 1.74 114.1 -170.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 106.15 -28.87 12.28 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 113.832 -1.531 . . . . 0.31 116.226 157.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.99 158.09 1.98 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.036 1.418 . . . . 1.3 113.411 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.663 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -83.86 -9.58 58.65 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.206 -0.906 . . . . 1.3500000000000001 111.356 174.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 30.6 t70 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 121.157 0.504 . . . . 2.1600000000000001 111.215 -178.188 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.589 HD12 ' HE3' ' A' ' 173' ' ' MET . 50.2 tp . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.305 0.574 . . . . 1.2 110.141 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.505 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -69.89 -23.42 63.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.485 -0.78 . . . . 1.1699999999999999 111.651 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.55 -16.54 53.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.026 -0.534 . . . . 2.1800000000000002 111.009 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -126.22 2.77 7.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.438 -0.505 . . . . 2.2599999999999998 111.785 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.517 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 11.6 p -58.78 136.91 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.508 -0.477 . . . . 1.1100000000000001 110.176 169.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.7 pt -115.76 -22.86 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.285 -0.416 . . . . 1.51 111.047 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.759 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 79.4 t90 -171.1 143.28 1.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.838 -0.431 . . . . 0.42999999999999999 109.838 -173.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -162.18 137.58 7.28 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.207 -0.308 . . . . 1.0700000000000001 111.553 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -142.02 125.72 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.02 -0.536 . . . . 1.45 110.885 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 28.5 t30 -101.77 104.87 15.68 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.793 -0.817 . . . . 1.6100000000000001 108.793 167.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HB1' ' OH ' ' A' ' 73' ' ' TYR . . . -65.52 89.11 0.1 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.245 -0.889 . . . . 1.1599999999999999 110.247 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.6 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -174.36 -67.73 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 O-C-N 125.385 1.678 . . . . 0.76000000000000001 112.249 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.85 -132.38 5.69 Favored Glycine 0 C--N 1.318 -0.441 0 C-N-CA 120.757 -0.735 . . . . 0.82999999999999996 112.997 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 1.057 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 25.3 tt0 -138.33 119.37 14.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 111.243 0.09 . . . . 1.8400000000000001 111.243 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 73.1 m 36.39 108.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.584 1.698 . . . . 1.75 115.584 170.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 82.6 t60 -137.76 128.37 26.74 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.928 -0.483 . . . . 0.52000000000000002 111.42 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 86.1 t -87.8 113.15 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.209 -0.905 . . . . 1.6100000000000001 109.074 171.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -78.38 161.33 27.24 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.333 -0.247 . . . . 0.77000000000000002 110.333 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.32 -27.84 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 124.585 1.178 . . . . 1.29 113.232 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.413 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 87.6 m-70 -80.34 -6.55 58.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.312 0.577 . . . . 1.02 109.559 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . 96.41 24.84 13.22 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.955 -1.021 . . . . 0.37 112.179 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.537 HD12 ' HG ' ' A' ' 6' ' ' LEU . 19.1 mm -99.36 109.18 23.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.178 0.513 . . . . 1.0900000000000001 110.937 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 7.7 t60 -86.71 110.99 20.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.139 -0.482 . . . . 1.1200000000000001 110.342 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.667 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -87.48 139.13 30.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.084 -0.339 . . . . 1.9199999999999999 110.084 175.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 13.3 ptp180 -92.97 138.66 31.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.131 0.491 . . . . 3.4399999999999999 110.664 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 1.057 ' HB3' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -73.9 136.91 43.38 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.939 1.088 . . . . 3.23 113.939 -173.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.421 ' CG ' ' HZ2' ' A' ' 31' ' ' LYS . 1.1 p30 28.54 54.67 0.5 Allowed Pre-proline 0 N--CA 1.484 1.246 0 CA-C-N 111.868 -2.424 . . . . 2.4100000000000001 116.09 167.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.485 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 67.3 Cg_endo . . . . . 0 N--CA 1.455 -0.773 0 C-N-CA 122.503 2.135 . . . . 1.8700000000000001 113.006 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.607 HD11 ' HA ' ' A' ' 62' ' ' GLN . 1.7 mp . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 121.863 0.84 . . . . 1.5900000000000001 109.712 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HB3' HG22 ' A' ' 125' ' ' THR . 2.8 tt -60.95 -35.51 76.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.592 -1.186 . . . . 2.48 110.962 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -88.09 33.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.951 0.722 . . . . 3.7200000000000002 112.951 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.446 ' HG ' ' CG ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -142.62 168.16 20.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.8 0.333 . . . . 0.96999999999999997 110.878 172.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -90.21 141.42 27.69 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.958 -0.756 . . . . 1.9199999999999999 108.958 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' HG22 ' A' ' 59' ' ' VAL . 60.3 Cg_exo -39.67 -42.74 2.96 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 124.101 3.201 . . . . 0.95999999999999996 115.947 -162.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -76.54 -44.37 35.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.248 0.476 . . . . 2.71 111.361 -177.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.494 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -81.2 -17.48 49.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.234 -0.654 . . . . 1.6299999999999999 109.234 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -58.85 -45.69 89.52 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.174 -0.921 . . . . 2.1200000000000001 109.135 167.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 55' ' ' PRO . 68.8 t -55.19 -44.6 75.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.487 0.66 . . . . 1.9099999999999999 109.593 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 35.0 tp -63.72 -18.94 64.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.644 -1.162 . . . . 1.77 112.141 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.615 ' CE2' ' HE2' ' A' ' 88' ' ' LYS . 13.6 m-30 -114.91 1.55 14.06 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 111.894 0.331 . . . . 1.3799999999999999 111.894 -175.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.607 ' HA ' HD11 ' A' ' 50' ' ' ILE . 39.2 tt0 -124.3 -41.36 2.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.626 0.973 . . . . 1.97 113.626 -170.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.496 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 2.1 m -61.1 132.49 53.93 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 121.072 -0.251 . . . . 1.54 111.451 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 1.001 ' HB2' HG21 ' A' ' 167' ' ' VAL . 36.5 tt0 -120.33 147.75 44.62 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.123 0.569 . . . . 1.96 110.397 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.902 HH22 ' HH ' ' A' ' 73' ' ' TYR . 16.6 mtm-85 . . . . . 0 N--CA 1.463 0.184 0 O-C-N 123.232 0.333 . . . . 4.0700000000000003 110.931 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.83 0.348 . . . . 1.78 110.437 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.739 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 8.4 p90 -107.28 126.61 52.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.132 -1.027 . . . . 2.2999999999999998 110.838 -176.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -145.4 154.06 25.68 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.942 -1.027 . . . . 1.1599999999999999 113.295 -173.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.902 ' HH ' HH22 ' A' ' 65' ' ' ARG . 53.5 m-85 -104.85 164.97 11.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.303 -0.448 . . . . 1.6200000000000001 111.156 -175.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.522 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 8.0 p-10 -115.42 118.8 34.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.741 -0.663 . . . . 2.4700000000000002 110.463 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.819 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.8 mp -104.5 90.88 3.59 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.333 -0.849 . . . . 1.1899999999999999 109.302 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.56 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 38.4 Cg_exo -59.74 120.04 7.61 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.251 1.967 . . . . 0.89000000000000001 112.405 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.769 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 72.4 mt -119.86 135.98 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.867 0.365 . . . . 1.1699999999999999 111.236 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 32.6 mtpt -130.9 7.67 4.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 3.7000000000000002 110.736 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.451 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 38.0 mt-10 -131.88 174.41 10.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.975 0.416 . . . . 2.1600000000000001 110.882 -173.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.559 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 9.0 mt-10 -112.82 -172.99 2.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.778 -0.646 . . . . 1.2 110.112 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.33 -167.48 13.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.895 -0.669 . . . . 0.35999999999999999 112.191 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 56.2 mt-10 -97.34 103.3 15.22 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 117.29 0.545 . . . . 1.96 109.747 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.662 ' HB2' HG12 ' A' ' 133' ' ' ILE . 10.9 m-30 -95.64 123.25 39.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 118.985 -1.086 . . . . 1.1399999999999999 108.398 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.968 HG22 ' HA ' ' A' ' 177' ' ' ALA . 74.7 t -114.71 106.68 21.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.518 -0.764 . . . . 1.0700000000000001 110.268 -172.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.418 HD11 ' N ' ' A' ' 85' ' ' LEU . 5.1 mp -88.82 104.47 16.94 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.457 -1.247 . . . . 2.0600000000000001 109.493 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.571 HG23 HG21 ' A' ' 130' ' ' ILE . 44.2 t -103.34 100.73 11.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 107.539 -1.282 . . . . 1.72 107.539 171.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.615 ' CB ' ' HA ' ' A' ' 170' ' ' LEU . 0.6 OUTLIER -109.23 132.24 54.31 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.106 -0.638 . . . . 2.0600000000000001 109.803 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.979 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 13.8 mptt -89.09 122.61 32.58 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.129 -0.628 . . . . 4.1900000000000004 110.393 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.14 135.21 48.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.227 -0.897 . . . . 0.54000000000000004 108.645 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.779 ' HB2' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.056 0 CA-C-O 121.095 0.474 . . . . 1.1599999999999999 109.968 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.916 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 6.4 m . . . . . 0 N--CA 1.446 -0.671 0 CA-C-O 121.477 0.656 . . . . 1.8200000000000001 110.356 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.69 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 23.5 m-85 -73.87 154.33 39.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.102 -0.954 . . . . 1.1699999999999999 110.887 -175.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.682 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 12.5 m-20 -105.75 137.81 42.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.469 -0.567 . . . . 1.53 109.469 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 2.5 t -134.47 120.18 32.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.762 0.315 . . . . 1.3500000000000001 110.682 -176.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 61.4 mtt180 -120.26 141.98 49.47 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.671 -0.695 . . . . 2.3100000000000001 111.666 -174.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.848 HG22 HD22 ' A' ' 153' ' ' LEU . 2.8 p -118.43 102.78 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.75 -0.659 . . . . 2.0899999999999999 109.845 172.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 55.44 51.45 12.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.266 -0.879 . . . . 2.0899999999999999 109.342 -172.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.31 -17.67 46.41 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.085 -0.961 . . . . 0.41999999999999998 113.313 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.496 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 90.2 m-70 -85.49 105.45 16.11 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.098 0.407 . . . . 0.81999999999999995 112.098 -172.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 113' ' ' LYS . 1.9 p -69.91 94.3 0.83 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.043 0.449 . . . . 1.3500000000000001 111.174 176.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 106' ' ' VAL . 21.5 t -78.12 -49.62 21.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.643 0.735 . . . . 1.6000000000000001 109.409 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.507 HG11 HD11 ' A' ' 115' ' ' LEU . 9.4 t -118.39 90.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.437 -0.801 . . . . 1.1200000000000001 109.714 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.544 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 0.4 OUTLIER -109.45 71.66 0.78 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.906 -1.146 . . . . 4.4000000000000004 107.906 176.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.916 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 6.6 p-10 168.86 19.29 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.026 -1.897 . . . . 1.96 109.698 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.69 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 11.5 tp -73.35 99.43 2.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.182 -0.463 . . . . 1.78 111.512 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.574 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 23.3 p-10 -110.59 91.08 3.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.161 0.981 . . . . 1.9299999999999999 109.873 174.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.6 mm -52.9 -44.3 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 114.632 -1.167 . . . . 1.4199999999999999 112.483 -170.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -56.96 -39.56 74.83 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 123.341 0.4 . . . . 1.2 111.755 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -73.18 -32.61 64.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.115 0.483 . . . . 0.95999999999999996 110.849 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 8.6 mmt180 -71.5 -44.43 64.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.634 -0.712 . . . . 2.1800000000000002 111.084 -173.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.77 -40.38 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.323 0.49 . . . . 2.0899999999999999 112.323 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.25 -58.26 4.96 Favored Glycine 0 C--O 1.23 -0.137 0 C-N-CA 121.133 -0.556 . . . . 1.3999999999999999 112.104 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -99.92 145.42 27.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.436 -0.579 . . . . 4.9100000000000001 109.436 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.0 m -54.38 94.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 O-C-N 123.691 0.619 . . . . 2.1499999999999999 111.03 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 51' ' ' LEU . 21.2 p -150.05 -174.9 4.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.217 -0.447 . . . . 1.3999999999999999 109.872 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.557 ' HB3' ' CG2' ' A' ' 50' ' ' ILE . . . -79.92 124.14 28.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.563 -0.29 . . . . 1.21 111.007 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -104.87 145.15 30.79 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.723 -1.214 . . . . 0.57999999999999996 107.723 168.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.727 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 23.8 p-10 -146.81 139.83 25.33 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.931 -0.708 . . . . 1.6399999999999999 112.141 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -103.85 114.02 27.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.219 -0.901 . . . . 1.6799999999999999 108.598 172.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.571 HG21 HG23 ' A' ' 86' ' ' VAL . 71.6 mt -95.73 110.05 23.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.997 -0.547 . . . . 1.3899999999999999 109.629 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.8 mt -119.7 97.45 49.83 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.37 -0.377 . . . . 1.8500000000000001 111.162 -173.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.403 ' HB3' HG21 ' A' ' 84' ' ' VAL . 5.2 Cg_exo -78.68 123.75 6.01 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.717 2.278 . . . . 0.33000000000000002 112.108 172.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.662 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.9 pt -110.03 154.05 11.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.727 -0.842 . . . . 1.1000000000000001 108.727 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.548 ' HG ' ' HB2' ' A' ' 141' ' ' SER . 8.9 p -123.78 109.42 13.64 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.852 0.358 . . . . 1.8200000000000001 110.323 175.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.695 HG12 ' HG ' ' A' ' 140' ' ' LEU . 29.2 mt -98.82 125.11 52.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.049 -0.722 . . . . 1.1399999999999999 109.049 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -151.0 135.57 17.1 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.71 0.631 . . . . 2.4300000000000002 109.435 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 1.073 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 7.6 mmpt? 61.98 25.85 15.55 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.538 0.524 . . . . 3.6000000000000001 111.316 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.25 9.98 85.96 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.731 -0.747 . . . . 0.45000000000000001 112.167 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.689 ' HG2' HG21 ' A' ' 148' ' ' THR . 26.3 mtpp -110.83 137.48 48.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.406 -0.59 . . . . 2.7000000000000002 109.406 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.695 ' HG ' HG12 ' A' ' 135' ' ' ILE . 4.9 tt -108.68 115.32 29.88 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.415 -0.587 . . . . 1.1100000000000001 109.415 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.548 ' HB2' ' HG ' ' A' ' 134' ' ' SER . 7.2 m -108.4 125.12 51.39 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.893 -0.594 . . . . 1.8100000000000001 110.091 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 85.5 t -113.09 95.5 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.769 -0.456 . . . . 1.5700000000000001 109.769 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 62.39 -91.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.427 -0.806 . . . . 1.8799999999999999 111.132 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.3 -10.46 29.54 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.922 -0.656 . . . . 1.25 112.594 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -97.47 149.98 21.57 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.803 -0.234 . . . . 1.95 110.763 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.92 125.76 13.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.168 0.509 . . . . 1.49 110.865 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.425 ' HB2' ' HE2' ' A' ' 109' ' ' HIS . 49.0 m -155.42 141.72 18.53 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.626 -0.509 . . . . 1.75 109.626 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.689 HG21 ' HG2' ' A' ' 139' ' ' LYS . 25.1 p -59.09 140.93 55.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.2 0.524 . . . . 1.8700000000000001 111.131 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.769 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 20.8 t80 -85.83 140.85 30.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.45 -0.795 . . . . 0.56999999999999995 110.301 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 t -144.41 118.01 9.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.509 0.671 . . . . 2.2400000000000002 110.923 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.21 -77.8 2.08 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.324 -0.853 . . . . 0.77000000000000002 113.607 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.56 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -159.72 169.47 23.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.038 0.447 . . . . 1.8 110.975 -174.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.848 HD22 HG22 ' A' ' 106' ' ' VAL . 6.7 tt -84.34 135.35 34.34 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.778 -0.823 . . . . 1.8300000000000001 108.778 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.463 ' N ' HD23 ' A' ' 153' ' ' LEU . 8.1 t -121.34 109.07 14.46 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.903 -0.719 . . . . 1.72 110.538 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 45.2 t -95.23 98.06 7.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.722 -0.473 . . . . 1.1699999999999999 109.722 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -114.95 134.3 55.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.205 -0.452 . . . . 1.98 110.434 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.739 ' HE2' ' CE2' ' A' ' 71' ' ' PHE . 0.1 OUTLIER -123.5 136.76 54.74 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.621 0.724 . . . . 2.9100000000000001 111.418 176.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 42.2 t -104.5 145.44 13.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 114.002 -1.454 . . . . 1.3 111.525 -170.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 N--CA 1.464 0.244 0 CA-C-N 113.973 -1.467 . . . . 2.6699999999999999 113.338 -178.093 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 1.001 HG21 ' HB2' ' A' ' 64' ' ' GLU . 52.1 t . . . . . 0 C--O 1.237 0.399 0 N-CA-C 110.079 -0.341 . . . . 1.8700000000000001 110.079 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 11.5 t -141.92 86.4 1.98 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 119.084 -1.046 . . . . 1.9099999999999999 113.592 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.979 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -75.68 37.02 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.718 1.207 . . . . 1.05 112.564 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.759 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 23.3 tp -50.5 101.97 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.659 0.784 . . . . 1.3500000000000001 113.111 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.723 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 5.0 t80 -114.82 128.29 56.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.832 -0.622 . . . . 0.60999999999999999 110.626 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.663 HG23 ' HE3' ' A' ' 12' ' ' TRP . 6.4 tt -121.15 124.82 72.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-O 121.529 0.68 . . . . 1.1000000000000001 111.349 174.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.723 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 2.0 ppp? -115.32 166.06 12.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.801 -0.636 . . . . 1.1399999999999999 109.395 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.435 ' HZ3' ' CD ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -120.14 148.73 43.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.4 1.095 . . . . 1.74 112.888 -170.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.52 -28.76 14.15 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 113.531 -1.668 . . . . 0.31 114.285 163.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.549 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.7 OUTLIER -166.62 152.24 8.19 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.545 0.943 . . . . 1.3 113.545 -174.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.968 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -85.1 -15.39 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.105 -0.952 . . . . 1.3500000000000001 110.223 167.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 114.965 -1.016 . . . . 2.1600000000000001 112.002 -173.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.645 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 16.5 tp . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.085 0.469 . . . . 1.2 110.557 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' HB1' ' HA3' ' A' ' 26' ' ' GLY . . . -71.01 -22.68 62.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.755 -0.657 . . . . 1.1699999999999999 111.385 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.05 -42.13 80.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.207 0.527 . . . . 2.1800000000000002 110.518 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 0.9 OUTLIER -103.29 -11.47 17.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.492 -0.776 . . . . 2.2599999999999998 112.412 -168.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 12.4 p -59.96 131.25 24.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 120.401 -0.52 . . . . 1.1100000000000001 111.015 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.514 HD12 HD13 ' A' ' 172' ' ' ILE . 22.7 pt -106.67 -22.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.952 -0.567 . . . . 1.51 110.071 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.744 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 34.9 t90 -168.81 142.13 2.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.775 -0.648 . . . . 0.42999999999999999 109.595 -169.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -158.03 136.11 10.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.686 0.279 . . . . 1.0700000000000001 111.195 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.812 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 18.8 t -146.71 125.18 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.418 0.627 . . . . 1.45 111.933 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.659 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 47.2 t30 -94.33 103.58 15.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.79 -1.189 . . . . 1.6100000000000001 107.79 164.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.692 ' HB1' ' HH ' ' A' ' 73' ' ' TYR . . . -62.15 91.04 0.03 OUTLIER 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.881 -1.155 . . . . 1.1599999999999999 107.881 171.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.764 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . 131.98 62.5 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.339 0 O-C-N 125.009 1.443 . . . . 0.76000000000000001 113.169 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.92 -136.37 2.86 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 119.893 -1.146 . . . . 0.82999999999999996 112.674 166.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.861 ' HG3' ' HD3' ' A' ' 31' ' ' LYS . 35.0 tt0 -161.64 118.12 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 119.724 -0.179 . . . . 1.8400000000000001 110.952 171.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.707 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 60.1 p 31.36 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.567 1.167 . . . . 1.75 113.518 174.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.679 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 73.4 t60 -125.4 136.21 53.19 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.979 -0.688 . . . . 0.52000000000000002 111.276 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.428 HG23 ' HD1' ' A' ' 28' ' ' HIS . 38.4 t -99.4 114.4 37.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.983 -0.553 . . . . 1.6100000000000001 110.285 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.79 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -72.3 152.35 42.18 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.312 -0.625 . . . . 0.77000000000000002 109.312 176.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.551 HG23 ' OD2' ' A' ' 57' ' ' ASP . 29.1 m -61.65 -10.83 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 113.594 0.961 . . . . 1.29 113.594 -170.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.463 ' HB2' HD23 ' A' ' 6' ' ' LEU . 65.5 m-70 -92.87 -3.44 54.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.972 -0.751 . . . . 1.02 108.972 176.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . 97.89 30.77 6.96 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.991 -1.004 . . . . 0.37 112.679 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.634 HD11 ' HG ' ' A' ' 6' ' ' LEU . 29.8 mm -103.83 108.09 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.127 0.489 . . . . 1.0900000000000001 110.689 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.428 ' HD1' HG23 ' A' ' 22' ' ' VAL . 8.8 t60 -94.42 113.22 25.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 1.1200000000000001 111.229 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.812 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -80.99 132.5 35.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.149 -0.478 . . . . 1.9199999999999999 110.631 175.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.829 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 5.2 ptm180 -90.74 113.51 25.64 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.451 0.47 . . . . 3.4399999999999999 110.673 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.861 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 39.0 ttpt -32.95 109.54 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.401 1.63 . . . . 3.23 115.401 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 59.3 m-20 23.7 63.02 0.39 Allowed Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 126.352 1.861 . . . . 2.4100000000000001 114.715 168.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.829 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 17.7 Cg_endo . . . . . 0 N--CA 1.455 -0.756 0 C-N-CA 123.47 2.78 . . . . 1.8700000000000001 113.823 -172.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.1 tp . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 120.828 0.346 . . . . 1.5900000000000001 111.699 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp 64.45 -67.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.503 0.721 . . . . 2.48 112.541 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -77.36 36.47 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.42 0.526 . . . . 3.7200000000000002 112.42 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.2 t -157.23 143.82 18.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.082 -0.34 . . . . 0.96999999999999997 110.082 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -65.71 145.35 99.04 Favored Pre-proline 0 C--O 1.223 -0.323 0 CA-C-N 115.659 -0.701 . . . . 1.9199999999999999 109.737 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -41.12 -45.01 5.36 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.577 3.518 . . . . 0.95999999999999996 115.462 -166.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.744 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.0 pt-20 -72.42 -46.91 52.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.019 0.914 . . . . 2.71 110.614 -176.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.79 ' OD1' ' HA ' ' A' ' 23' ' ' ASP . 68.3 m-20 -79.06 -14.63 59.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.553 -0.717 . . . . 1.6299999999999999 109.56 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 33.2 tt0 -59.75 -49.55 77.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.136 -0.938 . . . . 2.1200000000000001 109.269 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 56' ' ' GLU . 13.6 p -60.19 -35.27 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 119.726 -0.789 . . . . 1.9099999999999999 110.055 176.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.679 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 16.2 tp -69.34 -13.24 62.27 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.843 0.354 . . . . 1.77 111.763 176.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.539 ' CG ' ' HG2' ' A' ' 88' ' ' LYS . 15.8 m-30 -119.11 3.22 11.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.461 -0.336 . . . . 1.3799999999999999 111.329 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.517 ' HA ' HD13 ' A' ' 50' ' ' ILE . 6.8 tt0 -121.25 -49.54 2.16 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.367 0.877 . . . . 1.97 113.367 -167.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.764 ' HB ' ' O ' ' A' ' 17' ' ' GLY . 20.8 m -74.05 133.17 42.89 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.766 -0.373 . . . . 1.54 111.221 -173.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' HB3' HG21 ' A' ' 167' ' ' VAL . 2.1 pm0 -93.32 162.25 14.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 1.96 109.889 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HB2' ' C ' ' A' ' 16' ' ' ALA . 9.4 ttp180 . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.167 -0.679 . . . . 4.0700000000000003 109.167 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 121.358 0.599 . . . . 1.78 110.336 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.52 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 24.5 p90 -125.3 134.54 52.21 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.611 -0.722 . . . . 2.2999999999999998 109.541 -172.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.79 -151.76 5.78 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.243 -0.889 . . . . 1.1599999999999999 112.522 -174.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.692 ' HH ' ' HB1' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -142.01 160.06 40.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.1 0.476 . . . . 1.6200000000000001 111.334 -171.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.693 ' HB3' ' HG3' ' A' ' 152' ' ' LYS . 2.6 m-20 -110.23 117.5 33.85 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.495 -0.775 . . . . 2.4700000000000002 109.511 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.459 HD11 HD21 ' A' ' 153' ' ' LEU . 5.9 mt -106.58 90.64 5.17 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.187 -0.671 . . . . 1.1899999999999999 109.187 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.608 ' HA ' ' CB ' ' A' ' 152' ' ' LYS . 37.1 Cg_endo -67.22 116.08 4.0 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.015 1.143 . . . . 0.89000000000000001 111.96 -175.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.833 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 62.1 mt -107.52 130.99 58.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.948 -0.569 . . . . 1.1699999999999999 110.418 -174.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -122.64 5.95 9.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.228 -0.442 . . . . 3.7000000000000002 110.474 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -132.5 172.21 12.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.504 -0.317 . . . . 2.1600000000000001 110.215 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.518 ' HG2' HG21 ' A' ' 135' ' ' ILE . 9.5 mt-10 -114.67 176.42 5.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.895 0.379 . . . . 1.2 110.753 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.72 -166.14 21.32 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.76 -0.936 . . . . 0.35999999999999999 110.76 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -103.0 107.17 17.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.52 0.66 . . . . 1.96 109.587 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.659 ' HB2' HG12 ' A' ' 133' ' ' ILE . 93.3 m-85 -94.33 124.69 38.51 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 119.803 -0.759 . . . . 1.1399999999999999 109.074 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.633 HG23 ' CA ' ' A' ' 177' ' ' ALA . 96.9 t -113.49 107.67 23.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.669 -0.696 . . . . 1.0700000000000001 110.764 -171.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 85' ' ' LEU . 4.9 mp -90.12 104.78 17.32 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.475 -1.239 . . . . 2.0600000000000001 109.146 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.65 105.12 17.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.224 -1.028 . . . . 1.72 108.224 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' A' ' 170' ' ' LEU . 3.7 mp -100.81 132.24 46.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.814 -0.81 . . . . 2.0600000000000001 108.814 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.774 ' HD2' ' HB3' ' A' ' 128' ' ' ASP . 23.5 tptt -96.63 114.73 26.41 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.683 -0.858 . . . . 4.1900000000000004 108.683 173.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -104.56 137.12 42.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.82 -0.627 . . . . 0.54000000000000004 109.373 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.661 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.31 -1.119 0 CA-C-N 115.544 -0.753 . . . . 1.1599999999999999 111.262 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.2 m . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.292 0.567 . . . . 1.8200000000000001 110.261 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.611 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 18.4 m-85 -88.68 150.74 22.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.56 -0.745 . . . . 1.1699999999999999 110.864 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 23.5 m-20 -104.51 134.74 47.19 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.165 -1.05 . . . . 1.53 108.165 169.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.8 t -134.89 115.52 19.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.088 0.471 . . . . 1.3500000000000001 110.638 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.563 ' HB3' HG22 ' A' ' 110' ' ' THR . 23.2 ptt180 -124.42 126.41 45.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.664 -0.698 . . . . 2.3100000000000001 111.889 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 32.1 m -102.86 131.72 50.54 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 108.982 -0.748 . . . . 2.0899999999999999 108.982 173.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.58 HD21 ' HG ' ' A' ' 153' ' ' LEU . 1.6 p30 48.44 44.43 20.41 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.862 0.465 . . . . 2.0899999999999999 111.553 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.24 -1.79 63.62 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.917 -0.583 . . . . 0.41999999999999998 112.676 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.68 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 52.5 m-70 -101.73 103.18 13.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.274 0.629 . . . . 0.81999999999999995 111.202 -173.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -69.23 98.61 1.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.377 0.608 . . . . 1.3500000000000001 111.12 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.43 -52.0 15.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.631 -0.713 . . . . 1.6000000000000001 109.71 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.519 HG12 ' HG ' ' A' ' 115' ' ' LEU . 3.8 t -117.68 94.33 3.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.714 -0.676 . . . . 1.1200000000000001 109.811 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -111.86 73.26 0.81 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.566 0.698 . . . . 4.4000000000000004 109.353 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.617 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 12.2 p-10 162.71 27.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.72 -1.582 . . . . 1.96 108.834 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -69.4 91.95 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.405 -0.816 . . . . 1.78 111.199 -172.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 24.0 p-10 -101.9 96.96 7.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.767 0.794 . . . . 1.9299999999999999 109.275 171.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.7 mt -53.78 -35.76 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.979 -1.01 . . . . 1.4199999999999999 111.954 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 84.7 t80 -56.12 -44.66 79.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 1.2 111.251 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.53 -35.71 68.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.34 -0.391 . . . . 0.95999999999999996 111.525 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 5.3 mmt180 -75.62 -42.48 51.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.239 -0.437 . . . . 2.1800000000000002 111.776 -170.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 p -117.37 -28.05 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.538 -0.465 . . . . 2.0899999999999999 111.875 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 124.21 -151.46 17.17 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.851 -0.899 . . . . 1.3999999999999999 110.851 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -92.39 122.92 35.31 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.263 -0.575 . . . . 4.9100000000000001 109.972 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.0 m 65.27 -142.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.779 . . . . 2.1499999999999999 110.39 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 59.2 p 58.13 -174.22 0.09 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.711 0.804 . . . . 1.3999999999999999 111.865 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.3 131.57 53.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.385 . . . . 1.21 111.816 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.475 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 18.2 t60 -107.09 142.82 36.15 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 108.651 -0.87 . . . . 0.57999999999999996 108.651 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.774 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 5.4 p-10 -129.54 123.87 32.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.524 0.678 . . . . 1.6399999999999999 110.779 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -104.57 110.91 23.39 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.922 -1.035 . . . . 1.6799999999999999 109.148 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.76 111.52 25.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.865 -0.607 . . . . 1.3899999999999999 110.208 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.9 mt -118.81 95.71 49.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.242 -0.435 . . . . 1.8500000000000001 110.751 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' A' ' 84' ' ' VAL . 5.9 Cg_exo -81.23 128.85 6.51 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.068 2.512 . . . . 0.33000000000000002 112.202 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.71 ' HB ' HD23 ' A' ' 140' ' ' LEU . 3.5 pt -110.5 162.1 8.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.756 -0.831 . . . . 1.1000000000000001 108.756 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.5 t -127.48 106.57 9.28 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.488 -0.324 . . . . 1.8200000000000001 110.164 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.753 HG12 ' HG ' ' A' ' 140' ' ' LEU . 21.8 mt -101.05 124.04 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.236 -0.654 . . . . 1.1399999999999999 109.236 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -148.16 125.12 11.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.824 -0.626 . . . . 2.4300000000000002 109.395 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.502 ' HE3' ' HA ' ' A' ' 137' ' ' LYS . 0.2 OUTLIER 63.9 28.91 14.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.664 -0.698 . . . . 3.6000000000000001 111.558 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.04 14.33 80.79 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.958 -0.639 . . . . 0.45000000000000001 112.374 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.557 ' HG2' HG23 ' A' ' 148' ' ' THR . 55.0 mtpt -116.66 147.8 41.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.61 -0.515 . . . . 2.7000000000000002 109.61 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.753 ' HG ' HG12 ' A' ' 135' ' ' ILE . 3.1 tt -118.06 127.46 53.82 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.07 -0.345 . . . . 1.1100000000000001 110.07 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 15.0 m -114.6 125.29 53.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.053 -0.521 . . . . 1.8100000000000001 110.203 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.405 HG23 HD22 ' A' ' 140' ' ' LEU . 85.6 t -118.62 98.5 6.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.672 0.272 . . . . 1.5700000000000001 110.715 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 56.7 26.56 11.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.823 -0.626 . . . . 1.8799999999999999 112.145 173.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.86 -39.6 1.8 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.767 -0.651 . . . . 1.25 112.343 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 141' ' ' SER . 39.9 mt-10 -68.78 114.17 6.88 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.075 -0.342 . . . . 1.95 110.075 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.2 p -108.53 115.9 50.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.307 0.575 . . . . 1.49 110.747 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 m -135.85 176.51 8.61 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.869 -0.789 . . . . 1.75 108.869 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.557 HG23 ' HG2' ' A' ' 139' ' ' LYS . 37.1 p -91.23 138.51 31.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.912 -0.403 . . . . 1.8700000000000001 109.912 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.833 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 92.5 t80 -79.92 129.47 34.51 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.846 -0.427 . . . . 0.56999999999999995 109.846 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.6 t -121.07 96.05 4.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.649 0.738 . . . . 2.2400000000000002 112.062 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.93 -66.76 2.11 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.34 -0.845 . . . . 0.77000000000000002 114.23 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.693 ' HG3' ' HB3' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -148.58 160.26 43.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.291 0.567 . . . . 1.8 111.014 -173.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.58 ' HG ' HD21 ' A' ' 107' ' ' ASN . 5.7 tt -90.76 117.94 29.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.402 -0.962 . . . . 1.8300000000000001 108.402 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.475 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 3.6 t -107.37 111.69 24.15 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.91 -0.716 . . . . 1.72 110.559 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 22.7 t -98.94 98.6 7.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.13 -0.486 . . . . 1.1699999999999999 110.134 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.498 ' HB2' ' HE ' ' A' ' 105' ' ' ARG . 12.8 mm-40 -105.22 146.89 28.66 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.705 -0.48 . . . . 1.98 109.705 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.52 ' HE2' ' CE2' ' A' ' 71' ' ' PHE . 2.9 p90 -127.81 134.09 49.44 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.134 0.492 . . . . 2.9100000000000001 110.348 171.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 14.2 t -115.47 144.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.272 -0.876 . . . . 1.3 110.868 -170.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.6 pttp . . . . . 0 N--CA 1.447 -0.575 0 CA-C-N 115.915 -0.584 . . . . 2.6699999999999999 111.473 -179.033 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 46.1 t . . . . . 0 C--O 1.239 0.501 0 N-CA-C 109.895 -0.409 . . . . 1.8700000000000001 109.895 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 17.8 t -136.44 83.34 2.0 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.125 -0.63 . . . . 1.9099999999999999 112.432 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.716 ' HB3' ' CB ' ' A' ' 88' ' ' LYS . . . -76.61 37.34 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.645 1.178 . . . . 1.05 112.715 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.744 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 6.8 tp -58.1 110.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.351 0.596 . . . . 1.3500000000000001 111.834 -173.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.645 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -114.51 134.16 55.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.835 -0.621 . . . . 0.60999999999999999 109.423 174.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.563 ' CG2' ' HB3' ' A' ' 12' ' ' TRP . 3.7 tt -124.58 127.01 72.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-O 122.268 1.032 . . . . 1.1000000000000001 111.897 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.525 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 10.7 ptm -114.08 171.53 7.55 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.385 -1.28 . . . . 1.1399999999999999 109.31 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 19.2 ptmt -118.35 146.05 44.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.914 0.864 . . . . 1.74 112.665 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 176' ' ' THR . . . 103.04 -30.0 11.31 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 113.913 -1.494 . . . . 0.31 114.747 162.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 175' ' ' GLY . 0.4 OUTLIER -173.9 153.05 2.07 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.01 0.905 . . . . 1.3 112.744 -176.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.633 ' CA ' HG23 ' A' ' 84' ' ' VAL . . . -86.96 -14.24 42.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.013 -0.994 . . . . 1.3500000000000001 110.2 169.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.37 -0.832 . . . . 2.1600000000000001 111.415 -173.572 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.891 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 27.2 tp . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 121.0 0.428 . . . . 1.2 110.928 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 25' ' ' HIS . . . -62.45 -22.99 66.64 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.723 -0.671 . . . . 1.1699999999999999 111.544 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.33 -40.95 17.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.096 -0.502 . . . . 2.1800000000000002 110.952 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.483 ' HB2' ' CE ' ' A' ' 173' ' ' MET . 66.9 mmtt -97.12 -4.62 38.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.414 0.524 . . . . 2.2599999999999998 112.414 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 11.8 p -60.99 134.87 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.141 -0.624 . . . . 1.1100000000000001 110.422 171.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.517 HD11 ' HE2' ' A' ' 83' ' ' TYR . 42.4 pt -113.86 -22.77 4.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.235 -0.439 . . . . 1.51 110.447 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.764 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 75.0 t90 -164.42 147.5 9.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.42999999999999999 110.327 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -159.53 141.31 13.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.221 -0.289 . . . . 1.0700000000000001 110.221 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.92 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 24.8 t -144.22 115.97 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.703 0.763 . . . . 1.45 112.584 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 1.9 t-20 -88.24 88.03 7.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.369 -1.345 . . . . 1.6100000000000001 107.369 164.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.87 103.07 0.23 Allowed 'General case' 0 C--O 1.25 1.089 0 CA-C-N 115.768 -0.651 . . . . 1.1599999999999999 109.982 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 65' ' ' ARG . . . 160.44 -48.0 0.39 Allowed Glycine 0 N--CA 1.44 -1.064 0 O-C-N 125.127 1.517 . . . . 0.76000000000000001 113.083 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.09 -131.32 6.47 Favored Glycine 0 C--O 1.229 -0.199 0 C-N-CA 120.74 -0.743 . . . . 0.82999999999999996 113.627 -173.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 47.0 mt-10 -150.31 119.87 6.97 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 119.218 -0.42 . . . . 1.8400000000000001 110.625 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.695 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 72.1 m 33.18 108.29 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 115.484 1.661 . . . . 1.75 115.484 170.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.736 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 71.1 t60 -147.87 131.19 16.56 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.733 -0.604 . . . . 0.52000000000000002 110.861 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 1.1 p -96.79 124.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.235 -0.654 . . . . 1.6100000000000001 109.235 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.77 163.82 25.78 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.737 -0.665 . . . . 0.77000000000000002 109.66 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 m -55.24 -29.59 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 113.14 0.792 . . . . 1.29 113.14 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 32.8 m-70 -70.02 -18.31 63.3 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.346 -0.613 . . . . 1.02 109.346 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.71 31.66 5.38 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.104 -0.953 . . . . 0.37 111.235 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.622 HD12 ' HG ' ' A' ' 6' ' ' LEU . 17.9 mm -102.63 110.97 30.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 1.0900000000000001 110.861 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 3.3 t60 -97.44 111.7 23.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.21 -0.45 . . . . 1.1200000000000001 111.23 -172.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.92 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -76.85 131.15 38.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.94 -0.573 . . . . 1.9199999999999999 110.577 175.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.666 ' HD3' ' HG3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -88.36 107.05 18.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.805 -0.634 . . . . 3.4399999999999999 110.693 177.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 33.4 ttmt -18.62 126.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 125.034 1.459 . . . . 3.23 113.094 174.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 16' ' ' ALA . 2.5 m-20 -35.77 101.26 0.21 Allowed Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 123.197 1.475 . . . . 2.4100000000000001 114.046 -169.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.666 ' HG3' ' HD3' ' A' ' 30' ' ' ARG . 40.2 Cg_endo . . . . . 0 N--CA 1.449 -1.12 0 C-N-CA 125.174 3.916 . . . . 1.8700000000000001 115.071 -166.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.678 HG12 ' HE3' ' A' ' 88' ' ' LYS . 1.7 mp . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 122.287 1.041 . . . . 1.5900000000000001 109.91 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' HB2' HG21 ' A' ' 125' ' ' THR . 87.9 mt -76.42 -2.3 31.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.18 -1.373 . . . . 2.48 113.171 -171.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.861 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 14.1 mmm180 -109.36 18.3 20.58 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.085 -0.646 . . . . 3.7200000000000002 111.009 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.54 170.35 13.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.366 -0.379 . . . . 0.96999999999999997 110.162 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -93.04 139.46 23.11 Favored Pre-proline 0 C--O 1.216 -0.708 0 N-CA-C 109.01 -0.737 . . . . 1.9199999999999999 109.01 178.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.467 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 40.0 Cg_exo -38.63 -42.29 1.79 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 124.071 3.181 . . . . 0.95999999999999996 116.617 -163.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -76.05 -46.41 29.38 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.51 -0.744 . . . . 2.71 110.516 -177.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.531 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 3.5 p30 -79.75 -17.43 53.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.177 -0.465 . . . . 1.6299999999999999 110.119 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -57.89 -43.7 86.24 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 108.944 -0.762 . . . . 2.1200000000000001 108.944 167.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.41 -45.76 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.788 -0.449 . . . . 1.9099999999999999 109.788 172.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.736 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 24.3 tp -63.06 -15.24 55.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.458 -0.792 . . . . 1.77 111.489 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.524 ' CD2' ' HG3' ' A' ' 88' ' ' LYS . 4.2 m-30 -114.31 0.81 14.26 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.23 -0.441 . . . . 1.3799999999999999 111.403 -177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.534 ' HA ' HD11 ' A' ' 50' ' ' ILE . 49.8 tt0 -122.07 -43.27 2.34 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.792 0.664 . . . . 1.97 112.792 -169.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.5 m -59.97 131.13 49.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.117 -0.492 . . . . 1.54 111.413 -175.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.826 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.9 pm0 -116.98 158.94 23.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.581 0.585 . . . . 1.96 112.581 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.44 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 3.2 ptm180 . . . . . 0 C--O 1.234 0.243 0 CA-C-N 115.616 -0.72 . . . . 4.0700000000000003 110.182 172.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 32.1 t . . . . . 0 C--O 1.236 0.355 0 CA-C-O 120.98 0.419 . . . . 1.78 110.747 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -103.59 121.91 43.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.165 -0.614 . . . . 2.2999999999999998 109.973 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 155' ' ' VAL . . . -108.17 174.47 19.03 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 114.934 -1.03 . . . . 1.1599999999999999 113.808 -170.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.491 ' HB3' ' CZ2' ' A' ' 12' ' ' TRP . 52.4 m-85 -132.19 141.89 49.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.124 -0.538 . . . . 1.6200000000000001 109.583 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 4.7 p-10 -106.0 114.42 28.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.192 0.52 . . . . 2.4700000000000002 111.211 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.835 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.9 mp -106.91 91.34 6.19 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.662 -0.699 . . . . 1.1899999999999999 109.347 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 32.1 Cg_exo -59.67 117.5 4.25 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 121.987 1.792 . . . . 0.89000000000000001 111.892 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.791 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 60.6 mt -120.57 138.09 52.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.828 0.347 . . . . 1.1699999999999999 111.02 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -136.82 7.3 2.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.132 -0.485 . . . . 3.7000000000000002 110.709 173.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.467 ' HB2' ' HH ' ' A' ' 83' ' ' TYR . 6.6 mm-40 -121.87 -177.31 3.54 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.076 -0.342 . . . . 2.1600000000000001 110.076 -173.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 5.0 mt-10 -128.05 -179.22 4.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.277 -0.419 . . . . 1.2 110.525 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.55 -172.65 15.44 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.637 -0.985 . . . . 0.35999999999999999 110.637 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.25 108.78 20.2 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.099 -0.64 . . . . 1.96 109.463 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.696 ' HB2' HG12 ' A' ' 133' ' ' ILE . 61.8 m-85 -92.58 125.52 37.25 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.482 -0.933 . . . . 1.1399999999999999 108.482 -177.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.585 HG21 ' CA ' ' A' ' 177' ' ' ALA . 72.4 t -114.74 105.75 19.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.314 -0.857 . . . . 1.0700000000000001 110.257 -173.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.419 HD21 HD12 ' A' ' 170' ' ' LEU . 5.4 mp -89.21 104.4 16.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.495 -1.23 . . . . 2.0600000000000001 108.82 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 84' ' ' VAL . 80.4 t -103.47 102.17 13.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.068 -1.086 . . . . 1.72 108.068 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.687 ' CD2' ' HB3' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -103.95 132.98 49.67 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.033 -0.667 . . . . 2.0600000000000001 110.216 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.678 ' HE3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -87.92 121.64 30.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.388 -0.968 . . . . 4.1900000000000004 108.388 173.208 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 6.2 m-85 -107.05 141.25 38.57 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.119 0.485 . . . . 0.54000000000000004 111.451 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.879 ' HB1' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.832 0 CA-C-N 115.159 -0.928 . . . . 1.1599999999999999 109.097 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.67 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 16.8 m . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 121.593 0.711 . . . . 1.8200000000000001 110.611 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 73.2 m-85 -104.48 158.7 16.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.042 -0.981 . . . . 1.1699999999999999 110.922 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.655 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 16.2 m-20 -108.88 137.64 46.49 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.718 -0.475 . . . . 1.53 109.718 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 110' ' ' THR . 0.3 OUTLIER -140.01 125.1 20.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.335 0.588 . . . . 1.3500000000000001 110.945 -177.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.777 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 41.5 mtt180 -108.13 138.34 44.57 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.18 -0.918 . . . . 2.3100000000000001 111.172 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.807 HG11 HD22 ' A' ' 153' ' ' LEU . 74.2 t -113.35 103.03 14.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.281 -0.637 . . . . 2.0899999999999999 109.281 170.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.418 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.2 OUTLIER 64.18 39.26 7.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.202 -0.908 . . . . 2.0899999999999999 108.949 -175.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.8 -22.37 34.19 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.3 -0.864 . . . . 0.41999999999999998 112.452 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 83.6 m-70 -83.64 101.15 11.3 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.556 0.342 . . . . 0.81999999999999995 111.857 -173.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.706 HG21 ' HG2' ' A' ' 105' ' ' ARG . 3.3 p -62.88 93.05 0.05 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.331 0.586 . . . . 1.3500000000000001 111.245 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.528 HG13 HG22 ' A' ' 131' ' ' ILE . 11.9 t -73.05 -47.59 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.559 -0.746 . . . . 1.6000000000000001 109.742 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.674 HG13 ' HG ' ' A' ' 115' ' ' LEU . 11.7 t -117.62 90.19 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 109.245 -0.65 . . . . 1.1200000000000001 109.245 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.36 71.67 0.76 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.901 0.858 . . . . 4.4000000000000004 108.935 178.399 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.67 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.5 p30 164.18 24.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.686 -1.597 . . . . 1.96 108.601 -169.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.674 ' HG ' HG13 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -71.34 90.89 0.96 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.427 -0.806 . . . . 1.78 111.563 -170.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.591 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 14.0 p30 -104.88 94.57 5.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.676 0.75 . . . . 1.9299999999999999 110.067 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.497 ' CD1' ' HB3' ' A' ' 89' ' ' PHE . 83.2 mt -61.7 -37.11 77.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.125 -0.943 . . . . 1.4199999999999999 111.653 -170.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -59.4 -38.56 80.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.2 110.873 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.73 -32.1 67.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.929 0.395 . . . . 0.95999999999999996 110.969 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 12.0 mmt85 -76.36 -49.24 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.899 -0.591 . . . . 2.1800000000000002 111.765 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.63 HG22 ' HA ' ' A' ' 127' ' ' HIS . 60.0 t -107.52 -36.09 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.104 0.409 . . . . 2.0899999999999999 112.104 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.08 -111.55 2.11 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.401 -0.904 . . . . 1.3999999999999999 111.867 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.404 ' C ' ' HG ' ' A' ' 124' ' ' SER . 7.4 t-80 -112.02 112.55 24.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.979 0.418 . . . . 4.9100000000000001 111.198 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.404 ' HG ' ' C ' ' A' ' 123' ' ' HIS . 33.0 p 53.03 -149.81 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.394 1.078 . . . . 2.1499999999999999 112.277 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.861 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 29.1 p 64.85 -160.42 0.28 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.996 0.918 . . . . 1.3999999999999999 110.932 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.654 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -94.88 122.27 37.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.469 0.544 . . . . 1.21 112.469 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.63 ' HA ' HG22 ' A' ' 121' ' ' VAL . 13.6 t60 -92.44 130.65 38.05 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.466 -0.568 . . . . 0.57999999999999996 109.466 167.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.81 121.67 42.21 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.16 -0.927 . . . . 1.6399999999999999 109.572 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.687 ' HB3' ' CD2' ' A' ' 87' ' ' LEU . 4.5 tp10 -123.92 108.29 12.27 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.409 -0.96 . . . . 1.6799999999999999 108.409 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.444 HG12 HG23 ' A' ' 86' ' ' VAL . 80.1 mt -94.1 118.21 39.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.889 -0.596 . . . . 1.3899999999999999 110.166 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.528 HG22 HG13 ' A' ' 111' ' ' VAL . 68.2 mt -117.94 93.67 44.75 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.534 -0.303 . . . . 1.8500000000000001 110.864 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.89 124.39 3.43 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.877 2.385 . . . . 0.33000000000000002 112.797 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.696 HG12 ' HB2' ' A' ' 83' ' ' TYR . 3.5 pt -109.51 166.29 4.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.575 -1.269 . . . . 1.1000000000000001 107.575 173.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.6 t -131.78 106.62 8.23 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.904 -0.406 . . . . 1.8200000000000001 109.904 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 49.7 mt -99.27 122.99 51.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.291 -0.633 . . . . 1.1399999999999999 109.291 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -150.78 136.62 18.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.86 -0.793 . . . . 2.4300000000000002 108.86 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm 66.95 17.95 10.56 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.196 0.522 . . . . 3.6000000000000001 110.544 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.15 12.08 77.18 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.815 -0.629 . . . . 0.45000000000000001 112.383 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 94.5 mttt -112.72 140.15 47.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.97 0.385 . . . . 2.7000000000000002 110.601 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.476 ' HG ' HD13 ' A' ' 133' ' ' ILE . 6.9 tt -103.27 115.67 31.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.518 -0.549 . . . . 1.1100000000000001 109.518 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.0 m -110.87 107.15 16.53 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.599 -0.519 . . . . 1.8100000000000001 109.599 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.464 HG22 HG22 ' A' ' 111' ' ' VAL . 4.0 p -90.72 106.99 18.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.369 -0.604 . . . . 1.5700000000000001 109.369 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 63.69 -81.07 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.555 -0.748 . . . . 1.8799999999999999 110.841 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.76 -0.56 3.55 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.851 -0.69 . . . . 1.25 112.046 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -95.66 113.96 25.65 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.522 -0.547 . . . . 1.95 109.522 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.31 132.47 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.13 0.49 . . . . 1.49 111.8 -171.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t -160.3 133.65 6.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.673 -0.694 . . . . 1.75 109.181 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 9.1 t -55.38 139.41 43.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.286 0.565 . . . . 1.8700000000000001 111.081 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.791 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 25.9 t80 -80.0 133.87 36.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.34 -0.845 . . . . 0.56999999999999995 110.536 -175.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 p -127.61 96.46 4.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.091 0.472 . . . . 2.2400000000000002 112.229 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.17 -69.52 3.15 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.77000000000000002 113.96 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.635 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -159.23 164.02 35.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.176 0.488 . . . . 1.8 110.552 -176.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.835 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 6.1 tt -81.81 142.84 32.22 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.131 -1.063 . . . . 1.8300000000000001 108.131 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.56 ' N ' HD23 ' A' ' 153' ' ' LEU . 9.9 t -135.83 107.6 7.04 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.313 -0.555 . . . . 1.72 110.648 -172.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.777 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 59.4 t -97.08 99.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.389 -0.369 . . . . 1.1699999999999999 111.141 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.16 123.76 42.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.725 -0.39 . . . . 1.98 110.457 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.45 ' HD2' HG22 ' A' ' 104' ' ' VAL . 49.0 t80 -102.65 118.03 35.95 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.461 -0.94 . . . . 2.9100000000000001 108.461 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 21.9 t -103.67 144.25 14.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.558 -0.746 . . . . 1.3 110.422 -173.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.3 pttt . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 121.147 0.499 . . . . 2.6699999999999999 112.205 -174.208 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.879 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 39.6 t . . . . . 0 C--O 1.241 0.616 0 CA-C-O 120.426 0.155 . . . . 1.8700000000000001 111.066 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.7 t -132.15 141.16 49.02 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 120.228 -0.589 . . . . 1.9099999999999999 110.974 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.667 ' HB1' ' CB ' ' A' ' 88' ' ' LYS . . . -131.35 35.06 3.91 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.428 -0.805 . . . . 1.05 109.311 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.764 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 14.4 tp -58.29 102.65 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.635 -1.166 . . . . 1.3500000000000001 112.427 -175.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.891 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -111.21 132.63 54.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.698 -0.683 . . . . 0.60999999999999999 109.659 176.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.711 HG22 ' HE3' ' A' ' 12' ' ' TRP . 5.3 tt -117.9 123.6 71.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.885 0.85 . . . . 1.1000000000000001 111.577 176.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.671 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 2.5 ppp? -115.52 163.36 15.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.295 -1.002 . . . . 1.1399999999999999 108.295 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.426 ' HE3' ' CB ' ' A' ' 79' ' ' GLU . 11.6 ptmm? -119.3 147.91 43.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 122.629 1.204 . . . . 1.74 113.362 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 176' ' ' THR . . . 106.18 -29.64 10.83 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 112.863 -1.971 . . . . 0.31 114.84 167.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.494 HG21 ' O ' ' A' ' 175' ' ' GLY . 0.6 OUTLIER -175.38 154.93 1.76 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.525 1.163 . . . . 1.3 112.478 -177.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.585 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -84.39 -17.85 38.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.886 -0.597 . . . . 1.3500000000000001 110.465 169.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.766 -0.652 . . . . 2.1600000000000001 111.302 -177.947 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.645 ' HG ' HD12 ' A' ' 27' ' ' ILE . 24.7 tp . . . . . 0 C--O 1.235 0.318 0 CA-C-O 121.311 0.576 . . . . 1.2 110.589 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.5 ' HB1' ' HA3' ' A' ' 26' ' ' GLY . . . -60.92 -22.91 64.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.4 -0.818 . . . . 1.1699999999999999 112.215 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.18 -21.6 59.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.536 -0.302 . . . . 2.1800000000000002 110.63 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 59.8 mmtt -114.14 -16.59 12.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.649 -0.42 . . . . 2.2599999999999998 111.799 -177.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 14.8 p -56.57 136.1 19.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.48 0.657 . . . . 1.1100000000000001 111.729 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 174' ' ' LYS . 5.4 pt -115.27 -28.45 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.614 -0.721 . . . . 1.51 110.64 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.714 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 67.1 t90 -169.17 140.29 2.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.232 -0.44 . . . . 0.42999999999999999 110.177 -170.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -162.42 147.21 12.27 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.317 -0.24 . . . . 1.0700000000000001 111.224 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.696 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 2.2 p -151.16 125.6 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 113.197 0.814 . . . . 1.45 113.197 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 1.7 t-20 -94.05 95.79 9.25 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 114.956 -1.02 . . . . 1.6100000000000001 108.65 170.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.616 ' HB1' ' OH ' ' A' ' 73' ' ' TYR . . . -58.54 103.21 0.14 Allowed 'General case' 0 C--O 1.246 0.907 0 CA-C-N 116.116 -0.493 . . . . 1.1599999999999999 109.723 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.793 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 174.2 -42.26 0.14 Allowed Glycine 0 N--CA 1.438 -1.191 0 O-C-N 124.882 1.364 . . . . 0.76000000000000001 113.98 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.24 -121.09 1.79 Allowed Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.001 -1.095 . . . . 0.82999999999999996 113.072 -167.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.672 ' CA ' ' HH ' ' A' ' 29' ' ' TYR . 46.1 mt-10 -148.59 119.52 7.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.847 0.323 . . . . 1.8400000000000001 111.237 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 55.7 m 32.83 105.19 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.0 1.482 . . . . 1.75 115.0 170.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.733 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 71.9 t60 -133.68 122.49 23.48 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.686 -0.634 . . . . 0.52000000000000002 111.244 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.38 116.1 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.815 -0.63 . . . . 1.6100000000000001 109.712 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -83.57 162.75 20.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.002 -0.544 . . . . 0.77000000000000002 110.715 -177.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.74 -24.95 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 113.001 0.741 . . . . 1.29 113.001 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.425 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 78.2 m-70 -80.52 1.17 30.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.426 -0.583 . . . . 1.02 109.426 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.5 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . 82.84 28.5 37.95 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.061 -0.972 . . . . 0.37 111.508 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.645 HD12 ' HG ' ' A' ' 6' ' ' LEU . 11.8 mm -102.47 111.59 32.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.139 0.495 . . . . 1.0900000000000001 111.015 -175.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -88.1 113.86 24.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.84 -0.618 . . . . 1.1200000000000001 111.427 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.696 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -80.46 129.37 34.47 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.148 -0.478 . . . . 1.9199999999999999 109.849 170.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.742 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 2.1 ptm180 -85.96 114.69 23.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 3.4399999999999999 110.391 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HG3' ' HA ' ' A' ' 19' ' ' GLU . 37.0 ttmt -27.22 126.7 0.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.185 0.994 . . . . 3.23 112.032 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.662 ' OD2' ' HD3' ' A' ' 65' ' ' ARG . 1.4 m-20 -32.64 98.72 0.13 Allowed Pre-proline 0 N--CA 1.465 0.283 0 O-C-N 125.115 1.51 . . . . 2.4100000000000001 114.342 -168.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.742 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 69.6 Cg_endo . . . . . 0 N--CA 1.446 -1.268 1 C-N-CA 125.454 4.103 . . . . 1.8700000000000001 114.152 -169.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.659 HG12 ' HE3' ' A' ' 88' ' ' LYS . 1.7 mp . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.999 0.904 . . . . 1.5900000000000001 109.947 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.12 -18.2 65.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.336 -1.302 . . . . 2.48 112.977 -172.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -96.35 4.2 52.41 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.726 -0.39 . . . . 3.7200000000000002 111.181 -173.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 m -125.28 145.25 50.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.903 -0.59 . . . . 0.96999999999999997 111.156 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.452 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 2.1 p-10 -79.85 151.99 74.2 Favored Pre-proline 0 C--O 1.214 -0.776 0 N-CA-C 109.609 -0.515 . . . . 1.9199999999999999 109.609 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 54' ' ' ASN . 3.5 Cg_exo -38.76 -46.67 2.66 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 124.307 3.338 . . . . 0.95999999999999996 115.419 -164.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -69.94 -53.54 17.37 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 122.064 0.935 . . . . 2.71 110.483 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -22.21 55.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.437 -0.801 . . . . 1.6299999999999999 109.711 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -55.78 -45.15 78.22 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.688 -0.687 . . . . 2.1200000000000001 109.651 170.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.3 t -57.29 -46.08 85.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.784 -0.45 . . . . 1.9099999999999999 109.784 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.733 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 30.6 tp -60.14 -19.4 53.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.454 0.645 . . . . 1.77 111.138 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.482 ' CD2' ' HG3' ' A' ' 88' ' ' LYS . 2.9 m-30 -115.83 6.68 14.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.938 -0.573 . . . . 1.3799999999999999 111.189 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.636 ' HA ' HD12 ' A' ' 50' ' ' ILE . 35.4 tt0 -122.02 -35.63 3.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.106 0.479 . . . . 1.97 111.821 -172.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.475 ' O ' HG11 ' A' ' 167' ' ' VAL . 1.0 OUTLIER -70.35 136.86 50.08 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.721 -0.672 . . . . 1.54 110.911 -176.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.793 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -120.76 149.46 42.5 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.089 0.556 . . . . 1.96 109.864 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.662 ' HD3' ' OD2' ' A' ' 32' ' ' ASP . 13.7 ttp-105 . . . . . 0 C--O 1.237 0.447 0 N-CA-C 112.524 0.564 . . . . 4.0700000000000003 112.524 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.946 0.403 . . . . 1.78 111.107 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.474 ' HD2' HH22 ' A' ' 65' ' ' ARG . 0.1 OUTLIER -138.99 137.42 36.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 2.2999999999999998 110.756 -175.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.736 ' HA3' ' HB3' ' A' ' 156' ' ' GLU . . . -151.43 -176.27 24.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.172 -1.013 . . . . 1.1599999999999999 113.656 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.616 ' OH ' ' HB1' ' A' ' 16' ' ' ALA . 48.6 m-85 -128.62 169.41 14.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.014 -0.593 . . . . 1.6200000000000001 111.777 -170.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -115.31 119.75 37.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.247 -0.888 . . . . 2.4700000000000002 110.594 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.804 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.1 mp -107.34 90.31 5.66 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.977 -0.749 . . . . 1.1899999999999999 108.977 171.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.613 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 43.6 Cg_endo -71.76 116.94 4.9 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.83 1.687 . . . . 0.89000000000000001 111.631 -176.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.817 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 82.7 mt -116.4 141.45 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.853 -0.612 . . . . 1.1699999999999999 110.872 -171.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 71.5 mmtt -139.31 20.95 2.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.746 0.308 . . . . 3.7000000000000002 110.922 174.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.66 -175.93 4.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.227 0.537 . . . . 2.1600000000000001 110.769 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 3.3 mt-10 -121.43 -172.62 2.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.266 -0.879 . . . . 1.2 109.771 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.56 -164.57 13.97 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.076 -0.81 . . . . 0.35999999999999999 111.076 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 36.5 mt-10 -106.19 104.43 14.13 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.186 -0.606 . . . . 1.96 109.643 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.658 ' HB2' HG12 ' A' ' 133' ' ' ILE . 20.7 m-30 -94.06 122.73 36.88 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.411 -0.959 . . . . 1.1399999999999999 108.411 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.663 HG21 ' CA ' ' A' ' 177' ' ' ALA . 88.0 t -107.18 106.5 20.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.866 0.841 . . . . 1.0700000000000001 110.45 -172.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.748 HD11 HD13 ' A' ' 170' ' ' LEU . 12.7 tp -89.66 103.94 16.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.362 -1.29 . . . . 2.0600000000000001 109.88 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 43.7 t -108.24 111.37 35.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.357 -0.979 . . . . 1.72 108.357 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.597 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -114.23 134.96 54.57 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.093 -0.643 . . . . 2.0600000000000001 110.423 178.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.814 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -93.57 122.91 36.5 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.073 -0.651 . . . . 4.1900000000000004 109.903 177.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.65 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 8.8 m-85 -108.42 140.48 41.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.138 -0.483 . . . . 0.54000000000000004 111.34 175.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 115.695 -0.684 . . . . 1.1599999999999999 110.213 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 1.019 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 25.7 m . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.078 0.466 . . . . 1.8200000000000001 111.011 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -128.06 164.41 22.47 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.993 -0.549 . . . . 1.1699999999999999 112.017 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.709 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 1.8 m-20 -107.35 137.79 44.74 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.572 -0.529 . . . . 1.53 109.572 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.784 HG22 ' HD1' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -132.12 124.26 52.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 109.183 -0.673 . . . . 1.3500000000000001 109.183 178.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 37.6 ptt180 -136.11 139.91 43.31 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.839 0.681 . . . . 2.3100000000000001 112.839 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.891 ' HB ' HD12 ' A' ' 153' ' ' LEU . 16.1 m -109.47 114.28 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.093 -0.958 . . . . 2.0899999999999999 111.195 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.677 ' HB2' HD11 ' A' ' 153' ' ' LEU . 65.7 t30 55.91 36.54 27.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.266 1.031 . . . . 2.0899999999999999 108.875 -174.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.21 -17.63 58.93 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.393 -1.276 . . . . 0.41999999999999998 112.803 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.501 ' ND1' ' HB3' ' A' ' 145' ' ' GLU . 90.4 m-70 -85.73 101.77 13.06 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.255 0.465 . . . . 0.81999999999999995 112.255 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 20.1 p -63.44 113.15 3.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.192 0.52 . . . . 1.3500000000000001 110.784 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 131' ' ' ILE . 17.5 t -91.92 -41.11 12.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.662 -0.699 . . . . 1.6000000000000001 109.234 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.63 HG22 ' HG2' ' A' ' 129' ' ' GLU . 4.8 t -130.36 91.5 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.65 -0.704 . . . . 1.1200000000000001 109.966 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -100.81 146.37 27.37 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.769 -1.197 . . . . 4.4000000000000004 107.769 169.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 1.019 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 68.9 m-20 77.36 38.42 0.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.564 1.165 . . . . 1.96 108.823 -167.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.506 HD13 ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -69.58 86.69 0.46 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.032 -0.985 . . . . 1.78 110.031 175.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.616 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 11.6 t70 -102.23 106.02 16.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.522 -0.918 . . . . 1.9299999999999999 108.522 172.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.97 -33.45 58.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 1.4199999999999999 111.636 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -68.64 -37.98 80.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.992 0.425 . . . . 1.2 110.086 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.56 -28.66 67.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.068 0.461 . . . . 0.95999999999999996 111.182 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 14.7 mmt180 -81.32 -45.52 16.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.359 0.503 . . . . 2.1800000000000002 112.359 -173.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.606 HG11 ' HA ' ' A' ' 127' ' ' HIS . 15.6 m -128.34 0.34 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.207 0.817 . . . . 2.0899999999999999 113.207 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.84 -97.54 1.86 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.136 -1.03 . . . . 1.3999999999999999 112.648 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -113.17 108.78 17.76 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.558 -0.378 . . . . 4.9100000000000001 111.553 -175.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.4 m 44.41 -122.4 0.88 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.412 1.07 . . . . 2.1499999999999999 112.754 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 70.0 p 51.12 -158.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.413 0.685 . . . . 1.3999999999999999 111.124 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.794 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . . . -99.12 110.08 22.7 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.484 -0.487 . . . . 1.21 111.63 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.606 ' HA ' HG11 ' A' ' 121' ' ' VAL . 12.9 t60 -83.35 126.18 32.44 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.106 -1.072 . . . . 0.57999999999999996 108.106 167.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -123.56 108.19 12.36 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.486 0.66 . . . . 1.6399999999999999 110.403 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.63 ' HG2' HG22 ' A' ' 112' ' ' VAL . 2.2 tp10 -102.03 108.95 20.54 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.962 -0.755 . . . . 1.6799999999999999 108.962 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.9 mt -96.54 115.61 36.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.799 -0.637 . . . . 1.3899999999999999 109.615 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.451 HG21 HG21 ' A' ' 111' ' ' VAL . 59.5 mt -122.43 93.16 48.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.251 -0.431 . . . . 1.8500000000000001 110.777 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -74.46 123.01 7.84 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.662 2.241 . . . . 0.33000000000000002 112.019 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.658 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.1 pt -109.86 146.57 15.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.61 -0.885 . . . . 1.1000000000000001 108.61 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.537 ' HG ' ' HB2' ' A' ' 141' ' ' SER . 35.3 p -115.9 106.98 14.42 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.899 0.381 . . . . 1.8200000000000001 110.106 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.548 HG12 ' HG ' ' A' ' 140' ' ' LEU . 25.6 mt -98.74 120.69 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 107.761 -1.2 . . . . 1.1399999999999999 107.761 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -144.33 122.63 12.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.118 0.485 . . . . 2.4300000000000002 110.317 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 18.1 mmmt 57.24 35.24 25.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.79 -1.095 . . . . 3.6000000000000001 111.5 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.37 7.15 69.96 Favored Glycine 0 C--O 1.227 -0.318 0 CA-C-N 115.597 -0.729 . . . . 0.45000000000000001 113.18 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 99.6 mttt -109.22 145.6 35.58 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 122.649 -0.324 . . . . 2.7000000000000002 110.168 174.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.655 HD12 ' HD1' ' A' ' 149' ' ' PHE . 5.9 tt -114.46 115.12 26.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.878 -0.786 . . . . 1.1100000000000001 108.878 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.537 ' HB2' ' HG ' ' A' ' 134' ' ' SER . 14.9 m -117.3 136.25 53.25 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.375 -0.375 . . . . 1.8100000000000001 110.042 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.537 HG23 ' CG2' ' A' ' 106' ' ' VAL . 58.4 t -123.71 92.53 2.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.614 -0.513 . . . . 1.5700000000000001 109.614 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 56.63 -87.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.105 -0.952 . . . . 1.8799999999999999 111.632 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.49 -10.88 34.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 1.25 112.507 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.501 ' HB3' ' ND1' ' A' ' 109' ' ' HIS . 64.1 mm-40 -87.86 139.87 30.08 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.974 -0.38 . . . . 1.95 109.974 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.42 130.44 12.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.312 0.577 . . . . 1.49 111.728 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.6 m -159.9 166.86 29.34 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.631 -0.877 . . . . 1.75 108.631 174.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 66.6 p -74.71 147.04 41.78 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.125 -0.694 . . . . 1.8700000000000001 109.125 173.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.817 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 65.3 t80 -79.07 128.2 32.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.801 0.334 . . . . 0.56999999999999995 110.114 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 t -132.64 101.8 5.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.63 0.728 . . . . 2.2400000000000002 111.515 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.96 -74.36 2.43 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.543 -0.753 . . . . 0.77000000000000002 113.777 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.613 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -155.29 169.43 24.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.379 0.609 . . . . 1.8 111.13 -174.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.891 HD12 ' HB ' ' A' ' 106' ' ' VAL . 44.2 tp -90.83 127.52 36.39 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.092 -0.958 . . . . 1.8300000000000001 109.23 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 97.0 p -97.01 142.51 28.88 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 119.373 -0.931 . . . . 1.72 109.553 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.531 HG23 HG11 ' A' ' 106' ' ' VAL . 97.0 t -130.59 97.34 3.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.803 -0.814 . . . . 1.1699999999999999 108.803 170.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.736 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 1.4 pm0 -126.78 141.85 51.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.188 -0.605 . . . . 1.98 111.279 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.784 ' HD1' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -102.65 122.24 44.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.235 -0.893 . . . . 2.9100000000000001 108.789 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 26.1 t -84.13 127.65 39.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.35 -0.386 . . . . 1.3 110.282 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.331 -0.234 0 O-C-N 124.74 1.275 . . . . 2.6699999999999999 111.723 -178.657 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.771 HG21 ' HB3' ' A' ' 64' ' ' GLU . 86.9 t . . . . . 0 CA--C 1.506 -0.747 0 N-CA-C 109.851 -0.426 . . . . 1.8700000000000001 109.851 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -130.98 133.29 45.66 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 119.695 -0.802 . . . . 1.9099999999999999 110.745 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -129.62 37.89 3.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.965 -0.561 . . . . 1.05 110.828 -175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.748 HD13 HD11 ' A' ' 85' ' ' LEU . 10.8 tp -41.92 126.96 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.615 -1.175 . . . . 1.3500000000000001 112.018 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.688 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 7.5 t80 -144.84 119.22 9.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.79 -0.186 . . . . 0.60999999999999999 110.577 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.626 ' HB ' HD13 ' A' ' 85' ' ' LEU . 9.3 tt -115.18 123.56 70.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.981 0.896 . . . . 1.1000000000000001 110.699 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.688 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.0 ppp? -117.54 159.35 23.01 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.218 -0.901 . . . . 1.1399999999999999 109.613 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.555 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 1.9 ptmm? -113.85 142.26 46.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 122.712 1.244 . . . . 1.74 114.218 -168.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.67 -30.25 10.09 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 112.708 -2.042 . . . . 0.31 114.264 162.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.46 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.1 OUTLIER -176.99 158.16 1.52 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.002 0.901 . . . . 1.3 112.265 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.663 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -82.96 -9.93 59.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.965 -0.562 . . . . 1.3500000000000001 110.375 172.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.46 ' H ' ' HB ' ' A' ' 176' ' ' THR . 5.0 m-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.694 -0.685 . . . . 2.1600000000000001 111.357 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.141 0 CA-C-O 121.07 0.261 . . . . 2.02 112.916 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.547 ' HG ' HD11 ' A' ' 27' ' ' ILE . 25.8 tp -71.19 -29.37 65.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.241 0.543 . . . . 1.2 109.879 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -63.25 -23.02 67.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.204 -0.907 . . . . 1.1699999999999999 111.686 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.581 ' HB3' ' HE3' ' A' ' 9' ' ' LYS . 22.6 t70 -83.0 -35.27 25.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.91 -0.587 . . . . 2.1800000000000002 111.404 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.581 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 10.6 mmtp -94.26 -19.33 20.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.893 -0.323 . . . . 2.2599999999999998 111.593 -171.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.501 HG21 ' HE1' ' A' ' 171' ' ' PHE . 7.2 p -56.01 134.78 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.018 0.437 . . . . 1.1100000000000001 111.424 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 pt -110.88 -22.56 4.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.209 -0.45 . . . . 1.51 110.581 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.551 ' HB3' ' CG2' ' A' ' 172' ' ' ILE . 77.1 t90 -170.54 146.07 2.69 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.696 -0.483 . . . . 0.42999999999999999 109.696 -173.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.472 ' O ' ' HD3' ' A' ' 30' ' ' ARG . . . -163.01 138.28 6.71 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.32 -0.238 . . . . 1.0700000000000001 111.003 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.781 HG23 ' HB2' ' A' ' 30' ' ' ARG . 84.4 t -146.84 121.78 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 122.574 0.35 . . . . 1.45 111.568 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.601 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 46.5 t30 -102.61 99.58 9.59 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.703 -0.48 . . . . 1.6100000000000001 109.703 167.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.07 105.44 1.06 Allowed 'General case' 0 C--O 1.243 0.747 0 N-CA-C 109.414 -0.587 . . . . 1.1599999999999999 109.414 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.562 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 158.24 -47.1 0.45 Allowed Glycine 0 N--CA 1.447 -0.601 0 O-C-N 124.248 0.968 . . . . 0.76000000000000001 113.337 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.07 -132.77 7.76 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.853 -0.689 . . . . 0.82999999999999996 112.727 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 16.9 mt-10 -156.87 120.27 4.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 119.679 -0.2 . . . . 1.8400000000000001 111.237 174.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 4.0 p 35.31 90.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.644 1.215 . . . . 1.75 113.499 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.683 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 79.6 t60 -131.16 133.75 45.86 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.574 -0.851 . . . . 0.52000000000000002 111.687 -174.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.17 116.22 36.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.724 -0.671 . . . . 1.6100000000000001 110.038 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.82 155.99 39.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.991 -0.55 . . . . 0.77000000000000002 109.768 176.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.45 -13.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 113.422 0.897 . . . . 1.29 113.422 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -93.57 -0.66 56.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.421 0.629 . . . . 1.02 109.357 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 93.71 31.13 8.43 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 114.826 -1.079 . . . . 0.37 112.811 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.547 HD11 ' HG ' ' A' ' 6' ' ' LEU . 21.6 mm -103.93 109.3 26.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.14 0.495 . . . . 1.0900000000000001 110.907 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -92.11 114.03 26.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 1.1200000000000001 111.431 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.61 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -78.45 131.18 36.79 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.995 -0.548 . . . . 1.9199999999999999 110.881 176.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.781 ' HB2' HG23 ' A' ' 14' ' ' VAL . 8.2 mpt_? -69.9 102.5 1.99 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 125.018 1.449 . . . . 3.4399999999999999 111.565 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.627 ' HG2' ' HA3' ' A' ' 39' ' ' GLY . 14.7 ttmm -38.96 96.33 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.953 1.094 . . . . 3.23 113.953 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.949 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 75.0 m-20 30.22 78.25 0.29 Allowed Pre-proline 0 N--CA 1.476 0.859 0 C-N-CA 124.6 1.16 . . . . 2.4100000000000001 113.297 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 16.4 Cg_endo -97.42 2.81 1.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.985 2.456 . . . . 1.8700000000000001 114.347 -170.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.521 HD11 ' CD1' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -119.01 -24.41 6.55 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.208 1.188 . . . . 2.4399999999999999 114.208 -173.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.94 86.47 4.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.681 0.673 . . . . 5.3099999999999996 109.928 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' C ' ' HG2' ' A' ' 37' ' ' ARG . . . 73.85 -0.59 50.65 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 109.972 -1.251 . . . . 2.6899999999999999 109.972 -172.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.415 ' HG2' ' C ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 50.95 39.62 23.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 113.859 -1.171 . . . . 6.0700000000000003 110.803 -171.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 m -122.51 137.05 57.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.938 -0.574 . . . . 4.3700000000000001 110.394 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.949 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -99.89 135.4 12.12 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.929 -0.653 . . . . 2.9300000000000002 113.373 -173.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.863 ' HA ' ' HE ' ' A' ' 40' ' ' ARG . 1.3 mmp_? -149.56 95.42 2.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.01 -0.367 . . . . 6.8399999999999999 110.01 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.71 107.53 0.4 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.6 -0.727 . . . . 2.0800000000000001 111.236 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 m -102.96 50.1 0.82 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.264 -0.88 . . . . 2.8100000000000001 109.559 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.515 ' HA ' HG21 ' A' ' 63' ' ' THR . 0.3 OUTLIER -56.72 -74.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.359 -0.837 . . . . 2.52 110.923 178.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.6 t80 68.85 -63.2 0.37 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.288 0.635 . . . . 7.3399999999999999 112.16 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -102.79 60.48 0.51 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.078 -0.582 . . . . 3.54 112.499 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.444 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 58.8 mtp -71.88 -0.37 11.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.629 0.728 . . . . 2.7799999999999998 110.704 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -88.05 5.41 41.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.189 -0.914 . . . . 4.6399999999999997 110.474 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.612 HD12 HG12 ' A' ' 92' ' ' VAL . 93.1 mt -116.51 79.54 9.44 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.696 -0.684 . . . . 3.0299999999999998 110.102 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -57.76 144.45 93.3 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.935 2.423 . . . . 2.0600000000000001 112.694 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.6 HG21 ' HB2' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -81.04 -5.05 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.803 0.811 . . . . 1.5900000000000001 109.407 178.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.7 tp 69.26 -52.99 0.59 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.282 -1.326 . . . . 2.48 112.594 174.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -68.64 -21.88 64.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.449 -0.341 . . . . 3.7200000000000002 111.764 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.426 ' HB3' ' CA ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -113.67 146.49 39.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.993 0.738 . . . . 0.96999999999999997 112.993 -170.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.579 HD22 ' HG2' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -69.16 146.04 96.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 114.485 -1.234 . . . . 1.9199999999999999 109.312 175.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.553 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 52.9 Cg_exo -38.24 -43.56 1.81 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.162 3.241 . . . . 0.95999999999999996 116.161 -165.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.586 ' HB2' ' HE1' ' A' ' 21' ' ' HIS . 10.7 pt-20 -78.56 -50.1 12.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.203 0.525 . . . . 2.71 111.039 -173.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -74.88 -19.86 59.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.165 0.507 . . . . 1.6299999999999999 109.695 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.426 ' CA ' ' HB3' ' A' ' 53' ' ' SER . 27.8 tt0 -59.69 -43.29 94.11 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.725 -0.67 . . . . 2.1200000000000001 109.948 168.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 55' ' ' PRO . 91.4 t -54.18 -43.8 61.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.593 -0.521 . . . . 1.9099999999999999 109.593 173.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.683 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 26.5 tp -67.53 -14.03 62.58 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.148 -0.933 . . . . 1.77 111.653 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.685 ' CE2' ' HE3' ' A' ' 88' ' ' LYS . 12.0 m-30 -118.39 7.74 12.0 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 111.833 0.309 . . . . 1.3799999999999999 111.833 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.473 ' HB2' HD12 ' A' ' 50' ' ' ILE . 4.5 tt0 -127.2 -43.01 1.66 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.75 0.648 . . . . 1.97 112.75 -172.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.542 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 18.7 p -67.37 130.82 44.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.276 0.473 . . . . 1.54 112.276 -174.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.804 ' HB3' HG21 ' A' ' 167' ' ' VAL . 8.7 pt-20 -114.94 156.65 24.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.048 0.452 . . . . 1.96 111.59 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.604 ' HD2' ' CG ' ' A' ' 32' ' ' ASP . 37.8 mtp85 -106.22 -157.54 0.62 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.948 -0.569 . . . . 4.0700000000000003 111.461 173.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.471 ' H ' ' HB3' ' A' ' 65' ' ' ARG . 5.4 m-85 -96.85 99.19 10.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 5.0 111.384 -169.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.634 HD22 ' HG3' ' A' ' 166' ' ' LYS . 72.5 m-20 -68.22 132.64 47.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.339 -0.391 . . . . 5.1799999999999997 110.468 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.31 -59.93 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.996 -0.547 . . . . 3.7000000000000002 110.858 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -151.74 -163.69 1.81 Allowed 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.484 -0.562 . . . . 2.2000000000000002 109.484 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.3 t -63.68 107.7 1.23 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.701 0.286 . . . . 1.78 110.345 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.552 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 11.5 p90 -124.52 140.18 53.19 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.116 -0.698 . . . . 2.2999999999999998 109.116 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.511 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -136.77 161.81 25.12 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.133 -1.032 . . . . 1.1599999999999999 114.8 -167.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.521 ' CD1' HD11 ' A' ' 34' ' ' LEU . 60.1 m-85 -100.43 152.85 19.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.854 -0.673 . . . . 1.6200000000000001 111.847 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.549 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 9.4 t0 -116.24 103.61 10.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.067 -0.97 . . . . 2.4700000000000002 108.646 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.86 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.7 mp -103.87 89.87 2.6 Favored Pre-proline 0 N--CA 1.464 0.246 0 N-CA-C 110.121 -0.325 . . . . 1.1899999999999999 110.121 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.587 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 38.6 Cg_exo -57.59 117.53 4.25 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.194 1.929 . . . . 0.89000000000000001 112.733 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.663 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 67.9 mt -117.12 136.29 54.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.937 -0.574 . . . . 1.1699999999999999 110.237 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -130.45 10.16 5.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.405 -0.361 . . . . 3.7000000000000002 110.988 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.594 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 23.3 tt0 -139.09 -176.89 4.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.148 -0.316 . . . . 2.1600000000000001 110.148 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.638 ' HG3' ' O ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -130.32 157.51 42.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.559 -0.534 . . . . 1.2 109.559 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.08 -162.85 28.84 Favored Glycine 0 C--O 1.234 0.154 0 N-CA-C 110.354 -1.098 . . . . 0.35999999999999999 110.354 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 27.7 mt-10 -99.68 102.66 14.21 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 118.281 1.04 . . . . 1.96 110.198 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.637 ' HB2' HG12 ' A' ' 133' ' ' ILE . 79.1 m-85 -94.68 124.27 38.62 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.243 -1.021 . . . . 1.1399999999999999 108.243 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.809 HG22 ' HA ' ' A' ' 177' ' ' ALA . 52.9 t -104.8 105.68 19.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.64 0.734 . . . . 1.0700000000000001 109.902 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.778 HD13 ' HB ' ' A' ' 172' ' ' ILE . 7.5 tp -89.48 101.41 14.09 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.348 -1.297 . . . . 2.0600000000000001 108.548 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.57 104.61 17.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.778 0.799 . . . . 1.72 108.848 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.635 ' CD1' ' HB2' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -104.55 134.53 47.57 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.405 -0.816 . . . . 2.0600000000000001 109.959 -178.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.799 ' HD2' ' HB3' ' A' ' 126' ' ' ALA . 10.9 tppt? -96.05 120.08 35.69 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.941 -0.703 . . . . 4.1900000000000004 109.4 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.808 ' CE1' ' HB3' ' A' ' 165' ' ' PRO . 13.8 m-85 -106.26 141.81 36.99 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.781 -0.645 . . . . 0.54000000000000004 110.374 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.446 ' HB2' ' CG2' ' A' ' 167' ' ' VAL . . . -136.44 148.38 47.72 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.72 -0.673 . . . . 1.1599999999999999 109.661 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.596 ' HB2' HD12 ' A' ' 117' ' ' ILE . 38.6 tt0 -148.37 115.98 6.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.856 0.36 . . . . 2.6200000000000001 110.791 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.612 HG12 HD12 ' A' ' 48' ' ' LEU . 18.6 t -137.33 80.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 4.1900000000000004 109.651 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.763 ' HB2' ' HE2' ' A' ' 166' ' ' LYS . 18.4 t80 -150.37 -69.52 0.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.794 -0.362 . . . . 5.96 111.507 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -116.41 111.27 19.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 5.46 110.25 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.96 91.11 1.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.914 -0.584 . . . . 1.8500000000000001 111.656 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -156.25 140.44 16.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.061 -0.518 . . . . 3.3300000000000001 110.217 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.71 ' HB3' ' HB2' ' A' ' 119' ' ' ASP . 15.0 m -114.32 152.25 31.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.258 -0.428 . . . . 1.78 110.402 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 53.03 32.84 13.58 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.541 0.526 . . . . 2.75 112.258 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -138.08 -50.52 0.58 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.941 -0.762 . . . . 3.4300000000000002 108.941 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.636 ' HG2' ' HB3' ' A' ' 161' ' ' TYR . 7.0 mtpm? -79.38 75.36 5.97 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.691 -0.855 . . . . 3.25 108.691 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.3 m -106.6 110.2 30.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 122.134 0.969 . . . . 1.8200000000000001 110.316 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.811 ' HB3' ' HD3' ' A' ' 165' ' ' PRO . 11.8 m-85 -87.74 164.12 16.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.173 -1.376 . . . . 1.1699999999999999 111.682 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.65 137.8 41.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.566 -0.902 . . . . 1.53 108.566 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.635 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 2.5 t -131.91 113.09 21.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.902 -0.59 . . . . 1.3500000000000001 109.51 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.722 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 62.9 mtt180 -122.6 130.15 52.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 2.3100000000000001 111.471 -173.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.865 HG11 HD12 ' A' ' 153' ' ' LEU . 21.8 t -105.62 99.88 9.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.154 -0.93 . . . . 2.0899999999999999 109.413 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.799 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 4.1 t-20 57.87 51.81 8.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.219 1.009 . . . . 2.0899999999999999 109.022 -170.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.5 -20.18 19.64 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 114.544 -1.207 . . . . 0.41999999999999998 113.163 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.541 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 95.4 m-70 -79.25 107.33 11.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.01 0.374 . . . . 0.81999999999999995 112.01 -172.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.53 HG23 ' HG2' ' A' ' 105' ' ' ARG . 3.1 p -68.52 96.61 0.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.19 0.519 . . . . 1.3500000000000001 111.198 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.83 HG11 HD11 ' A' ' 131' ' ' ILE . 22.3 t -85.32 -46.14 17.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.832 -0.622 . . . . 1.6000000000000001 109.568 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.635 ' HB ' ' HB ' ' A' ' 104' ' ' VAL . 10.2 t -119.2 88.35 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.441 0.639 . . . . 1.1200000000000001 109.645 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 51.9 tptt -103.85 76.5 1.38 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.211 -1.033 . . . . 4.4000000000000004 108.211 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.559 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 4.8 p-10 162.43 14.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.154 -1.384 . . . . 1.96 110.457 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.719 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -66.47 98.29 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.867 0.365 . . . . 1.78 111.37 -169.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -112.87 94.58 4.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.066 0.936 . . . . 1.9299999999999999 109.641 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 91' ' ' GLU . 56.2 mt -61.03 -46.8 95.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.713 -1.13 . . . . 1.4199999999999999 111.829 -170.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.4 ' HD2' ' HG ' ' A' ' 97' ' ' SER . 86.7 t80 -53.64 -37.17 62.85 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.092 0.404 . . . . 1.2 112.092 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.71 ' HB2' ' HB3' ' A' ' 97' ' ' SER . 16.4 t70 -71.73 -39.54 70.02 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.719 -0.392 . . . . 0.95999999999999996 110.806 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -74.2 -43.72 56.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.89 -0.595 . . . . 2.1800000000000002 111.607 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 117' ' ' ILE . 29.7 m -92.71 -32.66 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.87 -0.332 . . . . 2.0899999999999999 111.829 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.1 -69.89 3.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 1.3999999999999999 111.789 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -114.92 169.47 9.06 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.032 -0.359 . . . . 4.9100000000000001 110.032 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.6 m -59.92 97.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.245 0.545 . . . . 2.1499999999999999 112.142 -173.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 36.8 p -144.75 -166.44 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.391 -0.822 . . . . 1.3999999999999999 109.004 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.799 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . . . -100.58 118.21 36.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.765 0.317 . . . . 1.21 111.69 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.456 ' HB2' ' CG1' ' A' ' 121' ' ' VAL . 83.8 t60 -95.57 136.98 35.26 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.206 -0.664 . . . . 0.57999999999999996 109.206 175.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.2 132.31 43.01 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.871 -0.732 . . . . 1.6399999999999999 112.167 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.635 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 77.0 mm-40 -110.95 114.09 27.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.12 -0.945 . . . . 1.6799999999999999 108.673 170.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.44 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 46.0 mt -96.34 109.8 23.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.084 -0.71 . . . . 1.3899999999999999 109.084 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.83 HD11 HG11 ' A' ' 111' ' ' VAL . 31.2 mm -118.43 88.14 32.8 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.612 -0.267 . . . . 1.8500000000000001 110.908 -171.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 130' ' ' ILE . 8.3 Cg_exo -74.57 127.47 11.02 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.593 2.196 . . . . 0.33000000000000002 111.796 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.637 HG12 ' HB2' ' A' ' 83' ' ' TYR . 3.4 pt -110.13 144.73 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.857 -0.794 . . . . 1.1000000000000001 108.857 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 p -116.34 107.67 15.12 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.205 0.526 . . . . 1.8200000000000001 110.44 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.638 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 3.9 mt -98.68 131.71 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.194 -0.669 . . . . 1.1399999999999999 109.194 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.44 ' HD3' ' HG3' ' A' ' 80' ' ' GLU . 71.6 mmtt -148.38 129.73 14.74 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 123.641 0.588 . . . . 2.4300000000000002 109.896 174.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 60.61 24.95 14.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.828 -0.624 . . . . 3.6000000000000001 111.526 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.05 8.43 66.89 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.557 -0.83 . . . . 0.45000000000000001 112.857 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.633 ' HG3' HG21 ' A' ' 148' ' ' THR . 8.9 mptt -111.69 139.65 46.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.682 -0.488 . . . . 2.7000000000000002 109.682 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.4 tt -115.08 115.73 27.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.981 -0.554 . . . . 1.1100000000000001 109.738 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.1 m -109.07 115.04 29.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 1.8100000000000001 110.837 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.81 104.92 17.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 O-C-N 122.282 -0.261 . . . . 1.5700000000000001 110.337 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 64.17 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.816 0.697 . . . . 1.8799999999999999 110.928 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.51 1.68 5.66 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.944 -0.646 . . . . 1.25 112.27 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -99.14 112.8 24.85 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.0 -0.37 . . . . 1.95 110.0 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 p -115.02 119.23 61.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.385 0.612 . . . . 1.49 111.482 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.8 m -145.94 156.16 43.33 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.928 -0.767 . . . . 1.75 108.928 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.633 HG21 ' HG3' ' A' ' 139' ' ' LYS . 41.6 p -63.17 140.58 58.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.835 0.35 . . . . 1.8700000000000001 110.536 176.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.663 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 18.0 t80 -79.48 142.8 35.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.618 . . . . 0.56999999999999995 109.489 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -137.95 102.71 4.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.274 0.559 . . . . 2.2400000000000002 111.798 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.65 -64.27 3.31 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.693 -0.685 . . . . 0.77000000000000002 113.979 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.675 ' HE2' ' HB3' ' A' ' 154' ' ' SER . 0.0 OUTLIER -155.92 170.65 21.62 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 117.137 0.469 . . . . 1.8 110.723 -178.332 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.865 HD12 HG11 ' A' ' 106' ' ' VAL . 22.7 tp -81.21 131.19 35.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.047 -1.094 . . . . 1.8300000000000001 108.047 174.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.799 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 p -123.51 102.35 7.83 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.6 -0.84 . . . . 1.72 111.85 -171.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.722 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 48.4 t -93.01 95.97 5.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.231 -0.588 . . . . 1.1699999999999999 110.146 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -98.72 119.83 38.12 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.203 -0.666 . . . . 1.98 109.203 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.552 ' CE2' ' CE1' ' A' ' 71' ' ' PHE . 1.9 p90 -115.92 126.57 54.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.047 0.927 . . . . 2.9100000000000001 110.535 175.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.45 144.59 16.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.791 -1.549 . . . . 1.3 110.87 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.623 ' HA ' ' HB3' ' A' ' 164' ' ' ASN . 24.8 pttm -68.02 137.11 54.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.593 -0.73 . . . . 2.6699999999999999 111.364 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -101.85 -93.61 2.21 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.534 -1.026 . . . . 1.45 110.534 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.636 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 76.9 t80 -89.86 87.11 6.83 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.719 -0.845 . . . . 4.5 108.719 172.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.456 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 88.6 t80 65.05 -71.58 0.08 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 124.027 0.83 . . . . 5.1500000000000004 111.296 -173.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.6 ' HB2' ' HZ1' ' A' ' 100' ' ' LYS . 15.7 m-20 -69.04 151.96 45.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.55 0.69 . . . . 2.6400000000000001 110.873 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.87 ' HB2' ' HD2' ' A' ' 165' ' ' PRO . 10.0 p30 -110.14 -165.11 0.06 OUTLIER Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 105.932 -1.877 . . . . 2.0600000000000001 105.932 161.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.87 ' HD2' ' HB2' ' A' ' 164' ' ' ASN . 23.5 Cg_exo -42.1 96.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.588 1.525 . . . . 3.6899999999999999 112.455 169.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.763 ' HE2' ' HB2' ' A' ' 93' ' ' TYR . 32.0 tttp -64.59 -62.61 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.745 -1.116 . . . . 3.5899999999999999 110.829 -170.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.804 HG21 ' HB3' ' A' ' 64' ' ' GLU . 61.7 t -96.92 132.63 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.353 -0.981 . . . . 1.8700000000000001 108.353 170.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 38.8 t -134.46 88.12 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.812 -0.755 . . . . 1.9099999999999999 112.133 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.75 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -80.0 36.49 0.34 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 124.466 1.106 . . . . 1.05 112.658 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.7 HD13 HD11 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -35.92 120.48 0.61 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.412 0.685 . . . . 1.3500000000000001 111.507 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 4.1 t80 -136.18 109.7 7.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.497 -0.32 . . . . 0.60999999999999999 110.317 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.778 ' HB ' HD13 ' A' ' 85' ' ' LEU . 6.7 tt -104.17 121.46 55.83 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 121.899 0.857 . . . . 1.1000000000000001 110.583 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.672 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.2 ppp? -119.07 152.53 36.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.435 -0.802 . . . . 1.1399999999999999 109.705 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.533 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 72.6 tttt -97.87 139.4 33.78 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 114.895 1.443 . . . . 1.74 114.895 -169.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.87 -28.89 12.97 Favored Glycine 0 C--N 1.317 -0.473 0 CA-C-N 113.196 -1.82 . . . . 0.31 115.61 155.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.81 155.0 3.77 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.28 1.04 . . . . 1.3 113.439 -174.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.809 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -84.78 -21.2 30.06 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.19 -0.914 . . . . 1.3500000000000001 110.973 173.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.113 0.482 . . . . 2.1600000000000001 111.582 -175.608 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 112.41 -0.276 . . . . 2.02 112.41 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.592 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.3 tp -58.67 -46.83 86.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.062 0.458 . . . . 1.2 110.618 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 25' ' ' HIS . . . -63.03 -23.79 67.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.628 -0.714 . . . . 1.1699999999999999 111.811 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.9 -43.94 14.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.285 -0.416 . . . . 2.1800000000000002 110.885 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.692 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 32.2 mmtp -87.24 -10.74 51.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.489 0.552 . . . . 2.2599999999999998 112.489 -172.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.569 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 14.1 p -57.28 135.77 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.323 0.583 . . . . 1.1100000000000001 111.111 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.471 HG22 ' HZ2' ' A' ' 174' ' ' LYS . 42.2 pt -119.35 -28.18 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.909 -0.587 . . . . 1.51 110.829 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.596 ' CH2' ' HB3' ' A' ' 73' ' ' TYR . 59.5 t90 -166.4 119.97 1.08 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.038 -0.528 . . . . 0.42999999999999999 109.908 -170.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -135.49 140.1 44.53 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.114 -0.328 . . . . 1.0700000000000001 110.114 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.89 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 55.0 t -140.5 105.71 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 112.615 0.598 . . . . 1.45 112.615 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.654 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 14.0 t-20 -81.53 89.3 6.17 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.082 -1.081 . . . . 1.6100000000000001 108.082 164.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.52 101.14 0.42 Allowed 'General case' 0 C--O 1.248 1.026 0 N-CA-C 109.268 -0.642 . . . . 1.1599999999999999 109.268 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.728 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 155.17 -44.08 0.56 Allowed Glycine 0 N--CA 1.441 -1.018 0 O-C-N 125.66 1.85 . . . . 0.76000000000000001 110.865 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' C ' ' HE2' ' A' ' 29' ' ' TYR . . . -102.42 -150.63 23.01 Favored Glycine 0 C--O 1.225 -0.409 0 CA-C-N 115.193 -0.504 . . . . 0.82999999999999996 112.958 -172.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.069 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 3.9 tm-20 -149.34 121.06 8.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.929 0.365 . . . . 1.8400000000000001 111.248 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.753 ' HB2' ' HB2' ' A' ' 31' ' ' LYS . 5.9 t 34.61 86.96 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.846 1.341 . . . . 1.75 112.839 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.875 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 67.4 t60 -129.42 132.01 46.9 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 119.75 -0.78 . . . . 0.52000000000000002 111.541 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.4 120.75 45.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.597 -0.729 . . . . 1.6100000000000001 110.338 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.86 154.36 31.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.754 -0.657 . . . . 0.77000000000000002 109.383 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.1 m -61.52 -10.22 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 113.871 1.063 . . . . 1.29 113.871 -171.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.522 ' HB2' HD21 ' A' ' 6' ' ' LEU . 66.7 m-70 -95.35 -0.82 52.28 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.213 -0.662 . . . . 1.02 109.213 175.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.05 30.4 8.34 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.128 -0.942 . . . . 0.37 112.923 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.592 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.9 mm -104.08 115.46 46.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.08 0.466 . . . . 1.0900000000000001 111.037 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -102.43 122.11 43.65 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.008 0.373 . . . . 1.1200000000000001 112.008 -171.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.89 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -86.4 139.47 30.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.222 -0.444 . . . . 1.9199999999999999 111.164 175.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.426 ' HG2' HG22 ' A' ' 14' ' ' VAL . 11.2 mmm180 -72.61 -7.89 52.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.527 1.677 . . . . 3.4399999999999999 115.527 -161.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 1.069 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 25.3 ttmt 70.18 103.92 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.434 0.531 . . . . 3.23 112.434 -176.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.983 ' HB3' ' HA ' ' A' ' 38' ' ' VAL . 2.3 m-20 60.13 58.27 4.39 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.849 1.055 . . . . 2.4100000000000001 113.849 165.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 30.0 Cg_endo -107.48 -153.23 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.639 2.893 . . . . 1.8700000000000001 113.492 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.978 HD12 ' HB2' ' A' ' 71' ' ' PHE . 0.2 OUTLIER 84.18 -71.76 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.476 1.11 . . . . 2.4399999999999999 112.775 169.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.781 ' HB2' ' HD3' ' A' ' 37' ' ' ARG . 14.2 mm-40 -126.1 28.85 5.98 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.322 -0.551 . . . . 5.3099999999999996 111.457 -172.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.91 1.86 90.64 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.841 -1.171 . . . . 2.6899999999999999 111.516 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.781 ' HD3' ' HB2' ' A' ' 35' ' ' GLU . 8.4 mpt_? -67.32 66.33 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.568 0.747 . . . . 6.0700000000000003 111.386 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.983 ' HA ' ' HB3' ' A' ' 32' ' ' ASP . 16.9 t -105.21 117.42 50.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.896 -0.593 . . . . 4.3700000000000001 109.694 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 166.33 -77.68 0.13 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.22 -0.991 . . . . 2.9300000000000002 113.037 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -119.75 135.63 54.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.206 0.527 . . . . 6.8399999999999999 112.048 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.721 ' HA ' ' NH2' ' A' ' 65' ' ' ARG . . . -82.05 98.3 8.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.259 -0.882 . . . . 2.0800000000000001 109.899 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.541 ' OG ' ' HA ' ' A' ' 65' ' ' ARG . 16.3 p -65.57 131.05 45.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.076 -0.511 . . . . 2.8100000000000001 110.455 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.542 ' HB2' ' HB2' ' A' ' 46' ' ' MET . 8.6 p-10 -139.74 36.9 2.0 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.91 0.862 . . . . 2.52 109.62 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -68.1 -25.92 65.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.892 -1.049 . . . . 7.3399999999999999 110.374 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.3 34.32 4.74 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.68 -0.691 . . . . 3.54 111.607 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.542 ' HB2' ' HB2' ' A' ' 43' ' ' ASP . 24.3 ttt -72.13 -13.2 61.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.021 0.439 . . . . 2.7799999999999998 110.577 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -83.58 57.52 4.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.426 0.631 . . . . 4.6399999999999997 109.649 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.51 73.59 20.31 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.871 -0.788 . . . . 3.0299999999999998 108.871 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.76 109.71 0.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.136 1.89 . . . . 2.0600000000000001 112.588 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.562 HG23 ' HB3' ' A' ' 126' ' ' ALA . 1.4 mp -68.49 111.92 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.676 -0.693 . . . . 1.5900000000000001 110.087 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -68.17 -23.25 64.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.409 -0.814 . . . . 2.48 112.52 -171.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -100.54 36.33 1.93 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.759 0.314 . . . . 3.7200000000000002 111.331 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.536 ' HB3' HG21 ' A' ' 50' ' ' ILE . 42.2 t -154.36 153.54 31.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.172 -0.467 . . . . 0.96999999999999997 111.142 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.9 140.93 50.54 Favored Pre-proline 0 C--O 1.219 -0.506 0 N-CA-C 109.087 -0.709 . . . . 1.9199999999999999 109.087 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.481 ' O ' HG21 ' A' ' 59' ' ' VAL . 5.1 Cg_exo -39.22 -39.54 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.537 3.491 . . . . 0.95999999999999996 115.992 -167.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.53 -55.09 6.78 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.484 1.135 . . . . 2.71 110.068 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.58 -15.11 60.4 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.048 -0.978 . . . . 1.6299999999999999 109.655 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -60.73 -43.09 98.34 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.464 -0.789 . . . . 2.1200000000000001 109.294 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 55' ' ' PRO . 58.3 t -58.52 -40.86 80.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.154 -0.476 . . . . 1.9099999999999999 109.848 174.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.875 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 23.6 tp -68.87 -22.78 64.18 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.583 -0.447 . . . . 1.77 111.573 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.441 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 9.1 m-30 -101.06 1.93 39.91 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.278 0.561 . . . . 1.3799999999999999 109.667 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.564 ' O ' HG11 ' A' ' 167' ' ' VAL . 11.5 tt0 -124.44 -124.55 0.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.034 -0.984 . . . . 1.97 109.301 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.728 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.7 OUTLIER 29.04 104.05 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.751 1.22 . . . . 1.54 114.143 -173.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HB2' ' HG2' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -81.82 148.16 29.0 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.086 0.469 . . . . 1.96 112.027 -178.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.721 ' NH2' ' HA ' ' A' ' 41' ' ' ALA . 2.1 ttm180 -109.86 91.33 3.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.533 -0.303 . . . . 4.0700000000000003 111.433 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 57.45 -160.79 0.23 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.536 0.684 . . . . 5.0 111.913 173.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -123.21 75.02 1.27 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.452 -0.794 . . . . 5.1799999999999997 109.395 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -78.59 -164.29 0.56 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.895 -1.048 . . . . 3.7000000000000002 111.919 -172.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -167.49 128.83 1.53 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.828 -1.078 . . . . 2.2000000000000002 109.875 -173.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 m 52.08 55.34 9.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 124.007 0.817 . . . . 1.78 110.574 168.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.978 ' HB2' HD12 ' A' ' 34' ' ' LEU . 2.2 p90 -111.24 138.37 47.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.911 -1.041 . . . . 2.2999999999999998 111.296 -167.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.527 ' O ' HD11 ' A' ' 34' ' ' LEU . . . -129.57 146.37 17.19 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.661 -0.78 . . . . 1.1599999999999999 113.658 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.596 ' HB3' ' CH2' ' A' ' 12' ' ' TRP . 57.7 m-85 -103.44 136.43 43.2 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.42 -0.39 . . . . 1.6200000000000001 110.769 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -99.51 115.63 29.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.034 -0.53 . . . . 2.4700000000000002 110.937 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.836 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.3 mp -110.01 89.86 8.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.602 -0.726 . . . . 1.1899999999999999 109.358 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.661 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 21.8 Cg_exo -63.66 121.19 8.85 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 C-N-CA 121.992 1.795 . . . . 0.89000000000000001 111.727 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.896 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 64.9 mt -121.47 143.05 35.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.715 0.293 . . . . 1.1699999999999999 111.019 -174.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -127.05 -12.25 5.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.262 -0.426 . . . . 3.7000000000000002 111.443 173.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -112.03 168.15 9.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 2.1600000000000001 111.387 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -106.5 -178.37 3.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.799 -0.637 . . . . 1.2 110.6 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.36 -169.58 15.6 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.144 -0.782 . . . . 0.35999999999999999 111.144 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 5.1 mm-40 -98.87 103.28 15.22 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.083 -0.71 . . . . 1.96 109.083 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.668 ' HB2' HG12 ' A' ' 133' ' ' ILE . 2.4 m-85 -92.37 124.37 36.37 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 119.225 -0.99 . . . . 1.1399999999999999 108.8 -173.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.559 HG22 ' CA ' ' A' ' 177' ' ' ALA . 49.0 t -107.3 105.6 19.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.22 -0.9 . . . . 1.0700000000000001 109.937 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' A' ' 172' ' ' ILE . 17.0 tp -90.37 104.6 17.16 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.286 -1.325 . . . . 2.0600000000000001 109.764 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 44.8 t -114.01 104.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.841 -0.8 . . . . 1.72 108.841 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.38 135.68 46.32 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.968 -0.693 . . . . 2.0600000000000001 110.616 178.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.697 ' HD2' ' HB3' ' A' ' 128' ' ' ASP . 16.2 tptt -98.7 120.63 39.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.302 -0.408 . . . . 4.1900000000000004 110.494 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.461 ' CE2' HD12 ' A' ' 115' ' ' LEU . 26.4 m-85 -107.35 142.11 37.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.911 0.386 . . . . 0.54000000000000004 111.253 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.48 ' HB2' ' HB ' ' A' ' 167' ' ' VAL . . . -139.33 135.14 33.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.424 -0.807 . . . . 1.1599999999999999 110.387 178.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.69 ' HG2' ' HA ' ' A' ' 124' ' ' SER . 7.3 pt-20 -94.5 162.94 13.6 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 124.069 0.856 . . . . 2.6200000000000001 110.91 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.499 HG21 ' HD2' ' A' ' 166' ' ' LYS . 25.9 m -139.41 -17.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.687 . . . . 4.1900000000000004 110.813 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.427 ' HD2' HG22 ' A' ' 92' ' ' VAL . 10.4 m-85 -146.57 162.84 37.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 5.96 110.744 -175.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 64.02 56.3 1.44 Allowed 'General case' 0 N--CA 1.463 0.182 0 O-C-N 123.84 0.712 . . . . 5.46 111.253 173.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.24 87.2 3.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.403 -0.817 . . . . 1.8500000000000001 111.103 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.557 HE21 ' HG2' ' A' ' 99' ' ' GLN . 16.5 pt20 -156.28 140.63 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.563 -0.744 . . . . 3.3300000000000001 109.858 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.542 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . 5.9 p -100.43 146.93 26.43 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.86 0.689 . . . . 1.78 112.86 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 56.66 53.68 8.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.062 -0.972 . . . . 2.75 110.096 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.557 ' HG2' HE21 ' A' ' 96' ' ' GLN . 27.3 tp60 -148.63 -49.51 0.16 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.671 -0.695 . . . . 3.4300000000000002 109.979 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -107.92 89.6 3.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.688 -0.687 . . . . 3.25 109.414 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.894 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 23.6 m -106.77 124.6 62.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.647 -0.706 . . . . 1.8200000000000001 110.063 -173.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.492 ' HD1' ' HA ' ' A' ' 159' ' ' LYS . 61.7 m-85 -104.12 163.53 12.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.512 -0.767 . . . . 1.1699999999999999 111.722 -173.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 24.6 m-20 -109.59 140.61 43.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.579 -0.282 . . . . 1.53 110.48 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.612 HG22 ' HD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -143.32 127.89 14.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.048 0.451 . . . . 1.3500000000000001 110.735 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.673 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -121.39 144.89 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.676 -0.693 . . . . 2.3100000000000001 112.189 -175.326 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.794 HG23 HD21 ' A' ' 153' ' ' LEU . 3.0 p -108.2 105.36 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.691 . . . . 2.0899999999999999 109.722 171.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.4 t30 57.67 44.22 21.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.882 0.848 . . . . 2.0899999999999999 109.149 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.95 -15.79 61.97 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 114.994 -1.003 . . . . 0.41999999999999998 113.017 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 94.6 m-70 -89.39 98.86 12.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.564 0.579 . . . . 0.81999999999999995 112.564 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 2.3 p -66.64 98.98 0.55 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.208 0.528 . . . . 1.3500000000000001 111.706 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.683 HG22 HG22 ' A' ' 131' ' ' ILE . 6.4 t -80.47 -47.79 20.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.636 -0.711 . . . . 1.6000000000000001 109.53 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.579 HG13 ' HG ' ' A' ' 115' ' ' LEU . 10.8 t -113.3 90.03 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.556 0.694 . . . . 1.1200000000000001 109.364 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -113.16 71.74 0.75 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 122.332 1.063 . . . . 4.4000000000000004 108.871 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.894 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.7 p30 162.66 30.2 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.186 -1.825 . . . . 1.96 107.218 -169.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.663 HD13 ' HE2' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -74.1 78.65 1.74 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.862 -1.063 . . . . 1.78 111.095 -172.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.411 ' HB2' HG11 ' A' ' 101' ' ' VAL . 10.9 t70 -101.95 103.74 14.4 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.727 -1.212 . . . . 1.9299999999999999 107.727 172.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.737 HD12 ' HB3' ' A' ' 165' ' ' PRO . 66.7 mt -55.0 -40.9 55.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.893 -0.594 . . . . 1.4199999999999999 111.173 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.563 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 2.3 t80 -64.12 -45.61 87.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.7 -0.682 . . . . 1.2 110.558 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.8 -32.86 68.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.31 -0.405 . . . . 0.95999999999999996 111.471 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.49 ' HB3' ' CE1' ' A' ' 127' ' ' HIS . 15.4 mmt180 -77.03 -50.1 13.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.276 -0.42 . . . . 2.1800000000000002 111.792 -173.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.9 p -118.79 -27.59 2.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.49 -0.484 . . . . 2.0899999999999999 112.295 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 123.6 -161.49 17.91 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.316 -1.114 . . . . 1.3999999999999999 110.316 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.4 ' C ' ' HG ' ' A' ' 124' ' ' SER . 38.6 t-80 -78.79 122.24 25.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.532 0.666 . . . . 4.9100000000000001 111.027 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.69 ' HA ' ' HG2' ' A' ' 91' ' ' GLU . 78.2 p 51.77 -121.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.163 -0.926 . . . . 2.1499999999999999 112.516 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.7 p 52.32 -161.41 0.1 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.469 0.707 . . . . 1.3999999999999999 110.796 -173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.622 ' HB1' ' HE3' ' A' ' 88' ' ' LYS . . . -98.95 109.08 21.89 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.67 -0.412 . . . . 1.21 110.304 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.559 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 18.9 t60 -93.84 133.05 37.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.247 -0.649 . . . . 0.57999999999999996 109.247 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.697 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.5 p30 -133.22 135.77 45.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.132 0.492 . . . . 1.6399999999999999 111.108 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.453 ' HB2' HD21 ' A' ' 87' ' ' LEU . 17.1 mm-40 -112.25 111.78 22.9 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.211 -1.033 . . . . 1.6799999999999999 108.211 171.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.414 HG22 HG22 ' A' ' 86' ' ' VAL . 65.5 mt -96.04 113.48 30.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.934 -0.575 . . . . 1.3899999999999999 109.668 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.683 HG22 HG22 ' A' ' 111' ' ' VAL . 47.2 mt -124.0 93.47 47.01 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.36 -0.382 . . . . 1.8500000000000001 111.293 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -72.42 122.07 7.99 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.317 2.011 . . . . 0.33000000000000002 112.648 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.668 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -109.74 160.61 8.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 106.959 -1.497 . . . . 1.1000000000000001 106.959 174.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.5 p -127.29 111.99 14.55 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.036 0.446 . . . . 1.8200000000000001 110.377 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 36.9 mt -99.87 122.41 51.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.191 -0.67 . . . . 1.1399999999999999 109.191 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -149.06 135.32 19.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.87 -0.418 . . . . 2.4300000000000002 109.87 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 61.28 25.04 15.07 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.606 0.566 . . . . 3.6000000000000001 110.586 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.16 14.46 81.74 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.73 -0.668 . . . . 0.45000000000000001 112.27 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 56.5 mtpt -111.9 150.53 30.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.583 -0.525 . . . . 2.7000000000000002 109.583 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.0 tt -121.25 116.31 24.63 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.701 -0.481 . . . . 1.1100000000000001 109.701 -175.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -116.65 111.04 19.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.61 -0.515 . . . . 1.8100000000000001 109.61 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.698 HG22 HG13 ' A' ' 106' ' ' VAL . 5.5 p -100.76 113.95 38.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.175 -0.306 . . . . 1.5700000000000001 110.175 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 58.77 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.015 -0.539 . . . . 1.8799999999999999 112.02 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.19 1.98 7.76 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.945 -0.645 . . . . 1.25 112.685 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -106.14 148.49 27.79 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.488 -0.56 . . . . 1.95 109.488 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.09 133.59 60.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.247 0.546 . . . . 1.49 111.616 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m -152.94 179.06 9.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.897 -0.779 . . . . 1.75 108.897 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 7.9 t -99.36 143.05 30.06 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.847 -0.798 . . . . 1.8700000000000001 108.847 168.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.896 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 51.6 t80 -79.62 121.98 25.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.264 -0.425 . . . . 0.56999999999999995 110.46 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 p -118.46 95.59 4.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.248 0.546 . . . . 2.2400000000000002 112.295 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.54 -71.6 2.87 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.77000000000000002 114.167 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.661 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -151.5 156.75 41.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.355 0.577 . . . . 1.8 111.015 -176.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.836 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 7.0 tt -82.13 140.42 33.81 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.67 -0.863 . . . . 1.8300000000000001 108.67 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.458 ' N ' HD22 ' A' ' 153' ' ' LEU . 5.5 t -124.29 109.17 13.04 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.876 -0.73 . . . . 1.72 110.241 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.736 HG12 HD21 ' A' ' 170' ' ' LEU . 49.1 t -91.51 96.03 5.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.029 -1.1 . . . . 1.1699999999999999 108.029 174.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.573 ' HB3' ' HG3' ' A' ' 105' ' ' ARG . 4.5 tt0 -99.57 120.53 39.81 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.074 -0.966 . . . . 1.98 109.766 -175.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.663 ' HE2' HD13 ' A' ' 115' ' ' LEU . 62.1 t80 -108.36 116.38 31.86 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.332 0.587 . . . . 2.9100000000000001 109.928 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 44.6 t -106.82 112.86 41.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.241 -0.89 . . . . 1.3 110.502 -176.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.744 ' HE3' ' HA ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -76.58 148.18 37.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.577 -0.738 . . . . 2.6699999999999999 110.066 172.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -89.3 -57.05 1.82 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.584 -0.817 . . . . 1.45 112.01 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -68.41 -72.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.822 -0.436 . . . . 4.5 109.822 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.744 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 85.1 t80 -175.47 -48.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.276 -1.009 . . . . 5.1500000000000004 108.276 174.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -66.62 147.04 53.82 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.364 -1.289 . . . . 2.6400000000000001 110.362 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.622 ' HB2' ' HD2' ' A' ' 165' ' ' PRO . 0.9 OUTLIER -114.07 -175.06 0.29 Allowed Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 112.902 -1.954 . . . . 2.0600000000000001 106.635 174.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.737 ' HB3' HD12 ' A' ' 117' ' ' ILE . 83.3 Cg_exo -49.63 -27.19 14.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 121.443 1.429 . . . . 3.6899999999999999 110.788 170.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.564 ' HA ' ' OD1' ' A' ' 164' ' ' ASN . 32.2 tttm 88.42 -39.82 0.03 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 113.825 -1.534 . . . . 3.5899999999999999 109.682 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 62' ' ' GLN . 38.8 t -98.08 132.17 43.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 116.423 -0.353 . . . . 1.8700000000000001 110.832 174.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.1 t -141.74 94.47 2.68 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 120.062 -0.655 . . . . 1.9099999999999999 112.32 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.673 ' HB2' ' CB ' ' A' ' 88' ' ' LYS . . . -87.64 38.59 0.84 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.841 1.256 . . . . 1.05 113.473 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.736 HD21 HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -31.0 131.91 0.09 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.58 0.752 . . . . 1.3500000000000001 112.137 177.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 5.4 t80 -144.97 115.65 7.71 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.242 -0.286 . . . . 0.60999999999999999 110.449 171.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.564 HG22 HG21 ' A' ' 75' ' ' ILE . 7.0 tt -113.89 125.72 71.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 122.268 1.032 . . . . 1.1000000000000001 111.007 172.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 9.7 ptm -117.58 163.55 16.27 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.58 -1.191 . . . . 1.1399999999999999 109.099 176.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.692 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -120.74 149.62 42.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.131 0.967 . . . . 1.74 112.635 -174.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.15 -29.63 12.03 Favored Glycine 0 C--N 1.306 -1.099 0 CA-C-N 114.105 -1.407 . . . . 0.31 114.34 162.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.494 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.0 OUTLIER -176.31 160.06 2.09 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.253 1.027 . . . . 1.3 112.115 179.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.559 ' CA ' HG22 ' A' ' 84' ' ' VAL . . . -85.48 -9.64 57.18 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.496 -0.775 . . . . 1.3500000000000001 110.048 168.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.494 ' H ' ' HB ' ' A' ' 176' ' ' THR . 2.4 m-20 . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.901 -0.59 . . . . 2.1600000000000001 111.618 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 112.116 -0.394 . . . . 2.02 112.116 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.573 ' HG ' HD11 ' A' ' 27' ' ' ILE . 27.2 tp -70.27 -36.84 74.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.113 0.482 . . . . 1.2 109.975 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . . . -66.5 -24.91 66.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.487 -0.779 . . . . 1.1699999999999999 111.288 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -75.33 -32.79 61.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.008 -0.542 . . . . 2.1800000000000002 110.606 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.679 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 30.6 mmtp -93.4 -28.82 15.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.09 -0.504 . . . . 2.2599999999999998 111.853 -171.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 9.6 p -57.63 119.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.627 0.727 . . . . 1.1100000000000001 111.901 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.2 pt -101.82 -24.62 4.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.784 -0.644 . . . . 1.51 110.181 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.786 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 35.5 t90 -159.24 135.25 8.85 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.53 -0.759 . . . . 0.42999999999999999 109.449 -172.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.76 131.34 10.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.722 0.296 . . . . 1.0700000000000001 110.76 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.48 ' HB ' ' CH2' ' A' ' 12' ' ' TRP . 4.1 t -140.33 125.16 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.514 0.673 . . . . 1.45 111.598 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.548 ' HB2' HD23 ' A' ' 60' ' ' LEU . 3.2 t-20 -97.49 90.48 5.06 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.751 -1.203 . . . . 1.6100000000000001 107.751 167.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.55 ' C ' ' HB2' ' A' ' 65' ' ' ARG . . . -62.38 102.2 0.29 Allowed 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.584 -0.734 . . . . 1.1599999999999999 109.446 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 150.56 -20.12 1.03 Allowed Glycine 0 N--CA 1.442 -0.938 0 O-C-N 125.398 1.686 . . . . 0.76000000000000001 112.333 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.64 -166.08 10.72 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.036 -1.078 . . . . 0.82999999999999996 112.924 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 31.7 tt0 -120.78 118.2 29.4 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.814 0.302 . . . . 1.8400000000000001 111.814 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.747 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 18.4 m 36.31 109.27 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 115.639 1.718 . . . . 1.75 115.639 166.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.841 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 71.4 t60 -147.02 143.42 28.39 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 121.668 -0.645 . . . . 0.52000000000000002 110.958 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.6 t -104.21 117.48 49.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.33 -0.85 . . . . 1.6100000000000001 109.934 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.763 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -70.98 148.63 47.47 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.236 -0.653 . . . . 0.77000000000000002 109.236 174.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.32 -17.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 114.219 1.192 . . . . 1.29 114.219 -173.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.52 ' HB2' HD21 ' A' ' 6' ' ' LEU . 63.9 m-70 -87.74 -11.52 47.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.255 -0.646 . . . . 1.02 109.255 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 7' ' ' ALA . . . 108.64 33.89 2.77 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.053 -0.976 . . . . 0.37 113.246 175.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.573 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.5 mm -103.32 105.53 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.043 -0.663 . . . . 1.0900000000000001 110.355 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -90.41 105.75 18.03 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.024 -0.534 . . . . 1.1200000000000001 110.604 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.841 ' CE2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -83.7 138.77 33.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.686 -0.688 . . . . 1.9199999999999999 109.269 175.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -95.23 149.29 21.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.861 0.362 . . . . 3.4399999999999999 110.557 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 76.6 tttt -43.24 143.38 0.85 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.802 -1.09 . . . . 3.23 112.28 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.568 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 13.3 p-10 -45.8 106.09 0.53 Allowed Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 124.763 1.29 . . . . 2.4100000000000001 113.387 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.568 ' HA ' HG11 ' A' ' 38' ' ' VAL . 33.8 Cg_endo -99.12 -72.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.967 3.111 . . . . 1.8700000000000001 113.717 174.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.543 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . 10.9 mp 65.63 -75.61 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.079 0.952 . . . . 2.4399999999999999 111.078 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.587 ' HG3' ' HD2' ' A' ' 37' ' ' ARG . 4.1 pt-20 -156.02 62.32 0.58 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.893 -1.048 . . . . 5.3099999999999996 111.369 -170.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.79 -0.49 89.5 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.522 -0.847 . . . . 2.6899999999999999 112.449 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.587 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -91.99 58.4 3.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.957 0.408 . . . . 6.0700000000000003 110.219 -175.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 33' ' ' PRO . 20.7 m -104.37 133.07 49.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.766 -0.652 . . . . 4.3700000000000001 110.783 -174.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.82 14.12 10.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.428 -0.891 . . . . 2.9300000000000002 112.633 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.445 HH21 ' HH ' ' A' ' 66' ' ' TYR . 15.4 tpt180 -105.01 -67.96 0.88 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.872 0.336 . . . . 6.8399999999999999 110.566 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 42' ' ' SER . . . 61.49 -86.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.173 0.589 . . . . 2.0800000000000001 111.582 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 47.5 t 74.76 41.49 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.476 0.655 . . . . 2.8100000000000001 109.312 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -81.27 47.7 1.06 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.369 -0.832 . . . . 2.52 110.712 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -132.07 128.38 38.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.381 -0.827 . . . . 7.3399999999999999 109.382 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.75 71.33 1.12 Allowed Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.511 -1.035 . . . . 3.54 110.511 -175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.486 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 1.8 mpt? -61.21 -38.93 88.35 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 123.55 0.206 . . . . 2.7799999999999998 110.672 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 46' ' ' MET . 24.3 ttpt 75.27 -51.08 0.66 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 113.695 0.998 . . . . 4.6399999999999997 113.695 168.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.457 HD21 ' HA ' ' A' ' 92' ' ' VAL . 27.8 tp -116.22 74.01 5.46 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 117.947 0.34 . . . . 3.0299999999999998 110.834 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 47' ' ' LYS . 52.6 Cg_exo -55.47 125.87 20.58 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.089 1.86 . . . . 2.0600000000000001 112.665 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.671 ' CG2' ' HB3' ' A' ' 126' ' ' ALA . 1.4 mp -75.29 114.34 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.649 0.738 . . . . 1.5900000000000001 110.335 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.53 ' HB2' HG21 ' A' ' 125' ' ' THR . 2.7 mm? -74.8 -2.83 28.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.389 -0.823 . . . . 2.48 112.744 -171.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.569 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 7.5 mmm180 -112.67 23.33 13.62 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.845 -0.342 . . . . 3.7200000000000002 111.166 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.7 t -142.81 157.55 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.371 0.605 . . . . 0.96999999999999997 112.346 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 22.6 t30 -63.75 129.25 93.66 Favored Pre-proline 0 C--O 1.213 -0.858 0 CA-C-N 114.983 -1.008 . . . . 1.9199999999999999 109.258 172.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.522 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 3.2 Cg_exo -40.19 -44.75 4.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.192 3.261 . . . . 0.95999999999999996 115.058 -170.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -64.31 -51.82 61.55 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 123.149 1.452 . . . . 2.71 109.407 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.763 ' OD1' ' HA ' ' A' ' 23' ' ' ASP . 31.6 m-20 -82.26 -6.87 59.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.231 -1.804 . . . . 1.6299999999999999 109.645 -174.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.522 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 22.4 tt0 -67.41 -41.37 85.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 2.1200000000000001 108.354 169.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.03 -50.4 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.311 -0.859 . . . . 1.9099999999999999 109.064 170.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.751 ' HG ' ' HD2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -55.9 -34.41 65.52 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.484 -0.78 . . . . 1.77 110.39 178.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' HA ' ' CB ' ' A' ' 169' ' ' ALA . 10.9 m-30 -94.58 1.51 55.64 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.952 -0.567 . . . . 1.3799999999999999 111.263 -174.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.688 ' HA ' HG21 ' A' ' 167' ' ' VAL . 2.1 tt0 -128.32 -110.05 0.28 Allowed 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 116.567 -0.288 . . . . 1.97 111.413 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.695 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 29.58 108.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.38 1.472 . . . . 1.54 114.584 -172.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.682 ' HB3' HG12 ' A' ' 167' ' ' VAL . 8.1 pt-20 -80.63 136.53 36.24 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.031 0.752 . . . . 1.96 113.031 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.568 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -112.71 73.73 0.83 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.011 -0.54 . . . . 4.0700000000000003 110.034 170.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.445 ' HH ' HH21 ' A' ' 40' ' ' ARG . 9.8 p90 -50.2 134.14 22.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.764 -0.653 . . . . 5.0 111.161 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.402 ' HB3' ' H ' ' A' ' 68' ' ' GLU . 6.5 t30 -133.61 -85.53 0.44 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.849 -0.34 . . . . 5.1799999999999997 110.882 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' H ' ' HB3' ' A' ' 67' ' ' ASN . 7.4 tp10 178.81 -72.89 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.918 0.39 . . . . 3.7000000000000002 110.445 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -166.45 156.02 11.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.422 -0.585 . . . . 2.2000000000000002 109.422 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.3 t 49.68 65.25 1.46 Allowed 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.908 0.755 . . . . 1.78 110.741 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.635 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 1.5 p90 -126.77 137.41 53.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.836 -0.431 . . . . 2.2999999999999998 109.836 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.08 -153.07 7.93 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.618 -0.801 . . . . 1.1599999999999999 112.873 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -143.96 168.16 20.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.196 0.522 . . . . 1.6200000000000001 111.589 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.435 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.6 m-20 -122.75 125.14 44.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.305 -0.861 . . . . 2.4700000000000002 109.129 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.0 mp -104.69 95.96 9.66 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.439 -0.578 . . . . 1.1899999999999999 109.439 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 32.0 Cg_exo -57.04 120.82 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.936 1.757 . . . . 0.89000000000000001 112.013 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.78 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 66.3 mt -126.67 133.03 69.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.436 -0.347 . . . . 1.1699999999999999 110.393 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -132.77 16.07 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.345 -0.389 . . . . 3.7000000000000002 110.825 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -135.43 174.29 10.77 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.725 -0.39 . . . . 2.1600000000000001 110.447 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.545 ' HG2' HG21 ' A' ' 135' ' ' ILE . 10.9 mt-10 -122.61 163.44 20.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.118 -0.492 . . . . 1.2 110.718 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.98 -173.99 21.89 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.644 -0.982 . . . . 0.35999999999999999 110.644 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -92.4 104.74 17.04 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 117.878 0.839 . . . . 1.96 109.267 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.661 ' HB2' HG12 ' A' ' 133' ' ' ILE . 92.9 m-85 -92.59 123.4 35.86 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.491 -0.929 . . . . 1.1399999999999999 108.491 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.496 HG23 ' CA ' ' A' ' 177' ' ' ALA . 88.8 t -116.14 106.65 20.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.633 -0.712 . . . . 1.0700000000000001 110.268 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.516 ' HG ' ' HB ' ' A' ' 172' ' ' ILE . 5.7 mp -86.77 104.69 16.38 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.955 -1.021 . . . . 2.0600000000000001 109.302 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 130' ' ' ILE . 53.3 t -102.87 102.64 13.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.694 -1.224 . . . . 1.72 107.694 172.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.598 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -113.26 133.33 55.15 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.55 -0.46 . . . . 2.0600000000000001 110.513 -176.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.752 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 5.3 mptp? -91.74 124.68 36.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.278 0.561 . . . . 4.1900000000000004 110.097 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.724 ' CE1' ' HB3' ' A' ' 165' ' ' PRO . 2.8 m-85 -108.95 141.78 40.54 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.486 -0.779 . . . . 0.54000000000000004 110.121 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.588 ' HB3' ' CG2' ' A' ' 167' ' ' VAL . . . -149.3 114.6 5.51 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.736 -0.665 . . . . 1.1599999999999999 109.901 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.7 ' HG3' ' HB3' ' A' ' 94' ' ' PHE . 10.5 pt-20 -92.44 129.42 38.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.387 -0.597 . . . . 2.6200000000000001 109.387 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.457 ' HA ' HD21 ' A' ' 48' ' ' LEU . 40.2 t -82.73 -30.09 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.082 -0.508 . . . . 4.1900000000000004 110.616 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -97.42 52.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.423 0.63 . . . . 5.96 109.471 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.7 ' HB3' ' HG3' ' A' ' 91' ' ' GLU . 22.9 p90 -77.09 101.03 5.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.488 -0.778 . . . . 5.46 110.894 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.42 14.27 0.5 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.335 0.495 . . . . 1.8500000000000001 112.335 175.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.52 HE21 ' HB2' ' A' ' 100' ' ' LYS . 28.5 tt0 -161.71 139.36 8.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.977 -0.379 . . . . 3.3300000000000001 109.977 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.482 ' CB ' ' HB2' ' A' ' 119' ' ' ASP . 2.6 p -103.22 -78.3 0.55 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.074 -0.512 . . . . 1.78 110.618 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -65.15 142.12 58.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.533 -0.543 . . . . 2.75 109.533 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 77.24 -1.82 2.71 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.662 0.785 . . . . 3.4300000000000002 110.238 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.52 ' HB2' HE21 ' A' ' 96' ' ' GLN . 62.7 tttm -126.95 51.49 1.87 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.674 -1.232 . . . . 3.25 107.674 169.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.839 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 13.3 m -107.57 118.8 56.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.038 -0.983 . . . . 1.8200000000000001 110.273 -173.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.597 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 22.5 m-85 -90.41 156.96 17.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.133 -0.94 . . . . 1.1699999999999999 111.469 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 6.7 t70 -107.57 136.33 47.51 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.507 -0.553 . . . . 1.53 109.507 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.68 122.41 23.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 1.3500000000000001 111.042 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.2 mtt180 -124.7 140.29 53.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.154 -0.93 . . . . 2.3100000000000001 111.258 -174.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.596 HG22 HD12 ' A' ' 153' ' ' LEU . 7.7 p -117.59 104.93 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 2.0899999999999999 109.611 173.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.918 ' HB2' HD11 ' A' ' 153' ' ' LEU . 28.4 t-20 61.3 41.54 13.02 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.52 1.152 . . . . 2.0899999999999999 108.193 -171.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.62 -21.29 26.78 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.747 -1.115 . . . . 0.41999999999999998 112.698 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 78.1 m-70 -74.08 105.35 5.26 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 122.631 0.373 . . . . 0.81999999999999995 111.717 -174.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.548 ' CG2' ' HG2' ' A' ' 105' ' ' ARG . 2.4 p -70.2 92.64 0.78 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.041 0.448 . . . . 1.3500000000000001 111.511 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.415 HG23 HG12 ' A' ' 106' ' ' VAL . 21.4 t -76.62 -41.76 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.917 -0.583 . . . . 1.6000000000000001 109.804 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.418 HG13 ' HG ' ' A' ' 115' ' ' LEU . 11.1 t -132.55 90.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.098 -0.501 . . . . 1.1200000000000001 110.148 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -105.08 72.49 1.0 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.655 0.741 . . . . 4.4000000000000004 109.777 175.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.839 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 7.8 p-10 161.24 32.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.587 -1.642 . . . . 1.96 108.226 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -69.65 85.43 0.46 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.91 -1.041 . . . . 1.78 111.093 -174.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.57 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 19.3 p-10 -98.0 88.69 4.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.574 -0.739 . . . . 1.9299999999999999 109.52 172.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.601 ' HB ' ' OE2' ' A' ' 91' ' ' GLU . 56.8 mt -59.62 -39.86 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.578 -0.737 . . . . 1.4199999999999999 111.166 -173.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.401 ' HD1' ' HB2' ' A' ' 94' ' ' PHE . 84.0 t80 -52.64 -37.15 57.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 1.2 111.585 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.482 ' HB2' ' CB ' ' A' ' 97' ' ' SER . 24.9 t70 -73.88 -37.21 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.896 -0.503 . . . . 0.95999999999999996 111.108 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 7.6 mmt180 -73.11 -51.91 16.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.721 -0.672 . . . . 2.1800000000000002 110.945 -170.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.93 -23.18 4.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.351 -0.386 . . . . 2.0899999999999999 111.813 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 118' ' ' PHE . . . 86.78 -83.34 1.6 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.186 -1.006 . . . . 1.3999999999999999 112.144 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -114.92 107.82 15.91 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.88 -0.328 . . . . 4.9100000000000001 111.043 -176.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.6 p 44.71 -123.73 0.98 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.775 -0.648 . . . . 2.1499999999999999 111.961 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.569 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 60.4 p 53.76 -169.27 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.859 0.863 . . . . 1.3999999999999999 112.425 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.671 ' HB3' ' CG2' ' A' ' 50' ' ' ILE . . . -100.02 129.15 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.315 0.487 . . . . 1.21 112.315 -177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.429 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 38.4 t60 -101.82 147.41 26.53 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.584 -1.265 . . . . 0.57999999999999996 107.584 169.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.594 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.5 p30 -142.78 127.65 18.29 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.145 -0.622 . . . . 1.6399999999999999 111.911 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.95 115.27 28.52 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.895 -1.048 . . . . 1.6799999999999999 108.793 172.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.405 HG23 HG23 ' A' ' 86' ' ' VAL . 64.2 mt -101.5 106.67 19.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.229 -0.656 . . . . 1.3899999999999999 109.229 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 54.3 mt -116.84 90.73 33.13 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.377 -0.374 . . . . 1.8500000000000001 110.956 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HB3' HG22 ' A' ' 84' ' ' VAL . 8.9 Cg_exo -77.43 119.69 5.0 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.568 2.179 . . . . 0.33000000000000002 112.237 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.661 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -109.68 144.59 17.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.875 -1.157 . . . . 1.1000000000000001 107.875 175.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -113.92 107.33 15.54 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 120.34 -0.544 . . . . 1.8200000000000001 110.503 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.568 HG12 ' HG ' ' A' ' 140' ' ' LEU . 33.5 mt -99.62 120.89 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.786 -0.45 . . . . 1.1399999999999999 109.786 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -149.8 137.76 20.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.563 -0.532 . . . . 2.4300000000000002 109.563 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.565 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 8.3 mptt 61.23 30.35 19.18 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.646 0.736 . . . . 3.6000000000000001 110.185 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.31 11.44 84.18 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 114.805 -1.089 . . . . 0.45000000000000001 112.607 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.733 ' HG2' HG22 ' A' ' 148' ' ' THR . 90.2 mttt -113.33 142.45 45.84 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.646 -0.326 . . . . 2.7000000000000002 110.159 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 5.8 tt -112.61 119.46 38.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.037 -0.529 . . . . 1.1100000000000001 110.096 -173.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 17.3 m -111.97 109.45 19.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.688 0.28 . . . . 1.8100000000000001 110.94 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' A' ' 140' ' ' LEU . 66.9 t -94.24 94.58 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.563 -0.903 . . . . 1.5700000000000001 108.563 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 59.27 -88.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.115 -0.948 . . . . 1.8799999999999999 111.068 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -107.23 -13.0 22.33 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.541 -0.838 . . . . 1.25 113.091 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 141' ' ' SER . 51.6 mt-10 -90.14 112.88 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.535 -0.391 . . . . 1.95 110.863 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.8 p -105.65 113.48 42.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.418 0.627 . . . . 1.49 110.378 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.3 t -147.42 137.46 23.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.689 . . . . 1.75 109.19 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.733 HG22 ' HG2' ' A' ' 139' ' ' LYS . 41.0 p -56.81 139.36 51.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.116 0.484 . . . . 1.8700000000000001 111.878 -175.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.78 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 22.8 t80 -79.91 129.09 34.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.497 -0.774 . . . . 0.56999999999999995 109.785 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 t -122.64 99.19 6.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 2.2400000000000002 111.971 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.37 -67.36 3.33 Favored Glycine 0 C--N 1.329 0.194 0 CA-C-N 115.742 -0.663 . . . . 0.77000000000000002 113.939 171.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -158.83 167.55 29.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.205 0.526 . . . . 1.8 110.08 -177.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.918 HD11 ' HB2' ' A' ' 107' ' ' ASN . 14.5 tp -81.87 144.02 31.29 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.574 -0.899 . . . . 1.8300000000000001 108.574 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.7 t -132.74 108.7 9.18 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.146 -1.022 . . . . 1.72 110.777 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 96.0 t -94.18 108.61 20.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.373 -0.376 . . . . 1.1699999999999999 110.19 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -114.46 138.41 50.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.782 -0.644 . . . . 1.98 110.121 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.647 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -129.21 128.31 43.07 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.511 0.672 . . . . 2.9100000000000001 110.705 168.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 44.5 t -106.47 144.63 15.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.423 -1.262 . . . . 1.3 111.085 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.548 ' HA ' ' OD1' ' A' ' 164' ' ' ASN . 36.0 ttpt -61.41 118.54 7.09 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.377 -0.828 . . . . 2.6699999999999999 111.794 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -99.33 0.23 57.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.93 -0.652 . . . . 1.45 111.671 175.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -175.43 -70.22 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.103 -1.073 . . . . 4.5 108.103 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.5 t80 179.71 -178.77 0.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.237 -1.394 . . . . 5.1500000000000004 107.237 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.7 t70 74.55 -52.45 0.68 Allowed 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.792 0.682 . . . . 2.6400000000000001 110.32 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.694 ' HB3' ' HD2' ' A' ' 165' ' ' PRO . 80.1 m-20 63.61 -174.84 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 O-C-N 123.814 0.696 . . . . 2.0600000000000001 109.88 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.724 ' HB3' ' CE1' ' A' ' 89' ' ' PHE . 80.4 Cg_exo -53.95 88.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 121.567 1.511 . . . . 3.6899999999999999 111.171 165.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 91' ' ' GLU . 1.1 mmtm -52.27 -57.97 8.08 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 115.711 -0.677 . . . . 3.5899999999999999 111.085 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 62' ' ' GLN . 1.0 OUTLIER -112.62 137.96 43.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 CA-C-N 115.918 -0.583 . . . . 1.8700000000000001 109.516 176.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 38.3 t -132.53 101.61 5.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.725 0.774 . . . . 1.9099999999999999 111.84 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.752 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -88.34 36.79 0.79 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.629 1.172 . . . . 1.05 112.094 -177.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.786 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 13.6 tp -61.64 116.59 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.798 0.666 . . . . 1.3500000000000001 112.798 -170.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 173' ' ' MET . 0.1 OUTLIER -124.22 123.47 40.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.652 -0.703 . . . . 0.60999999999999999 110.25 176.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.592 ' CG2' ' HB3' ' A' ' 12' ' ' TRP . 2.7 tt -113.0 123.41 68.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 122.001 0.905 . . . . 1.1000000000000001 111.366 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.584 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 12.3 ptm -111.4 164.57 12.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.997 -1.001 . . . . 1.1399999999999999 109.914 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.679 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 19.2 ptmt -115.66 141.16 48.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.371 1.081 . . . . 1.74 112.726 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.71 -28.84 13.72 Favored Glycine 0 C--N 1.304 -1.227 0 CA-C-N 113.853 -1.521 . . . . 0.31 114.827 161.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.419 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.2 OUTLIER -169.52 153.67 5.25 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.642 1.221 . . . . 1.3 113.023 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.496 ' CA ' HG23 ' A' ' 84' ' ' VAL . . . -86.43 -9.89 55.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.057 -0.974 . . . . 1.3500000000000001 109.981 168.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.419 ' H ' ' HB ' ' A' ' 176' ' ' THR . 10.9 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.524 -0.762 . . . . 2.1600000000000001 111.528 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 111.172 -0.771 . . . . 2.02 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.855 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 34.6 tp -56.06 -31.97 63.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.319 0.58 . . . . 1.2 110.789 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 10' ' ' VAL . . . -55.23 -43.08 74.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.878 -1.055 . . . . 1.1699999999999999 112.533 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.73 -17.76 34.99 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.441 -0.504 . . . . 2.1800000000000002 112.256 -173.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.609 ' HB2' ' HE1' ' A' ' 173' ' ' MET . 23.1 mmtm -91.55 -16.6 26.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.163 -0.615 . . . . 2.2599999999999998 111.409 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 7' ' ' ALA . 12.3 p -55.2 128.57 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.546 0.689 . . . . 1.1100000000000001 111.197 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.605 HG22 HG21 ' A' ' 172' ' ' ILE . 0.3 OUTLIER -96.63 -31.39 3.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.345 -0.843 . . . . 1.51 109.912 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.689 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 74.8 t90 -172.95 132.62 0.53 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.321 -0.854 . . . . 0.42999999999999999 109.396 -169.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.57 137.82 18.41 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.864 -0.522 . . . . 1.0700000000000001 110.827 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.655 HG21 ' O ' ' A' ' 30' ' ' ARG . 7.3 p -148.37 138.86 16.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 122.196 0.998 . . . . 1.45 112.57 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.529 ' HB2' HD11 ' A' ' 60' ' ' LEU . 10.9 t-20 -98.35 104.12 16.12 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.403 -1.271 . . . . 1.6100000000000001 107.623 167.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.3 89.14 0.13 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.002 -1.111 . . . . 1.1599999999999999 108.002 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.861 ' HA2' ' N ' ' A' ' 65' ' ' ARG . . . 179.1 -41.24 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.56 0 O-C-N 125.059 1.474 . . . . 0.76000000000000001 112.023 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.556 ' C ' ' HH ' ' A' ' 29' ' ' TYR . . . -144.66 -157.55 7.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.18 -1.009 . . . . 0.82999999999999996 112.937 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.835 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 44.1 mt-10 -119.35 120.09 35.88 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 111.528 0.196 . . . . 1.8400000000000001 111.528 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.844 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 67.2 m 39.1 112.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.504 2.039 . . . . 1.75 116.504 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.982 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 8.4 t60 -145.94 130.07 17.48 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.252 0.549 . . . . 0.52000000000000002 111.334 171.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -87.75 115.91 28.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.043 -0.981 . . . . 1.6100000000000001 109.646 174.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -82.42 164.53 20.94 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.769 -0.456 . . . . 0.77000000000000002 109.769 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 m -62.63 -17.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 O-C-N 124.16 0.913 . . . . 1.29 111.791 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.493 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 88.3 m-70 -84.64 -1.84 56.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.3 0.571 . . . . 1.02 109.966 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.48 25.94 34.51 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.166 -0.924 . . . . 0.37 111.81 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.593 HD13 ' HG ' ' A' ' 6' ' ' LEU . 26.1 mm -103.95 113.23 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.394 0.616 . . . . 1.0900000000000001 111.145 -175.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -92.96 110.83 22.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.42 -0.809 . . . . 1.1200000000000001 110.823 -173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.982 ' CE2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -85.7 145.4 27.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.5 0.191 . . . . 1.9199999999999999 110.59 179.119 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.655 ' O ' HG21 ' A' ' 14' ' ' VAL . 66.2 mtt180 -94.97 170.19 9.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.979 -0.555 . . . . 3.4399999999999999 111.689 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 61.1 mttp -84.7 82.49 8.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.017 0.747 . . . . 3.23 113.017 -169.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 1.041 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 39.45 45.9 1.05 Allowed Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 114.737 1.384 . . . . 2.4100000000000001 114.737 167.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.609 ' CD ' HG23 ' A' ' 14' ' ' VAL . 28.0 Cg_endo -96.09 50.28 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.15 3.234 . . . . 1.8700000000000001 113.76 -161.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.523 HD13 ' CE2' ' A' ' 73' ' ' TYR . 8.7 mp -81.82 -92.41 0.06 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.753 0.649 . . . . 2.4399999999999999 112.753 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -92.71 50.57 1.6 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.016 -0.538 . . . . 5.3099999999999996 112.173 -167.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.3 -3.45 81.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.565 -0.826 . . . . 2.6899999999999999 111.459 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -87.67 72.94 9.45 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.05 -0.722 . . . . 6.0700000000000003 109.05 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.9 t -102.64 116.83 47.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 120.487 -0.485 . . . . 4.3700000000000001 110.163 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.91 33.8 9.49 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.266 -0.734 . . . . 2.9300000000000002 111.266 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HB3' ' OD2' ' A' ' 32' ' ' ASP . 5.0 tpm_? -98.45 -44.51 6.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.458 -0.571 . . . . 6.8399999999999999 109.458 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.835 ' HB3' ' HG3' ' A' ' 19' ' ' GLU . . . 58.62 -81.96 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.612 -1.177 . . . . 2.0800000000000001 112.149 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.3 m 58.7 63.81 1.59 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.416 0.627 . . . . 2.8100000000000001 109.809 -170.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.49 63.18 0.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.147 -0.933 . . . . 2.52 111.397 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -111.26 15.5 21.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.606 -0.725 . . . . 7.3399999999999999 109.906 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.664 ' HA3' ' HG3' ' A' ' 64' ' ' GLU . . . -100.02 7.53 58.86 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.758 -1.11 . . . . 3.54 111.154 171.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.481 ' HE2' HG11 ' A' ' 59' ' ' VAL . 50.6 mmm -72.72 -12.66 61.1 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.659 0.743 . . . . 2.7799999999999998 109.166 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -83.24 -0.71 50.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.848 -1.069 . . . . 4.6399999999999997 110.787 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.6 mt -117.9 80.01 14.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.98 -0.554 . . . . 3.0299999999999998 109.673 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.07 128.43 15.74 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.62 2.213 . . . . 2.0600000000000001 112.254 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.885 HD12 ' HA ' ' A' ' 62' ' ' GLN . 1.7 mp -81.3 108.5 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.661 0.743 . . . . 1.5900000000000001 109.811 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.515 ' HB2' HG21 ' A' ' 125' ' ' THR . 3.6 mm? -65.29 -18.36 65.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.878 -1.055 . . . . 2.48 112.962 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HD3' ' HB ' ' A' ' 125' ' ' THR . 4.3 mpt_? -91.91 -9.83 41.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.481 -0.487 . . . . 3.7200000000000002 111.985 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.667 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 57.9 m -108.83 160.06 16.29 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.285 0.564 . . . . 0.96999999999999997 112.323 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.513 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -90.88 143.44 28.71 Favored Pre-proline 0 C--O 1.214 -0.798 0 CA-C-N 115.305 -0.861 . . . . 1.9199999999999999 109.26 -176.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.513 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 46.8 Cg_exo -37.48 -48.92 1.85 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.989 3.126 . . . . 0.95999999999999996 115.841 -164.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.543 ' HB3' ' HE1' ' A' ' 21' ' ' HIS . 25.5 mm-40 -64.22 -54.58 31.24 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.442 1.115 . . . . 2.71 109.659 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 3.3 p30 -77.85 -15.8 58.78 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.538 -1.21 . . . . 1.6299999999999999 110.577 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.708 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 9.4 tt0 -58.12 -50.5 73.26 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.556 -0.535 . . . . 2.1200000000000001 109.556 172.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.481 HG11 ' HE2' ' A' ' 46' ' ' MET . 98.4 t -55.25 -47.94 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.445 0.641 . . . . 1.9099999999999999 109.859 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.717 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 50.1 tp -56.78 -19.42 16.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.799 -1.091 . . . . 1.77 111.425 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.667 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 23.1 m-30 -120.51 5.34 10.63 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.072 -0.513 . . . . 1.3799999999999999 111.722 -173.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.885 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.7 OUTLIER -120.78 -38.25 2.88 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.812 -0.555 . . . . 1.97 112.453 -170.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.425 HG23 ' SD ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -67.56 139.41 56.92 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.477 -0.783 . . . . 1.54 110.479 -175.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.953 ' HB3' HG12 ' A' ' 167' ' ' VAL . 0.0 OUTLIER -122.87 -4.01 8.62 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.298 1.592 . . . . 1.96 115.298 -166.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 1.041 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 2.1 mtp-105 70.64 -83.24 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.377 0.608 . . . . 4.0700000000000003 112.179 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.0 t80 175.75 114.17 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.192 -0.913 . . . . 5.0 108.864 -166.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.538 ' HA ' ' HZ ' ' A' ' 71' ' ' PHE . 4.2 p-10 -64.82 135.29 55.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.069 -0.715 . . . . 5.1799999999999997 109.069 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -142.52 -76.86 0.26 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.007 0.432 . . . . 3.7000000000000002 111.655 -168.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 70' ' ' SER . 11.3 t70 -170.85 -162.51 0.27 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.427 -1.323 . . . . 2.2000000000000002 107.427 -172.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.41 ' H ' ' CG ' ' A' ' 69' ' ' ASP . 27.7 t -48.77 104.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.076 0.465 . . . . 1.78 109.808 176.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 71.4 m-85 -77.91 108.49 11.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.403 -0.962 . . . . 2.2999999999999998 108.403 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.11 144.63 16.5 Favored Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 115.361 -0.836 . . . . 1.1599999999999999 113.234 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.639 ' HH ' ' HG ' ' A' ' 168' ' ' CYS . 54.2 m-85 -132.42 129.26 39.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.344 -0.428 . . . . 1.6200000000000001 110.487 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.563 ' OD2' ' HE2' ' A' ' 152' ' ' LYS . 10.3 t70 -100.6 102.34 13.47 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.151 -0.685 . . . . 2.4700000000000002 109.151 177.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.624 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 6.1 mt -102.6 90.06 2.05 Favored Pre-proline 0 CA--C 1.513 -0.46 0 N-CA-C 109.158 -0.682 . . . . 1.1899999999999999 109.158 174.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.528 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 33.4 Cg_endo -66.12 116.58 4.09 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.305 1.337 . . . . 0.89000000000000001 111.751 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.844 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 43.6 mt -110.32 139.75 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.98 -0.554 . . . . 1.1699999999999999 111.113 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.29 16.29 4.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 3.7000000000000002 109.979 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 9.1 mm-40 -129.09 158.13 39.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.585 0.231 . . . . 2.1600000000000001 110.891 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG2' HG21 ' A' ' 135' ' ' ILE . 4.5 mt-10 -111.64 170.6 8.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.062 -0.517 . . . . 1.2 110.374 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.26 -162.98 24.02 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.447 -1.061 . . . . 0.35999999999999999 110.447 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -102.61 111.45 23.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.854 0.827 . . . . 1.96 109.83 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.661 ' HB2' HG12 ' A' ' 133' ' ' ILE . 73.6 m-85 -94.12 123.87 37.77 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 108.434 -0.95 . . . . 1.1399999999999999 108.434 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.59 HG22 ' CA ' ' A' ' 177' ' ' ALA . 86.1 t -113.63 106.15 20.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.646 0.736 . . . . 1.0700000000000001 110.289 -174.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.37 104.0 16.02 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.602 -1.181 . . . . 2.0600000000000001 109.127 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.517 HG21 HG22 ' A' ' 130' ' ' ILE . 50.3 t -106.02 103.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.754 -1.202 . . . . 1.72 107.754 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 1.1 pt? -116.0 132.01 56.77 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.076 -0.65 . . . . 2.0600000000000001 110.18 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.638 ' HG3' ' HB3' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -86.26 120.29 27.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.116 -0.698 . . . . 4.1900000000000004 109.116 178.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -106.29 140.47 39.18 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.099 -0.955 . . . . 0.54000000000000004 110.508 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.511 ' HB3' HG23 ' A' ' 167' ' ' VAL . . . -149.61 146.22 27.19 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.129 -0.693 . . . . 1.1599999999999999 109.129 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.561 ' HB3' HD11 ' A' ' 117' ' ' ILE . 6.9 pt-20 -120.13 -177.81 3.51 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.791 -0.364 . . . . 2.6200000000000001 111.023 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.694 HG22 ' CD2' ' A' ' 93' ' ' TYR . 14.2 p -80.99 -68.92 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 119.235 -0.412 . . . . 4.1900000000000004 112.07 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.694 ' CD2' HG22 ' A' ' 92' ' ' VAL . 35.5 p90 -176.16 25.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.566 0.621 . . . . 5.96 112.53 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.72 ' HB2' ' HZ2' ' A' ' 100' ' ' LYS . 29.1 m-85 -69.31 103.31 1.94 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.126 0.489 . . . . 5.46 110.585 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.69 67.24 5.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.251 0.834 . . . . 1.8500000000000001 113.251 -168.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.442 ' HG2' ' HG2' ' A' ' 100' ' ' LYS . 18.4 pm0 -152.4 140.66 20.46 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.684 -0.488 . . . . 3.3300000000000001 109.684 168.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.649 ' HB3' ' HB2' ' A' ' 119' ' ' ASP . 18.3 m -105.75 153.54 21.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.157 -0.474 . . . . 1.78 110.873 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 49.58 45.49 24.18 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.474 0.654 . . . . 2.75 111.834 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.61 -62.55 0.37 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.161 -1.052 . . . . 3.4300000000000002 108.161 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.72 ' HZ2' ' HB2' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -84.52 87.03 7.23 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.836 -1.075 . . . . 3.25 109.891 175.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.818 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.6 m -109.64 124.46 66.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.325 0.584 . . . . 1.8200000000000001 111.0 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.453 ' CD2' ' HD3' ' A' ' 165' ' ' PRO . 30.6 m-85 -96.79 165.49 12.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.172 -0.922 . . . . 1.1699999999999999 110.727 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.62 ' OD2' ' HB ' ' A' ' 158' ' ' VAL . 0.0 OUTLIER -106.54 136.94 45.43 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.786 -0.766 . . . . 1.53 109.905 173.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 1.8 t -121.55 119.19 58.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.844 -0.616 . . . . 1.3500000000000001 109.522 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.574 ' HG2' HG22 ' A' ' 110' ' ' THR . 24.5 mtt180 -121.38 139.42 53.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.088 0.471 . . . . 2.3100000000000001 111.447 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.862 HG11 HD11 ' A' ' 153' ' ' LEU . 79.9 t -122.39 100.07 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.24 -0.891 . . . . 2.0899999999999999 109.469 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.828 ' HB2' HD23 ' A' ' 153' ' ' LEU . 29.1 t-20 63.28 43.66 6.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.46 1.124 . . . . 2.0899999999999999 108.686 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.59 -5.4 78.32 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.941 -1.027 . . . . 0.41999999999999998 112.704 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 92.9 m-70 -92.35 106.64 18.6 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 122.017 0.127 . . . . 0.81999999999999995 111.15 -174.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.574 HG22 ' HG2' ' A' ' 105' ' ' ARG . 2.9 p -70.18 88.67 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.968 0.413 . . . . 1.3500000000000001 111.362 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.53 HG22 HG11 ' A' ' 142' ' ' VAL . 37.2 t -69.01 -51.46 43.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 1.6000000000000001 109.799 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 104' ' ' VAL . 35.6 t -120.88 88.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.938 -0.574 . . . . 1.1200000000000001 110.144 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.614 ' HG2' ' HB3' ' A' ' 103' ' ' ASP . 0.2 OUTLIER -102.57 76.88 1.57 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.515 -1.291 . . . . 4.4000000000000004 107.515 173.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.818 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 9.2 p-10 166.05 26.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.99 -1.459 . . . . 1.96 109.634 -172.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.73 101.11 3.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 1.78 111.499 -172.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 27.5 p-10 -118.16 85.88 2.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.288 1.042 . . . . 1.9299999999999999 109.72 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 91' ' ' GLU . 60.0 mt -54.21 -37.43 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.84 -1.073 . . . . 1.4199999999999999 112.167 -172.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -58.44 -38.63 77.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.691 0.282 . . . . 1.2 111.579 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.649 ' HB2' ' HB3' ' A' ' 97' ' ' SER . 9.4 t70 -70.15 -33.93 72.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.329 0.585 . . . . 0.95999999999999996 110.422 177.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 7.4 mmt180 -74.42 -51.38 15.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.531 -0.759 . . . . 2.1800000000000002 111.117 -173.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 m -115.18 -29.51 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 113.109 0.781 . . . . 2.0899999999999999 113.109 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.1 -73.97 2.58 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.517 -0.849 . . . . 1.3999999999999999 112.003 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -77.28 151.21 35.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.251 -0.277 . . . . 4.9100000000000001 110.251 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.6 t -68.55 80.22 0.27 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.785 0.802 . . . . 2.1499999999999999 109.762 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.515 HG21 ' HB2' ' A' ' 51' ' ' LEU . 41.5 p -125.38 -137.95 0.27 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.958 -1.019 . . . . 1.3999999999999999 109.188 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.585 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . . . -102.5 116.54 32.82 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.492 -0.483 . . . . 1.21 111.427 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 48.4 t60 -112.88 106.75 15.11 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 108.704 -0.85 . . . . 0.57999999999999996 108.704 170.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.53 ' OD1' ' HG2' ' A' ' 88' ' ' LYS . 13.6 m-20 -105.03 117.12 33.2 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.319 -0.552 . . . . 1.6399999999999999 111.384 -169.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -89.09 111.97 22.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.682 -0.69 . . . . 1.6799999999999999 109.546 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.517 HG22 HG21 ' A' ' 86' ' ' VAL . 61.3 mt -103.18 110.15 28.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.411 -0.588 . . . . 1.3899999999999999 109.411 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.461 HG23 HG21 ' A' ' 106' ' ' VAL . 65.5 mt -122.69 94.41 47.56 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.283 -0.417 . . . . 1.8500000000000001 111.099 -173.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.405 ' HB3' HG21 ' A' ' 84' ' ' VAL . 3.7 Cg_exo -80.83 121.81 4.19 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.728 2.285 . . . . 0.33000000000000002 111.988 172.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.661 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.6 OUTLIER -110.58 155.62 11.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.646 -0.872 . . . . 1.1000000000000001 108.646 177.057 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.515 ' OG ' ' HB2' ' A' ' 141' ' ' SER . 2.9 p -120.22 106.94 12.4 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.694 -0.402 . . . . 1.8200000000000001 110.799 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 34.1 mt -100.66 119.6 49.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.326 -0.62 . . . . 1.1399999999999999 109.326 176.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 27.5 mmtp -151.4 136.79 17.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.705 -0.48 . . . . 2.4300000000000002 109.705 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt 65.52 22.91 11.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.68 -0.691 . . . . 3.6000000000000001 110.47 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.64 9.47 86.37 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.844 -0.693 . . . . 0.45000000000000001 112.084 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 52.8 mtpt -106.61 166.51 10.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.687 -0.486 . . . . 2.7000000000000002 109.687 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.2 tt -140.73 116.35 10.2 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.636 -0.505 . . . . 1.1100000000000001 109.636 -174.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.515 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 40.6 m -110.73 131.07 55.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.26 -0.427 . . . . 1.8100000000000001 111.041 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.53 HG11 HG22 ' A' ' 111' ' ' VAL . 74.6 t -129.37 109.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 1.5700000000000001 111.136 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 50.79 37.5 17.13 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.82 -0.627 . . . . 1.8799999999999999 112.665 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.97 -24.33 25.37 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.783 -0.723 . . . . 1.25 112.576 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -85.06 112.12 20.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.02 -0.733 . . . . 1.95 109.02 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.6 p -105.57 125.67 60.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.771 -0.65 . . . . 1.49 110.611 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.3 m -144.51 -166.65 2.44 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.926 -0.768 . . . . 1.75 108.926 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 59.8 p -98.75 148.39 23.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.001 0.429 . . . . 1.8700000000000001 110.847 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.844 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 39.6 t80 -81.41 120.95 25.63 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.736 -1.209 . . . . 0.56999999999999995 107.736 168.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 m -130.51 95.92 4.0 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.122 0.487 . . . . 2.2400000000000002 110.75 -174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.13 -82.41 1.18 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.598 -0.728 . . . . 0.77000000000000002 113.781 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.563 ' HE2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -145.04 158.69 43.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.331 0.565 . . . . 1.8 111.004 -175.187 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.862 HD11 HG11 ' A' ' 106' ' ' VAL . 1.4 tm? -80.96 118.56 22.54 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.174 -1.417 . . . . 1.8300000000000001 107.174 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.502 ' CB ' ' HZ2' ' A' ' 152' ' ' LYS . 5.3 t -114.23 107.06 15.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.951 -0.699 . . . . 1.72 110.161 -171.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.516 ' O ' ' HD1' ' A' ' 73' ' ' TYR . 38.2 t -92.62 108.02 19.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.98 -0.748 . . . . 1.1699999999999999 108.98 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 25.4 mt-10 -130.33 108.91 10.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.174 -0.466 . . . . 1.98 110.156 -177.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.581 ' CE1' ' HE1' ' A' ' 73' ' ' TYR . 2.9 p90 -104.58 115.85 31.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.722 0.772 . . . . 2.9100000000000001 110.676 174.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.62 ' HB ' ' OD2' ' A' ' 103' ' ' ASP . 59.3 t -87.63 143.43 11.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 114.347 -1.297 . . . . 1.3 111.01 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -68.0 136.01 53.21 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.739 -1.119 . . . . 2.6699999999999999 111.585 -175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -86.61 -35.11 10.66 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.688 -0.768 . . . . 1.45 111.269 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -145.08 -97.71 0.1 Allowed 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.675 0.25 . . . . 4.5 111.675 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -112.0 -83.26 0.58 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.445 0.164 . . . . 5.1500000000000004 111.203 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.584 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 17.7 t70 -75.46 85.17 2.56 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.762 -0.829 . . . . 2.6400000000000001 108.762 176.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.717 ' HB2' ' HD2' ' A' ' 165' ' ' PRO . 20.1 p-10 -78.68 161.43 69.29 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.152 -0.931 . . . . 2.0600000000000001 109.692 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.717 ' HD2' ' HB2' ' A' ' 164' ' ' ASN . 32.6 Cg_exo -20.76 87.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 124.877 3.718 . . . . 3.6899999999999999 114.155 -168.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.505 ' HD2' ' HB ' ' A' ' 92' ' ' VAL . 36.8 tttp -55.86 -61.28 2.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.926 -1.488 . . . . 3.5899999999999999 112.44 -162.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.953 HG12 ' HB3' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -102.9 136.5 35.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 120.06 -0.656 . . . . 1.8700000000000001 110.169 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.639 ' HG ' ' HH ' ' A' ' 73' ' ' TYR . 47.7 t -125.81 135.35 51.89 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.672 0.749 . . . . 1.9099999999999999 110.313 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.579 ' HB2' ' HD1' ' A' ' 61' ' ' TYR . . . -123.05 36.76 4.57 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.615 -1.175 . . . . 1.05 109.869 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.689 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 9.9 tp -57.98 112.17 1.41 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.627 -1.17 . . . . 1.3500000000000001 112.715 -170.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.855 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -122.27 120.45 34.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.619 -0.719 . . . . 0.60999999999999999 110.243 176.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.605 HG21 HG22 ' A' ' 11' ' ' ILE . 6.9 tt -113.09 132.16 62.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.697 0.76 . . . . 1.1000000000000001 110.357 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.614 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 4.1 ppp? -127.02 164.09 22.29 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.562 -0.744 . . . . 1.1399999999999999 109.412 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.9 ptmt -112.61 142.16 45.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.565 1.174 . . . . 1.74 113.32 -173.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.504 ' O ' HG22 ' A' ' 176' ' ' THR . . . 105.37 -30.0 10.6 Favored Glycine 0 C--N 1.31 -0.865 0 CA-C-N 113.161 -1.836 . . . . 0.31 115.058 161.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 175' ' ' GLY . 0.6 OUTLIER -176.75 153.07 1.04 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.467 1.133 . . . . 1.3 113.238 -177.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.59 ' CA ' HG22 ' A' ' 84' ' ' VAL . . . -84.59 -14.61 48.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.755 -0.657 . . . . 1.3500000000000001 109.596 168.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.418 ' H ' ' HB ' ' A' ' 176' ' ' THR . 38.9 t70 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 114.937 -1.029 . . . . 2.1600000000000001 111.807 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.026 0 N-CA-C 111.768 -0.533 . . . . 2.02 111.768 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.743 HD21 ' HB3' ' A' ' 25' ' ' HIS . 27.6 tp -66.14 -30.49 70.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.099 0.476 . . . . 1.2 110.425 -175.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.433 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -61.32 -25.86 67.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.368 -0.833 . . . . 1.1699999999999999 111.91 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.73 -36.72 23.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.375 -0.375 . . . . 2.1800000000000002 111.358 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.638 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -90.15 -11.04 42.35 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.542 -0.463 . . . . 2.2599999999999998 111.582 -171.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.728 HG23 ' HE1' ' A' ' 171' ' ' PHE . 14.7 p -59.31 132.8 24.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.035 -0.666 . . . . 1.1100000000000001 111.546 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.659 HG22 HG23 ' A' ' 172' ' ' ILE . 0.6 OUTLIER -107.79 -38.4 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.051 -0.522 . . . . 1.51 110.563 176.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.739 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 49.6 t90 -165.33 143.63 6.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.825 -0.625 . . . . 0.42999999999999999 109.32 -172.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.85 135.75 11.76 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.66 -0.416 . . . . 1.0700000000000001 111.347 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.0 t -137.15 106.58 4.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.686 0.755 . . . . 1.45 110.922 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 3.2 t-20 -81.25 86.55 6.21 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.265 -1.383 . . . . 1.6100000000000001 107.265 163.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.575 ' HB2' ' SG ' ' A' ' 168' ' ' CYS . . . -66.61 103.85 1.16 Allowed 'General case' 0 C--O 1.255 1.362 0 CA-C-N 115.386 -0.824 . . . . 1.1599999999999999 109.813 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 172.93 -38.69 0.15 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 113.073 -1.876 . . . . 0.76000000000000001 112.279 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 41' ' ' ALA . . . -132.88 -141.26 4.58 Favored Glycine 0 N--CA 1.459 0.205 0 C-N-CA 120.702 -0.761 . . . . 0.82999999999999996 112.427 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -118.17 157.63 26.58 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.589 -0.359 . . . . 1.8400000000000001 110.893 175.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.684 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 23.2 m -19.03 122.44 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.307 1.595 . . . . 1.75 115.307 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.684 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 42.9 t60 -138.16 121.67 17.27 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.218 -0.901 . . . . 0.52000000000000002 111.271 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 28' ' ' HIS . 64.1 t -85.3 123.3 39.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.077 -0.965 . . . . 1.6100000000000001 109.019 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.543 ' OD1' ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -101.7 171.26 7.65 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.525 -0.47 . . . . 0.77000000000000002 110.715 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -56.53 -22.95 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 124.708 1.255 . . . . 1.29 112.808 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.743 ' HB3' HD21 ' A' ' 6' ' ' LEU . 34.0 m-70 -77.12 -10.61 59.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.35 0.595 . . . . 1.02 109.672 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 87.76 28.21 24.54 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.135 -0.939 . . . . 0.37 110.763 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.583 ' CD1' ' HB ' ' A' ' 10' ' ' VAL . 12.6 mm -102.14 112.49 35.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.136 0.493 . . . . 1.0900000000000001 110.1 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.568 ' HB2' HG22 ' A' ' 22' ' ' VAL . 29.9 t60 -93.63 113.09 25.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.973 -0.558 . . . . 1.1200000000000001 110.076 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.684 ' CD2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -90.5 142.38 27.8 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.643 -0.503 . . . . 1.9199999999999999 109.643 175.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.429 ' H ' ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -100.78 69.29 1.35 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.012 0.745 . . . . 3.4399999999999999 113.012 -169.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.736 ' HG2' ' H ' ' A' ' 32' ' ' ASP . 14.5 ttpp 60.83 -169.34 0.16 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.477 -0.783 . . . . 3.23 111.723 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.749 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 9.4 p-10 -103.09 88.93 1.71 Allowed Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-O 121.984 0.897 . . . . 2.4100000000000001 110.106 173.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.621 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 31.7 Cg_endo -86.57 -105.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.158 1.905 . . . . 1.8700000000000001 112.313 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp 67.86 -40.35 0.41 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.145 0.578 . . . . 2.4399999999999999 109.815 -170.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 33' ' ' PRO . 39.3 mt-10 78.53 149.29 0.1 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.216 -0.902 . . . . 5.3099999999999996 112.466 166.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.57 -6.7 44.41 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.182 -0.917 . . . . 2.6899999999999999 111.878 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -139.46 31.3 2.11 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.024 -0.362 . . . . 6.0700000000000003 110.024 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.5 m -104.03 161.49 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.107 0.48 . . . . 4.3700000000000001 111.591 -169.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.97 -54.57 0.73 Allowed Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.488 -0.778 . . . . 2.9300000000000002 111.413 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.751 HH21 ' HH ' ' A' ' 66' ' ' TYR . 13.3 mtp180 -101.65 100.93 11.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.894 0.378 . . . . 6.8399999999999999 111.587 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.445 ' HB2' ' HA2' ' A' ' 18' ' ' GLY . . . -89.81 -60.54 1.91 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.126 -0.694 . . . . 2.0800000000000001 109.126 170.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.8 t 69.29 75.29 0.24 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.674 0.75 . . . . 2.8100000000000001 110.883 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -89.39 -7.15 55.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.209 -0.905 . . . . 2.52 109.864 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -81.22 47.59 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.003 0.906 . . . . 7.3399999999999999 110.124 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.13 50.39 0.19 Allowed Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 114.372 -1.286 . . . . 3.54 110.126 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.548 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 24.4 mmt -59.11 -62.74 1.65 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.073 -0.563 . . . . 2.7799999999999998 109.827 -176.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 46' ' ' MET . 22.7 pttm 48.8 -168.17 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.408 1.067 . . . . 4.6399999999999997 112.448 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 30.4 66.5 0.82 Allowed Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 123.967 0.907 . . . . 3.0299999999999998 113.119 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.77 105.78 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.41 2.073 . . . . 2.0600000000000001 112.3 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.571 ' CG2' ' HB1' ' A' ' 126' ' ' ALA . 1.3 mp -57.62 111.87 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 121.891 0.853 . . . . 1.5900000000000001 110.462 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.542 HD11 ' H ' ' A' ' 51' ' ' LEU . 4.6 mp -68.86 -14.38 63.0 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.809 -1.087 . . . . 2.48 111.73 -172.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HB2' ' HB3' ' A' ' 126' ' ' ALA . 27.4 mmm180 -98.97 23.01 9.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.22 -0.445 . . . . 3.7200000000000002 111.423 -175.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -150.31 167.76 26.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 0.96999999999999997 112.186 -176.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.408 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 3.0 t30 -95.51 139.17 21.84 Favored Pre-proline 0 C--O 1.215 -0.744 0 CA-C-N 115.013 -0.994 . . . . 1.9199999999999999 108.83 177.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 3.7 Cg_exo -36.69 -54.7 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.512 3.475 . . . . 0.95999999999999996 116.246 -162.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -77.08 -28.71 54.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.172 0.896 . . . . 2.71 112.012 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -10.98 43.8 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 120.912 -1.117 . . . . 1.6299999999999999 109.026 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 19.7 tt0 -67.07 -46.38 74.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.722 -1.126 . . . . 2.1200000000000001 110.002 170.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.72 -39.98 86.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 109.684 -0.487 . . . . 1.9099999999999999 109.684 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.646 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 45.3 tp -60.69 -21.58 63.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.183 0.516 . . . . 1.77 111.153 173.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.573 ' CD2' ' HE3' ' A' ' 88' ' ' LYS . 8.6 m-30 -102.64 -2.21 28.75 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.937 -0.574 . . . . 1.3799999999999999 111.542 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.833 ' HA ' HG13 ' A' ' 167' ' ' VAL . 4.1 tt0 -121.67 -110.4 0.33 Allowed 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.637 -0.425 . . . . 1.97 110.147 174.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.62 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.6 OUTLIER 35.01 102.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.446 0.906 . . . . 1.54 113.446 -173.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -88.84 136.98 32.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.465 -0.334 . . . . 1.96 111.824 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.749 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -92.74 178.79 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 4.0700000000000003 110.469 173.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.751 ' HH ' HH21 ' A' ' 40' ' ' ARG . 91.2 m-85 -104.0 106.5 17.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 5.0 111.247 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -177.27 148.37 0.6 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.46 0.475 . . . . 5.1799999999999997 110.071 174.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.58 ' HA ' ' HB2' ' A' ' 164' ' ' ASN . 1.5 pt-20 -131.53 35.8 3.81 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.934 -0.395 . . . . 3.7000000000000002 109.934 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.636 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 26.8 t70 -142.34 -164.95 1.92 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.012 -0.675 . . . . 2.2000000000000002 109.581 -165.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.546 ' H ' ' CG ' ' A' ' 69' ' ' ASP . 8.9 t -62.87 91.6 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.059 0.457 . . . . 1.78 109.884 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.49 ' CG ' ' CE2' ' A' ' 157' ' ' PHE . 38.2 m-85 -71.24 94.82 1.21 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.945 -1.132 . . . . 2.2999999999999998 107.945 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.72 111.67 3.73 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.662 -0.78 . . . . 1.1599999999999999 112.495 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.689 ' HE1' ' CE1' ' A' ' 157' ' ' PHE . 35.0 m-85 -102.59 151.29 22.51 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.568 0.347 . . . . 1.6200000000000001 110.643 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -115.28 112.97 23.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.342 0.591 . . . . 2.4700000000000002 110.609 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.813 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.3 mp -103.55 93.42 4.97 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.611 -0.722 . . . . 1.1899999999999999 110.067 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.535 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 25.2 Cg_endo -65.8 119.33 6.34 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.683 1.588 . . . . 0.89000000000000001 112.108 -175.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.824 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 69.3 mt -117.97 132.2 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.658 -0.701 . . . . 1.1699999999999999 110.114 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.89 6.7 4.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.039 -0.528 . . . . 3.7000000000000002 111.134 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -134.92 176.66 8.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.836 0.35 . . . . 2.1600000000000001 110.625 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.552 ' HG2' HG22 ' A' ' 135' ' ' ILE . 5.5 mt-10 -122.12 159.06 27.94 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.807 -0.633 . . . . 1.2 110.108 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.97 -155.22 26.35 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.805 -0.918 . . . . 0.35999999999999999 110.805 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 47.0 mt-10 -110.92 106.48 15.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.265 0.532 . . . . 1.96 109.781 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.674 ' HB2' HG12 ' A' ' 133' ' ' ILE . 88.8 m-85 -94.76 125.4 39.39 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 119.735 -0.786 . . . . 1.1399999999999999 109.219 -176.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.649 HG21 ' CA ' ' A' ' 177' ' ' ALA . 52.8 t -108.67 106.02 19.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.165 0.983 . . . . 1.0700000000000001 110.039 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.574 HD12 HG21 ' A' ' 155' ' ' VAL . 9.1 tt -97.84 104.98 17.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.875 -1.511 . . . . 2.0600000000000001 109.141 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 129' ' ' GLU . 2.2 p -115.01 105.94 19.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 109.013 -0.736 . . . . 1.72 109.013 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -101.48 134.94 43.81 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.115 0.483 . . . . 2.0600000000000001 110.114 -177.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 1.048 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 10.9 tppt? -98.69 114.92 27.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.327 0.584 . . . . 4.1900000000000004 109.873 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.458 ' CD2' HD11 ' A' ' 115' ' ' LEU . 4.0 m-85 -106.53 146.79 30.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.455 -0.793 . . . . 0.54000000000000004 109.9 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.852 ' HB1' ' HB ' ' A' ' 167' ' ' VAL . . . -137.12 129.97 30.51 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.201 -0.454 . . . . 1.1599999999999999 110.159 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -121.63 118.14 28.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.723 -0.473 . . . . 2.6200000000000001 109.723 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.4 30.51 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.069 0.462 . . . . 4.1900000000000004 110.34 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -113.67 -46.27 3.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.135 -0.484 . . . . 5.96 111.105 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.786 ' HB3' ' HD2' ' A' ' 100' ' ' LYS . 42.2 t80 -137.8 109.02 6.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.061 0.458 . . . . 5.46 110.205 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.424 ' HB1' ' CE1' ' A' ' 118' ' ' PHE . . . -94.71 90.23 6.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.828 -0.624 . . . . 1.8500000000000001 111.556 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -160.23 143.98 14.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.955 -0.566 . . . . 3.3300000000000001 109.649 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.53 ' HG ' ' HD2' ' A' ' 118' ' ' PHE . 15.8 m -99.05 147.29 25.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.386 -0.37 . . . . 1.78 110.79 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 61.6 37.13 16.41 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.735 -0.666 . . . . 2.75 110.099 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -140.64 -47.05 0.41 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.727 -0.67 . . . . 3.4300000000000002 110.423 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.786 ' HD2' ' HB3' ' A' ' 94' ' ' PHE . 33.4 tttm -102.31 75.81 1.51 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.185 -0.672 . . . . 3.25 109.185 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 16.7 m -106.72 123.76 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.48 -0.782 . . . . 1.8200000000000001 110.466 -173.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.554 ' CE2' ' HG2' ' A' ' 100' ' ' LYS . 80.5 m-85 -114.65 168.66 9.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.335 -0.848 . . . . 1.1699999999999999 111.752 -173.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.625 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 11.3 m-20 -107.21 138.01 44.2 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 109.091 -0.707 . . . . 1.53 109.091 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 157' ' ' PHE . 7.4 t -136.3 113.33 13.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 117.699 0.227 . . . . 1.3500000000000001 111.525 -175.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.638 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 84.2 mtt180 -110.94 141.41 44.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.225 0.454 . . . . 2.3100000000000001 112.225 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.404 HG22 ' HB2' ' A' ' 109' ' ' HIS . 12.0 m -110.65 96.71 4.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.44 -0.8 . . . . 2.0899999999999999 109.662 168.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.742 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 3.7 t-20 55.05 58.52 4.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.013 -0.994 . . . . 2.0899999999999999 109.834 -172.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.25 -25.85 7.55 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.738 -1.119 . . . . 0.41999999999999998 112.895 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.404 ' HB2' HG22 ' A' ' 106' ' ' VAL . 90.1 m-70 -83.71 95.04 8.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.915 0.339 . . . . 0.81999999999999995 111.915 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -68.69 92.71 0.48 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.196 0.522 . . . . 1.3500000000000001 111.063 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 112' ' ' VAL . 6.5 m -74.6 -37.58 43.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.978 -0.556 . . . . 1.6000000000000001 110.904 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.582 HG23 HG22 ' A' ' 111' ' ' VAL . 5.6 t -120.88 89.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.986 0.422 . . . . 1.1200000000000001 109.963 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 11.6 tmtt? -106.98 73.9 0.96 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.733 -1.21 . . . . 4.4000000000000004 107.733 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 7.2 p-10 161.16 28.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.441 -1.709 . . . . 1.96 108.807 -172.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -71.09 80.4 0.68 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.074 -0.512 . . . . 1.78 111.76 -170.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 10.1 t70 -90.48 99.4 12.43 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.051 -1.092 . . . . 1.9299999999999999 108.051 169.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.0 mt -63.64 -36.33 76.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.092 -0.504 . . . . 1.4199999999999999 111.494 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.53 ' HD2' ' HG ' ' A' ' 97' ' ' SER . 68.9 t80 -67.13 -34.94 78.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.056 0.455 . . . . 1.2 110.343 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -67.51 -37.9 83.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.001 0.429 . . . . 0.95999999999999996 111.405 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 120' ' ' ARG . 14.1 mmt85 -77.15 -46.76 22.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.307 0.484 . . . . 2.1800000000000002 112.307 -169.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.682 HG13 ' HD1' ' A' ' 127' ' ' HIS . 4.6 m -113.54 -17.02 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.484 0.549 . . . . 2.0899999999999999 112.484 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.86 -146.66 16.71 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.261 -0.971 . . . . 1.3999999999999999 111.723 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -80.24 116.1 20.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.676 0.274 . . . . 4.9100000000000001 111.385 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.5 t 64.55 -146.74 0.27 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.792 -0.64 . . . . 2.1499999999999999 110.693 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 42.6 p 63.06 178.87 0.15 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.48 1.112 . . . . 1.3999999999999999 111.724 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.675 ' HB2' ' HD2' ' A' ' 88' ' ' LYS . . . -94.23 128.27 40.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.356 -0.384 . . . . 1.21 111.315 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.682 ' HD1' HG13 ' A' ' 121' ' ' VAL . 66.9 t60 -101.65 146.78 27.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.139 -0.689 . . . . 0.57999999999999996 109.139 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 1.1 p30 -143.91 137.62 27.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.301 0.572 . . . . 1.6399999999999999 111.305 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 81.6 mm-40 -110.03 114.63 28.31 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.267 -1.012 . . . . 1.6799999999999999 108.267 172.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.13 107.61 20.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.672 -0.492 . . . . 1.3899999999999999 109.672 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.4 mm -116.47 101.06 53.81 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.394 -0.367 . . . . 1.8500000000000001 111.017 -173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.6 121.56 3.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.815 2.343 . . . . 0.33000000000000002 111.616 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.2 pt -110.58 158.63 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.363 -0.606 . . . . 1.1000000000000001 109.363 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.7 p -124.67 107.09 10.63 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.014 0.435 . . . . 1.8200000000000001 110.773 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 35.0 mt -103.8 124.11 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.262 -0.426 . . . . 1.1399999999999999 110.138 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 53.0 mmtt -151.46 138.49 19.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.646 0.592 . . . . 2.4300000000000002 110.331 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt 62.42 31.62 17.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.45 0.643 . . . . 3.6000000000000001 110.507 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.09 22.01 77.15 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.015 -0.993 . . . . 0.45000000000000001 111.923 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.622 ' HG2' HG21 ' A' ' 148' ' ' THR . 58.1 mtpt -118.71 137.58 53.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.014 -0.365 . . . . 2.7000000000000002 110.014 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 7.1 tt -113.91 116.32 29.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.178 -0.464 . . . . 1.1100000000000001 109.777 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.6 t -111.26 132.95 53.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.407 -0.36 . . . . 1.8100000000000001 110.375 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 88.7 t -125.66 103.97 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.298 -0.41 . . . . 1.5700000000000001 110.246 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 57.41 -91.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.68 0.612 . . . . 1.8799999999999999 112.005 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -113.7 14.47 22.23 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.866 -0.683 . . . . 1.25 112.905 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -129.27 116.38 19.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.861 0.331 . . . . 1.95 111.201 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.21 129.85 57.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.071 0.462 . . . . 1.49 109.961 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m -144.03 -177.63 5.54 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.574 -0.528 . . . . 1.75 109.574 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.622 HG21 ' HG2' ' A' ' 139' ' ' LYS . 39.0 p -98.07 138.98 34.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.745 0.307 . . . . 1.8700000000000001 110.284 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.824 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 58.6 t80 -79.57 135.44 36.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.996 -0.547 . . . . 0.56999999999999995 109.966 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.7 t -132.17 102.31 5.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.526 0.679 . . . . 2.2400000000000002 111.949 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.31 -68.46 2.91 Favored Glycine 0 CA--C 1.508 -0.344 0 CA-C-N 115.421 -0.809 . . . . 0.77000000000000002 113.678 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -158.63 167.01 30.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.864 0.364 . . . . 1.8 110.452 -177.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.813 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 6.0 tt -80.92 127.55 32.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.539 -0.911 . . . . 1.8300000000000001 108.539 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.742 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 5.7 p -112.45 102.9 10.98 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.346 -0.542 . . . . 1.72 112.333 -172.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.574 HG21 HD12 ' A' ' 85' ' ' LEU . 97.1 t -91.72 109.35 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.783 -0.451 . . . . 1.1699999999999999 109.783 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.563 ' HB2' ' HD2' ' A' ' 105' ' ' ARG . 39.9 mt-10 -120.3 112.05 18.55 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.533 -0.758 . . . . 1.98 109.609 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.689 ' CE1' ' HE1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -99.71 114.47 27.59 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 118.569 -1.253 . . . . 2.9100000000000001 110.344 166.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 20.8 t -83.77 144.69 9.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 113.758 -1.565 . . . . 1.3 110.828 -169.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.719 ' HA ' ' OD1' ' A' ' 164' ' ' ASN . 8.3 ptmm? -63.15 132.82 53.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.064 -0.971 . . . . 2.6699999999999999 112.03 -172.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -113.86 -97.52 2.24 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.14 -0.936 . . . . 1.45 112.11 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.73 58.21 0.65 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.751 0.31 . . . . 4.5 111.468 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 68.83 155.48 0.12 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.514 -0.766 . . . . 5.1500000000000004 112.497 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.537 ' OD1' ' HG2' ' A' ' 166' ' ' LYS . 7.0 t0 48.68 68.33 0.72 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.353 -0.839 . . . . 2.6400000000000001 109.947 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.719 ' OD1' ' HA ' ' A' ' 159' ' ' LYS . 1.7 m-20 -57.56 135.09 82.26 Favored Pre-proline 0 CA--C 1.506 -0.734 0 CA-C-N 115.451 -0.795 . . . . 2.0600000000000001 109.883 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.487 ' HD3' ' CD2' ' A' ' 102' ' ' PHE . 62.4 Cg_exo -17.3 73.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.057 1 C-N-CA 126.102 4.534 . . . . 3.6899999999999999 114.681 -158.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.776 ' HA ' ' HE3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 1.32 -77.48 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 O-C-N 125.936 2.022 . . . . 3.5899999999999999 114.647 177.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.852 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 2.4 t -93.19 133.57 33.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.311 -0.404 . . . . 1.8700000000000001 110.699 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -129.95 74.42 1.59 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 119.623 -0.831 . . . . 1.9099999999999999 113.133 -172.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 1.048 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -80.12 36.08 0.34 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.708 1.203 . . . . 1.05 113.576 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.739 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 18.9 tp -53.76 117.37 3.11 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.688 0.625 . . . . 1.3500000000000001 112.688 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.728 ' HE1' HG23 ' A' ' 10' ' ' VAL . 8.4 t80 -123.89 127.79 48.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.963 0.505 . . . . 0.60999999999999999 110.555 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.659 HG23 HG22 ' A' ' 11' ' ' ILE . 8.7 tt -119.13 131.65 71.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 121.811 0.815 . . . . 1.1000000000000001 111.05 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 9.4 ptm -121.33 159.93 25.05 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.846 -0.616 . . . . 1.1399999999999999 109.534 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 16.2 ptmt -113.18 149.98 32.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.424 1.107 . . . . 1.74 113.063 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 176' ' ' THR . . . 103.58 -32.47 7.53 Favored Glycine 0 C--N 1.309 -0.917 0 CA-C-N 113.231 -1.804 . . . . 0.31 114.337 161.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.608 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.2 OUTLIER -177.49 162.22 1.82 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.052 0.926 . . . . 1.3 112.511 176.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.649 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -85.49 -10.36 56.18 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.22 -0.9 . . . . 1.3500000000000001 109.891 168.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.608 ' H ' ' HB ' ' A' ' 176' ' ' THR . 22.2 m-20 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.416 -0.811 . . . . 2.1600000000000001 111.616 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 111.338 -0.705 . . . . 2.02 111.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.584 ' HG ' HD11 ' A' ' 27' ' ' ILE . 47.6 tp -76.12 -31.55 58.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.159 0.504 . . . . 1.2 110.111 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -61.23 -22.87 65.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.204 -0.907 . . . . 1.1699999999999999 111.781 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -82.46 -34.3 28.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.41 -0.359 . . . . 2.1800000000000002 111.373 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.546 ' HB2' ' HE1' ' A' ' 173' ' ' MET . 57.8 mmtt -93.54 -15.39 25.52 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.59 -0.444 . . . . 2.2599999999999998 112.02 -171.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.73 HG23 ' HE1' ' A' ' 171' ' ' PHE . 7.1 p -54.02 132.53 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.027 0.441 . . . . 1.1100000000000001 111.775 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 pt -115.78 -32.28 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.226 -0.443 . . . . 1.51 110.705 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.724 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 42.0 t90 -159.63 133.0 7.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.046 -0.724 . . . . 0.42999999999999999 109.046 -172.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.84 131.45 13.09 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.848 -0.341 . . . . 1.0700000000000001 111.059 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.836 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 52.3 t -140.42 120.59 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.66 0.743 . . . . 1.45 111.357 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 51.4 t30 -98.15 101.63 13.15 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.109 -1.071 . . . . 1.6100000000000001 108.109 167.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.401 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -60.36 95.7 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 116.051 -0.522 . . . . 1.1599999999999999 110.036 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 175.94 -90.17 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 O-C-N 124.812 1.32 . . . . 0.76000000000000001 113.068 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.37 -130.11 0.26 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.562 -0.352 . . . . 0.82999999999999996 113.751 -172.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HG3' ' HD3' ' A' ' 31' ' ' LYS . 31.6 tt0 -144.95 119.44 9.68 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.572 -0.369 . . . . 1.8400000000000001 111.528 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.71 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 50.0 m 31.45 99.0 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.726 1.38 . . . . 1.75 114.726 172.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.869 ' HD2' ' HB2' ' A' ' 60' ' ' LEU . 76.2 t60 -135.33 134.97 40.4 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.786 -0.572 . . . . 0.52000000000000002 111.855 -177.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.409 ' CG2' ' HD1' ' A' ' 28' ' ' HIS . 83.7 t -88.45 115.48 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.46 -0.791 . . . . 1.6100000000000001 110.225 175.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.47 159.47 33.91 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.442 -0.577 . . . . 0.77000000000000002 109.442 176.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 57' ' ' ASP . 28.8 m -66.2 -6.96 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.999 0.74 . . . . 1.29 112.999 -171.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -99.0 7.35 46.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.856 -0.794 . . . . 1.02 108.856 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 87.3 30.8 18.44 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.877 -1.056 . . . . 0.37 112.706 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.584 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.7 mm -104.45 106.27 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 1.0900000000000001 111.34 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.409 ' HD1' ' CG2' ' A' ' 22' ' ' VAL . 30.3 t60 -86.33 109.43 18.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.289 0.566 . . . . 1.1200000000000001 111.459 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.836 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -77.12 138.82 39.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.498 -0.774 . . . . 1.9199999999999999 109.994 172.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -99.5 116.2 31.1 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.016 0.436 . . . . 3.4399999999999999 110.677 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.535 ' HG2' ' N ' ' A' ' 32' ' ' ASP . 8.9 ttpp -34.25 146.98 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.914 1.286 . . . . 3.23 114.371 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.535 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 7.7 p-10 -24.21 92.72 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 125.961 1.705 . . . . 2.4100000000000001 114.639 -173.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -106.75 39.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.879 3.053 . . . . 1.8700000000000001 113.507 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.562 ' HA ' ' HD2' ' A' ' 37' ' ' ARG . 19.7 tp -137.86 -66.1 0.51 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.971 0.73 . . . . 2.4399999999999999 112.971 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -84.05 97.54 9.36 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.332 -0.855 . . . . 5.3099999999999996 110.063 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 38' ' ' VAL . . . 92.81 -20.95 41.99 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.945 -1.262 . . . . 2.6899999999999999 109.945 -168.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.562 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 16.3 mmm180 64.41 -7.19 0.25 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.674 1.19 . . . . 6.0700000000000003 111.705 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.493 ' H ' ' C ' ' A' ' 36' ' ' GLY . 11.5 p -150.72 155.67 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.392 -0.596 . . . . 4.3700000000000001 109.392 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.44 -143.36 9.27 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.863 -0.684 . . . . 2.9300000000000002 112.025 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -132.18 -171.81 2.73 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.281 -0.266 . . . . 6.8399999999999999 110.281 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.1 -60.13 2.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.644 -0.253 . . . . 2.0800000000000001 111.261 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.7 m 55.27 50.84 14.16 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.647 -0.871 . . . . 2.8100000000000001 108.647 -171.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.515 ' OD2' ' HB3' ' A' ' 46' ' ' MET . 43.9 t0 -78.2 81.4 4.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.603 -1.181 . . . . 2.52 111.748 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -96.76 9.11 42.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.724 -0.671 . . . . 7.3399999999999999 109.661 171.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.844 ' HA3' ' HG2' ' A' ' 64' ' ' GLU . . . -104.89 -15.49 20.06 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.478 -0.783 . . . . 3.54 112.692 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.515 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 15.9 ptt? -66.07 0.63 1.83 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.356 0.502 . . . . 2.7799999999999998 112.356 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.749 ' HG3' HD23 ' A' ' 48' ' ' LEU . 46.7 pttt -95.22 9.81 38.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.629 -0.26 . . . . 4.6399999999999997 111.232 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.749 HD23 ' HG3' ' A' ' 47' ' ' LYS . 3.3 mm? -120.62 73.47 22.93 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.81 -0.177 . . . . 3.0299999999999998 110.622 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.21 109.75 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.019 2.48 . . . . 2.0600000000000001 113.489 -174.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.548 HD12 ' HG3' ' A' ' 62' ' ' GLN . 1.5 mp -61.82 116.15 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.765 -0.652 . . . . 1.5900000000000001 110.389 174.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.89 -17.54 62.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 2.48 111.595 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.521 ' HD3' ' HB ' ' A' ' 125' ' ' THR . 10.6 mpt_? -97.48 25.7 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.245 0.461 . . . . 3.7200000000000002 112.245 -175.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -153.46 165.87 34.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 0.96999999999999997 111.373 177.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 1.3 t30 -89.25 140.64 28.75 Favored Pre-proline 0 C--O 1.217 -0.655 0 CA-C-N 115.469 -0.787 . . . . 1.9199999999999999 109.901 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 38.2 Cg_exo -37.78 -53.04 1.59 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 124.681 3.587 . . . . 0.95999999999999996 117.339 -161.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -73.07 -45.97 54.27 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 119.419 1.008 . . . . 2.71 110.708 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.401 ' HB3' HG13 ' A' ' 24' ' ' VAL . 2.7 p30 -77.37 -20.8 54.24 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.004 -0.544 . . . . 1.6299999999999999 109.563 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.475 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 24.5 tt0 -54.19 -48.07 71.38 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.563 -0.744 . . . . 2.1200000000000001 109.378 169.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.79 -37.9 42.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.987 -0.551 . . . . 1.9099999999999999 110.576 172.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.869 ' HB2' ' HD2' ' A' ' 21' ' ' HIS . 0.4 OUTLIER -74.92 -10.53 59.57 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.932 0.396 . . . . 1.77 111.758 178.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.541 ' HA ' ' HB1' ' A' ' 169' ' ' ALA . 62.2 m-85 -115.78 12.66 15.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.276 1.036 . . . . 1.3799999999999999 108.756 175.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.548 ' HG3' HD12 ' A' ' 50' ' ' ILE . 8.3 tt0 -126.88 -130.6 0.23 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.401 -1.727 . . . . 1.97 108.716 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.653 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 40.7 p 39.03 106.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.956 1.465 . . . . 1.54 114.956 -176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.926 ' HB3' HG12 ' A' ' 167' ' ' VAL . 12.5 pt-20 -97.27 151.83 19.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.991 -1.114 . . . . 1.96 107.991 168.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.633 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 22.8 ptt180 -123.23 -46.02 2.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.353 0.501 . . . . 4.0700000000000003 112.353 -176.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -175.07 -175.93 0.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.142 -0.688 . . . . 5.0 109.142 -173.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.533 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 4.1 p30 -148.11 75.21 1.33 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.375 0.607 . . . . 5.1799999999999997 110.597 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -54.7 -70.15 0.11 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.753 -0.658 . . . . 3.7000000000000002 111.435 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -170.07 -161.25 0.26 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.277 -1.379 . . . . 2.2000000000000002 107.277 -175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 t -42.34 102.1 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.308 -0.626 . . . . 1.78 109.308 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.829 ' HB2' ' HD1' ' A' ' 157' ' ' PHE . 15.3 m-85 -66.63 104.99 1.41 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.74 -0.664 . . . . 2.2999999999999998 109.484 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.489 ' O ' HD11 ' A' ' 34' ' ' LEU . . . -109.43 95.04 0.86 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 119.75 -1.214 . . . . 1.1599999999999999 114.193 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.62 ' HH ' HH22 ' A' ' 65' ' ' ARG . 51.6 m-85 -84.4 148.33 26.66 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.305 -0.447 . . . . 1.6200000000000001 110.77 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -127.68 127.02 43.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.742 0.782 . . . . 2.4700000000000002 109.934 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.87 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.0 mp -110.6 92.46 14.21 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 114.664 -1.153 . . . . 1.1899999999999999 109.028 -176.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.56 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 34.5 Cg_exo -57.71 117.12 3.76 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.085 1.857 . . . . 0.89000000000000001 111.609 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.761 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 56.4 mt -115.6 130.43 70.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.165 0.507 . . . . 1.1699999999999999 111.634 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.52 -24.59 9.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.848 -0.615 . . . . 3.7000000000000002 110.789 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.725 ' HB2' ' HH ' ' A' ' 83' ' ' TYR . 7.4 mm-40 -99.06 176.06 5.7 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.864 0.364 . . . . 2.1600000000000001 110.575 -168.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 136' ' ' LYS . 2.3 tt0 -126.59 160.71 29.88 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.83 -0.623 . . . . 1.2 109.817 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.583 ' N ' ' HG2' ' A' ' 80' ' ' GLU . . . 139.45 -163.84 26.03 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 115.576 -0.738 . . . . 0.35999999999999999 111.534 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 27.4 mt-10 -98.75 109.77 22.47 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 120.373 -0.531 . . . . 1.96 109.857 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.725 ' HH ' ' HB2' ' A' ' 79' ' ' GLU . 74.8 m-85 -94.34 124.66 38.5 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.583 -0.895 . . . . 1.1399999999999999 108.583 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.663 HG21 ' HA ' ' A' ' 177' ' ' ALA . 52.9 t -104.74 106.13 19.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-O 121.909 0.862 . . . . 1.0700000000000001 109.902 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.735 HD12 HD11 ' A' ' 170' ' ' LEU . 10.9 tp -89.66 103.32 15.98 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.2 -1.364 . . . . 2.0600000000000001 109.291 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.13 107.72 23.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.64 0.734 . . . . 1.72 109.364 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 1.3 pp -113.23 140.73 47.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.601 -0.727 . . . . 2.0600000000000001 111.035 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.799 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 12.8 mptt -99.55 134.24 42.71 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.374 -0.53 . . . . 4.1900000000000004 110.203 173.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 165' ' ' PRO . 11.3 m-85 -117.17 138.01 51.96 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.696 -0.684 . . . . 0.54000000000000004 110.372 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.516 ' HB3' ' CG2' ' A' ' 167' ' ' VAL . . . -147.36 161.75 40.37 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.78 -0.368 . . . . 1.1599999999999999 111.252 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER 70.61 108.03 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 124.407 1.067 . . . . 2.6200000000000001 111.218 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 92' ' ' VAL . 5.0 p -120.47 82.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.705 0.764 . . . . 4.1900000000000004 109.51 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -47.43 -49.0 26.2 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.901 -1.045 . . . . 5.96 111.954 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.934 ' HB2' ' HD2' ' A' ' 100' ' ' LYS . 99.2 m-85 -85.37 86.93 7.34 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.253 -0.647 . . . . 5.46 109.253 175.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.93 91.44 0.33 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.557 -0.747 . . . . 1.8500000000000001 111.438 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.42 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . 5.9 tp60 -160.77 145.56 14.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.969 -0.56 . . . . 3.3300000000000001 110.057 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.6 p -101.53 143.14 31.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 1.78 110.438 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 59.03 53.05 5.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.278 0.561 . . . . 2.75 109.867 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -162.99 -48.8 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.847 -0.615 . . . . 3.4300000000000002 110.023 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.934 ' HD2' ' HB2' ' A' ' 94' ' ' PHE . 56.4 tttp -96.28 80.31 3.2 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.917 -0.771 . . . . 3.25 108.917 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.07 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.996 -1.002 . . . . 1.8200000000000001 110.809 -171.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.642 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 33.9 m-85 -77.36 158.19 30.24 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.532 -0.758 . . . . 1.1699999999999999 109.804 176.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.729 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 50.9 m-20 -112.23 135.15 53.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.439 -0.949 . . . . 1.53 108.439 172.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.881 HG22 ' HD2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -125.79 119.81 55.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.164 0.506 . . . . 1.3500000000000001 109.95 -177.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.704 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 79.6 mtt180 -116.83 141.87 47.66 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.017 -0.992 . . . . 2.3100000000000001 111.456 -171.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.653 HG11 HD13 ' A' ' 153' ' ' LEU . 41.8 t -116.5 102.25 13.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.663 -0.699 . . . . 2.0899999999999999 109.153 174.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.876 ' HB2' HD12 ' A' ' 153' ' ' LEU . 23.3 t-20 57.26 46.45 18.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.227 1.013 . . . . 2.0899999999999999 108.421 -170.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.79 -21.97 30.64 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.945 -1.025 . . . . 0.41999999999999998 113.315 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 93.0 m-70 -78.12 108.57 11.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.268 0.47 . . . . 0.81999999999999995 112.268 -173.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.496 ' CG2' ' HG2' ' A' ' 105' ' ' ARG . 5.9 p -69.35 87.81 0.45 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.779 0.323 . . . . 1.3500000000000001 111.029 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.6 t -67.78 -55.55 16.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.154 -0.684 . . . . 1.6000000000000001 109.154 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.573 HG23 ' HG2' ' A' ' 129' ' ' GLU . 17.3 t -112.53 90.52 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.874 -0.603 . . . . 1.1200000000000001 109.72 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -107.9 73.25 0.89 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.757 0.789 . . . . 4.4000000000000004 109.781 177.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 9.2 p-10 164.94 32.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.063 -1.426 . . . . 1.96 108.536 -172.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.642 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -78.11 71.08 4.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.217 -0.901 . . . . 1.78 112.042 -170.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.513 ' HB2' ' HB3' ' A' ' 119' ' ' ASP . 31.0 m-20 -77.16 93.57 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.937 -1.134 . . . . 1.9299999999999999 107.937 167.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.7 mt -54.01 -39.78 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.996 0.427 . . . . 1.4199999999999999 110.211 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 56.7 t80 -64.71 -39.53 93.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.417 -0.81 . . . . 1.2 110.987 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 12.1 t70 -71.98 -36.41 69.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.987 0.422 . . . . 0.95999999999999996 111.431 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -77.9 -49.56 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 2.1800000000000002 111.807 -171.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.676 HG11 ' HD1' ' A' ' 127' ' ' HIS . 15.9 m -110.5 -24.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.379 -0.529 . . . . 2.0899999999999999 112.284 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 112.81 -142.86 17.54 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.423 -0.894 . . . . 1.3999999999999999 111.961 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -89.14 110.29 21.04 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.173 -0.306 . . . . 4.9100000000000001 110.173 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.4 t 68.15 -150.71 0.16 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.621 -0.718 . . . . 2.1499999999999999 110.909 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.521 ' HB ' ' HD3' ' A' ' 52' ' ' ARG . 20.8 p 66.57 177.85 0.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.531 1.132 . . . . 1.3999999999999999 111.176 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.492 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -91.94 119.1 31.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.826 0.346 . . . . 1.21 111.574 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.676 ' HD1' HG11 ' A' ' 121' ' ' VAL . 84.0 t60 -89.37 130.04 35.8 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.714 -0.847 . . . . 0.57999999999999996 108.714 172.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -121.58 113.26 19.53 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.494 -0.321 . . . . 1.6399999999999999 110.912 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.573 ' HG2' HG23 ' A' ' 112' ' ' VAL . 2.6 tp10 -116.53 113.62 23.02 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.696 -0.483 . . . . 1.6799999999999999 109.696 177.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.4 mt -98.75 119.83 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.232 -0.44 . . . . 1.3899999999999999 109.828 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.538 HG21 HG21 ' A' ' 106' ' ' VAL . 58.2 mt -125.23 89.58 52.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.233 -0.44 . . . . 1.8500000000000001 110.63 -173.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -75.83 126.61 9.55 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.61 2.207 . . . . 0.33000000000000002 112.019 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.648 HG12 ' HB2' ' A' ' 83' ' ' TYR . 6.0 pt -110.38 157.16 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.043 -0.725 . . . . 1.1000000000000001 109.043 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 t -123.93 106.67 10.61 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.808 -0.442 . . . . 1.8200000000000001 109.808 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.735 HG12 ' HG ' ' A' ' 140' ' ' LEU . 5.2 mt -104.73 137.14 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 109.021 -0.733 . . . . 1.1399999999999999 109.021 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 53.1 mttm -152.77 131.13 12.08 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 123.699 0.625 . . . . 2.4300000000000002 111.104 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.674 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER 56.22 27.66 12.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.147 -0.933 . . . . 3.6000000000000001 111.239 177.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.62 13.62 62.75 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.792 -0.718 . . . . 0.45000000000000001 113.085 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 59.2 mtpt -115.17 137.54 51.91 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.391 -0.476 . . . . 2.7000000000000002 109.904 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.735 ' HG ' HG12 ' A' ' 135' ' ' ILE . 3.8 tt -115.51 121.44 42.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.314 -0.403 . . . . 1.1100000000000001 110.185 -172.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -117.47 114.17 23.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.32 -0.4 . . . . 1.8100000000000001 109.942 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 142' ' ' VAL . 5.5 m -90.73 111.07 23.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.97 -0.752 . . . . 1.5700000000000001 108.97 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 63.55 -85.41 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.128 -0.487 . . . . 1.8799999999999999 110.43 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -139.71 17.65 3.03 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.826 -0.625 . . . . 1.25 111.626 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -108.49 121.42 44.94 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.829 -0.804 . . . . 1.95 108.829 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.8 p -103.46 146.78 10.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.315 0.578 . . . . 1.49 111.943 -168.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.4 p -163.25 176.51 9.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.224 -0.898 . . . . 1.75 109.046 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.426 HG21 ' HG2' ' A' ' 139' ' ' LYS . 70.3 p -100.27 138.13 37.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.711 0.291 . . . . 1.8700000000000001 110.316 175.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.761 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 39.3 t80 -79.81 131.35 35.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.026 -0.361 . . . . 0.56999999999999995 110.026 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.3 t -131.39 111.06 11.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.464 0.649 . . . . 2.2400000000000002 111.473 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.37 -72.8 1.88 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.387 -0.824 . . . . 0.77000000000000002 113.678 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.56 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -155.75 169.11 25.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.973 0.416 . . . . 1.8 110.62 -175.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.876 HD12 ' HB2' ' A' ' 107' ' ' ASN . 22.7 tp -80.99 150.72 28.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.707 -0.849 . . . . 1.8300000000000001 108.707 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.6 t -132.53 104.11 6.51 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 118.994 -1.082 . . . . 1.72 110.353 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 15.5 t -92.91 96.44 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 108.401 -0.963 . . . . 1.1699999999999999 108.401 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HB3' ' HD2' ' A' ' 105' ' ' ARG . 4.3 tt0 -107.7 121.82 45.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.495 -1.229 . . . . 1.98 109.582 -173.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.881 ' HD2' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -113.32 115.52 28.27 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.178 -0.609 . . . . 2.9100000000000001 110.116 176.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 52.9 t -82.81 140.82 15.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.971 -1.013 . . . . 1.3 110.766 -173.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -66.02 109.84 2.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.999 -1.0 . . . . 2.6699999999999999 112.336 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.486 ' H ' ' HD1' ' A' ' 102' ' ' PHE . . . -84.0 84.62 1.57 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.457 -0.792 . . . . 1.45 111.805 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.1 t80 63.52 63.67 0.86 Allowed 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.116 0.539 . . . . 4.5 110.81 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 16.9 t80 63.34 173.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.686 -0.688 . . . . 5.1500000000000004 110.124 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.27 80.4 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.78 0.324 . . . . 2.6400000000000001 110.922 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 165' ' ' PRO . 3.4 m-20 -60.46 175.01 0.44 Allowed Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.632 -0.713 . . . . 2.0600000000000001 109.711 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 164' ' ' ASN . 73.0 Cg_exo -42.97 97.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.452 2.101 . . . . 3.6899999999999999 111.989 172.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.647 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 12.9 tptm -55.62 -61.91 2.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.947 -1.024 . . . . 3.5899999999999999 111.994 -162.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.926 HG12 ' HB3' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -109.77 136.87 44.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 108.341 -0.985 . . . . 1.8700000000000001 108.341 171.123 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 33.9 t -137.41 89.03 2.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.04 0.755 . . . . 1.9099999999999999 113.04 -168.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.799 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -75.39 38.4 0.14 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 124.479 1.112 . . . . 1.05 113.273 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.735 HD11 HD12 ' A' ' 85' ' ' LEU . 40.7 tp -54.12 104.42 0.11 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.769 0.655 . . . . 1.3500000000000001 112.769 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.772 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 4.3 t80 -117.99 124.62 48.62 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.489 -0.323 . . . . 0.60999999999999999 110.925 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.676 ' HB ' HD11 ' A' ' 85' ' ' LEU . 5.0 tt -114.53 123.7 70.46 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-O 122.226 1.012 . . . . 1.1000000000000001 111.359 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.772 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.6 ppp? -115.68 159.88 20.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.884 -1.053 . . . . 1.1399999999999999 109.99 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.569 ' HZ1' ' HG3' ' A' ' 79' ' ' GLU . 53.8 tttt -105.87 133.23 50.93 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 114.1 1.148 . . . . 1.74 114.1 -170.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 106.15 -28.87 12.28 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 113.832 -1.531 . . . . 0.31 116.226 157.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.99 158.09 1.98 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.036 1.418 . . . . 1.3 113.411 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.663 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -83.86 -9.58 58.65 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.206 -0.906 . . . . 1.3500000000000001 111.356 174.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 30.6 t70 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 121.157 0.504 . . . . 2.1600000000000001 111.215 -178.188 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 112.127 -0.389 . . . . 2.02 112.127 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.589 HD12 ' HE3' ' A' ' 173' ' ' MET . 50.2 tp -59.54 -36.83 76.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.305 0.574 . . . . 1.2 110.141 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -69.89 -23.42 63.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.485 -0.78 . . . . 1.1699999999999999 111.651 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.55 -16.54 53.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.026 -0.534 . . . . 2.1800000000000002 111.009 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -126.22 2.77 7.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.438 -0.505 . . . . 2.2599999999999998 111.785 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.517 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 11.6 p -58.78 136.91 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.508 -0.477 . . . . 1.1100000000000001 110.176 169.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.7 pt -115.76 -22.86 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.285 -0.416 . . . . 1.51 111.047 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.759 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 79.4 t90 -171.1 143.28 1.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.838 -0.431 . . . . 0.42999999999999999 109.838 -173.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -162.18 137.58 7.28 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.207 -0.308 . . . . 1.0700000000000001 111.553 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -142.02 125.72 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.02 -0.536 . . . . 1.45 110.885 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 28.5 t30 -101.77 104.87 15.68 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.793 -0.817 . . . . 1.6100000000000001 108.793 167.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HB1' ' OH ' ' A' ' 73' ' ' TYR . . . -65.52 89.11 0.1 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.245 -0.889 . . . . 1.1599999999999999 110.247 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.6 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -174.36 -67.73 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 O-C-N 125.385 1.678 . . . . 0.76000000000000001 112.249 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.85 -132.38 5.69 Favored Glycine 0 C--N 1.318 -0.441 0 C-N-CA 120.757 -0.735 . . . . 0.82999999999999996 112.997 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 1.057 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 25.3 tt0 -138.33 119.37 14.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 111.243 0.09 . . . . 1.8400000000000001 111.243 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 73.1 m 36.39 108.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.584 1.698 . . . . 1.75 115.584 170.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 82.6 t60 -137.76 128.37 26.74 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.928 -0.483 . . . . 0.52000000000000002 111.42 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 86.1 t -87.8 113.15 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.209 -0.905 . . . . 1.6100000000000001 109.074 171.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -78.38 161.33 27.24 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.333 -0.247 . . . . 0.77000000000000002 110.333 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.32 -27.84 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 124.585 1.178 . . . . 1.29 113.232 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.413 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 87.6 m-70 -80.34 -6.55 58.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.312 0.577 . . . . 1.02 109.559 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . 96.41 24.84 13.22 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.955 -1.021 . . . . 0.37 112.179 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.537 HD12 ' HG ' ' A' ' 6' ' ' LEU . 19.1 mm -99.36 109.18 23.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.178 0.513 . . . . 1.0900000000000001 110.937 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 7.7 t60 -86.71 110.99 20.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.139 -0.482 . . . . 1.1200000000000001 110.342 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.667 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -87.48 139.13 30.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.084 -0.339 . . . . 1.9199999999999999 110.084 175.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 13.3 ptp180 -92.97 138.66 31.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.131 0.491 . . . . 3.4399999999999999 110.664 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 1.057 ' HB3' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -73.9 136.91 43.38 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.939 1.088 . . . . 3.23 113.939 -173.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' CG ' ' HZ2' ' A' ' 31' ' ' LYS . 1.1 p30 28.54 54.67 0.5 Allowed Pre-proline 0 N--CA 1.484 1.246 0 CA-C-N 111.868 -2.424 . . . . 2.4100000000000001 116.09 167.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 67.3 Cg_endo -94.15 36.31 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.503 2.135 . . . . 1.8700000000000001 113.006 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.607 HD22 ' N ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -137.25 -54.93 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.477 0.547 . . . . 2.4399999999999999 112.477 -178.037 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.607 ' N ' HD22 ' A' ' 34' ' ' LEU . 7.5 pt-20 -79.45 89.52 5.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.623 0.725 . . . . 5.3099999999999996 110.159 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 38' ' ' VAL . . . 86.29 -10.11 67.72 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.414 -1.074 . . . . 2.6899999999999999 110.414 -170.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 7.9 mmt180 67.13 -26.3 0.12 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.079 1.352 . . . . 6.0700000000000003 112.301 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 36' ' ' GLY . 28.6 t -127.58 116.64 44.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.777 -0.453 . . . . 4.3700000000000001 109.777 177.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.75 -149.33 4.95 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.723 -0.751 . . . . 2.9300000000000002 112.356 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -153.13 69.5 0.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.822 0.344 . . . . 6.8399999999999999 110.639 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.553 ' HB1' ' HB2' ' A' ' 19' ' ' GLU . . . 52.06 81.54 0.08 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.706 -0.679 . . . . 2.0800000000000001 112.492 172.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.782 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 13.9 m -81.92 65.15 6.93 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.347 -0.388 . . . . 2.8100000000000001 110.301 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -75.49 57.88 0.97 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.828 0.823 . . . . 2.52 111.452 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -110.39 125.84 53.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.467 -0.788 . . . . 7.3399999999999999 109.044 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.29 8.02 60.3 Favored Glycine 0 C--O 1.227 -0.315 0 N-CA-C 110.741 -0.943 . . . . 3.54 110.741 -172.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.849 ' HG3' ' HA ' ' A' ' 63' ' ' THR . 23.9 ttt -70.59 -0.4 8.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.988 -0.606 . . . . 2.7799999999999998 111.734 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -80.16 69.75 6.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.521 0.676 . . . . 4.6399999999999997 110.628 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.609 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -153.81 74.03 6.43 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.225 -1.028 . . . . 3.0299999999999998 108.225 176.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.15 118.75 5.68 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.5 2.133 . . . . 2.0600000000000001 112.788 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.607 HD11 ' HA ' ' A' ' 62' ' ' GLN . 1.7 mp -80.39 99.42 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.863 0.84 . . . . 1.5900000000000001 109.712 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HB3' HG22 ' A' ' 125' ' ' THR . 2.8 tt -60.95 -35.51 76.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.592 -1.186 . . . . 2.48 110.962 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -88.09 33.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.951 0.722 . . . . 3.7200000000000002 112.951 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.446 ' HG ' ' CG ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -142.62 168.16 20.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.8 0.333 . . . . 0.96999999999999997 110.878 172.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -90.21 141.42 27.69 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.958 -0.756 . . . . 1.9199999999999999 108.958 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' HG22 ' A' ' 59' ' ' VAL . 60.3 Cg_exo -39.67 -42.74 2.96 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 124.101 3.201 . . . . 0.95999999999999996 115.947 -162.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -76.54 -44.37 35.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.248 0.476 . . . . 2.71 111.361 -177.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.494 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -81.2 -17.48 49.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.234 -0.654 . . . . 1.6299999999999999 109.234 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -58.85 -45.69 89.52 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.174 -0.921 . . . . 2.1200000000000001 109.135 167.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 55' ' ' PRO . 68.8 t -55.19 -44.6 75.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.487 0.66 . . . . 1.9099999999999999 109.593 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 35.0 tp -63.72 -18.94 64.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.644 -1.162 . . . . 1.77 112.141 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.615 ' CE2' ' HE2' ' A' ' 88' ' ' LYS . 13.6 m-30 -114.91 1.55 14.06 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 111.894 0.331 . . . . 1.3799999999999999 111.894 -175.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.609 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 39.2 tt0 -124.3 -41.36 2.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.626 0.973 . . . . 1.97 113.626 -170.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.849 ' HA ' ' HG3' ' A' ' 46' ' ' MET . 2.1 m -61.1 132.49 53.93 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 121.072 -0.251 . . . . 1.54 111.451 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 1.001 ' HB2' HG21 ' A' ' 167' ' ' VAL . 36.5 tt0 -120.33 147.75 44.62 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.123 0.569 . . . . 1.96 110.397 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.902 HH22 ' HH ' ' A' ' 73' ' ' TYR . 16.6 mtm-85 -103.83 -170.51 1.79 Allowed 'General case' 0 N--CA 1.463 0.184 0 O-C-N 123.232 0.333 . . . . 4.0700000000000003 110.931 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' A' ' 165' ' ' PRO . 51.2 t80 -79.23 -59.52 2.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.574 -0.284 . . . . 5.0 110.692 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 59.76 -164.66 0.21 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.583 -0.28 . . . . 5.1799999999999997 111.212 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -160.35 -91.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.94 0.4 . . . . 3.7000000000000002 111.82 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.931 ' HA ' HD21 ' A' ' 164' ' ' ASN . 19.2 t0 -149.36 142.22 24.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.575 -0.284 . . . . 2.2000000000000002 110.283 -173.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.5 t 45.96 62.59 2.17 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 124.159 0.912 . . . . 1.78 110.437 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.739 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 8.4 p90 -107.28 126.61 52.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.132 -1.027 . . . . 2.2999999999999998 110.838 -176.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.472 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -145.4 154.06 25.68 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.942 -1.027 . . . . 1.1599999999999999 113.295 -173.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.902 ' HH ' HH22 ' A' ' 65' ' ' ARG . 53.5 m-85 -104.85 164.97 11.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.303 -0.448 . . . . 1.6200000000000001 111.156 -175.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 8.0 p-10 -115.42 118.8 34.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.741 -0.663 . . . . 2.4700000000000002 110.463 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.819 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.8 mp -104.5 90.88 3.59 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.333 -0.849 . . . . 1.1899999999999999 109.302 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.56 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 38.4 Cg_exo -59.74 120.04 7.61 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.251 1.967 . . . . 0.89000000000000001 112.405 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.769 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 72.4 mt -119.86 135.98 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.867 0.365 . . . . 1.1699999999999999 111.236 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 32.6 mtpt -130.9 7.67 4.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 3.7000000000000002 110.736 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.451 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 38.0 mt-10 -131.88 174.41 10.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.975 0.416 . . . . 2.1600000000000001 110.882 -173.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.559 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 9.0 mt-10 -112.82 -172.99 2.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.778 -0.646 . . . . 1.2 110.112 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.33 -167.48 13.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.895 -0.669 . . . . 0.35999999999999999 112.191 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 56.2 mt-10 -97.34 103.3 15.22 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 117.29 0.545 . . . . 1.96 109.747 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.662 ' HB2' HG12 ' A' ' 133' ' ' ILE . 10.9 m-30 -95.64 123.25 39.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 118.985 -1.086 . . . . 1.1399999999999999 108.398 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.968 HG22 ' HA ' ' A' ' 177' ' ' ALA . 74.7 t -114.71 106.68 21.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.518 -0.764 . . . . 1.0700000000000001 110.268 -172.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.418 HD11 ' N ' ' A' ' 85' ' ' LEU . 5.1 mp -88.82 104.47 16.94 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.457 -1.247 . . . . 2.0600000000000001 109.493 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.571 HG23 HG21 ' A' ' 130' ' ' ILE . 44.2 t -103.34 100.73 11.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 107.539 -1.282 . . . . 1.72 107.539 171.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.615 ' CB ' ' HA ' ' A' ' 170' ' ' LEU . 0.6 OUTLIER -109.23 132.24 54.31 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.106 -0.638 . . . . 2.0600000000000001 109.803 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.979 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 13.8 mptt -89.09 122.61 32.58 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.129 -0.628 . . . . 4.1900000000000004 110.393 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.14 135.21 48.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.227 -0.897 . . . . 0.54000000000000004 108.645 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.779 ' HB2' ' HB ' ' A' ' 167' ' ' VAL . . . -125.62 121.91 34.92 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.095 0.474 . . . . 1.1599999999999999 109.968 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.525 ' O ' HG21 ' A' ' 92' ' ' VAL . 2.9 tp10 -165.88 143.48 5.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.817 -1.538 . . . . 2.6200000000000001 108.374 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 91' ' ' GLU . 0.9 OUTLIER 171.91 -27.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 124.585 1.154 . . . . 4.1900000000000004 108.253 -177.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -60.05 -32.76 71.22 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.294 -0.866 . . . . 5.96 110.675 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 100' ' ' LYS . 89.3 m-85 -96.86 85.36 3.77 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.599 -0.889 . . . . 5.46 108.599 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.45 102.57 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.669 -0.696 . . . . 1.8500000000000001 112.578 -172.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -170.87 139.75 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.363 -0.835 . . . . 3.3300000000000001 109.174 170.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.863 ' HB2' ' HB2' ' A' ' 119' ' ' ASP . 14.2 p -129.13 159.89 34.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.443 -0.344 . . . . 1.78 111.439 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.86 HE21 ' HA ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER 48.0 44.19 18.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.436 0.694 . . . . 2.75 112.247 178.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -147.97 -61.52 0.26 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.872 -0.788 . . . . 3.4300000000000002 108.872 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 161' ' ' TYR . 50.2 pttt -86.99 98.15 11.11 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.6 -0.727 . . . . 3.25 109.234 172.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.916 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 6.4 m -108.96 109.82 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.477 0.656 . . . . 1.8200000000000001 110.356 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.69 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 23.5 m-85 -73.87 154.33 39.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.102 -0.954 . . . . 1.1699999999999999 110.887 -175.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.682 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 12.5 m-20 -105.75 137.81 42.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.469 -0.567 . . . . 1.53 109.469 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 2.5 t -134.47 120.18 32.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.762 0.315 . . . . 1.3500000000000001 110.682 -176.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 61.4 mtt180 -120.26 141.98 49.47 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.671 -0.695 . . . . 2.3100000000000001 111.666 -174.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.848 HG22 HD22 ' A' ' 153' ' ' LEU . 2.8 p -118.43 102.78 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.75 -0.659 . . . . 2.0899999999999999 109.845 172.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 64.7 t30 55.44 51.45 12.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.266 -0.879 . . . . 2.0899999999999999 109.342 -172.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.31 -17.67 46.41 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.085 -0.961 . . . . 0.41999999999999998 113.313 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.496 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 90.2 m-70 -85.49 105.45 16.11 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.098 0.407 . . . . 0.81999999999999995 112.098 -172.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 113' ' ' LYS . 1.9 p -69.91 94.3 0.83 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.043 0.449 . . . . 1.3500000000000001 111.174 176.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 106' ' ' VAL . 21.5 t -78.12 -49.62 21.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.643 0.735 . . . . 1.6000000000000001 109.409 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.507 HG11 HD11 ' A' ' 115' ' ' LEU . 9.4 t -118.39 90.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.437 -0.801 . . . . 1.1200000000000001 109.714 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.544 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 0.4 OUTLIER -109.45 71.66 0.78 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.906 -1.146 . . . . 4.4000000000000004 107.906 176.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.916 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 6.6 p-10 168.86 19.29 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.026 -1.897 . . . . 1.96 109.698 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.69 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 11.5 tp -73.35 99.43 2.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.182 -0.463 . . . . 1.78 111.512 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.574 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 23.3 p-10 -110.59 91.08 3.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.161 0.981 . . . . 1.9299999999999999 109.873 174.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.6 mm -52.9 -44.3 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 114.632 -1.167 . . . . 1.4199999999999999 112.483 -170.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.521 ' HD1' HG22 ' A' ' 92' ' ' VAL . 69.5 t80 -56.96 -39.56 74.83 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 123.341 0.4 . . . . 1.2 111.755 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.863 ' HB2' ' HB2' ' A' ' 97' ' ' SER . 21.2 t70 -73.18 -32.61 64.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.115 0.483 . . . . 0.95999999999999996 110.849 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 8.6 mmt180 -71.5 -44.43 64.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.634 -0.712 . . . . 2.1800000000000002 111.084 -173.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.77 -40.38 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.323 0.49 . . . . 2.0899999999999999 112.323 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.25 -58.26 4.96 Favored Glycine 0 C--O 1.23 -0.137 0 C-N-CA 121.133 -0.556 . . . . 1.3999999999999999 112.104 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -99.92 145.42 27.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.436 -0.579 . . . . 4.9100000000000001 109.436 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.432 ' OG ' HG11 ' A' ' 92' ' ' VAL . 3.0 m -54.38 94.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 O-C-N 123.691 0.619 . . . . 2.1499999999999999 111.03 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 51' ' ' LEU . 21.2 p -150.05 -174.9 4.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.217 -0.447 . . . . 1.3999999999999999 109.872 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.557 ' HB3' ' CG2' ' A' ' 50' ' ' ILE . . . -79.92 124.14 28.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.563 -0.29 . . . . 1.21 111.007 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -104.87 145.15 30.79 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.723 -1.214 . . . . 0.57999999999999996 107.723 168.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.727 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 23.8 p-10 -146.81 139.83 25.33 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.931 -0.708 . . . . 1.6399999999999999 112.141 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -103.85 114.02 27.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.219 -0.901 . . . . 1.6799999999999999 108.598 172.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.571 HG21 HG23 ' A' ' 86' ' ' VAL . 71.6 mt -95.73 110.05 23.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.997 -0.547 . . . . 1.3899999999999999 109.629 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.8 mt -119.7 97.45 49.83 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.37 -0.377 . . . . 1.8500000000000001 111.162 -173.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.403 ' HB3' HG21 ' A' ' 84' ' ' VAL . 5.2 Cg_exo -78.68 123.75 6.01 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.717 2.278 . . . . 0.33000000000000002 112.108 172.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.662 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.9 pt -110.03 154.05 11.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.727 -0.842 . . . . 1.1000000000000001 108.727 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.548 ' HG ' ' HB2' ' A' ' 141' ' ' SER . 8.9 p -123.78 109.42 13.64 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.852 0.358 . . . . 1.8200000000000001 110.323 175.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.695 HG12 ' HG ' ' A' ' 140' ' ' LEU . 29.2 mt -98.82 125.11 52.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.049 -0.722 . . . . 1.1399999999999999 109.049 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -151.0 135.57 17.1 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.71 0.631 . . . . 2.4300000000000002 109.435 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 1.073 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 7.6 mmpt? 61.98 25.85 15.55 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.538 0.524 . . . . 3.6000000000000001 111.316 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.25 9.98 85.96 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.731 -0.747 . . . . 0.45000000000000001 112.167 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.689 ' HG2' HG21 ' A' ' 148' ' ' THR . 26.3 mtpp -110.83 137.48 48.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.406 -0.59 . . . . 2.7000000000000002 109.406 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.695 ' HG ' HG12 ' A' ' 135' ' ' ILE . 4.9 tt -108.68 115.32 29.88 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.415 -0.587 . . . . 1.1100000000000001 109.415 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.548 ' HB2' ' HG ' ' A' ' 134' ' ' SER . 7.2 m -108.4 125.12 51.39 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.893 -0.594 . . . . 1.8100000000000001 110.091 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 85.5 t -113.09 95.5 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.769 -0.456 . . . . 1.5700000000000001 109.769 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 62.39 -91.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.427 -0.806 . . . . 1.8799999999999999 111.132 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.3 -10.46 29.54 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.922 -0.656 . . . . 1.25 112.594 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -97.47 149.98 21.57 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.803 -0.234 . . . . 1.95 110.763 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.92 125.76 13.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.168 0.509 . . . . 1.49 110.865 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.425 ' HB2' ' HE2' ' A' ' 109' ' ' HIS . 49.0 m -155.42 141.72 18.53 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.626 -0.509 . . . . 1.75 109.626 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.689 HG21 ' HG2' ' A' ' 139' ' ' LYS . 25.1 p -59.09 140.93 55.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.2 0.524 . . . . 1.8700000000000001 111.131 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.769 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 20.8 t80 -85.83 140.85 30.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.45 -0.795 . . . . 0.56999999999999995 110.301 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 t -144.41 118.01 9.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.509 0.671 . . . . 2.2400000000000002 110.923 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.21 -77.8 2.08 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.324 -0.853 . . . . 0.77000000000000002 113.607 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.56 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -159.72 169.47 23.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.038 0.447 . . . . 1.8 110.975 -174.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.848 HD22 HG22 ' A' ' 106' ' ' VAL . 6.7 tt -84.34 135.35 34.34 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.778 -0.823 . . . . 1.8300000000000001 108.778 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.463 ' N ' HD23 ' A' ' 153' ' ' LEU . 8.1 t -121.34 109.07 14.46 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.903 -0.719 . . . . 1.72 110.538 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 45.2 t -95.23 98.06 7.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.722 -0.473 . . . . 1.1699999999999999 109.722 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -114.95 134.3 55.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.205 -0.452 . . . . 1.98 110.434 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.739 ' HE2' ' CE2' ' A' ' 71' ' ' PHE . 0.1 OUTLIER -123.5 136.76 54.74 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.621 0.724 . . . . 2.9100000000000001 111.418 176.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 42.2 t -104.5 145.44 13.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 114.002 -1.454 . . . . 1.3 111.525 -170.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.853 ' HA ' ' HB2' ' A' ' 164' ' ' ASN . 85.7 tttt -46.88 129.28 11.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 113.973 -1.467 . . . . 2.6699999999999999 113.338 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -97.54 -70.07 1.0 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.395 -0.821 . . . . 1.45 111.512 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 100' ' ' LYS . 38.3 t80 -123.86 -84.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.592 -0.358 . . . . 4.5 110.404 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -126.67 -3.82 6.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.651 1.215 . . . . 5.1500000000000004 108.281 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.71 37.98 3.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.298 -1.774 . . . . 2.6400000000000001 110.779 -168.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.931 HD21 ' HA ' ' A' ' 69' ' ' ASP . 53.9 t30 -62.45 -49.91 81.39 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 107.801 -1.185 . . . . 2.0600000000000001 107.801 164.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.711 ' HD3' ' HB3' ' A' ' 164' ' ' ASN . 34.8 Cg_exo -62.35 108.59 0.71 Allowed 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.091 1.861 . . . . 3.6899999999999999 111.108 169.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.511 ' HE3' ' CD2' ' A' ' 102' ' ' PHE . 14.0 pttm -147.89 177.16 9.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.296 -0.411 . . . . 3.5899999999999999 110.347 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 1.001 HG21 ' HB2' ' A' ' 64' ' ' GLU . 52.1 t -69.45 135.44 28.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 120.646 -0.422 . . . . 1.8700000000000001 110.079 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 11.5 t -141.92 86.4 1.98 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 119.084 -1.046 . . . . 1.9099999999999999 113.592 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.979 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -75.68 37.02 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.718 1.207 . . . . 1.05 112.564 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.759 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 23.3 tp -50.5 101.97 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.659 0.784 . . . . 1.3500000000000001 113.111 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.723 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 5.0 t80 -114.82 128.29 56.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.832 -0.622 . . . . 0.60999999999999999 110.626 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.663 HG23 ' HE3' ' A' ' 12' ' ' TRP . 6.4 tt -121.15 124.82 72.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-O 121.529 0.68 . . . . 1.1000000000000001 111.349 174.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.723 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 2.0 ppp? -115.32 166.06 12.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.801 -0.636 . . . . 1.1399999999999999 109.395 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.435 ' HZ3' ' CD ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -120.14 148.73 43.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.4 1.095 . . . . 1.74 112.888 -170.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.52 -28.76 14.15 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 113.531 -1.668 . . . . 0.31 114.285 163.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.549 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.7 OUTLIER -166.62 152.24 8.19 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.545 0.943 . . . . 1.3 113.545 -174.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.968 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -85.1 -15.39 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.105 -0.952 . . . . 1.3500000000000001 110.223 167.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 114.965 -1.016 . . . . 2.1600000000000001 112.002 -173.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.73 0 N-CA-C 110.977 -0.849 . . . . 2.02 110.977 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.645 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 16.5 tp -65.27 -27.49 68.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.085 0.469 . . . . 1.2 110.557 -174.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' HB1' ' HA3' ' A' ' 26' ' ' GLY . . . -71.01 -22.68 62.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.755 -0.657 . . . . 1.1699999999999999 111.385 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.05 -42.13 80.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.207 0.527 . . . . 2.1800000000000002 110.518 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 0.9 OUTLIER -103.29 -11.47 17.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.492 -0.776 . . . . 2.2599999999999998 112.412 -168.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 12.4 p -59.96 131.25 24.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 120.401 -0.52 . . . . 1.1100000000000001 111.015 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.514 HD12 HD13 ' A' ' 172' ' ' ILE . 22.7 pt -106.67 -22.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.952 -0.567 . . . . 1.51 110.071 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.744 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 34.9 t90 -168.81 142.13 2.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.775 -0.648 . . . . 0.42999999999999999 109.595 -169.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -158.03 136.11 10.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.686 0.279 . . . . 1.0700000000000001 111.195 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.812 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 18.8 t -146.71 125.18 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.418 0.627 . . . . 1.45 111.933 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.659 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 47.2 t30 -94.33 103.58 15.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.79 -1.189 . . . . 1.6100000000000001 107.79 164.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.692 ' HB1' ' HH ' ' A' ' 73' ' ' TYR . . . -62.15 91.04 0.03 OUTLIER 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.881 -1.155 . . . . 1.1599999999999999 107.881 171.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.764 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . 131.98 62.5 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.339 0 O-C-N 125.009 1.443 . . . . 0.76000000000000001 113.169 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.92 -136.37 2.86 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 119.893 -1.146 . . . . 0.82999999999999996 112.674 166.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.861 ' HG3' ' HD3' ' A' ' 31' ' ' LYS . 35.0 tt0 -161.64 118.12 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 119.724 -0.179 . . . . 1.8400000000000001 110.952 171.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.707 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 60.1 p 31.36 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.567 1.167 . . . . 1.75 113.518 174.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.679 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 73.4 t60 -125.4 136.21 53.19 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.979 -0.688 . . . . 0.52000000000000002 111.276 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.428 HG23 ' HD1' ' A' ' 28' ' ' HIS . 38.4 t -99.4 114.4 37.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.983 -0.553 . . . . 1.6100000000000001 110.285 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.79 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -72.3 152.35 42.18 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.312 -0.625 . . . . 0.77000000000000002 109.312 176.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.551 HG23 ' OD2' ' A' ' 57' ' ' ASP . 29.1 m -61.65 -10.83 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 113.594 0.961 . . . . 1.29 113.594 -170.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.463 ' HB2' HD23 ' A' ' 6' ' ' LEU . 65.5 m-70 -92.87 -3.44 54.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.972 -0.751 . . . . 1.02 108.972 176.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . 97.89 30.77 6.96 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.991 -1.004 . . . . 0.37 112.679 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.634 HD11 ' HG ' ' A' ' 6' ' ' LEU . 29.8 mm -103.83 108.09 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.127 0.489 . . . . 1.0900000000000001 110.689 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.428 ' HD1' HG23 ' A' ' 22' ' ' VAL . 8.8 t60 -94.42 113.22 25.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 1.1200000000000001 111.229 -174.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.812 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -80.99 132.5 35.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.149 -0.478 . . . . 1.9199999999999999 110.631 175.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.829 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 5.2 ptm180 -90.74 113.51 25.64 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.451 0.47 . . . . 3.4399999999999999 110.673 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.861 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 39.0 ttpt -32.95 109.54 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.401 1.63 . . . . 3.23 115.401 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.422 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 59.3 m-20 23.7 63.02 0.39 Allowed Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 126.352 1.861 . . . . 2.4100000000000001 114.715 168.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.829 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 17.7 Cg_endo -100.26 46.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.47 2.78 . . . . 1.8700000000000001 113.823 -172.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.444 HD22 ' HD2' ' A' ' 71' ' ' PHE . 6.3 mp -82.2 -77.68 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.466 -0.494 . . . . 2.4399999999999999 110.927 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.591 ' CD ' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -132.83 32.73 3.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.993 -0.549 . . . . 5.3099999999999996 111.967 -170.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.58 -14.65 50.17 Favored Glycine 0 C--N 1.322 -0.196 0 C-N-CA 120.595 -0.812 . . . . 2.6899999999999999 113.284 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.591 ' HD2' ' CD ' ' A' ' 35' ' ' GLU . 52.6 mtt85 -79.43 65.5 4.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.613 -0.514 . . . . 6.0700000000000003 109.613 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.784 HG11 ' HE3' ' A' ' 31' ' ' LYS . 22.1 t -105.2 118.57 52.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.309 -0.859 . . . . 4.3700000000000001 110.787 -173.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' HA2' ' HD2' ' A' ' 31' ' ' LYS . . . 93.17 15.83 49.81 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 2.9300000000000002 112.279 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.1 mtm180 -129.56 62.84 1.53 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.279 0.562 . . . . 6.8399999999999999 110.122 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 42' ' ' SER . . . -56.77 -45.27 82.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.877 -1.056 . . . . 2.0800000000000001 111.223 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 40.0 m 69.27 61.6 0.3 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.558 -0.904 . . . . 2.8100000000000001 108.558 -171.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.04 60.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.182 -1.372 . . . . 2.52 112.708 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -86.35 -20.36 28.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.156 0.503 . . . . 7.3399999999999999 109.678 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -98.59 1.04 58.29 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.724 -0.671 . . . . 3.54 111.954 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 46' ' ' MET . 40.7 ttm -73.16 -0.42 14.17 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.445 0.641 . . . . 2.7799999999999998 110.55 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' A' ' 47' ' ' LYS . 10.7 ttpp -102.03 14.05 33.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.37 0.605 . . . . 4.6399999999999997 110.017 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.32 87.24 23.74 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.758 -0.655 . . . . 3.0299999999999998 109.898 175.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -42.87 133.76 5.56 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.186 2.591 . . . . 2.0600000000000001 112.157 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.1 tp -83.36 -7.09 10.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 1.5900000000000001 111.699 -171.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp 64.45 -67.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.503 0.721 . . . . 2.48 112.541 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -77.36 36.47 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.42 0.526 . . . . 3.7200000000000002 112.42 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.2 t -157.23 143.82 18.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.082 -0.34 . . . . 0.96999999999999997 110.082 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -65.71 145.35 99.04 Favored Pre-proline 0 C--O 1.223 -0.323 0 CA-C-N 115.659 -0.701 . . . . 1.9199999999999999 109.737 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -41.12 -45.01 5.36 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.577 3.518 . . . . 0.95999999999999996 115.462 -166.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.744 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.0 pt-20 -72.42 -46.91 52.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.019 0.914 . . . . 2.71 110.614 -176.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.79 ' OD1' ' HA ' ' A' ' 23' ' ' ASP . 68.3 m-20 -79.06 -14.63 59.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.553 -0.717 . . . . 1.6299999999999999 109.56 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 33.2 tt0 -59.75 -49.55 77.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.136 -0.938 . . . . 2.1200000000000001 109.269 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 56' ' ' GLU . 13.6 p -60.19 -35.27 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 119.726 -0.789 . . . . 1.9099999999999999 110.055 176.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.679 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 16.2 tp -69.34 -13.24 62.27 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.843 0.354 . . . . 1.77 111.763 176.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.539 ' CG ' ' HG2' ' A' ' 88' ' ' LYS . 15.8 m-30 -119.11 3.22 11.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.461 -0.336 . . . . 1.3799999999999999 111.329 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.517 ' HA ' HD13 ' A' ' 50' ' ' ILE . 6.8 tt0 -121.25 -49.54 2.16 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.367 0.877 . . . . 1.97 113.367 -167.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.764 ' HB ' ' O ' ' A' ' 17' ' ' GLY . 20.8 m -74.05 133.17 42.89 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.766 -0.373 . . . . 1.54 111.221 -173.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' HB3' HG21 ' A' ' 167' ' ' VAL . 2.1 pm0 -93.32 162.25 14.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 1.96 109.889 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.535 ' NH1' ' HB2' ' A' ' 37' ' ' ARG . 9.4 ttp180 -103.12 168.79 8.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.167 -0.679 . . . . 4.0700000000000003 109.167 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.511 ' H ' ' HG2' ' A' ' 65' ' ' ARG . 40.1 t80 -56.3 119.29 5.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.285 0.564 . . . . 5.0 110.312 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.426 HD22 ' N ' ' A' ' 164' ' ' ASN . 17.3 t-20 -83.83 142.54 30.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.316 -0.856 . . . . 5.1799999999999997 110.239 -176.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -138.54 -94.07 0.19 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.774 -0.194 . . . . 3.7000000000000002 110.82 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.593 ' HB2' ' HE3' ' A' ' 159' ' ' LYS . 12.1 t70 -171.04 126.31 0.68 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.353 0.261 . . . . 2.2000000000000002 110.958 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t 44.49 68.07 0.6 Allowed 'General case' 0 N--CA 1.463 0.203 0 O-C-N 124.122 0.888 . . . . 1.78 110.336 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.52 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 24.5 p90 -125.3 134.54 52.21 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.611 -0.722 . . . . 2.2999999999999998 109.541 -172.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.79 -151.76 5.78 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.243 -0.889 . . . . 1.1599999999999999 112.522 -174.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.692 ' HH ' ' HB1' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -142.01 160.06 40.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.1 0.476 . . . . 1.6200000000000001 111.334 -171.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.693 ' HB3' ' HG3' ' A' ' 152' ' ' LYS . 2.6 m-20 -110.23 117.5 33.85 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.495 -0.775 . . . . 2.4700000000000002 109.511 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.459 HD11 HD21 ' A' ' 153' ' ' LEU . 5.9 mt -106.58 90.64 5.17 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.187 -0.671 . . . . 1.1899999999999999 109.187 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.608 ' HA ' ' CB ' ' A' ' 152' ' ' LYS . 37.1 Cg_endo -67.22 116.08 4.0 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.015 1.143 . . . . 0.89000000000000001 111.96 -175.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.833 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 62.1 mt -107.52 130.99 58.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.948 -0.569 . . . . 1.1699999999999999 110.418 -174.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -122.64 5.95 9.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.228 -0.442 . . . . 3.7000000000000002 110.474 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -132.5 172.21 12.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.504 -0.317 . . . . 2.1600000000000001 110.215 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.518 ' HG2' HG21 ' A' ' 135' ' ' ILE . 9.5 mt-10 -114.67 176.42 5.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.895 0.379 . . . . 1.2 110.753 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.72 -166.14 21.32 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.76 -0.936 . . . . 0.35999999999999999 110.76 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -103.0 107.17 17.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.52 0.66 . . . . 1.96 109.587 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.659 ' HB2' HG12 ' A' ' 133' ' ' ILE . 93.3 m-85 -94.33 124.69 38.51 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 119.803 -0.759 . . . . 1.1399999999999999 109.074 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.633 HG23 ' CA ' ' A' ' 177' ' ' ALA . 96.9 t -113.49 107.67 23.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.669 -0.696 . . . . 1.0700000000000001 110.764 -171.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 85' ' ' LEU . 4.9 mp -90.12 104.78 17.32 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.475 -1.239 . . . . 2.0600000000000001 109.146 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.65 105.12 17.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.224 -1.028 . . . . 1.72 108.224 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' A' ' 170' ' ' LEU . 3.7 mp -100.81 132.24 46.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.814 -0.81 . . . . 2.0600000000000001 108.814 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.774 ' HD2' ' HB3' ' A' ' 128' ' ' ASP . 23.5 tptt -96.63 114.73 26.41 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.683 -0.858 . . . . 4.1900000000000004 108.683 173.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -104.56 137.12 42.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.82 -0.627 . . . . 0.54000000000000004 109.373 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.661 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -133.09 133.64 43.24 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.544 -0.753 . . . . 1.1599999999999999 111.262 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 124' ' ' SER . 8.3 tp10 -124.42 112.79 17.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.007 -0.997 . . . . 2.6200000000000001 108.332 173.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.596 HG22 ' HE3' ' A' ' 166' ' ' LYS . 23.4 m -61.84 -40.69 87.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.536 -0.756 . . . . 4.1900000000000004 112.133 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.67 95.84 0.04 OUTLIER 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.969 0.414 . . . . 5.96 111.854 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -140.77 92.46 2.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.219 -1.03 . . . . 5.46 108.219 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' A' ' 118' ' ' PHE . . . -80.87 61.52 4.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.826 -0.625 . . . . 1.8500000000000001 112.32 -170.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -154.47 138.37 16.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.093 -0.336 . . . . 3.3300000000000001 110.093 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 119' ' ' ASP . 31.3 t -102.77 151.47 22.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.78 110.334 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 54.13 35.19 21.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.835 -0.62 . . . . 2.75 111.696 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -124.4 -61.47 1.33 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.748 -0.834 . . . . 3.4300000000000002 108.748 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -90.4 92.07 8.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.55 -0.907 . . . . 3.25 108.55 170.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.2 m -108.81 120.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.292 0.567 . . . . 1.8200000000000001 110.261 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.71 ' HB3' ' HG3' ' A' ' 165' ' ' PRO . 18.4 m-85 -88.68 150.74 22.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.56 -0.745 . . . . 1.1699999999999999 110.864 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 23.5 m-20 -104.51 134.74 47.19 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.165 -1.05 . . . . 1.53 108.165 169.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.8 t -134.89 115.52 19.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.088 0.471 . . . . 1.3500000000000001 110.638 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.563 ' HB3' HG22 ' A' ' 110' ' ' THR . 23.2 ptt180 -124.42 126.41 45.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.664 -0.698 . . . . 2.3100000000000001 111.889 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 32.1 m -102.86 131.72 50.54 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 108.982 -0.748 . . . . 2.0899999999999999 108.982 173.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.58 HD21 ' HG ' ' A' ' 153' ' ' LEU . 1.6 p30 48.44 44.43 20.41 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.862 0.465 . . . . 2.0899999999999999 111.553 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.24 -1.79 63.62 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.917 -0.583 . . . . 0.41999999999999998 112.676 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.68 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 52.5 m-70 -101.73 103.18 13.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.274 0.629 . . . . 0.81999999999999995 111.202 -173.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -69.23 98.61 1.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.377 0.608 . . . . 1.3500000000000001 111.12 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.43 -52.0 15.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.631 -0.713 . . . . 1.6000000000000001 109.71 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.519 HG12 ' HG ' ' A' ' 115' ' ' LEU . 3.8 t -117.68 94.33 3.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.714 -0.676 . . . . 1.1200000000000001 109.811 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -111.86 73.26 0.81 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.566 0.698 . . . . 4.4000000000000004 109.353 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.617 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 12.2 p-10 162.71 27.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.72 -1.582 . . . . 1.96 108.834 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -69.4 91.95 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.405 -0.816 . . . . 1.78 111.199 -172.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.563 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 24.0 p-10 -101.9 96.96 7.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.767 0.794 . . . . 1.9299999999999999 109.275 171.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.7 mt -53.78 -35.76 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.979 -1.01 . . . . 1.4199999999999999 111.954 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 84.7 t80 -56.12 -44.66 79.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 1.2 111.251 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.457 ' HB2' ' OG ' ' A' ' 97' ' ' SER . 15.3 t70 -72.53 -35.71 68.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.34 -0.391 . . . . 0.95999999999999996 111.525 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 5.3 mmt180 -75.62 -42.48 51.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.239 -0.437 . . . . 2.1800000000000002 111.776 -170.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 p -117.37 -28.05 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.538 -0.465 . . . . 2.0899999999999999 111.875 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 124.21 -151.46 17.17 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.851 -0.899 . . . . 1.3999999999999999 110.851 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -92.39 122.92 35.31 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.263 -0.575 . . . . 4.9100000000000001 109.972 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 11.0 m 65.27 -142.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.779 . . . . 2.1499999999999999 110.39 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 59.2 p 58.13 -174.22 0.09 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.711 0.804 . . . . 1.3999999999999999 111.865 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.3 131.57 53.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.385 . . . . 1.21 111.816 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.475 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 18.2 t60 -107.09 142.82 36.15 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 108.651 -0.87 . . . . 0.57999999999999996 108.651 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.774 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 5.4 p-10 -129.54 123.87 32.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.524 0.678 . . . . 1.6399999999999999 110.779 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -104.57 110.91 23.39 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.922 -1.035 . . . . 1.6799999999999999 109.148 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.76 111.52 25.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.865 -0.607 . . . . 1.3899999999999999 110.208 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.9 mt -118.81 95.71 49.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.242 -0.435 . . . . 1.8500000000000001 110.751 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.449 ' HB3' HG22 ' A' ' 84' ' ' VAL . 5.9 Cg_exo -81.23 128.85 6.51 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.068 2.512 . . . . 0.33000000000000002 112.202 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.71 ' HB ' HD23 ' A' ' 140' ' ' LEU . 3.5 pt -110.5 162.1 8.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.756 -0.831 . . . . 1.1000000000000001 108.756 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.5 t -127.48 106.57 9.28 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.488 -0.324 . . . . 1.8200000000000001 110.164 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.753 HG12 ' HG ' ' A' ' 140' ' ' LEU . 21.8 mt -101.05 124.04 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.236 -0.654 . . . . 1.1399999999999999 109.236 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -148.16 125.12 11.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.824 -0.626 . . . . 2.4300000000000002 109.395 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.502 ' HE3' ' HA ' ' A' ' 137' ' ' LYS . 0.2 OUTLIER 63.9 28.91 14.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.664 -0.698 . . . . 3.6000000000000001 111.558 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.04 14.33 80.79 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.958 -0.639 . . . . 0.45000000000000001 112.374 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.557 ' HG2' HG23 ' A' ' 148' ' ' THR . 55.0 mtpt -116.66 147.8 41.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.61 -0.515 . . . . 2.7000000000000002 109.61 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.753 ' HG ' HG12 ' A' ' 135' ' ' ILE . 3.1 tt -118.06 127.46 53.82 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.07 -0.345 . . . . 1.1100000000000001 110.07 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 15.0 m -114.6 125.29 53.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.053 -0.521 . . . . 1.8100000000000001 110.203 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.405 HG23 HD22 ' A' ' 140' ' ' LEU . 85.6 t -118.62 98.5 6.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.672 0.272 . . . . 1.5700000000000001 110.715 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 56.7 26.56 11.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.823 -0.626 . . . . 1.8799999999999999 112.145 173.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.86 -39.6 1.8 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.767 -0.651 . . . . 1.25 112.343 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 141' ' ' SER . 39.9 mt-10 -68.78 114.17 6.88 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.075 -0.342 . . . . 1.95 110.075 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.2 p -108.53 115.9 50.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.307 0.575 . . . . 1.49 110.747 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 m -135.85 176.51 8.61 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.869 -0.789 . . . . 1.75 108.869 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.557 HG23 ' HG2' ' A' ' 139' ' ' LYS . 37.1 p -91.23 138.51 31.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.912 -0.403 . . . . 1.8700000000000001 109.912 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.833 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 92.5 t80 -79.92 129.47 34.51 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.846 -0.427 . . . . 0.56999999999999995 109.846 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.6 t -121.07 96.05 4.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.649 0.738 . . . . 2.2400000000000002 112.062 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.93 -66.76 2.11 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.34 -0.845 . . . . 0.77000000000000002 114.23 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.693 ' HG3' ' HB3' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -148.58 160.26 43.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.291 0.567 . . . . 1.8 111.014 -173.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.58 ' HG ' HD21 ' A' ' 107' ' ' ASN . 5.7 tt -90.76 117.94 29.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.402 -0.962 . . . . 1.8300000000000001 108.402 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.475 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 3.6 t -107.37 111.69 24.15 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.91 -0.716 . . . . 1.72 110.559 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 22.7 t -98.94 98.6 7.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.13 -0.486 . . . . 1.1699999999999999 110.134 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.498 ' HB2' ' HE ' ' A' ' 105' ' ' ARG . 12.8 mm-40 -105.22 146.89 28.66 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.705 -0.48 . . . . 1.98 109.705 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.814 ' HB2' ' HG2' ' A' ' 165' ' ' PRO . 2.9 p90 -127.81 134.09 49.44 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.134 0.492 . . . . 2.9100000000000001 110.348 171.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 14.2 t -115.47 144.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.272 -0.876 . . . . 1.3 110.868 -170.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.593 ' HE3' ' HB2' ' A' ' 69' ' ' ASP . 16.6 pttp -77.83 112.68 14.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.915 -0.584 . . . . 2.6699999999999999 111.473 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.95 -10.41 80.93 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.434 -0.889 . . . . 1.45 110.923 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -161.34 68.32 0.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.674 -0.263 . . . . 4.5 110.754 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.439 ' O ' ' HD3' ' A' ' 159' ' ' LYS . 96.7 m-85 67.81 -67.06 0.19 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.588 0.755 . . . . 5.1500000000000004 112.61 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.52 105.2 7.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.916 -0.584 . . . . 2.6400000000000001 109.706 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.592 HD22 ' HA ' ' A' ' 69' ' ' ASP . 44.3 m-80 -60.68 164.16 7.9 Favored Pre-proline 0 N--CA 1.462 0.155 0 N-CA-C 107.573 -1.269 . . . . 2.0600000000000001 107.573 168.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.814 ' HG2' ' HB2' ' A' ' 157' ' ' PHE . 64.8 Cg_exo -42.21 99.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.49 2.127 . . . . 3.6899999999999999 112.031 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.596 ' HE3' HG22 ' A' ' 92' ' ' VAL . 20.1 ttmm -49.24 -68.1 0.21 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.732 -1.122 . . . . 3.5899999999999999 112.084 -165.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 46.1 t -101.36 134.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.895 -0.409 . . . . 1.8700000000000001 109.895 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 17.8 t -136.44 83.34 2.0 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.125 -0.63 . . . . 1.9099999999999999 112.432 -174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.716 ' HB3' ' CB ' ' A' ' 88' ' ' LYS . . . -76.61 37.34 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.645 1.178 . . . . 1.05 112.715 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.744 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 6.8 tp -58.1 110.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.351 0.596 . . . . 1.3500000000000001 111.834 -173.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.645 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -114.51 134.16 55.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.835 -0.621 . . . . 0.60999999999999999 109.423 174.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.563 ' CG2' ' HB3' ' A' ' 12' ' ' TRP . 3.7 tt -124.58 127.01 72.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-O 122.268 1.032 . . . . 1.1000000000000001 111.897 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.525 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 10.7 ptm -114.08 171.53 7.55 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.385 -1.28 . . . . 1.1399999999999999 109.31 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 19.2 ptmt -118.35 146.05 44.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.914 0.864 . . . . 1.74 112.665 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 176' ' ' THR . . . 103.04 -30.0 11.31 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 113.913 -1.494 . . . . 0.31 114.747 162.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 175' ' ' GLY . 0.4 OUTLIER -173.9 153.05 2.07 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.01 0.905 . . . . 1.3 112.744 -176.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.633 ' CA ' HG23 ' A' ' 84' ' ' VAL . . . -86.96 -14.24 42.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.013 -0.994 . . . . 1.3500000000000001 110.2 169.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.37 -0.832 . . . . 2.1600000000000001 111.415 -173.572 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.764 0 N-CA-C 111.737 -0.545 . . . . 2.02 111.737 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.891 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 27.2 tp -60.02 -45.44 92.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.0 0.428 . . . . 1.2 110.928 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 25' ' ' HIS . . . -62.45 -22.99 66.64 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.723 -0.671 . . . . 1.1699999999999999 111.544 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.33 -40.95 17.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.096 -0.502 . . . . 2.1800000000000002 110.952 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.483 ' HB2' ' CE ' ' A' ' 173' ' ' MET . 66.9 mmtt -97.12 -4.62 38.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.414 0.524 . . . . 2.2599999999999998 112.414 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 11.8 p -60.99 134.87 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.141 -0.624 . . . . 1.1100000000000001 110.422 171.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.517 HD11 ' HE2' ' A' ' 83' ' ' TYR . 42.4 pt -113.86 -22.77 4.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.235 -0.439 . . . . 1.51 110.447 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.764 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 75.0 t90 -164.42 147.5 9.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.42999999999999999 110.327 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -159.53 141.31 13.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.221 -0.289 . . . . 1.0700000000000001 110.221 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.92 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 24.8 t -144.22 115.97 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.703 0.763 . . . . 1.45 112.584 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 1.9 t-20 -88.24 88.03 7.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.369 -1.345 . . . . 1.6100000000000001 107.369 164.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . . . -60.87 103.07 0.23 Allowed 'General case' 0 C--O 1.25 1.089 0 CA-C-N 115.768 -0.651 . . . . 1.1599999999999999 109.982 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 65' ' ' ARG . . . 160.44 -48.0 0.39 Allowed Glycine 0 N--CA 1.44 -1.064 0 O-C-N 125.127 1.517 . . . . 0.76000000000000001 113.083 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.09 -131.32 6.47 Favored Glycine 0 C--O 1.229 -0.199 0 C-N-CA 120.74 -0.743 . . . . 0.82999999999999996 113.627 -173.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 47.0 mt-10 -150.31 119.87 6.97 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 119.218 -0.42 . . . . 1.8400000000000001 110.625 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.695 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 72.1 m 33.18 108.29 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 115.484 1.661 . . . . 1.75 115.484 170.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.736 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 71.1 t60 -147.87 131.19 16.56 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.733 -0.604 . . . . 0.52000000000000002 110.861 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 1.1 p -96.79 124.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.235 -0.654 . . . . 1.6100000000000001 109.235 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.77 163.82 25.78 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.737 -0.665 . . . . 0.77000000000000002 109.66 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 m -55.24 -29.59 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 113.14 0.792 . . . . 1.29 113.14 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 32.8 m-70 -70.02 -18.31 63.3 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.346 -0.613 . . . . 1.02 109.346 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.71 31.66 5.38 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.104 -0.953 . . . . 0.37 111.235 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.622 HD12 ' HG ' ' A' ' 6' ' ' LEU . 17.9 mm -102.63 110.97 30.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 1.0900000000000001 110.861 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 3.3 t60 -97.44 111.7 23.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.21 -0.45 . . . . 1.1200000000000001 111.23 -172.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.92 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -76.85 131.15 38.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.94 -0.573 . . . . 1.9199999999999999 110.577 175.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.666 ' HD3' ' HG3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -88.36 107.05 18.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.805 -0.634 . . . . 3.4399999999999999 110.693 177.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.902 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 33.4 ttmt -18.62 126.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 125.034 1.459 . . . . 3.23 113.094 174.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 16' ' ' ALA . 2.5 m-20 -35.77 101.26 0.21 Allowed Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 123.197 1.475 . . . . 2.4100000000000001 114.046 -169.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.666 ' HG3' ' HD3' ' A' ' 30' ' ' ARG . 40.2 Cg_endo -103.05 37.16 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 125.174 3.916 . . . . 1.8700000000000001 115.071 -166.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.526 HD21 ' N ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -132.34 -35.32 1.17 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.134 -1.026 . . . . 2.4399999999999999 113.128 -179.22 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.526 ' N ' HD21 ' A' ' 34' ' ' LEU . 7.6 pt-20 -90.37 72.33 7.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.768 0.795 . . . . 5.3099999999999996 110.338 176.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.401 ' C ' ' HG2' ' A' ' 37' ' ' ARG . . . 80.78 -1.2 84.52 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.48 -0.782 . . . . 2.6899999999999999 111.311 -177.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.426 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER 46.21 53.61 9.22 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.432 0.693 . . . . 6.0700000000000003 110.099 -176.011 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.91 156.18 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.074 -0.966 . . . . 4.3700000000000001 109.779 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.902 ' HA2' ' HD3' ' A' ' 31' ' ' LYS . . . -75.58 72.92 1.69 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.763 -0.732 . . . . 2.9300000000000002 111.511 174.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -115.12 76.66 1.01 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.776 0.322 . . . . 6.8399999999999999 110.59 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.4 112.96 3.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.376 -0.601 . . . . 2.0800000000000001 109.376 175.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.64 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 47.8 t -100.69 35.92 2.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.931 -0.577 . . . . 2.8100000000000001 110.713 -171.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -73.84 56.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.651 0.738 . . . . 2.52 111.478 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -90.57 -25.42 20.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.766 -0.652 . . . . 7.3399999999999999 110.243 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.57 44.31 1.39 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.208 -1.157 . . . . 3.54 110.208 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 46' ' ' MET . 37.8 ttm -62.03 -11.97 16.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.972 -0.614 . . . . 2.7799999999999998 112.317 -172.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.504 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -69.45 100.09 1.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.404 0.621 . . . . 4.6399999999999997 111.705 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER 170.27 66.8 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 113.743 -1.571 . . . . 3.0299999999999998 108.321 -178.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.94 113.55 2.42 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.26 1.973 . . . . 2.0600000000000001 112.526 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.678 HG12 ' HE3' ' A' ' 88' ' ' LYS . 1.7 mp -71.06 100.77 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 122.287 1.041 . . . . 1.5900000000000001 109.91 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' HB2' HG21 ' A' ' 125' ' ' THR . 87.9 mt -76.42 -2.3 31.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.18 -1.373 . . . . 2.48 113.171 -171.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.861 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 14.1 mmm180 -109.36 18.3 20.58 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.085 -0.646 . . . . 3.7200000000000002 111.009 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.54 170.35 13.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.366 -0.379 . . . . 0.96999999999999997 110.162 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -93.04 139.46 23.11 Favored Pre-proline 0 C--O 1.216 -0.708 0 N-CA-C 109.01 -0.737 . . . . 1.9199999999999999 109.01 178.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.467 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 40.0 Cg_exo -38.63 -42.29 1.79 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 124.071 3.181 . . . . 0.95999999999999996 116.617 -163.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -76.05 -46.41 29.38 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.51 -0.744 . . . . 2.71 110.516 -177.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.531 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 3.5 p30 -79.75 -17.43 53.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.177 -0.465 . . . . 1.6299999999999999 110.119 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -57.89 -43.7 86.24 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 108.944 -0.762 . . . . 2.1200000000000001 108.944 167.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.41 -45.76 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.788 -0.449 . . . . 1.9099999999999999 109.788 172.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.736 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 24.3 tp -63.06 -15.24 55.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.458 -0.792 . . . . 1.77 111.489 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.524 ' CD2' ' HG3' ' A' ' 88' ' ' LYS . 4.2 m-30 -114.31 0.81 14.26 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.23 -0.441 . . . . 1.3799999999999999 111.403 -177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.534 ' HA ' HD11 ' A' ' 50' ' ' ILE . 49.8 tt0 -122.07 -43.27 2.34 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.792 0.664 . . . . 1.97 112.792 -169.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.5 m -59.97 131.13 49.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.117 -0.492 . . . . 1.54 111.413 -175.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.826 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.9 pm0 -116.98 158.94 23.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.581 0.585 . . . . 1.96 112.581 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 3.2 ptm180 -139.29 156.19 47.21 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.616 -0.72 . . . . 4.0700000000000003 110.182 172.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.428 ' HA ' ' CB ' ' A' ' 165' ' ' PRO . 44.9 p90 -121.8 144.6 48.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.382 -0.229 . . . . 5.0 110.382 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -165.87 64.14 0.11 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.072 0.463 . . . . 5.1799999999999997 111.241 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 12.1 tp10 61.42 -93.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.206 -0.906 . . . . 3.7000000000000002 112.854 173.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.815 ' HA ' ' ND2' ' A' ' 164' ' ' ASN . 2.9 p30 -164.87 153.26 12.14 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 122.209 -0.307 . . . . 2.2000000000000002 111.302 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 32.1 t 54.16 61.52 3.01 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.164 -0.926 . . . . 1.78 110.747 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.818 ' CZ ' ' HA ' ' A' ' 165' ' ' PRO . 16.2 p90 -103.59 121.91 43.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.165 -0.614 . . . . 2.2999999999999998 109.973 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 155' ' ' VAL . . . -108.17 174.47 19.03 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 114.934 -1.03 . . . . 1.1599999999999999 113.808 -170.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.491 ' HB3' ' CZ2' ' A' ' 12' ' ' TRP . 52.4 m-85 -132.19 141.89 49.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.124 -0.538 . . . . 1.6200000000000001 109.583 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 4.7 p-10 -106.0 114.42 28.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.192 0.52 . . . . 2.4700000000000002 111.211 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.835 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.9 mp -106.91 91.34 6.19 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.662 -0.699 . . . . 1.1899999999999999 109.347 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 32.1 Cg_exo -59.67 117.5 4.25 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 121.987 1.792 . . . . 0.89000000000000001 111.892 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.791 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 60.6 mt -120.57 138.09 52.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.828 0.347 . . . . 1.1699999999999999 111.02 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -136.82 7.3 2.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.132 -0.485 . . . . 3.7000000000000002 110.709 173.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.467 ' HB2' ' HH ' ' A' ' 83' ' ' TYR . 6.6 mm-40 -121.87 -177.31 3.54 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.076 -0.342 . . . . 2.1600000000000001 110.076 -173.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 5.0 mt-10 -128.05 -179.22 4.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.277 -0.419 . . . . 1.2 110.525 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.55 -172.65 15.44 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.637 -0.985 . . . . 0.35999999999999999 110.637 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.25 108.78 20.2 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.099 -0.64 . . . . 1.96 109.463 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.696 ' HB2' HG12 ' A' ' 133' ' ' ILE . 61.8 m-85 -92.58 125.52 37.25 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.482 -0.933 . . . . 1.1399999999999999 108.482 -177.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.585 HG21 ' CA ' ' A' ' 177' ' ' ALA . 72.4 t -114.74 105.75 19.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.314 -0.857 . . . . 1.0700000000000001 110.257 -173.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.419 HD21 HD12 ' A' ' 170' ' ' LEU . 5.4 mp -89.21 104.4 16.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.495 -1.23 . . . . 2.0600000000000001 108.82 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 84' ' ' VAL . 80.4 t -103.47 102.17 13.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.068 -1.086 . . . . 1.72 108.068 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.687 ' CD2' ' HB3' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -103.95 132.98 49.67 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.033 -0.667 . . . . 2.0600000000000001 110.216 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.678 ' HE3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -87.92 121.64 30.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.388 -0.968 . . . . 4.1900000000000004 108.388 173.208 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.792 ' HE1' ' HZ3' ' A' ' 166' ' ' LYS . 6.2 m-85 -107.05 141.25 38.57 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.119 0.485 . . . . 0.54000000000000004 111.451 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.879 ' HB1' ' HB ' ' A' ' 167' ' ' VAL . . . -134.08 113.8 12.48 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.159 -0.928 . . . . 1.1599999999999999 109.097 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.796 ' HB2' HD13 ' A' ' 117' ' ' ILE . 29.6 tt0 -102.38 144.58 30.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 2.6200000000000001 110.803 -173.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 p -108.14 107.39 22.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.628 0.727 . . . . 4.1900000000000004 109.484 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.497 ' HH ' ' HA ' ' A' ' 123' ' ' HIS . 0.7 OUTLIER -139.14 173.78 11.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.621 -0.718 . . . . 5.96 111.479 -171.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -105.87 41.81 1.34 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.521 -0.763 . . . . 5.46 109.624 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.45 ' H ' ' HD1' ' A' ' 93' ' ' TYR . . . 57.82 75.4 0.38 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.198 -0.91 . . . . 1.8500000000000001 111.848 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -159.6 140.85 12.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.756 -0.656 . . . . 3.3300000000000001 109.997 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.742 ' HB2' ' HB2' ' A' ' 119' ' ' ASP . 19.8 p -132.47 -177.03 4.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.551 -0.295 . . . . 1.78 111.003 -177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 54.36 36.76 26.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.378 0.609 . . . . 2.75 111.408 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -167.65 -37.9 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.14 -1.059 . . . . 3.4300000000000002 108.14 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 12.4 mmmm -75.7 67.65 2.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.207 -0.906 . . . . 3.25 109.377 168.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.67 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 16.8 m -108.25 120.54 59.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.593 0.711 . . . . 1.8200000000000001 110.611 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 73.2 m-85 -104.48 158.7 16.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.042 -0.981 . . . . 1.1699999999999999 110.922 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.655 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 16.2 m-20 -108.88 137.64 46.49 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.718 -0.475 . . . . 1.53 109.718 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 110' ' ' THR . 0.3 OUTLIER -140.01 125.1 20.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.335 0.588 . . . . 1.3500000000000001 110.945 -177.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.777 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 41.5 mtt180 -108.13 138.34 44.57 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.18 -0.918 . . . . 2.3100000000000001 111.172 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.807 HG11 HD22 ' A' ' 153' ' ' LEU . 74.2 t -113.35 103.03 14.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.281 -0.637 . . . . 2.0899999999999999 109.281 170.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.418 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.2 OUTLIER 64.18 39.26 7.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.202 -0.908 . . . . 2.0899999999999999 108.949 -175.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.8 -22.37 34.19 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.3 -0.864 . . . . 0.41999999999999998 112.452 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 83.6 m-70 -83.64 101.15 11.3 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.556 0.342 . . . . 0.81999999999999995 111.857 -173.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.706 HG21 ' HG2' ' A' ' 105' ' ' ARG . 3.3 p -62.88 93.05 0.05 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.331 0.586 . . . . 1.3500000000000001 111.245 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.528 HG13 HG22 ' A' ' 131' ' ' ILE . 11.9 t -73.05 -47.59 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.559 -0.746 . . . . 1.6000000000000001 109.742 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.674 HG13 ' HG ' ' A' ' 115' ' ' LEU . 11.7 t -117.62 90.19 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 109.245 -0.65 . . . . 1.1200000000000001 109.245 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.36 71.67 0.76 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.901 0.858 . . . . 4.4000000000000004 108.935 178.399 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.67 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.5 p30 164.18 24.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.686 -1.597 . . . . 1.96 108.601 -169.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.674 ' HG ' HG13 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -71.34 90.89 0.96 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.427 -0.806 . . . . 1.78 111.563 -170.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.591 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 14.0 p30 -104.88 94.57 5.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.676 0.75 . . . . 1.9299999999999999 110.067 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.796 HD13 ' HB2' ' A' ' 91' ' ' GLU . 83.2 mt -61.7 -37.11 77.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.125 -0.943 . . . . 1.4199999999999999 111.653 -170.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.519 ' HD2' ' HB3' ' A' ' 97' ' ' SER . 75.6 t80 -59.4 -38.56 80.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.2 110.873 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.742 ' HB2' ' HB2' ' A' ' 97' ' ' SER . 18.7 t70 -71.73 -32.1 67.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.929 0.395 . . . . 0.95999999999999996 110.969 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.591 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 12.0 mmt85 -76.36 -49.24 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.899 -0.591 . . . . 2.1800000000000002 111.765 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.63 HG22 ' HA ' ' A' ' 127' ' ' HIS . 60.0 t -107.52 -36.09 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.104 0.409 . . . . 2.0899999999999999 112.104 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.08 -111.55 2.11 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.401 -0.904 . . . . 1.3999999999999999 111.867 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.497 ' HA ' ' HH ' ' A' ' 93' ' ' TYR . 7.4 t-80 -112.02 112.55 24.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.979 0.418 . . . . 4.9100000000000001 111.198 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.429 ' H ' ' HH ' ' A' ' 93' ' ' TYR . 33.0 p 53.03 -149.81 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.394 1.078 . . . . 2.1499999999999999 112.277 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.861 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 29.1 p 64.85 -160.42 0.28 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.996 0.918 . . . . 1.3999999999999999 110.932 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.654 ' HB2' HG21 ' A' ' 50' ' ' ILE . . . -94.88 122.27 37.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.469 0.544 . . . . 1.21 112.469 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.63 ' HA ' HG22 ' A' ' 121' ' ' VAL . 13.6 t60 -92.44 130.65 38.05 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.466 -0.568 . . . . 0.57999999999999996 109.466 167.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.81 121.67 42.21 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.16 -0.927 . . . . 1.6399999999999999 109.572 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.687 ' HB3' ' CD2' ' A' ' 87' ' ' LEU . 4.5 tp10 -123.92 108.29 12.27 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.409 -0.96 . . . . 1.6799999999999999 108.409 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.444 HG12 HG23 ' A' ' 86' ' ' VAL . 80.1 mt -94.1 118.21 39.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.889 -0.596 . . . . 1.3899999999999999 110.166 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.528 HG22 HG13 ' A' ' 111' ' ' VAL . 68.2 mt -117.94 93.67 44.75 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.534 -0.303 . . . . 1.8500000000000001 110.864 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.89 124.39 3.43 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.877 2.385 . . . . 0.33000000000000002 112.797 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.696 HG12 ' HB2' ' A' ' 83' ' ' TYR . 3.5 pt -109.51 166.29 4.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.575 -1.269 . . . . 1.1000000000000001 107.575 173.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.6 t -131.78 106.62 8.23 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.904 -0.406 . . . . 1.8200000000000001 109.904 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 49.7 mt -99.27 122.99 51.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.291 -0.633 . . . . 1.1399999999999999 109.291 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -150.78 136.62 18.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.86 -0.793 . . . . 2.4300000000000002 108.86 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm 66.95 17.95 10.56 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.196 0.522 . . . . 3.6000000000000001 110.544 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.15 12.08 77.18 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.815 -0.629 . . . . 0.45000000000000001 112.383 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 94.5 mttt -112.72 140.15 47.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.97 0.385 . . . . 2.7000000000000002 110.601 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.476 ' HG ' HD13 ' A' ' 133' ' ' ILE . 6.9 tt -103.27 115.67 31.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.518 -0.549 . . . . 1.1100000000000001 109.518 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.0 m -110.87 107.15 16.53 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.599 -0.519 . . . . 1.8100000000000001 109.599 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.464 HG22 HG22 ' A' ' 111' ' ' VAL . 4.0 p -90.72 106.99 18.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.369 -0.604 . . . . 1.5700000000000001 109.369 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 63.69 -81.07 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.555 -0.748 . . . . 1.8799999999999999 110.841 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.76 -0.56 3.55 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.851 -0.69 . . . . 1.25 112.046 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -95.66 113.96 25.65 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.522 -0.547 . . . . 1.95 109.522 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.31 132.47 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.13 0.49 . . . . 1.49 111.8 -171.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t -160.3 133.65 6.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.673 -0.694 . . . . 1.75 109.181 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 9.1 t -55.38 139.41 43.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.286 0.565 . . . . 1.8700000000000001 111.081 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.791 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 25.9 t80 -80.0 133.87 36.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.34 -0.845 . . . . 0.56999999999999995 110.536 -175.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 p -127.61 96.46 4.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.091 0.472 . . . . 2.2400000000000002 112.229 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.17 -69.52 3.15 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.77000000000000002 113.96 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.635 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -159.23 164.02 35.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.176 0.488 . . . . 1.8 110.552 -176.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.835 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 6.1 tt -81.81 142.84 32.22 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.131 -1.063 . . . . 1.8300000000000001 108.131 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.56 ' N ' HD23 ' A' ' 153' ' ' LEU . 9.9 t -135.83 107.6 7.04 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.313 -0.555 . . . . 1.72 110.648 -172.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.777 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 59.4 t -97.08 99.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.389 -0.369 . . . . 1.1699999999999999 111.141 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.16 123.76 42.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.725 -0.39 . . . . 1.98 110.457 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.484 ' HE1' ' HA ' ' A' ' 164' ' ' ASN . 49.0 t80 -102.65 118.03 35.95 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.461 -0.94 . . . . 2.9100000000000001 108.461 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 21.9 t -103.67 144.25 14.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.558 -0.746 . . . . 1.3 110.422 -173.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.894 ' HA ' ' HB2' ' A' ' 164' ' ' ASN . 61.3 pttt -66.18 128.61 36.8 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 121.147 0.499 . . . . 2.6699999999999999 112.205 -174.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.33 -31.4 5.88 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.433 -0.803 . . . . 1.45 111.981 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.459 ' HB3' ' H ' ' A' ' 162' ' ' TYR . 16.1 t80 -138.35 -88.21 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.46 -0.57 . . . . 4.5 109.46 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.487 ' O ' ' HD2' ' A' ' 165' ' ' PRO . 80.5 t80 -133.34 -48.17 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.791 -0.186 . . . . 5.1500000000000004 110.526 174.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -74.65 49.34 0.39 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.903 0.858 . . . . 2.6400000000000001 111.965 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.894 ' HB2' ' HA ' ' A' ' 159' ' ' LYS . 1.7 t30 -62.01 -45.28 91.52 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 114.388 -1.278 . . . . 2.0600000000000001 109.023 162.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.818 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 36.2 Cg_endo -69.08 65.85 1.38 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.046 1.83 . . . . 3.6899999999999999 112.092 169.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.792 ' HZ3' ' HE1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -102.58 179.96 4.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.585 -0.734 . . . . 3.5899999999999999 111.559 178.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.879 ' HB ' ' HB1' ' A' ' 90' ' ' ALA . 39.6 t -74.71 135.18 27.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 116.39 -0.368 . . . . 1.8700000000000001 111.066 -175.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.557 ' HB2' ' HZ1' ' A' ' 166' ' ' LYS . 4.7 t -132.15 141.16 49.02 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 120.228 -0.589 . . . . 1.9099999999999999 110.974 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.667 ' HB1' ' CB ' ' A' ' 88' ' ' LYS . . . -131.35 35.06 3.91 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.428 -0.805 . . . . 1.05 109.311 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.764 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 14.4 tp -58.29 102.65 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.635 -1.166 . . . . 1.3500000000000001 112.427 -175.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.891 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -111.21 132.63 54.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.698 -0.683 . . . . 0.60999999999999999 109.659 176.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.711 HG22 ' HE3' ' A' ' 12' ' ' TRP . 5.3 tt -117.9 123.6 71.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.885 0.85 . . . . 1.1000000000000001 111.577 176.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.671 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 2.5 ppp? -115.52 163.36 15.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.295 -1.002 . . . . 1.1399999999999999 108.295 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.426 ' HE3' ' CB ' ' A' ' 79' ' ' GLU . 11.6 ptmm? -119.3 147.91 43.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 122.629 1.204 . . . . 1.74 113.362 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.494 ' O ' HG21 ' A' ' 176' ' ' THR . . . 106.18 -29.64 10.83 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 112.863 -1.971 . . . . 0.31 114.84 167.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.494 HG21 ' O ' ' A' ' 175' ' ' GLY . 0.6 OUTLIER -175.38 154.93 1.76 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.525 1.163 . . . . 1.3 112.478 -177.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.585 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -84.39 -17.85 38.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.886 -0.597 . . . . 1.3500000000000001 110.465 169.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.766 -0.652 . . . . 2.1600000000000001 111.302 -177.947 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 111.266 -0.734 . . . . 2.02 111.266 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.645 ' HG ' HD12 ' A' ' 27' ' ' ILE . 24.7 tp -64.46 -25.34 67.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.926 -0.637 . . . . 1.2 110.589 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.5 ' HB1' ' HA3' ' A' ' 26' ' ' GLY . . . -60.92 -22.91 64.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.4 -0.818 . . . . 1.1699999999999999 112.215 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.18 -21.6 59.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.536 -0.302 . . . . 2.1800000000000002 110.63 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 59.8 mmtt -114.14 -16.59 12.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.649 -0.42 . . . . 2.2599999999999998 111.799 -177.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 14.8 p -56.57 136.1 19.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.48 0.657 . . . . 1.1100000000000001 111.729 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 174' ' ' LYS . 5.4 pt -115.27 -28.45 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.614 -0.721 . . . . 1.51 110.64 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.714 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 67.1 t90 -169.17 140.29 2.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.232 -0.44 . . . . 0.42999999999999999 110.177 -170.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -162.42 147.21 12.27 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.317 -0.24 . . . . 1.0700000000000001 111.224 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.696 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 2.2 p -151.16 125.6 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 113.197 0.814 . . . . 1.45 113.197 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 1.7 t-20 -94.05 95.79 9.25 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 114.956 -1.02 . . . . 1.6100000000000001 108.65 170.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.616 ' HB1' ' OH ' ' A' ' 73' ' ' TYR . . . -58.54 103.21 0.14 Allowed 'General case' 0 C--O 1.246 0.907 0 CA-C-N 116.116 -0.493 . . . . 1.1599999999999999 109.723 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.793 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 174.2 -42.26 0.14 Allowed Glycine 0 N--CA 1.438 -1.191 0 O-C-N 124.882 1.364 . . . . 0.76000000000000001 113.98 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 41' ' ' ALA . . . -140.24 -121.09 1.79 Allowed Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.001 -1.095 . . . . 0.82999999999999996 113.072 -167.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.672 ' CA ' ' HH ' ' A' ' 29' ' ' TYR . 46.1 mt-10 -148.59 119.52 7.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.847 0.323 . . . . 1.8400000000000001 111.237 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 55.7 m 32.83 105.19 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.0 1.482 . . . . 1.75 115.0 170.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.733 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 71.9 t60 -133.68 122.49 23.48 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.686 -0.634 . . . . 0.52000000000000002 111.244 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.38 116.1 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.815 -0.63 . . . . 1.6100000000000001 109.712 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -83.57 162.75 20.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.002 -0.544 . . . . 0.77000000000000002 110.715 -177.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.74 -24.95 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 113.001 0.741 . . . . 1.29 113.001 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.425 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 78.2 m-70 -80.52 1.17 30.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.426 -0.583 . . . . 1.02 109.426 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.5 ' HA3' ' HB1' ' A' ' 7' ' ' ALA . . . 82.84 28.5 37.95 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.061 -0.972 . . . . 0.37 111.508 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.645 HD12 ' HG ' ' A' ' 6' ' ' LEU . 11.8 mm -102.47 111.59 32.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.139 0.495 . . . . 1.0900000000000001 111.015 -175.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -88.1 113.86 24.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.84 -0.618 . . . . 1.1200000000000001 111.427 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.696 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -80.46 129.37 34.47 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.148 -0.478 . . . . 1.9199999999999999 109.849 170.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.742 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 2.1 ptm180 -85.96 114.69 23.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 3.4399999999999999 110.391 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HG3' ' HA ' ' A' ' 19' ' ' GLU . 37.0 ttmt -27.22 126.7 0.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.185 0.994 . . . . 3.23 112.032 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.662 ' OD2' ' HD3' ' A' ' 65' ' ' ARG . 1.4 m-20 -32.64 98.72 0.13 Allowed Pre-proline 0 N--CA 1.465 0.283 0 O-C-N 125.115 1.51 . . . . 2.4100000000000001 114.342 -168.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.742 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 69.6 Cg_endo -100.07 37.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.268 1 C-N-CA 125.454 4.103 . . . . 1.8700000000000001 114.152 -169.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.411 HD12 ' CE2' ' A' ' 73' ' ' TYR . 3.6 mp -89.9 -88.35 0.17 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.276 -0.569 . . . . 2.4399999999999999 110.036 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.587 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 12.8 mm-40 -123.83 33.83 5.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 5.3099999999999996 111.018 -172.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.17 1.34 68.71 Favored Glycine 0 CA--C 1.516 0.104 0 C-N-CA 120.013 -1.089 . . . . 2.6899999999999999 112.186 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.587 ' HD2' ' HB2' ' A' ' 35' ' ' GLU . 26.1 mtt180 -72.08 45.22 0.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.725 0.81 . . . . 6.0700000000000003 113.032 -172.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.09 117.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.183 0.516 . . . . 4.3700000000000001 110.576 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.47 -60.46 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.801 -0.714 . . . . 2.9300000000000002 111.656 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.7 mtm-85 -103.54 -4.94 23.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.417 -0.216 . . . . 6.8399999999999999 110.417 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 17' ' ' GLY . . . 65.63 -171.28 0.19 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.853 0.721 . . . . 2.0800000000000001 110.239 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 45.3 m -131.4 30.6 4.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.322 0.582 . . . . 2.8100000000000001 110.151 176.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -86.92 -16.56 35.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 2.52 110.895 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -61.09 104.57 0.39 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.567 -0.288 . . . . 7.3399999999999999 110.662 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.56 45.63 94.32 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.899 -0.667 . . . . 3.54 111.883 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -71.64 -36.28 70.66 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.819 0.303 . . . . 2.7799999999999998 111.819 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HB3' ' H ' ' A' ' 48' ' ' LEU . 49.6 mtpt 57.26 -161.68 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.243 0.34 . . . . 4.6399999999999997 111.109 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' H ' ' HB3' ' A' ' 47' ' ' LYS . 89.7 mt 55.81 64.73 5.02 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.861 -0.608 . . . . 3.0299999999999998 111.083 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.08 124.15 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.388 2.059 . . . . 2.0600000000000001 112.047 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.659 HG12 ' HE3' ' A' ' 88' ' ' LYS . 1.7 mp -69.65 105.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.999 0.904 . . . . 1.5900000000000001 109.947 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.12 -18.2 65.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.336 -1.302 . . . . 2.48 112.977 -172.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -96.35 4.2 52.41 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.726 -0.39 . . . . 3.7200000000000002 111.181 -173.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 m -125.28 145.25 50.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.903 -0.59 . . . . 0.96999999999999997 111.156 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.452 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 2.1 p-10 -79.85 151.99 74.2 Favored Pre-proline 0 C--O 1.214 -0.776 0 N-CA-C 109.609 -0.515 . . . . 1.9199999999999999 109.609 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 54' ' ' ASN . 3.5 Cg_exo -38.76 -46.67 2.66 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 124.307 3.338 . . . . 0.95999999999999996 115.419 -164.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -69.94 -53.54 17.37 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 122.064 0.935 . . . . 2.71 110.483 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -22.21 55.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.437 -0.801 . . . . 1.6299999999999999 109.711 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -55.78 -45.15 78.22 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.688 -0.687 . . . . 2.1200000000000001 109.651 170.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.3 t -57.29 -46.08 85.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.784 -0.45 . . . . 1.9099999999999999 109.784 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.733 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 30.6 tp -60.14 -19.4 53.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.454 0.645 . . . . 1.77 111.138 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.482 ' CD2' ' HG3' ' A' ' 88' ' ' LYS . 2.9 m-30 -115.83 6.68 14.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.938 -0.573 . . . . 1.3799999999999999 111.189 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.636 ' HA ' HD12 ' A' ' 50' ' ' ILE . 35.4 tt0 -122.02 -35.63 3.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.106 0.479 . . . . 1.97 111.821 -172.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.475 ' O ' HG11 ' A' ' 167' ' ' VAL . 1.0 OUTLIER -70.35 136.86 50.08 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.721 -0.672 . . . . 1.54 110.911 -176.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.793 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -120.76 149.46 42.5 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.089 0.556 . . . . 1.96 109.864 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.662 ' HD3' ' OD2' ' A' ' 32' ' ' ASP . 13.7 ttp-105 -114.76 72.96 0.81 Allowed 'General case' 0 C--O 1.237 0.447 0 N-CA-C 112.524 0.564 . . . . 4.0700000000000003 112.524 -174.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 67.4 t80 70.61 -69.21 0.18 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.481 0.548 . . . . 5.0 112.481 169.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 38.1 m-80 73.51 123.26 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.476 0.71 . . . . 5.1799999999999997 111.698 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -137.91 -93.26 0.21 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.041 -0.527 . . . . 3.7000000000000002 111.145 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.587 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 0.6 OUTLIER -114.54 -169.45 1.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.541 -0.54 . . . . 2.2000000000000002 109.541 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 p -45.18 114.71 0.78 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.946 0.403 . . . . 1.78 111.107 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.474 ' HD2' HH22 ' A' ' 65' ' ' ARG . 0.1 OUTLIER -138.99 137.42 36.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 2.2999999999999998 110.756 -175.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.736 ' HA3' ' HB3' ' A' ' 156' ' ' GLU . . . -151.43 -176.27 24.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.172 -1.013 . . . . 1.1599999999999999 113.656 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.616 ' OH ' ' HB1' ' A' ' 16' ' ' ALA . 48.6 m-85 -128.62 169.41 14.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.014 -0.593 . . . . 1.6200000000000001 111.777 -170.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -115.31 119.75 37.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.247 -0.888 . . . . 2.4700000000000002 110.594 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.804 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.1 mp -107.34 90.31 5.66 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.977 -0.749 . . . . 1.1899999999999999 108.977 171.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.613 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 43.6 Cg_endo -71.76 116.94 4.9 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.83 1.687 . . . . 0.89000000000000001 111.631 -176.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.817 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 82.7 mt -116.4 141.45 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.853 -0.612 . . . . 1.1699999999999999 110.872 -171.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 71.5 mmtt -139.31 20.95 2.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.746 0.308 . . . . 3.7000000000000002 110.922 174.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.66 -175.93 4.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.227 0.537 . . . . 2.1600000000000001 110.769 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 3.3 mt-10 -121.43 -172.62 2.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.266 -0.879 . . . . 1.2 109.771 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.56 -164.57 13.97 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.076 -0.81 . . . . 0.35999999999999999 111.076 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 36.5 mt-10 -106.19 104.43 14.13 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.186 -0.606 . . . . 1.96 109.643 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.658 ' HB2' HG12 ' A' ' 133' ' ' ILE . 20.7 m-30 -94.06 122.73 36.88 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.411 -0.959 . . . . 1.1399999999999999 108.411 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.663 HG21 ' CA ' ' A' ' 177' ' ' ALA . 88.0 t -107.18 106.5 20.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.866 0.841 . . . . 1.0700000000000001 110.45 -172.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.748 HD11 HD13 ' A' ' 170' ' ' LEU . 12.7 tp -89.66 103.94 16.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.362 -1.29 . . . . 2.0600000000000001 109.88 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 43.7 t -108.24 111.37 35.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.357 -0.979 . . . . 1.72 108.357 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.597 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -114.23 134.96 54.57 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.093 -0.643 . . . . 2.0600000000000001 110.423 178.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.814 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -93.57 122.91 36.5 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.073 -0.651 . . . . 4.1900000000000004 109.903 177.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.65 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 8.8 m-85 -108.42 140.48 41.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.138 -0.483 . . . . 0.54000000000000004 111.34 175.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -146.2 117.79 8.05 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.695 -0.684 . . . . 1.1599999999999999 110.213 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.687 ' HB3' HD12 ' A' ' 117' ' ' ILE . 4.8 tm-20 -178.23 129.13 0.13 Allowed 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.027 0.204 . . . . 2.6200000000000001 110.943 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.539 HG21 ' H ' ' A' ' 124' ' ' SER . 43.5 t -144.19 74.16 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 120.922 0.391 . . . . 4.1900000000000004 110.169 175.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -91.15 -31.94 16.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.066 0.46 . . . . 5.96 110.3 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -114.11 105.78 13.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.721 -0.672 . . . . 5.46 109.425 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.96 64.64 5.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 1.8500000000000001 111.845 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.623 HE21 ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -160.09 139.87 11.31 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.893 -0.78 . . . . 3.3300000000000001 108.893 175.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.604 ' HG ' ' HD1' ' A' ' 118' ' ' PHE . 6.8 m -85.7 141.06 30.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.17 0.509 . . . . 1.78 111.948 -172.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 59.91 49.84 7.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.77 -1.105 . . . . 2.75 109.819 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -128.32 -38.31 1.78 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.759 -1.109 . . . . 3.4300000000000002 109.893 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.696 ' HG3' ' HB2' ' A' ' 161' ' ' TYR . 27.8 ttpp -119.77 89.99 3.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.986 -0.746 . . . . 3.25 108.986 176.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.019 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 25.7 m -107.67 142.85 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.524 -0.762 . . . . 1.8200000000000001 111.011 -169.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.638 ' CD2' ' HD3' ' A' ' 165' ' ' PRO . 75.1 m-85 -128.06 164.41 22.47 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.993 -0.549 . . . . 1.1699999999999999 112.017 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.709 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 1.8 m-20 -107.35 137.79 44.74 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.572 -0.529 . . . . 1.53 109.572 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.784 HG22 ' HD1' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -132.12 124.26 52.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 109.183 -0.673 . . . . 1.3500000000000001 109.183 178.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 37.6 ptt180 -136.11 139.91 43.31 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.839 0.681 . . . . 2.3100000000000001 112.839 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.891 ' HB ' HD12 ' A' ' 153' ' ' LEU . 16.1 m -109.47 114.28 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.093 -0.958 . . . . 2.0899999999999999 111.195 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.677 ' HB2' HD11 ' A' ' 153' ' ' LEU . 65.7 t30 55.91 36.54 27.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.266 1.031 . . . . 2.0899999999999999 108.875 -174.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.21 -17.63 58.93 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.393 -1.276 . . . . 0.41999999999999998 112.803 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.501 ' ND1' ' HB3' ' A' ' 145' ' ' GLU . 90.4 m-70 -85.73 101.77 13.06 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.255 0.465 . . . . 0.81999999999999995 112.255 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 104' ' ' VAL . 20.1 p -63.44 113.15 3.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.192 0.52 . . . . 1.3500000000000001 110.784 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 131' ' ' ILE . 17.5 t -91.92 -41.11 12.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.662 -0.699 . . . . 1.6000000000000001 109.234 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.63 HG22 ' HG2' ' A' ' 129' ' ' GLU . 4.8 t -130.36 91.5 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.65 -0.704 . . . . 1.1200000000000001 109.966 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -100.81 146.37 27.37 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.769 -1.197 . . . . 4.4000000000000004 107.769 169.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 1.019 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 68.9 m-20 77.36 38.42 0.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.564 1.165 . . . . 1.96 108.823 -167.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.506 HD13 ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -69.58 86.69 0.46 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.032 -0.985 . . . . 1.78 110.031 175.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.616 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 11.6 t70 -102.23 106.02 16.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.522 -0.918 . . . . 1.9299999999999999 108.522 172.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.687 HD12 ' HB3' ' A' ' 91' ' ' GLU . 60.8 mt -61.97 -33.45 58.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 1.4199999999999999 111.636 -171.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.604 ' HD1' ' HG ' ' A' ' 97' ' ' SER . 32.7 t80 -68.64 -37.98 80.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.992 0.425 . . . . 1.2 110.086 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.538 ' HB2' ' HB3' ' A' ' 97' ' ' SER . 20.0 t70 -68.56 -28.66 67.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.068 0.461 . . . . 0.95999999999999996 111.182 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 14.7 mmt180 -81.32 -45.52 16.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.359 0.503 . . . . 2.1800000000000002 112.359 -173.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.606 HG11 ' HA ' ' A' ' 127' ' ' HIS . 15.6 m -128.34 0.34 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.207 0.817 . . . . 2.0899999999999999 113.207 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.84 -97.54 1.86 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.136 -1.03 . . . . 1.3999999999999999 112.648 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -113.17 108.78 17.76 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.558 -0.378 . . . . 4.9100000000000001 111.553 -175.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.539 ' H ' HG21 ' A' ' 92' ' ' VAL . 9.4 m 44.41 -122.4 0.88 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.412 1.07 . . . . 2.1499999999999999 112.754 175.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 70.0 p 51.12 -158.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.413 0.685 . . . . 1.3999999999999999 111.124 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.794 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . . . -99.12 110.08 22.7 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.484 -0.487 . . . . 1.21 111.63 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.606 ' HA ' HG11 ' A' ' 121' ' ' VAL . 12.9 t60 -83.35 126.18 32.44 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.106 -1.072 . . . . 0.57999999999999996 108.106 167.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -123.56 108.19 12.36 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.486 0.66 . . . . 1.6399999999999999 110.403 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.63 ' HG2' HG22 ' A' ' 112' ' ' VAL . 2.2 tp10 -102.03 108.95 20.54 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.962 -0.755 . . . . 1.6799999999999999 108.962 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 64.9 mt -96.54 115.61 36.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.799 -0.637 . . . . 1.3899999999999999 109.615 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.451 HG21 HG21 ' A' ' 111' ' ' VAL . 59.5 mt -122.43 93.16 48.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.251 -0.431 . . . . 1.8500000000000001 110.777 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -74.46 123.01 7.84 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.662 2.241 . . . . 0.33000000000000002 112.019 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.658 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.1 pt -109.86 146.57 15.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.61 -0.885 . . . . 1.1000000000000001 108.61 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.537 ' HG ' ' HB2' ' A' ' 141' ' ' SER . 35.3 p -115.9 106.98 14.42 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.899 0.381 . . . . 1.8200000000000001 110.106 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.548 HG12 ' HG ' ' A' ' 140' ' ' LEU . 25.6 mt -98.74 120.69 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 107.761 -1.2 . . . . 1.1399999999999999 107.761 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -144.33 122.63 12.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.118 0.485 . . . . 2.4300000000000002 110.317 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 18.1 mmmt 57.24 35.24 25.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.79 -1.095 . . . . 3.6000000000000001 111.5 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.37 7.15 69.96 Favored Glycine 0 C--O 1.227 -0.318 0 CA-C-N 115.597 -0.729 . . . . 0.45000000000000001 113.18 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 99.6 mttt -109.22 145.6 35.58 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 122.649 -0.324 . . . . 2.7000000000000002 110.168 174.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.655 HD12 ' HD1' ' A' ' 149' ' ' PHE . 5.9 tt -114.46 115.12 26.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.878 -0.786 . . . . 1.1100000000000001 108.878 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.537 ' HB2' ' HG ' ' A' ' 134' ' ' SER . 14.9 m -117.3 136.25 53.25 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.375 -0.375 . . . . 1.8100000000000001 110.042 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.537 HG23 ' CG2' ' A' ' 106' ' ' VAL . 58.4 t -123.71 92.53 2.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.614 -0.513 . . . . 1.5700000000000001 109.614 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 56.63 -87.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.105 -0.952 . . . . 1.8799999999999999 111.632 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.49 -10.88 34.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 1.25 112.507 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.501 ' HB3' ' ND1' ' A' ' 109' ' ' HIS . 64.1 mm-40 -87.86 139.87 30.08 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.974 -0.38 . . . . 1.95 109.974 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.42 130.44 12.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.312 0.577 . . . . 1.49 111.728 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.6 m -159.9 166.86 29.34 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.631 -0.877 . . . . 1.75 108.631 174.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 66.6 p -74.71 147.04 41.78 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.125 -0.694 . . . . 1.8700000000000001 109.125 173.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.817 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 65.3 t80 -79.07 128.2 32.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.801 0.334 . . . . 0.56999999999999995 110.114 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 t -132.64 101.8 5.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.63 0.728 . . . . 2.2400000000000002 111.515 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.96 -74.36 2.43 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.543 -0.753 . . . . 0.77000000000000002 113.777 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.613 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -155.29 169.43 24.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.379 0.609 . . . . 1.8 111.13 -174.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.891 HD12 ' HB ' ' A' ' 106' ' ' VAL . 44.2 tp -90.83 127.52 36.39 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.092 -0.958 . . . . 1.8300000000000001 109.23 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 97.0 p -97.01 142.51 28.88 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 119.373 -0.931 . . . . 1.72 109.553 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.531 HG23 HG11 ' A' ' 106' ' ' VAL . 97.0 t -130.59 97.34 3.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.803 -0.814 . . . . 1.1699999999999999 108.803 170.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.736 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 1.4 pm0 -126.78 141.85 51.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.188 -0.605 . . . . 1.98 111.279 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.784 ' HD1' HG22 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -102.65 122.24 44.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.235 -0.893 . . . . 2.9100000000000001 108.789 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 26.1 t -84.13 127.65 39.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.35 -0.386 . . . . 1.3 110.282 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.587 ' HD2' ' HA ' ' A' ' 69' ' ' ASP . 86.8 tttt -53.28 123.9 13.15 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.74 1.275 . . . . 2.6699999999999999 111.723 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -106.6 -90.71 2.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.891 -0.671 . . . . 1.45 112.353 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.696 ' HB2' ' HG3' ' A' ' 100' ' ' LYS . 85.7 m-85 -111.69 44.1 1.42 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.82 -0.224 . . . . 4.5 110.622 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 68.46 160.34 0.18 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.868 -0.605 . . . . 5.1500000000000004 111.534 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 51.12 65.3 1.52 Allowed 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.524 -0.762 . . . . 2.6400000000000001 110.13 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.561 ' OD1' ' HA ' ' A' ' 159' ' ' LYS . 50.5 m-20 -55.97 159.68 5.36 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.337 -1.301 . . . . 2.0600000000000001 108.651 173.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.638 ' HD3' ' CD2' ' A' ' 102' ' ' PHE . 50.1 Cg_exo -34.66 94.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.854 3.036 . . . . 3.6899999999999999 113.569 -172.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.587 ' HB2' ' HG3' ' A' ' 91' ' ' GLU . 10.9 tptp -52.49 -64.21 0.89 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 114.971 -1.013 . . . . 3.5899999999999999 112.501 -163.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.771 HG21 ' HB3' ' A' ' 64' ' ' GLU . 86.9 t -87.24 132.22 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 C-N-CA 120.083 -0.647 . . . . 1.8700000000000001 109.851 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -130.98 133.29 45.66 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 119.695 -0.802 . . . . 1.9099999999999999 110.745 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -129.62 37.89 3.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.965 -0.561 . . . . 1.05 110.828 -175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.748 HD13 HD11 ' A' ' 85' ' ' LEU . 10.8 tp -41.92 126.96 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.615 -1.175 . . . . 1.3500000000000001 112.018 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.688 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 7.5 t80 -144.84 119.22 9.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.79 -0.186 . . . . 0.60999999999999999 110.577 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.626 ' HB ' HD13 ' A' ' 85' ' ' LEU . 9.3 tt -115.18 123.56 70.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.981 0.896 . . . . 1.1000000000000001 110.699 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.688 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.0 ppp? -117.54 159.35 23.01 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.218 -0.901 . . . . 1.1399999999999999 109.613 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.555 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 1.9 ptmm? -113.85 142.26 46.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 122.712 1.244 . . . . 1.74 114.218 -168.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.67 -30.25 10.09 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 112.708 -2.042 . . . . 0.31 114.264 162.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.46 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.1 OUTLIER -176.99 158.16 1.52 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.002 0.901 . . . . 1.3 112.265 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.663 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -82.96 -9.93 59.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.965 -0.562 . . . . 1.3500000000000001 110.375 172.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.46 ' H ' ' HB ' ' A' ' 176' ' ' THR . 5.0 m-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.694 -0.685 . . . . 2.1600000000000001 111.357 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.583 ' HG ' HD11 ' A' ' 27' ' ' ILE . 25.8 tp . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.241 0.543 . . . . 0.72 109.879 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -63.25 -23.02 67.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.204 -0.907 . . . . 0.53 111.686 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.595 ' HB3' ' HE3' ' A' ' 9' ' ' LYS . 22.6 t70 -83.0 -35.27 25.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.91 -0.587 . . . . 2.18 111.404 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.595 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 10.6 mmtp -94.26 -19.33 20.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.893 -0.323 . . . . 1.79 111.593 -171.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.523 ' HB ' HD12 ' A' ' 27' ' ' ILE . 7.2 p -56.01 134.78 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.018 0.437 . . . . 0.33 111.424 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 pt -110.88 -22.56 4.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.209 -0.45 . . . . 0.92 110.581 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.578 ' HE3' HG22 ' A' ' 172' ' ' ILE . 77.1 t90 -170.54 146.07 2.69 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.696 -0.483 . . . . 0.36 109.696 -173.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 30' ' ' ARG . . . -163.01 138.28 6.71 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.32 -0.238 . . . . 0.26 111.003 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.775 HG22 ' HB2' ' A' ' 30' ' ' ARG . 84.4 t -146.84 121.78 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 122.574 0.35 . . . . 0.79 111.568 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 46.5 t30 -102.61 99.58 9.59 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.703 -0.48 . . . . 1.49 109.703 167.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -65.07 105.44 1.06 Allowed 'General case' 0 C--O 1.243 0.747 0 N-CA-C 109.414 -0.587 . . . . 0.48 109.414 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.567 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 158.24 -47.1 0.45 Allowed Glycine 0 N--CA 1.447 -0.601 0 O-C-N 124.248 0.968 . . . . 0.76 113.337 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.07 -132.77 7.76 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.853 -0.689 . . . . 0.74 112.727 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.444 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 16.9 mt-10 -156.87 120.27 4.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 119.679 -0.2 . . . . 1.77 111.237 174.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 4.0 p 35.31 90.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.644 1.215 . . . . 1.29 113.499 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.507 ' HD1' ' HB2' ' A' ' 60' ' ' LEU . 37.7 t-80 -131.16 133.75 45.86 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.574 -0.851 . . . . 0.42 111.687 -174.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.17 116.22 36.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.724 -0.671 . . . . 1.01 110.038 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 0.8 OUTLIER -71.82 155.99 39.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.991 -0.55 . . . . 0.77 109.768 176.217 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.45 -13.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 113.422 0.897 . . . . 0.62 113.422 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -93.57 -0.66 56.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.421 0.629 . . . . 0.86 109.357 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.577 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 93.71 31.13 8.43 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 114.826 -1.079 . . . . 0.33 112.811 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.583 HD11 ' HG ' ' A' ' 6' ' ' LEU . 21.6 mm -103.93 109.3 26.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.14 0.495 . . . . 0.31 110.907 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -92.11 114.03 26.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.8 111.431 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.601 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -78.45 131.18 36.79 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.995 -0.548 . . . . 1.75 110.881 176.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.775 ' HB2' HG22 ' A' ' 14' ' ' VAL . 8.2 mpt_? -69.9 102.5 1.99 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 125.018 1.449 . . . . 2.94 111.565 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 20' ' ' SER . 14.7 ttmm -38.96 96.33 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.953 1.094 . . . . 2.78 113.953 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.62 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 75.0 m-20 30.22 78.25 0.29 Allowed Pre-proline 0 N--CA 1.476 0.859 0 C-N-CA 124.6 1.16 . . . . 2.41 113.297 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 16.4 Cg_endo . . . . . 0 N--CA 1.456 -0.72 0 C-N-CA 122.985 2.456 . . . . 1.87 114.347 -170.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.56 HG23 ' HB2' ' A' ' 126' ' ' ALA . 1.0 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.803 0.811 . . . . 1.59 109.407 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.423 ' HB3' HG22 ' A' ' 125' ' ' THR . 57.7 tp 69.26 -52.99 0.59 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.282 -1.326 . . . . 1.91 112.594 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -68.64 -21.88 64.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.449 -0.341 . . . . 3.17 111.764 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.436 ' HB3' ' CA ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -113.67 146.49 39.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.993 0.738 . . . . 0.97 112.993 -170.438 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.612 HD21 ' HG2' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -69.16 146.04 96.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 114.485 -1.234 . . . . 1.92 109.312 175.146 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.554 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 52.9 Cg_exo -38.24 -43.56 1.81 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.162 3.241 . . . . 0.7 116.161 -165.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.612 ' HG2' HD21 ' A' ' 54' ' ' ASN . 10.7 pt-20 -78.56 -50.1 12.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.203 0.525 . . . . 2.71 111.039 -173.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -74.88 -19.86 59.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.165 0.507 . . . . 1.63 109.695 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.436 ' CA ' ' HB3' ' A' ' 53' ' ' SER . 27.8 tt0 -59.69 -43.29 94.11 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.725 -0.67 . . . . 1.58 109.948 168.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 55' ' ' PRO . 91.4 t -54.18 -43.8 61.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.593 -0.521 . . . . 1.27 109.593 173.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.507 ' HB2' ' HD1' ' A' ' 21' ' ' HIS . 26.5 tp -67.53 -14.03 62.58 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.148 -0.933 . . . . 1.18 111.653 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.7 ' CE2' ' HE3' ' A' ' 88' ' ' LYS . 12.0 m-30 -118.39 7.74 12.0 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 111.833 0.309 . . . . 0.99 111.833 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.466 ' HB2' HD13 ' A' ' 50' ' ' ILE . 32.8 tt0 -127.2 -43.01 1.66 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.75 0.648 . . . . 1.97 112.75 -172.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.558 ' O ' HG13 ' A' ' 167' ' ' VAL . 18.7 p -67.37 130.82 44.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.276 0.473 . . . . 1.27 112.276 -174.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.814 ' HB3' HG22 ' A' ' 167' ' ' VAL . 8.7 pt-20 -114.94 156.65 24.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.048 0.452 . . . . 1.96 111.59 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.62 ' HD2' ' CG ' ' A' ' 32' ' ' ASP . 37.8 mtp85 . . . . . 0 CA--C 1.531 0.237 0 CA-C-N 115.948 -0.569 . . . . 3.35 111.461 173.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.3 t . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.701 0.286 . . . . 1.41 110.345 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.552 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 11.5 p90 -124.52 140.18 53.19 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.116 -0.698 . . . . 1.57 109.116 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -136.77 161.81 25.12 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.133 -1.032 . . . . 0.78 114.8 -167.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.494 ' HB3' ' CH2' ' A' ' 12' ' ' TRP . 60.1 m-85 -100.43 152.85 19.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.854 -0.673 . . . . 1.21 111.847 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.574 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 9.4 t0 -116.24 103.61 10.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.067 -0.97 . . . . 2.47 108.646 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.879 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.7 mp -103.87 89.87 2.6 Favored Pre-proline 0 N--CA 1.464 0.246 0 N-CA-C 110.121 -0.325 . . . . 0.38 110.121 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.644 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 38.6 Cg_exo -57.59 117.53 4.25 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.194 1.929 . . . . 0.59 112.733 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.667 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 67.9 mt -117.12 136.29 54.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.937 -0.574 . . . . 0.49 110.237 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -130.45 10.16 5.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.405 -0.361 . . . . 3.32 110.988 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.584 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 23.3 tt0 -139.09 -176.89 4.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.148 -0.316 . . . . 2.16 110.148 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.646 ' HG3' ' O ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -130.32 157.51 42.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.559 -0.534 . . . . 1.2 109.559 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.08 -162.85 28.84 Favored Glycine 0 C--O 1.234 0.154 0 N-CA-C 110.354 -1.098 . . . . 0.3 110.354 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 27.7 mt-10 -99.68 102.66 14.21 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 118.281 1.04 . . . . 1.96 110.198 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.634 ' HB2' HG12 ' A' ' 133' ' ' ILE . 79.1 m-85 -94.68 124.27 38.62 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.243 -1.021 . . . . 0.71 108.243 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.812 HG21 ' HA ' ' A' ' 177' ' ' ALA . 52.9 t -104.8 105.68 19.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.64 0.734 . . . . 0.26 109.902 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.791 HD12 ' HB ' ' A' ' 172' ' ' ILE . 7.5 tp -89.48 101.41 14.09 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.348 -1.297 . . . . 1.56 108.548 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.57 104.61 17.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.778 0.799 . . . . 1.14 108.848 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.649 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -104.55 134.53 47.57 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.405 -0.816 . . . . 1.44 109.959 -178.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.838 ' HD2' ' HB1' ' A' ' 126' ' ' ALA . 10.9 tppt? -96.05 120.08 35.69 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.941 -0.703 . . . . 3.73 109.4 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.707 ' CD2' HD11 ' A' ' 115' ' ' LEU . 13.8 m-85 -106.26 141.81 36.99 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.781 -0.645 . . . . 0.45 110.374 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.891 0 CA-C-N 115.72 -0.673 . . . . 0.51 109.661 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.56 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.3 m . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 122.134 0.969 . . . . 1.22 110.316 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.713 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 11.8 m-85 -87.74 164.12 16.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.173 -1.376 . . . . 0.99 111.682 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.65 137.8 41.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.566 -0.902 . . . . 1.53 108.566 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.652 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 2.5 t -131.91 113.09 21.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.902 -0.59 . . . . 0.63 109.51 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.724 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 62.9 mtt180 -122.6 130.15 52.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 1.95 111.471 -173.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.867 HG12 HD11 ' A' ' 153' ' ' LEU . 21.8 t -105.62 99.88 9.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.154 -0.93 . . . . 1.44 109.413 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.827 ' HB2' HD12 ' A' ' 153' ' ' LEU . 4.1 t-20 57.87 51.81 8.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.219 1.009 . . . . 1.65 109.022 -170.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.5 -20.18 19.64 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 114.544 -1.207 . . . . 0.42 113.163 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 47.8 m80 -79.25 107.33 11.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.01 0.374 . . . . 0.68 112.01 -172.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.531 HG22 ' HG2' ' A' ' 105' ' ' ARG . 3.1 p -68.52 96.61 0.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.19 0.519 . . . . 0.77 111.198 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.816 HG11 HD12 ' A' ' 131' ' ' ILE . 22.3 t -85.32 -46.14 17.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.832 -0.622 . . . . 0.94 109.568 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.652 ' HB ' ' HB ' ' A' ' 104' ' ' VAL . 10.2 t -119.2 88.35 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.441 0.639 . . . . 0.35 109.645 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 51.9 tptt -103.85 76.5 1.38 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.211 -1.033 . . . . 4.01 108.211 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 4.8 p-10 162.43 14.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.154 -1.384 . . . . 1.96 110.457 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -66.47 98.29 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.867 0.365 . . . . 1.18 111.37 -169.208 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -112.87 94.58 4.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.066 0.936 . . . . 1.93 109.641 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.56 ' O ' HG22 ' A' ' 121' ' ' VAL . 56.2 mt -61.03 -46.8 95.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.713 -1.13 . . . . 0.82 111.829 -170.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -53.64 -37.17 62.85 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.092 0.404 . . . . 1.08 112.092 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.73 -39.54 70.02 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.719 -0.392 . . . . 0.96 110.806 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -74.2 -43.72 56.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.89 -0.595 . . . . 1.69 111.607 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 117' ' ' ILE . 29.7 m -92.71 -32.66 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.87 -0.332 . . . . 1.49 111.829 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.1 -69.89 3.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 1.4 111.789 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -114.92 169.47 9.06 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.032 -0.359 . . . . 4.11 110.032 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.6 m -59.92 97.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.245 0.545 . . . . 1.97 112.142 -173.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 36.8 p -144.75 -166.44 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.391 -0.822 . . . . 0.85 109.004 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 88' ' ' LYS . . . -100.58 118.21 36.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.765 0.317 . . . . 0.57 111.69 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.461 ' HB2' ' CG1' ' A' ' 121' ' ' VAL . 83.8 t60 -95.57 136.98 35.26 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.206 -0.664 . . . . 0.55 109.206 175.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.2 132.31 43.01 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.871 -0.732 . . . . 1.64 112.167 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.644 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 77.0 mm-40 -110.95 114.09 27.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.12 -0.945 . . . . 1.12 108.673 170.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.464 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 46.0 mt -96.34 109.8 23.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.084 -0.71 . . . . 0.74 109.084 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.816 HD12 HG11 ' A' ' 111' ' ' VAL . 31.2 mm -118.43 88.14 32.8 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.612 -0.267 . . . . 1.25 110.908 -171.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 130' ' ' ILE . 8.3 Cg_exo -74.57 127.47 11.02 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.593 2.196 . . . . 0.29 111.796 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.634 HG12 ' HB2' ' A' ' 83' ' ' TYR . 3.4 pt -110.13 144.73 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.857 -0.794 . . . . 0.27 108.857 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 p -116.34 107.67 15.12 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.205 0.526 . . . . 1.24 110.44 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.646 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 3.9 mt -98.68 131.71 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.194 -0.669 . . . . 0.34 109.194 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.445 ' HD3' ' HG3' ' A' ' 80' ' ' GLU . 71.6 mmtt -148.38 129.73 14.74 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 123.641 0.588 . . . . 1.95 109.896 174.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 60.61 24.95 14.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.828 -0.624 . . . . 3.13 111.526 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.05 8.43 66.89 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.557 -0.83 . . . . 0.41 112.857 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.668 ' HG3' HG22 ' A' ' 148' ' ' THR . 8.9 mptt -111.69 139.65 46.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.682 -0.488 . . . . 2.23 109.682 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.4 tt -115.08 115.73 27.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.981 -0.554 . . . . 0.41 109.738 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.1 m -109.07 115.04 29.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 1.19 110.837 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.81 104.92 17.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 O-C-N 122.282 -0.261 . . . . 0.92 110.337 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 64.17 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.816 0.697 . . . . 1.88 110.928 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.51 1.68 5.66 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.944 -0.646 . . . . 1.02 112.27 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -99.14 112.8 24.85 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.0 -0.37 . . . . 1.95 110.0 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 p -115.02 119.23 61.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.385 0.612 . . . . 0.92 111.482 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.8 m -145.94 156.16 43.33 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.928 -0.767 . . . . 1.27 108.928 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.668 HG22 ' HG3' ' A' ' 139' ' ' LYS . 41.6 p -63.17 140.58 58.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.835 0.35 . . . . 1.45 110.536 176.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.667 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 18.0 t80 -79.48 142.8 35.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.618 . . . . 0.47 109.489 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -137.95 102.71 4.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.274 0.559 . . . . 1.79 111.798 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.65 -64.27 3.31 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.693 -0.685 . . . . 0.42 113.979 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.697 ' HE2' ' HB3' ' A' ' 154' ' ' SER . 0.0 OUTLIER -155.92 170.65 21.62 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 117.137 0.469 . . . . 1.23 110.723 -178.332 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.879 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 22.7 tp -81.21 131.19 35.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.047 -1.094 . . . . 1.17 108.047 174.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.815 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 p -123.51 102.35 7.83 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.6 -0.84 . . . . 1.35 111.85 -171.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 48.4 t -93.01 95.97 5.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.231 -0.588 . . . . 0.42 110.146 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 154' ' ' SER . 3.3 mp0 -98.72 119.83 38.12 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.203 -0.666 . . . . 1.98 109.203 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.552 ' CE2' ' CE1' ' A' ' 71' ' ' PHE . 1.9 p90 -115.92 126.57 54.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.047 0.927 . . . . 2.32 110.535 175.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.45 144.59 16.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.791 -1.549 . . . . 0.62 110.87 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.8 pttm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.593 -0.73 . . . . 2.26 111.364 -176.684 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.814 HG22 ' HB3' ' A' ' 64' ' ' GLU . 61.7 t . . . . . 0 CA--C 1.506 -0.715 0 N-CA-C 108.353 -0.981 . . . . 1.19 108.353 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 38.8 t -134.46 88.12 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.812 -0.755 . . . . 1.36 112.133 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -80.0 36.49 0.34 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 124.466 1.106 . . . . 0.31 112.658 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -35.92 120.48 0.61 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.412 0.685 . . . . 0.69 111.507 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.677 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 4.1 t80 -136.18 109.7 7.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.497 -0.32 . . . . 0.48 110.317 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.791 ' HB ' HD12 ' A' ' 85' ' ' LEU . 6.7 tt -104.17 121.46 55.83 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 121.899 0.857 . . . . 0.3 110.583 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.677 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.2 ppp? -119.07 152.53 36.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.435 -0.802 . . . . 0.99 109.705 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.537 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 72.6 tttt -97.87 139.4 33.78 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 114.895 1.443 . . . . 1.22 114.895 -169.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.87 -28.89 12.97 Favored Glycine 0 C--N 1.317 -0.473 0 CA-C-N 113.196 -1.82 . . . . 0.31 115.61 155.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -171.81 155.0 3.77 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.28 1.04 . . . . 0.68 113.439 -174.425 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.812 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -84.78 -21.2 30.06 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.19 -0.914 . . . . 0.86 110.973 173.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.113 0.482 . . . . 2.16 111.582 -175.608 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.628 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.3 tp . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.062 0.458 . . . . 0.72 110.618 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -63.03 -23.79 67.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.628 -0.714 . . . . 0.53 111.811 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.9 -43.94 14.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.285 -0.416 . . . . 2.18 110.885 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.71 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 32.2 mmtp -87.24 -10.74 51.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.489 0.552 . . . . 1.79 112.489 -172.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.577 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 14.1 p -57.28 135.77 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.323 0.583 . . . . 0.33 111.111 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.2 pt -119.35 -28.18 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.909 -0.587 . . . . 0.92 110.829 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.613 ' CH2' ' HB3' ' A' ' 73' ' ' TYR . 59.5 t90 -166.4 119.97 1.08 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.038 -0.528 . . . . 0.36 109.908 -170.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -135.49 140.1 44.53 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.114 -0.328 . . . . 0.26 110.114 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.897 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 55.0 t -140.5 105.71 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 112.615 0.598 . . . . 0.79 112.615 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 14.0 t-20 -81.53 89.3 6.17 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.082 -1.081 . . . . 1.49 108.082 164.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -64.52 101.14 0.42 Allowed 'General case' 0 C--O 1.248 1.026 0 N-CA-C 109.268 -0.642 . . . . 0.48 109.268 176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 155.17 -44.08 0.56 Allowed Glycine 0 N--CA 1.441 -1.018 0 O-C-N 125.66 1.85 . . . . 0.76 110.865 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.411 ' C ' ' HE2' ' A' ' 29' ' ' TYR . . . -102.42 -150.63 23.01 Favored Glycine 0 C--O 1.225 -0.409 0 CA-C-N 115.193 -0.504 . . . . 0.74 112.958 -172.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 1.032 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 3.9 tm-20 -149.34 121.06 8.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.929 0.365 . . . . 1.77 111.248 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.761 ' HB2' ' HB2' ' A' ' 31' ' ' LYS . 5.9 t 34.61 86.96 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.846 1.341 . . . . 1.29 112.839 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.683 ' ND1' ' HB2' ' A' ' 60' ' ' LEU . 29.6 t-80 -129.42 132.01 46.9 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 119.75 -0.78 . . . . 0.42 111.541 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.4 120.75 45.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.597 -0.729 . . . . 1.01 110.338 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.86 154.36 31.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.754 -0.657 . . . . 0.77 109.383 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.1 m -61.52 -10.22 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 113.871 1.063 . . . . 0.62 113.871 -171.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.549 ' HB2' HD23 ' A' ' 6' ' ' LEU . 66.7 m-70 -95.35 -0.82 52.28 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.213 -0.662 . . . . 0.86 109.213 175.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 95.05 30.4 8.34 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.128 -0.942 . . . . 0.33 112.923 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.628 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.9 mm -104.08 115.46 46.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.08 0.466 . . . . 0.31 111.037 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -102.43 122.11 43.65 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.008 0.373 . . . . 0.8 112.008 -171.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.897 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -86.4 139.47 30.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.222 -0.444 . . . . 1.75 111.164 175.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.46 ' HG2' HG22 ' A' ' 14' ' ' VAL . 11.2 mmm180 -72.61 -7.89 52.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.527 1.677 . . . . 2.94 115.527 -161.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 1.032 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 25.3 ttmt 70.18 103.92 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.434 0.531 . . . . 2.78 112.434 -176.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.539 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 2.3 m-20 60.13 58.27 4.39 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.849 1.055 . . . . 2.41 113.849 165.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 30.0 Cg_endo . . . . . 0 CA--C 1.541 0.839 0 C-N-CA 123.639 2.893 . . . . 1.87 113.492 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.583 HG22 ' HB3' ' A' ' 53' ' ' SER . 1.4 mp . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 121.552 0.691 . . . . 1.59 110.087 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -68.17 -23.25 64.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.409 -0.814 . . . . 1.91 112.52 -171.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 126' ' ' ALA . 4.6 mpt_? -100.54 36.33 1.93 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.759 0.314 . . . . 3.17 111.331 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.583 ' HB3' HG22 ' A' ' 50' ' ' ILE . 42.2 t -154.36 153.54 31.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.172 -0.467 . . . . 0.97 111.142 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.9 140.93 50.54 Favored Pre-proline 0 C--O 1.219 -0.506 0 N-CA-C 109.087 -0.709 . . . . 1.92 109.087 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.491 ' O ' HG23 ' A' ' 59' ' ' VAL . 5.1 Cg_exo -39.22 -39.54 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.537 3.491 . . . . 0.7 115.992 -167.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.53 -55.09 6.78 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.484 1.135 . . . . 2.71 110.068 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.58 -15.11 60.4 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.048 -0.978 . . . . 1.63 109.655 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.413 ' HG3' ' HB ' ' A' ' 50' ' ' ILE . 33.5 tt0 -60.73 -43.09 98.34 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.464 -0.789 . . . . 1.58 109.294 170.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 55' ' ' PRO . 58.3 t -58.52 -40.86 80.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.154 -0.476 . . . . 1.27 109.848 174.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.683 ' HB2' ' ND1' ' A' ' 21' ' ' HIS . 23.6 tp -68.87 -22.78 64.18 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.583 -0.447 . . . . 1.18 111.573 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.451 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 9.1 m-30 -101.06 1.93 39.91 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.278 0.561 . . . . 0.99 109.667 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.533 ' O ' HG13 ' A' ' 167' ' ' VAL . 11.5 tt0 -124.44 -124.55 0.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.034 -0.984 . . . . 1.97 109.301 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.739 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.7 OUTLIER 29.04 104.05 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.751 1.22 . . . . 1.27 114.143 -173.529 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.82 148.16 29.0 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.086 0.469 . . . . 1.96 112.027 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.595 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.1 ttm180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.533 -0.303 . . . . 3.35 111.433 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.794 0.807 . . . . 1.41 110.574 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -111.24 138.37 47.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.911 -1.041 . . . . 1.57 111.296 -167.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -129.57 146.37 17.19 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.661 -0.78 . . . . 0.78 113.658 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.613 ' HB3' ' CH2' ' A' ' 12' ' ' TRP . 57.7 m-85 -103.44 136.43 43.2 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.42 -0.39 . . . . 1.21 110.769 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.418 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.4 p-10 -99.51 115.63 29.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.034 -0.53 . . . . 2.47 110.937 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.842 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.3 mp -110.01 89.86 8.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.602 -0.726 . . . . 0.38 109.358 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.681 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 21.8 Cg_exo -63.66 121.19 8.85 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 C-N-CA 121.992 1.795 . . . . 0.59 111.727 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.901 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 64.9 mt -121.47 143.05 35.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.715 0.293 . . . . 0.49 111.019 -174.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -127.05 -12.25 5.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.262 -0.426 . . . . 3.32 111.443 173.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -112.03 168.15 9.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 2.16 111.387 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -106.5 -178.37 3.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.799 -0.637 . . . . 1.2 110.6 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.36 -169.58 15.6 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.144 -0.782 . . . . 0.3 111.144 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 5.1 mm-40 -98.87 103.28 15.22 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.083 -0.71 . . . . 1.96 109.083 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.68 ' HB2' HG12 ' A' ' 133' ' ' ILE . 2.4 m-85 -92.37 124.37 36.37 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 119.225 -0.99 . . . . 0.71 108.8 -173.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.574 HG21 ' CA ' ' A' ' 177' ' ' ALA . 49.0 t -107.3 105.6 19.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.22 -0.9 . . . . 0.26 109.937 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 170' ' ' LEU . 17.0 tp -90.37 104.6 17.16 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.286 -1.325 . . . . 1.56 109.764 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 44.8 t -114.01 104.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.841 -0.8 . . . . 1.14 108.841 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.586 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.38 135.68 46.32 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.968 -0.693 . . . . 1.44 110.616 178.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.758 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 16.2 tptt -98.7 120.63 39.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.302 -0.408 . . . . 3.73 110.494 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CE2' HD11 ' A' ' 115' ' ' LEU . 26.4 m-85 -107.35 142.11 37.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.911 0.386 . . . . 0.45 111.253 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.424 -0.807 . . . . 0.51 110.387 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.866 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 23.6 m . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.321 0.581 . . . . 1.22 110.063 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.498 ' HD1' ' HA ' ' A' ' 159' ' ' LYS . 61.7 m-85 -104.12 163.53 12.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.512 -0.767 . . . . 0.99 111.722 -173.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 24.6 m-20 -109.59 140.61 43.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.579 -0.282 . . . . 1.53 110.48 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.603 HG23 ' HD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -143.32 127.89 14.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.048 0.451 . . . . 0.63 110.735 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.659 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -121.39 144.89 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.676 -0.693 . . . . 1.95 112.189 -175.326 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.804 HG23 HD21 ' A' ' 153' ' ' LEU . 3.0 p -108.2 105.36 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.691 . . . . 1.44 109.722 171.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.447 ' HA ' ' H ' ' A' ' 154' ' ' SER . 65.4 t30 57.67 44.22 21.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.882 0.848 . . . . 1.65 109.149 -174.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.95 -15.79 61.97 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 114.994 -1.003 . . . . 0.42 113.017 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 94.6 m-70 -89.39 98.86 12.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.564 0.579 . . . . 0.68 112.564 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 2.3 p -66.64 98.98 0.55 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.208 0.528 . . . . 0.77 111.706 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.688 HG21 HG21 ' A' ' 131' ' ' ILE . 6.4 t -80.47 -47.79 20.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.636 -0.711 . . . . 0.94 109.53 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.615 HG11 ' HG ' ' A' ' 115' ' ' LEU . 10.8 t -113.3 90.03 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.556 0.694 . . . . 0.35 109.364 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -113.16 71.74 0.75 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 122.332 1.063 . . . . 4.01 108.871 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.866 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.7 p30 162.66 30.2 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.186 -1.825 . . . . 1.96 107.218 -169.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.662 HD13 ' HE2' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -74.1 78.65 1.74 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.862 -1.063 . . . . 1.18 111.095 -172.33 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.531 ' HB2' HG12 ' A' ' 101' ' ' VAL . 10.9 t70 -101.95 103.74 14.4 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.727 -1.212 . . . . 1.93 107.727 172.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 66.7 mt -55.0 -40.9 55.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.893 -0.594 . . . . 0.82 111.173 -174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.567 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 2.3 t80 -64.12 -45.61 87.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.7 -0.682 . . . . 1.08 110.558 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.8 -32.86 68.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.31 -0.405 . . . . 0.96 111.471 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HB3' ' CE1' ' A' ' 127' ' ' HIS . 15.4 mmt180 -77.03 -50.1 13.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.276 -0.42 . . . . 1.69 111.792 -173.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.9 p -118.79 -27.59 2.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.49 -0.484 . . . . 1.49 112.295 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 123.6 -161.49 17.91 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.316 -1.114 . . . . 1.4 110.316 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -78.79 122.24 25.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.532 0.666 . . . . 4.11 111.027 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.2 p 51.77 -121.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.163 -0.926 . . . . 1.97 112.516 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.7 p 52.32 -161.41 0.1 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.469 0.707 . . . . 0.85 110.796 -173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.683 ' HB1' ' HE3' ' A' ' 88' ' ' LYS . . . -98.95 109.08 21.89 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.67 -0.412 . . . . 0.57 110.304 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 18.9 t60 -93.84 133.05 37.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.247 -0.649 . . . . 0.55 109.247 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.719 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.5 p30 -133.22 135.77 45.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.132 0.492 . . . . 1.64 111.108 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.448 ' HB2' HD21 ' A' ' 87' ' ' LEU . 17.1 mm-40 -112.25 111.78 22.9 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.211 -1.033 . . . . 1.12 108.211 171.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 86' ' ' VAL . 65.5 mt -96.04 113.48 30.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.934 -0.575 . . . . 0.74 109.668 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.688 HG21 HG21 ' A' ' 111' ' ' VAL . 47.2 mt -124.0 93.47 47.01 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.36 -0.382 . . . . 1.25 111.293 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -72.42 122.07 7.99 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.317 2.011 . . . . 0.29 112.648 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.68 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -109.74 160.61 8.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 106.959 -1.497 . . . . 0.27 106.959 174.415 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.5 p -127.29 111.99 14.55 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.036 0.446 . . . . 1.24 110.377 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 36.9 mt -99.87 122.41 51.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.191 -0.67 . . . . 0.34 109.191 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -149.06 135.32 19.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.87 -0.418 . . . . 1.95 109.87 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 61.28 25.04 15.07 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.606 0.566 . . . . 3.13 110.586 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.16 14.46 81.74 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.73 -0.668 . . . . 0.41 112.27 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 56.5 mtpt -111.9 150.53 30.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.583 -0.525 . . . . 2.23 109.583 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.0 tt -121.25 116.31 24.63 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.701 -0.481 . . . . 0.41 109.701 -175.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -116.65 111.04 19.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.61 -0.515 . . . . 1.19 109.61 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.685 HG21 HG11 ' A' ' 106' ' ' VAL . 5.5 p -100.76 113.95 38.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.175 -0.306 . . . . 0.92 110.175 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 58.77 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.015 -0.539 . . . . 1.88 112.02 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.19 1.98 7.76 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.945 -0.645 . . . . 1.02 112.685 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -106.14 148.49 27.79 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.488 -0.56 . . . . 1.95 109.488 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.09 133.59 60.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.247 0.546 . . . . 0.92 111.616 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m -152.94 179.06 9.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.897 -0.779 . . . . 1.27 108.897 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.763 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 7.9 t -99.36 143.05 30.06 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.847 -0.798 . . . . 1.45 108.847 168.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.901 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 51.6 t80 -79.62 121.98 25.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.264 -0.425 . . . . 0.47 110.46 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 p -118.46 95.59 4.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.248 0.546 . . . . 1.79 112.295 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.54 -71.6 2.87 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.42 114.167 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.681 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -151.5 156.75 41.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.355 0.577 . . . . 1.23 111.015 -176.143 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.842 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 7.0 tt -82.13 140.42 33.81 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.67 -0.863 . . . . 1.17 108.67 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.46 ' N ' HD23 ' A' ' 153' ' ' LEU . 5.5 t -124.29 109.17 13.04 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.876 -0.73 . . . . 1.35 110.241 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.729 HG11 HD21 ' A' ' 170' ' ' LEU . 49.1 t -91.51 96.03 5.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.029 -1.1 . . . . 0.42 108.029 174.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.596 ' HB3' ' HG3' ' A' ' 105' ' ' ARG . 4.5 tt0 -99.57 120.53 39.81 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.074 -0.966 . . . . 1.98 109.766 -175.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.662 ' HE2' HD13 ' A' ' 115' ' ' LEU . 62.1 t80 -108.36 116.38 31.86 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.332 0.587 . . . . 2.32 109.928 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 44.6 t -106.82 112.86 41.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.241 -0.89 . . . . 0.62 110.502 -176.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.498 ' HA ' ' HD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.577 -0.738 . . . . 2.26 110.066 172.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 62' ' ' GLN . 38.8 t . . . . . 0 C--O 1.242 0.66 0 CA-C-O 119.658 -0.21 . . . . 1.19 110.832 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 29.1 t -141.74 94.47 2.68 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 120.062 -0.655 . . . . 1.36 112.32 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -87.64 38.59 0.84 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.841 1.256 . . . . 0.31 113.473 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.729 HD21 HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -31.0 131.91 0.09 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.58 0.752 . . . . 0.69 112.137 177.623 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 5.4 t80 -144.97 115.65 7.71 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.242 -0.286 . . . . 0.48 110.449 171.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.568 HG21 HG21 ' A' ' 75' ' ' ILE . 7.0 tt -113.89 125.72 71.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 122.268 1.032 . . . . 0.3 111.007 172.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 9.7 ptm -117.58 163.55 16.27 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.58 -1.191 . . . . 0.99 109.099 176.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.71 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -120.74 149.62 42.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.131 0.967 . . . . 1.22 112.635 -174.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.15 -29.63 12.03 Favored Glycine 0 C--N 1.306 -1.099 0 CA-C-N 114.105 -1.407 . . . . 0.31 114.34 162.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.562 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.0 OUTLIER -176.31 160.06 2.09 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.253 1.027 . . . . 0.68 112.115 179.14 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.574 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -85.48 -9.64 57.18 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.496 -0.775 . . . . 0.86 110.048 168.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.562 ' H ' ' HB ' ' A' ' 176' ' ' THR . 2.4 m-20 . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.901 -0.59 . . . . 2.16 111.618 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.765 ' HG ' HD11 ' A' ' 27' ' ' ILE . 27.2 tp . . . . . 0 N--CA 1.45 -0.454 0 CA-C-O 121.113 0.482 . . . . 0.72 109.975 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.488 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -66.5 -24.91 66.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.487 -0.779 . . . . 0.53 111.288 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -75.33 -32.79 61.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.008 -0.542 . . . . 2.18 110.606 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.682 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 30.6 mmtp -93.4 -28.82 15.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.09 -0.504 . . . . 1.79 111.853 -171.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.612 ' HB ' HD12 ' A' ' 27' ' ' ILE . 9.6 p -57.63 119.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.627 0.727 . . . . 0.33 111.901 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.2 pt -101.82 -24.62 4.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.784 -0.644 . . . . 0.92 110.181 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.797 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 35.5 t90 -159.24 135.25 8.85 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.53 -0.759 . . . . 0.36 109.449 -172.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -154.76 131.34 10.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.722 0.296 . . . . 0.26 110.76 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.476 ' HB ' ' CH2' ' A' ' 12' ' ' TRP . 4.1 t -140.33 125.16 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.514 0.673 . . . . 0.79 111.598 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.742 ' HB2' HD23 ' A' ' 60' ' ' LEU . 3.2 t-20 -97.49 90.48 5.06 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.751 -1.203 . . . . 1.49 107.751 167.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.557 ' C ' ' HB2' ' A' ' 65' ' ' ARG . . . -62.38 102.2 0.29 Allowed 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.584 -0.734 . . . . 0.48 109.446 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 150.56 -20.12 1.03 Allowed Glycine 0 N--CA 1.442 -0.938 0 O-C-N 125.398 1.686 . . . . 0.76 112.333 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.64 -166.08 10.72 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.036 -1.078 . . . . 0.74 112.924 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 31.7 tt0 -120.78 118.2 29.4 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.814 0.302 . . . . 1.77 111.814 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.756 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 18.4 m 36.31 109.27 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 115.639 1.718 . . . . 1.29 115.639 166.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.86 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 71.4 t60 -147.02 143.42 28.39 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 121.668 -0.645 . . . . 0.42 110.958 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.6 t -104.21 117.48 49.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.33 -0.85 . . . . 1.01 109.934 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.782 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -70.98 148.63 47.47 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.236 -0.653 . . . . 0.77 109.236 174.229 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.32 -17.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 114.219 1.192 . . . . 0.62 114.219 -173.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.532 ' HB2' HD23 ' A' ' 6' ' ' LEU . 63.9 m-70 -87.74 -11.52 47.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.255 -0.646 . . . . 0.86 109.255 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 108.64 33.89 2.77 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.053 -0.976 . . . . 0.33 113.246 175.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.765 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.5 mm -103.32 105.53 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.043 -0.663 . . . . 0.31 110.355 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -90.41 105.75 18.03 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.024 -0.534 . . . . 0.8 110.604 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.86 ' CE2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -83.7 138.77 33.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.686 -0.688 . . . . 1.75 109.269 175.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -95.23 149.29 21.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.861 0.362 . . . . 2.94 110.557 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 76.6 tttt -43.24 143.38 0.85 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.802 -1.09 . . . . 2.78 112.28 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.589 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 13.3 p-10 -45.8 106.09 0.53 Allowed Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 124.763 1.29 . . . . 2.41 113.387 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 N--CA 1.455 -0.774 0 C-N-CA 123.967 3.111 . . . . 1.87 113.717 174.845 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.679 ' CG2' ' HB2' ' A' ' 126' ' ' ALA . 1.4 mp . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 121.649 0.738 . . . . 1.59 110.335 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.547 ' HB2' HG22 ' A' ' 125' ' ' THR . 2.7 mm? -74.8 -2.83 28.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.389 -0.823 . . . . 1.91 112.744 -171.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 7.5 mmm180 -112.67 23.33 13.62 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.845 -0.342 . . . . 3.17 111.166 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.7 t -142.81 157.55 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.371 0.605 . . . . 0.97 112.346 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.447 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 22.6 t30 -63.75 129.25 93.66 Favored Pre-proline 0 C--O 1.213 -0.858 0 CA-C-N 114.983 -1.008 . . . . 1.92 109.258 172.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.534 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 3.2 Cg_exo -40.19 -44.75 4.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.192 3.261 . . . . 0.7 115.058 -170.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -64.31 -51.82 61.55 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 123.149 1.452 . . . . 2.71 109.407 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.782 ' OD1' ' HA ' ' A' ' 23' ' ' ASP . 31.6 m-20 -82.26 -6.87 59.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.231 -1.804 . . . . 1.63 109.645 -174.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.534 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 32.2 tt0 -67.41 -41.37 85.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 1.58 108.354 169.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.03 -50.4 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.311 -0.859 . . . . 1.27 109.064 170.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.751 ' HG ' ' HD2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -55.9 -34.41 65.52 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.484 -0.78 . . . . 1.18 110.39 178.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.601 ' HA ' ' CB ' ' A' ' 169' ' ' ALA . 10.9 m-30 -94.58 1.51 55.64 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.952 -0.567 . . . . 0.99 111.263 -174.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.733 ' HA ' HG21 ' A' ' 167' ' ' VAL . 7.9 tt0 -128.32 -110.05 0.28 Allowed 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 116.567 -0.288 . . . . 1.97 111.413 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.702 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 29.58 108.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.38 1.472 . . . . 1.27 114.584 -172.419 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.693 ' HB3' HG12 ' A' ' 167' ' ' VAL . 8.1 pt-20 -80.63 136.53 36.24 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.031 0.752 . . . . 1.96 113.031 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.589 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.265 0 CA-C-N 116.011 -0.54 . . . . 3.35 110.034 170.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 C--O 1.234 0.269 0 CA-C-O 121.237 0.541 . . . . 1.41 110.741 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.637 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 1.5 p90 -126.77 137.41 53.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.836 -0.431 . . . . 1.57 109.836 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.08 -153.07 7.93 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.618 -0.801 . . . . 0.78 112.873 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -143.96 168.16 20.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.196 0.522 . . . . 1.21 111.589 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.451 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.6 m-20 -122.75 125.14 44.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.305 -0.861 . . . . 2.47 109.129 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.944 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.0 mp -104.69 95.96 9.66 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.439 -0.578 . . . . 0.38 109.439 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 32.0 Cg_exo -57.04 120.82 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.936 1.757 . . . . 0.59 112.013 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.783 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 66.3 mt -126.67 133.03 69.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.436 -0.347 . . . . 0.49 110.393 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -132.77 16.07 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.345 -0.389 . . . . 3.32 110.825 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -135.43 174.29 10.77 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.725 -0.39 . . . . 2.16 110.447 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.589 ' HG2' HG22 ' A' ' 135' ' ' ILE . 10.9 mt-10 -122.61 163.44 20.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.118 -0.492 . . . . 1.2 110.718 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.98 -173.99 21.89 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.644 -0.982 . . . . 0.3 110.644 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -92.4 104.74 17.04 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 117.878 0.839 . . . . 1.96 109.267 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.684 ' HB2' HG12 ' A' ' 133' ' ' ILE . 92.9 m-85 -92.59 123.4 35.86 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.491 -0.929 . . . . 0.71 108.491 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.508 HG21 ' CA ' ' A' ' 177' ' ' ALA . 88.8 t -116.14 106.65 20.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.633 -0.712 . . . . 0.26 110.268 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 172' ' ' ILE . 5.7 mp -86.77 104.69 16.38 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.955 -1.021 . . . . 1.56 109.302 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 130' ' ' ILE . 53.3 t -102.87 102.64 13.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.694 -1.224 . . . . 1.14 107.694 172.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -113.26 133.33 55.15 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.55 -0.46 . . . . 1.44 110.513 -176.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.763 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 5.3 mptp? -91.74 124.68 36.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.278 0.561 . . . . 3.73 110.097 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD2' HD11 ' A' ' 115' ' ' LEU . 2.8 m-85 -108.95 141.78 40.54 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.486 -0.779 . . . . 0.45 110.121 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.602 ' HB3' ' CG2' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.313 -0.995 0 CA-C-N 115.736 -0.665 . . . . 0.51 109.901 174.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.854 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 13.3 m . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 121.602 0.715 . . . . 1.22 110.273 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.605 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 22.5 m-85 -90.41 156.96 17.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.133 -0.94 . . . . 0.99 111.469 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.667 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 6.7 t70 -107.57 136.33 47.51 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.507 -0.553 . . . . 1.53 109.507 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.68 122.41 23.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 0.63 111.042 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.2 mtt180 -124.7 140.29 53.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.154 -0.93 . . . . 1.95 111.258 -174.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.624 HG22 HD11 ' A' ' 153' ' ' LEU . 7.7 p -117.59 104.93 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 1.44 109.611 173.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.931 ' HB2' HD12 ' A' ' 153' ' ' LEU . 28.4 t-20 61.3 41.54 13.02 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.52 1.152 . . . . 1.65 108.193 -171.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.62 -21.29 26.78 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.747 -1.115 . . . . 0.42 112.698 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 78.1 m-70 -74.08 105.35 5.26 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 122.631 0.373 . . . . 0.68 111.717 -174.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.561 HG22 ' HG2' ' A' ' 105' ' ' ARG . 2.4 p -70.2 92.64 0.78 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.041 0.448 . . . . 0.77 111.511 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.416 HG23 HG12 ' A' ' 106' ' ' VAL . 21.4 t -76.62 -41.76 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.917 -0.583 . . . . 0.94 109.804 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.433 HG11 ' HG ' ' A' ' 115' ' ' LEU . 11.1 t -132.55 90.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.098 -0.501 . . . . 0.35 110.148 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -105.08 72.49 1.0 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.655 0.741 . . . . 4.01 109.777 175.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.854 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 7.8 p-10 161.24 32.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.587 -1.642 . . . . 1.96 108.226 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -69.65 85.43 0.46 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.91 -1.041 . . . . 1.18 111.093 -174.55 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 19.3 p-10 -98.0 88.69 4.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.574 -0.739 . . . . 1.93 109.52 172.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.8 mt -59.62 -39.86 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.578 -0.737 . . . . 0.82 111.166 -173.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -52.64 -37.15 57.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 1.08 111.585 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.88 -37.21 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.896 -0.503 . . . . 0.96 111.108 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 7.6 mmt180 -73.11 -51.91 16.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.721 -0.672 . . . . 1.69 110.945 -170.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.93 -23.18 4.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.351 -0.386 . . . . 1.49 111.813 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.78 -83.34 1.6 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.186 -1.006 . . . . 1.4 112.144 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -114.92 107.82 15.91 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.88 -0.328 . . . . 4.11 111.043 -176.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.6 p 44.71 -123.73 0.98 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.775 -0.648 . . . . 1.97 111.961 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.597 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 60.4 p 53.76 -169.27 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.859 0.863 . . . . 0.85 112.425 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.679 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -100.02 129.15 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.315 0.487 . . . . 0.57 112.315 -177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 38.4 t60 -101.82 147.41 26.53 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.584 -1.265 . . . . 0.55 107.584 169.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.602 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.5 p30 -142.78 127.65 18.29 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.145 -0.622 . . . . 1.64 111.911 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.95 115.27 28.52 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.895 -1.048 . . . . 1.12 108.793 172.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.42 HG23 HG22 ' A' ' 86' ' ' VAL . 64.2 mt -101.5 106.67 19.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.229 -0.656 . . . . 0.74 109.229 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 111' ' ' VAL . 54.3 mt -116.84 90.73 33.13 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.377 -0.374 . . . . 1.25 110.956 -173.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.452 ' HB3' HG22 ' A' ' 84' ' ' VAL . 8.9 Cg_exo -77.43 119.69 5.0 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.568 2.179 . . . . 0.29 112.237 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.684 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -109.68 144.59 17.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.875 -1.157 . . . . 0.27 107.875 175.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -113.92 107.33 15.54 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 120.34 -0.544 . . . . 1.24 110.503 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.589 HG22 ' HG2' ' A' ' 80' ' ' GLU . 33.5 mt -99.62 120.89 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.786 -0.45 . . . . 0.34 109.786 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -149.8 137.76 20.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.563 -0.532 . . . . 1.95 109.563 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 8.3 mptt 61.23 30.35 19.18 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.646 0.736 . . . . 3.13 110.185 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.31 11.44 84.18 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 114.805 -1.089 . . . . 0.41 112.607 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.769 ' HG2' HG22 ' A' ' 148' ' ' THR . 90.2 mttt -113.33 142.45 45.84 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.646 -0.326 . . . . 2.23 110.159 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 5.8 tt -112.61 119.46 38.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.037 -0.529 . . . . 0.41 110.096 -173.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 17.3 m -111.97 109.45 19.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.688 0.28 . . . . 1.19 110.94 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.44 HG23 ' CD2' ' A' ' 140' ' ' LEU . 66.9 t -94.24 94.58 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.563 -0.903 . . . . 0.92 108.563 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 59.27 -88.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.115 -0.948 . . . . 1.88 111.068 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -107.23 -13.0 22.33 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.541 -0.838 . . . . 1.02 113.091 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 141' ' ' SER . 51.6 mt-10 -90.14 112.88 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.535 -0.391 . . . . 1.95 110.863 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.8 p -105.65 113.48 42.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.418 0.627 . . . . 0.92 110.378 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.3 t -147.42 137.46 23.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.689 . . . . 1.27 109.19 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.769 HG22 ' HG2' ' A' ' 139' ' ' LYS . 41.0 p -56.81 139.36 51.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.116 0.484 . . . . 1.45 111.878 -175.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.783 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 22.8 t80 -79.91 129.09 34.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.497 -0.774 . . . . 0.47 109.785 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 t -122.64 99.19 6.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 1.79 111.971 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.37 -67.36 3.33 Favored Glycine 0 C--N 1.329 0.194 0 CA-C-N 115.742 -0.663 . . . . 0.42 113.939 171.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.616 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -158.83 167.55 29.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.205 0.526 . . . . 1.23 110.08 -177.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.944 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 14.5 tp -81.87 144.02 31.29 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.574 -0.899 . . . . 1.17 108.574 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.7 t -132.74 108.7 9.18 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.146 -1.022 . . . . 1.35 110.777 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 96.0 t -94.18 108.61 20.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.373 -0.376 . . . . 0.42 110.19 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -114.46 138.41 50.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.782 -0.644 . . . . 1.98 110.121 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.667 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -129.21 128.31 43.07 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.511 0.672 . . . . 2.32 110.705 168.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 44.5 t -106.47 144.63 15.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.423 -1.262 . . . . 0.62 111.085 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt . . . . . 0 C--O 1.233 0.217 0 CA-C-N 115.377 -0.828 . . . . 2.26 111.794 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.733 HG21 ' HA ' ' A' ' 62' ' ' GLN . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 N-CA-C 109.516 -0.55 . . . . 1.19 109.516 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 38.3 t -132.53 101.61 5.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.725 0.774 . . . . 1.36 111.84 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.763 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -88.34 36.79 0.79 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.629 1.172 . . . . 0.31 112.094 -177.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.797 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 13.6 tp -61.64 116.59 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.798 0.666 . . . . 0.69 112.798 -170.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 173' ' ' MET . 0.1 OUTLIER -124.22 123.47 40.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.652 -0.703 . . . . 0.48 110.25 176.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.598 ' CG2' ' HB3' ' A' ' 12' ' ' TRP . 2.7 tt -113.0 123.41 68.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 122.001 0.905 . . . . 0.3 111.366 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.61 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 12.3 ptm -111.4 164.57 12.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.997 -1.001 . . . . 0.99 109.914 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.682 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 19.2 ptmt -115.66 141.16 48.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.371 1.081 . . . . 1.22 112.726 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.71 -28.84 13.72 Favored Glycine 0 C--N 1.304 -1.227 0 CA-C-N 113.853 -1.521 . . . . 0.31 114.827 161.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.2 OUTLIER -169.52 153.67 5.25 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.642 1.221 . . . . 0.68 113.023 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.508 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -86.43 -9.89 55.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.057 -0.974 . . . . 0.86 109.981 168.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.492 ' H ' ' HB ' ' A' ' 176' ' ' THR . 10.9 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.524 -0.762 . . . . 2.16 111.528 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.854 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 34.6 tp . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 121.319 0.58 . . . . 0.72 110.789 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.525 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.23 -43.08 74.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.878 -1.055 . . . . 0.53 112.533 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.73 -17.76 34.99 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.441 -0.504 . . . . 2.18 112.256 -173.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 23.1 mmtm -91.55 -16.6 26.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.163 -0.615 . . . . 1.79 111.409 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.3 p -55.2 128.57 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.546 0.689 . . . . 0.33 111.197 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.652 HG23 HG23 ' A' ' 172' ' ' ILE . 0.3 OUTLIER -96.63 -31.39 3.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.345 -0.843 . . . . 0.92 109.912 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.654 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 74.8 t90 -172.95 132.62 0.53 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.321 -0.854 . . . . 0.36 109.396 -169.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.57 137.82 18.41 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.864 -0.522 . . . . 0.26 110.827 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.681 HG21 ' CD ' ' A' ' 33' ' ' PRO . 7.3 p -148.37 138.86 16.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 122.196 0.998 . . . . 0.79 112.57 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.675 ' HB2' HD12 ' A' ' 60' ' ' LEU . 10.9 t-20 -98.35 104.12 16.12 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.403 -1.271 . . . . 1.49 107.623 167.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -66.3 89.14 0.13 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.002 -1.111 . . . . 0.48 108.002 172.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.876 ' HA2' ' N ' ' A' ' 65' ' ' ARG . . . 179.1 -41.24 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.56 0 O-C-N 125.059 1.474 . . . . 0.76 112.023 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.66 -157.55 7.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.18 -1.009 . . . . 0.74 112.937 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.525 ' HB3' ' HG2' ' A' ' 31' ' ' LYS . 44.1 mt-10 -119.35 120.09 35.88 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 111.528 0.196 . . . . 1.77 111.528 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.854 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 67.2 m 39.1 112.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.504 2.039 . . . . 1.29 116.504 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.998 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.9 t-80 -145.94 130.07 17.48 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.252 0.549 . . . . 0.42 111.334 171.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -87.75 115.91 28.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.043 -0.981 . . . . 1.01 109.646 174.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -82.42 164.53 20.94 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.769 -0.456 . . . . 0.77 109.769 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 m -62.63 -17.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 O-C-N 124.16 0.913 . . . . 0.62 111.791 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.484 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 88.3 m-70 -84.64 -1.84 56.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.3 0.571 . . . . 0.86 109.966 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.511 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 86.48 25.94 34.51 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.166 -0.924 . . . . 0.33 111.81 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.626 HD11 ' HG ' ' A' ' 6' ' ' LEU . 26.1 mm -103.95 113.23 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.394 0.616 . . . . 0.31 111.145 -175.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -92.96 110.83 22.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.42 -0.809 . . . . 0.8 110.823 -173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.998 ' CE2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -85.7 145.4 27.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.5 0.191 . . . . 1.75 110.59 179.119 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.672 ' O ' HG23 ' A' ' 14' ' ' VAL . 66.2 mtt180 -94.97 170.19 9.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.979 -0.555 . . . . 2.94 111.689 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 61.1 mttp -84.7 82.49 8.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.017 0.747 . . . . 2.78 113.017 -169.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 1.029 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 39.45 45.9 1.05 Allowed Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 114.737 1.384 . . . . 2.41 114.737 167.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.681 ' CD ' HG21 ' A' ' 14' ' ' VAL . 28.0 Cg_endo . . . . . 0 N--CA 1.456 -0.699 0 C-N-CA 124.15 3.234 . . . . 1.87 113.76 -161.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.889 HD13 ' HA ' ' A' ' 62' ' ' GLN . 1.7 mp . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.661 0.743 . . . . 1.59 109.811 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.556 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.6 mm? -65.29 -18.36 65.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.878 -1.055 . . . . 1.91 112.962 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -91.91 -9.83 41.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.481 -0.487 . . . . 3.17 111.985 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.501 ' OG ' ' HD2' ' A' ' 61' ' ' TYR . 57.9 m -108.83 160.06 16.29 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.285 0.564 . . . . 0.97 112.323 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.523 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -90.88 143.44 28.71 Favored Pre-proline 0 C--O 1.214 -0.798 0 CA-C-N 115.305 -0.861 . . . . 1.92 109.26 -176.55 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 46.8 Cg_exo -37.48 -48.92 1.85 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.989 3.126 . . . . 0.7 115.841 -164.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -64.22 -54.58 31.24 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.442 1.115 . . . . 2.71 109.659 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 3.3 p30 -77.85 -15.8 58.78 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.538 -1.21 . . . . 1.63 110.577 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.711 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 63.1 tt0 -58.12 -50.5 73.26 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.556 -0.535 . . . . 1.58 109.556 172.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.4 t -55.25 -47.94 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.445 0.641 . . . . 1.27 109.859 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 15' ' ' ASN . 50.1 tp -56.78 -19.42 16.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.799 -1.091 . . . . 1.18 111.425 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.62 ' HB3' ' HG3' ' A' ' 88' ' ' LYS . 23.1 m-30 -120.51 5.34 10.63 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.072 -0.513 . . . . 0.99 111.722 -173.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.889 ' HA ' HD13 ' A' ' 50' ' ' ILE . 0.7 OUTLIER -120.78 -38.25 2.88 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.812 -0.555 . . . . 1.97 112.453 -170.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.403 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -67.56 139.41 56.92 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.477 -0.783 . . . . 1.27 110.479 -175.349 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.975 ' HB3' HG12 ' A' ' 167' ' ' VAL . 0.0 OUTLIER -122.87 -4.01 8.62 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.298 1.592 . . . . 1.96 115.298 -166.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 1.029 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 2.1 mtp-105 . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 121.377 0.608 . . . . 3.35 112.179 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 121.076 0.465 . . . . 1.41 109.808 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.563 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 71.4 m-85 -77.91 108.49 11.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.403 -0.962 . . . . 1.57 108.403 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.11 144.63 16.5 Favored Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 115.361 -0.836 . . . . 0.78 113.234 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.568 ' HE1' ' CE1' ' A' ' 157' ' ' PHE . 54.2 m-85 -132.42 129.26 39.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.344 -0.428 . . . . 1.21 110.487 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.555 ' OD2' ' HE2' ' A' ' 152' ' ' LYS . 10.3 t70 -100.6 102.34 13.47 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.151 -0.685 . . . . 2.47 109.151 177.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 6.1 mt -102.6 90.06 2.05 Favored Pre-proline 0 CA--C 1.513 -0.46 0 N-CA-C 109.158 -0.682 . . . . 0.38 109.158 174.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 33.4 Cg_endo -66.12 116.58 4.09 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.305 1.337 . . . . 0.59 111.751 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.843 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 43.6 mt -110.32 139.75 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.98 -0.554 . . . . 0.49 111.113 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.29 16.29 4.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 3.32 109.979 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.509 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 9.1 mm-40 -129.09 158.13 39.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.585 0.231 . . . . 2.16 110.891 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.519 ' HG2' HG22 ' A' ' 135' ' ' ILE . 4.5 mt-10 -111.64 170.6 8.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.062 -0.517 . . . . 1.2 110.374 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.26 -162.98 24.02 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.447 -1.061 . . . . 0.3 110.447 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 67.0 mt-10 -102.61 111.45 23.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.854 0.827 . . . . 1.96 109.83 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.674 ' HB2' HG12 ' A' ' 133' ' ' ILE . 73.6 m-85 -94.12 123.87 37.77 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 108.434 -0.95 . . . . 0.71 108.434 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.599 HG21 ' CA ' ' A' ' 177' ' ' ALA . 86.1 t -113.63 106.15 20.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.646 0.736 . . . . 0.26 110.289 -174.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.5 mp -87.37 104.0 16.02 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.602 -1.181 . . . . 1.56 109.127 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.525 HG22 HG23 ' A' ' 130' ' ' ILE . 50.3 t -106.02 103.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.754 -1.202 . . . . 1.14 107.754 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 1.1 pt? -116.0 132.01 56.77 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.076 -0.65 . . . . 1.44 110.18 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.672 ' HE3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -86.26 120.29 27.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.116 -0.698 . . . . 3.73 109.116 178.019 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.545 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -106.29 140.47 39.18 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.099 -0.955 . . . . 0.45 110.508 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.533 ' HB3' HG22 ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.792 0 N-CA-C 109.129 -0.693 . . . . 0.51 109.129 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.812 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.6 m . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.325 0.584 . . . . 1.22 111.0 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -96.79 165.49 12.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.172 -0.922 . . . . 0.99 110.727 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.621 ' OD2' ' HB ' ' A' ' 158' ' ' VAL . 0.0 OUTLIER -106.54 136.94 45.43 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.786 -0.766 . . . . 1.53 109.905 173.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 1.8 t -121.55 119.19 58.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.844 -0.616 . . . . 0.63 109.522 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.589 ' HG2' HG22 ' A' ' 110' ' ' THR . 24.5 mtt180 -121.38 139.42 53.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.088 0.471 . . . . 1.95 111.447 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.899 HG13 HD11 ' A' ' 153' ' ' LEU . 79.9 t -122.39 100.07 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.24 -0.891 . . . . 1.44 109.469 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.858 ' HB2' HD22 ' A' ' 153' ' ' LEU . 29.1 t-20 63.28 43.66 6.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.46 1.124 . . . . 1.65 108.686 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.59 -5.4 78.32 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.941 -1.027 . . . . 0.42 112.704 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 92.9 m-70 -92.35 106.64 18.6 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 122.017 0.127 . . . . 0.68 111.15 -174.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.589 HG22 ' HG2' ' A' ' 105' ' ' ARG . 2.9 p -70.18 88.67 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.968 0.413 . . . . 0.77 111.362 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.539 HG22 HG11 ' A' ' 142' ' ' VAL . 37.2 t -69.01 -51.46 43.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.94 109.799 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 104' ' ' VAL . 35.6 t -120.88 88.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.35 110.144 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.621 ' HG2' ' HB3' ' A' ' 103' ' ' ASP . 0.2 OUTLIER -102.57 76.88 1.57 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.515 -1.291 . . . . 4.01 107.515 173.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.812 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 9.2 p-10 166.05 26.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.99 -1.459 . . . . 1.96 109.634 -172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.73 101.11 3.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 1.18 111.499 -172.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 27.5 p-10 -118.16 85.88 2.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.288 1.042 . . . . 1.93 109.72 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 60.0 mt -54.21 -37.43 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.84 -1.073 . . . . 0.82 112.167 -172.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -58.44 -38.63 77.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.691 0.282 . . . . 1.08 111.579 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.15 -33.93 72.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.329 0.585 . . . . 0.96 110.422 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 7.4 mmt180 -74.42 -51.38 15.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.531 -0.759 . . . . 1.69 111.117 -173.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 m -115.18 -29.51 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 113.109 0.781 . . . . 1.49 113.109 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.1 -73.97 2.58 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.517 -0.849 . . . . 1.4 112.003 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -77.28 151.21 35.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.251 -0.277 . . . . 4.11 110.251 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.6 t -68.55 80.22 0.27 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.785 0.802 . . . . 1.97 109.762 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.556 HG22 ' HB2' ' A' ' 51' ' ' LEU . 41.5 p -125.38 -137.95 0.27 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.958 -1.019 . . . . 0.85 109.188 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.591 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . . . -102.5 116.54 32.82 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.492 -0.483 . . . . 0.57 111.427 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 48.4 t60 -112.88 106.75 15.11 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 108.704 -0.85 . . . . 0.55 108.704 170.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.538 ' OD1' ' HG2' ' A' ' 88' ' ' LYS . 13.6 m-20 -105.03 117.12 33.2 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.319 -0.552 . . . . 1.64 111.384 -169.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -89.09 111.97 22.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.682 -0.69 . . . . 1.12 109.546 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.525 HG23 HG22 ' A' ' 86' ' ' VAL . 61.3 mt -103.18 110.15 28.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.411 -0.588 . . . . 0.74 109.411 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.481 HG21 HG21 ' A' ' 106' ' ' VAL . 65.5 mt -122.69 94.41 47.56 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.283 -0.417 . . . . 1.25 111.099 -173.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -80.83 121.81 4.19 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.728 2.285 . . . . 0.29 111.988 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.6 OUTLIER -110.58 155.62 11.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.646 -0.872 . . . . 0.27 108.646 177.057 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.528 ' OG ' ' HB2' ' A' ' 141' ' ' SER . 2.9 p -120.22 106.94 12.4 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.694 -0.402 . . . . 1.24 110.799 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 34.1 mt -100.66 119.6 49.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.326 -0.62 . . . . 0.34 109.326 176.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 27.5 mmtp -151.4 136.79 17.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.705 -0.48 . . . . 1.95 109.705 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt 65.52 22.91 11.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.68 -0.691 . . . . 3.13 110.47 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.64 9.47 86.37 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.844 -0.693 . . . . 0.41 112.084 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 52.8 mtpt -106.61 166.51 10.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.687 -0.486 . . . . 2.23 109.687 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.2 tt -140.73 116.35 10.2 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.636 -0.505 . . . . 0.41 109.636 -174.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.528 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 40.6 m -110.73 131.07 55.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.26 -0.427 . . . . 1.19 111.041 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.539 HG11 HG22 ' A' ' 111' ' ' VAL . 74.6 t -129.37 109.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.92 111.136 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 50.79 37.5 17.13 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.82 -0.627 . . . . 1.88 112.665 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.97 -24.33 25.37 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.783 -0.723 . . . . 1.02 112.576 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -85.06 112.12 20.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.02 -0.733 . . . . 1.95 109.02 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.6 p -105.57 125.67 60.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.771 -0.65 . . . . 0.92 110.611 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.3 m -144.51 -166.65 2.44 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.926 -0.768 . . . . 1.27 108.926 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 59.8 p -98.75 148.39 23.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.001 0.429 . . . . 1.45 110.847 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.843 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 39.6 t80 -81.41 120.95 25.63 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.736 -1.209 . . . . 0.47 107.736 168.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 m -130.51 95.92 4.0 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.122 0.487 . . . . 1.79 110.75 -174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.13 -82.41 1.18 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.598 -0.728 . . . . 0.42 113.781 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.555 ' HE2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -145.04 158.69 43.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.331 0.565 . . . . 1.23 111.004 -175.187 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.899 HD11 HG13 ' A' ' 106' ' ' VAL . 1.4 tm? -80.96 118.56 22.54 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.174 -1.417 . . . . 1.17 107.174 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 5.3 t -114.23 107.06 15.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.951 -0.699 . . . . 1.35 110.161 -171.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.516 ' O ' ' HD1' ' A' ' 73' ' ' TYR . 38.2 t -92.62 108.02 19.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.98 -0.748 . . . . 0.42 108.98 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 25.4 mt-10 -130.33 108.91 10.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.174 -0.466 . . . . 1.98 110.156 -177.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 2.9 p90 -104.58 115.85 31.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.722 0.772 . . . . 2.32 110.676 174.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.621 ' HB ' ' OD2' ' A' ' 103' ' ' ASP . 59.3 t -87.63 143.43 11.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 114.347 -1.297 . . . . 0.62 111.01 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 N--CA 1.454 -0.231 0 CA-C-N 114.739 -1.119 . . . . 2.26 111.585 -175.877 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.975 HG12 ' HB3' ' A' ' 64' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 120.859 0.361 . . . . 1.19 110.169 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 47.7 t -125.81 135.35 51.89 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.672 0.749 . . . . 1.36 110.313 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.6 ' HB1' ' HD1' ' A' ' 61' ' ' TYR . . . -123.05 36.76 4.57 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.615 -1.175 . . . . 0.31 109.869 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.654 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 9.9 tp -57.98 112.17 1.41 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.627 -1.17 . . . . 0.69 112.715 -170.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.854 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -122.27 120.45 34.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.619 -0.719 . . . . 0.48 110.243 176.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.652 HG23 HG23 ' A' ' 11' ' ' ILE . 6.9 tt -113.09 132.16 62.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.697 0.76 . . . . 0.3 110.357 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.618 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 4.1 ppp? -127.02 164.09 22.29 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.562 -0.744 . . . . 0.99 109.412 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.9 ptmt -112.61 142.16 45.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.565 1.174 . . . . 1.22 113.32 -173.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 176' ' ' THR . . . 105.37 -30.0 10.6 Favored Glycine 0 C--N 1.31 -0.865 0 CA-C-N 113.161 -1.836 . . . . 0.31 115.058 161.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.6 OUTLIER -176.75 153.07 1.04 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.467 1.133 . . . . 0.68 113.238 -177.268 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.599 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -84.59 -14.61 48.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.755 -0.657 . . . . 0.86 109.596 168.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.478 ' H ' ' HB ' ' A' ' 176' ' ' THR . 38.9 t70 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 114.937 -1.029 . . . . 2.16 111.807 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.772 HD23 ' HB3' ' A' ' 25' ' ' HIS . 27.6 tp . . . . . 0 C--O 1.233 0.221 0 CA-C-O 121.099 0.476 . . . . 0.72 110.425 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.535 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -61.32 -25.86 67.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.368 -0.833 . . . . 0.53 111.91 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.73 -36.72 23.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.375 -0.375 . . . . 2.18 111.358 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.649 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -90.15 -11.04 42.35 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.542 -0.463 . . . . 1.79 111.582 -171.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.75 HG23 ' HE1' ' A' ' 171' ' ' PHE . 14.7 p -59.31 132.8 24.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.035 -0.666 . . . . 0.33 111.546 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.681 HG23 HG23 ' A' ' 172' ' ' ILE . 0.6 OUTLIER -107.79 -38.4 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.051 -0.522 . . . . 0.92 110.563 176.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.733 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 49.6 t90 -165.33 143.63 6.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.825 -0.625 . . . . 0.36 109.32 -172.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.85 135.75 11.76 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.66 -0.416 . . . . 0.26 111.347 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.0 t -137.15 106.58 4.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.686 0.755 . . . . 0.79 110.922 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 3.2 t-20 -81.25 86.55 6.21 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.265 -1.383 . . . . 1.49 107.265 163.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -66.61 103.85 1.16 Allowed 'General case' 0 C--O 1.255 1.362 0 CA-C-N 115.386 -0.824 . . . . 0.48 109.813 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 172.93 -38.69 0.15 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 113.073 -1.876 . . . . 0.76 112.279 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.88 -141.26 4.58 Favored Glycine 0 N--CA 1.459 0.205 0 C-N-CA 120.702 -0.761 . . . . 0.74 112.427 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -118.17 157.63 26.58 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.589 -0.359 . . . . 1.77 110.893 175.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 23.2 m -19.03 122.44 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.307 1.595 . . . . 1.29 115.307 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.691 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 17.2 t-80 -138.16 121.67 17.27 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.218 -0.901 . . . . 0.42 111.271 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 28' ' ' HIS . 64.1 t -85.3 123.3 39.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.077 -0.965 . . . . 1.01 109.019 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.76 ' HB3' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -101.7 171.26 7.65 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.525 -0.47 . . . . 0.77 110.715 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -56.53 -22.95 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 124.708 1.255 . . . . 0.62 112.808 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.772 ' HB3' HD23 ' A' ' 6' ' ' LEU . 34.0 m-70 -77.12 -10.61 59.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.35 0.595 . . . . 0.86 109.672 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.535 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 87.76 28.21 24.54 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.135 -0.939 . . . . 0.33 110.763 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.659 HD11 ' HG ' ' A' ' 6' ' ' LEU . 12.6 mm -102.14 112.49 35.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.136 0.493 . . . . 0.31 110.1 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.573 ' HB2' HG22 ' A' ' 22' ' ' VAL . 29.9 t60 -93.63 113.09 25.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.973 -0.558 . . . . 0.8 110.076 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.691 ' CD2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -90.5 142.38 27.8 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.643 -0.503 . . . . 1.75 109.643 175.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -100.78 69.29 1.35 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.012 0.745 . . . . 2.94 113.012 -169.417 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.746 ' HG2' ' H ' ' A' ' 32' ' ' ASP . 14.5 ttpp 60.83 -169.34 0.16 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.477 -0.783 . . . . 2.78 111.723 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.778 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 9.4 p-10 -103.09 88.93 1.71 Allowed Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-O 121.984 0.897 . . . . 2.41 110.106 173.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.638 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 31.7 Cg_endo . . . . . 0 N--CA 1.446 -1.279 0 C-N-CA 122.158 1.905 . . . . 1.87 112.313 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 126' ' ' ALA . 1.3 mp . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 121.891 0.853 . . . . 1.59 110.462 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 51' ' ' LEU . 4.6 mp -68.86 -14.38 63.0 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.809 -1.087 . . . . 1.91 111.73 -172.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.641 ' HB2' ' HB3' ' A' ' 126' ' ' ALA . 27.4 mmm180 -98.97 23.01 9.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.22 -0.445 . . . . 3.17 111.423 -175.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -150.31 167.76 26.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 0.97 112.186 -176.32 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.403 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 3.0 t30 -95.51 139.17 21.84 Favored Pre-proline 0 C--O 1.215 -0.744 0 CA-C-N 115.013 -0.994 . . . . 1.92 108.83 177.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.481 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 3.7 Cg_exo -36.69 -54.7 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.512 3.475 . . . . 0.7 116.246 -162.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 1.7 pm0 -77.08 -28.71 54.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.172 0.896 . . . . 2.71 112.012 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -10.98 43.8 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 120.912 -1.117 . . . . 1.63 109.026 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.481 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 19.7 tt0 -67.07 -46.38 74.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.722 -1.126 . . . . 1.58 110.002 170.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.72 -39.98 86.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 109.684 -0.487 . . . . 1.27 109.684 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' ' 23' ' ' ASP . 45.3 tp -60.69 -21.58 63.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.183 0.516 . . . . 1.18 111.153 173.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.577 ' CD2' ' HE3' ' A' ' 88' ' ' LYS . 8.6 m-30 -102.64 -2.21 28.75 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.937 -0.574 . . . . 0.99 111.542 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.829 ' HA ' HG11 ' A' ' 167' ' ' VAL . 4.1 tt0 -121.67 -110.4 0.33 Allowed 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.637 -0.425 . . . . 1.97 110.147 174.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.629 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.6 OUTLIER 35.01 102.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.446 0.906 . . . . 1.27 113.446 -173.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -88.84 136.98 32.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.465 -0.334 . . . . 1.96 111.824 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.778 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 3.35 110.469 173.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.059 0.457 . . . . 1.41 109.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.49 ' CG ' ' CE2' ' A' ' 157' ' ' PHE . 38.2 m-85 -71.24 94.82 1.21 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.945 -1.132 . . . . 1.57 107.945 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.72 111.67 3.73 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.662 -0.78 . . . . 0.78 112.495 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.672 ' HE1' ' CE1' ' A' ' 157' ' ' PHE . 35.0 m-85 -102.59 151.29 22.51 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.568 0.347 . . . . 1.21 110.643 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.416 ' HB2' ' HG3' ' A' ' 152' ' ' LYS . 13.1 p-10 -115.28 112.97 23.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.342 0.591 . . . . 2.47 110.609 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.819 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.3 mp -103.55 93.42 4.97 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.38 110.067 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 25.2 Cg_endo -65.8 119.33 6.34 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.683 1.588 . . . . 0.59 112.108 -175.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.829 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 69.3 mt -117.97 132.2 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.658 -0.701 . . . . 0.49 110.114 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.89 6.7 4.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.039 -0.528 . . . . 3.32 111.134 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -134.92 176.66 8.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.836 0.35 . . . . 2.16 110.625 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.597 ' HG2' HG22 ' A' ' 135' ' ' ILE . 5.5 mt-10 -122.12 159.06 27.94 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.807 -0.633 . . . . 1.2 110.108 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.97 -155.22 26.35 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.805 -0.918 . . . . 0.3 110.805 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 47.0 mt-10 -110.92 106.48 15.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.265 0.532 . . . . 1.96 109.781 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.672 ' HB2' HG12 ' A' ' 133' ' ' ILE . 88.8 m-85 -94.76 125.4 39.39 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 119.735 -0.786 . . . . 0.71 109.219 -176.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.661 HG21 ' CA ' ' A' ' 177' ' ' ALA . 52.8 t -108.67 106.02 19.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.165 0.983 . . . . 0.26 110.039 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 155' ' ' VAL . 9.1 tt -97.84 104.98 17.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.875 -1.511 . . . . 1.56 109.141 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 129' ' ' GLU . 2.2 p -115.01 105.94 19.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 109.013 -0.736 . . . . 1.14 109.013 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -101.48 134.94 43.81 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.115 0.483 . . . . 1.44 110.114 -177.568 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 1.078 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 10.9 tppt? -98.69 114.92 27.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.327 0.584 . . . . 3.73 109.873 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 115' ' ' LEU . 4.0 m-85 -106.53 146.79 30.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.455 -0.793 . . . . 0.45 109.9 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.878 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 116.201 -0.454 . . . . 0.51 110.159 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 116' ' ' ASP . 16.7 m . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.44 0.638 . . . . 1.22 110.466 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 80.5 m-85 -114.65 168.66 9.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.335 -0.848 . . . . 0.99 111.752 -173.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.635 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 11.3 m-20 -107.21 138.01 44.2 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 109.091 -0.707 . . . . 1.53 109.091 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 110' ' ' THR . 7.4 t -136.3 113.33 13.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 117.699 0.227 . . . . 0.63 111.525 -175.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.675 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 84.2 mtt180 -110.94 141.41 44.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.225 0.454 . . . . 1.95 112.225 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.426 HG23 ' HB2' ' A' ' 109' ' ' HIS . 12.0 m -110.65 96.71 4.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.44 -0.8 . . . . 1.44 109.662 168.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.762 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 3.7 t-20 55.05 58.52 4.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.013 -0.994 . . . . 1.65 109.834 -172.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.25 -25.85 7.55 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.738 -1.119 . . . . 0.42 112.895 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.426 ' HB2' HG23 ' A' ' 106' ' ' VAL . 90.1 m-70 -83.71 95.04 8.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.915 0.339 . . . . 0.68 111.915 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -68.69 92.71 0.48 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.196 0.522 . . . . 0.77 111.063 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 112' ' ' VAL . 6.5 m -74.6 -37.58 43.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.978 -0.556 . . . . 0.94 110.904 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 111' ' ' VAL . 5.6 t -120.88 89.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.986 0.422 . . . . 0.35 109.963 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 11.6 tmtt? -106.98 73.9 0.96 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.733 -1.21 . . . . 4.01 107.733 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 7.2 p-10 161.16 28.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.441 -1.709 . . . . 1.96 108.807 -172.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -71.09 80.4 0.68 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.074 -0.512 . . . . 1.18 111.76 -170.502 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.481 ' HB2' HG12 ' A' ' 101' ' ' VAL . 10.1 t70 -90.48 99.4 12.43 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.051 -1.092 . . . . 1.93 108.051 169.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.0 mt -63.64 -36.33 76.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.092 -0.504 . . . . 0.82 111.494 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -67.13 -34.94 78.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.056 0.455 . . . . 1.08 110.343 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -67.51 -37.9 83.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.001 0.429 . . . . 0.96 111.405 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 120' ' ' ARG . 14.1 mmt85 -77.15 -46.76 22.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.307 0.484 . . . . 1.69 112.307 -169.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.455 HG13 ' ND1' ' A' ' 127' ' ' HIS . 4.6 m -113.54 -17.02 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.484 0.549 . . . . 1.49 112.484 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.86 -146.66 16.71 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.261 -0.971 . . . . 1.4 111.723 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -80.24 116.1 20.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.676 0.274 . . . . 4.11 111.385 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.5 t 64.55 -146.74 0.27 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.792 -0.64 . . . . 1.97 110.693 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.402 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 42.6 p 63.06 178.87 0.15 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.48 1.112 . . . . 0.85 111.724 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.849 ' HB1' ' HD2' ' A' ' 88' ' ' LYS . . . -94.23 128.27 40.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.356 -0.384 . . . . 0.57 111.315 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.516 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 66.9 t60 -101.65 146.78 27.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.139 -0.689 . . . . 0.55 109.139 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 1.1 p30 -143.91 137.62 27.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.301 0.572 . . . . 1.64 111.305 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 81.6 mm-40 -110.03 114.63 28.31 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.267 -1.012 . . . . 1.12 108.267 172.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.13 107.61 20.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.672 -0.492 . . . . 0.74 109.672 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.4 mm -116.47 101.06 53.81 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.394 -0.367 . . . . 1.25 111.017 -173.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.6 121.56 3.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.815 2.343 . . . . 0.29 111.616 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.672 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.2 pt -110.58 158.63 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.363 -0.606 . . . . 0.27 109.363 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.7 p -124.67 107.09 10.63 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.014 0.435 . . . . 1.24 110.773 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.597 HG22 ' HG2' ' A' ' 80' ' ' GLU . 35.0 mt -103.8 124.11 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.262 -0.426 . . . . 0.34 110.138 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 53.0 mmtt -151.46 138.49 19.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.646 0.592 . . . . 1.95 110.331 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 137' ' ' LYS . 63.5 mmtt 62.42 31.62 17.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.45 0.643 . . . . 3.13 110.507 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.09 22.01 77.15 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.015 -0.993 . . . . 0.41 111.923 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.648 ' HG2' HG22 ' A' ' 148' ' ' THR . 58.1 mtpt -118.71 137.58 53.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.014 -0.365 . . . . 2.23 110.014 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 7.1 tt -113.91 116.32 29.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.178 -0.464 . . . . 0.41 109.777 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.6 t -111.26 132.95 53.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.407 -0.36 . . . . 1.19 110.375 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 88.7 t -125.66 103.97 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.298 -0.41 . . . . 0.92 110.246 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 57.41 -91.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.68 0.612 . . . . 1.88 112.005 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -113.7 14.47 22.23 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.866 -0.683 . . . . 1.02 112.905 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -129.27 116.38 19.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.861 0.331 . . . . 1.95 111.201 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.21 129.85 57.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.071 0.462 . . . . 0.92 109.961 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m -144.03 -177.63 5.54 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.574 -0.528 . . . . 1.27 109.574 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.648 HG22 ' HG2' ' A' ' 139' ' ' LYS . 39.0 p -98.07 138.98 34.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.745 0.307 . . . . 1.45 110.284 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.829 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 58.6 t80 -79.57 135.44 36.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.996 -0.547 . . . . 0.47 109.966 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.7 t -132.17 102.31 5.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.526 0.679 . . . . 1.79 111.949 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.31 -68.46 2.91 Favored Glycine 0 CA--C 1.508 -0.344 0 CA-C-N 115.421 -0.809 . . . . 0.42 113.678 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -158.63 167.01 30.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.864 0.364 . . . . 1.23 110.452 -177.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.819 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 6.0 tt -80.92 127.55 32.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.539 -0.911 . . . . 1.17 108.539 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.762 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 5.7 p -112.45 102.9 10.98 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.346 -0.542 . . . . 1.35 112.333 -172.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 85' ' ' LEU . 97.1 t -91.72 109.35 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.783 -0.451 . . . . 0.42 109.783 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.581 ' HB2' ' HD2' ' A' ' 105' ' ' ARG . 39.9 mt-10 -120.3 112.05 18.55 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.533 -0.758 . . . . 1.98 109.609 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.672 ' CE1' ' HE1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -99.71 114.47 27.59 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 118.569 -1.253 . . . . 2.32 110.344 166.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 20.8 t -83.77 144.69 9.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 113.758 -1.565 . . . . 0.62 110.828 -169.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? . . . . . 0 C--O 1.234 0.256 0 CA-C-N 115.064 -0.971 . . . . 2.26 112.03 -172.002 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.878 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 2.4 t . . . . . 0 C--O 1.238 0.475 0 CA-C-O 119.727 -0.178 . . . . 1.19 110.699 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -129.95 74.42 1.59 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 119.623 -0.831 . . . . 1.36 113.133 -172.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 1.078 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -80.12 36.08 0.34 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.708 1.203 . . . . 0.31 113.576 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.733 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 18.9 tp -53.76 117.37 3.11 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.688 0.625 . . . . 0.69 112.688 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.75 ' HE1' HG23 ' A' ' 10' ' ' VAL . 8.4 t80 -123.89 127.79 48.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.963 0.505 . . . . 0.48 110.555 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.681 HG23 HG23 ' A' ' 11' ' ' ILE . 8.7 tt -119.13 131.65 71.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 121.811 0.815 . . . . 0.3 111.05 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 9.4 ptm -121.33 159.93 25.05 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.846 -0.616 . . . . 0.99 109.534 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 16.2 ptmt -113.18 149.98 32.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.424 1.107 . . . . 1.22 113.063 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' ' 176' ' ' THR . . . 103.58 -32.47 7.53 Favored Glycine 0 C--N 1.309 -0.917 0 CA-C-N 113.231 -1.804 . . . . 0.31 114.337 161.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.677 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.2 OUTLIER -177.49 162.22 1.82 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.052 0.926 . . . . 0.68 112.511 176.291 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.661 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -85.49 -10.36 56.18 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.22 -0.9 . . . . 0.86 109.891 168.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.677 ' H ' ' HB ' ' A' ' 176' ' ' THR . 22.2 m-20 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.416 -0.811 . . . . 2.16 111.616 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.704 ' HG ' HD11 ' A' ' 27' ' ' ILE . 47.6 tp . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 121.159 0.504 . . . . 0.72 110.111 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.502 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -61.23 -22.87 65.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.204 -0.907 . . . . 0.53 111.781 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -82.46 -34.3 28.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.41 -0.359 . . . . 2.18 111.373 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 57.8 mmtt -93.54 -15.39 25.52 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.59 -0.444 . . . . 1.79 112.02 -171.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.743 HG23 ' HE1' ' A' ' 171' ' ' PHE . 7.1 p -54.02 132.53 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.027 0.441 . . . . 0.33 111.775 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 pt -115.78 -32.28 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.226 -0.443 . . . . 0.92 110.705 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.72 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 42.0 t90 -159.63 133.0 7.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.046 -0.724 . . . . 0.36 109.046 -172.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.84 131.45 13.09 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.848 -0.341 . . . . 0.26 111.059 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.843 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 52.3 t -140.42 120.59 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.66 0.743 . . . . 0.79 111.357 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 51.4 t30 -98.15 101.63 13.15 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.109 -1.071 . . . . 1.49 108.109 167.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -60.36 95.7 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 116.051 -0.522 . . . . 0.48 110.036 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 175.94 -90.17 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 O-C-N 124.812 1.32 . . . . 0.76 113.068 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.37 -130.11 0.26 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.562 -0.352 . . . . 0.74 113.751 -172.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' HG3' ' HD3' ' A' ' 31' ' ' LYS . 31.6 tt0 -144.95 119.44 9.68 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.572 -0.369 . . . . 1.77 111.528 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.71 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 50.0 m 31.45 99.0 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.726 1.38 . . . . 1.29 114.726 172.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.609 ' ND1' ' HB2' ' A' ' 60' ' ' LEU . 33.4 t-80 -135.33 134.97 40.4 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.786 -0.572 . . . . 0.42 111.855 -177.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 83.7 t -88.45 115.48 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.46 -0.791 . . . . 1.01 110.225 175.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.47 159.47 33.91 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.442 -0.577 . . . . 0.77 109.442 176.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 57' ' ' ASP . 28.8 m -66.2 -6.96 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.999 0.74 . . . . 0.62 112.999 -171.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -99.0 7.35 46.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.856 -0.794 . . . . 0.86 108.856 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 87.3 30.8 18.44 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.877 -1.056 . . . . 0.33 112.706 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.704 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.7 mm -104.45 106.27 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 0.31 111.34 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 30.3 t60 -86.33 109.43 18.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.289 0.566 . . . . 0.8 111.459 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.843 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -77.12 138.82 39.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.498 -0.774 . . . . 1.75 109.994 172.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -99.5 116.2 31.1 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.016 0.436 . . . . 2.94 110.677 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HG2' ' N ' ' A' ' 32' ' ' ASP . 8.9 ttpp -34.25 146.98 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.914 1.286 . . . . 2.78 114.371 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.54 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 7.7 p-10 -24.21 92.72 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 125.961 1.705 . . . . 2.41 114.639 -173.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.451 -1.015 0 C-N-CA 123.879 3.053 . . . . 1.87 113.507 176.138 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.539 HD13 ' HG3' ' A' ' 62' ' ' GLN . 1.5 mp . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 121.294 0.569 . . . . 1.59 110.389 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.89 -17.54 62.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 1.91 111.595 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HD3' ' HB ' ' A' ' 125' ' ' THR . 10.6 mpt_? -97.48 25.7 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.245 0.461 . . . . 3.17 112.245 -175.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -153.46 165.87 34.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 0.97 111.373 177.078 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.489 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 1.3 t30 -89.25 140.64 28.75 Favored Pre-proline 0 C--O 1.217 -0.655 0 CA-C-N 115.469 -0.787 . . . . 1.92 109.901 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.489 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 38.2 Cg_exo -37.78 -53.04 1.59 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 124.681 3.587 . . . . 0.7 117.339 -161.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -73.07 -45.97 54.27 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 119.419 1.008 . . . . 2.71 110.708 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.4 ' HB3' HG13 ' A' ' 24' ' ' VAL . 2.7 p30 -77.37 -20.8 54.24 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.004 -0.544 . . . . 1.63 109.563 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 24.5 tt0 -54.19 -48.07 71.38 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.563 -0.744 . . . . 1.58 109.378 169.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 63' ' ' THR . 61.4 t -54.79 -37.9 42.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.987 -0.551 . . . . 1.27 110.576 172.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -74.92 -10.53 59.57 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.932 0.396 . . . . 1.18 111.758 178.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 169' ' ' ALA . 62.2 m-85 -115.78 12.66 15.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.276 1.036 . . . . 0.99 108.756 175.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.56 ' HG2' ' H ' ' A' ' 63' ' ' THR . 47.0 tt0 -126.88 -130.6 0.23 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.401 -1.727 . . . . 1.97 108.716 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.665 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 40.7 p 39.03 106.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.956 1.465 . . . . 1.27 114.956 -176.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.938 ' HB3' HG12 ' A' ' 167' ' ' VAL . 12.5 pt-20 -97.27 151.83 19.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.991 -1.114 . . . . 1.96 107.991 168.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.614 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 22.8 ptt180 . . . . . 0 C--N 1.328 -0.364 0 N-CA-C 112.353 0.501 . . . . 3.35 112.353 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.465 0.281 0 N-CA-C 109.308 -0.626 . . . . 1.41 109.308 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.857 ' HB2' ' HD1' ' A' ' 157' ' ' PHE . 15.3 m-85 -66.63 104.99 1.41 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.74 -0.664 . . . . 1.57 109.484 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.43 95.04 0.86 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 119.75 -1.214 . . . . 0.78 114.193 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.553 ' CE1' HG11 ' A' ' 14' ' ' VAL . 51.6 m-85 -84.4 148.33 26.66 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.305 -0.447 . . . . 1.21 110.77 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 1.9 p-10 -127.68 127.02 43.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.742 0.782 . . . . 2.47 109.934 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.912 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.0 mp -110.6 92.46 14.21 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 114.664 -1.153 . . . . 0.38 109.028 -176.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 34.5 Cg_exo -57.71 117.12 3.76 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.085 1.857 . . . . 0.59 111.609 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.767 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 56.4 mt -115.6 130.43 70.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.165 0.507 . . . . 0.49 111.634 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.52 -24.59 9.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.848 -0.615 . . . . 3.32 110.789 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.524 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 7.4 mm-40 -99.06 176.06 5.7 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.864 0.364 . . . . 2.16 110.575 -168.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 136' ' ' LYS . 2.3 tt0 -126.59 160.71 29.88 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.83 -0.623 . . . . 1.2 109.817 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.584 ' N ' ' HG2' ' A' ' 80' ' ' GLU . . . 139.45 -163.84 26.03 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 115.576 -0.738 . . . . 0.3 111.534 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 27.4 mt-10 -98.75 109.77 22.47 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 120.373 -0.531 . . . . 1.96 109.857 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.647 ' HB2' HG12 ' A' ' 133' ' ' ILE . 74.8 m-85 -94.34 124.66 38.5 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.583 -0.895 . . . . 0.71 108.583 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 177' ' ' ALA . 52.9 t -104.74 106.13 19.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-O 121.909 0.862 . . . . 0.26 109.902 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.738 HD11 HD11 ' A' ' 170' ' ' LEU . 10.9 tp -89.66 103.32 15.98 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.2 -1.364 . . . . 1.56 109.291 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.13 107.72 23.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.64 0.734 . . . . 1.14 109.364 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.612 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 1.3 pp -113.23 140.73 47.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.601 -0.727 . . . . 1.44 111.035 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.863 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 12.8 mptt -99.55 134.24 42.71 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.374 -0.53 . . . . 3.73 110.203 173.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CE2' HD13 ' A' ' 87' ' ' LEU . 11.3 m-85 -117.17 138.01 51.96 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.696 -0.684 . . . . 0.45 110.372 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.559 ' HB3' ' CG2' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.977 0 C-N-CA 120.78 -0.368 . . . . 0.51 111.252 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.646 0 CA-C-O 121.26 0.552 . . . . 1.22 110.809 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 33.9 m-85 -77.36 158.19 30.24 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.532 -0.758 . . . . 0.99 109.804 176.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.734 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 50.9 m-20 -112.23 135.15 53.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.439 -0.949 . . . . 1.53 108.439 172.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.893 HG22 ' HD2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -125.79 119.81 55.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.164 0.506 . . . . 0.63 109.95 -177.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.712 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 79.6 mtt180 -116.83 141.87 47.66 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.017 -0.992 . . . . 1.95 111.456 -171.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 153' ' ' LEU . 41.8 t -116.5 102.25 13.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.663 -0.699 . . . . 1.44 109.153 174.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.896 ' HB2' HD12 ' A' ' 153' ' ' LEU . 23.3 t-20 57.26 46.45 18.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.227 1.013 . . . . 1.65 108.421 -170.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.79 -21.97 30.64 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.945 -1.025 . . . . 0.42 113.315 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 93.0 m-70 -78.12 108.57 11.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.268 0.47 . . . . 0.68 112.268 -173.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.51 ' CG2' ' HG2' ' A' ' 105' ' ' ARG . 5.9 p -69.35 87.81 0.45 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.779 0.323 . . . . 0.77 111.029 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.421 HG21 HG21 ' A' ' 131' ' ' ILE . 43.6 t -67.78 -55.55 16.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.154 -0.684 . . . . 0.94 109.154 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.597 HG21 ' HG2' ' A' ' 129' ' ' GLU . 17.3 t -112.53 90.52 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.874 -0.603 . . . . 0.35 109.72 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -107.9 73.25 0.89 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.757 0.789 . . . . 4.01 109.781 177.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 9.2 p-10 164.94 32.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.063 -1.426 . . . . 1.96 108.536 -172.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -78.11 71.08 4.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.217 -0.901 . . . . 1.18 112.042 -170.007 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 119' ' ' ASP . 31.0 m-20 -77.16 93.57 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.937 -1.134 . . . . 1.93 107.937 167.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.7 mt -54.01 -39.78 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.996 0.427 . . . . 0.82 110.211 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 56.7 t80 -64.71 -39.53 93.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.417 -0.81 . . . . 1.08 110.987 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 12.1 t70 -71.98 -36.41 69.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.987 0.422 . . . . 0.96 111.431 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -77.9 -49.56 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 1.69 111.807 -171.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 127' ' ' HIS . 15.9 m -110.5 -24.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.379 -0.529 . . . . 1.49 112.284 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 112.81 -142.86 17.54 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.423 -0.894 . . . . 1.4 111.961 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -89.14 110.29 21.04 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.173 -0.306 . . . . 4.11 110.173 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.4 t 68.15 -150.71 0.16 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.621 -0.718 . . . . 1.97 110.909 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.514 ' HB ' ' HD3' ' A' ' 52' ' ' ARG . 20.8 p 66.57 177.85 0.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.531 1.132 . . . . 0.85 111.176 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.49 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -91.94 119.1 31.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.826 0.346 . . . . 0.57 111.574 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.479 ' HA ' HG11 ' A' ' 121' ' ' VAL . 84.0 t60 -89.37 130.04 35.8 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.714 -0.847 . . . . 0.55 108.714 172.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -121.58 113.26 19.53 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.494 -0.321 . . . . 1.64 110.912 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.597 ' HG2' HG21 ' A' ' 112' ' ' VAL . 2.6 tp10 -116.53 113.62 23.02 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.696 -0.483 . . . . 1.12 109.696 177.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.4 mt -98.75 119.83 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.232 -0.44 . . . . 0.74 109.828 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.553 HG21 HG21 ' A' ' 106' ' ' VAL . 58.2 mt -125.23 89.58 52.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.233 -0.44 . . . . 1.25 110.63 -173.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -75.83 126.61 9.55 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.61 2.207 . . . . 0.29 112.019 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.647 HG12 ' HB2' ' A' ' 83' ' ' TYR . 6.0 pt -110.38 157.16 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.043 -0.725 . . . . 0.27 109.043 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 t -123.93 106.67 10.61 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.808 -0.442 . . . . 1.24 109.808 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.749 HG12 ' HG ' ' A' ' 140' ' ' LEU . 5.2 mt -104.73 137.14 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 109.021 -0.733 . . . . 0.34 109.021 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 53.1 mttm -152.77 131.13 12.08 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 123.699 0.625 . . . . 1.95 111.104 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.675 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER 56.22 27.66 12.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.147 -0.933 . . . . 3.13 111.239 177.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.62 13.62 62.75 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.792 -0.718 . . . . 0.41 113.085 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 59.2 mtpt -115.17 137.54 51.91 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.391 -0.476 . . . . 2.23 109.904 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.749 ' HG ' HG12 ' A' ' 135' ' ' ILE . 3.8 tt -115.51 121.44 42.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.314 -0.403 . . . . 0.41 110.185 -172.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -117.47 114.17 23.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.32 -0.4 . . . . 1.19 109.942 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 142' ' ' VAL . 5.5 m -90.73 111.07 23.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.97 -0.752 . . . . 0.92 108.97 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 63.55 -85.41 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.128 -0.487 . . . . 1.88 110.43 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -139.71 17.65 3.03 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.826 -0.625 . . . . 1.02 111.626 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -108.49 121.42 44.94 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.829 -0.804 . . . . 1.95 108.829 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.8 p -103.46 146.78 10.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.315 0.578 . . . . 0.92 111.943 -168.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.4 p -163.25 176.51 9.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.224 -0.898 . . . . 1.27 109.046 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 139' ' ' LYS . 70.3 p -100.27 138.13 37.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.711 0.291 . . . . 1.45 110.316 175.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.767 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 39.3 t80 -79.81 131.35 35.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.026 -0.361 . . . . 0.47 110.026 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.3 t -131.39 111.06 11.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.464 0.649 . . . . 1.79 111.473 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.37 -72.8 1.88 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.387 -0.824 . . . . 0.42 113.678 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -155.75 169.11 25.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.973 0.416 . . . . 1.23 110.62 -175.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.912 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 22.7 tp -80.99 150.72 28.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.707 -0.849 . . . . 1.17 108.707 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.6 t -132.53 104.11 6.51 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 118.994 -1.082 . . . . 1.35 110.353 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 15.5 t -92.91 96.44 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 108.401 -0.963 . . . . 0.42 108.401 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 105' ' ' ARG . 4.3 tt0 -107.7 121.82 45.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.495 -1.229 . . . . 1.98 109.582 -173.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.893 ' HD2' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -113.32 115.52 28.27 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.178 -0.609 . . . . 2.32 110.116 176.225 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 52.9 t -82.81 140.82 15.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.971 -1.013 . . . . 0.62 110.766 -173.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.3 pttm . . . . . 0 N--CA 1.454 -0.259 0 CA-C-N 114.999 -1.0 . . . . 2.26 112.336 -173.946 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.938 HG12 ' HB3' ' A' ' 64' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.802 0 N-CA-C 108.341 -0.985 . . . . 1.19 108.341 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 33.9 t -137.41 89.03 2.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.04 0.755 . . . . 1.36 113.04 -168.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.863 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -75.39 38.4 0.14 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 124.479 1.112 . . . . 0.31 113.273 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.738 HD11 HD11 ' A' ' 85' ' ' LEU . 40.7 tp -54.12 104.42 0.11 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.769 0.655 . . . . 0.69 112.769 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.782 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 4.3 t80 -117.99 124.62 48.62 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.489 -0.323 . . . . 0.48 110.925 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.664 ' HB ' HD12 ' A' ' 85' ' ' LEU . 5.0 tt -114.53 123.7 70.46 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-O 122.226 1.012 . . . . 0.3 111.359 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.782 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.6 ppp? -115.68 159.88 20.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.884 -1.053 . . . . 0.99 109.99 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 53.8 tttt -105.87 133.23 50.93 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 114.1 1.148 . . . . 1.22 114.1 -170.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 106.15 -28.87 12.28 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 113.832 -1.531 . . . . 0.31 116.226 157.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.99 158.09 1.98 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.036 1.418 . . . . 0.68 113.411 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.653 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -83.86 -9.58 58.65 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.206 -0.906 . . . . 0.86 111.356 174.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 30.6 t70 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 121.157 0.504 . . . . 2.16 111.215 -178.188 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.722 HD12 ' HE3' ' A' ' 173' ' ' MET . 50.2 tp . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.305 0.574 . . . . 0.72 110.141 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -69.89 -23.42 63.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.485 -0.78 . . . . 0.53 111.651 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.55 -16.54 53.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.026 -0.534 . . . . 2.18 111.009 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.454 ' HB2' ' HE2' ' A' ' 173' ' ' MET . 37.1 mtpt -126.22 2.77 7.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.438 -0.505 . . . . 1.79 111.785 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.522 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 11.6 p -58.78 136.91 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.508 -0.477 . . . . 0.33 110.176 169.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 174' ' ' LYS . 10.7 pt -115.76 -22.86 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.285 -0.416 . . . . 0.92 111.047 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.752 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 79.4 t90 -171.1 143.28 1.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.838 -0.431 . . . . 0.36 109.838 -173.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -162.18 137.58 7.28 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.207 -0.308 . . . . 0.26 111.553 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.402 HG11 ' CE2' ' A' ' 73' ' ' TYR . 45.2 t -142.02 125.72 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.02 -0.536 . . . . 0.79 110.885 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 28.5 t30 -101.77 104.87 15.68 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.793 -0.817 . . . . 1.49 108.793 167.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.602 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -65.52 89.11 0.1 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.245 -0.889 . . . . 0.48 110.247 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.617 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -174.36 -67.73 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 O-C-N 125.385 1.678 . . . . 0.76 112.249 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.85 -132.38 5.69 Favored Glycine 0 C--N 1.318 -0.441 0 C-N-CA 120.757 -0.735 . . . . 0.74 112.997 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 1.069 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 25.3 tt0 -138.33 119.37 14.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 111.243 0.09 . . . . 1.77 111.243 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.684 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 73.1 m 36.39 108.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.584 1.698 . . . . 1.29 115.584 170.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.614 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 82.6 t60 -137.76 128.37 26.74 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.928 -0.483 . . . . 0.42 111.42 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 86.1 t -87.8 113.15 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.209 -0.905 . . . . 1.01 109.074 171.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -78.38 161.33 27.24 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.333 -0.247 . . . . 0.77 110.333 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.32 -27.84 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 124.585 1.178 . . . . 0.62 113.232 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.441 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 35.1 m80 -80.34 -6.55 58.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.312 0.577 . . . . 0.86 109.559 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 96.41 24.84 13.22 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.955 -1.021 . . . . 0.33 112.179 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.557 HD11 ' HG ' ' A' ' 6' ' ' LEU . 19.1 mm -99.36 109.18 23.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.178 0.513 . . . . 0.31 110.937 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 7.7 t60 -86.71 110.99 20.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.139 -0.482 . . . . 0.8 110.342 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.684 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -87.48 139.13 30.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.084 -0.339 . . . . 1.75 110.084 175.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.498 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 13.3 ptp180 -92.97 138.66 31.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.131 0.491 . . . . 2.94 110.664 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 1.069 ' HB3' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -73.9 136.91 43.38 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.939 1.088 . . . . 2.78 113.939 -173.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' CG ' ' HZ2' ' A' ' 31' ' ' LYS . 1.1 p30 28.54 54.67 0.5 Allowed Pre-proline 0 N--CA 1.484 1.246 0 CA-C-N 111.868 -2.424 . . . . 2.41 116.09 167.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 67.3 Cg_endo . . . . . 0 N--CA 1.455 -0.773 0 C-N-CA 122.503 2.135 . . . . 1.87 113.006 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' A' ' 62' ' ' GLN . 1.7 mp . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 121.863 0.84 . . . . 1.59 109.712 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.486 ' HB3' HG22 ' A' ' 125' ' ' THR . 2.8 tt -60.95 -35.51 76.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.592 -1.186 . . . . 1.91 110.962 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -88.09 33.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.951 0.722 . . . . 3.17 112.951 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -142.62 168.16 20.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.8 0.333 . . . . 0.97 110.878 172.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -90.21 141.42 27.69 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.958 -0.756 . . . . 1.92 108.958 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.425 ' O ' HG23 ' A' ' 59' ' ' VAL . 60.3 Cg_exo -39.67 -42.74 2.96 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 124.101 3.201 . . . . 0.7 115.947 -162.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -76.54 -44.37 35.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.248 0.476 . . . . 2.71 111.361 -177.455 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -81.2 -17.48 49.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.234 -0.654 . . . . 1.63 109.234 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -58.85 -45.69 89.52 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.174 -0.921 . . . . 1.58 109.135 167.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 55' ' ' PRO . 68.8 t -55.19 -44.6 75.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.487 0.66 . . . . 1.27 109.593 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 15' ' ' ASN . 35.0 tp -63.72 -18.94 64.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.644 -1.162 . . . . 1.18 112.141 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.614 ' CE2' ' HE2' ' A' ' 88' ' ' LYS . 13.6 m-30 -114.91 1.55 14.06 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 111.894 0.331 . . . . 0.99 111.894 -175.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.598 ' HA ' HD13 ' A' ' 50' ' ' ILE . 39.2 tt0 -124.3 -41.36 2.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.626 0.973 . . . . 1.97 113.626 -170.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.518 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 2.1 m -61.1 132.49 53.93 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 121.072 -0.251 . . . . 1.27 111.451 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 1.029 ' HB2' HG22 ' A' ' 167' ' ' VAL . 36.5 tt0 -120.33 147.75 44.62 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.123 0.569 . . . . 1.96 110.397 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.571 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 16.6 mtm-85 . . . . . 0 N--CA 1.463 0.184 0 O-C-N 123.232 0.333 . . . . 3.35 110.931 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.83 0.348 . . . . 1.41 110.437 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.737 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 8.4 p90 -107.28 126.61 52.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.132 -1.027 . . . . 1.57 110.838 -176.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -145.4 154.06 25.68 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.942 -1.027 . . . . 0.78 113.295 -173.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.602 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 53.5 m-85 -104.85 164.97 11.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.303 -0.448 . . . . 1.21 111.156 -175.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 8.0 p-10 -115.42 118.8 34.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.741 -0.663 . . . . 2.47 110.463 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.845 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.8 mp -104.5 90.88 3.59 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.333 -0.849 . . . . 0.38 109.302 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 38.4 Cg_exo -59.74 120.04 7.61 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.251 1.967 . . . . 0.59 112.405 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.775 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 72.4 mt -119.86 135.98 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.867 0.365 . . . . 0.49 111.236 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.484 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 32.6 mtpt -130.9 7.67 4.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 3.32 110.736 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.47 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 38.0 mt-10 -131.88 174.41 10.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.975 0.416 . . . . 2.16 110.882 -173.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 9.0 mt-10 -112.82 -172.99 2.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.778 -0.646 . . . . 1.2 110.112 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.33 -167.48 13.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.895 -0.669 . . . . 0.3 112.191 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.651 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 56.2 mt-10 -97.34 103.3 15.22 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 117.29 0.545 . . . . 1.96 109.747 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.666 ' HB2' HG12 ' A' ' 133' ' ' ILE . 10.9 m-30 -95.64 123.25 39.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 118.985 -1.086 . . . . 0.71 108.398 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.984 HG21 ' HA ' ' A' ' 177' ' ' ALA . 74.7 t -114.71 106.68 21.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.518 -0.764 . . . . 0.26 110.268 -172.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.1 mp -88.82 104.47 16.94 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.457 -1.247 . . . . 1.56 109.493 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.608 HG22 HG23 ' A' ' 130' ' ' ILE . 44.2 t -103.34 100.73 11.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 107.539 -1.282 . . . . 1.14 107.539 171.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.615 ' CB ' ' HA ' ' A' ' 170' ' ' LEU . 0.6 OUTLIER -109.23 132.24 54.31 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.106 -0.638 . . . . 1.44 109.803 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.994 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 13.8 mptt -89.09 122.61 32.58 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.129 -0.628 . . . . 3.73 110.393 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.14 135.21 48.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.227 -0.897 . . . . 0.45 108.645 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.843 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.056 0 CA-C-O 121.095 0.474 . . . . 0.51 109.968 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.928 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 6.4 m . . . . . 0 N--CA 1.446 -0.671 0 CA-C-O 121.477 0.656 . . . . 1.22 110.356 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.711 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 23.5 m-85 -73.87 154.33 39.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.102 -0.954 . . . . 0.99 110.887 -175.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.681 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 12.5 m-20 -105.75 137.81 42.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.469 -0.567 . . . . 1.53 109.469 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 2.5 t -134.47 120.18 32.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.762 0.315 . . . . 0.63 110.682 -176.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 61.4 mtt180 -120.26 141.98 49.47 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.671 -0.695 . . . . 1.95 111.666 -174.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.872 HG23 HD21 ' A' ' 153' ' ' LEU . 2.8 p -118.43 102.78 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.75 -0.659 . . . . 1.44 109.845 172.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.415 ' HA ' ' H ' ' A' ' 154' ' ' SER . 64.7 t30 55.44 51.45 12.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.266 -0.879 . . . . 1.65 109.342 -172.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.31 -17.67 46.41 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.085 -0.961 . . . . 0.42 113.313 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 90.2 m-70 -85.49 105.45 16.11 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.098 0.407 . . . . 0.68 112.098 -172.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.575 ' HB ' ' HD2' ' A' ' 113' ' ' LYS . 1.9 p -69.91 94.3 0.83 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.043 0.449 . . . . 0.77 111.174 176.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.46 HG23 HG12 ' A' ' 106' ' ' VAL . 21.5 t -78.12 -49.62 21.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.643 0.735 . . . . 0.94 109.409 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.521 HG11 HD13 ' A' ' 115' ' ' LEU . 9.4 t -118.39 90.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.437 -0.801 . . . . 0.35 109.714 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.575 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 0.4 OUTLIER -109.45 71.66 0.78 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.906 -1.146 . . . . 4.01 107.906 176.662 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.928 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 6.6 p-10 168.86 19.29 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.026 -1.897 . . . . 1.96 109.698 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.711 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 11.5 tp -73.35 99.43 2.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.182 -0.463 . . . . 1.18 111.512 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 23.3 p-10 -110.59 91.08 3.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.161 0.981 . . . . 1.93 109.873 174.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.6 mm -52.9 -44.3 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 114.632 -1.167 . . . . 0.82 112.483 -170.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -56.96 -39.56 74.83 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 123.341 0.4 . . . . 1.08 111.755 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -73.18 -32.61 64.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.115 0.483 . . . . 0.96 110.849 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 8.6 mmt180 -71.5 -44.43 64.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.634 -0.712 . . . . 1.69 111.084 -173.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.77 -40.38 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.323 0.49 . . . . 1.49 112.323 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.25 -58.26 4.96 Favored Glycine 0 C--O 1.23 -0.137 0 C-N-CA 121.133 -0.556 . . . . 1.4 112.104 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -99.92 145.42 27.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.436 -0.579 . . . . 4.11 109.436 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.0 m -54.38 94.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 O-C-N 123.691 0.619 . . . . 1.97 111.03 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 51' ' ' LEU . 21.2 p -150.05 -174.9 4.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.217 -0.447 . . . . 0.85 109.872 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.567 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -79.92 124.14 28.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.563 -0.29 . . . . 0.57 111.007 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -104.87 145.15 30.79 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.723 -1.214 . . . . 0.55 107.723 168.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.73 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 23.8 p-10 -146.81 139.83 25.33 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.931 -0.708 . . . . 1.64 112.141 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -103.85 114.02 27.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.219 -0.901 . . . . 1.12 108.598 172.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.608 HG23 HG22 ' A' ' 86' ' ' VAL . 71.6 mt -95.73 110.05 23.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.997 -0.547 . . . . 0.74 109.629 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.8 mt -119.7 97.45 49.83 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.37 -0.377 . . . . 1.25 111.162 -173.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -78.68 123.75 6.01 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.717 2.278 . . . . 0.29 112.108 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.666 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.9 pt -110.03 154.05 11.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.727 -0.842 . . . . 0.27 108.727 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.9 p -123.78 109.42 13.64 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.852 0.358 . . . . 1.24 110.323 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.718 HG12 ' HG ' ' A' ' 140' ' ' LEU . 29.2 mt -98.82 125.11 52.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.049 -0.722 . . . . 0.34 109.049 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -151.0 135.57 17.1 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.71 0.631 . . . . 1.95 109.435 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 1.066 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 7.6 mmpt? 61.98 25.85 15.55 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.538 0.524 . . . . 3.13 111.316 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.25 9.98 85.96 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.731 -0.747 . . . . 0.41 112.167 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.746 ' HG2' HG22 ' A' ' 148' ' ' THR . 26.3 mtpp -110.83 137.48 48.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.406 -0.59 . . . . 2.23 109.406 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.718 ' HG ' HG12 ' A' ' 135' ' ' ILE . 4.9 tt -108.68 115.32 29.88 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.415 -0.587 . . . . 0.41 109.415 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 m -108.4 125.12 51.39 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.893 -0.594 . . . . 1.19 110.091 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.405 HG21 HG13 ' A' ' 106' ' ' VAL . 85.5 t -113.09 95.5 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.769 -0.456 . . . . 0.92 109.769 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 62.39 -91.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.427 -0.806 . . . . 1.88 111.132 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.3 -10.46 29.54 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.922 -0.656 . . . . 1.02 112.594 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -97.47 149.98 21.57 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.803 -0.234 . . . . 1.95 110.763 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.92 125.76 13.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.168 0.509 . . . . 0.92 110.865 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.0 m -155.42 141.72 18.53 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.626 -0.509 . . . . 1.27 109.626 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.746 HG22 ' HG2' ' A' ' 139' ' ' LYS . 25.1 p -59.09 140.93 55.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.2 0.524 . . . . 1.45 111.131 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.775 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 20.8 t80 -85.83 140.85 30.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.45 -0.795 . . . . 0.47 110.301 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 t -144.41 118.01 9.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.509 0.671 . . . . 1.79 110.923 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.21 -77.8 2.08 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.324 -0.853 . . . . 0.42 113.607 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -159.72 169.47 23.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.038 0.447 . . . . 1.23 110.975 -174.254 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.872 HD21 HG23 ' A' ' 106' ' ' VAL . 6.7 tt -84.34 135.35 34.34 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.778 -0.823 . . . . 1.17 108.778 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.475 ' N ' HD23 ' A' ' 153' ' ' LEU . 8.1 t -121.34 109.07 14.46 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.903 -0.719 . . . . 1.35 110.538 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 45.2 t -95.23 98.06 7.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.722 -0.473 . . . . 0.42 109.722 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -114.95 134.3 55.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.205 -0.452 . . . . 1.98 110.434 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.737 ' HE2' ' CE2' ' A' ' 71' ' ' PHE . 0.1 OUTLIER -123.5 136.76 54.74 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.621 0.724 . . . . 2.32 111.418 176.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 42.2 t -104.5 145.44 13.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 114.002 -1.454 . . . . 0.62 111.525 -170.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 N--CA 1.464 0.244 0 CA-C-N 113.973 -1.467 . . . . 2.26 113.338 -178.093 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 1.029 HG22 ' HB2' ' A' ' 64' ' ' GLU . 52.1 t . . . . . 0 C--O 1.237 0.399 0 N-CA-C 110.079 -0.341 . . . . 1.19 110.079 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 11.5 t -141.92 86.4 1.98 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 119.084 -1.046 . . . . 1.36 113.592 -175.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.994 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -75.68 37.02 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.718 1.207 . . . . 0.31 112.564 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.752 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 23.3 tp -50.5 101.97 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.659 0.784 . . . . 0.69 113.111 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.736 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 5.0 t80 -114.82 128.29 56.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.832 -0.622 . . . . 0.48 110.626 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.681 HG22 ' HE3' ' A' ' 12' ' ' TRP . 6.4 tt -121.15 124.82 72.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-O 121.529 0.68 . . . . 0.3 111.349 174.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.736 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 2.0 ppp? -115.32 166.06 12.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.801 -0.636 . . . . 0.99 109.395 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.445 ' HB3' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -120.14 148.73 43.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.4 1.095 . . . . 1.22 112.888 -170.015 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.52 -28.76 14.15 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 113.531 -1.668 . . . . 0.31 114.285 163.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.651 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.7 OUTLIER -166.62 152.24 8.19 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.545 0.943 . . . . 0.68 113.545 -174.169 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.984 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -85.1 -15.39 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.105 -0.952 . . . . 0.86 110.223 167.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.434 ' H ' ' HB ' ' A' ' 176' ' ' THR . 20.2 t70 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 114.965 -1.016 . . . . 2.16 112.002 -173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.661 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.5 tp . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.085 0.469 . . . . 0.72 110.557 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -71.01 -22.68 62.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.755 -0.657 . . . . 0.53 111.385 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.402 ' OD2' ' HG2' ' A' ' 9' ' ' LYS . 6.3 t70 -68.05 -42.13 80.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.207 0.527 . . . . 2.18 110.518 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 0.9 OUTLIER -103.29 -11.47 17.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.492 -0.776 . . . . 1.79 112.412 -168.406 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 12.4 p -59.96 131.25 24.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 120.401 -0.52 . . . . 0.33 111.015 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.509 HD11 HD13 ' A' ' 172' ' ' ILE . 22.7 pt -106.67 -22.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.952 -0.567 . . . . 0.92 110.071 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.741 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 34.9 t90 -168.81 142.13 2.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.775 -0.648 . . . . 0.36 109.595 -169.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -158.03 136.11 10.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.686 0.279 . . . . 0.26 111.195 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.801 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 18.8 t -146.71 125.18 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.418 0.627 . . . . 0.79 111.933 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 47.2 t30 -94.33 103.58 15.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.79 -1.189 . . . . 1.49 107.79 164.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -62.15 91.04 0.03 OUTLIER 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.881 -1.155 . . . . 0.48 107.881 171.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.781 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . 131.98 62.5 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.339 0 O-C-N 125.009 1.443 . . . . 0.76 113.169 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.92 -136.37 2.86 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 119.893 -1.146 . . . . 0.74 112.674 166.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.853 ' HG3' ' HD3' ' A' ' 31' ' ' LYS . 35.0 tt0 -161.64 118.12 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 119.724 -0.179 . . . . 1.77 110.952 171.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.731 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 60.1 p 31.36 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.567 1.167 . . . . 1.29 113.518 174.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.69 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 73.4 t60 -125.4 136.21 53.19 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.979 -0.688 . . . . 0.42 111.276 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.4 114.4 37.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.983 -0.553 . . . . 1.01 110.285 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.816 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -72.3 152.35 42.18 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.312 -0.625 . . . . 0.77 109.312 176.095 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG22 ' OD2' ' A' ' 57' ' ' ASP . 29.1 m -61.65 -10.83 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 113.594 0.961 . . . . 0.62 113.594 -170.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.484 ' HB2' HD23 ' A' ' 6' ' ' LEU . 28.6 m80 -92.87 -3.44 54.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.972 -0.751 . . . . 0.86 108.972 176.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 97.89 30.77 6.96 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.991 -1.004 . . . . 0.33 112.679 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.661 HD11 ' HG ' ' A' ' 6' ' ' LEU . 29.8 mm -103.83 108.09 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.127 0.489 . . . . 0.31 110.689 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -94.42 113.22 25.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.8 111.229 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.801 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -80.99 132.5 35.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.149 -0.478 . . . . 1.75 110.631 175.289 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.847 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 5.2 ptm180 -90.74 113.51 25.64 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.451 0.47 . . . . 2.94 110.673 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.853 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 39.0 ttpt -32.95 109.54 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.401 1.63 . . . . 2.78 115.401 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 59.3 m-20 23.7 63.02 0.39 Allowed Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 126.352 1.861 . . . . 2.41 114.715 168.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.847 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 17.7 Cg_endo . . . . . 0 N--CA 1.455 -0.756 0 C-N-CA 123.47 2.78 . . . . 1.87 113.823 -172.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.1 tp . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 120.828 0.346 . . . . 1.59 111.699 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 125' ' ' THR . 9.1 mp 64.45 -67.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.503 0.721 . . . . 1.91 112.541 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -77.36 36.47 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.42 0.526 . . . . 3.17 112.42 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.2 t -157.23 143.82 18.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.082 -0.34 . . . . 0.97 110.082 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -65.71 145.35 99.04 Favored Pre-proline 0 C--O 1.223 -0.323 0 CA-C-N 115.659 -0.701 . . . . 1.92 109.737 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -41.12 -45.01 5.36 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.577 3.518 . . . . 0.7 115.462 -166.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.737 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.0 pt-20 -72.42 -46.91 52.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.019 0.914 . . . . 2.71 110.614 -176.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.816 ' OD1' ' HA ' ' A' ' 23' ' ' ASP . 68.3 m-20 -79.06 -14.63 59.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.553 -0.717 . . . . 1.63 109.56 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 33.2 tt0 -59.75 -49.55 77.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.136 -0.938 . . . . 1.58 109.269 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 56' ' ' GLU . 13.6 p -60.19 -35.27 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 119.726 -0.789 . . . . 1.27 110.055 176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.69 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 16.2 tp -69.34 -13.24 62.27 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.843 0.354 . . . . 1.18 111.763 176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.537 ' CG ' ' HG2' ' A' ' 88' ' ' LYS . 15.8 m-30 -119.11 3.22 11.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.461 -0.336 . . . . 0.99 111.329 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.49 ' HA ' HD13 ' A' ' 50' ' ' ILE . 6.8 tt0 -121.25 -49.54 2.16 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.367 0.877 . . . . 1.97 113.367 -167.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.781 ' HB ' ' O ' ' A' ' 17' ' ' GLY . 20.8 m -74.05 133.17 42.89 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.766 -0.373 . . . . 1.27 111.221 -173.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' HB3' HG22 ' A' ' 167' ' ' VAL . 2.1 pm0 -93.32 162.25 14.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 1.96 109.889 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.45 ' HB2' ' C ' ' A' ' 16' ' ' ALA . 9.4 ttp180 . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.167 -0.679 . . . . 3.35 109.167 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 121.358 0.599 . . . . 1.41 110.336 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.519 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 24.5 p90 -125.3 134.54 52.21 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.611 -0.722 . . . . 1.57 109.541 -172.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.79 -151.76 5.78 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.243 -0.889 . . . . 0.78 112.522 -174.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.586 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -142.01 160.06 40.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.1 0.476 . . . . 1.21 111.334 -171.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.73 ' HB3' ' HG3' ' A' ' 152' ' ' LYS . 2.6 m-20 -110.23 117.5 33.85 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.495 -0.775 . . . . 2.47 109.511 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.486 HD12 HD22 ' A' ' 153' ' ' LEU . 5.9 mt -106.58 90.64 5.17 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.187 -0.671 . . . . 0.38 109.187 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HA ' ' CB ' ' A' ' 152' ' ' LYS . 37.1 Cg_endo -67.22 116.08 4.0 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.015 1.143 . . . . 0.59 111.96 -175.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.844 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 62.1 mt -107.52 130.99 58.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.948 -0.569 . . . . 0.49 110.418 -174.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -122.64 5.95 9.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.228 -0.442 . . . . 3.32 110.474 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -132.5 172.21 12.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.504 -0.317 . . . . 2.16 110.215 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.57 ' HG2' HG22 ' A' ' 135' ' ' ILE . 9.5 mt-10 -114.67 176.42 5.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.895 0.379 . . . . 1.2 110.753 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.72 -166.14 21.32 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.76 -0.936 . . . . 0.3 110.76 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 24.7 mt-10 -103.0 107.17 17.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.52 0.66 . . . . 1.96 109.587 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.653 ' HB2' HG12 ' A' ' 133' ' ' ILE . 93.3 m-85 -94.33 124.69 38.51 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 119.803 -0.759 . . . . 0.71 109.074 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.642 HG21 ' CA ' ' A' ' 177' ' ' ALA . 96.9 t -113.49 107.67 23.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.669 -0.696 . . . . 0.26 110.764 -171.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 85' ' ' LEU . 4.9 mp -90.12 104.78 17.32 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.475 -1.239 . . . . 1.56 109.146 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.65 105.12 17.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.224 -1.028 . . . . 1.14 108.224 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.576 ' HG ' HD13 ' A' ' 170' ' ' LEU . 3.7 mp -100.81 132.24 46.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.814 -0.81 . . . . 1.44 108.814 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.796 ' HD2' ' HB3' ' A' ' 128' ' ' ASP . 23.5 tptt -96.63 114.73 26.41 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.683 -0.858 . . . . 3.73 108.683 173.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -104.56 137.12 42.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.82 -0.627 . . . . 0.45 109.373 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.31 -1.119 0 CA-C-N 115.544 -0.753 . . . . 0.51 111.262 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.2 m . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.292 0.567 . . . . 1.22 110.261 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.615 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 18.4 m-85 -88.68 150.74 22.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.56 -0.745 . . . . 0.99 110.864 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 23.5 m-20 -104.51 134.74 47.19 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.165 -1.05 . . . . 1.53 108.165 169.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.404 HG21 HD12 ' A' ' 115' ' ' LEU . 4.8 t -134.89 115.52 19.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.088 0.471 . . . . 0.63 110.638 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.581 ' HB3' HG23 ' A' ' 110' ' ' THR . 23.2 ptt180 -124.42 126.41 45.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.664 -0.698 . . . . 1.95 111.889 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.681 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 32.1 m -102.86 131.72 50.54 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 108.982 -0.748 . . . . 1.44 108.982 173.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.577 HD22 ' HG ' ' A' ' 153' ' ' LEU . 1.6 p30 48.44 44.43 20.41 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.862 0.465 . . . . 1.65 111.553 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.24 -1.79 63.62 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.917 -0.583 . . . . 0.42 112.676 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.681 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 52.5 m-70 -101.73 103.18 13.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.274 0.629 . . . . 0.68 111.202 -173.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.581 HG23 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -69.23 98.61 1.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.377 0.608 . . . . 0.77 111.12 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.43 -52.0 15.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.631 -0.713 . . . . 0.94 109.71 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.56 HG11 ' HG ' ' A' ' 115' ' ' LEU . 3.8 t -117.68 94.33 3.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.714 -0.676 . . . . 0.35 109.811 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -111.86 73.26 0.81 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.566 0.698 . . . . 4.01 109.353 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.601 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 12.2 p-10 162.71 27.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.72 -1.582 . . . . 1.96 108.834 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -69.4 91.95 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.405 -0.816 . . . . 1.18 111.199 -172.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 24.0 p-10 -101.9 96.96 7.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.767 0.794 . . . . 1.93 109.275 171.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.7 mt -53.78 -35.76 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.979 -1.01 . . . . 0.82 111.954 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 84.7 t80 -56.12 -44.66 79.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 1.08 111.251 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.53 -35.71 68.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.34 -0.391 . . . . 0.96 111.525 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 5.3 mmt180 -75.62 -42.48 51.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.239 -0.437 . . . . 1.69 111.776 -170.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 p -117.37 -28.05 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.538 -0.465 . . . . 1.49 111.875 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 124.21 -151.46 17.17 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.851 -0.899 . . . . 1.4 110.851 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -92.39 122.92 35.31 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.263 -0.575 . . . . 4.11 109.972 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.0 m 65.27 -142.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.779 . . . . 1.97 110.39 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 59.2 p 58.13 -174.22 0.09 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.711 0.804 . . . . 0.85 111.865 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.3 131.57 53.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.385 . . . . 0.57 111.816 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 18.2 t60 -107.09 142.82 36.15 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 108.651 -0.87 . . . . 0.55 108.651 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.796 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 5.4 p-10 -129.54 123.87 32.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.524 0.678 . . . . 1.64 110.779 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -104.57 110.91 23.39 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.922 -1.035 . . . . 1.12 109.148 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.76 111.52 25.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.865 -0.607 . . . . 0.74 110.208 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.9 mt -118.81 95.71 49.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.242 -0.435 . . . . 1.25 110.751 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.443 ' HB3' HG22 ' A' ' 84' ' ' VAL . 5.9 Cg_exo -81.23 128.85 6.51 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.068 2.512 . . . . 0.29 112.202 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.705 ' HB ' HD21 ' A' ' 140' ' ' LEU . 3.5 pt -110.5 162.1 8.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.756 -0.831 . . . . 0.27 108.756 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.5 t -127.48 106.57 9.28 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.488 -0.324 . . . . 1.24 110.164 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.779 HG12 ' HG ' ' A' ' 140' ' ' LEU . 21.8 mt -101.05 124.04 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.236 -0.654 . . . . 0.34 109.236 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -148.16 125.12 11.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.824 -0.626 . . . . 1.95 109.395 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.2 OUTLIER 63.9 28.91 14.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.664 -0.698 . . . . 3.13 111.558 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.04 14.33 80.79 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.958 -0.639 . . . . 0.41 112.374 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.569 ' HG2' HG22 ' A' ' 148' ' ' THR . 55.0 mtpt -116.66 147.8 41.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.61 -0.515 . . . . 2.23 109.61 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.779 ' HG ' HG12 ' A' ' 135' ' ' ILE . 3.1 tt -118.06 127.46 53.82 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.07 -0.345 . . . . 0.41 110.07 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 15.0 m -114.6 125.29 53.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.053 -0.521 . . . . 1.19 110.203 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.42 HG23 HD22 ' A' ' 140' ' ' LEU . 85.6 t -118.62 98.5 6.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.672 0.272 . . . . 0.92 110.715 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 56.7 26.56 11.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.823 -0.626 . . . . 1.88 112.145 173.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.86 -39.6 1.8 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.767 -0.651 . . . . 1.02 112.343 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 141' ' ' SER . 39.9 mt-10 -68.78 114.17 6.88 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.075 -0.342 . . . . 1.95 110.075 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.2 p -108.53 115.9 50.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.307 0.575 . . . . 0.92 110.747 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 m -135.85 176.51 8.61 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.869 -0.789 . . . . 1.27 108.869 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.569 HG22 ' HG2' ' A' ' 139' ' ' LYS . 37.1 p -91.23 138.51 31.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.912 -0.403 . . . . 1.45 109.912 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.844 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 92.5 t80 -79.92 129.47 34.51 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.846 -0.427 . . . . 0.47 109.846 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.6 t -121.07 96.05 4.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.649 0.738 . . . . 1.79 112.062 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.93 -66.76 2.11 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.34 -0.845 . . . . 0.42 114.23 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.73 ' HG3' ' HB3' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -148.58 160.26 43.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.291 0.567 . . . . 1.23 111.014 -173.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.577 ' HG ' HD22 ' A' ' 107' ' ' ASN . 5.7 tt -90.76 117.94 29.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.402 -0.962 . . . . 1.17 108.402 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.535 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 3.6 t -107.37 111.69 24.15 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.91 -0.716 . . . . 1.35 110.559 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 22.7 t -98.94 98.6 7.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.13 -0.486 . . . . 0.42 110.134 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.541 ' HB2' ' HE ' ' A' ' 105' ' ' ARG . 12.8 mm-40 -105.22 146.89 28.66 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.705 -0.48 . . . . 1.98 109.705 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.519 ' HE2' ' CE2' ' A' ' 71' ' ' PHE . 2.9 p90 -127.81 134.09 49.44 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.134 0.492 . . . . 2.32 110.348 171.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 14.2 t -115.47 144.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.272 -0.876 . . . . 0.62 110.868 -170.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.6 pttp . . . . . 0 N--CA 1.447 -0.575 0 CA-C-N 115.915 -0.584 . . . . 2.26 111.473 -179.033 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.728 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 46.1 t . . . . . 0 C--O 1.239 0.501 0 N-CA-C 109.895 -0.409 . . . . 1.19 109.895 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 17.8 t -136.44 83.34 2.0 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.125 -0.63 . . . . 1.36 112.432 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.749 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -76.61 37.34 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.645 1.178 . . . . 0.31 112.715 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.741 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 6.8 tp -58.1 110.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.351 0.596 . . . . 0.69 111.834 -173.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.631 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -114.51 134.16 55.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.835 -0.621 . . . . 0.48 109.423 174.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.569 ' CG2' ' HB3' ' A' ' 12' ' ' TRP . 3.7 tt -124.58 127.01 72.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-O 122.268 1.032 . . . . 0.3 111.897 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.545 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 10.7 ptm -114.08 171.53 7.55 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.385 -1.28 . . . . 0.99 109.31 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 19.2 ptmt -118.35 146.05 44.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.914 0.864 . . . . 1.22 112.665 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 176' ' ' THR . . . 103.04 -30.0 11.31 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 113.913 -1.494 . . . . 0.31 114.747 162.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.4 OUTLIER -173.9 153.05 2.07 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.01 0.905 . . . . 0.68 112.744 -176.731 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.642 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -86.96 -14.24 42.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.013 -0.994 . . . . 0.86 110.2 169.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.37 -0.832 . . . . 2.16 111.415 -173.572 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.898 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 27.2 tp . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 121.0 0.428 . . . . 0.72 110.928 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 25' ' ' HIS . . . -62.45 -22.99 66.64 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.723 -0.671 . . . . 0.53 111.544 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.33 -40.95 17.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.096 -0.502 . . . . 2.18 110.952 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 173' ' ' MET . 66.9 mmtt -97.12 -4.62 38.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.414 0.524 . . . . 1.79 112.414 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 11.8 p -60.99 134.87 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.141 -0.624 . . . . 0.33 110.422 171.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.508 HD13 ' HE2' ' A' ' 83' ' ' TYR . 42.4 pt -113.86 -22.77 4.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.235 -0.439 . . . . 0.92 110.447 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.765 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 75.0 t90 -164.42 147.5 9.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.36 110.327 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -159.53 141.31 13.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.221 -0.289 . . . . 0.26 110.221 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.925 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 24.8 t -144.22 115.97 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.703 0.763 . . . . 0.79 112.584 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 1.9 t-20 -88.24 88.03 7.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.369 -1.345 . . . . 1.49 107.369 164.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.606 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -60.87 103.07 0.23 Allowed 'General case' 0 C--O 1.25 1.089 0 CA-C-N 115.768 -0.651 . . . . 0.48 109.982 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.427 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 160.44 -48.0 0.39 Allowed Glycine 0 N--CA 1.44 -1.064 0 O-C-N 125.127 1.517 . . . . 0.76 113.083 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.09 -131.32 6.47 Favored Glycine 0 C--O 1.229 -0.199 0 C-N-CA 120.74 -0.743 . . . . 0.74 113.627 -173.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 47.0 mt-10 -150.31 119.87 6.97 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 119.218 -0.42 . . . . 1.77 110.625 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 72.1 m 33.18 108.29 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 115.484 1.661 . . . . 1.29 115.484 170.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.543 ' ND1' ' HB2' ' A' ' 60' ' ' LEU . 27.6 t-80 -147.87 131.19 16.56 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.733 -0.604 . . . . 0.42 110.861 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 1.1 p -96.79 124.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.235 -0.654 . . . . 1.01 109.235 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.41 ' OD1' ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -77.77 163.82 25.78 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.737 -0.665 . . . . 0.77 109.66 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 m -55.24 -29.59 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 113.14 0.792 . . . . 0.62 113.14 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 19.4 m170 -70.02 -18.31 63.3 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.346 -0.613 . . . . 0.86 109.346 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 101.71 31.66 5.38 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.104 -0.953 . . . . 0.33 111.235 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.643 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.9 mm -102.63 110.97 30.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 0.31 110.861 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 3.3 t60 -97.44 111.7 23.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.21 -0.45 . . . . 0.8 111.23 -172.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.925 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -76.85 131.15 38.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.94 -0.573 . . . . 1.75 110.577 175.102 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.685 ' HD3' ' HG3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -88.36 107.05 18.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.805 -0.634 . . . . 2.94 110.693 177.475 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 33.4 ttmt -18.62 126.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 125.034 1.459 . . . . 2.78 113.094 174.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 16' ' ' ALA . 2.5 m-20 -35.77 101.26 0.21 Allowed Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 123.197 1.475 . . . . 2.41 114.046 -169.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.685 ' HG3' ' HD3' ' A' ' 30' ' ' ARG . 40.2 Cg_endo . . . . . 0 N--CA 1.449 -1.12 0 C-N-CA 125.174 3.916 . . . . 1.87 115.071 -166.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.714 HG12 ' HE3' ' A' ' 88' ' ' LYS . 1.7 mp . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 122.287 1.041 . . . . 1.59 109.91 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HB2' HG22 ' A' ' 125' ' ' THR . 87.9 mt -76.42 -2.3 31.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.18 -1.373 . . . . 1.91 113.171 -171.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.892 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 14.1 mmm180 -109.36 18.3 20.58 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.085 -0.646 . . . . 3.17 111.009 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB2' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -128.54 170.35 13.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.366 -0.379 . . . . 0.97 110.162 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.482 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -93.04 139.46 23.11 Favored Pre-proline 0 C--O 1.216 -0.708 0 N-CA-C 109.01 -0.737 . . . . 1.92 109.01 178.211 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 40.0 Cg_exo -38.63 -42.29 1.79 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 124.071 3.181 . . . . 0.7 116.617 -163.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.509 ' HG3' ' H ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -76.05 -46.41 29.38 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.51 -0.744 . . . . 2.71 110.516 -177.126 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 3.5 p30 -79.75 -17.43 53.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.177 -0.465 . . . . 1.63 110.119 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -57.89 -43.7 86.24 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 108.944 -0.762 . . . . 1.58 108.944 167.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.41 -45.76 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.788 -0.449 . . . . 1.27 109.788 172.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.543 ' HB2' ' ND1' ' A' ' 21' ' ' HIS . 24.3 tp -63.06 -15.24 55.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.458 -0.792 . . . . 1.18 111.489 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.54 ' CD2' ' HG3' ' A' ' 88' ' ' LYS . 4.2 m-30 -114.31 0.81 14.26 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.23 -0.441 . . . . 0.99 111.403 -177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.539 ' HA ' HD13 ' A' ' 50' ' ' ILE . 49.8 tt0 -122.07 -43.27 2.34 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.792 0.664 . . . . 1.97 112.792 -169.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.5 m -59.97 131.13 49.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.117 -0.492 . . . . 1.27 111.413 -175.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.851 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.9 pm0 -116.98 158.94 23.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.581 0.585 . . . . 1.96 112.581 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 3.2 ptm180 . . . . . 0 C--O 1.234 0.243 0 CA-C-N 115.616 -0.72 . . . . 3.35 110.182 172.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 32.1 t . . . . . 0 C--O 1.236 0.355 0 CA-C-O 120.98 0.419 . . . . 1.41 110.747 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -103.59 121.91 43.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.165 -0.614 . . . . 1.57 109.973 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 155' ' ' VAL . . . -108.17 174.47 19.03 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 114.934 -1.03 . . . . 0.78 113.808 -170.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.504 ' HB3' ' CZ2' ' A' ' 12' ' ' TRP . 52.4 m-85 -132.19 141.89 49.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.124 -0.538 . . . . 1.21 109.583 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 4.7 p-10 -106.0 114.42 28.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.192 0.52 . . . . 2.47 111.211 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.857 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.9 mp -106.91 91.34 6.19 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.662 -0.699 . . . . 0.38 109.347 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.701 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 32.1 Cg_exo -59.67 117.5 4.25 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 121.987 1.792 . . . . 0.59 111.892 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.795 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 60.6 mt -120.57 138.09 52.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.828 0.347 . . . . 0.49 111.02 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -136.82 7.3 2.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.132 -0.485 . . . . 3.32 110.709 173.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.447 ' HB2' ' HE3' ' A' ' 174' ' ' LYS . 6.6 mm-40 -121.87 -177.31 3.54 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.076 -0.342 . . . . 2.16 110.076 -173.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 5.0 mt-10 -128.05 -179.22 4.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.277 -0.419 . . . . 1.2 110.525 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.55 -172.65 15.44 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.637 -0.985 . . . . 0.3 110.637 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.25 108.78 20.2 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.099 -0.64 . . . . 1.96 109.463 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.706 ' HB2' HG12 ' A' ' 133' ' ' ILE . 61.8 m-85 -92.58 125.52 37.25 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.482 -0.933 . . . . 0.71 108.482 -177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.592 HG21 ' CA ' ' A' ' 177' ' ' ALA . 72.4 t -114.74 105.75 19.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.314 -0.857 . . . . 0.26 110.257 -173.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 170' ' ' LEU . 5.4 mp -89.21 104.4 16.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.495 -1.23 . . . . 1.56 108.82 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG23 HG12 ' A' ' 84' ' ' VAL . 80.4 t -103.47 102.17 13.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.068 -1.086 . . . . 1.14 108.068 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.703 ' CD2' ' HB3' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -103.95 132.98 49.67 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.033 -0.667 . . . . 1.44 110.216 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.714 ' HE3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -87.92 121.64 30.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.388 -0.968 . . . . 3.73 108.388 173.208 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 6.2 m-85 -107.05 141.25 38.57 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.119 0.485 . . . . 0.45 111.451 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.906 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.832 0 CA-C-N 115.159 -0.928 . . . . 0.51 109.097 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.649 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 16.8 m . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 121.593 0.711 . . . . 1.22 110.611 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 73.2 m-85 -104.48 158.7 16.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.042 -0.981 . . . . 0.99 110.922 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.676 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 16.2 m-20 -108.88 137.64 46.49 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.718 -0.475 . . . . 1.53 109.718 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 110' ' ' THR . 0.3 OUTLIER -140.01 125.1 20.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.335 0.588 . . . . 0.63 110.945 -177.386 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.782 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 41.5 mtt180 -108.13 138.34 44.57 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.18 -0.918 . . . . 1.95 111.172 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.831 HG13 HD21 ' A' ' 153' ' ' LEU . 74.2 t -113.35 103.03 14.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.281 -0.637 . . . . 1.44 109.281 170.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.48 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.2 OUTLIER 64.18 39.26 7.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.202 -0.908 . . . . 1.65 108.949 -175.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.8 -22.37 34.19 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.3 -0.864 . . . . 0.42 112.452 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 83.6 m-70 -83.64 101.15 11.3 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.556 0.342 . . . . 0.68 111.857 -173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.686 HG23 ' HG2' ' A' ' 105' ' ' ARG . 3.3 p -62.88 93.05 0.05 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.331 0.586 . . . . 0.77 111.245 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.532 HG11 HG23 ' A' ' 131' ' ' ILE . 11.9 t -73.05 -47.59 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.559 -0.746 . . . . 0.94 109.742 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.702 HG11 ' HG ' ' A' ' 115' ' ' LEU . 11.7 t -117.62 90.19 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 109.245 -0.65 . . . . 0.35 109.245 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.36 71.67 0.76 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.901 0.858 . . . . 4.01 108.935 178.399 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.649 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.5 p30 164.18 24.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.686 -1.597 . . . . 1.96 108.601 -169.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.702 ' HG ' HG11 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -71.34 90.89 0.96 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.427 -0.806 . . . . 1.18 111.563 -170.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 14.0 p30 -104.88 94.57 5.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.676 0.75 . . . . 1.93 110.067 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 89' ' ' PHE . 83.2 mt -61.7 -37.11 77.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.125 -0.943 . . . . 0.82 111.653 -170.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -59.4 -38.56 80.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.08 110.873 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.73 -32.1 67.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.929 0.395 . . . . 0.96 110.969 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 12.0 mmt85 -76.36 -49.24 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.899 -0.591 . . . . 1.69 111.765 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 127' ' ' HIS . 60.0 t -107.52 -36.09 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.104 0.409 . . . . 1.49 112.104 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.08 -111.55 2.11 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.401 -0.904 . . . . 1.4 111.867 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -112.02 112.55 24.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.979 0.418 . . . . 4.11 111.198 -176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 125' ' ' THR . 33.0 p 53.03 -149.81 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.394 1.078 . . . . 1.97 112.277 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.892 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 29.1 p 64.85 -160.42 0.28 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.996 0.918 . . . . 0.85 110.932 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 50' ' ' ILE . . . -94.88 122.27 37.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.469 0.544 . . . . 0.57 112.469 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.673 ' HA ' HG21 ' A' ' 121' ' ' VAL . 13.6 t60 -92.44 130.65 38.05 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.466 -0.568 . . . . 0.55 109.466 167.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.81 121.67 42.21 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.16 -0.927 . . . . 1.64 109.572 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.703 ' HB3' ' CD2' ' A' ' 87' ' ' LEU . 4.5 tp10 -123.92 108.29 12.27 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.409 -0.96 . . . . 1.12 108.409 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.458 HG12 HG22 ' A' ' 86' ' ' VAL . 80.1 mt -94.1 118.21 39.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.889 -0.596 . . . . 0.74 110.166 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.532 HG23 HG11 ' A' ' 111' ' ' VAL . 68.2 mt -117.94 93.67 44.75 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.534 -0.303 . . . . 1.25 110.864 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.89 124.39 3.43 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.877 2.385 . . . . 0.29 112.797 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.706 HG12 ' HB2' ' A' ' 83' ' ' TYR . 3.5 pt -109.51 166.29 4.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.575 -1.269 . . . . 0.27 107.575 173.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.6 t -131.78 106.62 8.23 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.904 -0.406 . . . . 1.24 109.904 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 49.7 mt -99.27 122.99 51.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.291 -0.633 . . . . 0.34 109.291 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -150.78 136.62 18.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.86 -0.793 . . . . 1.95 108.86 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm 66.95 17.95 10.56 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.196 0.522 . . . . 3.13 110.544 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.15 12.08 77.18 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.815 -0.629 . . . . 0.41 112.383 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 94.5 mttt -112.72 140.15 47.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.97 0.385 . . . . 2.23 110.601 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.459 ' HG ' HD12 ' A' ' 133' ' ' ILE . 6.9 tt -103.27 115.67 31.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.518 -0.549 . . . . 0.41 109.518 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.0 m -110.87 107.15 16.53 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.599 -0.519 . . . . 1.19 109.599 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.436 HG21 HG22 ' A' ' 111' ' ' VAL . 4.0 p -90.72 106.99 18.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.369 -0.604 . . . . 0.92 109.369 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 63.69 -81.07 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.555 -0.748 . . . . 1.88 110.841 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.76 -0.56 3.55 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.851 -0.69 . . . . 1.02 112.046 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -95.66 113.96 25.65 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.522 -0.547 . . . . 1.95 109.522 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.31 132.47 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.13 0.49 . . . . 0.92 111.8 -171.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t -160.3 133.65 6.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.673 -0.694 . . . . 1.27 109.181 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.713 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 9.1 t -55.38 139.41 43.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.286 0.565 . . . . 1.45 111.081 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.795 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 25.9 t80 -80.0 133.87 36.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.34 -0.845 . . . . 0.47 110.536 -175.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 p -127.61 96.46 4.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.091 0.472 . . . . 1.79 112.229 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.17 -69.52 3.15 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.42 113.96 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.701 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -159.23 164.02 35.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.176 0.488 . . . . 1.23 110.552 -176.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.857 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 6.1 tt -81.81 142.84 32.22 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.131 -1.063 . . . . 1.17 108.131 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.585 ' N ' HD23 ' A' ' 153' ' ' LEU . 9.9 t -135.83 107.6 7.04 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.313 -0.555 . . . . 1.35 110.648 -172.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 59.4 t -97.08 99.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.389 -0.369 . . . . 0.42 111.141 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.16 123.76 42.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.725 -0.39 . . . . 1.98 110.457 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.454 ' HD2' HG23 ' A' ' 104' ' ' VAL . 49.0 t80 -102.65 118.03 35.95 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.461 -0.94 . . . . 2.32 108.461 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 21.9 t -103.67 144.25 14.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.558 -0.746 . . . . 0.62 110.422 -173.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.3 pttt . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 121.147 0.499 . . . . 2.26 112.205 -174.208 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.906 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 39.6 t . . . . . 0 C--O 1.241 0.616 0 CA-C-O 120.426 0.155 . . . . 1.19 111.066 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.7 t -132.15 141.16 49.02 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 120.228 -0.589 . . . . 1.36 110.974 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.693 ' HB3' ' CB ' ' A' ' 88' ' ' LYS . . . -131.35 35.06 3.91 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.428 -0.805 . . . . 0.31 109.311 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.765 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 14.4 tp -58.29 102.65 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.635 -1.166 . . . . 0.69 112.427 -175.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.898 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -111.21 132.63 54.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.698 -0.683 . . . . 0.48 109.659 176.269 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.713 HG22 ' HE3' ' A' ' 12' ' ' TRP . 5.3 tt -117.9 123.6 71.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.885 0.85 . . . . 0.3 111.577 176.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.68 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 2.5 ppp? -115.52 163.36 15.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.295 -1.002 . . . . 0.99 108.295 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 79' ' ' GLU . 11.6 ptmm? -119.3 147.91 43.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 122.629 1.204 . . . . 1.22 113.362 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 176' ' ' THR . . . 106.18 -29.64 10.83 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 112.863 -1.971 . . . . 0.31 114.84 167.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.6 OUTLIER -175.38 154.93 1.76 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.525 1.163 . . . . 0.68 112.478 -177.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.592 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -84.39 -17.85 38.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.886 -0.597 . . . . 0.86 110.465 169.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.766 -0.652 . . . . 2.16 111.302 -177.947 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 27' ' ' ILE . 24.7 tp . . . . . 0 C--O 1.235 0.318 0 CA-C-O 121.311 0.576 . . . . 0.72 110.589 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.528 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -60.92 -22.91 64.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.4 -0.818 . . . . 0.53 112.215 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.18 -21.6 59.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.536 -0.302 . . . . 2.18 110.63 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 59.8 mmtt -114.14 -16.59 12.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.649 -0.42 . . . . 1.79 111.799 -177.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.569 ' HB ' HD12 ' A' ' 27' ' ' ILE . 14.8 p -56.57 136.1 19.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.48 0.657 . . . . 0.33 111.729 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 174' ' ' LYS . 5.4 pt -115.27 -28.45 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.614 -0.721 . . . . 0.92 110.64 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.702 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 67.1 t90 -169.17 140.29 2.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.232 -0.44 . . . . 0.36 110.177 -170.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -162.42 147.21 12.27 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.317 -0.24 . . . . 0.26 111.224 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.69 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 2.2 p -151.16 125.6 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 113.197 0.814 . . . . 0.79 113.197 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.469 ' CB ' HD12 ' A' ' 60' ' ' LEU . 1.7 t-20 -94.05 95.79 9.25 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 114.956 -1.02 . . . . 1.49 108.65 170.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.687 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -58.54 103.21 0.14 Allowed 'General case' 0 C--O 1.246 0.907 0 CA-C-N 116.116 -0.493 . . . . 0.48 109.723 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.809 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 174.2 -42.26 0.14 Allowed Glycine 0 N--CA 1.438 -1.191 0 O-C-N 124.882 1.364 . . . . 0.76 113.98 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.24 -121.09 1.79 Allowed Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.001 -1.095 . . . . 0.74 113.072 -167.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . 46.1 mt-10 -148.59 119.52 7.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.847 0.323 . . . . 1.77 111.237 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 55.7 m 32.83 105.19 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.0 1.482 . . . . 1.29 115.0 170.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.539 ' ND1' ' HB2' ' A' ' 60' ' ' LEU . 28.5 t-80 -133.68 122.49 23.48 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.686 -0.634 . . . . 0.42 111.244 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.38 116.1 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.815 -0.63 . . . . 1.01 109.712 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -83.57 162.75 20.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.002 -0.544 . . . . 0.77 110.715 -177.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.74 -24.95 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 113.001 0.741 . . . . 0.62 113.001 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.451 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 28.1 m80 -80.52 1.17 30.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.426 -0.583 . . . . 0.86 109.426 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 82.84 28.5 37.95 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.061 -0.972 . . . . 0.33 111.508 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.646 HD11 ' HG ' ' A' ' 6' ' ' LEU . 11.8 mm -102.47 111.59 32.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.139 0.495 . . . . 0.31 111.015 -175.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -88.1 113.86 24.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.84 -0.618 . . . . 0.8 111.427 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.69 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -80.46 129.37 34.47 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.148 -0.478 . . . . 1.75 109.849 170.083 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.747 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 2.1 ptm180 -85.96 114.69 23.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 2.94 110.391 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 19' ' ' GLU . 37.0 ttmt -27.22 126.7 0.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.185 0.994 . . . . 2.78 112.032 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.683 ' OD2' ' HD3' ' A' ' 65' ' ' ARG . 1.4 m-20 -32.64 98.72 0.13 Allowed Pre-proline 0 N--CA 1.465 0.283 0 O-C-N 125.115 1.51 . . . . 2.41 114.342 -168.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.747 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 69.6 Cg_endo . . . . . 0 N--CA 1.446 -1.268 1 C-N-CA 125.454 4.103 . . . . 1.87 114.152 -169.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.695 HG12 ' HE3' ' A' ' 88' ' ' LYS . 1.7 mp . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.999 0.904 . . . . 1.59 109.947 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HB2' HG22 ' A' ' 125' ' ' THR . 85.7 mt -65.12 -18.2 65.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.336 -1.302 . . . . 1.91 112.977 -172.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -96.35 4.2 52.41 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.726 -0.39 . . . . 3.17 111.181 -173.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.516 ' HB2' HG22 ' A' ' 50' ' ' ILE . 3.2 m -125.28 145.25 50.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.903 -0.59 . . . . 0.97 111.156 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.465 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 3.0 p30 -79.85 151.99 74.2 Favored Pre-proline 0 C--O 1.214 -0.776 0 N-CA-C 109.609 -0.515 . . . . 1.92 109.609 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 54' ' ' ASN . 3.5 Cg_exo -38.76 -46.67 2.66 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 124.307 3.338 . . . . 0.7 115.419 -164.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -69.94 -53.54 17.37 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 122.064 0.935 . . . . 2.71 110.483 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -22.21 55.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.437 -0.801 . . . . 1.63 109.711 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 39.9 tt0 -55.78 -45.15 78.22 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.688 -0.687 . . . . 1.58 109.651 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.3 t -57.29 -46.08 85.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.784 -0.45 . . . . 1.27 109.784 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.539 ' HB2' ' ND1' ' A' ' 21' ' ' HIS . 30.6 tp -60.14 -19.4 53.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.454 0.645 . . . . 1.18 111.138 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.507 ' HE1' HD23 ' A' ' 60' ' ' LEU . 2.9 m-30 -115.83 6.68 14.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.938 -0.573 . . . . 0.99 111.189 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.643 ' HA ' HD13 ' A' ' 50' ' ' ILE . 35.4 tt0 -122.02 -35.63 3.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.106 0.479 . . . . 1.97 111.821 -172.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 167' ' ' VAL . 1.0 OUTLIER -70.35 136.86 50.08 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.721 -0.672 . . . . 1.27 110.911 -176.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.809 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -120.76 149.46 42.5 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.089 0.556 . . . . 1.96 109.864 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.683 ' HD3' ' OD2' ' A' ' 32' ' ' ASP . 13.7 ttp-105 . . . . . 0 C--O 1.237 0.447 0 N-CA-C 112.524 0.564 . . . . 3.35 112.524 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.946 0.403 . . . . 1.41 111.107 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.486 ' HD2' HH22 ' A' ' 65' ' ' ARG . 0.1 OUTLIER -138.99 137.42 36.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 1.57 110.756 -175.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.762 ' HA3' ' HB3' ' A' ' 156' ' ' GLU . . . -151.43 -176.27 24.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.172 -1.013 . . . . 0.78 113.656 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.687 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 48.6 m-85 -128.62 169.41 14.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.014 -0.593 . . . . 1.21 111.777 -170.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -115.31 119.75 37.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.247 -0.888 . . . . 2.47 110.594 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.812 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.1 mp -107.34 90.31 5.66 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.977 -0.749 . . . . 0.38 108.977 171.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.62 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 43.6 Cg_endo -71.76 116.94 4.9 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.83 1.687 . . . . 0.59 111.631 -176.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.821 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 82.7 mt -116.4 141.45 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.853 -0.612 . . . . 0.49 110.872 -171.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 71.5 mmtt -139.31 20.95 2.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.746 0.308 . . . . 3.32 110.922 174.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.66 -175.93 4.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.227 0.537 . . . . 2.16 110.769 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 3.3 mt-10 -121.43 -172.62 2.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.266 -0.879 . . . . 1.2 109.771 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.56 -164.57 13.97 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.076 -0.81 . . . . 0.3 111.076 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 36.5 mt-10 -106.19 104.43 14.13 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.186 -0.606 . . . . 1.96 109.643 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.664 ' HB2' HG12 ' A' ' 133' ' ' ILE . 20.7 m-30 -94.06 122.73 36.88 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.411 -0.959 . . . . 0.71 108.411 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.674 HG21 ' CA ' ' A' ' 177' ' ' ALA . 88.0 t -107.18 106.5 20.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.866 0.841 . . . . 0.26 110.45 -172.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 170' ' ' LEU . 12.7 tp -89.66 103.94 16.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.362 -1.29 . . . . 1.56 109.88 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 43.7 t -108.24 111.37 35.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.357 -0.979 . . . . 1.14 108.357 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -114.23 134.96 54.57 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.093 -0.643 . . . . 1.44 110.423 178.186 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.816 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -93.57 122.91 36.5 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.073 -0.651 . . . . 3.73 109.903 177.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.656 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 8.8 m-85 -108.42 140.48 41.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.138 -0.483 . . . . 0.45 111.34 175.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.816 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 115.695 -0.684 . . . . 0.51 110.213 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 1.021 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 25.7 m . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.078 0.466 . . . . 1.22 111.011 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -128.06 164.41 22.47 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.993 -0.549 . . . . 0.99 112.017 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.733 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 1.8 m-20 -107.35 137.79 44.74 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.572 -0.529 . . . . 1.53 109.572 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.789 HG23 ' HD1' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -132.12 124.26 52.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 109.183 -0.673 . . . . 0.63 109.183 178.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.438 ' HE ' ' CG ' ' A' ' 156' ' ' GLU . 37.6 ptt180 -136.11 139.91 43.31 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.839 0.681 . . . . 1.95 112.839 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.909 ' HB ' HD11 ' A' ' 153' ' ' LEU . 16.1 m -109.47 114.28 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.093 -0.958 . . . . 1.44 111.195 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.704 ' HB2' HD12 ' A' ' 153' ' ' LEU . 65.7 t30 55.91 36.54 27.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.266 1.031 . . . . 1.65 108.875 -174.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.21 -17.63 58.93 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.393 -1.276 . . . . 0.42 112.803 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.503 ' ND1' ' HB3' ' A' ' 145' ' ' GLU . 90.4 m-70 -85.73 101.77 13.06 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.255 0.465 . . . . 0.68 112.255 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 20.1 p -63.44 113.15 3.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.192 0.52 . . . . 0.77 110.784 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 131' ' ' ILE . 17.5 t -91.92 -41.11 12.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.662 -0.699 . . . . 0.94 109.234 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.647 HG21 ' HG2' ' A' ' 129' ' ' GLU . 4.8 t -130.36 91.5 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.65 -0.704 . . . . 0.35 109.966 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -100.81 146.37 27.37 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.769 -1.197 . . . . 4.01 107.769 169.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 1.021 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 68.9 m-20 77.36 38.42 0.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.564 1.165 . . . . 1.96 108.823 -167.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.501 HD11 ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -69.58 86.69 0.46 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.032 -0.985 . . . . 1.18 110.031 175.67 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 11.6 t70 -102.23 106.02 16.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.522 -0.918 . . . . 1.93 108.522 172.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.97 -33.45 58.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.82 111.636 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -68.64 -37.98 80.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.992 0.425 . . . . 1.08 110.086 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.56 -28.66 67.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.068 0.461 . . . . 0.96 111.182 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 14.7 mmt180 -81.32 -45.52 16.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.359 0.503 . . . . 1.69 112.359 -173.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.655 HG11 ' HA ' ' A' ' 127' ' ' HIS . 15.6 m -128.34 0.34 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.207 0.817 . . . . 1.49 113.207 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.84 -97.54 1.86 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.136 -1.03 . . . . 1.4 112.648 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -113.17 108.78 17.76 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.558 -0.378 . . . . 4.11 111.553 -175.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.4 m 44.41 -122.4 0.88 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.412 1.07 . . . . 1.97 112.754 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 51' ' ' LEU . 70.0 p 51.12 -158.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.413 0.685 . . . . 0.85 111.124 -175.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.803 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . . . -99.12 110.08 22.7 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.484 -0.487 . . . . 0.57 111.63 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.655 ' HA ' HG11 ' A' ' 121' ' ' VAL . 12.9 t60 -83.35 126.18 32.44 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.106 -1.072 . . . . 0.55 108.106 167.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -123.56 108.19 12.36 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.486 0.66 . . . . 1.64 110.403 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.647 ' HG2' HG21 ' A' ' 112' ' ' VAL . 2.2 tp10 -102.03 108.95 20.54 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.962 -0.755 . . . . 1.12 108.962 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.409 HG23 HG22 ' A' ' 86' ' ' VAL . 64.9 mt -96.54 115.61 36.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.799 -0.637 . . . . 0.74 109.615 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.448 HG21 HG21 ' A' ' 111' ' ' VAL . 59.5 mt -122.43 93.16 48.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.251 -0.431 . . . . 1.25 110.777 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -74.46 123.01 7.84 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.662 2.241 . . . . 0.29 112.019 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.1 pt -109.86 146.57 15.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.61 -0.885 . . . . 0.27 108.61 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.3 p -115.9 106.98 14.42 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.899 0.381 . . . . 1.24 110.106 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.572 HG12 ' HG ' ' A' ' 140' ' ' LEU . 25.6 mt -98.74 120.69 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 107.761 -1.2 . . . . 0.34 107.761 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -144.33 122.63 12.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.118 0.485 . . . . 1.95 110.317 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 18.1 mmmt 57.24 35.24 25.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.79 -1.095 . . . . 3.13 111.5 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.37 7.15 69.96 Favored Glycine 0 C--O 1.227 -0.318 0 CA-C-N 115.597 -0.729 . . . . 0.41 113.18 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 99.6 mttt -109.22 145.6 35.58 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 122.649 -0.324 . . . . 2.23 110.168 174.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.663 HD12 ' HD1' ' A' ' 149' ' ' PHE . 5.9 tt -114.46 115.12 26.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.878 -0.786 . . . . 0.41 108.878 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.9 m -117.3 136.25 53.25 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.375 -0.375 . . . . 1.19 110.042 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.547 HG21 ' CG2' ' A' ' 106' ' ' VAL . 58.4 t -123.71 92.53 2.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.614 -0.513 . . . . 0.92 109.614 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 56.63 -87.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.105 -0.952 . . . . 1.88 111.632 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.49 -10.88 34.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 1.02 112.507 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.503 ' HB3' ' ND1' ' A' ' 109' ' ' HIS . 64.1 mm-40 -87.86 139.87 30.08 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.974 -0.38 . . . . 1.95 109.974 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.42 130.44 12.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.312 0.577 . . . . 0.92 111.728 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.6 m -159.9 166.86 29.34 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.631 -0.877 . . . . 1.27 108.631 174.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 66.6 p -74.71 147.04 41.78 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.125 -0.694 . . . . 1.45 109.125 173.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.821 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 65.3 t80 -79.07 128.2 32.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.801 0.334 . . . . 0.47 110.114 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 t -132.64 101.8 5.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.63 0.728 . . . . 1.79 111.515 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.96 -74.36 2.43 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.543 -0.753 . . . . 0.42 113.777 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -155.29 169.43 24.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.379 0.609 . . . . 1.23 111.13 -174.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.909 HD11 ' HB ' ' A' ' 106' ' ' VAL . 44.2 tp -90.83 127.52 36.39 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.092 -0.958 . . . . 1.17 109.23 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.732 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 97.0 p -97.01 142.51 28.88 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 119.373 -0.931 . . . . 1.35 109.553 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 106' ' ' VAL . 97.0 t -130.59 97.34 3.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.803 -0.814 . . . . 0.42 108.803 170.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.762 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 1.4 pm0 -126.78 141.85 51.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.188 -0.605 . . . . 1.98 111.279 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.789 ' HD1' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -102.65 122.24 44.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.235 -0.893 . . . . 2.32 108.789 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 26.1 t -84.13 127.65 39.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.35 -0.386 . . . . 0.62 110.282 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.331 -0.234 0 O-C-N 124.74 1.275 . . . . 2.26 111.723 -178.657 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.763 HG22 ' HB3' ' A' ' 64' ' ' GLU . 86.9 t . . . . . 0 CA--C 1.506 -0.747 0 N-CA-C 109.851 -0.426 . . . . 1.19 109.851 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -130.98 133.29 45.66 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 119.695 -0.802 . . . . 1.36 110.745 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -129.62 37.89 3.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.965 -0.561 . . . . 0.31 110.828 -175.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 85' ' ' LEU . 10.8 tp -41.92 126.96 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.615 -1.175 . . . . 0.69 112.018 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.69 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 7.5 t80 -144.84 119.22 9.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.79 -0.186 . . . . 0.48 110.577 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.63 HG22 ' HE3' ' A' ' 12' ' ' TRP . 9.3 tt -115.18 123.56 70.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.981 0.896 . . . . 0.3 110.699 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.69 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.0 ppp? -117.54 159.35 23.01 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.218 -0.901 . . . . 0.99 109.613 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 1.9 ptmm? -113.85 142.26 46.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 122.712 1.244 . . . . 1.22 114.218 -168.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.67 -30.25 10.09 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 112.708 -2.042 . . . . 0.31 114.264 162.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -176.99 158.16 1.52 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.002 0.901 . . . . 0.68 112.265 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.674 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -82.96 -9.93 59.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.965 -0.562 . . . . 0.86 110.375 172.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.515 ' H ' ' HB ' ' A' ' 176' ' ' THR . 5.0 m-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.694 -0.685 . . . . 2.16 111.357 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.141 0 CA-C-O 121.07 0.261 . . . . 1.48 112.916 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.583 ' HG ' HD11 ' A' ' 27' ' ' ILE . 25.8 tp -71.19 -29.37 65.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.241 0.543 . . . . 0.72 109.879 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -63.25 -23.02 67.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.204 -0.907 . . . . 0.53 111.686 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.595 ' HB3' ' HE3' ' A' ' 9' ' ' LYS . 22.6 t70 -83.0 -35.27 25.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.91 -0.587 . . . . 2.18 111.404 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.595 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 10.6 mmtp -94.26 -19.33 20.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.893 -0.323 . . . . 1.79 111.593 -171.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.523 ' HB ' HD12 ' A' ' 27' ' ' ILE . 7.2 p -56.01 134.78 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.018 0.437 . . . . 0.33 111.424 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 pt -110.88 -22.56 4.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.209 -0.45 . . . . 0.92 110.581 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.578 ' HE3' HG22 ' A' ' 172' ' ' ILE . 77.1 t90 -170.54 146.07 2.69 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.696 -0.483 . . . . 0.36 109.696 -173.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 30' ' ' ARG . . . -163.01 138.28 6.71 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.32 -0.238 . . . . 0.26 111.003 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.775 HG22 ' HB2' ' A' ' 30' ' ' ARG . 84.4 t -146.84 121.78 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 122.574 0.35 . . . . 0.79 111.568 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 46.5 t30 -102.61 99.58 9.59 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.703 -0.48 . . . . 1.49 109.703 167.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -65.07 105.44 1.06 Allowed 'General case' 0 C--O 1.243 0.747 0 N-CA-C 109.414 -0.587 . . . . 0.48 109.414 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.567 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 158.24 -47.1 0.45 Allowed Glycine 0 N--CA 1.447 -0.601 0 O-C-N 124.248 0.968 . . . . 0.76 113.337 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.07 -132.77 7.76 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.853 -0.689 . . . . 0.74 112.727 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.444 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 16.9 mt-10 -156.87 120.27 4.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 119.679 -0.2 . . . . 1.77 111.237 174.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 4.0 p 35.31 90.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.644 1.215 . . . . 1.29 113.499 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.507 ' HD1' ' HB2' ' A' ' 60' ' ' LEU . 37.7 t-80 -131.16 133.75 45.86 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.574 -0.851 . . . . 0.42 111.687 -174.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.17 116.22 36.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.724 -0.671 . . . . 1.01 110.038 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 0.8 OUTLIER -71.82 155.99 39.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.991 -0.55 . . . . 0.77 109.768 176.217 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.45 -13.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 113.422 0.897 . . . . 0.62 113.422 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -93.57 -0.66 56.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.421 0.629 . . . . 0.86 109.357 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.577 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 93.71 31.13 8.43 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 114.826 -1.079 . . . . 0.33 112.811 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.583 HD11 ' HG ' ' A' ' 6' ' ' LEU . 21.6 mm -103.93 109.3 26.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.14 0.495 . . . . 0.31 110.907 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -92.11 114.03 26.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.8 111.431 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.601 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -78.45 131.18 36.79 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.995 -0.548 . . . . 1.75 110.881 176.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.775 ' HB2' HG22 ' A' ' 14' ' ' VAL . 8.2 mpt_? -69.9 102.5 1.99 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 125.018 1.449 . . . . 2.94 111.565 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.646 ' HG2' ' HA3' ' A' ' 39' ' ' GLY . 14.7 ttmm -38.96 96.33 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.953 1.094 . . . . 2.78 113.953 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.956 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 75.0 m-20 30.22 78.25 0.29 Allowed Pre-proline 0 N--CA 1.476 0.859 0 C-N-CA 124.6 1.16 . . . . 2.41 113.297 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 16.4 Cg_endo -97.42 2.81 1.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.985 2.456 . . . . 1.87 114.347 -170.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.537 HD13 ' CD1' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -119.01 -24.41 6.55 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.208 1.188 . . . . 1.99 114.208 -173.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.94 86.47 4.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.681 0.673 . . . . 5.31 109.928 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' C ' ' HG2' ' A' ' 37' ' ' ARG . . . 73.85 -0.59 50.65 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 109.972 -1.251 . . . . 2.64 109.972 -172.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.405 ' HG2' ' C ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 50.95 39.62 23.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 113.859 -1.171 . . . . 5.64 110.803 -171.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 m -122.51 137.05 57.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.938 -0.574 . . . . 3.96 110.394 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.956 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -99.89 135.4 12.12 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.929 -0.653 . . . . 2.56 113.373 -173.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.9 ' HE ' ' HA ' ' A' ' 40' ' ' ARG . 1.3 mmp_? -149.56 95.42 2.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.01 -0.367 . . . . 6.2 110.01 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.71 107.53 0.4 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.6 -0.727 . . . . 2.0 111.236 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 m -102.96 50.1 0.82 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.264 -0.88 . . . . 2.52 109.559 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.531 ' HA ' HG22 ' A' ' 63' ' ' THR . 0.3 OUTLIER -56.72 -74.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.359 -0.837 . . . . 2.52 110.923 178.092 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.6 t80 68.85 -63.2 0.37 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.288 0.635 . . . . 7.02 112.16 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -102.79 60.48 0.51 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.078 -0.582 . . . . 3.06 112.499 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.455 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 58.8 mtp -71.88 -0.37 11.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.629 0.728 . . . . 2.35 110.704 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -88.05 5.41 41.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.189 -0.914 . . . . 4.25 110.474 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.64 HD13 HG11 ' A' ' 92' ' ' VAL . 93.1 mt -116.51 79.54 9.44 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.696 -0.684 . . . . 2.56 110.102 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -57.76 144.45 93.3 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.935 2.423 . . . . 1.69 112.694 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.56 HG23 ' HB2' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -81.04 -5.05 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.803 0.811 . . . . 1.59 109.407 178.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.423 ' HB3' HG22 ' A' ' 125' ' ' THR . 57.7 tp 69.26 -52.99 0.59 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.282 -1.326 . . . . 1.91 112.594 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -68.64 -21.88 64.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.449 -0.341 . . . . 3.17 111.764 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.436 ' HB3' ' CA ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -113.67 146.49 39.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.993 0.738 . . . . 0.97 112.993 -170.438 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.612 HD21 ' HG2' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -69.16 146.04 96.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 114.485 -1.234 . . . . 1.92 109.312 175.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.554 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 52.9 Cg_exo -38.24 -43.56 1.81 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.162 3.241 . . . . 0.7 116.161 -165.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.612 ' HG2' HD21 ' A' ' 54' ' ' ASN . 10.7 pt-20 -78.56 -50.1 12.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.203 0.525 . . . . 2.71 111.039 -173.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -74.88 -19.86 59.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.165 0.507 . . . . 1.63 109.695 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.436 ' CA ' ' HB3' ' A' ' 53' ' ' SER . 27.8 tt0 -59.69 -43.29 94.11 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.725 -0.67 . . . . 1.58 109.948 168.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 55' ' ' PRO . 91.4 t -54.18 -43.8 61.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.593 -0.521 . . . . 1.27 109.593 173.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.507 ' HB2' ' HD1' ' A' ' 21' ' ' HIS . 26.5 tp -67.53 -14.03 62.58 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.148 -0.933 . . . . 1.18 111.653 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.7 ' CE2' ' HE3' ' A' ' 88' ' ' LYS . 12.0 m-30 -118.39 7.74 12.0 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 111.833 0.309 . . . . 0.99 111.833 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.466 ' HB2' HD13 ' A' ' 50' ' ' ILE . 4.5 tt0 -127.2 -43.01 1.66 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.75 0.648 . . . . 1.97 112.75 -172.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.558 ' O ' HG13 ' A' ' 167' ' ' VAL . 18.7 p -67.37 130.82 44.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.276 0.473 . . . . 1.27 112.276 -174.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.814 ' HB3' HG22 ' A' ' 167' ' ' VAL . 8.7 pt-20 -114.94 156.65 24.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.048 0.452 . . . . 1.96 111.59 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.62 ' HD2' ' CG ' ' A' ' 32' ' ' ASP . 37.8 mtp85 -106.22 -157.54 0.62 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.948 -0.569 . . . . 3.35 111.461 173.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.497 ' H ' ' HB3' ' A' ' 65' ' ' ARG . 5.4 m-85 -96.85 99.19 10.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 4.71 111.384 -169.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.544 HD22 ' HA ' ' A' ' 166' ' ' LYS . 10.5 m120 -68.22 132.64 47.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.339 -0.391 . . . . 4.38 110.468 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.31 -59.93 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.996 -0.547 . . . . 3.7 110.858 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -151.74 -163.69 1.81 Allowed 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.484 -0.562 . . . . 2.2 109.484 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.3 t -63.68 107.7 1.23 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.701 0.286 . . . . 1.41 110.345 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.552 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 11.5 p90 -124.52 140.18 53.19 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.116 -0.698 . . . . 1.57 109.116 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.508 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -136.77 161.81 25.12 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.133 -1.032 . . . . 0.78 114.8 -167.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.537 ' CD1' HD13 ' A' ' 34' ' ' LEU . 60.1 m-85 -100.43 152.85 19.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.854 -0.673 . . . . 1.21 111.847 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.574 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 9.4 t0 -116.24 103.61 10.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.067 -0.97 . . . . 2.47 108.646 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.879 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.7 mp -103.87 89.87 2.6 Favored Pre-proline 0 N--CA 1.464 0.246 0 N-CA-C 110.121 -0.325 . . . . 0.38 110.121 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.644 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 38.6 Cg_exo -57.59 117.53 4.25 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.194 1.929 . . . . 0.59 112.733 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.667 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 67.9 mt -117.12 136.29 54.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.937 -0.574 . . . . 0.49 110.237 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -130.45 10.16 5.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.405 -0.361 . . . . 3.32 110.988 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.584 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 23.3 tt0 -139.09 -176.89 4.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.148 -0.316 . . . . 2.16 110.148 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.646 ' HG3' ' O ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -130.32 157.51 42.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.559 -0.534 . . . . 1.2 109.559 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.08 -162.85 28.84 Favored Glycine 0 C--O 1.234 0.154 0 N-CA-C 110.354 -1.098 . . . . 0.3 110.354 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 27.7 mt-10 -99.68 102.66 14.21 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 118.281 1.04 . . . . 1.96 110.198 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.634 ' HB2' HG12 ' A' ' 133' ' ' ILE . 79.1 m-85 -94.68 124.27 38.62 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.243 -1.021 . . . . 0.71 108.243 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.812 HG21 ' HA ' ' A' ' 177' ' ' ALA . 52.9 t -104.8 105.68 19.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.64 0.734 . . . . 0.26 109.902 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.791 HD12 ' HB ' ' A' ' 172' ' ' ILE . 7.5 tp -89.48 101.41 14.09 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.348 -1.297 . . . . 1.56 108.548 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.57 104.61 17.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.778 0.799 . . . . 1.14 108.848 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.649 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -104.55 134.53 47.57 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.405 -0.816 . . . . 1.44 109.959 -178.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.838 ' HD2' ' HB1' ' A' ' 126' ' ' ALA . 10.9 tppt? -96.05 120.08 35.69 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.941 -0.703 . . . . 3.73 109.4 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.833 ' CE1' ' HB3' ' A' ' 165' ' ' PRO . 13.8 m-85 -106.26 141.81 36.99 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.781 -0.645 . . . . 0.45 110.374 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -136.44 148.38 47.72 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.72 -0.673 . . . . 0.51 109.661 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.608 ' HB2' HD12 ' A' ' 117' ' ' ILE . 38.6 tt0 -148.37 115.98 6.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.856 0.36 . . . . 2.62 110.791 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.64 HG11 HD13 ' A' ' 48' ' ' LEU . 18.6 t -137.33 80.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 3.77 109.651 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.793 ' HB2' ' HE2' ' A' ' 166' ' ' LYS . 18.4 t80 -150.37 -69.52 0.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.794 -0.362 . . . . 5.68 111.507 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.403 ' HB3' ' HE3' ' A' ' 100' ' ' LYS . 43.8 t80 -116.41 111.27 19.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 4.65 110.25 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.96 91.11 1.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.914 -0.584 . . . . 1.39 111.656 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -156.25 140.44 16.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.061 -0.518 . . . . 2.75 110.217 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.697 ' HB3' ' HB2' ' A' ' 119' ' ' ASP . 15.0 m -114.32 152.25 31.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.258 -0.428 . . . . 1.4 110.402 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 53.03 32.84 13.58 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.541 0.526 . . . . 2.38 112.258 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -138.08 -50.52 0.58 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.941 -0.762 . . . . 2.89 108.941 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 161' ' ' TYR . 7.0 mtpm? -79.38 75.36 5.97 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.691 -0.855 . . . . 2.79 108.691 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.56 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.3 m -106.6 110.2 30.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 122.134 0.969 . . . . 1.22 110.316 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.829 ' HB3' ' HD3' ' A' ' 165' ' ' PRO . 11.8 m-85 -87.74 164.12 16.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.173 -1.376 . . . . 0.99 111.682 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.65 137.8 41.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.566 -0.902 . . . . 1.53 108.566 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.652 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 2.5 t -131.91 113.09 21.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.902 -0.59 . . . . 0.63 109.51 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.724 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 62.9 mtt180 -122.6 130.15 52.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 1.95 111.471 -173.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.867 HG12 HD11 ' A' ' 153' ' ' LEU . 21.8 t -105.62 99.88 9.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.154 -0.93 . . . . 1.44 109.413 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.827 ' HB2' HD12 ' A' ' 153' ' ' LEU . 4.1 t-20 57.87 51.81 8.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.219 1.009 . . . . 1.65 109.022 -170.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.5 -20.18 19.64 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 114.544 -1.207 . . . . 0.42 113.163 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 47.8 m80 -79.25 107.33 11.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.01 0.374 . . . . 0.68 112.01 -172.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.531 HG22 ' HG2' ' A' ' 105' ' ' ARG . 3.1 p -68.52 96.61 0.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.19 0.519 . . . . 0.77 111.198 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.816 HG11 HD12 ' A' ' 131' ' ' ILE . 22.3 t -85.32 -46.14 17.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.832 -0.622 . . . . 0.94 109.568 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.652 ' HB ' ' HB ' ' A' ' 104' ' ' VAL . 10.2 t -119.2 88.35 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.441 0.639 . . . . 0.35 109.645 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 51.9 tptt -103.85 76.5 1.38 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.211 -1.033 . . . . 4.01 108.211 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 4.8 p-10 162.43 14.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.154 -1.384 . . . . 1.96 110.457 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -66.47 98.29 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.867 0.365 . . . . 1.18 111.37 -169.208 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -112.87 94.58 4.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.066 0.936 . . . . 1.93 109.641 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 91' ' ' GLU . 56.2 mt -61.03 -46.8 95.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.713 -1.13 . . . . 0.82 111.829 -170.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -53.64 -37.17 62.85 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.092 0.404 . . . . 1.08 112.092 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.697 ' HB2' ' HB3' ' A' ' 97' ' ' SER . 16.4 t70 -71.73 -39.54 70.02 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.719 -0.392 . . . . 0.96 110.806 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -74.2 -43.72 56.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.89 -0.595 . . . . 1.69 111.607 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 117' ' ' ILE . 29.7 m -92.71 -32.66 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.87 -0.332 . . . . 1.49 111.829 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.1 -69.89 3.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 1.4 111.789 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -114.92 169.47 9.06 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.032 -0.359 . . . . 4.11 110.032 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.6 m -59.92 97.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.245 0.545 . . . . 1.97 112.142 -173.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 36.8 p -144.75 -166.44 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.391 -0.822 . . . . 0.85 109.004 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 88' ' ' LYS . . . -100.58 118.21 36.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.765 0.317 . . . . 0.57 111.69 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.461 ' HB2' ' CG1' ' A' ' 121' ' ' VAL . 83.8 t60 -95.57 136.98 35.26 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.206 -0.664 . . . . 0.55 109.206 175.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.2 132.31 43.01 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.871 -0.732 . . . . 1.64 112.167 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.644 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 77.0 mm-40 -110.95 114.09 27.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.12 -0.945 . . . . 1.12 108.673 170.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.464 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 46.0 mt -96.34 109.8 23.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.084 -0.71 . . . . 0.74 109.084 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.816 HD12 HG11 ' A' ' 111' ' ' VAL . 31.2 mm -118.43 88.14 32.8 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.612 -0.267 . . . . 1.25 110.908 -171.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 130' ' ' ILE . 8.3 Cg_exo -74.57 127.47 11.02 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.593 2.196 . . . . 0.29 111.796 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.634 HG12 ' HB2' ' A' ' 83' ' ' TYR . 3.4 pt -110.13 144.73 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.857 -0.794 . . . . 0.27 108.857 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 p -116.34 107.67 15.12 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.205 0.526 . . . . 1.24 110.44 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.646 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 3.9 mt -98.68 131.71 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.194 -0.669 . . . . 0.34 109.194 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.445 ' HD3' ' HG3' ' A' ' 80' ' ' GLU . 71.6 mmtt -148.38 129.73 14.74 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 123.641 0.588 . . . . 1.95 109.896 174.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 60.61 24.95 14.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.828 -0.624 . . . . 3.13 111.526 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.05 8.43 66.89 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.557 -0.83 . . . . 0.41 112.857 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.668 ' HG3' HG22 ' A' ' 148' ' ' THR . 8.9 mptt -111.69 139.65 46.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.682 -0.488 . . . . 2.23 109.682 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.4 tt -115.08 115.73 27.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.981 -0.554 . . . . 0.41 109.738 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.1 m -109.07 115.04 29.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 1.19 110.837 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.81 104.92 17.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 O-C-N 122.282 -0.261 . . . . 0.92 110.337 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 64.17 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.816 0.697 . . . . 1.88 110.928 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.51 1.68 5.66 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.944 -0.646 . . . . 1.02 112.27 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -99.14 112.8 24.85 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.0 -0.37 . . . . 1.95 110.0 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 p -115.02 119.23 61.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.385 0.612 . . . . 0.92 111.482 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.8 m -145.94 156.16 43.33 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.928 -0.767 . . . . 1.27 108.928 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.668 HG22 ' HG3' ' A' ' 139' ' ' LYS . 41.6 p -63.17 140.58 58.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.835 0.35 . . . . 1.45 110.536 176.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.667 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 18.0 t80 -79.48 142.8 35.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.618 . . . . 0.47 109.489 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -137.95 102.71 4.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.274 0.559 . . . . 1.79 111.798 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.65 -64.27 3.31 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.693 -0.685 . . . . 0.42 113.979 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.697 ' HE2' ' HB3' ' A' ' 154' ' ' SER . 0.0 OUTLIER -155.92 170.65 21.62 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 117.137 0.469 . . . . 1.23 110.723 -178.332 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.879 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 22.7 tp -81.21 131.19 35.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.047 -1.094 . . . . 1.17 108.047 174.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.815 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 p -123.51 102.35 7.83 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.6 -0.84 . . . . 1.35 111.85 -171.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 48.4 t -93.01 95.97 5.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.231 -0.588 . . . . 0.42 110.146 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 154' ' ' SER . 3.3 mp0 -98.72 119.83 38.12 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.203 -0.666 . . . . 1.98 109.203 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.552 ' CE2' ' CE1' ' A' ' 71' ' ' PHE . 1.9 p90 -115.92 126.57 54.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.047 0.927 . . . . 2.32 110.535 175.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.45 144.59 16.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.791 -1.549 . . . . 0.62 110.87 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.626 ' HA ' ' HB3' ' A' ' 164' ' ' ASN . 24.8 pttm -68.02 137.11 54.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.593 -0.73 . . . . 2.26 111.364 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -101.85 -93.61 2.21 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.534 -1.026 . . . . 1.45 110.534 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.638 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 76.9 t80 -89.86 87.11 6.83 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.719 -0.845 . . . . 4.24 108.719 172.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 88.6 t80 65.05 -71.58 0.08 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 124.027 0.83 . . . . 4.98 111.296 -173.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.04 151.96 45.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.55 0.69 . . . . 2.64 110.873 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.888 ' HB2' ' HD2' ' A' ' 165' ' ' PRO . 10.0 p30 -110.14 -165.11 0.06 OUTLIER Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 105.932 -1.877 . . . . 2.06 105.932 161.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.888 ' HD2' ' HB2' ' A' ' 164' ' ' ASN . 23.5 Cg_exo -42.1 96.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.588 1.525 . . . . 3.16 112.455 169.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.793 ' HE2' ' HB2' ' A' ' 93' ' ' TYR . 32.0 tttp -64.59 -62.61 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.745 -1.116 . . . . 3.18 110.829 -170.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.814 HG22 ' HB3' ' A' ' 64' ' ' GLU . 61.7 t -96.92 132.63 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.353 -0.981 . . . . 1.19 108.353 170.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 38.8 t -134.46 88.12 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.812 -0.755 . . . . 1.36 112.133 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -80.0 36.49 0.34 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 124.466 1.106 . . . . 0.31 112.658 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -35.92 120.48 0.61 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.412 0.685 . . . . 0.69 111.507 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.677 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 4.1 t80 -136.18 109.7 7.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.497 -0.32 . . . . 0.48 110.317 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.791 ' HB ' HD12 ' A' ' 85' ' ' LEU . 6.7 tt -104.17 121.46 55.83 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 121.899 0.857 . . . . 0.3 110.583 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.677 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.2 ppp? -119.07 152.53 36.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.435 -0.802 . . . . 0.99 109.705 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.537 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 72.6 tttt -97.87 139.4 33.78 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 114.895 1.443 . . . . 1.22 114.895 -169.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.87 -28.89 12.97 Favored Glycine 0 C--N 1.317 -0.473 0 CA-C-N 113.196 -1.82 . . . . 0.31 115.61 155.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -171.81 155.0 3.77 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.28 1.04 . . . . 0.68 113.439 -174.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.812 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -84.78 -21.2 30.06 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.19 -0.914 . . . . 0.86 110.973 173.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.113 0.482 . . . . 2.16 111.582 -175.608 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 112.41 -0.276 . . . . 1.48 112.41 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.628 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.3 tp -58.67 -46.83 86.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.062 0.458 . . . . 0.72 110.618 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -63.03 -23.79 67.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.628 -0.714 . . . . 0.53 111.811 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.9 -43.94 14.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.285 -0.416 . . . . 2.18 110.885 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.71 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 32.2 mmtp -87.24 -10.74 51.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.489 0.552 . . . . 1.79 112.489 -172.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.577 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 14.1 p -57.28 135.77 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.323 0.583 . . . . 0.33 111.111 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.2 pt -119.35 -28.18 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.909 -0.587 . . . . 0.92 110.829 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.613 ' CH2' ' HB3' ' A' ' 73' ' ' TYR . 59.5 t90 -166.4 119.97 1.08 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.038 -0.528 . . . . 0.36 109.908 -170.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -135.49 140.1 44.53 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.114 -0.328 . . . . 0.26 110.114 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.897 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 55.0 t -140.5 105.71 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 112.615 0.598 . . . . 0.79 112.615 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 14.0 t-20 -81.53 89.3 6.17 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.082 -1.081 . . . . 1.49 108.082 164.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -64.52 101.14 0.42 Allowed 'General case' 0 C--O 1.248 1.026 0 N-CA-C 109.268 -0.642 . . . . 0.48 109.268 176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 155.17 -44.08 0.56 Allowed Glycine 0 N--CA 1.441 -1.018 0 O-C-N 125.66 1.85 . . . . 0.76 110.865 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.411 ' C ' ' HE2' ' A' ' 29' ' ' TYR . . . -102.42 -150.63 23.01 Favored Glycine 0 C--O 1.225 -0.409 0 CA-C-N 115.193 -0.504 . . . . 0.74 112.958 -172.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 1.032 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 3.9 tm-20 -149.34 121.06 8.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.929 0.365 . . . . 1.77 111.248 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.761 ' HB2' ' HB2' ' A' ' 31' ' ' LYS . 5.9 t 34.61 86.96 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.846 1.341 . . . . 1.29 112.839 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.683 ' ND1' ' HB2' ' A' ' 60' ' ' LEU . 29.6 t-80 -129.42 132.01 46.9 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 119.75 -0.78 . . . . 0.42 111.541 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.4 120.75 45.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.597 -0.729 . . . . 1.01 110.338 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.86 154.36 31.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.754 -0.657 . . . . 0.77 109.383 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.1 m -61.52 -10.22 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 113.871 1.063 . . . . 0.62 113.871 -171.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.549 ' HB2' HD23 ' A' ' 6' ' ' LEU . 66.7 m-70 -95.35 -0.82 52.28 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.213 -0.662 . . . . 0.86 109.213 175.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 95.05 30.4 8.34 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.128 -0.942 . . . . 0.33 112.923 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.628 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.9 mm -104.08 115.46 46.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.08 0.466 . . . . 0.31 111.037 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -102.43 122.11 43.65 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.008 0.373 . . . . 0.8 112.008 -171.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.897 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -86.4 139.47 30.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.222 -0.444 . . . . 1.75 111.164 175.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.46 ' HG2' HG22 ' A' ' 14' ' ' VAL . 11.2 mmm180 -72.61 -7.89 52.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.527 1.677 . . . . 2.94 115.527 -161.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 1.032 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 25.3 ttmt 70.18 103.92 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.434 0.531 . . . . 2.78 112.434 -176.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 1.011 ' HB3' ' HA ' ' A' ' 38' ' ' VAL . 2.3 m-20 60.13 58.27 4.39 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.849 1.055 . . . . 2.41 113.849 165.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 30.0 Cg_endo -107.48 -153.23 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.639 2.893 . . . . 1.87 113.492 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.999 HD11 ' HB2' ' A' ' 71' ' ' PHE . 0.2 OUTLIER 84.18 -71.76 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.476 1.11 . . . . 1.99 112.775 169.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.79 ' HB2' ' HD3' ' A' ' 37' ' ' ARG . 14.2 mm-40 -126.1 28.85 5.98 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.322 -0.551 . . . . 5.31 111.457 -172.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.91 1.86 90.64 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.841 -1.171 . . . . 2.64 111.516 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.79 ' HD3' ' HB2' ' A' ' 35' ' ' GLU . 8.4 mpt_? -67.32 66.33 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.568 0.747 . . . . 5.64 111.386 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.011 ' HA ' ' HB3' ' A' ' 32' ' ' ASP . 16.9 t -105.21 117.42 50.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.896 -0.593 . . . . 3.96 109.694 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 166.33 -77.68 0.13 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.22 -0.991 . . . . 2.56 113.037 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -119.75 135.63 54.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.206 0.527 . . . . 6.2 112.048 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HA ' ' NH2' ' A' ' 65' ' ' ARG . . . -82.05 98.3 8.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.259 -0.882 . . . . 2.0 109.899 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 65' ' ' ARG . 16.3 p -65.57 131.05 45.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.076 -0.511 . . . . 2.52 110.455 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 46' ' ' MET . 8.6 p-10 -139.74 36.9 2.0 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.91 0.862 . . . . 2.52 109.62 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -68.1 -25.92 65.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.892 -1.049 . . . . 7.02 110.374 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.3 34.32 4.74 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.68 -0.691 . . . . 3.06 111.607 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.553 ' HB2' ' HB2' ' A' ' 43' ' ' ASP . 24.3 ttt -72.13 -13.2 61.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.021 0.439 . . . . 2.35 110.577 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -83.58 57.52 4.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.426 0.631 . . . . 4.25 109.649 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.51 73.59 20.31 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.871 -0.788 . . . . 2.56 108.871 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.76 109.71 0.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.136 1.89 . . . . 1.69 112.588 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.583 HG22 ' HB3' ' A' ' 53' ' ' SER . 1.4 mp -68.49 111.92 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.676 -0.693 . . . . 1.59 110.087 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -68.17 -23.25 64.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.409 -0.814 . . . . 1.91 112.52 -171.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 126' ' ' ALA . 4.6 mpt_? -100.54 36.33 1.93 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.759 0.314 . . . . 3.17 111.331 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.583 ' HB3' HG22 ' A' ' 50' ' ' ILE . 42.2 t -154.36 153.54 31.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.172 -0.467 . . . . 0.97 111.142 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.9 140.93 50.54 Favored Pre-proline 0 C--O 1.219 -0.506 0 N-CA-C 109.087 -0.709 . . . . 1.92 109.087 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.491 ' O ' HG23 ' A' ' 59' ' ' VAL . 5.1 Cg_exo -39.22 -39.54 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.537 3.491 . . . . 0.7 115.992 -167.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.53 -55.09 6.78 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.484 1.135 . . . . 2.71 110.068 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.58 -15.11 60.4 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.048 -0.978 . . . . 1.63 109.655 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.413 ' HG3' ' HB ' ' A' ' 50' ' ' ILE . 33.5 tt0 -60.73 -43.09 98.34 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.464 -0.789 . . . . 1.58 109.294 170.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 55' ' ' PRO . 58.3 t -58.52 -40.86 80.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.154 -0.476 . . . . 1.27 109.848 174.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.683 ' HB2' ' ND1' ' A' ' 21' ' ' HIS . 23.6 tp -68.87 -22.78 64.18 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.583 -0.447 . . . . 1.18 111.573 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.451 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 9.1 m-30 -101.06 1.93 39.91 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.278 0.561 . . . . 0.99 109.667 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.533 ' O ' HG13 ' A' ' 167' ' ' VAL . 11.5 tt0 -124.44 -124.55 0.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.034 -0.984 . . . . 1.97 109.301 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.739 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.7 OUTLIER 29.04 104.05 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.751 1.22 . . . . 1.27 114.143 -173.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.436 ' HB2' ' HG2' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -81.82 148.16 29.0 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.086 0.469 . . . . 1.96 112.027 -178.02 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.727 ' NH2' ' HA ' ' A' ' 41' ' ' ALA . 2.1 ttm180 -109.86 91.33 3.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.533 -0.303 . . . . 3.35 111.433 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 57.45 -160.79 0.23 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.536 0.684 . . . . 4.71 111.913 173.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -123.21 75.02 1.27 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.452 -0.794 . . . . 4.38 109.395 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.419 ' CD ' ' HE ' ' A' ' 37' ' ' ARG . 1.7 tp10 -78.59 -164.29 0.56 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.895 -1.048 . . . . 3.7 111.919 -172.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -167.49 128.83 1.53 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.828 -1.078 . . . . 2.2 109.875 -173.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 m 52.08 55.34 9.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 124.007 0.817 . . . . 1.41 110.574 168.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.999 ' HB2' HD11 ' A' ' 34' ' ' LEU . 2.2 p90 -111.24 138.37 47.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.911 -1.041 . . . . 1.57 111.296 -167.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.536 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -129.57 146.37 17.19 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.661 -0.78 . . . . 0.78 113.658 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.613 ' HB3' ' CH2' ' A' ' 12' ' ' TRP . 57.7 m-85 -103.44 136.43 43.2 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.42 -0.39 . . . . 1.21 110.769 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.418 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.4 p-10 -99.51 115.63 29.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.034 -0.53 . . . . 2.47 110.937 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.842 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.3 mp -110.01 89.86 8.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.602 -0.726 . . . . 0.38 109.358 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.681 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 21.8 Cg_exo -63.66 121.19 8.85 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 C-N-CA 121.992 1.795 . . . . 0.59 111.727 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.901 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 64.9 mt -121.47 143.05 35.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.715 0.293 . . . . 0.49 111.019 -174.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -127.05 -12.25 5.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.262 -0.426 . . . . 3.32 111.443 173.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -112.03 168.15 9.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 2.16 111.387 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -106.5 -178.37 3.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.799 -0.637 . . . . 1.2 110.6 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.36 -169.58 15.6 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.144 -0.782 . . . . 0.3 111.144 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 5.1 mm-40 -98.87 103.28 15.22 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.083 -0.71 . . . . 1.96 109.083 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.68 ' HB2' HG12 ' A' ' 133' ' ' ILE . 2.4 m-85 -92.37 124.37 36.37 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 119.225 -0.99 . . . . 0.71 108.8 -173.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.574 HG21 ' CA ' ' A' ' 177' ' ' ALA . 49.0 t -107.3 105.6 19.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.22 -0.9 . . . . 0.26 109.937 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 170' ' ' LEU . 17.0 tp -90.37 104.6 17.16 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.286 -1.325 . . . . 1.56 109.764 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 44.8 t -114.01 104.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.841 -0.8 . . . . 1.14 108.841 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.586 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.38 135.68 46.32 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.968 -0.693 . . . . 1.44 110.616 178.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.758 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 16.2 tptt -98.7 120.63 39.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.302 -0.408 . . . . 3.73 110.494 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CE2' HD11 ' A' ' 115' ' ' LEU . 26.4 m-85 -107.35 142.11 37.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.911 0.386 . . . . 0.45 111.253 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -139.33 135.14 33.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.424 -0.807 . . . . 0.51 110.387 178.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' A' ' 124' ' ' SER . 7.3 pt-20 -94.5 162.94 13.6 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 124.069 0.856 . . . . 2.62 110.91 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.538 HG21 ' HD2' ' A' ' 166' ' ' LYS . 25.9 m -139.41 -17.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.687 . . . . 3.77 110.813 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.449 ' HD2' HG23 ' A' ' 92' ' ' VAL . 10.4 m-85 -146.57 162.84 37.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 5.68 110.744 -175.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 64.02 56.3 1.44 Allowed 'General case' 0 N--CA 1.463 0.182 0 O-C-N 123.84 0.712 . . . . 4.65 111.253 173.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.24 87.2 3.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.403 -0.817 . . . . 1.39 111.103 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -156.28 140.63 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.563 -0.744 . . . . 2.75 109.858 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . 5.9 p -100.43 146.93 26.43 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.86 0.689 . . . . 1.4 112.86 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 56.66 53.68 8.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.062 -0.972 . . . . 2.38 110.096 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -148.63 -49.51 0.16 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.671 -0.695 . . . . 2.89 109.979 -178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -107.92 89.6 3.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.688 -0.687 . . . . 2.79 109.414 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.866 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 23.6 m -106.77 124.6 62.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.647 -0.706 . . . . 1.22 110.063 -173.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.498 ' HD1' ' HA ' ' A' ' 159' ' ' LYS . 61.7 m-85 -104.12 163.53 12.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.512 -0.767 . . . . 0.99 111.722 -173.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 24.6 m-20 -109.59 140.61 43.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.579 -0.282 . . . . 1.53 110.48 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.603 HG23 ' HD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -143.32 127.89 14.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.048 0.451 . . . . 0.63 110.735 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.659 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -121.39 144.89 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.676 -0.693 . . . . 1.95 112.189 -175.326 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.804 HG23 HD21 ' A' ' 153' ' ' LEU . 3.0 p -108.2 105.36 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.691 . . . . 1.44 109.722 171.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.447 ' HA ' ' H ' ' A' ' 154' ' ' SER . 65.4 t30 57.67 44.22 21.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.882 0.848 . . . . 1.65 109.149 -174.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.95 -15.79 61.97 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 114.994 -1.003 . . . . 0.42 113.017 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 94.6 m-70 -89.39 98.86 12.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.564 0.579 . . . . 0.68 112.564 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 2.3 p -66.64 98.98 0.55 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.208 0.528 . . . . 0.77 111.706 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.688 HG21 HG21 ' A' ' 131' ' ' ILE . 6.4 t -80.47 -47.79 20.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.636 -0.711 . . . . 0.94 109.53 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.615 HG11 ' HG ' ' A' ' 115' ' ' LEU . 10.8 t -113.3 90.03 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.556 0.694 . . . . 0.35 109.364 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -113.16 71.74 0.75 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 122.332 1.063 . . . . 4.01 108.871 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.866 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.7 p30 162.66 30.2 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.186 -1.825 . . . . 1.96 107.218 -169.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.662 HD13 ' HE2' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -74.1 78.65 1.74 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.862 -1.063 . . . . 1.18 111.095 -172.33 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.531 ' HB2' HG12 ' A' ' 101' ' ' VAL . 10.9 t70 -101.95 103.74 14.4 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.727 -1.212 . . . . 1.93 107.727 172.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 165' ' ' PRO . 66.7 mt -55.0 -40.9 55.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.893 -0.594 . . . . 0.82 111.173 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.567 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 2.3 t80 -64.12 -45.61 87.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.7 -0.682 . . . . 1.08 110.558 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.8 -32.86 68.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.31 -0.405 . . . . 0.96 111.471 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HB3' ' CE1' ' A' ' 127' ' ' HIS . 15.4 mmt180 -77.03 -50.1 13.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.276 -0.42 . . . . 1.69 111.792 -173.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.9 p -118.79 -27.59 2.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.49 -0.484 . . . . 1.49 112.295 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 123.6 -161.49 17.91 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.316 -1.114 . . . . 1.4 110.316 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -78.79 122.24 25.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.532 0.666 . . . . 4.11 111.027 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.7 ' HA ' ' HG2' ' A' ' 91' ' ' GLU . 78.2 p 51.77 -121.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.163 -0.926 . . . . 1.97 112.516 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.7 p 52.32 -161.41 0.1 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.469 0.707 . . . . 0.85 110.796 -173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.683 ' HB1' ' HE3' ' A' ' 88' ' ' LYS . . . -98.95 109.08 21.89 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.67 -0.412 . . . . 0.57 110.304 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 18.9 t60 -93.84 133.05 37.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.247 -0.649 . . . . 0.55 109.247 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.719 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.5 p30 -133.22 135.77 45.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.132 0.492 . . . . 1.64 111.108 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.448 ' HB2' HD21 ' A' ' 87' ' ' LEU . 17.1 mm-40 -112.25 111.78 22.9 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.211 -1.033 . . . . 1.12 108.211 171.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 86' ' ' VAL . 65.5 mt -96.04 113.48 30.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.934 -0.575 . . . . 0.74 109.668 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.688 HG21 HG21 ' A' ' 111' ' ' VAL . 47.2 mt -124.0 93.47 47.01 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.36 -0.382 . . . . 1.25 111.293 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -72.42 122.07 7.99 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.317 2.011 . . . . 0.29 112.648 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.68 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -109.74 160.61 8.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 106.959 -1.497 . . . . 0.27 106.959 174.415 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.5 p -127.29 111.99 14.55 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.036 0.446 . . . . 1.24 110.377 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 36.9 mt -99.87 122.41 51.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.191 -0.67 . . . . 0.34 109.191 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -149.06 135.32 19.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.87 -0.418 . . . . 1.95 109.87 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 61.28 25.04 15.07 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.606 0.566 . . . . 3.13 110.586 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.16 14.46 81.74 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.73 -0.668 . . . . 0.41 112.27 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 56.5 mtpt -111.9 150.53 30.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.583 -0.525 . . . . 2.23 109.583 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.0 tt -121.25 116.31 24.63 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.701 -0.481 . . . . 0.41 109.701 -175.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -116.65 111.04 19.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.61 -0.515 . . . . 1.19 109.61 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.685 HG21 HG11 ' A' ' 106' ' ' VAL . 5.5 p -100.76 113.95 38.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.175 -0.306 . . . . 0.92 110.175 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 58.77 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.015 -0.539 . . . . 1.88 112.02 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.19 1.98 7.76 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.945 -0.645 . . . . 1.02 112.685 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -106.14 148.49 27.79 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.488 -0.56 . . . . 1.95 109.488 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.09 133.59 60.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.247 0.546 . . . . 0.92 111.616 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m -152.94 179.06 9.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.897 -0.779 . . . . 1.27 108.897 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.763 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 7.9 t -99.36 143.05 30.06 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.847 -0.798 . . . . 1.45 108.847 168.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.901 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 51.6 t80 -79.62 121.98 25.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.264 -0.425 . . . . 0.47 110.46 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 p -118.46 95.59 4.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.248 0.546 . . . . 1.79 112.295 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.54 -71.6 2.87 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.42 114.167 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.681 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -151.5 156.75 41.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.355 0.577 . . . . 1.23 111.015 -176.143 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.842 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 7.0 tt -82.13 140.42 33.81 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.67 -0.863 . . . . 1.17 108.67 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.46 ' N ' HD23 ' A' ' 153' ' ' LEU . 5.5 t -124.29 109.17 13.04 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.876 -0.73 . . . . 1.35 110.241 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.729 HG11 HD21 ' A' ' 170' ' ' LEU . 49.1 t -91.51 96.03 5.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.029 -1.1 . . . . 0.42 108.029 174.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.596 ' HB3' ' HG3' ' A' ' 105' ' ' ARG . 4.5 tt0 -99.57 120.53 39.81 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.074 -0.966 . . . . 1.98 109.766 -175.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.662 ' HE2' HD13 ' A' ' 115' ' ' LEU . 62.1 t80 -108.36 116.38 31.86 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.332 0.587 . . . . 2.32 109.928 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 44.6 t -106.82 112.86 41.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.241 -0.89 . . . . 0.62 110.502 -176.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.766 ' HE3' ' HA ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -76.58 148.18 37.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.577 -0.738 . . . . 2.26 110.066 172.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -89.3 -57.05 1.82 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.584 -0.817 . . . . 1.45 112.01 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -68.41 -72.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.822 -0.436 . . . . 4.24 109.822 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.766 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 85.1 t80 -175.47 -48.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.276 -1.009 . . . . 4.98 108.276 174.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -66.62 147.04 53.82 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.364 -1.289 . . . . 2.64 110.362 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.644 ' HB2' ' HD2' ' A' ' 165' ' ' PRO . 0.9 OUTLIER -114.07 -175.06 0.29 Allowed Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 112.902 -1.954 . . . . 2.06 106.635 174.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.746 ' HB3' HD11 ' A' ' 117' ' ' ILE . 83.3 Cg_exo -49.63 -27.19 14.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 121.443 1.429 . . . . 3.16 110.788 170.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.538 ' HD2' HG21 ' A' ' 92' ' ' VAL . 32.2 tttm 88.42 -39.82 0.03 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 113.825 -1.534 . . . . 3.18 109.682 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 62' ' ' GLN . 38.8 t -98.08 132.17 43.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 116.423 -0.353 . . . . 1.19 110.832 174.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 29.1 t -141.74 94.47 2.68 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 120.062 -0.655 . . . . 1.36 112.32 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -87.64 38.59 0.84 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.841 1.256 . . . . 0.31 113.473 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.729 HD21 HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -31.0 131.91 0.09 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.58 0.752 . . . . 0.69 112.137 177.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 5.4 t80 -144.97 115.65 7.71 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.242 -0.286 . . . . 0.48 110.449 171.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.568 HG21 HG21 ' A' ' 75' ' ' ILE . 7.0 tt -113.89 125.72 71.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 122.268 1.032 . . . . 0.3 111.007 172.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 9.7 ptm -117.58 163.55 16.27 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.58 -1.191 . . . . 0.99 109.099 176.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.71 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -120.74 149.62 42.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.131 0.967 . . . . 1.22 112.635 -174.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.15 -29.63 12.03 Favored Glycine 0 C--N 1.306 -1.099 0 CA-C-N 114.105 -1.407 . . . . 0.31 114.34 162.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.562 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.0 OUTLIER -176.31 160.06 2.09 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.253 1.027 . . . . 0.68 112.115 179.14 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.574 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -85.48 -9.64 57.18 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.496 -0.775 . . . . 0.86 110.048 168.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.562 ' H ' ' HB ' ' A' ' 176' ' ' THR . 2.4 m-20 . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.901 -0.59 . . . . 2.16 111.618 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 112.116 -0.394 . . . . 1.48 112.116 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.765 ' HG ' HD11 ' A' ' 27' ' ' ILE . 27.2 tp -70.27 -36.84 74.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.113 0.482 . . . . 0.72 109.975 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.488 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -66.5 -24.91 66.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.487 -0.779 . . . . 0.53 111.288 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -75.33 -32.79 61.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.008 -0.542 . . . . 2.18 110.606 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.682 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 30.6 mmtp -93.4 -28.82 15.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.09 -0.504 . . . . 1.79 111.853 -171.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.612 ' HB ' HD12 ' A' ' 27' ' ' ILE . 9.6 p -57.63 119.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.627 0.727 . . . . 0.33 111.901 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.2 pt -101.82 -24.62 4.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.784 -0.644 . . . . 0.92 110.181 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.797 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 35.5 t90 -159.24 135.25 8.85 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.53 -0.759 . . . . 0.36 109.449 -172.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -154.76 131.34 10.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.722 0.296 . . . . 0.26 110.76 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.476 ' HB ' ' CH2' ' A' ' 12' ' ' TRP . 4.1 t -140.33 125.16 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.514 0.673 . . . . 0.79 111.598 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.742 ' HB2' HD23 ' A' ' 60' ' ' LEU . 3.2 t-20 -97.49 90.48 5.06 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.751 -1.203 . . . . 1.49 107.751 167.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.557 ' C ' ' HB2' ' A' ' 65' ' ' ARG . . . -62.38 102.2 0.29 Allowed 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.584 -0.734 . . . . 0.48 109.446 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 150.56 -20.12 1.03 Allowed Glycine 0 N--CA 1.442 -0.938 0 O-C-N 125.398 1.686 . . . . 0.76 112.333 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 43' ' ' ASP . . . -136.64 -166.08 10.72 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.036 -1.078 . . . . 0.74 112.924 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 31.7 tt0 -120.78 118.2 29.4 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.814 0.302 . . . . 1.77 111.814 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.756 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 18.4 m 36.31 109.27 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 115.639 1.718 . . . . 1.29 115.639 166.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.86 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 71.4 t60 -147.02 143.42 28.39 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 121.668 -0.645 . . . . 0.42 110.958 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.6 t -104.21 117.48 49.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.33 -0.85 . . . . 1.01 109.934 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.782 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -70.98 148.63 47.47 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.236 -0.653 . . . . 0.77 109.236 174.229 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.32 -17.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 114.219 1.192 . . . . 0.62 114.219 -173.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.532 ' HB2' HD23 ' A' ' 6' ' ' LEU . 63.9 m-70 -87.74 -11.52 47.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.255 -0.646 . . . . 0.86 109.255 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 108.64 33.89 2.77 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.053 -0.976 . . . . 0.33 113.246 175.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.765 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.5 mm -103.32 105.53 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.043 -0.663 . . . . 0.31 110.355 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -90.41 105.75 18.03 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.024 -0.534 . . . . 0.8 110.604 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.86 ' CE2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -83.7 138.77 33.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.686 -0.688 . . . . 1.75 109.269 175.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -95.23 149.29 21.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.861 0.362 . . . . 2.94 110.557 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 76.6 tttt -43.24 143.38 0.85 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.802 -1.09 . . . . 2.78 112.28 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.589 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 13.3 p-10 -45.8 106.09 0.53 Allowed Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 124.763 1.29 . . . . 2.41 113.387 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.509 ' HA ' HG12 ' A' ' 38' ' ' VAL . 33.8 Cg_endo -99.12 -72.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.967 3.111 . . . . 1.87 113.717 174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.58 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . 10.9 mp 65.63 -75.61 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.079 0.952 . . . . 1.99 111.078 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.588 ' HG3' ' HD2' ' A' ' 37' ' ' ARG . 4.1 pt-20 -156.02 62.32 0.58 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.893 -1.048 . . . . 5.31 111.369 -170.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.79 -0.49 89.5 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.522 -0.847 . . . . 2.64 112.449 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.588 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -91.99 58.4 3.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.957 0.408 . . . . 5.64 110.219 -175.071 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 33' ' ' PRO . 20.7 m -104.37 133.07 49.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.766 -0.652 . . . . 3.96 110.783 -174.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.82 14.12 10.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.428 -0.891 . . . . 2.56 112.633 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 40' ' ' ARG . 15.4 tpt180 -105.01 -67.96 0.88 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.872 0.336 . . . . 6.2 110.566 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 42' ' ' SER . . . 61.49 -86.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.173 0.589 . . . . 2.0 111.582 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.511 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 47.5 t 74.76 41.49 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.476 0.655 . . . . 2.52 109.312 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' HA2' ' A' ' 18' ' ' GLY . 11.5 p-10 -81.27 47.7 1.06 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.369 -0.832 . . . . 2.52 110.712 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -132.07 128.38 38.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.381 -0.827 . . . . 7.02 109.382 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.75 71.33 1.12 Allowed Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.511 -1.035 . . . . 3.06 110.511 -175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.486 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 1.8 mpt? -61.21 -38.93 88.35 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 123.55 0.206 . . . . 2.35 110.672 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 46' ' ' MET . 24.3 ttpt 75.27 -51.08 0.66 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 113.695 0.998 . . . . 4.25 113.695 168.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 92' ' ' VAL . 27.8 tp -116.22 74.01 5.46 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 117.947 0.34 . . . . 2.56 110.834 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HD3' ' C ' ' A' ' 47' ' ' LYS . 52.6 Cg_exo -55.47 125.87 20.58 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.089 1.86 . . . . 1.69 112.665 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.679 ' CG2' ' HB2' ' A' ' 126' ' ' ALA . 1.4 mp -75.29 114.34 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.649 0.738 . . . . 1.59 110.335 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.547 ' HB2' HG22 ' A' ' 125' ' ' THR . 2.7 mm? -74.8 -2.83 28.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.389 -0.823 . . . . 1.91 112.744 -171.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 7.5 mmm180 -112.67 23.33 13.62 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.845 -0.342 . . . . 3.17 111.166 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.7 t -142.81 157.55 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.371 0.605 . . . . 0.97 112.346 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.447 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 22.6 t30 -63.75 129.25 93.66 Favored Pre-proline 0 C--O 1.213 -0.858 0 CA-C-N 114.983 -1.008 . . . . 1.92 109.258 172.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.534 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 3.2 Cg_exo -40.19 -44.75 4.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.192 3.261 . . . . 0.7 115.058 -170.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -64.31 -51.82 61.55 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 123.149 1.452 . . . . 2.71 109.407 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.782 ' OD1' ' HA ' ' A' ' 23' ' ' ASP . 31.6 m-20 -82.26 -6.87 59.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.231 -1.804 . . . . 1.63 109.645 -174.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.534 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 32.2 tt0 -67.41 -41.37 85.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 1.58 108.354 169.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.03 -50.4 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.311 -0.859 . . . . 1.27 109.064 170.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.751 ' HG ' ' HD2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -55.9 -34.41 65.52 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.484 -0.78 . . . . 1.18 110.39 178.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.601 ' HA ' ' CB ' ' A' ' 169' ' ' ALA . 10.9 m-30 -94.58 1.51 55.64 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.952 -0.567 . . . . 0.99 111.263 -174.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.733 ' HA ' HG21 ' A' ' 167' ' ' VAL . 7.9 tt0 -128.32 -110.05 0.28 Allowed 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 116.567 -0.288 . . . . 1.97 111.413 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.702 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 29.58 108.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.38 1.472 . . . . 1.27 114.584 -172.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.693 ' HB3' HG12 ' A' ' 167' ' ' VAL . 8.1 pt-20 -80.63 136.53 36.24 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.031 0.752 . . . . 1.96 113.031 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.589 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -112.71 73.73 0.83 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.011 -0.54 . . . . 3.35 110.034 170.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -50.2 134.14 22.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.764 -0.653 . . . . 4.71 111.161 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -133.61 -85.53 0.44 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.849 -0.34 . . . . 4.38 110.882 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 178.81 -72.89 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.918 0.39 . . . . 3.7 110.445 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -166.45 156.02 11.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.422 -0.585 . . . . 2.2 109.422 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.3 t 49.68 65.25 1.46 Allowed 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.908 0.755 . . . . 1.41 110.741 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.637 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 1.5 p90 -126.77 137.41 53.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.836 -0.431 . . . . 1.57 109.836 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.08 -153.07 7.93 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.618 -0.801 . . . . 0.78 112.873 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -143.96 168.16 20.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.196 0.522 . . . . 1.21 111.589 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.451 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.6 m-20 -122.75 125.14 44.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.305 -0.861 . . . . 2.47 109.129 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.944 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.0 mp -104.69 95.96 9.66 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.439 -0.578 . . . . 0.38 109.439 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 32.0 Cg_exo -57.04 120.82 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.936 1.757 . . . . 0.59 112.013 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.783 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 66.3 mt -126.67 133.03 69.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.436 -0.347 . . . . 0.49 110.393 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -132.77 16.07 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.345 -0.389 . . . . 3.32 110.825 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -135.43 174.29 10.77 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.725 -0.39 . . . . 2.16 110.447 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.589 ' HG2' HG22 ' A' ' 135' ' ' ILE . 10.9 mt-10 -122.61 163.44 20.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.118 -0.492 . . . . 1.2 110.718 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.98 -173.99 21.89 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.644 -0.982 . . . . 0.3 110.644 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -92.4 104.74 17.04 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 117.878 0.839 . . . . 1.96 109.267 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.684 ' HB2' HG12 ' A' ' 133' ' ' ILE . 92.9 m-85 -92.59 123.4 35.86 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.491 -0.929 . . . . 0.71 108.491 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.508 HG21 ' CA ' ' A' ' 177' ' ' ALA . 88.8 t -116.14 106.65 20.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.633 -0.712 . . . . 0.26 110.268 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 172' ' ' ILE . 5.7 mp -86.77 104.69 16.38 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.955 -1.021 . . . . 1.56 109.302 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 130' ' ' ILE . 53.3 t -102.87 102.64 13.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.694 -1.224 . . . . 1.14 107.694 172.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -113.26 133.33 55.15 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.55 -0.46 . . . . 1.44 110.513 -176.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.763 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 5.3 mptp? -91.74 124.68 36.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.278 0.561 . . . . 3.73 110.097 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.75 ' CE1' ' HB3' ' A' ' 165' ' ' PRO . 2.8 m-85 -108.95 141.78 40.54 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.486 -0.779 . . . . 0.45 110.121 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.602 ' HB3' ' CG2' ' A' ' 167' ' ' VAL . . . -149.3 114.6 5.51 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.736 -0.665 . . . . 0.51 109.901 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.727 ' HG3' ' HB3' ' A' ' 94' ' ' PHE . 10.5 pt-20 -92.44 129.42 38.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.387 -0.597 . . . . 2.62 109.387 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.465 ' HA ' HD22 ' A' ' 48' ' ' LEU . 40.2 t -82.73 -30.09 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.082 -0.508 . . . . 3.77 110.616 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -97.42 52.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.423 0.63 . . . . 5.68 109.471 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.727 ' HB3' ' HG3' ' A' ' 91' ' ' GLU . 22.9 p90 -77.09 101.03 5.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.488 -0.778 . . . . 4.65 110.894 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.42 14.27 0.5 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.335 0.495 . . . . 1.39 112.335 175.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -161.71 139.36 8.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.977 -0.379 . . . . 2.75 109.977 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 119' ' ' ASP . 2.6 p -103.22 -78.3 0.55 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.074 -0.512 . . . . 1.4 110.618 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -65.15 142.12 58.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.533 -0.543 . . . . 2.38 109.533 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 77.24 -1.82 2.71 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.662 0.785 . . . . 2.89 110.238 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -126.95 51.49 1.87 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.674 -1.232 . . . . 2.79 107.674 169.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.854 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 13.3 m -107.57 118.8 56.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.038 -0.983 . . . . 1.22 110.273 -173.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.605 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 22.5 m-85 -90.41 156.96 17.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.133 -0.94 . . . . 0.99 111.469 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.667 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 6.7 t70 -107.57 136.33 47.51 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.507 -0.553 . . . . 1.53 109.507 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.68 122.41 23.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 0.63 111.042 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.2 mtt180 -124.7 140.29 53.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.154 -0.93 . . . . 1.95 111.258 -174.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.624 HG22 HD11 ' A' ' 153' ' ' LEU . 7.7 p -117.59 104.93 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 1.44 109.611 173.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.931 ' HB2' HD12 ' A' ' 153' ' ' LEU . 28.4 t-20 61.3 41.54 13.02 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.52 1.152 . . . . 1.65 108.193 -171.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.62 -21.29 26.78 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.747 -1.115 . . . . 0.42 112.698 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 78.1 m-70 -74.08 105.35 5.26 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 122.631 0.373 . . . . 0.68 111.717 -174.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.561 HG22 ' HG2' ' A' ' 105' ' ' ARG . 2.4 p -70.2 92.64 0.78 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.041 0.448 . . . . 0.77 111.511 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.416 HG23 HG12 ' A' ' 106' ' ' VAL . 21.4 t -76.62 -41.76 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.917 -0.583 . . . . 0.94 109.804 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.433 HG11 ' HG ' ' A' ' 115' ' ' LEU . 11.1 t -132.55 90.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.098 -0.501 . . . . 0.35 110.148 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -105.08 72.49 1.0 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.655 0.741 . . . . 4.01 109.777 175.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.854 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 7.8 p-10 161.24 32.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.587 -1.642 . . . . 1.96 108.226 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -69.65 85.43 0.46 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.91 -1.041 . . . . 1.18 111.093 -174.55 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 19.3 p-10 -98.0 88.69 4.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.574 -0.739 . . . . 1.93 109.52 172.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.611 ' HB ' ' OE2' ' A' ' 91' ' ' GLU . 56.8 mt -59.62 -39.86 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.578 -0.737 . . . . 0.82 111.166 -173.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.409 ' HD1' ' HB2' ' A' ' 94' ' ' PHE . 84.0 t80 -52.64 -37.15 57.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 1.08 111.585 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 97' ' ' SER . 24.9 t70 -73.88 -37.21 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.896 -0.503 . . . . 0.96 111.108 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 7.6 mmt180 -73.11 -51.91 16.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.721 -0.672 . . . . 1.69 110.945 -170.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.93 -23.18 4.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.351 -0.386 . . . . 1.49 111.813 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.78 -83.34 1.6 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.186 -1.006 . . . . 1.4 112.144 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -114.92 107.82 15.91 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.88 -0.328 . . . . 4.11 111.043 -176.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.6 p 44.71 -123.73 0.98 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.775 -0.648 . . . . 1.97 111.961 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.597 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 60.4 p 53.76 -169.27 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.859 0.863 . . . . 0.85 112.425 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.679 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -100.02 129.15 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.315 0.487 . . . . 0.57 112.315 -177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 38.4 t60 -101.82 147.41 26.53 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.584 -1.265 . . . . 0.55 107.584 169.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.602 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.5 p30 -142.78 127.65 18.29 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.145 -0.622 . . . . 1.64 111.911 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.95 115.27 28.52 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.895 -1.048 . . . . 1.12 108.793 172.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.42 HG23 HG22 ' A' ' 86' ' ' VAL . 64.2 mt -101.5 106.67 19.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.229 -0.656 . . . . 0.74 109.229 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 111' ' ' VAL . 54.3 mt -116.84 90.73 33.13 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.377 -0.374 . . . . 1.25 110.956 -173.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.452 ' HB3' HG22 ' A' ' 84' ' ' VAL . 8.9 Cg_exo -77.43 119.69 5.0 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.568 2.179 . . . . 0.29 112.237 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.684 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -109.68 144.59 17.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.875 -1.157 . . . . 0.27 107.875 175.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -113.92 107.33 15.54 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 120.34 -0.544 . . . . 1.24 110.503 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.589 HG22 ' HG2' ' A' ' 80' ' ' GLU . 33.5 mt -99.62 120.89 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.786 -0.45 . . . . 0.34 109.786 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -149.8 137.76 20.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.563 -0.532 . . . . 1.95 109.563 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 8.3 mptt 61.23 30.35 19.18 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.646 0.736 . . . . 3.13 110.185 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.31 11.44 84.18 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 114.805 -1.089 . . . . 0.41 112.607 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.769 ' HG2' HG22 ' A' ' 148' ' ' THR . 90.2 mttt -113.33 142.45 45.84 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.646 -0.326 . . . . 2.23 110.159 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 5.8 tt -112.61 119.46 38.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.037 -0.529 . . . . 0.41 110.096 -173.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 17.3 m -111.97 109.45 19.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.688 0.28 . . . . 1.19 110.94 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.44 HG23 ' CD2' ' A' ' 140' ' ' LEU . 66.9 t -94.24 94.58 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.563 -0.903 . . . . 0.92 108.563 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 59.27 -88.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.115 -0.948 . . . . 1.88 111.068 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -107.23 -13.0 22.33 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.541 -0.838 . . . . 1.02 113.091 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 141' ' ' SER . 51.6 mt-10 -90.14 112.88 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.535 -0.391 . . . . 1.95 110.863 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.8 p -105.65 113.48 42.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.418 0.627 . . . . 0.92 110.378 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.3 t -147.42 137.46 23.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.689 . . . . 1.27 109.19 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.769 HG22 ' HG2' ' A' ' 139' ' ' LYS . 41.0 p -56.81 139.36 51.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.116 0.484 . . . . 1.45 111.878 -175.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.783 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 22.8 t80 -79.91 129.09 34.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.497 -0.774 . . . . 0.47 109.785 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 t -122.64 99.19 6.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 1.79 111.971 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.37 -67.36 3.33 Favored Glycine 0 C--N 1.329 0.194 0 CA-C-N 115.742 -0.663 . . . . 0.42 113.939 171.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.616 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -158.83 167.55 29.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.205 0.526 . . . . 1.23 110.08 -177.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.944 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 14.5 tp -81.87 144.02 31.29 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.574 -0.899 . . . . 1.17 108.574 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.7 t -132.74 108.7 9.18 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.146 -1.022 . . . . 1.35 110.777 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 96.0 t -94.18 108.61 20.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.373 -0.376 . . . . 0.42 110.19 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -114.46 138.41 50.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.782 -0.644 . . . . 1.98 110.121 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.667 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -129.21 128.31 43.07 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.511 0.672 . . . . 2.32 110.705 168.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 44.5 t -106.47 144.63 15.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.423 -1.262 . . . . 0.62 111.085 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.54 ' HA ' ' OD1' ' A' ' 164' ' ' ASN . 36.0 ttpt -61.41 118.54 7.09 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.377 -0.828 . . . . 2.26 111.794 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -99.33 0.23 57.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.93 -0.652 . . . . 1.45 111.671 175.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -175.43 -70.22 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.103 -1.073 . . . . 4.24 108.103 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.401 ' O ' ' HB3' ' A' ' 163' ' ' ASP . 2.5 t80 179.71 -178.77 0.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.237 -1.394 . . . . 4.98 107.237 170.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 162' ' ' TYR . 38.7 t70 74.55 -52.45 0.68 Allowed 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.792 0.682 . . . . 2.64 110.32 -178.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.726 ' HB3' ' HD2' ' A' ' 165' ' ' PRO . 80.1 m-20 63.61 -174.84 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 O-C-N 123.814 0.696 . . . . 2.06 109.88 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.75 ' HB3' ' CE1' ' A' ' 89' ' ' PHE . 80.4 Cg_exo -53.95 88.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 121.567 1.511 . . . . 3.16 111.171 165.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.473 ' HB2' ' HA ' ' A' ' 91' ' ' GLU . 1.1 mmtm -52.27 -57.97 8.08 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 115.711 -0.677 . . . . 3.18 111.085 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.733 HG21 ' HA ' ' A' ' 62' ' ' GLN . 1.0 OUTLIER -112.62 137.96 43.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 CA-C-N 115.918 -0.583 . . . . 1.19 109.516 176.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 38.3 t -132.53 101.61 5.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.725 0.774 . . . . 1.36 111.84 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.763 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -88.34 36.79 0.79 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.629 1.172 . . . . 0.31 112.094 -177.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.797 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 13.6 tp -61.64 116.59 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.798 0.666 . . . . 0.69 112.798 -170.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 173' ' ' MET . 0.1 OUTLIER -124.22 123.47 40.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.652 -0.703 . . . . 0.48 110.25 176.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.598 ' CG2' ' HB3' ' A' ' 12' ' ' TRP . 2.7 tt -113.0 123.41 68.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 122.001 0.905 . . . . 0.3 111.366 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.61 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 12.3 ptm -111.4 164.57 12.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.997 -1.001 . . . . 0.99 109.914 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.682 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 19.2 ptmt -115.66 141.16 48.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.371 1.081 . . . . 1.22 112.726 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.71 -28.84 13.72 Favored Glycine 0 C--N 1.304 -1.227 0 CA-C-N 113.853 -1.521 . . . . 0.31 114.827 161.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.2 OUTLIER -169.52 153.67 5.25 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.642 1.221 . . . . 0.68 113.023 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.508 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -86.43 -9.89 55.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.057 -0.974 . . . . 0.86 109.981 168.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.492 ' H ' ' HB ' ' A' ' 176' ' ' THR . 10.9 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.524 -0.762 . . . . 2.16 111.528 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 111.172 -0.771 . . . . 1.48 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.854 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 34.6 tp -56.06 -31.97 63.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.319 0.58 . . . . 0.72 110.789 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.525 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.23 -43.08 74.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.878 -1.055 . . . . 0.53 112.533 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.73 -17.76 34.99 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.441 -0.504 . . . . 2.18 112.256 -173.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 23.1 mmtm -91.55 -16.6 26.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.163 -0.615 . . . . 1.79 111.409 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.3 p -55.2 128.57 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.546 0.689 . . . . 0.33 111.197 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.652 HG23 HG23 ' A' ' 172' ' ' ILE . 0.3 OUTLIER -96.63 -31.39 3.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.345 -0.843 . . . . 0.92 109.912 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.654 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 74.8 t90 -172.95 132.62 0.53 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.321 -0.854 . . . . 0.36 109.396 -169.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.57 137.82 18.41 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.864 -0.522 . . . . 0.26 110.827 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.681 HG21 ' CD ' ' A' ' 33' ' ' PRO . 7.3 p -148.37 138.86 16.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 122.196 0.998 . . . . 0.79 112.57 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.675 ' HB2' HD12 ' A' ' 60' ' ' LEU . 10.9 t-20 -98.35 104.12 16.12 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.403 -1.271 . . . . 1.49 107.623 167.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -66.3 89.14 0.13 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.002 -1.111 . . . . 0.48 108.002 172.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.876 ' HA2' ' N ' ' A' ' 65' ' ' ARG . . . 179.1 -41.24 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.56 0 O-C-N 125.059 1.474 . . . . 0.76 112.023 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.66 -157.55 7.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.18 -1.009 . . . . 0.74 112.937 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.858 ' HG3' ' HB2' ' A' ' 41' ' ' ALA . 44.1 mt-10 -119.35 120.09 35.88 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 111.528 0.196 . . . . 1.77 111.528 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.854 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 67.2 m 39.1 112.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.504 2.039 . . . . 1.29 116.504 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.998 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 1.9 t-80 -145.94 130.07 17.48 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.252 0.549 . . . . 0.42 111.334 171.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -87.75 115.91 28.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.043 -0.981 . . . . 1.01 109.646 174.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -82.42 164.53 20.94 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.769 -0.456 . . . . 0.77 109.769 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 m -62.63 -17.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 O-C-N 124.16 0.913 . . . . 0.62 111.791 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.484 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 88.3 m-70 -84.64 -1.84 56.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.3 0.571 . . . . 0.86 109.966 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.511 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 86.48 25.94 34.51 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.166 -0.924 . . . . 0.33 111.81 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.626 HD11 ' HG ' ' A' ' 6' ' ' LEU . 26.1 mm -103.95 113.23 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.394 0.616 . . . . 0.31 111.145 -175.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -92.96 110.83 22.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.42 -0.809 . . . . 0.8 110.823 -173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.998 ' CE2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -85.7 145.4 27.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.5 0.191 . . . . 1.75 110.59 179.119 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.672 ' O ' HG23 ' A' ' 14' ' ' VAL . 66.2 mtt180 -94.97 170.19 9.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.979 -0.555 . . . . 2.94 111.689 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 61.1 mttp -84.7 82.49 8.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.017 0.747 . . . . 2.78 113.017 -169.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 1.029 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 39.45 45.9 1.05 Allowed Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 114.737 1.384 . . . . 2.41 114.737 167.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.681 ' CD ' HG21 ' A' ' 14' ' ' VAL . 28.0 Cg_endo -96.09 50.28 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.15 3.234 . . . . 1.87 113.76 -161.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.531 HD11 ' CE2' ' A' ' 73' ' ' TYR . 8.7 mp -81.82 -92.41 0.06 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.753 0.649 . . . . 1.99 112.753 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' O ' ' HD2' ' A' ' 37' ' ' ARG . 11.8 mm-40 -92.71 50.57 1.6 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.016 -0.538 . . . . 5.31 112.173 -167.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.3 -3.45 81.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.565 -0.826 . . . . 2.64 111.459 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 35' ' ' GLU . 4.9 mpt_? -87.67 72.94 9.45 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.05 -0.722 . . . . 5.64 109.05 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.9 t -102.64 116.83 47.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 120.487 -0.485 . . . . 3.96 110.163 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.91 33.8 9.49 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.266 -0.734 . . . . 2.56 111.266 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.476 ' HB3' ' OD2' ' A' ' 32' ' ' ASP . 5.0 tpm_? -98.45 -44.51 6.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.458 -0.571 . . . . 6.2 109.458 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.858 ' HB2' ' HG3' ' A' ' 19' ' ' GLU . . . 58.62 -81.96 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.612 -1.177 . . . . 2.0 112.149 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.3 m 58.7 63.81 1.59 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.416 0.627 . . . . 2.52 109.809 -170.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.49 63.18 0.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.147 -0.933 . . . . 2.52 111.397 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -111.26 15.5 21.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.606 -0.725 . . . . 7.02 109.906 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.692 ' HA3' ' HG3' ' A' ' 64' ' ' GLU . . . -100.02 7.53 58.86 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.758 -1.11 . . . . 3.06 111.154 171.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.432 ' SD ' HG23 ' A' ' 63' ' ' THR . 50.6 mmm -72.72 -12.66 61.1 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.659 0.743 . . . . 2.35 109.166 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -83.24 -0.71 50.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.848 -1.069 . . . . 4.25 110.787 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.6 mt -117.9 80.01 14.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.98 -0.554 . . . . 2.56 109.673 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.07 128.43 15.74 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.62 2.213 . . . . 1.69 112.254 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.889 HD13 ' HA ' ' A' ' 62' ' ' GLN . 1.7 mp -81.3 108.5 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.661 0.743 . . . . 1.59 109.811 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.556 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.6 mm? -65.29 -18.36 65.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.878 -1.055 . . . . 1.91 112.962 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -91.91 -9.83 41.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.481 -0.487 . . . . 3.17 111.985 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.501 ' OG ' ' HD2' ' A' ' 61' ' ' TYR . 57.9 m -108.83 160.06 16.29 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.285 0.564 . . . . 0.97 112.323 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.523 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -90.88 143.44 28.71 Favored Pre-proline 0 C--O 1.214 -0.798 0 CA-C-N 115.305 -0.861 . . . . 1.92 109.26 -176.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 46.8 Cg_exo -37.48 -48.92 1.85 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.989 3.126 . . . . 0.7 115.841 -164.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -64.22 -54.58 31.24 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.442 1.115 . . . . 2.71 109.659 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 3.3 p30 -77.85 -15.8 58.78 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.538 -1.21 . . . . 1.63 110.577 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.711 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 63.1 tt0 -58.12 -50.5 73.26 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.556 -0.535 . . . . 1.58 109.556 172.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.4 t -55.25 -47.94 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.445 0.641 . . . . 1.27 109.859 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 15' ' ' ASN . 50.1 tp -56.78 -19.42 16.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.799 -1.091 . . . . 1.18 111.425 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.62 ' HB3' ' HG3' ' A' ' 88' ' ' LYS . 23.1 m-30 -120.51 5.34 10.63 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.072 -0.513 . . . . 0.99 111.722 -173.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.889 ' HA ' HD13 ' A' ' 50' ' ' ILE . 0.7 OUTLIER -120.78 -38.25 2.88 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.812 -0.555 . . . . 1.97 112.453 -170.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.432 HG23 ' SD ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -67.56 139.41 56.92 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.477 -0.783 . . . . 1.27 110.479 -175.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.975 ' HB3' HG12 ' A' ' 167' ' ' VAL . 0.0 OUTLIER -122.87 -4.01 8.62 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.298 1.592 . . . . 1.96 115.298 -166.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 1.029 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 2.1 mtp-105 70.64 -83.24 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.377 0.608 . . . . 3.35 112.179 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.0 t80 175.75 114.17 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.192 -0.913 . . . . 4.71 108.864 -166.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.528 ' HA ' ' HZ ' ' A' ' 71' ' ' PHE . 4.2 p-10 -64.82 135.29 55.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.069 -0.715 . . . . 4.38 109.069 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -142.52 -76.86 0.26 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.007 0.432 . . . . 3.7 111.655 -168.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -170.85 -162.51 0.27 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.427 -1.323 . . . . 2.2 107.427 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.7 t -48.77 104.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.076 0.465 . . . . 1.41 109.808 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.563 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 71.4 m-85 -77.91 108.49 11.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.403 -0.962 . . . . 1.57 108.403 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.11 144.63 16.5 Favored Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 115.361 -0.836 . . . . 0.78 113.234 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.568 ' HE1' ' CE1' ' A' ' 157' ' ' PHE . 54.2 m-85 -132.42 129.26 39.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.344 -0.428 . . . . 1.21 110.487 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.555 ' OD2' ' HE2' ' A' ' 152' ' ' LYS . 10.3 t70 -100.6 102.34 13.47 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.151 -0.685 . . . . 2.47 109.151 177.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 6.1 mt -102.6 90.06 2.05 Favored Pre-proline 0 CA--C 1.513 -0.46 0 N-CA-C 109.158 -0.682 . . . . 0.38 109.158 174.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 33.4 Cg_endo -66.12 116.58 4.09 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.305 1.337 . . . . 0.59 111.751 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.843 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 43.6 mt -110.32 139.75 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.98 -0.554 . . . . 0.49 111.113 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.29 16.29 4.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 3.32 109.979 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.509 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 9.1 mm-40 -129.09 158.13 39.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.585 0.231 . . . . 2.16 110.891 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.519 ' HG2' HG22 ' A' ' 135' ' ' ILE . 4.5 mt-10 -111.64 170.6 8.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.062 -0.517 . . . . 1.2 110.374 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.26 -162.98 24.02 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.447 -1.061 . . . . 0.3 110.447 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 67.0 mt-10 -102.61 111.45 23.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.854 0.827 . . . . 1.96 109.83 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.674 ' HB2' HG12 ' A' ' 133' ' ' ILE . 73.6 m-85 -94.12 123.87 37.77 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 108.434 -0.95 . . . . 0.71 108.434 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.599 HG21 ' CA ' ' A' ' 177' ' ' ALA . 86.1 t -113.63 106.15 20.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.646 0.736 . . . . 0.26 110.289 -174.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.5 mp -87.37 104.0 16.02 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.602 -1.181 . . . . 1.56 109.127 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.525 HG22 HG23 ' A' ' 130' ' ' ILE . 50.3 t -106.02 103.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.754 -1.202 . . . . 1.14 107.754 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 1.1 pt? -116.0 132.01 56.77 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.076 -0.65 . . . . 1.44 110.18 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.672 ' HE3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -86.26 120.29 27.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.116 -0.698 . . . . 3.73 109.116 178.019 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.545 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -106.29 140.47 39.18 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.099 -0.955 . . . . 0.45 110.508 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.533 ' HB3' HG22 ' A' ' 167' ' ' VAL . . . -149.61 146.22 27.19 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.129 -0.693 . . . . 0.51 109.129 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.56 ' HB3' HD12 ' A' ' 117' ' ' ILE . 6.9 pt-20 -120.13 -177.81 3.51 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.791 -0.364 . . . . 2.62 111.023 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.703 HG22 ' CD2' ' A' ' 93' ' ' TYR . 14.2 p -80.99 -68.92 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 119.235 -0.412 . . . . 3.77 112.07 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.703 ' CD2' HG22 ' A' ' 92' ' ' VAL . 35.5 p90 -176.16 25.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.566 0.621 . . . . 5.68 112.53 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.599 ' CE2' ' HB3' ' A' ' 163' ' ' ASP . 29.1 m-85 -69.31 103.31 1.94 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.126 0.489 . . . . 4.65 110.585 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.69 67.24 5.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.251 0.834 . . . . 1.39 113.251 -168.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.468 ' HG2' ' HG2' ' A' ' 100' ' ' LYS . 18.4 pm0 -152.4 140.66 20.46 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.684 -0.488 . . . . 2.75 109.684 168.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' A' ' 119' ' ' ASP . 18.3 m -105.75 153.54 21.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.157 -0.474 . . . . 1.4 110.873 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 49.58 45.49 24.18 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.474 0.654 . . . . 2.38 111.834 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.61 -62.55 0.37 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.161 -1.052 . . . . 2.89 108.161 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HG2' ' HG2' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -84.52 87.03 7.23 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.836 -1.075 . . . . 2.79 109.891 175.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.812 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.6 m -109.64 124.46 66.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.325 0.584 . . . . 1.22 111.0 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.455 ' CD2' ' HD3' ' A' ' 165' ' ' PRO . 30.6 m-85 -96.79 165.49 12.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.172 -0.922 . . . . 0.99 110.727 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.621 ' OD2' ' HB ' ' A' ' 158' ' ' VAL . 0.0 OUTLIER -106.54 136.94 45.43 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.786 -0.766 . . . . 1.53 109.905 173.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 1.8 t -121.55 119.19 58.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.844 -0.616 . . . . 0.63 109.522 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.589 ' HG2' HG22 ' A' ' 110' ' ' THR . 24.5 mtt180 -121.38 139.42 53.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.088 0.471 . . . . 1.95 111.447 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.899 HG13 HD11 ' A' ' 153' ' ' LEU . 79.9 t -122.39 100.07 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.24 -0.891 . . . . 1.44 109.469 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.858 ' HB2' HD22 ' A' ' 153' ' ' LEU . 29.1 t-20 63.28 43.66 6.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.46 1.124 . . . . 1.65 108.686 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.59 -5.4 78.32 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.941 -1.027 . . . . 0.42 112.704 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 92.9 m-70 -92.35 106.64 18.6 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 122.017 0.127 . . . . 0.68 111.15 -174.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.589 HG22 ' HG2' ' A' ' 105' ' ' ARG . 2.9 p -70.18 88.67 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.968 0.413 . . . . 0.77 111.362 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.539 HG22 HG11 ' A' ' 142' ' ' VAL . 37.2 t -69.01 -51.46 43.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.94 109.799 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 104' ' ' VAL . 35.6 t -120.88 88.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.35 110.144 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.621 ' HG2' ' HB3' ' A' ' 103' ' ' ASP . 0.2 OUTLIER -102.57 76.88 1.57 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.515 -1.291 . . . . 4.01 107.515 173.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.812 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 9.2 p-10 166.05 26.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.99 -1.459 . . . . 1.96 109.634 -172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.73 101.11 3.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 1.18 111.499 -172.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 27.5 p-10 -118.16 85.88 2.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.288 1.042 . . . . 1.93 109.72 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 91' ' ' GLU . 60.0 mt -54.21 -37.43 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.84 -1.073 . . . . 0.82 112.167 -172.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -58.44 -38.63 77.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.691 0.282 . . . . 1.08 111.579 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.632 ' HB2' ' HB3' ' A' ' 97' ' ' SER . 9.4 t70 -70.15 -33.93 72.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.329 0.585 . . . . 0.96 110.422 177.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 7.4 mmt180 -74.42 -51.38 15.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.531 -0.759 . . . . 1.69 111.117 -173.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 m -115.18 -29.51 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 113.109 0.781 . . . . 1.49 113.109 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.1 -73.97 2.58 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.517 -0.849 . . . . 1.4 112.003 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -77.28 151.21 35.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.251 -0.277 . . . . 4.11 110.251 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.6 t -68.55 80.22 0.27 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.785 0.802 . . . . 1.97 109.762 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.556 HG22 ' HB2' ' A' ' 51' ' ' LEU . 41.5 p -125.38 -137.95 0.27 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.958 -1.019 . . . . 0.85 109.188 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.591 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . . . -102.5 116.54 32.82 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.492 -0.483 . . . . 0.57 111.427 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 48.4 t60 -112.88 106.75 15.11 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 108.704 -0.85 . . . . 0.55 108.704 170.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.538 ' OD1' ' HG2' ' A' ' 88' ' ' LYS . 13.6 m-20 -105.03 117.12 33.2 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.319 -0.552 . . . . 1.64 111.384 -169.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -89.09 111.97 22.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.682 -0.69 . . . . 1.12 109.546 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.525 HG23 HG22 ' A' ' 86' ' ' VAL . 61.3 mt -103.18 110.15 28.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.411 -0.588 . . . . 0.74 109.411 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.481 HG21 HG21 ' A' ' 106' ' ' VAL . 65.5 mt -122.69 94.41 47.56 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.283 -0.417 . . . . 1.25 111.099 -173.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -80.83 121.81 4.19 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.728 2.285 . . . . 0.29 111.988 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.6 OUTLIER -110.58 155.62 11.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.646 -0.872 . . . . 0.27 108.646 177.057 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.528 ' OG ' ' HB2' ' A' ' 141' ' ' SER . 2.9 p -120.22 106.94 12.4 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.694 -0.402 . . . . 1.24 110.799 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 34.1 mt -100.66 119.6 49.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.326 -0.62 . . . . 0.34 109.326 176.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 27.5 mmtp -151.4 136.79 17.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.705 -0.48 . . . . 1.95 109.705 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt 65.52 22.91 11.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.68 -0.691 . . . . 3.13 110.47 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.64 9.47 86.37 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.844 -0.693 . . . . 0.41 112.084 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 52.8 mtpt -106.61 166.51 10.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.687 -0.486 . . . . 2.23 109.687 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.2 tt -140.73 116.35 10.2 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.636 -0.505 . . . . 0.41 109.636 -174.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.528 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 40.6 m -110.73 131.07 55.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.26 -0.427 . . . . 1.19 111.041 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.539 HG11 HG22 ' A' ' 111' ' ' VAL . 74.6 t -129.37 109.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.92 111.136 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 50.79 37.5 17.13 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.82 -0.627 . . . . 1.88 112.665 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.97 -24.33 25.37 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.783 -0.723 . . . . 1.02 112.576 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -85.06 112.12 20.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.02 -0.733 . . . . 1.95 109.02 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.6 p -105.57 125.67 60.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.771 -0.65 . . . . 0.92 110.611 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.3 m -144.51 -166.65 2.44 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.926 -0.768 . . . . 1.27 108.926 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 59.8 p -98.75 148.39 23.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.001 0.429 . . . . 1.45 110.847 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.843 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 39.6 t80 -81.41 120.95 25.63 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.736 -1.209 . . . . 0.47 107.736 168.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 m -130.51 95.92 4.0 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.122 0.487 . . . . 1.79 110.75 -174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.13 -82.41 1.18 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.598 -0.728 . . . . 0.42 113.781 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.555 ' HE2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -145.04 158.69 43.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.331 0.565 . . . . 1.23 111.004 -175.187 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.899 HD11 HG13 ' A' ' 106' ' ' VAL . 1.4 tm? -80.96 118.56 22.54 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.174 -1.417 . . . . 1.17 107.174 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 5.3 t -114.23 107.06 15.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.951 -0.699 . . . . 1.35 110.161 -171.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.516 ' O ' ' HD1' ' A' ' 73' ' ' TYR . 38.2 t -92.62 108.02 19.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.98 -0.748 . . . . 0.42 108.98 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 25.4 mt-10 -130.33 108.91 10.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.174 -0.466 . . . . 1.98 110.156 -177.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 2.9 p90 -104.58 115.85 31.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.722 0.772 . . . . 2.32 110.676 174.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.621 ' HB ' ' OD2' ' A' ' 103' ' ' ASP . 59.3 t -87.63 143.43 11.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 114.347 -1.297 . . . . 0.62 111.01 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -68.0 136.01 53.21 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.739 -1.119 . . . . 2.26 111.585 -175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -86.61 -35.11 10.66 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.688 -0.768 . . . . 1.45 111.269 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -145.08 -97.71 0.1 Allowed 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.675 0.25 . . . . 4.24 111.675 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -112.0 -83.26 0.58 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.445 0.164 . . . . 4.98 111.203 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.599 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 17.7 t70 -75.46 85.17 2.56 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.762 -0.829 . . . . 2.64 108.762 176.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.731 ' HB2' ' HD2' ' A' ' 165' ' ' PRO . 20.1 p-10 -78.68 161.43 69.29 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.152 -0.931 . . . . 2.06 109.692 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.731 ' HD2' ' HB2' ' A' ' 164' ' ' ASN . 32.6 Cg_exo -20.76 87.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 124.877 3.718 . . . . 3.16 114.155 -168.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.533 ' HD2' ' HB ' ' A' ' 92' ' ' VAL . 36.8 tttp -55.86 -61.28 2.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.926 -1.488 . . . . 3.18 112.44 -162.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.975 HG12 ' HB3' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -102.9 136.5 35.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 120.06 -0.656 . . . . 1.19 110.169 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 47.7 t -125.81 135.35 51.89 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.672 0.749 . . . . 1.36 110.313 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.6 ' HB1' ' HD1' ' A' ' 61' ' ' TYR . . . -123.05 36.76 4.57 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.615 -1.175 . . . . 0.31 109.869 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.654 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 9.9 tp -57.98 112.17 1.41 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.627 -1.17 . . . . 0.69 112.715 -170.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.854 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -122.27 120.45 34.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.619 -0.719 . . . . 0.48 110.243 176.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.652 HG23 HG23 ' A' ' 11' ' ' ILE . 6.9 tt -113.09 132.16 62.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.697 0.76 . . . . 0.3 110.357 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.618 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 4.1 ppp? -127.02 164.09 22.29 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.562 -0.744 . . . . 0.99 109.412 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.9 ptmt -112.61 142.16 45.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.565 1.174 . . . . 1.22 113.32 -173.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 176' ' ' THR . . . 105.37 -30.0 10.6 Favored Glycine 0 C--N 1.31 -0.865 0 CA-C-N 113.161 -1.836 . . . . 0.31 115.058 161.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.6 OUTLIER -176.75 153.07 1.04 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.467 1.133 . . . . 0.68 113.238 -177.268 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.599 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -84.59 -14.61 48.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.755 -0.657 . . . . 0.86 109.596 168.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.478 ' H ' ' HB ' ' A' ' 176' ' ' THR . 38.9 t70 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 114.937 -1.029 . . . . 2.16 111.807 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.026 0 N-CA-C 111.768 -0.533 . . . . 1.48 111.768 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.772 HD23 ' HB3' ' A' ' 25' ' ' HIS . 27.6 tp -66.14 -30.49 70.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.099 0.476 . . . . 0.72 110.425 -175.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.535 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -61.32 -25.86 67.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.368 -0.833 . . . . 0.53 111.91 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.73 -36.72 23.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.375 -0.375 . . . . 2.18 111.358 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.649 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -90.15 -11.04 42.35 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.542 -0.463 . . . . 1.79 111.582 -171.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.75 HG23 ' HE1' ' A' ' 171' ' ' PHE . 14.7 p -59.31 132.8 24.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.035 -0.666 . . . . 0.33 111.546 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.681 HG23 HG23 ' A' ' 172' ' ' ILE . 0.6 OUTLIER -107.79 -38.4 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.051 -0.522 . . . . 0.92 110.563 176.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.733 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 49.6 t90 -165.33 143.63 6.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.825 -0.625 . . . . 0.36 109.32 -172.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.85 135.75 11.76 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.66 -0.416 . . . . 0.26 111.347 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.0 t -137.15 106.58 4.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.686 0.755 . . . . 0.79 110.922 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 3.2 t-20 -81.25 86.55 6.21 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.265 -1.383 . . . . 1.49 107.265 163.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -66.61 103.85 1.16 Allowed 'General case' 0 C--O 1.255 1.362 0 CA-C-N 115.386 -0.824 . . . . 0.48 109.813 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 172.93 -38.69 0.15 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 113.073 -1.876 . . . . 0.76 112.279 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.455 ' HA2' ' HB1' ' A' ' 41' ' ' ALA . . . -132.88 -141.26 4.58 Favored Glycine 0 N--CA 1.459 0.205 0 C-N-CA 120.702 -0.761 . . . . 0.74 112.427 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -118.17 157.63 26.58 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.589 -0.359 . . . . 1.77 110.893 175.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 23.2 m -19.03 122.44 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.307 1.595 . . . . 1.29 115.307 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.691 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 17.2 t-80 -138.16 121.67 17.27 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.218 -0.901 . . . . 0.42 111.271 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 28' ' ' HIS . 64.1 t -85.3 123.3 39.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.077 -0.965 . . . . 1.01 109.019 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.76 ' HB3' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -101.7 171.26 7.65 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.525 -0.47 . . . . 0.77 110.715 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -56.53 -22.95 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 124.708 1.255 . . . . 0.62 112.808 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.772 ' HB3' HD23 ' A' ' 6' ' ' LEU . 34.0 m-70 -77.12 -10.61 59.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.35 0.595 . . . . 0.86 109.672 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.535 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 87.76 28.21 24.54 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.135 -0.939 . . . . 0.33 110.763 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.659 HD11 ' HG ' ' A' ' 6' ' ' LEU . 12.6 mm -102.14 112.49 35.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.136 0.493 . . . . 0.31 110.1 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.573 ' HB2' HG22 ' A' ' 22' ' ' VAL . 29.9 t60 -93.63 113.09 25.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.973 -0.558 . . . . 0.8 110.076 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.691 ' CD2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -90.5 142.38 27.8 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.643 -0.503 . . . . 1.75 109.643 175.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -100.78 69.29 1.35 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.012 0.745 . . . . 2.94 113.012 -169.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.746 ' HG2' ' H ' ' A' ' 32' ' ' ASP . 14.5 ttpp 60.83 -169.34 0.16 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.477 -0.783 . . . . 2.78 111.723 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.778 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 9.4 p-10 -103.09 88.93 1.71 Allowed Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-O 121.984 0.897 . . . . 2.41 110.106 173.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.638 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 31.7 Cg_endo -86.57 -105.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.158 1.905 . . . . 1.87 112.313 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp 67.86 -40.35 0.41 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.145 0.578 . . . . 1.99 109.815 -170.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 33' ' ' PRO . 39.3 mt-10 78.53 149.29 0.1 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.216 -0.902 . . . . 5.31 112.466 166.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.57 -6.7 44.41 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.182 -0.917 . . . . 2.64 111.878 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -139.46 31.3 2.11 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.024 -0.362 . . . . 5.64 110.024 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.5 m -104.03 161.49 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.107 0.48 . . . . 3.96 111.591 -169.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.97 -54.57 0.73 Allowed Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.488 -0.778 . . . . 2.56 111.413 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -101.65 100.93 11.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.894 0.378 . . . . 6.2 111.587 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.455 ' HB1' ' HA2' ' A' ' 18' ' ' GLY . . . -89.81 -60.54 1.91 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.126 -0.694 . . . . 2.0 109.126 170.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.8 t 69.29 75.29 0.24 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.674 0.75 . . . . 2.52 110.883 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -89.39 -7.15 55.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.209 -0.905 . . . . 2.52 109.864 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -81.22 47.59 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.003 0.906 . . . . 7.02 110.124 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.13 50.39 0.19 Allowed Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 114.372 -1.286 . . . . 3.06 110.126 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.563 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 24.4 mmt -59.11 -62.74 1.65 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.073 -0.563 . . . . 2.35 109.827 -176.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 46' ' ' MET . 22.7 pttm 48.8 -168.17 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.408 1.067 . . . . 4.25 112.448 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 30.4 66.5 0.82 Allowed Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 123.967 0.907 . . . . 2.56 113.119 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.77 105.78 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.41 2.073 . . . . 1.69 112.3 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 126' ' ' ALA . 1.3 mp -57.62 111.87 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 121.891 0.853 . . . . 1.59 110.462 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 51' ' ' LEU . 4.6 mp -68.86 -14.38 63.0 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.809 -1.087 . . . . 1.91 111.73 -172.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.641 ' HB2' ' HB3' ' A' ' 126' ' ' ALA . 27.4 mmm180 -98.97 23.01 9.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.22 -0.445 . . . . 3.17 111.423 -175.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -150.31 167.76 26.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 0.97 112.186 -176.32 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.403 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 3.0 t30 -95.51 139.17 21.84 Favored Pre-proline 0 C--O 1.215 -0.744 0 CA-C-N 115.013 -0.994 . . . . 1.92 108.83 177.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.481 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 3.7 Cg_exo -36.69 -54.7 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.512 3.475 . . . . 0.7 116.246 -162.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' O ' ' CE1' ' A' ' 21' ' ' HIS . 1.7 pm0 -77.08 -28.71 54.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.172 0.896 . . . . 2.71 112.012 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -10.98 43.8 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 120.912 -1.117 . . . . 1.63 109.026 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.481 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 28.3 tt0 -67.07 -46.38 74.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.722 -1.126 . . . . 1.58 110.002 170.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.72 -39.98 86.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 109.684 -0.487 . . . . 1.27 109.684 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' ' 23' ' ' ASP . 45.3 tp -60.69 -21.58 63.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.183 0.516 . . . . 1.18 111.153 173.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.577 ' CD2' ' HE3' ' A' ' 88' ' ' LYS . 8.6 m-30 -102.64 -2.21 28.75 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.937 -0.574 . . . . 0.99 111.542 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.829 ' HA ' HG11 ' A' ' 167' ' ' VAL . 4.1 tt0 -121.67 -110.4 0.33 Allowed 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.637 -0.425 . . . . 1.97 110.147 174.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.629 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.6 OUTLIER 35.01 102.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.446 0.906 . . . . 1.27 113.446 -173.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -88.84 136.98 32.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.465 -0.334 . . . . 1.96 111.824 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.778 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -92.74 178.79 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 3.35 110.469 173.165 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -104.0 106.5 17.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 4.71 111.247 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -177.27 148.37 0.6 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.46 0.475 . . . . 4.38 110.071 174.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.578 ' HA ' ' HB2' ' A' ' 164' ' ' ASN . 1.5 pt-20 -131.53 35.8 3.81 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.934 -0.395 . . . . 3.7 109.934 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.662 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 26.8 t70 -142.34 -164.95 1.92 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.012 -0.675 . . . . 2.2 109.581 -165.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.512 ' H ' ' CG ' ' A' ' 69' ' ' ASP . 8.9 t -62.87 91.6 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.059 0.457 . . . . 1.41 109.884 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.49 ' CG ' ' CE2' ' A' ' 157' ' ' PHE . 38.2 m-85 -71.24 94.82 1.21 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.945 -1.132 . . . . 1.57 107.945 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.72 111.67 3.73 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.662 -0.78 . . . . 0.78 112.495 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.672 ' HE1' ' CE1' ' A' ' 157' ' ' PHE . 35.0 m-85 -102.59 151.29 22.51 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.568 0.347 . . . . 1.21 110.643 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.416 ' HB2' ' HG3' ' A' ' 152' ' ' LYS . 13.1 p-10 -115.28 112.97 23.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.342 0.591 . . . . 2.47 110.609 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.819 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.3 mp -103.55 93.42 4.97 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.38 110.067 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 25.2 Cg_endo -65.8 119.33 6.34 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.683 1.588 . . . . 0.59 112.108 -175.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.829 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 69.3 mt -117.97 132.2 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.658 -0.701 . . . . 0.49 110.114 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.89 6.7 4.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.039 -0.528 . . . . 3.32 111.134 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -134.92 176.66 8.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.836 0.35 . . . . 2.16 110.625 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.597 ' HG2' HG22 ' A' ' 135' ' ' ILE . 5.5 mt-10 -122.12 159.06 27.94 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.807 -0.633 . . . . 1.2 110.108 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.97 -155.22 26.35 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.805 -0.918 . . . . 0.3 110.805 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 47.0 mt-10 -110.92 106.48 15.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.265 0.532 . . . . 1.96 109.781 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.672 ' HB2' HG12 ' A' ' 133' ' ' ILE . 88.8 m-85 -94.76 125.4 39.39 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 119.735 -0.786 . . . . 0.71 109.219 -176.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.661 HG21 ' CA ' ' A' ' 177' ' ' ALA . 52.8 t -108.67 106.02 19.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.165 0.983 . . . . 0.26 110.039 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 155' ' ' VAL . 9.1 tt -97.84 104.98 17.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.875 -1.511 . . . . 1.56 109.141 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 129' ' ' GLU . 2.2 p -115.01 105.94 19.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 109.013 -0.736 . . . . 1.14 109.013 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -101.48 134.94 43.81 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.115 0.483 . . . . 1.44 110.114 -177.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 1.078 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 10.9 tppt? -98.69 114.92 27.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.327 0.584 . . . . 3.73 109.873 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 115' ' ' LEU . 4.0 m-85 -106.53 146.79 30.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.455 -0.793 . . . . 0.45 109.9 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.878 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -137.12 129.97 30.51 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.201 -0.454 . . . . 0.51 110.159 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -121.63 118.14 28.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.723 -0.473 . . . . 2.62 109.723 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.4 30.51 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.069 0.462 . . . . 3.77 110.34 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -113.67 -46.27 3.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.135 -0.484 . . . . 5.68 111.105 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.8 ' HB3' ' HD2' ' A' ' 100' ' ' LYS . 42.2 t80 -137.8 109.02 6.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.061 0.458 . . . . 4.65 110.205 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.402 ' HB1' ' CE1' ' A' ' 118' ' ' PHE . . . -94.71 90.23 6.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.828 -0.624 . . . . 1.39 111.556 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -160.23 143.98 14.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.955 -0.566 . . . . 2.75 109.649 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.8 m -99.05 147.29 25.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.386 -0.37 . . . . 1.4 110.79 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 61.6 37.13 16.41 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.735 -0.666 . . . . 2.38 110.099 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -140.64 -47.05 0.41 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.727 -0.67 . . . . 2.89 110.423 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.8 ' HD2' ' HB3' ' A' ' 94' ' ' PHE . 33.4 tttm -102.31 75.81 1.51 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.185 -0.672 . . . . 2.79 109.185 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 116' ' ' ASP . 16.7 m -106.72 123.76 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.48 -0.782 . . . . 1.22 110.466 -173.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.566 ' CE2' ' HG2' ' A' ' 100' ' ' LYS . 80.5 m-85 -114.65 168.66 9.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.335 -0.848 . . . . 0.99 111.752 -173.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.635 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 11.3 m-20 -107.21 138.01 44.2 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 109.091 -0.707 . . . . 1.53 109.091 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 110' ' ' THR . 7.4 t -136.3 113.33 13.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 117.699 0.227 . . . . 0.63 111.525 -175.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.675 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 84.2 mtt180 -110.94 141.41 44.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.225 0.454 . . . . 1.95 112.225 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.426 HG23 ' HB2' ' A' ' 109' ' ' HIS . 12.0 m -110.65 96.71 4.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.44 -0.8 . . . . 1.44 109.662 168.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.762 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 3.7 t-20 55.05 58.52 4.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.013 -0.994 . . . . 1.65 109.834 -172.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.25 -25.85 7.55 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.738 -1.119 . . . . 0.42 112.895 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.426 ' HB2' HG23 ' A' ' 106' ' ' VAL . 90.1 m-70 -83.71 95.04 8.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.915 0.339 . . . . 0.68 111.915 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -68.69 92.71 0.48 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.196 0.522 . . . . 0.77 111.063 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 112' ' ' VAL . 6.5 m -74.6 -37.58 43.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.978 -0.556 . . . . 0.94 110.904 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 111' ' ' VAL . 5.6 t -120.88 89.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.986 0.422 . . . . 0.35 109.963 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 11.6 tmtt? -106.98 73.9 0.96 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.733 -1.21 . . . . 4.01 107.733 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 7.2 p-10 161.16 28.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.441 -1.709 . . . . 1.96 108.807 -172.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -71.09 80.4 0.68 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.074 -0.512 . . . . 1.18 111.76 -170.502 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 10.1 t70 -90.48 99.4 12.43 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.051 -1.092 . . . . 1.93 108.051 169.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.0 mt -63.64 -36.33 76.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.092 -0.504 . . . . 0.82 111.494 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.402 ' CE1' ' HB1' ' A' ' 95' ' ' ALA . 68.9 t80 -67.13 -34.94 78.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.056 0.455 . . . . 1.08 110.343 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -67.51 -37.9 83.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.001 0.429 . . . . 0.96 111.405 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 120' ' ' ARG . 14.1 mmt85 -77.15 -46.76 22.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.307 0.484 . . . . 1.69 112.307 -169.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.455 HG13 ' ND1' ' A' ' 127' ' ' HIS . 4.6 m -113.54 -17.02 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.484 0.549 . . . . 1.49 112.484 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.86 -146.66 16.71 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.261 -0.971 . . . . 1.4 111.723 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -80.24 116.1 20.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.676 0.274 . . . . 4.11 111.385 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.5 t 64.55 -146.74 0.27 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.792 -0.64 . . . . 1.97 110.693 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.402 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 42.6 p 63.06 178.87 0.15 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.48 1.112 . . . . 0.85 111.724 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.849 ' HB1' ' HD2' ' A' ' 88' ' ' LYS . . . -94.23 128.27 40.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.356 -0.384 . . . . 0.57 111.315 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.516 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 66.9 t60 -101.65 146.78 27.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.139 -0.689 . . . . 0.55 109.139 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 1.1 p30 -143.91 137.62 27.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.301 0.572 . . . . 1.64 111.305 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 81.6 mm-40 -110.03 114.63 28.31 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.267 -1.012 . . . . 1.12 108.267 172.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.13 107.61 20.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.672 -0.492 . . . . 0.74 109.672 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.4 mm -116.47 101.06 53.81 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.394 -0.367 . . . . 1.25 111.017 -173.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.6 121.56 3.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.815 2.343 . . . . 0.29 111.616 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.672 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.2 pt -110.58 158.63 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.363 -0.606 . . . . 0.27 109.363 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.7 p -124.67 107.09 10.63 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.014 0.435 . . . . 1.24 110.773 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.597 HG22 ' HG2' ' A' ' 80' ' ' GLU . 35.0 mt -103.8 124.11 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.262 -0.426 . . . . 0.34 110.138 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 53.0 mmtt -151.46 138.49 19.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.646 0.592 . . . . 1.95 110.331 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 137' ' ' LYS . 63.5 mmtt 62.42 31.62 17.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.45 0.643 . . . . 3.13 110.507 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.09 22.01 77.15 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.015 -0.993 . . . . 0.41 111.923 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.648 ' HG2' HG22 ' A' ' 148' ' ' THR . 58.1 mtpt -118.71 137.58 53.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.014 -0.365 . . . . 2.23 110.014 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 7.1 tt -113.91 116.32 29.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.178 -0.464 . . . . 0.41 109.777 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.6 t -111.26 132.95 53.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.407 -0.36 . . . . 1.19 110.375 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 88.7 t -125.66 103.97 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.298 -0.41 . . . . 0.92 110.246 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 57.41 -91.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.68 0.612 . . . . 1.88 112.005 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -113.7 14.47 22.23 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.866 -0.683 . . . . 1.02 112.905 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -129.27 116.38 19.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.861 0.331 . . . . 1.95 111.201 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.21 129.85 57.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.071 0.462 . . . . 0.92 109.961 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m -144.03 -177.63 5.54 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.574 -0.528 . . . . 1.27 109.574 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.648 HG22 ' HG2' ' A' ' 139' ' ' LYS . 39.0 p -98.07 138.98 34.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.745 0.307 . . . . 1.45 110.284 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.829 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 58.6 t80 -79.57 135.44 36.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.996 -0.547 . . . . 0.47 109.966 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.7 t -132.17 102.31 5.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.526 0.679 . . . . 1.79 111.949 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.31 -68.46 2.91 Favored Glycine 0 CA--C 1.508 -0.344 0 CA-C-N 115.421 -0.809 . . . . 0.42 113.678 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -158.63 167.01 30.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.864 0.364 . . . . 1.23 110.452 -177.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.819 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 6.0 tt -80.92 127.55 32.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.539 -0.911 . . . . 1.17 108.539 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.762 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 5.7 p -112.45 102.9 10.98 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.346 -0.542 . . . . 1.35 112.333 -172.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 85' ' ' LEU . 97.1 t -91.72 109.35 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.783 -0.451 . . . . 0.42 109.783 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.581 ' HB2' ' HD2' ' A' ' 105' ' ' ARG . 39.9 mt-10 -120.3 112.05 18.55 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.533 -0.758 . . . . 1.98 109.609 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.672 ' CE1' ' HE1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -99.71 114.47 27.59 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 118.569 -1.253 . . . . 2.32 110.344 166.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 20.8 t -83.77 144.69 9.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 113.758 -1.565 . . . . 0.62 110.828 -169.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.73 ' HA ' ' OD1' ' A' ' 164' ' ' ASN . 8.3 ptmm? -63.15 132.82 53.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.064 -0.971 . . . . 2.26 112.03 -172.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -113.86 -97.52 2.24 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.14 -0.936 . . . . 1.45 112.11 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.73 58.21 0.65 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.751 0.31 . . . . 4.24 111.468 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 68.83 155.48 0.12 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.514 -0.766 . . . . 4.98 112.497 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.534 ' OD1' ' HG2' ' A' ' 166' ' ' LYS . 7.0 t0 48.68 68.33 0.72 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.353 -0.839 . . . . 2.64 109.947 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.73 ' OD1' ' HA ' ' A' ' 159' ' ' LYS . 1.7 m-20 -57.56 135.09 82.26 Favored Pre-proline 0 CA--C 1.506 -0.734 0 CA-C-N 115.451 -0.795 . . . . 2.06 109.883 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.488 ' HD3' ' CD2' ' A' ' 102' ' ' PHE . 62.4 Cg_exo -17.3 73.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.057 1 C-N-CA 126.102 4.534 . . . . 3.16 114.681 -158.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.781 ' HA ' ' HE3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 1.32 -77.48 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 O-C-N 125.936 2.022 . . . . 3.18 114.647 177.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.878 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 2.4 t -93.19 133.57 33.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.311 -0.404 . . . . 1.19 110.699 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -129.95 74.42 1.59 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 119.623 -0.831 . . . . 1.36 113.133 -172.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 1.078 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -80.12 36.08 0.34 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.708 1.203 . . . . 0.31 113.576 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.733 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 18.9 tp -53.76 117.37 3.11 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.688 0.625 . . . . 0.69 112.688 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.75 ' HE1' HG23 ' A' ' 10' ' ' VAL . 8.4 t80 -123.89 127.79 48.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.963 0.505 . . . . 0.48 110.555 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.681 HG23 HG23 ' A' ' 11' ' ' ILE . 8.7 tt -119.13 131.65 71.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 121.811 0.815 . . . . 0.3 111.05 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 9.4 ptm -121.33 159.93 25.05 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.846 -0.616 . . . . 0.99 109.534 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 16.2 ptmt -113.18 149.98 32.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.424 1.107 . . . . 1.22 113.063 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' ' 176' ' ' THR . . . 103.58 -32.47 7.53 Favored Glycine 0 C--N 1.309 -0.917 0 CA-C-N 113.231 -1.804 . . . . 0.31 114.337 161.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.677 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.2 OUTLIER -177.49 162.22 1.82 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.052 0.926 . . . . 0.68 112.511 176.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.661 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -85.49 -10.36 56.18 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.22 -0.9 . . . . 0.86 109.891 168.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.677 ' H ' ' HB ' ' A' ' 176' ' ' THR . 22.2 m-20 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.416 -0.811 . . . . 2.16 111.616 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 111.338 -0.705 . . . . 1.48 111.338 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.704 ' HG ' HD11 ' A' ' 27' ' ' ILE . 47.6 tp -76.12 -31.55 58.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.159 0.504 . . . . 0.72 110.111 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.502 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -61.23 -22.87 65.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.204 -0.907 . . . . 0.53 111.781 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -82.46 -34.3 28.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.41 -0.359 . . . . 2.18 111.373 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 57.8 mmtt -93.54 -15.39 25.52 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.59 -0.444 . . . . 1.79 112.02 -171.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.743 HG23 ' HE1' ' A' ' 171' ' ' PHE . 7.1 p -54.02 132.53 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.027 0.441 . . . . 0.33 111.775 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 pt -115.78 -32.28 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.226 -0.443 . . . . 0.92 110.705 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.72 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 42.0 t90 -159.63 133.0 7.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.046 -0.724 . . . . 0.36 109.046 -172.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.84 131.45 13.09 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.848 -0.341 . . . . 0.26 111.059 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.843 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 52.3 t -140.42 120.59 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.66 0.743 . . . . 0.79 111.357 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 51.4 t30 -98.15 101.63 13.15 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.109 -1.071 . . . . 1.49 108.109 167.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -60.36 95.7 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 116.051 -0.522 . . . . 0.48 110.036 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 175.94 -90.17 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 O-C-N 124.812 1.32 . . . . 0.76 113.068 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.37 -130.11 0.26 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.562 -0.352 . . . . 0.74 113.751 -172.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' HG3' ' HD3' ' A' ' 31' ' ' LYS . 31.6 tt0 -144.95 119.44 9.68 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.572 -0.369 . . . . 1.77 111.528 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.71 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 50.0 m 31.45 99.0 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.726 1.38 . . . . 1.29 114.726 172.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.609 ' ND1' ' HB2' ' A' ' 60' ' ' LEU . 33.4 t-80 -135.33 134.97 40.4 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.786 -0.572 . . . . 0.42 111.855 -177.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 83.7 t -88.45 115.48 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.46 -0.791 . . . . 1.01 110.225 175.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.47 159.47 33.91 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.442 -0.577 . . . . 0.77 109.442 176.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 57' ' ' ASP . 28.8 m -66.2 -6.96 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.999 0.74 . . . . 0.62 112.999 -171.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -99.0 7.35 46.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.856 -0.794 . . . . 0.86 108.856 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 87.3 30.8 18.44 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.877 -1.056 . . . . 0.33 112.706 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.704 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.7 mm -104.45 106.27 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 0.31 111.34 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 30.3 t60 -86.33 109.43 18.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.289 0.566 . . . . 0.8 111.459 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.843 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -77.12 138.82 39.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.498 -0.774 . . . . 1.75 109.994 172.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -99.5 116.2 31.1 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.016 0.436 . . . . 2.94 110.677 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HG2' ' N ' ' A' ' 32' ' ' ASP . 8.9 ttpp -34.25 146.98 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.914 1.286 . . . . 2.78 114.371 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.54 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 7.7 p-10 -24.21 92.72 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 125.961 1.705 . . . . 2.41 114.639 -173.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -106.75 39.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.879 3.053 . . . . 1.87 113.507 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.598 ' HA ' ' HD2' ' A' ' 37' ' ' ARG . 19.7 tp -137.86 -66.1 0.51 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.971 0.73 . . . . 1.99 112.971 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -84.05 97.54 9.36 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.332 -0.855 . . . . 5.31 110.063 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 38' ' ' VAL . . . 92.81 -20.95 41.99 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.945 -1.262 . . . . 2.64 109.945 -168.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.598 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 16.3 mmm180 64.41 -7.19 0.25 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.674 1.19 . . . . 5.64 111.705 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.471 ' H ' ' C ' ' A' ' 36' ' ' GLY . 11.5 p -150.72 155.67 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.392 -0.596 . . . . 3.96 109.392 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.44 -143.36 9.27 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.863 -0.684 . . . . 2.56 112.025 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -132.18 -171.81 2.73 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.281 -0.266 . . . . 6.2 110.281 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.1 -60.13 2.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.644 -0.253 . . . . 2.0 111.261 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.7 m 55.27 50.84 14.16 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.647 -0.871 . . . . 2.52 108.647 -171.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.515 ' OD2' ' HB3' ' A' ' 46' ' ' MET . 43.9 t0 -78.2 81.4 4.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.603 -1.181 . . . . 2.52 111.748 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -96.76 9.11 42.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.724 -0.671 . . . . 7.02 109.661 171.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.878 ' HA3' ' HG2' ' A' ' 64' ' ' GLU . . . -104.89 -15.49 20.06 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.478 -0.783 . . . . 3.06 112.692 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.515 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 15.9 ptt? -66.07 0.63 1.83 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.356 0.502 . . . . 2.35 112.356 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.766 ' HG3' HD22 ' A' ' 48' ' ' LEU . 46.7 pttt -95.22 9.81 38.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.629 -0.26 . . . . 4.25 111.232 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD22 ' HG3' ' A' ' 47' ' ' LYS . 3.3 mm? -120.62 73.47 22.93 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.81 -0.177 . . . . 2.56 110.622 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.21 109.75 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.019 2.48 . . . . 1.69 113.489 -174.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.539 HD13 ' HG3' ' A' ' 62' ' ' GLN . 1.5 mp -61.82 116.15 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.765 -0.652 . . . . 1.59 110.389 174.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.89 -17.54 62.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 1.91 111.595 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HD3' ' HB ' ' A' ' 125' ' ' THR . 10.6 mpt_? -97.48 25.7 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.245 0.461 . . . . 3.17 112.245 -175.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -153.46 165.87 34.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 0.97 111.373 177.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.489 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 1.3 t30 -89.25 140.64 28.75 Favored Pre-proline 0 C--O 1.217 -0.655 0 CA-C-N 115.469 -0.787 . . . . 1.92 109.901 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.489 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 38.2 Cg_exo -37.78 -53.04 1.59 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 124.681 3.587 . . . . 0.7 117.339 -161.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -73.07 -45.97 54.27 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 119.419 1.008 . . . . 2.71 110.708 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' HB3' HG13 ' A' ' 24' ' ' VAL . 2.7 p30 -77.37 -20.8 54.24 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.004 -0.544 . . . . 1.63 109.563 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 24.5 tt0 -54.19 -48.07 71.38 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.563 -0.744 . . . . 1.58 109.378 169.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 63' ' ' THR . 61.4 t -54.79 -37.9 42.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.987 -0.551 . . . . 1.27 110.576 172.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -74.92 -10.53 59.57 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.932 0.396 . . . . 1.18 111.758 178.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 169' ' ' ALA . 62.2 m-85 -115.78 12.66 15.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.276 1.036 . . . . 0.99 108.756 175.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.56 ' HG2' ' H ' ' A' ' 63' ' ' THR . 47.0 tt0 -126.88 -130.6 0.23 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.401 -1.727 . . . . 1.97 108.716 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.665 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 40.7 p 39.03 106.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.956 1.465 . . . . 1.27 114.956 -176.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.938 ' HB3' HG12 ' A' ' 167' ' ' VAL . 12.5 pt-20 -97.27 151.83 19.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.991 -1.114 . . . . 1.96 107.991 168.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.614 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 22.8 ptt180 -123.23 -46.02 2.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.353 0.501 . . . . 3.35 112.353 -176.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -175.07 -175.93 0.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.142 -0.688 . . . . 4.71 109.142 -173.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 4.1 p30 -148.11 75.21 1.33 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.375 0.607 . . . . 4.38 110.597 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -54.7 -70.15 0.11 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.753 -0.658 . . . . 3.7 111.435 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -170.07 -161.25 0.26 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.277 -1.379 . . . . 2.2 107.277 -175.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 t -42.34 102.1 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.308 -0.626 . . . . 1.41 109.308 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.857 ' HB2' ' HD1' ' A' ' 157' ' ' PHE . 15.3 m-85 -66.63 104.99 1.41 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.74 -0.664 . . . . 1.57 109.484 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.487 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -109.43 95.04 0.86 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 119.75 -1.214 . . . . 0.78 114.193 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.553 ' CE1' HG11 ' A' ' 14' ' ' VAL . 51.6 m-85 -84.4 148.33 26.66 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.305 -0.447 . . . . 1.21 110.77 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 1.9 p-10 -127.68 127.02 43.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.742 0.782 . . . . 2.47 109.934 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.912 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.0 mp -110.6 92.46 14.21 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 114.664 -1.153 . . . . 0.38 109.028 -176.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 34.5 Cg_exo -57.71 117.12 3.76 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.085 1.857 . . . . 0.59 111.609 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.767 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 56.4 mt -115.6 130.43 70.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.165 0.507 . . . . 0.49 111.634 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.52 -24.59 9.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.848 -0.615 . . . . 3.32 110.789 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.524 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 7.4 mm-40 -99.06 176.06 5.7 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.864 0.364 . . . . 2.16 110.575 -168.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 136' ' ' LYS . 2.3 tt0 -126.59 160.71 29.88 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.83 -0.623 . . . . 1.2 109.817 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.584 ' N ' ' HG2' ' A' ' 80' ' ' GLU . . . 139.45 -163.84 26.03 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 115.576 -0.738 . . . . 0.3 111.534 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 27.4 mt-10 -98.75 109.77 22.47 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 120.373 -0.531 . . . . 1.96 109.857 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.647 ' HB2' HG12 ' A' ' 133' ' ' ILE . 74.8 m-85 -94.34 124.66 38.5 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.583 -0.895 . . . . 0.71 108.583 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 177' ' ' ALA . 52.9 t -104.74 106.13 19.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-O 121.909 0.862 . . . . 0.26 109.902 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.738 HD11 HD11 ' A' ' 170' ' ' LEU . 10.9 tp -89.66 103.32 15.98 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.2 -1.364 . . . . 1.56 109.291 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.13 107.72 23.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.64 0.734 . . . . 1.14 109.364 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.612 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 1.3 pp -113.23 140.73 47.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.601 -0.727 . . . . 1.44 111.035 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.863 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 12.8 mptt -99.55 134.24 42.71 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.374 -0.53 . . . . 3.73 110.203 173.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' A' ' 165' ' ' PRO . 11.3 m-85 -117.17 138.01 51.96 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.696 -0.684 . . . . 0.45 110.372 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.559 ' HB3' ' CG2' ' A' ' 167' ' ' VAL . . . -147.36 161.75 40.37 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.78 -0.368 . . . . 0.51 111.252 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER 70.61 108.03 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 124.407 1.067 . . . . 2.62 111.218 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 118' ' ' PHE . 5.0 p -120.47 82.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.705 0.764 . . . . 3.77 109.51 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -47.43 -49.0 26.2 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.901 -1.045 . . . . 5.68 111.954 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.963 ' HB2' ' HD2' ' A' ' 100' ' ' LYS . 99.2 m-85 -85.37 86.93 7.34 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.253 -0.647 . . . . 4.65 109.253 175.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.93 91.44 0.33 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.557 -0.747 . . . . 1.39 111.438 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . 5.9 tp60 -160.77 145.56 14.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.969 -0.56 . . . . 2.75 110.057 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.6 p -101.53 143.14 31.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 1.4 110.438 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 59.03 53.05 5.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.278 0.561 . . . . 2.38 109.867 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -162.99 -48.8 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.847 -0.615 . . . . 2.89 110.023 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.963 ' HD2' ' HB2' ' A' ' 94' ' ' PHE . 56.4 tttp -96.28 80.31 3.2 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.917 -0.771 . . . . 2.79 108.917 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.07 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.996 -1.002 . . . . 1.22 110.809 -171.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 33.9 m-85 -77.36 158.19 30.24 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.532 -0.758 . . . . 0.99 109.804 176.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.734 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 50.9 m-20 -112.23 135.15 53.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.439 -0.949 . . . . 1.53 108.439 172.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.893 HG22 ' HD2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -125.79 119.81 55.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.164 0.506 . . . . 0.63 109.95 -177.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.712 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 79.6 mtt180 -116.83 141.87 47.66 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.017 -0.992 . . . . 1.95 111.456 -171.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 153' ' ' LEU . 41.8 t -116.5 102.25 13.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.663 -0.699 . . . . 1.44 109.153 174.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.896 ' HB2' HD12 ' A' ' 153' ' ' LEU . 23.3 t-20 57.26 46.45 18.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.227 1.013 . . . . 1.65 108.421 -170.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.79 -21.97 30.64 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.945 -1.025 . . . . 0.42 113.315 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 93.0 m-70 -78.12 108.57 11.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.268 0.47 . . . . 0.68 112.268 -173.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.51 ' CG2' ' HG2' ' A' ' 105' ' ' ARG . 5.9 p -69.35 87.81 0.45 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.779 0.323 . . . . 0.77 111.029 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.421 HG21 HG21 ' A' ' 131' ' ' ILE . 43.6 t -67.78 -55.55 16.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.154 -0.684 . . . . 0.94 109.154 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.597 HG21 ' HG2' ' A' ' 129' ' ' GLU . 17.3 t -112.53 90.52 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.874 -0.603 . . . . 0.35 109.72 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -107.9 73.25 0.89 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.757 0.789 . . . . 4.01 109.781 177.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 9.2 p-10 164.94 32.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.063 -1.426 . . . . 1.96 108.536 -172.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -78.11 71.08 4.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.217 -0.901 . . . . 1.18 112.042 -170.007 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 119' ' ' ASP . 31.0 m-20 -77.16 93.57 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.937 -1.134 . . . . 1.93 107.937 167.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.7 mt -54.01 -39.78 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.996 0.427 . . . . 0.82 110.211 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 56.7 t80 -64.71 -39.53 93.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.417 -0.81 . . . . 1.08 110.987 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 12.1 t70 -71.98 -36.41 69.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.987 0.422 . . . . 0.96 111.431 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -77.9 -49.56 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 1.69 111.807 -171.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 127' ' ' HIS . 15.9 m -110.5 -24.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.379 -0.529 . . . . 1.49 112.284 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 112.81 -142.86 17.54 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.423 -0.894 . . . . 1.4 111.961 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -89.14 110.29 21.04 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.173 -0.306 . . . . 4.11 110.173 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.4 t 68.15 -150.71 0.16 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.621 -0.718 . . . . 1.97 110.909 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.514 ' HB ' ' HD3' ' A' ' 52' ' ' ARG . 20.8 p 66.57 177.85 0.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.531 1.132 . . . . 0.85 111.176 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.49 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -91.94 119.1 31.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.826 0.346 . . . . 0.57 111.574 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.479 ' HA ' HG11 ' A' ' 121' ' ' VAL . 84.0 t60 -89.37 130.04 35.8 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.714 -0.847 . . . . 0.55 108.714 172.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -121.58 113.26 19.53 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.494 -0.321 . . . . 1.64 110.912 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.597 ' HG2' HG21 ' A' ' 112' ' ' VAL . 2.6 tp10 -116.53 113.62 23.02 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.696 -0.483 . . . . 1.12 109.696 177.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.4 mt -98.75 119.83 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.232 -0.44 . . . . 0.74 109.828 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.553 HG21 HG21 ' A' ' 106' ' ' VAL . 58.2 mt -125.23 89.58 52.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.233 -0.44 . . . . 1.25 110.63 -173.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -75.83 126.61 9.55 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.61 2.207 . . . . 0.29 112.019 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.647 HG12 ' HB2' ' A' ' 83' ' ' TYR . 6.0 pt -110.38 157.16 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.043 -0.725 . . . . 0.27 109.043 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 t -123.93 106.67 10.61 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.808 -0.442 . . . . 1.24 109.808 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.749 HG12 ' HG ' ' A' ' 140' ' ' LEU . 5.2 mt -104.73 137.14 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 109.021 -0.733 . . . . 0.34 109.021 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 53.1 mttm -152.77 131.13 12.08 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 123.699 0.625 . . . . 1.95 111.104 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.675 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER 56.22 27.66 12.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.147 -0.933 . . . . 3.13 111.239 177.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.62 13.62 62.75 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.792 -0.718 . . . . 0.41 113.085 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 59.2 mtpt -115.17 137.54 51.91 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.391 -0.476 . . . . 2.23 109.904 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.749 ' HG ' HG12 ' A' ' 135' ' ' ILE . 3.8 tt -115.51 121.44 42.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.314 -0.403 . . . . 0.41 110.185 -172.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -117.47 114.17 23.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.32 -0.4 . . . . 1.19 109.942 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 142' ' ' VAL . 5.5 m -90.73 111.07 23.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.97 -0.752 . . . . 0.92 108.97 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 63.55 -85.41 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.128 -0.487 . . . . 1.88 110.43 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -139.71 17.65 3.03 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.826 -0.625 . . . . 1.02 111.626 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -108.49 121.42 44.94 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.829 -0.804 . . . . 1.95 108.829 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.8 p -103.46 146.78 10.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.315 0.578 . . . . 0.92 111.943 -168.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.4 p -163.25 176.51 9.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.224 -0.898 . . . . 1.27 109.046 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 139' ' ' LYS . 70.3 p -100.27 138.13 37.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.711 0.291 . . . . 1.45 110.316 175.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.767 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 39.3 t80 -79.81 131.35 35.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.026 -0.361 . . . . 0.47 110.026 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.3 t -131.39 111.06 11.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.464 0.649 . . . . 1.79 111.473 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.37 -72.8 1.88 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.387 -0.824 . . . . 0.42 113.678 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -155.75 169.11 25.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.973 0.416 . . . . 1.23 110.62 -175.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.912 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 22.7 tp -80.99 150.72 28.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.707 -0.849 . . . . 1.17 108.707 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.6 t -132.53 104.11 6.51 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 118.994 -1.082 . . . . 1.35 110.353 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 15.5 t -92.91 96.44 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 108.401 -0.963 . . . . 0.42 108.401 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 105' ' ' ARG . 4.3 tt0 -107.7 121.82 45.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.495 -1.229 . . . . 1.98 109.582 -173.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.893 ' HD2' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -113.32 115.52 28.27 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.178 -0.609 . . . . 2.32 110.116 176.225 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 52.9 t -82.81 140.82 15.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.971 -1.013 . . . . 0.62 110.766 -173.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.406 ' HB3' ' OD1' ' A' ' 164' ' ' ASN . 24.3 pttm -66.02 109.84 2.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.999 -1.0 . . . . 2.26 112.336 -173.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.548 ' H ' ' HD1' ' A' ' 102' ' ' PHE . . . -84.0 84.62 1.57 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.457 -0.792 . . . . 1.45 111.805 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.1 t80 63.52 63.67 0.86 Allowed 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.116 0.539 . . . . 4.24 110.81 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 16.9 t80 63.34 173.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.686 -0.688 . . . . 4.98 110.124 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.27 80.4 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.78 0.324 . . . . 2.64 110.922 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.639 ' HB3' ' HD2' ' A' ' 165' ' ' PRO . 3.4 m-20 -60.46 175.01 0.44 Allowed Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.632 -0.713 . . . . 2.06 109.711 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.639 ' HD2' ' HB3' ' A' ' 164' ' ' ASN . 73.0 Cg_exo -42.97 97.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.452 2.101 . . . . 3.16 111.989 172.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.656 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 12.9 tptm -55.62 -61.91 2.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.947 -1.024 . . . . 3.18 111.994 -162.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.938 HG12 ' HB3' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -109.77 136.87 44.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 108.341 -0.985 . . . . 1.19 108.341 171.123 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 33.9 t -137.41 89.03 2.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.04 0.755 . . . . 1.36 113.04 -168.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.863 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -75.39 38.4 0.14 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 124.479 1.112 . . . . 0.31 113.273 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.738 HD11 HD11 ' A' ' 85' ' ' LEU . 40.7 tp -54.12 104.42 0.11 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.769 0.655 . . . . 0.69 112.769 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.782 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 4.3 t80 -117.99 124.62 48.62 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.489 -0.323 . . . . 0.48 110.925 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.664 ' HB ' HD12 ' A' ' 85' ' ' LEU . 5.0 tt -114.53 123.7 70.46 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-O 122.226 1.012 . . . . 0.3 111.359 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.782 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.6 ppp? -115.68 159.88 20.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.884 -1.053 . . . . 0.99 109.99 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 53.8 tttt -105.87 133.23 50.93 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 114.1 1.148 . . . . 1.22 114.1 -170.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 106.15 -28.87 12.28 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 113.832 -1.531 . . . . 0.31 116.226 157.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.99 158.09 1.98 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.036 1.418 . . . . 0.68 113.411 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.653 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -83.86 -9.58 58.65 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.206 -0.906 . . . . 0.86 111.356 174.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 30.6 t70 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 121.157 0.504 . . . . 2.16 111.215 -178.188 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.402 ' HA2' ' OD2' ' A' ' 8' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 112.127 -0.389 . . . . 1.48 112.127 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.722 HD12 ' HE3' ' A' ' 173' ' ' MET . 50.2 tp -59.54 -36.83 76.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.305 0.574 . . . . 0.72 110.141 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -69.89 -23.42 63.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.485 -0.78 . . . . 0.53 111.651 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.402 ' OD2' ' HA2' ' A' ' 5' ' ' GLY . 10.8 m-20 -80.55 -16.54 53.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.026 -0.534 . . . . 2.18 111.009 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.454 ' HB2' ' HE2' ' A' ' 173' ' ' MET . 37.1 mtpt -126.22 2.77 7.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.438 -0.505 . . . . 1.79 111.785 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.522 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 11.6 p -58.78 136.91 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.508 -0.477 . . . . 0.33 110.176 169.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 174' ' ' LYS . 10.7 pt -115.76 -22.86 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.285 -0.416 . . . . 0.92 111.047 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.752 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 79.4 t90 -171.1 143.28 1.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.838 -0.431 . . . . 0.36 109.838 -173.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -162.18 137.58 7.28 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.207 -0.308 . . . . 0.26 111.553 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.402 HG11 ' CE2' ' A' ' 73' ' ' TYR . 45.2 t -142.02 125.72 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.02 -0.536 . . . . 0.79 110.885 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 28.5 t30 -101.77 104.87 15.68 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.793 -0.817 . . . . 1.49 108.793 167.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.602 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -65.52 89.11 0.1 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.245 -0.889 . . . . 0.48 110.247 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.617 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -174.36 -67.73 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 O-C-N 125.385 1.678 . . . . 0.76 112.249 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.85 -132.38 5.69 Favored Glycine 0 C--N 1.318 -0.441 0 C-N-CA 120.757 -0.735 . . . . 0.74 112.997 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 1.069 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 25.3 tt0 -138.33 119.37 14.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 111.243 0.09 . . . . 1.77 111.243 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.684 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 73.1 m 36.39 108.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.584 1.698 . . . . 1.29 115.584 170.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.614 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 82.6 t60 -137.76 128.37 26.74 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.928 -0.483 . . . . 0.42 111.42 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 86.1 t -87.8 113.15 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.209 -0.905 . . . . 1.01 109.074 171.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -78.38 161.33 27.24 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.333 -0.247 . . . . 0.77 110.333 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.32 -27.84 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 124.585 1.178 . . . . 0.62 113.232 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.441 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 35.1 m80 -80.34 -6.55 58.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.312 0.577 . . . . 0.86 109.559 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 96.41 24.84 13.22 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.955 -1.021 . . . . 0.33 112.179 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.557 HD11 ' HG ' ' A' ' 6' ' ' LEU . 19.1 mm -99.36 109.18 23.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.178 0.513 . . . . 0.31 110.937 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 7.7 t60 -86.71 110.99 20.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.139 -0.482 . . . . 0.8 110.342 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.684 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -87.48 139.13 30.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.084 -0.339 . . . . 1.75 110.084 175.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.498 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 13.3 ptp180 -92.97 138.66 31.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.131 0.491 . . . . 2.94 110.664 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 1.069 ' HB3' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -73.9 136.91 43.38 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.939 1.088 . . . . 2.78 113.939 -173.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' CG ' ' HZ2' ' A' ' 31' ' ' LYS . 1.1 p30 28.54 54.67 0.5 Allowed Pre-proline 0 N--CA 1.484 1.246 0 CA-C-N 111.868 -2.424 . . . . 2.41 116.09 167.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 67.3 Cg_endo -94.15 36.31 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.503 2.135 . . . . 1.87 113.006 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.615 HD23 ' N ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -137.25 -54.93 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.477 0.547 . . . . 1.99 112.477 -178.037 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.615 ' N ' HD23 ' A' ' 34' ' ' LEU . 7.5 pt-20 -79.45 89.52 5.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.623 0.725 . . . . 5.31 110.159 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 38' ' ' VAL . . . 86.29 -10.11 67.72 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.414 -1.074 . . . . 2.64 110.414 -170.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 7.9 mmt180 67.13 -26.3 0.12 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.079 1.352 . . . . 5.64 112.301 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.466 ' H ' ' C ' ' A' ' 36' ' ' GLY . 28.6 t -127.58 116.64 44.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.777 -0.453 . . . . 3.96 109.777 177.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.75 -149.33 4.95 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.723 -0.751 . . . . 2.56 112.356 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -153.13 69.5 0.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.822 0.344 . . . . 6.2 110.639 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . . . 52.06 81.54 0.08 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.706 -0.679 . . . . 2.0 112.492 172.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.785 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 13.9 m -81.92 65.15 6.93 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.347 -0.388 . . . . 2.52 110.301 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -75.49 57.88 0.97 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.828 0.823 . . . . 2.52 111.452 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -110.39 125.84 53.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.467 -0.788 . . . . 7.02 109.044 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.29 8.02 60.3 Favored Glycine 0 C--O 1.227 -0.315 0 N-CA-C 110.741 -0.943 . . . . 3.06 110.741 -172.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.861 ' HG3' ' HA ' ' A' ' 63' ' ' THR . 23.9 ttt -70.59 -0.4 8.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.988 -0.606 . . . . 2.35 111.734 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HE2' ' HD3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -80.16 69.75 6.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.521 0.676 . . . . 4.25 110.628 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.616 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -153.81 74.03 6.43 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.225 -1.028 . . . . 2.56 108.225 176.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HD3' ' HE2' ' A' ' 47' ' ' LYS . 14.5 Cg_endo -59.15 118.75 5.68 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.5 2.133 . . . . 1.69 112.788 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' A' ' 62' ' ' GLN . 1.7 mp -80.39 99.42 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.863 0.84 . . . . 1.59 109.712 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.486 ' HB3' HG22 ' A' ' 125' ' ' THR . 2.8 tt -60.95 -35.51 76.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.592 -1.186 . . . . 1.91 110.962 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -88.09 33.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.951 0.722 . . . . 3.17 112.951 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -142.62 168.16 20.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.8 0.333 . . . . 0.97 110.878 172.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -90.21 141.42 27.69 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.958 -0.756 . . . . 1.92 108.958 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.425 ' O ' HG23 ' A' ' 59' ' ' VAL . 60.3 Cg_exo -39.67 -42.74 2.96 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 124.101 3.201 . . . . 0.7 115.947 -162.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -76.54 -44.37 35.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.248 0.476 . . . . 2.71 111.361 -177.455 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -81.2 -17.48 49.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.234 -0.654 . . . . 1.63 109.234 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -58.85 -45.69 89.52 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.174 -0.921 . . . . 1.58 109.135 167.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 55' ' ' PRO . 68.8 t -55.19 -44.6 75.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.487 0.66 . . . . 1.27 109.593 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 15' ' ' ASN . 35.0 tp -63.72 -18.94 64.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.644 -1.162 . . . . 1.18 112.141 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.614 ' CE2' ' HE2' ' A' ' 88' ' ' LYS . 13.6 m-30 -114.91 1.55 14.06 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 111.894 0.331 . . . . 0.99 111.894 -175.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 39.2 tt0 -124.3 -41.36 2.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.626 0.973 . . . . 1.97 113.626 -170.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.861 ' HA ' ' HG3' ' A' ' 46' ' ' MET . 2.1 m -61.1 132.49 53.93 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 121.072 -0.251 . . . . 1.27 111.451 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 1.029 ' HB2' HG22 ' A' ' 167' ' ' VAL . 36.5 tt0 -120.33 147.75 44.62 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.123 0.569 . . . . 1.96 110.397 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.785 ' HA ' ' O ' ' A' ' 42' ' ' SER . 16.6 mtm-85 -103.83 -170.51 1.79 Allowed 'General case' 0 N--CA 1.463 0.184 0 O-C-N 123.232 0.333 . . . . 3.35 110.931 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.525 ' O ' ' HB3' ' A' ' 165' ' ' PRO . 51.2 t80 -79.23 -59.52 2.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.574 -0.284 . . . . 4.71 110.692 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 59.76 -164.66 0.21 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.583 -0.28 . . . . 4.38 111.212 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -160.35 -91.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.94 0.4 . . . . 3.7 111.82 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.628 ' HA ' ' OD1' ' A' ' 164' ' ' ASN . 19.2 t0 -149.36 142.22 24.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.575 -0.284 . . . . 2.2 110.283 -173.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.5 t 45.96 62.59 2.17 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 124.159 0.912 . . . . 1.41 110.437 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.813 ' HZ ' ' HA ' ' A' ' 165' ' ' PRO . 8.4 p90 -107.28 126.61 52.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.132 -1.027 . . . . 1.57 110.838 -176.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.467 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -145.4 154.06 25.68 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.942 -1.027 . . . . 0.78 113.295 -173.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.602 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 53.5 m-85 -104.85 164.97 11.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.303 -0.448 . . . . 1.21 111.156 -175.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 8.0 p-10 -115.42 118.8 34.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.741 -0.663 . . . . 2.47 110.463 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.845 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.8 mp -104.5 90.88 3.59 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.333 -0.849 . . . . 0.38 109.302 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 38.4 Cg_exo -59.74 120.04 7.61 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.251 1.967 . . . . 0.59 112.405 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.775 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 72.4 mt -119.86 135.98 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.867 0.365 . . . . 0.49 111.236 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.484 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 32.6 mtpt -130.9 7.67 4.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 3.32 110.736 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.47 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 38.0 mt-10 -131.88 174.41 10.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.975 0.416 . . . . 2.16 110.882 -173.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 9.0 mt-10 -112.82 -172.99 2.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.778 -0.646 . . . . 1.2 110.112 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.33 -167.48 13.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.895 -0.669 . . . . 0.3 112.191 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.651 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 56.2 mt-10 -97.34 103.3 15.22 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 117.29 0.545 . . . . 1.96 109.747 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.666 ' HB2' HG12 ' A' ' 133' ' ' ILE . 10.9 m-30 -95.64 123.25 39.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 118.985 -1.086 . . . . 0.71 108.398 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.984 HG21 ' HA ' ' A' ' 177' ' ' ALA . 74.7 t -114.71 106.68 21.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.518 -0.764 . . . . 0.26 110.268 -172.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.1 mp -88.82 104.47 16.94 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.457 -1.247 . . . . 1.56 109.493 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.608 HG22 HG23 ' A' ' 130' ' ' ILE . 44.2 t -103.34 100.73 11.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 107.539 -1.282 . . . . 1.14 107.539 171.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.615 ' CB ' ' HA ' ' A' ' 170' ' ' LEU . 0.6 OUTLIER -109.23 132.24 54.31 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.106 -0.638 . . . . 1.44 109.803 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.994 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 13.8 mptt -89.09 122.61 32.58 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.129 -0.628 . . . . 3.73 110.393 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.14 135.21 48.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.227 -0.897 . . . . 0.45 108.645 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.843 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -125.62 121.91 34.92 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.095 0.474 . . . . 0.51 109.968 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 92' ' ' VAL . 2.9 tp10 -165.88 143.48 5.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.817 -1.538 . . . . 2.62 108.374 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 91' ' ' GLU . 0.9 OUTLIER 171.91 -27.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 124.585 1.154 . . . . 3.77 108.253 -177.319 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -60.05 -32.76 71.22 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.294 -0.866 . . . . 5.68 110.675 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.503 ' HB2' ' NZ ' ' A' ' 100' ' ' LYS . 89.3 m-85 -96.86 85.36 3.77 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.599 -0.889 . . . . 4.65 108.599 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.45 102.57 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.669 -0.696 . . . . 1.39 112.578 -172.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -170.87 139.75 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.363 -0.835 . . . . 2.75 109.174 170.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.878 ' HB2' ' HB2' ' A' ' 119' ' ' ASP . 14.2 p -129.13 159.89 34.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.443 -0.344 . . . . 1.4 111.439 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 48.0 44.19 18.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.436 0.694 . . . . 2.38 112.247 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -147.97 -61.52 0.26 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.872 -0.788 . . . . 2.89 108.872 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.663 ' HB3' ' HB2' ' A' ' 161' ' ' TYR . 50.2 pttt -86.99 98.15 11.11 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.6 -0.727 . . . . 2.79 109.234 172.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.928 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 6.4 m -108.96 109.82 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.477 0.656 . . . . 1.22 110.356 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.711 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 23.5 m-85 -73.87 154.33 39.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.102 -0.954 . . . . 0.99 110.887 -175.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.681 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 12.5 m-20 -105.75 137.81 42.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.469 -0.567 . . . . 1.53 109.469 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 2.5 t -134.47 120.18 32.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.762 0.315 . . . . 0.63 110.682 -176.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 61.4 mtt180 -120.26 141.98 49.47 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.671 -0.695 . . . . 1.95 111.666 -174.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.872 HG23 HD21 ' A' ' 153' ' ' LEU . 2.8 p -118.43 102.78 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.75 -0.659 . . . . 1.44 109.845 172.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.415 ' HA ' ' H ' ' A' ' 154' ' ' SER . 64.7 t30 55.44 51.45 12.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.266 -0.879 . . . . 1.65 109.342 -172.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.31 -17.67 46.41 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.085 -0.961 . . . . 0.42 113.313 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 90.2 m-70 -85.49 105.45 16.11 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.098 0.407 . . . . 0.68 112.098 -172.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.575 ' HB ' ' HD2' ' A' ' 113' ' ' LYS . 1.9 p -69.91 94.3 0.83 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.043 0.449 . . . . 0.77 111.174 176.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.46 HG23 HG12 ' A' ' 106' ' ' VAL . 21.5 t -78.12 -49.62 21.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.643 0.735 . . . . 0.94 109.409 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.521 HG11 HD13 ' A' ' 115' ' ' LEU . 9.4 t -118.39 90.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.437 -0.801 . . . . 0.35 109.714 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.575 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 0.4 OUTLIER -109.45 71.66 0.78 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.906 -1.146 . . . . 4.01 107.906 176.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.928 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 6.6 p-10 168.86 19.29 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.026 -1.897 . . . . 1.96 109.698 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.711 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 11.5 tp -73.35 99.43 2.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.182 -0.463 . . . . 1.18 111.512 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 23.3 p-10 -110.59 91.08 3.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.161 0.981 . . . . 1.93 109.873 174.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.6 mm -52.9 -44.3 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 114.632 -1.167 . . . . 0.82 112.483 -170.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.53 ' HD1' HG22 ' A' ' 92' ' ' VAL . 69.5 t80 -56.96 -39.56 74.83 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 123.341 0.4 . . . . 1.08 111.755 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.878 ' HB2' ' HB2' ' A' ' 97' ' ' SER . 21.2 t70 -73.18 -32.61 64.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.115 0.483 . . . . 0.96 110.849 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 8.6 mmt180 -71.5 -44.43 64.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.634 -0.712 . . . . 1.69 111.084 -173.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.77 -40.38 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.323 0.49 . . . . 1.49 112.323 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.25 -58.26 4.96 Favored Glycine 0 C--O 1.23 -0.137 0 C-N-CA 121.133 -0.556 . . . . 1.4 112.104 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -99.92 145.42 27.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.436 -0.579 . . . . 4.11 109.436 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.419 ' OG ' HG11 ' A' ' 92' ' ' VAL . 3.0 m -54.38 94.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 O-C-N 123.691 0.619 . . . . 1.97 111.03 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 51' ' ' LEU . 21.2 p -150.05 -174.9 4.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.217 -0.447 . . . . 0.85 109.872 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.567 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -79.92 124.14 28.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.563 -0.29 . . . . 0.57 111.007 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -104.87 145.15 30.79 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.723 -1.214 . . . . 0.55 107.723 168.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.73 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 23.8 p-10 -146.81 139.83 25.33 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.931 -0.708 . . . . 1.64 112.141 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -103.85 114.02 27.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.219 -0.901 . . . . 1.12 108.598 172.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.608 HG23 HG22 ' A' ' 86' ' ' VAL . 71.6 mt -95.73 110.05 23.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.997 -0.547 . . . . 0.74 109.629 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.8 mt -119.7 97.45 49.83 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.37 -0.377 . . . . 1.25 111.162 -173.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -78.68 123.75 6.01 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.717 2.278 . . . . 0.29 112.108 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.666 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.9 pt -110.03 154.05 11.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.727 -0.842 . . . . 0.27 108.727 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.9 p -123.78 109.42 13.64 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.852 0.358 . . . . 1.24 110.323 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.718 HG12 ' HG ' ' A' ' 140' ' ' LEU . 29.2 mt -98.82 125.11 52.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.049 -0.722 . . . . 0.34 109.049 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -151.0 135.57 17.1 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.71 0.631 . . . . 1.95 109.435 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 1.066 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 7.6 mmpt? 61.98 25.85 15.55 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.538 0.524 . . . . 3.13 111.316 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.25 9.98 85.96 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.731 -0.747 . . . . 0.41 112.167 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.746 ' HG2' HG22 ' A' ' 148' ' ' THR . 26.3 mtpp -110.83 137.48 48.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.406 -0.59 . . . . 2.23 109.406 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.718 ' HG ' HG12 ' A' ' 135' ' ' ILE . 4.9 tt -108.68 115.32 29.88 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.415 -0.587 . . . . 0.41 109.415 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 m -108.4 125.12 51.39 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.893 -0.594 . . . . 1.19 110.091 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.405 HG21 HG13 ' A' ' 106' ' ' VAL . 85.5 t -113.09 95.5 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.769 -0.456 . . . . 0.92 109.769 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 62.39 -91.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.427 -0.806 . . . . 1.88 111.132 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.3 -10.46 29.54 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.922 -0.656 . . . . 1.02 112.594 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -97.47 149.98 21.57 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.803 -0.234 . . . . 1.95 110.763 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.92 125.76 13.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.168 0.509 . . . . 0.92 110.865 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.0 m -155.42 141.72 18.53 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.626 -0.509 . . . . 1.27 109.626 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.746 HG22 ' HG2' ' A' ' 139' ' ' LYS . 25.1 p -59.09 140.93 55.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.2 0.524 . . . . 1.45 111.131 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.775 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 20.8 t80 -85.83 140.85 30.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.45 -0.795 . . . . 0.47 110.301 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 t -144.41 118.01 9.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.509 0.671 . . . . 1.79 110.923 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.21 -77.8 2.08 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.324 -0.853 . . . . 0.42 113.607 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -159.72 169.47 23.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.038 0.447 . . . . 1.23 110.975 -174.254 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.872 HD21 HG23 ' A' ' 106' ' ' VAL . 6.7 tt -84.34 135.35 34.34 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.778 -0.823 . . . . 1.17 108.778 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.475 ' N ' HD23 ' A' ' 153' ' ' LEU . 8.1 t -121.34 109.07 14.46 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.903 -0.719 . . . . 1.35 110.538 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 45.2 t -95.23 98.06 7.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.722 -0.473 . . . . 0.42 109.722 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -114.95 134.3 55.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.205 -0.452 . . . . 1.98 110.434 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.737 ' HE2' ' CE2' ' A' ' 71' ' ' PHE . 0.1 OUTLIER -123.5 136.76 54.74 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.621 0.724 . . . . 2.32 111.418 176.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 42.2 t -104.5 145.44 13.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 114.002 -1.454 . . . . 0.62 111.525 -170.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.844 ' HA ' ' HB2' ' A' ' 164' ' ' ASN . 85.7 tttt -46.88 129.28 11.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 113.973 -1.467 . . . . 2.26 113.338 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -97.54 -70.07 1.0 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.395 -0.821 . . . . 1.45 111.512 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.663 ' HB2' ' HB3' ' A' ' 100' ' ' LYS . 38.3 t80 -123.86 -84.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.592 -0.358 . . . . 4.24 110.404 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -126.67 -3.82 6.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.651 1.215 . . . . 4.98 108.281 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.71 37.98 3.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.298 -1.774 . . . . 2.64 110.779 -168.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.844 ' HB2' ' HA ' ' A' ' 159' ' ' LYS . 2.8 t-20 -62.45 -49.91 81.39 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 107.801 -1.185 . . . . 2.06 107.801 164.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.813 ' HA ' ' HZ ' ' A' ' 71' ' ' PHE . 34.8 Cg_exo -62.35 108.59 0.71 Allowed 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.091 1.861 . . . . 3.16 111.108 169.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.503 ' HE3' ' CD2' ' A' ' 102' ' ' PHE . 14.0 pttm -147.89 177.16 9.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.296 -0.411 . . . . 3.18 110.347 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 1.029 HG22 ' HB2' ' A' ' 64' ' ' GLU . 52.1 t -69.45 135.44 28.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 120.646 -0.422 . . . . 1.19 110.079 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 11.5 t -141.92 86.4 1.98 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 119.084 -1.046 . . . . 1.36 113.592 -175.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.994 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -75.68 37.02 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.718 1.207 . . . . 0.31 112.564 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.752 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 23.3 tp -50.5 101.97 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.659 0.784 . . . . 0.69 113.111 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.736 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 5.0 t80 -114.82 128.29 56.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.832 -0.622 . . . . 0.48 110.626 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.681 HG22 ' HE3' ' A' ' 12' ' ' TRP . 6.4 tt -121.15 124.82 72.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-O 121.529 0.68 . . . . 0.3 111.349 174.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.736 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 2.0 ppp? -115.32 166.06 12.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.801 -0.636 . . . . 0.99 109.395 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.445 ' HB3' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -120.14 148.73 43.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.4 1.095 . . . . 1.22 112.888 -170.015 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.52 -28.76 14.15 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 113.531 -1.668 . . . . 0.31 114.285 163.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.651 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.7 OUTLIER -166.62 152.24 8.19 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.545 0.943 . . . . 0.68 113.545 -174.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.984 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -85.1 -15.39 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.105 -0.952 . . . . 0.86 110.223 167.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.434 ' H ' ' HB ' ' A' ' 176' ' ' THR . 20.2 t70 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 114.965 -1.016 . . . . 2.16 112.002 -173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.73 0 N-CA-C 110.977 -0.849 . . . . 1.48 110.977 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.661 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.5 tp -65.27 -27.49 68.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.085 0.469 . . . . 0.72 110.557 -174.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -71.01 -22.68 62.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.755 -0.657 . . . . 0.53 111.385 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.402 ' OD2' ' HG2' ' A' ' 9' ' ' LYS . 6.3 t70 -68.05 -42.13 80.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.207 0.527 . . . . 2.18 110.518 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 0.9 OUTLIER -103.29 -11.47 17.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.492 -0.776 . . . . 1.79 112.412 -168.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 12.4 p -59.96 131.25 24.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 120.401 -0.52 . . . . 0.33 111.015 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.509 HD11 HD13 ' A' ' 172' ' ' ILE . 22.7 pt -106.67 -22.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.952 -0.567 . . . . 0.92 110.071 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.741 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 34.9 t90 -168.81 142.13 2.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.775 -0.648 . . . . 0.36 109.595 -169.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -158.03 136.11 10.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.686 0.279 . . . . 0.26 111.195 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.801 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 18.8 t -146.71 125.18 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.418 0.627 . . . . 0.79 111.933 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 47.2 t30 -94.33 103.58 15.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.79 -1.189 . . . . 1.49 107.79 164.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -62.15 91.04 0.03 OUTLIER 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.881 -1.155 . . . . 0.48 107.881 171.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.781 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . 131.98 62.5 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.339 0 O-C-N 125.009 1.443 . . . . 0.76 113.169 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.92 -136.37 2.86 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 119.893 -1.146 . . . . 0.74 112.674 166.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.853 ' HG3' ' HD3' ' A' ' 31' ' ' LYS . 35.0 tt0 -161.64 118.12 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 119.724 -0.179 . . . . 1.77 110.952 171.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.731 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 60.1 p 31.36 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.567 1.167 . . . . 1.29 113.518 174.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.69 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 73.4 t60 -125.4 136.21 53.19 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.979 -0.688 . . . . 0.42 111.276 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.4 114.4 37.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.983 -0.553 . . . . 1.01 110.285 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.816 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -72.3 152.35 42.18 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.312 -0.625 . . . . 0.77 109.312 176.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG22 ' OD2' ' A' ' 57' ' ' ASP . 29.1 m -61.65 -10.83 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 113.594 0.961 . . . . 0.62 113.594 -170.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.484 ' HB2' HD23 ' A' ' 6' ' ' LEU . 28.6 m80 -92.87 -3.44 54.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.972 -0.751 . . . . 0.86 108.972 176.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 97.89 30.77 6.96 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.991 -1.004 . . . . 0.33 112.679 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.661 HD11 ' HG ' ' A' ' 6' ' ' LEU . 29.8 mm -103.83 108.09 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.127 0.489 . . . . 0.31 110.689 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -94.42 113.22 25.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.8 111.229 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.801 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -80.99 132.5 35.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.149 -0.478 . . . . 1.75 110.631 175.289 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.847 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 5.2 ptm180 -90.74 113.51 25.64 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.451 0.47 . . . . 2.94 110.673 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.853 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 39.0 ttpt -32.95 109.54 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.401 1.63 . . . . 2.78 115.401 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 59.3 m-20 23.7 63.02 0.39 Allowed Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 126.352 1.861 . . . . 2.41 114.715 168.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.847 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 17.7 Cg_endo -100.26 46.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.47 2.78 . . . . 1.87 113.823 -172.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.444 HD13 ' NH1' ' A' ' 65' ' ' ARG . 6.3 mp -82.2 -77.68 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.466 -0.494 . . . . 1.99 110.927 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.592 ' CD ' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -132.83 32.73 3.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.993 -0.549 . . . . 5.31 111.967 -170.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.58 -14.65 50.17 Favored Glycine 0 C--N 1.322 -0.196 0 C-N-CA 120.595 -0.812 . . . . 2.64 113.284 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.592 ' HD2' ' CD ' ' A' ' 35' ' ' GLU . 52.6 mtt85 -79.43 65.5 4.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.613 -0.514 . . . . 5.64 109.613 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.802 HG12 ' HE3' ' A' ' 31' ' ' LYS . 22.1 t -105.2 118.57 52.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.309 -0.859 . . . . 3.96 110.787 -173.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA2' ' HD2' ' A' ' 31' ' ' LYS . . . 93.17 15.83 49.81 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 2.56 112.279 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.1 mtm180 -129.56 62.84 1.53 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.279 0.562 . . . . 6.2 110.122 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.77 -45.27 82.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.877 -1.056 . . . . 2.0 111.223 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.0 m 69.27 61.6 0.3 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.558 -0.904 . . . . 2.52 108.558 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 46' ' ' MET . 4.6 p-10 -72.04 60.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.182 -1.372 . . . . 2.52 112.708 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -86.35 -20.36 28.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.156 0.503 . . . . 7.02 109.678 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -98.59 1.04 58.29 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.724 -0.671 . . . . 3.06 111.954 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' A' ' 46' ' ' MET . 40.7 ttm -73.16 -0.42 14.17 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.445 0.641 . . . . 2.35 110.55 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 47' ' ' LYS . 10.7 ttpp -102.03 14.05 33.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.37 0.605 . . . . 4.25 110.017 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 48' ' ' LEU . 3.4 mm? -117.32 87.24 23.74 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.758 -0.655 . . . . 2.56 109.898 175.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -42.87 133.76 5.56 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.186 2.591 . . . . 1.69 112.157 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.1 tp -83.36 -7.09 10.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 1.59 111.699 -171.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 125' ' ' THR . 9.1 mp 64.45 -67.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.503 0.721 . . . . 1.91 112.541 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -77.36 36.47 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.42 0.526 . . . . 3.17 112.42 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.2 t -157.23 143.82 18.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.082 -0.34 . . . . 0.97 110.082 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -65.71 145.35 99.04 Favored Pre-proline 0 C--O 1.223 -0.323 0 CA-C-N 115.659 -0.701 . . . . 1.92 109.737 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -41.12 -45.01 5.36 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.577 3.518 . . . . 0.7 115.462 -166.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.737 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.0 pt-20 -72.42 -46.91 52.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.019 0.914 . . . . 2.71 110.614 -176.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.816 ' OD1' ' HA ' ' A' ' 23' ' ' ASP . 68.3 m-20 -79.06 -14.63 59.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.553 -0.717 . . . . 1.63 109.56 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 33.2 tt0 -59.75 -49.55 77.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.136 -0.938 . . . . 1.58 109.269 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 56' ' ' GLU . 13.6 p -60.19 -35.27 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 119.726 -0.789 . . . . 1.27 110.055 176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.69 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 16.2 tp -69.34 -13.24 62.27 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.843 0.354 . . . . 1.18 111.763 176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.537 ' CG ' ' HG2' ' A' ' 88' ' ' LYS . 15.8 m-30 -119.11 3.22 11.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.461 -0.336 . . . . 0.99 111.329 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.49 ' HA ' HD13 ' A' ' 50' ' ' ILE . 6.8 tt0 -121.25 -49.54 2.16 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.367 0.877 . . . . 1.97 113.367 -167.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.781 ' HB ' ' O ' ' A' ' 17' ' ' GLY . 20.8 m -74.05 133.17 42.89 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.766 -0.373 . . . . 1.27 111.221 -173.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' HB3' HG22 ' A' ' 167' ' ' VAL . 2.1 pm0 -93.32 162.25 14.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 1.96 109.889 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.55 ' NH1' ' HB2' ' A' ' 37' ' ' ARG . 9.4 ttp180 -103.12 168.79 8.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.167 -0.679 . . . . 3.35 109.167 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.513 ' H ' ' HG2' ' A' ' 65' ' ' ARG . 40.1 t80 -56.3 119.29 5.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.285 0.564 . . . . 4.71 110.312 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.45 HD21 ' N ' ' A' ' 164' ' ' ASN . 17.3 t-20 -83.83 142.54 30.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.316 -0.856 . . . . 4.38 110.239 -176.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -138.54 -94.07 0.19 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.774 -0.194 . . . . 3.7 110.82 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.655 ' HA ' HD21 ' A' ' 164' ' ' ASN . 12.1 t70 -171.04 126.31 0.68 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.353 0.261 . . . . 2.2 110.958 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t 44.49 68.07 0.6 Allowed 'General case' 0 N--CA 1.463 0.203 0 O-C-N 124.122 0.888 . . . . 1.41 110.336 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.519 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 24.5 p90 -125.3 134.54 52.21 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.611 -0.722 . . . . 1.57 109.541 -172.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.79 -151.76 5.78 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.243 -0.889 . . . . 0.78 112.522 -174.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.586 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -142.01 160.06 40.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.1 0.476 . . . . 1.21 111.334 -171.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.73 ' HB3' ' HG3' ' A' ' 152' ' ' LYS . 2.6 m-20 -110.23 117.5 33.85 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.495 -0.775 . . . . 2.47 109.511 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.486 HD12 HD22 ' A' ' 153' ' ' LEU . 5.9 mt -106.58 90.64 5.17 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.187 -0.671 . . . . 0.38 109.187 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HA ' ' CB ' ' A' ' 152' ' ' LYS . 37.1 Cg_endo -67.22 116.08 4.0 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.015 1.143 . . . . 0.59 111.96 -175.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.844 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 62.1 mt -107.52 130.99 58.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.948 -0.569 . . . . 0.49 110.418 -174.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -122.64 5.95 9.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.228 -0.442 . . . . 3.32 110.474 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -132.5 172.21 12.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.504 -0.317 . . . . 2.16 110.215 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.57 ' HG2' HG22 ' A' ' 135' ' ' ILE . 9.5 mt-10 -114.67 176.42 5.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.895 0.379 . . . . 1.2 110.753 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.72 -166.14 21.32 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.76 -0.936 . . . . 0.3 110.76 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 24.7 mt-10 -103.0 107.17 17.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.52 0.66 . . . . 1.96 109.587 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.653 ' HB2' HG12 ' A' ' 133' ' ' ILE . 93.3 m-85 -94.33 124.69 38.51 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 119.803 -0.759 . . . . 0.71 109.074 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.642 HG21 ' CA ' ' A' ' 177' ' ' ALA . 96.9 t -113.49 107.67 23.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.669 -0.696 . . . . 0.26 110.764 -171.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 85' ' ' LEU . 4.9 mp -90.12 104.78 17.32 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.475 -1.239 . . . . 1.56 109.146 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.65 105.12 17.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.224 -1.028 . . . . 1.14 108.224 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.576 ' HG ' HD13 ' A' ' 170' ' ' LEU . 3.7 mp -100.81 132.24 46.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.814 -0.81 . . . . 1.44 108.814 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.796 ' HD2' ' HB3' ' A' ' 128' ' ' ASP . 23.5 tptt -96.63 114.73 26.41 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.683 -0.858 . . . . 3.73 108.683 173.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -104.56 137.12 42.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.82 -0.627 . . . . 0.45 109.373 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -133.09 133.64 43.24 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.544 -0.753 . . . . 0.51 111.262 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 124' ' ' SER . 8.3 tp10 -124.42 112.79 17.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.007 -0.997 . . . . 2.62 108.332 173.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.604 HG22 ' HE3' ' A' ' 166' ' ' LYS . 23.4 m -61.84 -40.69 87.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.536 -0.756 . . . . 3.77 112.133 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.67 95.84 0.04 OUTLIER 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.969 0.414 . . . . 5.68 111.854 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -140.77 92.46 2.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.219 -1.03 . . . . 4.65 108.219 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.484 ' HA ' ' CE1' ' A' ' 118' ' ' PHE . . . -80.87 61.52 4.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.826 -0.625 . . . . 1.39 112.32 -170.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -154.47 138.37 16.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.093 -0.336 . . . . 2.75 110.093 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 119' ' ' ASP . 31.3 t -102.77 151.47 22.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.4 110.334 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 54.13 35.19 21.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.835 -0.62 . . . . 2.38 111.696 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -124.4 -61.47 1.33 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.748 -0.834 . . . . 2.89 108.748 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -90.4 92.07 8.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.55 -0.907 . . . . 2.79 108.55 170.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.2 m -108.81 120.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.292 0.567 . . . . 1.22 110.261 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.724 ' HB3' ' HG3' ' A' ' 165' ' ' PRO . 18.4 m-85 -88.68 150.74 22.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.56 -0.745 . . . . 0.99 110.864 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 23.5 m-20 -104.51 134.74 47.19 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.165 -1.05 . . . . 1.53 108.165 169.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.404 HG21 HD12 ' A' ' 115' ' ' LEU . 4.8 t -134.89 115.52 19.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.088 0.471 . . . . 0.63 110.638 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.581 ' HB3' HG23 ' A' ' 110' ' ' THR . 23.2 ptt180 -124.42 126.41 45.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.664 -0.698 . . . . 1.95 111.889 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.681 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 32.1 m -102.86 131.72 50.54 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 108.982 -0.748 . . . . 1.44 108.982 173.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.577 HD22 ' HG ' ' A' ' 153' ' ' LEU . 1.6 p30 48.44 44.43 20.41 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.862 0.465 . . . . 1.65 111.553 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.24 -1.79 63.62 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.917 -0.583 . . . . 0.42 112.676 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.681 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 52.5 m-70 -101.73 103.18 13.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.274 0.629 . . . . 0.68 111.202 -173.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.581 HG23 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -69.23 98.61 1.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.377 0.608 . . . . 0.77 111.12 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.43 -52.0 15.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.631 -0.713 . . . . 0.94 109.71 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.56 HG11 ' HG ' ' A' ' 115' ' ' LEU . 3.8 t -117.68 94.33 3.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.714 -0.676 . . . . 0.35 109.811 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -111.86 73.26 0.81 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.566 0.698 . . . . 4.01 109.353 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.601 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 12.2 p-10 162.71 27.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.72 -1.582 . . . . 1.96 108.834 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -69.4 91.95 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.405 -0.816 . . . . 1.18 111.199 -172.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 24.0 p-10 -101.9 96.96 7.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.767 0.794 . . . . 1.93 109.275 171.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.7 mt -53.78 -35.76 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.979 -1.01 . . . . 0.82 111.954 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 84.7 t80 -56.12 -44.66 79.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 1.08 111.251 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.465 ' HB2' ' OG ' ' A' ' 97' ' ' SER . 15.3 t70 -72.53 -35.71 68.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.34 -0.391 . . . . 0.96 111.525 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 5.3 mmt180 -75.62 -42.48 51.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.239 -0.437 . . . . 1.69 111.776 -170.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 p -117.37 -28.05 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.538 -0.465 . . . . 1.49 111.875 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 124.21 -151.46 17.17 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.851 -0.899 . . . . 1.4 110.851 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -92.39 122.92 35.31 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.263 -0.575 . . . . 4.11 109.972 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 11.0 m 65.27 -142.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.779 . . . . 1.97 110.39 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 59.2 p 58.13 -174.22 0.09 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.711 0.804 . . . . 0.85 111.865 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.3 131.57 53.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.385 . . . . 0.57 111.816 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 18.2 t60 -107.09 142.82 36.15 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 108.651 -0.87 . . . . 0.55 108.651 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.796 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 5.4 p-10 -129.54 123.87 32.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.524 0.678 . . . . 1.64 110.779 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -104.57 110.91 23.39 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.922 -1.035 . . . . 1.12 109.148 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.76 111.52 25.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.865 -0.607 . . . . 0.74 110.208 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.9 mt -118.81 95.71 49.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.242 -0.435 . . . . 1.25 110.751 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.443 ' HB3' HG22 ' A' ' 84' ' ' VAL . 5.9 Cg_exo -81.23 128.85 6.51 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.068 2.512 . . . . 0.29 112.202 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.705 ' HB ' HD21 ' A' ' 140' ' ' LEU . 3.5 pt -110.5 162.1 8.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.756 -0.831 . . . . 0.27 108.756 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.5 t -127.48 106.57 9.28 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.488 -0.324 . . . . 1.24 110.164 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.779 HG12 ' HG ' ' A' ' 140' ' ' LEU . 21.8 mt -101.05 124.04 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.236 -0.654 . . . . 0.34 109.236 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -148.16 125.12 11.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.824 -0.626 . . . . 1.95 109.395 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.2 OUTLIER 63.9 28.91 14.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.664 -0.698 . . . . 3.13 111.558 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.04 14.33 80.79 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.958 -0.639 . . . . 0.41 112.374 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.569 ' HG2' HG22 ' A' ' 148' ' ' THR . 55.0 mtpt -116.66 147.8 41.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.61 -0.515 . . . . 2.23 109.61 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.779 ' HG ' HG12 ' A' ' 135' ' ' ILE . 3.1 tt -118.06 127.46 53.82 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.07 -0.345 . . . . 0.41 110.07 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 15.0 m -114.6 125.29 53.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.053 -0.521 . . . . 1.19 110.203 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.42 HG23 HD22 ' A' ' 140' ' ' LEU . 85.6 t -118.62 98.5 6.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.672 0.272 . . . . 0.92 110.715 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 56.7 26.56 11.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.823 -0.626 . . . . 1.88 112.145 173.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.86 -39.6 1.8 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.767 -0.651 . . . . 1.02 112.343 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 141' ' ' SER . 39.9 mt-10 -68.78 114.17 6.88 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.075 -0.342 . . . . 1.95 110.075 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.2 p -108.53 115.9 50.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.307 0.575 . . . . 0.92 110.747 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 m -135.85 176.51 8.61 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.869 -0.789 . . . . 1.27 108.869 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.569 HG22 ' HG2' ' A' ' 139' ' ' LYS . 37.1 p -91.23 138.51 31.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.912 -0.403 . . . . 1.45 109.912 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.844 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 92.5 t80 -79.92 129.47 34.51 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.846 -0.427 . . . . 0.47 109.846 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.6 t -121.07 96.05 4.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.649 0.738 . . . . 1.79 112.062 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.93 -66.76 2.11 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.34 -0.845 . . . . 0.42 114.23 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.73 ' HG3' ' HB3' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -148.58 160.26 43.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.291 0.567 . . . . 1.23 111.014 -173.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.577 ' HG ' HD22 ' A' ' 107' ' ' ASN . 5.7 tt -90.76 117.94 29.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.402 -0.962 . . . . 1.17 108.402 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.535 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 3.6 t -107.37 111.69 24.15 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.91 -0.716 . . . . 1.35 110.559 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 22.7 t -98.94 98.6 7.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.13 -0.486 . . . . 0.42 110.134 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.541 ' HB2' ' HE ' ' A' ' 105' ' ' ARG . 12.8 mm-40 -105.22 146.89 28.66 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.705 -0.48 . . . . 1.98 109.705 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.827 ' HB2' ' HG2' ' A' ' 165' ' ' PRO . 2.9 p90 -127.81 134.09 49.44 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.134 0.492 . . . . 2.32 110.348 171.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 14.2 t -115.47 144.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.272 -0.876 . . . . 0.62 110.868 -170.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.593 ' HE3' ' HB2' ' A' ' 69' ' ' ASP . 16.6 pttp -77.83 112.68 14.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.915 -0.584 . . . . 2.26 111.473 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.95 -10.41 80.93 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.434 -0.889 . . . . 1.45 110.923 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -161.34 68.32 0.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.674 -0.263 . . . . 4.24 110.754 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' A' ' 159' ' ' LYS . 96.7 m-85 67.81 -67.06 0.19 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.588 0.755 . . . . 4.98 112.61 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.52 105.2 7.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.916 -0.584 . . . . 2.64 109.706 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.655 HD21 ' HA ' ' A' ' 69' ' ' ASP . 44.3 m-80 -60.68 164.16 7.9 Favored Pre-proline 0 N--CA 1.462 0.155 0 N-CA-C 107.573 -1.269 . . . . 2.06 107.573 168.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.827 ' HG2' ' HB2' ' A' ' 157' ' ' PHE . 64.8 Cg_exo -42.21 99.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.49 2.127 . . . . 3.16 112.031 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.604 ' HE3' HG22 ' A' ' 92' ' ' VAL . 20.1 ttmm -49.24 -68.1 0.21 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.732 -1.122 . . . . 3.18 112.084 -165.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.728 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 46.1 t -101.36 134.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.895 -0.409 . . . . 1.19 109.895 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 17.8 t -136.44 83.34 2.0 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.125 -0.63 . . . . 1.36 112.432 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.749 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -76.61 37.34 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.645 1.178 . . . . 0.31 112.715 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.741 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 6.8 tp -58.1 110.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.351 0.596 . . . . 0.69 111.834 -173.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.631 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -114.51 134.16 55.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.835 -0.621 . . . . 0.48 109.423 174.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.569 ' CG2' ' HB3' ' A' ' 12' ' ' TRP . 3.7 tt -124.58 127.01 72.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-O 122.268 1.032 . . . . 0.3 111.897 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.545 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 10.7 ptm -114.08 171.53 7.55 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.385 -1.28 . . . . 0.99 109.31 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 19.2 ptmt -118.35 146.05 44.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.914 0.864 . . . . 1.22 112.665 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 176' ' ' THR . . . 103.04 -30.0 11.31 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 113.913 -1.494 . . . . 0.31 114.747 162.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.4 OUTLIER -173.9 153.05 2.07 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.01 0.905 . . . . 0.68 112.744 -176.731 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.642 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -86.96 -14.24 42.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.013 -0.994 . . . . 0.86 110.2 169.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.37 -0.832 . . . . 2.16 111.415 -173.572 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.764 0 N-CA-C 111.737 -0.545 . . . . 1.48 111.737 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.898 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 27.2 tp -60.02 -45.44 92.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.0 0.428 . . . . 0.72 110.928 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 25' ' ' HIS . . . -62.45 -22.99 66.64 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.723 -0.671 . . . . 0.53 111.544 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.33 -40.95 17.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.096 -0.502 . . . . 2.18 110.952 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 173' ' ' MET . 66.9 mmtt -97.12 -4.62 38.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.414 0.524 . . . . 1.79 112.414 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 11.8 p -60.99 134.87 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.141 -0.624 . . . . 0.33 110.422 171.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.508 HD13 ' HE2' ' A' ' 83' ' ' TYR . 42.4 pt -113.86 -22.77 4.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.235 -0.439 . . . . 0.92 110.447 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.765 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 75.0 t90 -164.42 147.5 9.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.36 110.327 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -159.53 141.31 13.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.221 -0.289 . . . . 0.26 110.221 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.925 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 24.8 t -144.22 115.97 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.703 0.763 . . . . 0.79 112.584 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 1.9 t-20 -88.24 88.03 7.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.369 -1.345 . . . . 1.49 107.369 164.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.606 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -60.87 103.07 0.23 Allowed 'General case' 0 C--O 1.25 1.089 0 CA-C-N 115.768 -0.651 . . . . 0.48 109.982 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.427 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 160.44 -48.0 0.39 Allowed Glycine 0 N--CA 1.44 -1.064 0 O-C-N 125.127 1.517 . . . . 0.76 113.083 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.09 -131.32 6.47 Favored Glycine 0 C--O 1.229 -0.199 0 C-N-CA 120.74 -0.743 . . . . 0.74 113.627 -173.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 47.0 mt-10 -150.31 119.87 6.97 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 119.218 -0.42 . . . . 1.77 110.625 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 72.1 m 33.18 108.29 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 115.484 1.661 . . . . 1.29 115.484 170.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.543 ' ND1' ' HB2' ' A' ' 60' ' ' LEU . 27.6 t-80 -147.87 131.19 16.56 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.733 -0.604 . . . . 0.42 110.861 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 1.1 p -96.79 124.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.235 -0.654 . . . . 1.01 109.235 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' OD1' ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -77.77 163.82 25.78 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.737 -0.665 . . . . 0.77 109.66 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 m -55.24 -29.59 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 113.14 0.792 . . . . 0.62 113.14 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 19.4 m170 -70.02 -18.31 63.3 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.346 -0.613 . . . . 0.86 109.346 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 101.71 31.66 5.38 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.104 -0.953 . . . . 0.33 111.235 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.643 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.9 mm -102.63 110.97 30.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 0.31 110.861 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 3.3 t60 -97.44 111.7 23.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.21 -0.45 . . . . 0.8 111.23 -172.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.925 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -76.85 131.15 38.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.94 -0.573 . . . . 1.75 110.577 175.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.685 ' HD3' ' HG3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -88.36 107.05 18.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.805 -0.634 . . . . 2.94 110.693 177.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.922 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 33.4 ttmt -18.62 126.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 125.034 1.459 . . . . 2.78 113.094 174.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 16' ' ' ALA . 2.5 m-20 -35.77 101.26 0.21 Allowed Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 123.197 1.475 . . . . 2.41 114.046 -169.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.685 ' HG3' ' HD3' ' A' ' 30' ' ' ARG . 40.2 Cg_endo -103.05 37.16 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 125.174 3.916 . . . . 1.87 115.071 -166.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.557 HD11 ' NH1' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -132.34 -35.32 1.17 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.134 -1.026 . . . . 1.99 113.128 -179.22 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' N ' HD22 ' A' ' 34' ' ' LEU . 7.6 pt-20 -90.37 72.33 7.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.768 0.795 . . . . 5.31 110.338 176.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.78 -1.2 84.52 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.48 -0.782 . . . . 2.64 111.311 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.451 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER 46.21 53.61 9.22 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.432 0.693 . . . . 5.64 110.099 -176.011 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.91 156.18 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.074 -0.966 . . . . 3.96 109.779 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.922 ' HA2' ' HD3' ' A' ' 31' ' ' LYS . . . -75.58 72.92 1.69 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.763 -0.732 . . . . 2.56 111.511 174.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -115.12 76.66 1.01 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.776 0.322 . . . . 6.2 110.59 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.4 112.96 3.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.376 -0.601 . . . . 2.0 109.376 175.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 47.8 t -100.69 35.92 2.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.931 -0.577 . . . . 2.52 110.713 -171.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -73.84 56.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.651 0.738 . . . . 2.52 111.478 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -90.57 -25.42 20.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.766 -0.652 . . . . 7.02 110.243 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.57 44.31 1.39 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.208 -1.157 . . . . 3.06 110.208 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 46' ' ' MET . 37.8 ttm -62.03 -11.97 16.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.972 -0.614 . . . . 2.35 112.317 -172.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -69.45 100.09 1.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.404 0.621 . . . . 4.25 111.705 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER 170.27 66.8 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 113.743 -1.571 . . . . 2.56 108.321 -178.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.94 113.55 2.42 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.26 1.973 . . . . 1.69 112.526 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.714 HG12 ' HE3' ' A' ' 88' ' ' LYS . 1.7 mp -71.06 100.77 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 122.287 1.041 . . . . 1.59 109.91 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HB2' HG22 ' A' ' 125' ' ' THR . 87.9 mt -76.42 -2.3 31.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.18 -1.373 . . . . 1.91 113.171 -171.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.892 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 14.1 mmm180 -109.36 18.3 20.58 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.085 -0.646 . . . . 3.17 111.009 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB2' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -128.54 170.35 13.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.366 -0.379 . . . . 0.97 110.162 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.482 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -93.04 139.46 23.11 Favored Pre-proline 0 C--O 1.216 -0.708 0 N-CA-C 109.01 -0.737 . . . . 1.92 109.01 178.211 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 40.0 Cg_exo -38.63 -42.29 1.79 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 124.071 3.181 . . . . 0.7 116.617 -163.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.509 ' HG3' ' H ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -76.05 -46.41 29.38 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.51 -0.744 . . . . 2.71 110.516 -177.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 3.5 p30 -79.75 -17.43 53.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.177 -0.465 . . . . 1.63 110.119 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -57.89 -43.7 86.24 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 108.944 -0.762 . . . . 1.58 108.944 167.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.41 -45.76 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.788 -0.449 . . . . 1.27 109.788 172.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.543 ' HB2' ' ND1' ' A' ' 21' ' ' HIS . 24.3 tp -63.06 -15.24 55.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.458 -0.792 . . . . 1.18 111.489 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.54 ' CD2' ' HG3' ' A' ' 88' ' ' LYS . 4.2 m-30 -114.31 0.81 14.26 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.23 -0.441 . . . . 0.99 111.403 -177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.539 ' HA ' HD13 ' A' ' 50' ' ' ILE . 49.8 tt0 -122.07 -43.27 2.34 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.792 0.664 . . . . 1.97 112.792 -169.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.5 m -59.97 131.13 49.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.117 -0.492 . . . . 1.27 111.413 -175.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.851 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.9 pm0 -116.98 158.94 23.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.581 0.585 . . . . 1.96 112.581 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.648 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 3.2 ptm180 -139.29 156.19 47.21 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.616 -0.72 . . . . 3.35 110.182 172.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.445 ' HA ' ' CB ' ' A' ' 165' ' ' PRO . 44.9 p90 -121.8 144.6 48.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.382 -0.229 . . . . 4.71 110.382 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -165.87 64.14 0.11 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.072 0.463 . . . . 4.38 111.241 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.429 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 12.1 tp10 61.42 -93.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.206 -0.906 . . . . 3.7 112.854 173.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.675 ' HA ' ' OD1' ' A' ' 164' ' ' ASN . 2.9 p30 -164.87 153.26 12.14 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 122.209 -0.307 . . . . 2.2 111.302 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 32.1 t 54.16 61.52 3.01 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.164 -0.926 . . . . 1.41 110.747 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.825 ' CZ ' ' HA ' ' A' ' 165' ' ' PRO . 16.2 p90 -103.59 121.91 43.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.165 -0.614 . . . . 1.57 109.973 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 155' ' ' VAL . . . -108.17 174.47 19.03 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 114.934 -1.03 . . . . 0.78 113.808 -170.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.504 ' HB3' ' CZ2' ' A' ' 12' ' ' TRP . 52.4 m-85 -132.19 141.89 49.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.124 -0.538 . . . . 1.21 109.583 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 4.7 p-10 -106.0 114.42 28.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.192 0.52 . . . . 2.47 111.211 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.857 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.9 mp -106.91 91.34 6.19 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.662 -0.699 . . . . 0.38 109.347 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.701 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 32.1 Cg_exo -59.67 117.5 4.25 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 121.987 1.792 . . . . 0.59 111.892 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.795 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 60.6 mt -120.57 138.09 52.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.828 0.347 . . . . 0.49 111.02 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -136.82 7.3 2.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.132 -0.485 . . . . 3.32 110.709 173.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.447 ' HB2' ' HE3' ' A' ' 174' ' ' LYS . 6.6 mm-40 -121.87 -177.31 3.54 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.076 -0.342 . . . . 2.16 110.076 -173.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 5.0 mt-10 -128.05 -179.22 4.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.277 -0.419 . . . . 1.2 110.525 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.55 -172.65 15.44 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.637 -0.985 . . . . 0.3 110.637 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.25 108.78 20.2 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.099 -0.64 . . . . 1.96 109.463 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.706 ' HB2' HG12 ' A' ' 133' ' ' ILE . 61.8 m-85 -92.58 125.52 37.25 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.482 -0.933 . . . . 0.71 108.482 -177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.592 HG21 ' CA ' ' A' ' 177' ' ' ALA . 72.4 t -114.74 105.75 19.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.314 -0.857 . . . . 0.26 110.257 -173.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 170' ' ' LEU . 5.4 mp -89.21 104.4 16.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.495 -1.23 . . . . 1.56 108.82 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG23 HG12 ' A' ' 84' ' ' VAL . 80.4 t -103.47 102.17 13.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.068 -1.086 . . . . 1.14 108.068 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.703 ' CD2' ' HB3' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -103.95 132.98 49.67 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.033 -0.667 . . . . 1.44 110.216 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.714 ' HE3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -87.92 121.64 30.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.388 -0.968 . . . . 3.73 108.388 173.208 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 6.2 m-85 -107.05 141.25 38.57 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.119 0.485 . . . . 0.45 111.451 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.906 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -134.08 113.8 12.48 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.159 -0.928 . . . . 0.51 109.097 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.818 ' HB2' HD12 ' A' ' 117' ' ' ILE . 29.6 tt0 -102.38 144.58 30.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 2.62 110.803 -173.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 p -108.14 107.39 22.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.628 0.727 . . . . 3.77 109.484 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.503 ' HD1' ' H ' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -139.14 173.78 11.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.621 -0.718 . . . . 5.68 111.479 -171.372 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -105.87 41.81 1.34 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.521 -0.763 . . . . 4.65 109.624 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.503 ' H ' ' HD1' ' A' ' 93' ' ' TYR . . . 57.82 75.4 0.38 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.198 -0.91 . . . . 1.39 111.848 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -159.6 140.85 12.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.756 -0.656 . . . . 2.75 109.997 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.768 ' HB2' ' HB2' ' A' ' 119' ' ' ASP . 19.8 p -132.47 -177.03 4.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.551 -0.295 . . . . 1.4 111.003 -177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 54.36 36.76 26.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.378 0.609 . . . . 2.38 111.408 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -167.65 -37.9 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.14 -1.059 . . . . 2.89 108.14 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 12.4 mmmm -75.7 67.65 2.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.207 -0.906 . . . . 2.79 109.377 168.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.649 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 16.8 m -108.25 120.54 59.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.593 0.711 . . . . 1.22 110.611 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 73.2 m-85 -104.48 158.7 16.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.042 -0.981 . . . . 0.99 110.922 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.676 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 16.2 m-20 -108.88 137.64 46.49 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.718 -0.475 . . . . 1.53 109.718 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 110' ' ' THR . 0.3 OUTLIER -140.01 125.1 20.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.335 0.588 . . . . 0.63 110.945 -177.386 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.782 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 41.5 mtt180 -108.13 138.34 44.57 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.18 -0.918 . . . . 1.95 111.172 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.831 HG13 HD21 ' A' ' 153' ' ' LEU . 74.2 t -113.35 103.03 14.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.281 -0.637 . . . . 1.44 109.281 170.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.48 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.2 OUTLIER 64.18 39.26 7.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.202 -0.908 . . . . 1.65 108.949 -175.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.8 -22.37 34.19 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.3 -0.864 . . . . 0.42 112.452 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 83.6 m-70 -83.64 101.15 11.3 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.556 0.342 . . . . 0.68 111.857 -173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.686 HG23 ' HG2' ' A' ' 105' ' ' ARG . 3.3 p -62.88 93.05 0.05 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.331 0.586 . . . . 0.77 111.245 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.532 HG11 HG23 ' A' ' 131' ' ' ILE . 11.9 t -73.05 -47.59 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.559 -0.746 . . . . 0.94 109.742 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.702 HG11 ' HG ' ' A' ' 115' ' ' LEU . 11.7 t -117.62 90.19 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 109.245 -0.65 . . . . 0.35 109.245 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.36 71.67 0.76 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.901 0.858 . . . . 4.01 108.935 178.399 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.649 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.5 p30 164.18 24.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.686 -1.597 . . . . 1.96 108.601 -169.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.702 ' HG ' HG11 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -71.34 90.89 0.96 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.427 -0.806 . . . . 1.18 111.563 -170.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 14.0 p30 -104.88 94.57 5.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.676 0.75 . . . . 1.93 110.067 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.818 HD12 ' HB2' ' A' ' 91' ' ' GLU . 83.2 mt -61.7 -37.11 77.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.125 -0.943 . . . . 0.82 111.653 -170.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.503 ' HD2' ' HB3' ' A' ' 97' ' ' SER . 75.6 t80 -59.4 -38.56 80.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.08 110.873 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.768 ' HB2' ' HB2' ' A' ' 97' ' ' SER . 18.7 t70 -71.73 -32.1 67.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.929 0.395 . . . . 0.96 110.969 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 12.0 mmt85 -76.36 -49.24 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.899 -0.591 . . . . 1.69 111.765 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 127' ' ' HIS . 60.0 t -107.52 -36.09 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.104 0.409 . . . . 1.49 112.104 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.08 -111.55 2.11 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.401 -0.904 . . . . 1.4 111.867 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -112.02 112.55 24.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.979 0.418 . . . . 4.11 111.198 -176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 125' ' ' THR . 33.0 p 53.03 -149.81 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.394 1.078 . . . . 1.97 112.277 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.892 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 29.1 p 64.85 -160.42 0.28 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.996 0.918 . . . . 0.85 110.932 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 50' ' ' ILE . . . -94.88 122.27 37.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.469 0.544 . . . . 0.57 112.469 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.673 ' HA ' HG21 ' A' ' 121' ' ' VAL . 13.6 t60 -92.44 130.65 38.05 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.466 -0.568 . . . . 0.55 109.466 167.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.81 121.67 42.21 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.16 -0.927 . . . . 1.64 109.572 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.703 ' HB3' ' CD2' ' A' ' 87' ' ' LEU . 4.5 tp10 -123.92 108.29 12.27 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.409 -0.96 . . . . 1.12 108.409 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.458 HG12 HG22 ' A' ' 86' ' ' VAL . 80.1 mt -94.1 118.21 39.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.889 -0.596 . . . . 0.74 110.166 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.532 HG23 HG11 ' A' ' 111' ' ' VAL . 68.2 mt -117.94 93.67 44.75 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.534 -0.303 . . . . 1.25 110.864 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.89 124.39 3.43 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.877 2.385 . . . . 0.29 112.797 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.706 HG12 ' HB2' ' A' ' 83' ' ' TYR . 3.5 pt -109.51 166.29 4.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.575 -1.269 . . . . 0.27 107.575 173.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.6 t -131.78 106.62 8.23 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.904 -0.406 . . . . 1.24 109.904 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 49.7 mt -99.27 122.99 51.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.291 -0.633 . . . . 0.34 109.291 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -150.78 136.62 18.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.86 -0.793 . . . . 1.95 108.86 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm 66.95 17.95 10.56 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.196 0.522 . . . . 3.13 110.544 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.15 12.08 77.18 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.815 -0.629 . . . . 0.41 112.383 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 94.5 mttt -112.72 140.15 47.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.97 0.385 . . . . 2.23 110.601 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.459 ' HG ' HD12 ' A' ' 133' ' ' ILE . 6.9 tt -103.27 115.67 31.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.518 -0.549 . . . . 0.41 109.518 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.0 m -110.87 107.15 16.53 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.599 -0.519 . . . . 1.19 109.599 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.436 HG21 HG22 ' A' ' 111' ' ' VAL . 4.0 p -90.72 106.99 18.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.369 -0.604 . . . . 0.92 109.369 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 63.69 -81.07 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.555 -0.748 . . . . 1.88 110.841 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.76 -0.56 3.55 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.851 -0.69 . . . . 1.02 112.046 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -95.66 113.96 25.65 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.522 -0.547 . . . . 1.95 109.522 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.31 132.47 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.13 0.49 . . . . 0.92 111.8 -171.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t -160.3 133.65 6.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.673 -0.694 . . . . 1.27 109.181 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.713 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 9.1 t -55.38 139.41 43.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.286 0.565 . . . . 1.45 111.081 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.795 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 25.9 t80 -80.0 133.87 36.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.34 -0.845 . . . . 0.47 110.536 -175.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 p -127.61 96.46 4.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.091 0.472 . . . . 1.79 112.229 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.17 -69.52 3.15 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.42 113.96 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.701 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -159.23 164.02 35.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.176 0.488 . . . . 1.23 110.552 -176.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.857 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 6.1 tt -81.81 142.84 32.22 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.131 -1.063 . . . . 1.17 108.131 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.585 ' N ' HD23 ' A' ' 153' ' ' LEU . 9.9 t -135.83 107.6 7.04 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.313 -0.555 . . . . 1.35 110.648 -172.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 59.4 t -97.08 99.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.389 -0.369 . . . . 0.42 111.141 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.16 123.76 42.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.725 -0.39 . . . . 1.98 110.457 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.508 ' HE1' ' HA ' ' A' ' 164' ' ' ASN . 49.0 t80 -102.65 118.03 35.95 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.461 -0.94 . . . . 2.32 108.461 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 21.9 t -103.67 144.25 14.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.558 -0.746 . . . . 0.62 110.422 -173.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.885 ' HA ' ' HB2' ' A' ' 164' ' ' ASN . 61.3 pttt -66.18 128.61 36.8 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 121.147 0.499 . . . . 2.26 112.205 -174.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.33 -31.4 5.88 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.433 -0.803 . . . . 1.45 111.981 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -138.35 -88.21 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.46 -0.57 . . . . 4.24 109.46 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.514 ' O ' ' HD2' ' A' ' 165' ' ' PRO . 80.5 t80 -133.34 -48.17 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.791 -0.186 . . . . 4.98 110.526 174.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -74.65 49.34 0.39 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.903 0.858 . . . . 2.64 111.965 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.885 ' HB2' ' HA ' ' A' ' 159' ' ' LYS . 2.3 t-20 -62.01 -45.28 91.52 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 114.388 -1.278 . . . . 2.06 109.023 162.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.825 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 36.2 Cg_endo -69.08 65.85 1.38 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.046 1.83 . . . . 3.16 112.092 169.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.526 ' HE3' ' H ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -102.58 179.96 4.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.585 -0.734 . . . . 3.18 111.559 178.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.906 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 39.6 t -74.71 135.18 27.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 116.39 -0.368 . . . . 1.19 111.066 -175.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.7 t -132.15 141.16 49.02 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 120.228 -0.589 . . . . 1.36 110.974 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.693 ' HB3' ' CB ' ' A' ' 88' ' ' LYS . . . -131.35 35.06 3.91 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.428 -0.805 . . . . 0.31 109.311 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.765 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 14.4 tp -58.29 102.65 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.635 -1.166 . . . . 0.69 112.427 -175.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.898 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -111.21 132.63 54.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.698 -0.683 . . . . 0.48 109.659 176.269 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.713 HG22 ' HE3' ' A' ' 12' ' ' TRP . 5.3 tt -117.9 123.6 71.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.885 0.85 . . . . 0.3 111.577 176.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.68 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 2.5 ppp? -115.52 163.36 15.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.295 -1.002 . . . . 0.99 108.295 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 79' ' ' GLU . 11.6 ptmm? -119.3 147.91 43.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 122.629 1.204 . . . . 1.22 113.362 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 176' ' ' THR . . . 106.18 -29.64 10.83 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 112.863 -1.971 . . . . 0.31 114.84 167.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.6 OUTLIER -175.38 154.93 1.76 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.525 1.163 . . . . 0.68 112.478 -177.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.592 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -84.39 -17.85 38.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.886 -0.597 . . . . 0.86 110.465 169.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.766 -0.652 . . . . 2.16 111.302 -177.947 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 111.266 -0.734 . . . . 1.48 111.266 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 27' ' ' ILE . 24.7 tp -64.46 -25.34 67.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.926 -0.637 . . . . 0.72 110.589 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.528 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -60.92 -22.91 64.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.4 -0.818 . . . . 0.53 112.215 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.18 -21.6 59.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.536 -0.302 . . . . 2.18 110.63 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 59.8 mmtt -114.14 -16.59 12.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.649 -0.42 . . . . 1.79 111.799 -177.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.569 ' HB ' HD12 ' A' ' 27' ' ' ILE . 14.8 p -56.57 136.1 19.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.48 0.657 . . . . 0.33 111.729 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 174' ' ' LYS . 5.4 pt -115.27 -28.45 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.614 -0.721 . . . . 0.92 110.64 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.702 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 67.1 t90 -169.17 140.29 2.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.232 -0.44 . . . . 0.36 110.177 -170.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -162.42 147.21 12.27 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.317 -0.24 . . . . 0.26 111.224 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.69 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 2.2 p -151.16 125.6 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 113.197 0.814 . . . . 0.79 113.197 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.469 ' CB ' HD12 ' A' ' 60' ' ' LEU . 1.7 t-20 -94.05 95.79 9.25 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 114.956 -1.02 . . . . 1.49 108.65 170.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.687 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -58.54 103.21 0.14 Allowed 'General case' 0 C--O 1.246 0.907 0 CA-C-N 116.116 -0.493 . . . . 0.48 109.723 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.809 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 174.2 -42.26 0.14 Allowed Glycine 0 N--CA 1.438 -1.191 0 O-C-N 124.882 1.364 . . . . 0.76 113.98 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.24 -121.09 1.79 Allowed Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.001 -1.095 . . . . 0.74 113.072 -167.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . 46.1 mt-10 -148.59 119.52 7.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.847 0.323 . . . . 1.77 111.237 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 55.7 m 32.83 105.19 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.0 1.482 . . . . 1.29 115.0 170.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.539 ' ND1' ' HB2' ' A' ' 60' ' ' LEU . 28.5 t-80 -133.68 122.49 23.48 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.686 -0.634 . . . . 0.42 111.244 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.38 116.1 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.815 -0.63 . . . . 1.01 109.712 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -83.57 162.75 20.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.002 -0.544 . . . . 0.77 110.715 -177.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.74 -24.95 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 113.001 0.741 . . . . 0.62 113.001 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.451 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 28.1 m80 -80.52 1.17 30.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.426 -0.583 . . . . 0.86 109.426 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 82.84 28.5 37.95 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.061 -0.972 . . . . 0.33 111.508 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.646 HD11 ' HG ' ' A' ' 6' ' ' LEU . 11.8 mm -102.47 111.59 32.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.139 0.495 . . . . 0.31 111.015 -175.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -88.1 113.86 24.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.84 -0.618 . . . . 0.8 111.427 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.69 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -80.46 129.37 34.47 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.148 -0.478 . . . . 1.75 109.849 170.083 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.747 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 2.1 ptm180 -85.96 114.69 23.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 2.94 110.391 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 19' ' ' GLU . 37.0 ttmt -27.22 126.7 0.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.185 0.994 . . . . 2.78 112.032 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.683 ' OD2' ' HD3' ' A' ' 65' ' ' ARG . 1.4 m-20 -32.64 98.72 0.13 Allowed Pre-proline 0 N--CA 1.465 0.283 0 O-C-N 125.115 1.51 . . . . 2.41 114.342 -168.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.747 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 69.6 Cg_endo -100.07 37.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.268 1 C-N-CA 125.454 4.103 . . . . 1.87 114.152 -169.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.563 HD11 ' CE2' ' A' ' 73' ' ' TYR . 3.6 mp -89.9 -88.35 0.17 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.276 -0.569 . . . . 1.99 110.036 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.58 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 12.8 mm-40 -123.83 33.83 5.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 5.31 111.018 -172.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.17 1.34 68.71 Favored Glycine 0 CA--C 1.516 0.104 0 C-N-CA 120.013 -1.089 . . . . 2.64 112.186 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.58 ' HD2' ' HB2' ' A' ' 35' ' ' GLU . 26.1 mtt180 -72.08 45.22 0.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.725 0.81 . . . . 5.64 113.032 -172.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.09 117.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.183 0.516 . . . . 3.96 110.576 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.47 -60.46 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.801 -0.714 . . . . 2.56 111.656 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.7 mtm-85 -103.54 -4.94 23.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.417 -0.216 . . . . 6.2 110.417 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 17' ' ' GLY . . . 65.63 -171.28 0.19 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.853 0.721 . . . . 2.0 110.239 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.585 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 45.3 m -131.4 30.6 4.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.322 0.582 . . . . 2.52 110.151 176.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -86.92 -16.56 35.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 2.52 110.895 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -61.09 104.57 0.39 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.567 -0.288 . . . . 7.02 110.662 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.56 45.63 94.32 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.899 -0.667 . . . . 3.06 111.883 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -71.64 -36.28 70.66 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.819 0.303 . . . . 2.35 111.819 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 48' ' ' LEU . 49.6 mtpt 57.26 -161.68 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.243 0.34 . . . . 4.25 111.109 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.406 ' H ' ' HB3' ' A' ' 47' ' ' LYS . 89.7 mt 55.81 64.73 5.02 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.861 -0.608 . . . . 2.56 111.083 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.08 124.15 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.388 2.059 . . . . 1.69 112.047 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.695 HG12 ' HE3' ' A' ' 88' ' ' LYS . 1.7 mp -69.65 105.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.999 0.904 . . . . 1.59 109.947 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HB2' HG22 ' A' ' 125' ' ' THR . 85.7 mt -65.12 -18.2 65.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.336 -1.302 . . . . 1.91 112.977 -172.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -96.35 4.2 52.41 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.726 -0.39 . . . . 3.17 111.181 -173.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.516 ' HB2' HG22 ' A' ' 50' ' ' ILE . 3.2 m -125.28 145.25 50.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.903 -0.59 . . . . 0.97 111.156 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.465 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 3.0 p30 -79.85 151.99 74.2 Favored Pre-proline 0 C--O 1.214 -0.776 0 N-CA-C 109.609 -0.515 . . . . 1.92 109.609 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 54' ' ' ASN . 3.5 Cg_exo -38.76 -46.67 2.66 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 124.307 3.338 . . . . 0.7 115.419 -164.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -69.94 -53.54 17.37 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 122.064 0.935 . . . . 2.71 110.483 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -22.21 55.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.437 -0.801 . . . . 1.63 109.711 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 39.9 tt0 -55.78 -45.15 78.22 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.688 -0.687 . . . . 1.58 109.651 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.3 t -57.29 -46.08 85.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.784 -0.45 . . . . 1.27 109.784 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.539 ' HB2' ' ND1' ' A' ' 21' ' ' HIS . 30.6 tp -60.14 -19.4 53.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.454 0.645 . . . . 1.18 111.138 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.507 ' HE1' HD23 ' A' ' 60' ' ' LEU . 2.9 m-30 -115.83 6.68 14.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.938 -0.573 . . . . 0.99 111.189 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.643 ' HA ' HD13 ' A' ' 50' ' ' ILE . 35.4 tt0 -122.02 -35.63 3.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.106 0.479 . . . . 1.97 111.821 -172.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 167' ' ' VAL . 1.0 OUTLIER -70.35 136.86 50.08 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.721 -0.672 . . . . 1.27 110.911 -176.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.809 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -120.76 149.46 42.5 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.089 0.556 . . . . 1.96 109.864 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.683 ' HD3' ' OD2' ' A' ' 32' ' ' ASP . 13.7 ttp-105 -114.76 72.96 0.81 Allowed 'General case' 0 C--O 1.237 0.447 0 N-CA-C 112.524 0.564 . . . . 3.35 112.524 -174.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.457 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 67.4 t80 70.61 -69.21 0.18 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.481 0.548 . . . . 4.71 112.481 169.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 38.1 m-80 73.51 123.26 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.476 0.71 . . . . 4.38 111.698 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -137.91 -93.26 0.21 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.041 -0.527 . . . . 3.7 111.145 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.613 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 0.6 OUTLIER -114.54 -169.45 1.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.541 -0.54 . . . . 2.2 109.541 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 p -45.18 114.71 0.78 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.946 0.403 . . . . 1.41 111.107 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.486 ' HD2' HH22 ' A' ' 65' ' ' ARG . 0.1 OUTLIER -138.99 137.42 36.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 1.57 110.756 -175.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.762 ' HA3' ' HB3' ' A' ' 156' ' ' GLU . . . -151.43 -176.27 24.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.172 -1.013 . . . . 0.78 113.656 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.687 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 48.6 m-85 -128.62 169.41 14.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.014 -0.593 . . . . 1.21 111.777 -170.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -115.31 119.75 37.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.247 -0.888 . . . . 2.47 110.594 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.812 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.1 mp -107.34 90.31 5.66 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.977 -0.749 . . . . 0.38 108.977 171.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.62 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 43.6 Cg_endo -71.76 116.94 4.9 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.83 1.687 . . . . 0.59 111.631 -176.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.821 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 82.7 mt -116.4 141.45 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.853 -0.612 . . . . 0.49 110.872 -171.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 71.5 mmtt -139.31 20.95 2.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.746 0.308 . . . . 3.32 110.922 174.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.66 -175.93 4.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.227 0.537 . . . . 2.16 110.769 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 3.3 mt-10 -121.43 -172.62 2.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.266 -0.879 . . . . 1.2 109.771 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.56 -164.57 13.97 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.076 -0.81 . . . . 0.3 111.076 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 36.5 mt-10 -106.19 104.43 14.13 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.186 -0.606 . . . . 1.96 109.643 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.664 ' HB2' HG12 ' A' ' 133' ' ' ILE . 20.7 m-30 -94.06 122.73 36.88 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.411 -0.959 . . . . 0.71 108.411 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.674 HG21 ' CA ' ' A' ' 177' ' ' ALA . 88.0 t -107.18 106.5 20.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.866 0.841 . . . . 0.26 110.45 -172.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 170' ' ' LEU . 12.7 tp -89.66 103.94 16.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.362 -1.29 . . . . 1.56 109.88 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 43.7 t -108.24 111.37 35.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.357 -0.979 . . . . 1.14 108.357 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -114.23 134.96 54.57 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.093 -0.643 . . . . 1.44 110.423 178.186 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.816 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -93.57 122.91 36.5 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.073 -0.651 . . . . 3.73 109.903 177.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.656 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 8.8 m-85 -108.42 140.48 41.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.138 -0.483 . . . . 0.45 111.34 175.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.816 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -146.2 117.79 8.05 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.695 -0.684 . . . . 0.51 110.213 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.706 ' HB3' HD12 ' A' ' 117' ' ' ILE . 4.8 tm-20 -178.23 129.13 0.13 Allowed 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.027 0.204 . . . . 2.62 110.943 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.573 HG21 ' H ' ' A' ' 124' ' ' SER . 43.5 t -144.19 74.16 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 120.922 0.391 . . . . 3.77 110.169 175.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -91.15 -31.94 16.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.066 0.46 . . . . 5.68 110.3 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -114.11 105.78 13.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.721 -0.672 . . . . 4.65 109.425 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.96 64.64 5.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 1.39 111.845 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -160.09 139.87 11.31 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.893 -0.78 . . . . 2.75 108.893 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 119' ' ' ASP . 6.8 m -85.7 141.06 30.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.17 0.509 . . . . 1.4 111.948 -172.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 59.91 49.84 7.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.77 -1.105 . . . . 2.38 109.819 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -128.32 -38.31 1.78 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.759 -1.109 . . . . 2.89 109.893 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.7 ' HG3' ' HB2' ' A' ' 161' ' ' TYR . 27.8 ttpp -119.77 89.99 3.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.986 -0.746 . . . . 2.79 108.986 176.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.021 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 25.7 m -107.67 142.85 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.524 -0.762 . . . . 1.22 111.011 -169.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.636 ' CD2' ' HD3' ' A' ' 165' ' ' PRO . 75.1 m-85 -128.06 164.41 22.47 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.993 -0.549 . . . . 0.99 112.017 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.733 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 1.8 m-20 -107.35 137.79 44.74 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.572 -0.529 . . . . 1.53 109.572 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.789 HG23 ' HD1' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -132.12 124.26 52.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 109.183 -0.673 . . . . 0.63 109.183 178.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.438 ' HE ' ' CG ' ' A' ' 156' ' ' GLU . 37.6 ptt180 -136.11 139.91 43.31 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.839 0.681 . . . . 1.95 112.839 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.909 ' HB ' HD11 ' A' ' 153' ' ' LEU . 16.1 m -109.47 114.28 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.093 -0.958 . . . . 1.44 111.195 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.704 ' HB2' HD12 ' A' ' 153' ' ' LEU . 65.7 t30 55.91 36.54 27.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.266 1.031 . . . . 1.65 108.875 -174.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.21 -17.63 58.93 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.393 -1.276 . . . . 0.42 112.803 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.503 ' ND1' ' HB3' ' A' ' 145' ' ' GLU . 90.4 m-70 -85.73 101.77 13.06 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.255 0.465 . . . . 0.68 112.255 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 20.1 p -63.44 113.15 3.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.192 0.52 . . . . 0.77 110.784 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 131' ' ' ILE . 17.5 t -91.92 -41.11 12.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.662 -0.699 . . . . 0.94 109.234 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.647 HG21 ' HG2' ' A' ' 129' ' ' GLU . 4.8 t -130.36 91.5 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.65 -0.704 . . . . 0.35 109.966 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -100.81 146.37 27.37 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.769 -1.197 . . . . 4.01 107.769 169.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 1.021 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 68.9 m-20 77.36 38.42 0.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.564 1.165 . . . . 1.96 108.823 -167.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.501 HD11 ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -69.58 86.69 0.46 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.032 -0.985 . . . . 1.18 110.031 175.67 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 11.6 t70 -102.23 106.02 16.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.522 -0.918 . . . . 1.93 108.522 172.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.706 HD12 ' HB3' ' A' ' 91' ' ' GLU . 60.8 mt -61.97 -33.45 58.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.82 111.636 -171.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.478 ' HD2' HG13 ' A' ' 92' ' ' VAL . 32.7 t80 -68.64 -37.98 80.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.992 0.425 . . . . 1.08 110.086 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 97' ' ' SER . 20.0 t70 -68.56 -28.66 67.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.068 0.461 . . . . 0.96 111.182 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 14.7 mmt180 -81.32 -45.52 16.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.359 0.503 . . . . 1.69 112.359 -173.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.655 HG11 ' HA ' ' A' ' 127' ' ' HIS . 15.6 m -128.34 0.34 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.207 0.817 . . . . 1.49 113.207 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.84 -97.54 1.86 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.136 -1.03 . . . . 1.4 112.648 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -113.17 108.78 17.76 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.558 -0.378 . . . . 4.11 111.553 -175.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.573 ' H ' HG21 ' A' ' 92' ' ' VAL . 9.4 m 44.41 -122.4 0.88 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.412 1.07 . . . . 1.97 112.754 175.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 51' ' ' LEU . 70.0 p 51.12 -158.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.413 0.685 . . . . 0.85 111.124 -175.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.803 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . . . -99.12 110.08 22.7 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.484 -0.487 . . . . 0.57 111.63 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.655 ' HA ' HG11 ' A' ' 121' ' ' VAL . 12.9 t60 -83.35 126.18 32.44 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.106 -1.072 . . . . 0.55 108.106 167.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -123.56 108.19 12.36 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.486 0.66 . . . . 1.64 110.403 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.647 ' HG2' HG21 ' A' ' 112' ' ' VAL . 2.2 tp10 -102.03 108.95 20.54 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.962 -0.755 . . . . 1.12 108.962 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.409 HG23 HG22 ' A' ' 86' ' ' VAL . 64.9 mt -96.54 115.61 36.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.799 -0.637 . . . . 0.74 109.615 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.448 HG21 HG21 ' A' ' 111' ' ' VAL . 59.5 mt -122.43 93.16 48.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.251 -0.431 . . . . 1.25 110.777 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -74.46 123.01 7.84 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.662 2.241 . . . . 0.29 112.019 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.1 pt -109.86 146.57 15.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.61 -0.885 . . . . 0.27 108.61 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.3 p -115.9 106.98 14.42 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.899 0.381 . . . . 1.24 110.106 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.572 HG12 ' HG ' ' A' ' 140' ' ' LEU . 25.6 mt -98.74 120.69 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 107.761 -1.2 . . . . 0.34 107.761 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -144.33 122.63 12.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.118 0.485 . . . . 1.95 110.317 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 18.1 mmmt 57.24 35.24 25.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.79 -1.095 . . . . 3.13 111.5 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.37 7.15 69.96 Favored Glycine 0 C--O 1.227 -0.318 0 CA-C-N 115.597 -0.729 . . . . 0.41 113.18 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 99.6 mttt -109.22 145.6 35.58 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 122.649 -0.324 . . . . 2.23 110.168 174.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.663 HD12 ' HD1' ' A' ' 149' ' ' PHE . 5.9 tt -114.46 115.12 26.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.878 -0.786 . . . . 0.41 108.878 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.9 m -117.3 136.25 53.25 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.375 -0.375 . . . . 1.19 110.042 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.547 HG21 ' CG2' ' A' ' 106' ' ' VAL . 58.4 t -123.71 92.53 2.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.614 -0.513 . . . . 0.92 109.614 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 56.63 -87.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.105 -0.952 . . . . 1.88 111.632 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.49 -10.88 34.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 1.02 112.507 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.503 ' HB3' ' ND1' ' A' ' 109' ' ' HIS . 64.1 mm-40 -87.86 139.87 30.08 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.974 -0.38 . . . . 1.95 109.974 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.42 130.44 12.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.312 0.577 . . . . 0.92 111.728 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.6 m -159.9 166.86 29.34 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.631 -0.877 . . . . 1.27 108.631 174.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 66.6 p -74.71 147.04 41.78 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.125 -0.694 . . . . 1.45 109.125 173.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.821 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 65.3 t80 -79.07 128.2 32.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.801 0.334 . . . . 0.47 110.114 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 t -132.64 101.8 5.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.63 0.728 . . . . 1.79 111.515 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.96 -74.36 2.43 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.543 -0.753 . . . . 0.42 113.777 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -155.29 169.43 24.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.379 0.609 . . . . 1.23 111.13 -174.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.909 HD11 ' HB ' ' A' ' 106' ' ' VAL . 44.2 tp -90.83 127.52 36.39 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.092 -0.958 . . . . 1.17 109.23 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.732 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 97.0 p -97.01 142.51 28.88 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 119.373 -0.931 . . . . 1.35 109.553 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 106' ' ' VAL . 97.0 t -130.59 97.34 3.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.803 -0.814 . . . . 0.42 108.803 170.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.762 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 1.4 pm0 -126.78 141.85 51.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.188 -0.605 . . . . 1.98 111.279 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.789 ' HD1' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -102.65 122.24 44.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.235 -0.893 . . . . 2.32 108.789 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 26.1 t -84.13 127.65 39.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.35 -0.386 . . . . 0.62 110.282 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.613 ' HD2' ' HA ' ' A' ' 69' ' ' ASP . 86.8 tttt -53.28 123.9 13.15 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.74 1.275 . . . . 2.26 111.723 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -106.6 -90.71 2.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.891 -0.671 . . . . 1.45 112.353 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.7 ' HB2' ' HG3' ' A' ' 100' ' ' LYS . 85.7 m-85 -111.69 44.1 1.42 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.82 -0.224 . . . . 4.24 110.622 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 68.46 160.34 0.18 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.868 -0.605 . . . . 4.98 111.534 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 51.12 65.3 1.52 Allowed 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.524 -0.762 . . . . 2.64 110.13 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 159' ' ' LYS . 50.5 m-20 -55.97 159.68 5.36 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.337 -1.301 . . . . 2.06 108.651 173.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.636 ' HD3' ' CD2' ' A' ' 102' ' ' PHE . 50.1 Cg_exo -34.66 94.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.854 3.036 . . . . 3.16 113.569 -172.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.615 ' HB2' ' HG3' ' A' ' 91' ' ' GLU . 10.9 tptp -52.49 -64.21 0.89 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 114.971 -1.013 . . . . 3.18 112.501 -163.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.763 HG22 ' HB3' ' A' ' 64' ' ' GLU . 86.9 t -87.24 132.22 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 C-N-CA 120.083 -0.647 . . . . 1.19 109.851 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -130.98 133.29 45.66 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 119.695 -0.802 . . . . 1.36 110.745 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -129.62 37.89 3.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.965 -0.561 . . . . 0.31 110.828 -175.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 85' ' ' LEU . 10.8 tp -41.92 126.96 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.615 -1.175 . . . . 0.69 112.018 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.69 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 7.5 t80 -144.84 119.22 9.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.79 -0.186 . . . . 0.48 110.577 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.63 HG22 ' HE3' ' A' ' 12' ' ' TRP . 9.3 tt -115.18 123.56 70.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.981 0.896 . . . . 0.3 110.699 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.69 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.0 ppp? -117.54 159.35 23.01 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.218 -0.901 . . . . 0.99 109.613 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 1.9 ptmm? -113.85 142.26 46.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 122.712 1.244 . . . . 1.22 114.218 -168.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.67 -30.25 10.09 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 112.708 -2.042 . . . . 0.31 114.264 162.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -176.99 158.16 1.52 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.002 0.901 . . . . 0.68 112.265 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.674 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -82.96 -9.93 59.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.965 -0.562 . . . . 0.86 110.375 172.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.515 ' H ' ' HB ' ' A' ' 176' ' ' THR . 5.0 m-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.694 -0.685 . . . . 2.16 111.357 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.583 ' HG ' HD11 ' A' ' 27' ' ' ILE . 25.8 tp . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.241 0.543 . . . . 0.72 109.879 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -63.25 -23.02 67.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.204 -0.907 . . . . 0.53 111.686 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.595 ' HB3' ' HE3' ' A' ' 9' ' ' LYS . 22.6 t70 -83.0 -35.27 25.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.91 -0.587 . . . . 2.18 111.404 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.595 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 10.6 mmtp -94.26 -19.33 20.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.893 -0.323 . . . . 1.79 111.593 -171.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.523 ' HB ' HD12 ' A' ' 27' ' ' ILE . 7.2 p -56.01 134.78 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.018 0.437 . . . . 0.33 111.424 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 pt -110.88 -22.56 4.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.209 -0.45 . . . . 0.92 110.581 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.578 ' HE3' HG22 ' A' ' 172' ' ' ILE . 77.1 t90 -170.54 146.07 2.69 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.696 -0.483 . . . . 0.36 109.696 -173.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 30' ' ' ARG . . . -163.01 138.28 6.71 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.32 -0.238 . . . . 0.26 111.003 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.775 HG22 ' HB2' ' A' ' 30' ' ' ARG . 84.4 t -146.84 121.78 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 122.574 0.35 . . . . 0.79 111.568 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 46.5 t30 -102.61 99.58 9.59 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.703 -0.48 . . . . 1.49 109.703 167.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -65.07 105.44 1.06 Allowed 'General case' 0 C--O 1.243 0.747 0 N-CA-C 109.414 -0.587 . . . . 0.48 109.414 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.567 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 158.24 -47.1 0.45 Allowed Glycine 0 N--CA 1.447 -0.601 0 O-C-N 124.248 0.968 . . . . 0.76 113.337 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.07 -132.77 7.76 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.853 -0.689 . . . . 0.74 112.727 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.444 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 16.9 mt-10 -156.87 120.27 4.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 119.679 -0.2 . . . . 1.77 111.237 174.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 4.0 p 35.31 90.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.644 1.215 . . . . 1.29 113.499 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.692 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 79.6 t60 -131.16 133.75 45.86 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.574 -0.851 . . . . 0.42 111.687 -174.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.17 116.22 36.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.724 -0.671 . . . . 1.01 110.038 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 0.8 OUTLIER -71.82 155.99 39.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.991 -0.55 . . . . 0.77 109.768 176.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.45 -13.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 113.422 0.897 . . . . 0.62 113.422 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -93.57 -0.66 56.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.421 0.629 . . . . 0.86 109.357 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.577 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 93.71 31.13 8.43 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 114.826 -1.079 . . . . 0.33 112.811 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.583 HD11 ' HG ' ' A' ' 6' ' ' LEU . 21.6 mm -103.93 109.3 26.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.14 0.495 . . . . 0.31 110.907 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -92.11 114.03 26.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.8 111.431 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.601 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -78.45 131.18 36.79 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.995 -0.548 . . . . 1.75 110.881 176.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.775 ' HB2' HG22 ' A' ' 14' ' ' VAL . 8.2 mpt_? -69.9 102.5 1.99 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 125.018 1.449 . . . . 2.94 111.565 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 20' ' ' SER . 14.7 ttmm -38.96 96.33 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.953 1.094 . . . . 2.78 113.953 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.62 ' CG ' ' HD2' ' A' ' 65' ' ' ARG . 75.0 m-20 30.22 78.25 0.29 Allowed Pre-proline 0 N--CA 1.476 0.859 0 C-N-CA 124.6 1.16 . . . . 2.41 113.297 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 16.4 Cg_endo . . . . . 0 N--CA 1.456 -0.72 0 C-N-CA 122.985 2.456 . . . . 1.87 114.347 -170.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.56 HG23 ' HB2' ' A' ' 126' ' ' ALA . 1.0 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.803 0.811 . . . . 1.59 109.407 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.423 ' HB3' HG22 ' A' ' 125' ' ' THR . 57.7 tp 69.26 -52.99 0.59 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.282 -1.326 . . . . 1.91 112.594 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -68.64 -21.88 64.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.449 -0.341 . . . . 3.17 111.764 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.436 ' HB3' ' CA ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -113.67 146.49 39.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.993 0.738 . . . . 0.97 112.993 -170.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.612 HD21 ' HG2' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -69.16 146.04 96.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 114.485 -1.234 . . . . 1.92 109.312 175.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.554 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 52.9 Cg_exo -38.24 -43.56 1.81 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.162 3.241 . . . . 0.7 116.161 -165.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.612 ' HG2' HD21 ' A' ' 54' ' ' ASN . 10.7 pt-20 -78.56 -50.1 12.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.203 0.525 . . . . 2.71 111.039 -173.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -74.88 -19.86 59.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.165 0.507 . . . . 1.63 109.695 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.436 ' CA ' ' HB3' ' A' ' 53' ' ' SER . 27.8 tt0 -59.69 -43.29 94.11 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.725 -0.67 . . . . 1.58 109.948 168.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 55' ' ' PRO . 91.4 t -54.18 -43.8 61.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.593 -0.521 . . . . 1.27 109.593 173.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.692 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 26.5 tp -67.53 -14.03 62.58 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.148 -0.933 . . . . 1.18 111.653 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.7 ' CE2' ' HE3' ' A' ' 88' ' ' LYS . 12.0 m-30 -118.39 7.74 12.0 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 111.833 0.309 . . . . 0.99 111.833 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.466 ' HB2' HD13 ' A' ' 50' ' ' ILE . 4.5 tt0 -127.2 -43.01 1.66 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.75 0.648 . . . . 1.97 112.75 -172.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.558 ' O ' HG13 ' A' ' 167' ' ' VAL . 18.7 p -67.37 130.82 44.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.276 0.473 . . . . 1.27 112.276 -174.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.814 ' HB3' HG22 ' A' ' 167' ' ' VAL . 8.7 pt-20 -114.94 156.65 24.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.048 0.452 . . . . 1.96 111.59 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.62 ' HD2' ' CG ' ' A' ' 32' ' ' ASP . 37.8 mtp85 . . . . . 0 CA--C 1.531 0.237 0 CA-C-N 115.948 -0.569 . . . . 3.35 111.461 173.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.3 t . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.701 0.286 . . . . 1.41 110.345 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.552 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 11.5 p90 -124.52 140.18 53.19 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.116 -0.698 . . . . 1.57 109.116 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -136.77 161.81 25.12 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.133 -1.032 . . . . 0.78 114.8 -167.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.494 ' HB3' ' CH2' ' A' ' 12' ' ' TRP . 60.1 m-85 -100.43 152.85 19.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.854 -0.673 . . . . 1.21 111.847 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.574 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 9.4 t0 -116.24 103.61 10.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.067 -0.97 . . . . 2.47 108.646 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.879 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.7 mp -103.87 89.87 2.6 Favored Pre-proline 0 N--CA 1.464 0.246 0 N-CA-C 110.121 -0.325 . . . . 0.38 110.121 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.644 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 38.6 Cg_exo -57.59 117.53 4.25 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.194 1.929 . . . . 0.59 112.733 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.667 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 67.9 mt -117.12 136.29 54.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.937 -0.574 . . . . 0.49 110.237 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -130.45 10.16 5.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.405 -0.361 . . . . 3.32 110.988 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.584 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 23.3 tt0 -139.09 -176.89 4.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.148 -0.316 . . . . 2.16 110.148 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.646 ' HG3' ' O ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -130.32 157.51 42.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.559 -0.534 . . . . 1.2 109.559 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.08 -162.85 28.84 Favored Glycine 0 C--O 1.234 0.154 0 N-CA-C 110.354 -1.098 . . . . 0.3 110.354 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 27.7 mt-10 -99.68 102.66 14.21 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 118.281 1.04 . . . . 1.96 110.198 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.634 ' HB2' HG12 ' A' ' 133' ' ' ILE . 79.1 m-85 -94.68 124.27 38.62 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.243 -1.021 . . . . 0.71 108.243 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.812 HG21 ' HA ' ' A' ' 177' ' ' ALA . 52.9 t -104.8 105.68 19.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.64 0.734 . . . . 0.26 109.902 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.791 HD12 ' HB ' ' A' ' 172' ' ' ILE . 7.5 tp -89.48 101.41 14.09 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.348 -1.297 . . . . 1.56 108.548 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.57 104.61 17.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.778 0.799 . . . . 1.14 108.848 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.649 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -104.55 134.53 47.57 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.405 -0.816 . . . . 1.44 109.959 -178.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.838 ' HD2' ' HB1' ' A' ' 126' ' ' ALA . 10.9 tppt? -96.05 120.08 35.69 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.941 -0.703 . . . . 3.73 109.4 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.707 ' CD2' HD11 ' A' ' 115' ' ' LEU . 13.8 m-85 -106.26 141.81 36.99 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.781 -0.645 . . . . 0.45 110.374 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.891 0 CA-C-N 115.72 -0.673 . . . . 0.51 109.661 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.56 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.3 m . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 122.134 0.969 . . . . 1.22 110.316 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.713 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 11.8 m-85 -87.74 164.12 16.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.173 -1.376 . . . . 0.99 111.682 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.65 137.8 41.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.566 -0.902 . . . . 1.53 108.566 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.652 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 2.5 t -131.91 113.09 21.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.902 -0.59 . . . . 0.63 109.51 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.724 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 62.9 mtt180 -122.6 130.15 52.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 1.95 111.471 -173.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.867 HG12 HD11 ' A' ' 153' ' ' LEU . 21.8 t -105.62 99.88 9.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.154 -0.93 . . . . 1.44 109.413 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.827 ' HB2' HD12 ' A' ' 153' ' ' LEU . 4.1 t-20 57.87 51.81 8.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.219 1.009 . . . . 1.65 109.022 -170.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.5 -20.18 19.64 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 114.544 -1.207 . . . . 0.42 113.163 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 95.4 m-70 -79.25 107.33 11.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.01 0.374 . . . . 0.68 112.01 -172.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.531 HG22 ' HG2' ' A' ' 105' ' ' ARG . 3.1 p -68.52 96.61 0.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.19 0.519 . . . . 0.77 111.198 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.816 HG11 HD12 ' A' ' 131' ' ' ILE . 22.3 t -85.32 -46.14 17.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.832 -0.622 . . . . 0.94 109.568 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.652 ' HB ' ' HB ' ' A' ' 104' ' ' VAL . 10.2 t -119.2 88.35 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.441 0.639 . . . . 0.35 109.645 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 51.9 tptt -103.85 76.5 1.38 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.211 -1.033 . . . . 4.01 108.211 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 4.8 p-10 162.43 14.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.154 -1.384 . . . . 1.96 110.457 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -66.47 98.29 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.867 0.365 . . . . 1.18 111.37 -169.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -112.87 94.58 4.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.066 0.936 . . . . 1.93 109.641 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.56 ' O ' HG22 ' A' ' 121' ' ' VAL . 56.2 mt -61.03 -46.8 95.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.713 -1.13 . . . . 0.82 111.829 -170.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -53.64 -37.17 62.85 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.092 0.404 . . . . 1.08 112.092 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.73 -39.54 70.02 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.719 -0.392 . . . . 0.96 110.806 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -74.2 -43.72 56.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.89 -0.595 . . . . 1.69 111.607 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 117' ' ' ILE . 29.7 m -92.71 -32.66 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.87 -0.332 . . . . 1.49 111.829 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.1 -69.89 3.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 1.4 111.789 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -114.92 169.47 9.06 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.032 -0.359 . . . . 4.11 110.032 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.6 m -59.92 97.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.245 0.545 . . . . 1.97 112.142 -173.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 36.8 p -144.75 -166.44 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.391 -0.822 . . . . 0.85 109.004 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 88' ' ' LYS . . . -100.58 118.21 36.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.765 0.317 . . . . 0.57 111.69 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.461 ' HB2' ' CG1' ' A' ' 121' ' ' VAL . 83.8 t60 -95.57 136.98 35.26 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.206 -0.664 . . . . 0.55 109.206 175.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.2 132.31 43.01 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.871 -0.732 . . . . 1.64 112.167 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.644 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 77.0 mm-40 -110.95 114.09 27.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.12 -0.945 . . . . 1.12 108.673 170.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.464 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 46.0 mt -96.34 109.8 23.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.084 -0.71 . . . . 0.74 109.084 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.816 HD12 HG11 ' A' ' 111' ' ' VAL . 31.2 mm -118.43 88.14 32.8 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.612 -0.267 . . . . 1.25 110.908 -171.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 130' ' ' ILE . 8.3 Cg_exo -74.57 127.47 11.02 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.593 2.196 . . . . 0.29 111.796 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.634 HG12 ' HB2' ' A' ' 83' ' ' TYR . 3.4 pt -110.13 144.73 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.857 -0.794 . . . . 0.27 108.857 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 p -116.34 107.67 15.12 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.205 0.526 . . . . 1.24 110.44 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.646 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 3.9 mt -98.68 131.71 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.194 -0.669 . . . . 0.34 109.194 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.445 ' HD3' ' HG3' ' A' ' 80' ' ' GLU . 71.6 mmtt -148.38 129.73 14.74 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 123.641 0.588 . . . . 1.95 109.896 174.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 60.61 24.95 14.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.828 -0.624 . . . . 3.13 111.526 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.05 8.43 66.89 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.557 -0.83 . . . . 0.41 112.857 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.668 ' HG3' HG22 ' A' ' 148' ' ' THR . 8.9 mptt -111.69 139.65 46.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.682 -0.488 . . . . 2.23 109.682 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.4 tt -115.08 115.73 27.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.981 -0.554 . . . . 0.41 109.738 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.1 m -109.07 115.04 29.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 1.19 110.837 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.81 104.92 17.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 O-C-N 122.282 -0.261 . . . . 0.92 110.337 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 64.17 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.816 0.697 . . . . 1.88 110.928 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.51 1.68 5.66 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.944 -0.646 . . . . 1.02 112.27 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -99.14 112.8 24.85 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.0 -0.37 . . . . 1.95 110.0 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 p -115.02 119.23 61.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.385 0.612 . . . . 0.92 111.482 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.8 m -145.94 156.16 43.33 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.928 -0.767 . . . . 1.27 108.928 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.668 HG22 ' HG3' ' A' ' 139' ' ' LYS . 41.6 p -63.17 140.58 58.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.835 0.35 . . . . 1.45 110.536 176.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.667 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 18.0 t80 -79.48 142.8 35.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.618 . . . . 0.47 109.489 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -137.95 102.71 4.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.274 0.559 . . . . 1.79 111.798 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.65 -64.27 3.31 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.693 -0.685 . . . . 0.42 113.979 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.697 ' HE2' ' HB3' ' A' ' 154' ' ' SER . 0.0 OUTLIER -155.92 170.65 21.62 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 117.137 0.469 . . . . 1.23 110.723 -178.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.879 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 22.7 tp -81.21 131.19 35.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.047 -1.094 . . . . 1.17 108.047 174.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.815 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 p -123.51 102.35 7.83 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.6 -0.84 . . . . 1.35 111.85 -171.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 48.4 t -93.01 95.97 5.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.231 -0.588 . . . . 0.42 110.146 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 154' ' ' SER . 3.3 mp0 -98.72 119.83 38.12 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.203 -0.666 . . . . 1.98 109.203 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.552 ' CE2' ' CE1' ' A' ' 71' ' ' PHE . 1.9 p90 -115.92 126.57 54.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.047 0.927 . . . . 2.32 110.535 175.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.45 144.59 16.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.791 -1.549 . . . . 0.62 110.87 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.8 pttm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.593 -0.73 . . . . 2.26 111.364 -176.684 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.814 HG22 ' HB3' ' A' ' 64' ' ' GLU . 61.7 t . . . . . 0 CA--C 1.506 -0.715 0 N-CA-C 108.353 -0.981 . . . . 1.19 108.353 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 38.8 t -134.46 88.12 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.812 -0.755 . . . . 1.36 112.133 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -80.0 36.49 0.34 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 124.466 1.106 . . . . 0.31 112.658 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -35.92 120.48 0.61 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.412 0.685 . . . . 0.69 111.507 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.677 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 4.1 t80 -136.18 109.7 7.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.497 -0.32 . . . . 0.48 110.317 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.791 ' HB ' HD12 ' A' ' 85' ' ' LEU . 6.7 tt -104.17 121.46 55.83 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 121.899 0.857 . . . . 0.3 110.583 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.677 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.2 ppp? -119.07 152.53 36.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.435 -0.802 . . . . 0.99 109.705 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.537 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 72.6 tttt -97.87 139.4 33.78 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 114.895 1.443 . . . . 1.22 114.895 -169.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.87 -28.89 12.97 Favored Glycine 0 C--N 1.317 -0.473 0 CA-C-N 113.196 -1.82 . . . . 0.31 115.61 155.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -171.81 155.0 3.77 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.28 1.04 . . . . 0.68 113.439 -174.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.812 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -84.78 -21.2 30.06 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.19 -0.914 . . . . 0.86 110.973 173.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.113 0.482 . . . . 2.16 111.582 -175.608 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.628 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.3 tp . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.062 0.458 . . . . 0.72 110.618 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -63.03 -23.79 67.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.628 -0.714 . . . . 0.53 111.811 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.9 -43.94 14.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.285 -0.416 . . . . 2.18 110.885 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.71 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 32.2 mmtp -87.24 -10.74 51.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.489 0.552 . . . . 1.79 112.489 -172.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.577 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 14.1 p -57.28 135.77 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.323 0.583 . . . . 0.33 111.111 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.2 pt -119.35 -28.18 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.909 -0.587 . . . . 0.92 110.829 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.613 ' CH2' ' HB3' ' A' ' 73' ' ' TYR . 59.5 t90 -166.4 119.97 1.08 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.038 -0.528 . . . . 0.36 109.908 -170.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -135.49 140.1 44.53 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.114 -0.328 . . . . 0.26 110.114 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.897 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 55.0 t -140.5 105.71 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 112.615 0.598 . . . . 0.79 112.615 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 14.0 t-20 -81.53 89.3 6.17 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.082 -1.081 . . . . 1.49 108.082 164.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -64.52 101.14 0.42 Allowed 'General case' 0 C--O 1.248 1.026 0 N-CA-C 109.268 -0.642 . . . . 0.48 109.268 176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 155.17 -44.08 0.56 Allowed Glycine 0 N--CA 1.441 -1.018 0 O-C-N 125.66 1.85 . . . . 0.76 110.865 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.411 ' C ' ' HE2' ' A' ' 29' ' ' TYR . . . -102.42 -150.63 23.01 Favored Glycine 0 C--O 1.225 -0.409 0 CA-C-N 115.193 -0.504 . . . . 0.74 112.958 -172.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 1.032 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 3.9 tm-20 -149.34 121.06 8.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.929 0.365 . . . . 1.77 111.248 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.761 ' HB2' ' HB2' ' A' ' 31' ' ' LYS . 5.9 t 34.61 86.96 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.846 1.341 . . . . 1.29 112.839 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.883 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 67.4 t60 -129.42 132.01 46.9 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 119.75 -0.78 . . . . 0.42 111.541 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.4 120.75 45.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.597 -0.729 . . . . 1.01 110.338 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.86 154.36 31.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.754 -0.657 . . . . 0.77 109.383 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.1 m -61.52 -10.22 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 113.871 1.063 . . . . 0.62 113.871 -171.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.549 ' HB2' HD23 ' A' ' 6' ' ' LEU . 66.7 m-70 -95.35 -0.82 52.28 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.213 -0.662 . . . . 0.86 109.213 175.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 95.05 30.4 8.34 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.128 -0.942 . . . . 0.33 112.923 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.628 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.9 mm -104.08 115.46 46.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.08 0.466 . . . . 0.31 111.037 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -102.43 122.11 43.65 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.008 0.373 . . . . 0.8 112.008 -171.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.897 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -86.4 139.47 30.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.222 -0.444 . . . . 1.75 111.164 175.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.46 ' HG2' HG22 ' A' ' 14' ' ' VAL . 11.2 mmm180 -72.61 -7.89 52.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.527 1.677 . . . . 2.94 115.527 -161.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 1.032 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 25.3 ttmt 70.18 103.92 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.434 0.531 . . . . 2.78 112.434 -176.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.539 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 2.3 m-20 60.13 58.27 4.39 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.849 1.055 . . . . 2.41 113.849 165.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 30.0 Cg_endo . . . . . 0 CA--C 1.541 0.839 0 C-N-CA 123.639 2.893 . . . . 1.87 113.492 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.583 HG22 ' HB3' ' A' ' 53' ' ' SER . 1.4 mp . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 121.552 0.691 . . . . 1.59 110.087 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -68.17 -23.25 64.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.409 -0.814 . . . . 1.91 112.52 -171.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 126' ' ' ALA . 4.6 mpt_? -100.54 36.33 1.93 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.759 0.314 . . . . 3.17 111.331 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.583 ' HB3' HG22 ' A' ' 50' ' ' ILE . 42.2 t -154.36 153.54 31.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.172 -0.467 . . . . 0.97 111.142 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.9 140.93 50.54 Favored Pre-proline 0 C--O 1.219 -0.506 0 N-CA-C 109.087 -0.709 . . . . 1.92 109.087 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.491 ' O ' HG23 ' A' ' 59' ' ' VAL . 5.1 Cg_exo -39.22 -39.54 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.537 3.491 . . . . 0.7 115.992 -167.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.53 -55.09 6.78 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.484 1.135 . . . . 2.71 110.068 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.58 -15.11 60.4 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.048 -0.978 . . . . 1.63 109.655 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.413 ' HG3' ' HB ' ' A' ' 50' ' ' ILE . 27.4 tt0 -60.73 -43.09 98.34 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.464 -0.789 . . . . 1.58 109.294 170.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 55' ' ' PRO . 58.3 t -58.52 -40.86 80.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.154 -0.476 . . . . 1.27 109.848 174.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.883 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 23.6 tp -68.87 -22.78 64.18 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.583 -0.447 . . . . 1.18 111.573 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.451 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 9.1 m-30 -101.06 1.93 39.91 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.278 0.561 . . . . 0.99 109.667 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.533 ' O ' HG13 ' A' ' 167' ' ' VAL . 11.5 tt0 -124.44 -124.55 0.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.034 -0.984 . . . . 1.97 109.301 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.739 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.7 OUTLIER 29.04 104.05 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.751 1.22 . . . . 1.27 114.143 -173.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.82 148.16 29.0 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.086 0.469 . . . . 1.96 112.027 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.595 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 2.1 ttm180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.533 -0.303 . . . . 3.35 111.433 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.794 0.807 . . . . 1.41 110.574 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -111.24 138.37 47.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.911 -1.041 . . . . 1.57 111.296 -167.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -129.57 146.37 17.19 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.661 -0.78 . . . . 0.78 113.658 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.613 ' HB3' ' CH2' ' A' ' 12' ' ' TRP . 57.7 m-85 -103.44 136.43 43.2 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.42 -0.39 . . . . 1.21 110.769 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.418 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.4 p-10 -99.51 115.63 29.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.034 -0.53 . . . . 2.47 110.937 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.842 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.3 mp -110.01 89.86 8.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.602 -0.726 . . . . 0.38 109.358 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.681 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 21.8 Cg_exo -63.66 121.19 8.85 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 C-N-CA 121.992 1.795 . . . . 0.59 111.727 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.901 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 64.9 mt -121.47 143.05 35.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.715 0.293 . . . . 0.49 111.019 -174.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -127.05 -12.25 5.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.262 -0.426 . . . . 3.32 111.443 173.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -112.03 168.15 9.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 2.16 111.387 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -106.5 -178.37 3.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.799 -0.637 . . . . 1.2 110.6 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.36 -169.58 15.6 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.144 -0.782 . . . . 0.3 111.144 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 5.1 mm-40 -98.87 103.28 15.22 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.083 -0.71 . . . . 1.96 109.083 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.68 ' HB2' HG12 ' A' ' 133' ' ' ILE . 2.4 m-85 -92.37 124.37 36.37 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 119.225 -0.99 . . . . 0.71 108.8 -173.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.574 HG21 ' CA ' ' A' ' 177' ' ' ALA . 49.0 t -107.3 105.6 19.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.22 -0.9 . . . . 0.26 109.937 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 170' ' ' LEU . 17.0 tp -90.37 104.6 17.16 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.286 -1.325 . . . . 1.56 109.764 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 44.8 t -114.01 104.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.841 -0.8 . . . . 1.14 108.841 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.586 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.38 135.68 46.32 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.968 -0.693 . . . . 1.44 110.616 178.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.758 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 16.2 tptt -98.7 120.63 39.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.302 -0.408 . . . . 3.73 110.494 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CE2' HD11 ' A' ' 115' ' ' LEU . 26.4 m-85 -107.35 142.11 37.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.911 0.386 . . . . 0.45 111.253 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 115.424 -0.807 . . . . 0.51 110.387 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.866 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 23.6 m . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.321 0.581 . . . . 1.22 110.063 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.498 ' HD1' ' HA ' ' A' ' 159' ' ' LYS . 61.7 m-85 -104.12 163.53 12.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.512 -0.767 . . . . 0.99 111.722 -173.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 24.6 m-20 -109.59 140.61 43.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.579 -0.282 . . . . 1.53 110.48 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.603 HG23 ' HD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -143.32 127.89 14.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.048 0.451 . . . . 0.63 110.735 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.659 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -121.39 144.89 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.676 -0.693 . . . . 1.95 112.189 -175.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.804 HG23 HD21 ' A' ' 153' ' ' LEU . 3.0 p -108.2 105.36 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.691 . . . . 1.44 109.722 171.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.447 ' HA ' ' H ' ' A' ' 154' ' ' SER . 65.4 t30 57.67 44.22 21.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.882 0.848 . . . . 1.65 109.149 -174.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.95 -15.79 61.97 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 114.994 -1.003 . . . . 0.42 113.017 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 94.6 m-70 -89.39 98.86 12.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.564 0.579 . . . . 0.68 112.564 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 2.3 p -66.64 98.98 0.55 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.208 0.528 . . . . 0.77 111.706 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.688 HG21 HG21 ' A' ' 131' ' ' ILE . 6.4 t -80.47 -47.79 20.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.636 -0.711 . . . . 0.94 109.53 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.615 HG11 ' HG ' ' A' ' 115' ' ' LEU . 10.8 t -113.3 90.03 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.556 0.694 . . . . 0.35 109.364 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -113.16 71.74 0.75 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 122.332 1.063 . . . . 4.01 108.871 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.866 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.7 p30 162.66 30.2 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.186 -1.825 . . . . 1.96 107.218 -169.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.662 HD13 ' HE2' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -74.1 78.65 1.74 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.862 -1.063 . . . . 1.18 111.095 -172.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.531 ' HB2' HG12 ' A' ' 101' ' ' VAL . 10.9 t70 -101.95 103.74 14.4 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.727 -1.212 . . . . 1.93 107.727 172.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 66.7 mt -55.0 -40.9 55.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.893 -0.594 . . . . 0.82 111.173 -174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.567 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 2.3 t80 -64.12 -45.61 87.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.7 -0.682 . . . . 1.08 110.558 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.8 -32.86 68.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.31 -0.405 . . . . 0.96 111.471 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HB3' ' CE1' ' A' ' 127' ' ' HIS . 15.4 mmt180 -77.03 -50.1 13.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.276 -0.42 . . . . 1.69 111.792 -173.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.9 p -118.79 -27.59 2.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.49 -0.484 . . . . 1.49 112.295 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 123.6 -161.49 17.91 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.316 -1.114 . . . . 1.4 110.316 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -78.79 122.24 25.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.532 0.666 . . . . 4.11 111.027 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 78.2 p 51.77 -121.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.163 -0.926 . . . . 1.97 112.516 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.7 p 52.32 -161.41 0.1 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.469 0.707 . . . . 0.85 110.796 -173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.683 ' HB1' ' HE3' ' A' ' 88' ' ' LYS . . . -98.95 109.08 21.89 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.67 -0.412 . . . . 0.57 110.304 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 18.9 t60 -93.84 133.05 37.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.247 -0.649 . . . . 0.55 109.247 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.719 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.5 p30 -133.22 135.77 45.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.132 0.492 . . . . 1.64 111.108 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.448 ' HB2' HD21 ' A' ' 87' ' ' LEU . 17.1 mm-40 -112.25 111.78 22.9 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.211 -1.033 . . . . 1.12 108.211 171.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 86' ' ' VAL . 65.5 mt -96.04 113.48 30.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.934 -0.575 . . . . 0.74 109.668 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.688 HG21 HG21 ' A' ' 111' ' ' VAL . 47.2 mt -124.0 93.47 47.01 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.36 -0.382 . . . . 1.25 111.293 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -72.42 122.07 7.99 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.317 2.011 . . . . 0.29 112.648 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.68 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -109.74 160.61 8.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 106.959 -1.497 . . . . 0.27 106.959 174.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.5 p -127.29 111.99 14.55 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.036 0.446 . . . . 1.24 110.377 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 36.9 mt -99.87 122.41 51.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.191 -0.67 . . . . 0.34 109.191 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -149.06 135.32 19.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.87 -0.418 . . . . 1.95 109.87 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 61.28 25.04 15.07 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.606 0.566 . . . . 3.13 110.586 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.16 14.46 81.74 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.73 -0.668 . . . . 0.41 112.27 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 56.5 mtpt -111.9 150.53 30.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.583 -0.525 . . . . 2.23 109.583 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.0 tt -121.25 116.31 24.63 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.701 -0.481 . . . . 0.41 109.701 -175.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -116.65 111.04 19.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.61 -0.515 . . . . 1.19 109.61 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.685 HG21 HG11 ' A' ' 106' ' ' VAL . 5.5 p -100.76 113.95 38.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.175 -0.306 . . . . 0.92 110.175 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 58.77 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.015 -0.539 . . . . 1.88 112.02 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.19 1.98 7.76 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.945 -0.645 . . . . 1.02 112.685 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -106.14 148.49 27.79 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.488 -0.56 . . . . 1.95 109.488 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.09 133.59 60.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.247 0.546 . . . . 0.92 111.616 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m -152.94 179.06 9.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.897 -0.779 . . . . 1.27 108.897 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.763 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 7.9 t -99.36 143.05 30.06 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.847 -0.798 . . . . 1.45 108.847 168.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.901 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 51.6 t80 -79.62 121.98 25.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.264 -0.425 . . . . 0.47 110.46 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 p -118.46 95.59 4.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.248 0.546 . . . . 1.79 112.295 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.54 -71.6 2.87 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.42 114.167 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.681 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -151.5 156.75 41.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.355 0.577 . . . . 1.23 111.015 -176.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.842 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 7.0 tt -82.13 140.42 33.81 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.67 -0.863 . . . . 1.17 108.67 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.46 ' N ' HD23 ' A' ' 153' ' ' LEU . 5.5 t -124.29 109.17 13.04 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.876 -0.73 . . . . 1.35 110.241 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.729 HG11 HD21 ' A' ' 170' ' ' LEU . 49.1 t -91.51 96.03 5.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.029 -1.1 . . . . 0.42 108.029 174.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.596 ' HB3' ' HG3' ' A' ' 105' ' ' ARG . 4.5 tt0 -99.57 120.53 39.81 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.074 -0.966 . . . . 1.98 109.766 -175.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.662 ' HE2' HD13 ' A' ' 115' ' ' LEU . 62.1 t80 -108.36 116.38 31.86 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.332 0.587 . . . . 2.32 109.928 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 44.6 t -106.82 112.86 41.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.241 -0.89 . . . . 0.62 110.502 -176.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.498 ' HA ' ' HD1' ' A' ' 102' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.577 -0.738 . . . . 2.26 110.066 172.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 62' ' ' GLN . 38.8 t . . . . . 0 C--O 1.242 0.66 0 CA-C-O 119.658 -0.21 . . . . 1.19 110.832 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 29.1 t -141.74 94.47 2.68 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 120.062 -0.655 . . . . 1.36 112.32 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -87.64 38.59 0.84 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.841 1.256 . . . . 0.31 113.473 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.729 HD21 HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -31.0 131.91 0.09 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.58 0.752 . . . . 0.69 112.137 177.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 5.4 t80 -144.97 115.65 7.71 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.242 -0.286 . . . . 0.48 110.449 171.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.568 HG21 HG21 ' A' ' 75' ' ' ILE . 7.0 tt -113.89 125.72 71.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 122.268 1.032 . . . . 0.3 111.007 172.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 9.7 ptm -117.58 163.55 16.27 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.58 -1.191 . . . . 0.99 109.099 176.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.71 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -120.74 149.62 42.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.131 0.967 . . . . 1.22 112.635 -174.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.15 -29.63 12.03 Favored Glycine 0 C--N 1.306 -1.099 0 CA-C-N 114.105 -1.407 . . . . 0.31 114.34 162.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.562 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.0 OUTLIER -176.31 160.06 2.09 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.253 1.027 . . . . 0.68 112.115 179.14 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.574 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -85.48 -9.64 57.18 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.496 -0.775 . . . . 0.86 110.048 168.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.562 ' H ' ' HB ' ' A' ' 176' ' ' THR . 2.4 m-20 . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.901 -0.59 . . . . 2.16 111.618 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.765 ' HG ' HD11 ' A' ' 27' ' ' ILE . 27.2 tp . . . . . 0 N--CA 1.45 -0.454 0 CA-C-O 121.113 0.482 . . . . 0.72 109.975 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.488 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -66.5 -24.91 66.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.487 -0.779 . . . . 0.53 111.288 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -75.33 -32.79 61.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.008 -0.542 . . . . 2.18 110.606 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.682 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 30.6 mmtp -93.4 -28.82 15.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.09 -0.504 . . . . 1.79 111.853 -171.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.612 ' HB ' HD12 ' A' ' 27' ' ' ILE . 9.6 p -57.63 119.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.627 0.727 . . . . 0.33 111.901 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.2 pt -101.82 -24.62 4.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.784 -0.644 . . . . 0.92 110.181 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.797 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 35.5 t90 -159.24 135.25 8.85 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.53 -0.759 . . . . 0.36 109.449 -172.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -154.76 131.34 10.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.722 0.296 . . . . 0.26 110.76 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.476 ' HB ' ' CH2' ' A' ' 12' ' ' TRP . 4.1 t -140.33 125.16 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.514 0.673 . . . . 0.79 111.598 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.742 ' HB2' HD23 ' A' ' 60' ' ' LEU . 3.2 t-20 -97.49 90.48 5.06 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.751 -1.203 . . . . 1.49 107.751 167.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.557 ' C ' ' HB2' ' A' ' 65' ' ' ARG . . . -62.38 102.2 0.29 Allowed 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.584 -0.734 . . . . 0.48 109.446 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 150.56 -20.12 1.03 Allowed Glycine 0 N--CA 1.442 -0.938 0 O-C-N 125.398 1.686 . . . . 0.76 112.333 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -136.64 -166.08 10.72 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.036 -1.078 . . . . 0.74 112.924 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 31.7 tt0 -120.78 118.2 29.4 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.814 0.302 . . . . 1.77 111.814 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.756 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 18.4 m 36.31 109.27 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 115.639 1.718 . . . . 1.29 115.639 166.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.86 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 71.4 t60 -147.02 143.42 28.39 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 121.668 -0.645 . . . . 0.42 110.958 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.6 t -104.21 117.48 49.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.33 -0.85 . . . . 1.01 109.934 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.782 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -70.98 148.63 47.47 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.236 -0.653 . . . . 0.77 109.236 174.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.32 -17.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 114.219 1.192 . . . . 0.62 114.219 -173.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.532 ' HB2' HD23 ' A' ' 6' ' ' LEU . 63.9 m-70 -87.74 -11.52 47.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.255 -0.646 . . . . 0.86 109.255 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 108.64 33.89 2.77 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.053 -0.976 . . . . 0.33 113.246 175.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.765 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.5 mm -103.32 105.53 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.043 -0.663 . . . . 0.31 110.355 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -90.41 105.75 18.03 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.024 -0.534 . . . . 0.8 110.604 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.86 ' CE2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -83.7 138.77 33.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.686 -0.688 . . . . 1.75 109.269 175.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -95.23 149.29 21.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.861 0.362 . . . . 2.94 110.557 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 76.6 tttt -43.24 143.38 0.85 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.802 -1.09 . . . . 2.78 112.28 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.589 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 13.3 p-10 -45.8 106.09 0.53 Allowed Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 124.763 1.29 . . . . 2.41 113.387 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 N--CA 1.455 -0.774 0 C-N-CA 123.967 3.111 . . . . 1.87 113.717 174.845 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.679 ' CG2' ' HB2' ' A' ' 126' ' ' ALA . 1.4 mp . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 121.649 0.738 . . . . 1.59 110.335 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.547 ' HB2' HG22 ' A' ' 125' ' ' THR . 2.7 mm? -74.8 -2.83 28.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.389 -0.823 . . . . 1.91 112.744 -171.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 7.5 mmm180 -112.67 23.33 13.62 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.845 -0.342 . . . . 3.17 111.166 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.7 t -142.81 157.55 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.371 0.605 . . . . 0.97 112.346 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.447 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 22.6 t30 -63.75 129.25 93.66 Favored Pre-proline 0 C--O 1.213 -0.858 0 CA-C-N 114.983 -1.008 . . . . 1.92 109.258 172.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.534 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 3.2 Cg_exo -40.19 -44.75 4.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.192 3.261 . . . . 0.7 115.058 -170.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -64.31 -51.82 61.55 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 123.149 1.452 . . . . 2.71 109.407 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.782 ' OD1' ' HA ' ' A' ' 23' ' ' ASP . 31.6 m-20 -82.26 -6.87 59.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.231 -1.804 . . . . 1.63 109.645 -174.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.534 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 22.4 tt0 -67.41 -41.37 85.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 1.58 108.354 169.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.03 -50.4 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.311 -0.859 . . . . 1.27 109.064 170.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.751 ' HG ' ' HD2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -55.9 -34.41 65.52 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.484 -0.78 . . . . 1.18 110.39 178.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.601 ' HA ' ' CB ' ' A' ' 169' ' ' ALA . 10.9 m-30 -94.58 1.51 55.64 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.952 -0.567 . . . . 0.99 111.263 -174.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.733 ' HA ' HG21 ' A' ' 167' ' ' VAL . 2.1 tt0 -128.32 -110.05 0.28 Allowed 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 116.567 -0.288 . . . . 1.97 111.413 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.702 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 29.58 108.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.38 1.472 . . . . 1.27 114.584 -172.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.693 ' HB3' HG12 ' A' ' 167' ' ' VAL . 8.1 pt-20 -80.63 136.53 36.24 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.031 0.752 . . . . 1.96 113.031 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.589 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.265 0 CA-C-N 116.011 -0.54 . . . . 3.35 110.034 170.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 C--O 1.234 0.269 0 CA-C-O 121.237 0.541 . . . . 1.41 110.741 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.637 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 1.5 p90 -126.77 137.41 53.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.836 -0.431 . . . . 1.57 109.836 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.08 -153.07 7.93 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.618 -0.801 . . . . 0.78 112.873 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -143.96 168.16 20.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.196 0.522 . . . . 1.21 111.589 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.451 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.6 m-20 -122.75 125.14 44.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.305 -0.861 . . . . 2.47 109.129 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.944 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.0 mp -104.69 95.96 9.66 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.439 -0.578 . . . . 0.38 109.439 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 32.0 Cg_exo -57.04 120.82 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.936 1.757 . . . . 0.59 112.013 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.783 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 66.3 mt -126.67 133.03 69.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.436 -0.347 . . . . 0.49 110.393 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -132.77 16.07 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.345 -0.389 . . . . 3.32 110.825 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -135.43 174.29 10.77 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.725 -0.39 . . . . 2.16 110.447 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.589 ' HG2' HG22 ' A' ' 135' ' ' ILE . 10.9 mt-10 -122.61 163.44 20.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.118 -0.492 . . . . 1.2 110.718 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.98 -173.99 21.89 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.644 -0.982 . . . . 0.3 110.644 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -92.4 104.74 17.04 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 117.878 0.839 . . . . 1.96 109.267 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.684 ' HB2' HG12 ' A' ' 133' ' ' ILE . 92.9 m-85 -92.59 123.4 35.86 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.491 -0.929 . . . . 0.71 108.491 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.508 HG21 ' CA ' ' A' ' 177' ' ' ALA . 88.8 t -116.14 106.65 20.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.633 -0.712 . . . . 0.26 110.268 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 172' ' ' ILE . 5.7 mp -86.77 104.69 16.38 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.955 -1.021 . . . . 1.56 109.302 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 130' ' ' ILE . 53.3 t -102.87 102.64 13.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.694 -1.224 . . . . 1.14 107.694 172.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -113.26 133.33 55.15 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.55 -0.46 . . . . 1.44 110.513 -176.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.763 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 5.3 mptp? -91.74 124.68 36.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.278 0.561 . . . . 3.73 110.097 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD2' HD11 ' A' ' 115' ' ' LEU . 2.8 m-85 -108.95 141.78 40.54 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.486 -0.779 . . . . 0.45 110.121 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.602 ' HB3' ' CG2' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.313 -0.995 0 CA-C-N 115.736 -0.665 . . . . 0.51 109.901 174.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.854 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 13.3 m . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 121.602 0.715 . . . . 1.22 110.273 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.605 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 22.5 m-85 -90.41 156.96 17.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.133 -0.94 . . . . 0.99 111.469 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.667 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 6.7 t70 -107.57 136.33 47.51 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.507 -0.553 . . . . 1.53 109.507 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.68 122.41 23.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 0.63 111.042 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.2 mtt180 -124.7 140.29 53.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.154 -0.93 . . . . 1.95 111.258 -174.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.624 HG22 HD11 ' A' ' 153' ' ' LEU . 7.7 p -117.59 104.93 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 1.44 109.611 173.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.931 ' HB2' HD12 ' A' ' 153' ' ' LEU . 28.4 t-20 61.3 41.54 13.02 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.52 1.152 . . . . 1.65 108.193 -171.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.62 -21.29 26.78 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.747 -1.115 . . . . 0.42 112.698 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 78.1 m-70 -74.08 105.35 5.26 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 122.631 0.373 . . . . 0.68 111.717 -174.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.561 HG22 ' HG2' ' A' ' 105' ' ' ARG . 2.4 p -70.2 92.64 0.78 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.041 0.448 . . . . 0.77 111.511 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.416 HG23 HG12 ' A' ' 106' ' ' VAL . 21.4 t -76.62 -41.76 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.917 -0.583 . . . . 0.94 109.804 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.433 HG11 ' HG ' ' A' ' 115' ' ' LEU . 11.1 t -132.55 90.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.098 -0.501 . . . . 0.35 110.148 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -105.08 72.49 1.0 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.655 0.741 . . . . 4.01 109.777 175.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.854 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 7.8 p-10 161.24 32.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.587 -1.642 . . . . 1.96 108.226 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -69.65 85.43 0.46 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.91 -1.041 . . . . 1.18 111.093 -174.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 19.3 p-10 -98.0 88.69 4.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.574 -0.739 . . . . 1.93 109.52 172.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 56.8 mt -59.62 -39.86 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.578 -0.737 . . . . 0.82 111.166 -173.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -52.64 -37.15 57.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 1.08 111.585 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.88 -37.21 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.896 -0.503 . . . . 0.96 111.108 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 7.6 mmt180 -73.11 -51.91 16.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.721 -0.672 . . . . 1.69 110.945 -170.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.93 -23.18 4.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.351 -0.386 . . . . 1.49 111.813 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.78 -83.34 1.6 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.186 -1.006 . . . . 1.4 112.144 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -114.92 107.82 15.91 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.88 -0.328 . . . . 4.11 111.043 -176.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.6 p 44.71 -123.73 0.98 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.775 -0.648 . . . . 1.97 111.961 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.597 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 60.4 p 53.76 -169.27 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.859 0.863 . . . . 0.85 112.425 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.679 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -100.02 129.15 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.315 0.487 . . . . 0.57 112.315 -177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 38.4 t60 -101.82 147.41 26.53 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.584 -1.265 . . . . 0.55 107.584 169.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.602 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.5 p30 -142.78 127.65 18.29 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.145 -0.622 . . . . 1.64 111.911 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.95 115.27 28.52 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.895 -1.048 . . . . 1.12 108.793 172.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.42 HG23 HG22 ' A' ' 86' ' ' VAL . 64.2 mt -101.5 106.67 19.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.229 -0.656 . . . . 0.74 109.229 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 111' ' ' VAL . 54.3 mt -116.84 90.73 33.13 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.377 -0.374 . . . . 1.25 110.956 -173.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.452 ' HB3' HG22 ' A' ' 84' ' ' VAL . 8.9 Cg_exo -77.43 119.69 5.0 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.568 2.179 . . . . 0.29 112.237 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.684 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -109.68 144.59 17.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.875 -1.157 . . . . 0.27 107.875 175.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -113.92 107.33 15.54 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 120.34 -0.544 . . . . 1.24 110.503 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.589 HG22 ' HG2' ' A' ' 80' ' ' GLU . 33.5 mt -99.62 120.89 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.786 -0.45 . . . . 0.34 109.786 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -149.8 137.76 20.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.563 -0.532 . . . . 1.95 109.563 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 8.3 mptt 61.23 30.35 19.18 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.646 0.736 . . . . 3.13 110.185 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.31 11.44 84.18 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 114.805 -1.089 . . . . 0.41 112.607 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.769 ' HG2' HG22 ' A' ' 148' ' ' THR . 90.2 mttt -113.33 142.45 45.84 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.646 -0.326 . . . . 2.23 110.159 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 5.8 tt -112.61 119.46 38.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.037 -0.529 . . . . 0.41 110.096 -173.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 17.3 m -111.97 109.45 19.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.688 0.28 . . . . 1.19 110.94 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.44 HG23 ' CD2' ' A' ' 140' ' ' LEU . 66.9 t -94.24 94.58 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.563 -0.903 . . . . 0.92 108.563 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 59.27 -88.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.115 -0.948 . . . . 1.88 111.068 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -107.23 -13.0 22.33 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.541 -0.838 . . . . 1.02 113.091 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 141' ' ' SER . 51.6 mt-10 -90.14 112.88 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.535 -0.391 . . . . 1.95 110.863 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.8 p -105.65 113.48 42.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.418 0.627 . . . . 0.92 110.378 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.3 t -147.42 137.46 23.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.689 . . . . 1.27 109.19 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.769 HG22 ' HG2' ' A' ' 139' ' ' LYS . 41.0 p -56.81 139.36 51.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.116 0.484 . . . . 1.45 111.878 -175.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.783 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 22.8 t80 -79.91 129.09 34.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.497 -0.774 . . . . 0.47 109.785 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 t -122.64 99.19 6.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 1.79 111.971 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.37 -67.36 3.33 Favored Glycine 0 C--N 1.329 0.194 0 CA-C-N 115.742 -0.663 . . . . 0.42 113.939 171.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.616 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -158.83 167.55 29.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.205 0.526 . . . . 1.23 110.08 -177.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.944 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 14.5 tp -81.87 144.02 31.29 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.574 -0.899 . . . . 1.17 108.574 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.7 t -132.74 108.7 9.18 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.146 -1.022 . . . . 1.35 110.777 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 96.0 t -94.18 108.61 20.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.373 -0.376 . . . . 0.42 110.19 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -114.46 138.41 50.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.782 -0.644 . . . . 1.98 110.121 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.667 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -129.21 128.31 43.07 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.511 0.672 . . . . 2.32 110.705 168.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 44.5 t -106.47 144.63 15.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.423 -1.262 . . . . 0.62 111.085 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt . . . . . 0 C--O 1.233 0.217 0 CA-C-N 115.377 -0.828 . . . . 2.26 111.794 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.733 HG21 ' HA ' ' A' ' 62' ' ' GLN . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.047 0 N-CA-C 109.516 -0.55 . . . . 1.19 109.516 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 38.3 t -132.53 101.61 5.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.725 0.774 . . . . 1.36 111.84 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.763 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -88.34 36.79 0.79 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.629 1.172 . . . . 0.31 112.094 -177.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.797 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 13.6 tp -61.64 116.59 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.798 0.666 . . . . 0.69 112.798 -170.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 173' ' ' MET . 0.1 OUTLIER -124.22 123.47 40.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.652 -0.703 . . . . 0.48 110.25 176.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.598 ' CG2' ' HB3' ' A' ' 12' ' ' TRP . 2.7 tt -113.0 123.41 68.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 122.001 0.905 . . . . 0.3 111.366 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.61 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 12.3 ptm -111.4 164.57 12.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.997 -1.001 . . . . 0.99 109.914 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.682 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 19.2 ptmt -115.66 141.16 48.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.371 1.081 . . . . 1.22 112.726 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.71 -28.84 13.72 Favored Glycine 0 C--N 1.304 -1.227 0 CA-C-N 113.853 -1.521 . . . . 0.31 114.827 161.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.2 OUTLIER -169.52 153.67 5.25 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.642 1.221 . . . . 0.68 113.023 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.508 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -86.43 -9.89 55.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.057 -0.974 . . . . 0.86 109.981 168.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.492 ' H ' ' HB ' ' A' ' 176' ' ' THR . 10.9 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.524 -0.762 . . . . 2.16 111.528 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.854 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 34.6 tp . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 121.319 0.58 . . . . 0.72 110.789 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.525 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.23 -43.08 74.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.878 -1.055 . . . . 0.53 112.533 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.73 -17.76 34.99 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.441 -0.504 . . . . 2.18 112.256 -173.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 23.1 mmtm -91.55 -16.6 26.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.163 -0.615 . . . . 1.79 111.409 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.3 p -55.2 128.57 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.546 0.689 . . . . 0.33 111.197 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.652 HG23 HG23 ' A' ' 172' ' ' ILE . 0.3 OUTLIER -96.63 -31.39 3.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.345 -0.843 . . . . 0.92 109.912 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.654 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 74.8 t90 -172.95 132.62 0.53 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.321 -0.854 . . . . 0.36 109.396 -169.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.57 137.82 18.41 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.864 -0.522 . . . . 0.26 110.827 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.681 HG21 ' CD ' ' A' ' 33' ' ' PRO . 7.3 p -148.37 138.86 16.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 122.196 0.998 . . . . 0.79 112.57 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.675 ' HB2' HD12 ' A' ' 60' ' ' LEU . 10.9 t-20 -98.35 104.12 16.12 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.403 -1.271 . . . . 1.49 107.623 167.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -66.3 89.14 0.13 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.002 -1.111 . . . . 0.48 108.002 172.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.876 ' HA2' ' N ' ' A' ' 65' ' ' ARG . . . 179.1 -41.24 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.56 0 O-C-N 125.059 1.474 . . . . 0.76 112.023 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.66 -157.55 7.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.18 -1.009 . . . . 0.74 112.937 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.525 ' HB3' ' HG2' ' A' ' 31' ' ' LYS . 44.1 mt-10 -119.35 120.09 35.88 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 111.528 0.196 . . . . 1.77 111.528 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.854 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 67.2 m 39.1 112.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.504 2.039 . . . . 1.29 116.504 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.998 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 8.4 t60 -145.94 130.07 17.48 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.252 0.549 . . . . 0.42 111.334 171.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -87.75 115.91 28.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.043 -0.981 . . . . 1.01 109.646 174.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -82.42 164.53 20.94 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.769 -0.456 . . . . 0.77 109.769 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 m -62.63 -17.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 O-C-N 124.16 0.913 . . . . 0.62 111.791 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.484 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 88.3 m-70 -84.64 -1.84 56.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.3 0.571 . . . . 0.86 109.966 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.511 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 86.48 25.94 34.51 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.166 -0.924 . . . . 0.33 111.81 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.626 HD11 ' HG ' ' A' ' 6' ' ' LEU . 26.1 mm -103.95 113.23 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.394 0.616 . . . . 0.31 111.145 -175.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -92.96 110.83 22.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.42 -0.809 . . . . 0.8 110.823 -173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.998 ' CE2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -85.7 145.4 27.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.5 0.191 . . . . 1.75 110.59 179.119 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.672 ' O ' HG23 ' A' ' 14' ' ' VAL . 66.2 mtt180 -94.97 170.19 9.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.979 -0.555 . . . . 2.94 111.689 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 61.1 mttp -84.7 82.49 8.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.017 0.747 . . . . 2.78 113.017 -169.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 1.029 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 39.45 45.9 1.05 Allowed Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 114.737 1.384 . . . . 2.41 114.737 167.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.681 ' CD ' HG21 ' A' ' 14' ' ' VAL . 28.0 Cg_endo . . . . . 0 N--CA 1.456 -0.699 0 C-N-CA 124.15 3.234 . . . . 1.87 113.76 -161.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.889 HD13 ' HA ' ' A' ' 62' ' ' GLN . 1.7 mp . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.661 0.743 . . . . 1.59 109.811 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.556 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.6 mm? -65.29 -18.36 65.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.878 -1.055 . . . . 1.91 112.962 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -91.91 -9.83 41.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.481 -0.487 . . . . 3.17 111.985 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.501 ' OG ' ' HD2' ' A' ' 61' ' ' TYR . 57.9 m -108.83 160.06 16.29 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.285 0.564 . . . . 0.97 112.323 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.523 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -90.88 143.44 28.71 Favored Pre-proline 0 C--O 1.214 -0.798 0 CA-C-N 115.305 -0.861 . . . . 1.92 109.26 -176.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 46.8 Cg_exo -37.48 -48.92 1.85 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.989 3.126 . . . . 0.7 115.841 -164.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HB3' ' HE1' ' A' ' 21' ' ' HIS . 25.5 mm-40 -64.22 -54.58 31.24 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.442 1.115 . . . . 2.71 109.659 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 3.3 p30 -77.85 -15.8 58.78 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.538 -1.21 . . . . 1.63 110.577 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.711 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 9.4 tt0 -58.12 -50.5 73.26 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.556 -0.535 . . . . 1.58 109.556 172.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.4 t -55.25 -47.94 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.445 0.641 . . . . 1.27 109.859 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.727 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 50.1 tp -56.78 -19.42 16.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.799 -1.091 . . . . 1.18 111.425 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.62 ' HB3' ' HG3' ' A' ' 88' ' ' LYS . 23.1 m-30 -120.51 5.34 10.63 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.072 -0.513 . . . . 0.99 111.722 -173.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.889 ' HA ' HD13 ' A' ' 50' ' ' ILE . 0.7 OUTLIER -120.78 -38.25 2.88 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.812 -0.555 . . . . 1.97 112.453 -170.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.403 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -67.56 139.41 56.92 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.477 -0.783 . . . . 1.27 110.479 -175.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.975 ' HB3' HG12 ' A' ' 167' ' ' VAL . 0.0 OUTLIER -122.87 -4.01 8.62 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.298 1.592 . . . . 1.96 115.298 -166.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 1.029 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 2.1 mtp-105 . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 121.377 0.608 . . . . 3.35 112.179 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 121.076 0.465 . . . . 1.41 109.808 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.563 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 71.4 m-85 -77.91 108.49 11.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.403 -0.962 . . . . 1.57 108.403 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.11 144.63 16.5 Favored Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 115.361 -0.836 . . . . 0.78 113.234 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.568 ' HE1' ' CE1' ' A' ' 157' ' ' PHE . 54.2 m-85 -132.42 129.26 39.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.344 -0.428 . . . . 1.21 110.487 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.555 ' OD2' ' HE2' ' A' ' 152' ' ' LYS . 10.3 t70 -100.6 102.34 13.47 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.151 -0.685 . . . . 2.47 109.151 177.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 6.1 mt -102.6 90.06 2.05 Favored Pre-proline 0 CA--C 1.513 -0.46 0 N-CA-C 109.158 -0.682 . . . . 0.38 109.158 174.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 33.4 Cg_endo -66.12 116.58 4.09 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.305 1.337 . . . . 0.59 111.751 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.843 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 43.6 mt -110.32 139.75 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.98 -0.554 . . . . 0.49 111.113 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.29 16.29 4.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 3.32 109.979 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.509 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 9.1 mm-40 -129.09 158.13 39.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.585 0.231 . . . . 2.16 110.891 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.519 ' HG2' HG22 ' A' ' 135' ' ' ILE . 4.5 mt-10 -111.64 170.6 8.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.062 -0.517 . . . . 1.2 110.374 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.26 -162.98 24.02 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.447 -1.061 . . . . 0.3 110.447 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 67.0 mt-10 -102.61 111.45 23.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.854 0.827 . . . . 1.96 109.83 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.674 ' HB2' HG12 ' A' ' 133' ' ' ILE . 73.6 m-85 -94.12 123.87 37.77 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 108.434 -0.95 . . . . 0.71 108.434 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.599 HG21 ' CA ' ' A' ' 177' ' ' ALA . 86.1 t -113.63 106.15 20.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.646 0.736 . . . . 0.26 110.289 -174.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.5 mp -87.37 104.0 16.02 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.602 -1.181 . . . . 1.56 109.127 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.525 HG22 HG23 ' A' ' 130' ' ' ILE . 50.3 t -106.02 103.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.754 -1.202 . . . . 1.14 107.754 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 1.1 pt? -116.0 132.01 56.77 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.076 -0.65 . . . . 1.44 110.18 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.672 ' HE3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -86.26 120.29 27.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.116 -0.698 . . . . 3.73 109.116 178.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.545 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -106.29 140.47 39.18 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.099 -0.955 . . . . 0.45 110.508 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.533 ' HB3' HG22 ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.318 -0.792 0 N-CA-C 109.129 -0.693 . . . . 0.51 109.129 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.812 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.6 m . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.325 0.584 . . . . 1.22 111.0 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -96.79 165.49 12.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.172 -0.922 . . . . 0.99 110.727 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.621 ' OD2' ' HB ' ' A' ' 158' ' ' VAL . 0.0 OUTLIER -106.54 136.94 45.43 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.786 -0.766 . . . . 1.53 109.905 173.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 1.8 t -121.55 119.19 58.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.844 -0.616 . . . . 0.63 109.522 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.589 ' HG2' HG22 ' A' ' 110' ' ' THR . 24.5 mtt180 -121.38 139.42 53.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.088 0.471 . . . . 1.95 111.447 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.899 HG13 HD11 ' A' ' 153' ' ' LEU . 79.9 t -122.39 100.07 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.24 -0.891 . . . . 1.44 109.469 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.858 ' HB2' HD22 ' A' ' 153' ' ' LEU . 29.1 t-20 63.28 43.66 6.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.46 1.124 . . . . 1.65 108.686 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.59 -5.4 78.32 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.941 -1.027 . . . . 0.42 112.704 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 92.9 m-70 -92.35 106.64 18.6 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 122.017 0.127 . . . . 0.68 111.15 -174.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.589 HG22 ' HG2' ' A' ' 105' ' ' ARG . 2.9 p -70.18 88.67 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.968 0.413 . . . . 0.77 111.362 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.539 HG22 HG11 ' A' ' 142' ' ' VAL . 37.2 t -69.01 -51.46 43.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.94 109.799 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 104' ' ' VAL . 35.6 t -120.88 88.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.35 110.144 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.621 ' HG2' ' HB3' ' A' ' 103' ' ' ASP . 0.2 OUTLIER -102.57 76.88 1.57 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.515 -1.291 . . . . 4.01 107.515 173.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.812 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 9.2 p-10 166.05 26.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.99 -1.459 . . . . 1.96 109.634 -172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.73 101.11 3.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 1.18 111.499 -172.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 27.5 p-10 -118.16 85.88 2.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.288 1.042 . . . . 1.93 109.72 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 60.0 mt -54.21 -37.43 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.84 -1.073 . . . . 0.82 112.167 -172.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -58.44 -38.63 77.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.691 0.282 . . . . 1.08 111.579 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -70.15 -33.93 72.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.329 0.585 . . . . 0.96 110.422 177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 7.4 mmt180 -74.42 -51.38 15.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.531 -0.759 . . . . 1.69 111.117 -173.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 m -115.18 -29.51 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 113.109 0.781 . . . . 1.49 113.109 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.1 -73.97 2.58 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.517 -0.849 . . . . 1.4 112.003 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -77.28 151.21 35.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.251 -0.277 . . . . 4.11 110.251 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.6 t -68.55 80.22 0.27 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.785 0.802 . . . . 1.97 109.762 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.556 HG22 ' HB2' ' A' ' 51' ' ' LEU . 41.5 p -125.38 -137.95 0.27 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.958 -1.019 . . . . 0.85 109.188 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.591 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . . . -102.5 116.54 32.82 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.492 -0.483 . . . . 0.57 111.427 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 48.4 t60 -112.88 106.75 15.11 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 108.704 -0.85 . . . . 0.55 108.704 170.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.538 ' OD1' ' HG2' ' A' ' 88' ' ' LYS . 13.6 m-20 -105.03 117.12 33.2 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.319 -0.552 . . . . 1.64 111.384 -169.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -89.09 111.97 22.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.682 -0.69 . . . . 1.12 109.546 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.525 HG23 HG22 ' A' ' 86' ' ' VAL . 61.3 mt -103.18 110.15 28.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.411 -0.588 . . . . 0.74 109.411 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.481 HG21 HG21 ' A' ' 106' ' ' VAL . 65.5 mt -122.69 94.41 47.56 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.283 -0.417 . . . . 1.25 111.099 -173.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -80.83 121.81 4.19 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.728 2.285 . . . . 0.29 111.988 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.6 OUTLIER -110.58 155.62 11.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.646 -0.872 . . . . 0.27 108.646 177.057 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.528 ' OG ' ' HB2' ' A' ' 141' ' ' SER . 2.9 p -120.22 106.94 12.4 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.694 -0.402 . . . . 1.24 110.799 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 34.1 mt -100.66 119.6 49.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.326 -0.62 . . . . 0.34 109.326 176.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 27.5 mmtp -151.4 136.79 17.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.705 -0.48 . . . . 1.95 109.705 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt 65.52 22.91 11.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.68 -0.691 . . . . 3.13 110.47 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.64 9.47 86.37 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.844 -0.693 . . . . 0.41 112.084 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 52.8 mtpt -106.61 166.51 10.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.687 -0.486 . . . . 2.23 109.687 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.2 tt -140.73 116.35 10.2 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.636 -0.505 . . . . 0.41 109.636 -174.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.528 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 40.6 m -110.73 131.07 55.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.26 -0.427 . . . . 1.19 111.041 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.539 HG11 HG22 ' A' ' 111' ' ' VAL . 74.6 t -129.37 109.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.92 111.136 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 50.79 37.5 17.13 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.82 -0.627 . . . . 1.88 112.665 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.97 -24.33 25.37 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.783 -0.723 . . . . 1.02 112.576 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -85.06 112.12 20.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.02 -0.733 . . . . 1.95 109.02 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.6 p -105.57 125.67 60.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.771 -0.65 . . . . 0.92 110.611 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.3 m -144.51 -166.65 2.44 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.926 -0.768 . . . . 1.27 108.926 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 59.8 p -98.75 148.39 23.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.001 0.429 . . . . 1.45 110.847 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.843 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 39.6 t80 -81.41 120.95 25.63 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.736 -1.209 . . . . 0.47 107.736 168.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 m -130.51 95.92 4.0 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.122 0.487 . . . . 1.79 110.75 -174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.13 -82.41 1.18 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.598 -0.728 . . . . 0.42 113.781 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.555 ' HE2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -145.04 158.69 43.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.331 0.565 . . . . 1.23 111.004 -175.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.899 HD11 HG13 ' A' ' 106' ' ' VAL . 1.4 tm? -80.96 118.56 22.54 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.174 -1.417 . . . . 1.17 107.174 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 5.3 t -114.23 107.06 15.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.951 -0.699 . . . . 1.35 110.161 -171.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.516 ' O ' ' HD1' ' A' ' 73' ' ' TYR . 38.2 t -92.62 108.02 19.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.98 -0.748 . . . . 0.42 108.98 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 25.4 mt-10 -130.33 108.91 10.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.174 -0.466 . . . . 1.98 110.156 -177.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 2.9 p90 -104.58 115.85 31.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.722 0.772 . . . . 2.32 110.676 174.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.621 ' HB ' ' OD2' ' A' ' 103' ' ' ASP . 59.3 t -87.63 143.43 11.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 114.347 -1.297 . . . . 0.62 111.01 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 N--CA 1.454 -0.231 0 CA-C-N 114.739 -1.119 . . . . 2.26 111.585 -175.877 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.975 HG12 ' HB3' ' A' ' 64' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 120.859 0.361 . . . . 1.19 110.169 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 47.7 t -125.81 135.35 51.89 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.672 0.749 . . . . 1.36 110.313 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.6 ' HB1' ' HD1' ' A' ' 61' ' ' TYR . . . -123.05 36.76 4.57 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.615 -1.175 . . . . 0.31 109.869 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.654 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 9.9 tp -57.98 112.17 1.41 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.627 -1.17 . . . . 0.69 112.715 -170.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.854 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -122.27 120.45 34.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.619 -0.719 . . . . 0.48 110.243 176.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.652 HG23 HG23 ' A' ' 11' ' ' ILE . 6.9 tt -113.09 132.16 62.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.697 0.76 . . . . 0.3 110.357 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.618 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 4.1 ppp? -127.02 164.09 22.29 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.562 -0.744 . . . . 0.99 109.412 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.9 ptmt -112.61 142.16 45.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.565 1.174 . . . . 1.22 113.32 -173.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 176' ' ' THR . . . 105.37 -30.0 10.6 Favored Glycine 0 C--N 1.31 -0.865 0 CA-C-N 113.161 -1.836 . . . . 0.31 115.058 161.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.6 OUTLIER -176.75 153.07 1.04 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.467 1.133 . . . . 0.68 113.238 -177.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.599 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -84.59 -14.61 48.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.755 -0.657 . . . . 0.86 109.596 168.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.478 ' H ' ' HB ' ' A' ' 176' ' ' THR . 38.9 t70 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 114.937 -1.029 . . . . 2.16 111.807 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.772 HD23 ' HB3' ' A' ' 25' ' ' HIS . 27.6 tp . . . . . 0 C--O 1.233 0.221 0 CA-C-O 121.099 0.476 . . . . 0.72 110.425 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.535 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -61.32 -25.86 67.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.368 -0.833 . . . . 0.53 111.91 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.73 -36.72 23.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.375 -0.375 . . . . 2.18 111.358 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.649 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -90.15 -11.04 42.35 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.542 -0.463 . . . . 1.79 111.582 -171.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.75 HG23 ' HE1' ' A' ' 171' ' ' PHE . 14.7 p -59.31 132.8 24.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.035 -0.666 . . . . 0.33 111.546 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.681 HG23 HG23 ' A' ' 172' ' ' ILE . 0.6 OUTLIER -107.79 -38.4 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.051 -0.522 . . . . 0.92 110.563 176.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.733 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 49.6 t90 -165.33 143.63 6.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.825 -0.625 . . . . 0.36 109.32 -172.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.85 135.75 11.76 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.66 -0.416 . . . . 0.26 111.347 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.0 t -137.15 106.58 4.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.686 0.755 . . . . 0.79 110.922 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 3.2 t-20 -81.25 86.55 6.21 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.265 -1.383 . . . . 1.49 107.265 163.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -66.61 103.85 1.16 Allowed 'General case' 0 C--O 1.255 1.362 0 CA-C-N 115.386 -0.824 . . . . 0.48 109.813 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 172.93 -38.69 0.15 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 113.073 -1.876 . . . . 0.76 112.279 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.88 -141.26 4.58 Favored Glycine 0 N--CA 1.459 0.205 0 C-N-CA 120.702 -0.761 . . . . 0.74 112.427 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -118.17 157.63 26.58 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.589 -0.359 . . . . 1.77 110.893 175.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 23.2 m -19.03 122.44 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.307 1.595 . . . . 1.29 115.307 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.691 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 42.9 t60 -138.16 121.67 17.27 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.218 -0.901 . . . . 0.42 111.271 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 28' ' ' HIS . 64.1 t -85.3 123.3 39.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.077 -0.965 . . . . 1.01 109.019 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.76 ' HB3' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -101.7 171.26 7.65 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.525 -0.47 . . . . 0.77 110.715 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -56.53 -22.95 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 124.708 1.255 . . . . 0.62 112.808 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.772 ' HB3' HD23 ' A' ' 6' ' ' LEU . 34.0 m-70 -77.12 -10.61 59.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.35 0.595 . . . . 0.86 109.672 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.535 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 87.76 28.21 24.54 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.135 -0.939 . . . . 0.33 110.763 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.659 HD11 ' HG ' ' A' ' 6' ' ' LEU . 12.6 mm -102.14 112.49 35.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.136 0.493 . . . . 0.31 110.1 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.573 ' HB2' HG22 ' A' ' 22' ' ' VAL . 29.9 t60 -93.63 113.09 25.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.973 -0.558 . . . . 0.8 110.076 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.691 ' CD2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -90.5 142.38 27.8 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.643 -0.503 . . . . 1.75 109.643 175.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -100.78 69.29 1.35 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.012 0.745 . . . . 2.94 113.012 -169.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.746 ' HG2' ' H ' ' A' ' 32' ' ' ASP . 14.5 ttpp 60.83 -169.34 0.16 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.477 -0.783 . . . . 2.78 111.723 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.778 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 9.4 p-10 -103.09 88.93 1.71 Allowed Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-O 121.984 0.897 . . . . 2.41 110.106 173.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.638 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 31.7 Cg_endo . . . . . 0 N--CA 1.446 -1.279 0 C-N-CA 122.158 1.905 . . . . 1.87 112.313 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 126' ' ' ALA . 1.3 mp . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 121.891 0.853 . . . . 1.59 110.462 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 51' ' ' LEU . 4.6 mp -68.86 -14.38 63.0 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.809 -1.087 . . . . 1.91 111.73 -172.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.641 ' HB2' ' HB3' ' A' ' 126' ' ' ALA . 27.4 mmm180 -98.97 23.01 9.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.22 -0.445 . . . . 3.17 111.423 -175.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -150.31 167.76 26.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 0.97 112.186 -176.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.403 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 3.0 t30 -95.51 139.17 21.84 Favored Pre-proline 0 C--O 1.215 -0.744 0 CA-C-N 115.013 -0.994 . . . . 1.92 108.83 177.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.481 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 3.7 Cg_exo -36.69 -54.7 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.512 3.475 . . . . 0.7 116.246 -162.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -77.08 -28.71 54.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.172 0.896 . . . . 2.71 112.012 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -10.98 43.8 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 120.912 -1.117 . . . . 1.63 109.026 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.481 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 19.7 tt0 -67.07 -46.38 74.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.722 -1.126 . . . . 1.58 110.002 170.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.72 -39.98 86.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 109.684 -0.487 . . . . 1.27 109.684 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' ' 23' ' ' ASP . 45.3 tp -60.69 -21.58 63.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.183 0.516 . . . . 1.18 111.153 173.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.577 ' CD2' ' HE3' ' A' ' 88' ' ' LYS . 8.6 m-30 -102.64 -2.21 28.75 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.937 -0.574 . . . . 0.99 111.542 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.829 ' HA ' HG11 ' A' ' 167' ' ' VAL . 4.1 tt0 -121.67 -110.4 0.33 Allowed 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.637 -0.425 . . . . 1.97 110.147 174.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.629 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.6 OUTLIER 35.01 102.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.446 0.906 . . . . 1.27 113.446 -173.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -88.84 136.98 32.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.465 -0.334 . . . . 1.96 111.824 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.778 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 3.35 110.469 173.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.059 0.457 . . . . 1.41 109.884 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.49 ' CG ' ' CE2' ' A' ' 157' ' ' PHE . 38.2 m-85 -71.24 94.82 1.21 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.945 -1.132 . . . . 1.57 107.945 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.72 111.67 3.73 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.662 -0.78 . . . . 0.78 112.495 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.672 ' HE1' ' CE1' ' A' ' 157' ' ' PHE . 35.0 m-85 -102.59 151.29 22.51 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.568 0.347 . . . . 1.21 110.643 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.416 ' HB2' ' HG3' ' A' ' 152' ' ' LYS . 13.1 p-10 -115.28 112.97 23.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.342 0.591 . . . . 2.47 110.609 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.819 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.3 mp -103.55 93.42 4.97 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.38 110.067 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 25.2 Cg_endo -65.8 119.33 6.34 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.683 1.588 . . . . 0.59 112.108 -175.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.829 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 69.3 mt -117.97 132.2 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.658 -0.701 . . . . 0.49 110.114 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.89 6.7 4.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.039 -0.528 . . . . 3.32 111.134 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -134.92 176.66 8.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.836 0.35 . . . . 2.16 110.625 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.597 ' HG2' HG22 ' A' ' 135' ' ' ILE . 5.5 mt-10 -122.12 159.06 27.94 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.807 -0.633 . . . . 1.2 110.108 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.97 -155.22 26.35 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.805 -0.918 . . . . 0.3 110.805 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 47.0 mt-10 -110.92 106.48 15.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.265 0.532 . . . . 1.96 109.781 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.672 ' HB2' HG12 ' A' ' 133' ' ' ILE . 88.8 m-85 -94.76 125.4 39.39 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 119.735 -0.786 . . . . 0.71 109.219 -176.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.661 HG21 ' CA ' ' A' ' 177' ' ' ALA . 52.8 t -108.67 106.02 19.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.165 0.983 . . . . 0.26 110.039 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 155' ' ' VAL . 9.1 tt -97.84 104.98 17.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.875 -1.511 . . . . 1.56 109.141 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 129' ' ' GLU . 2.2 p -115.01 105.94 19.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 109.013 -0.736 . . . . 1.14 109.013 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -101.48 134.94 43.81 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.115 0.483 . . . . 1.44 110.114 -177.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 1.078 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 10.9 tppt? -98.69 114.92 27.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.327 0.584 . . . . 3.73 109.873 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 115' ' ' LEU . 4.0 m-85 -106.53 146.79 30.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.455 -0.793 . . . . 0.45 109.9 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.878 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 116.201 -0.454 . . . . 0.51 110.159 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 116' ' ' ASP . 16.7 m . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.44 0.638 . . . . 1.22 110.466 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 80.5 m-85 -114.65 168.66 9.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.335 -0.848 . . . . 0.99 111.752 -173.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.635 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 11.3 m-20 -107.21 138.01 44.2 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 109.091 -0.707 . . . . 1.53 109.091 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 110' ' ' THR . 7.4 t -136.3 113.33 13.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 117.699 0.227 . . . . 0.63 111.525 -175.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.675 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 84.2 mtt180 -110.94 141.41 44.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.225 0.454 . . . . 1.95 112.225 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.426 HG23 ' HB2' ' A' ' 109' ' ' HIS . 12.0 m -110.65 96.71 4.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.44 -0.8 . . . . 1.44 109.662 168.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.762 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 3.7 t-20 55.05 58.52 4.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.013 -0.994 . . . . 1.65 109.834 -172.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.25 -25.85 7.55 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.738 -1.119 . . . . 0.42 112.895 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.426 ' HB2' HG23 ' A' ' 106' ' ' VAL . 90.1 m-70 -83.71 95.04 8.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.915 0.339 . . . . 0.68 111.915 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -68.69 92.71 0.48 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.196 0.522 . . . . 0.77 111.063 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 112' ' ' VAL . 6.5 m -74.6 -37.58 43.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.978 -0.556 . . . . 0.94 110.904 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 111' ' ' VAL . 5.6 t -120.88 89.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.986 0.422 . . . . 0.35 109.963 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 11.6 tmtt? -106.98 73.9 0.96 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.733 -1.21 . . . . 4.01 107.733 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 7.2 p-10 161.16 28.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.441 -1.709 . . . . 1.96 108.807 -172.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -71.09 80.4 0.68 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.074 -0.512 . . . . 1.18 111.76 -170.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.481 ' HB2' HG12 ' A' ' 101' ' ' VAL . 10.1 t70 -90.48 99.4 12.43 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.051 -1.092 . . . . 1.93 108.051 169.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.0 mt -63.64 -36.33 76.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.092 -0.504 . . . . 0.82 111.494 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -67.13 -34.94 78.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.056 0.455 . . . . 1.08 110.343 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -67.51 -37.9 83.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.001 0.429 . . . . 0.96 111.405 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 120' ' ' ARG . 14.1 mmt85 -77.15 -46.76 22.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.307 0.484 . . . . 1.69 112.307 -169.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.455 HG13 ' ND1' ' A' ' 127' ' ' HIS . 4.6 m -113.54 -17.02 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.484 0.549 . . . . 1.49 112.484 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.86 -146.66 16.71 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.261 -0.971 . . . . 1.4 111.723 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -80.24 116.1 20.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.676 0.274 . . . . 4.11 111.385 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.5 t 64.55 -146.74 0.27 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.792 -0.64 . . . . 1.97 110.693 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.402 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 42.6 p 63.06 178.87 0.15 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.48 1.112 . . . . 0.85 111.724 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.849 ' HB1' ' HD2' ' A' ' 88' ' ' LYS . . . -94.23 128.27 40.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.356 -0.384 . . . . 0.57 111.315 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.516 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 66.9 t60 -101.65 146.78 27.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.139 -0.689 . . . . 0.55 109.139 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 1.1 p30 -143.91 137.62 27.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.301 0.572 . . . . 1.64 111.305 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 81.6 mm-40 -110.03 114.63 28.31 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.267 -1.012 . . . . 1.12 108.267 172.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.13 107.61 20.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.672 -0.492 . . . . 0.74 109.672 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.4 mm -116.47 101.06 53.81 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.394 -0.367 . . . . 1.25 111.017 -173.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.6 121.56 3.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.815 2.343 . . . . 0.29 111.616 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.672 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.2 pt -110.58 158.63 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.363 -0.606 . . . . 0.27 109.363 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.7 p -124.67 107.09 10.63 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.014 0.435 . . . . 1.24 110.773 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.597 HG22 ' HG2' ' A' ' 80' ' ' GLU . 35.0 mt -103.8 124.11 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.262 -0.426 . . . . 0.34 110.138 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 53.0 mmtt -151.46 138.49 19.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.646 0.592 . . . . 1.95 110.331 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 137' ' ' LYS . 63.5 mmtt 62.42 31.62 17.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.45 0.643 . . . . 3.13 110.507 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.09 22.01 77.15 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.015 -0.993 . . . . 0.41 111.923 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.648 ' HG2' HG22 ' A' ' 148' ' ' THR . 58.1 mtpt -118.71 137.58 53.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.014 -0.365 . . . . 2.23 110.014 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 7.1 tt -113.91 116.32 29.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.178 -0.464 . . . . 0.41 109.777 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.6 t -111.26 132.95 53.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.407 -0.36 . . . . 1.19 110.375 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 88.7 t -125.66 103.97 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.298 -0.41 . . . . 0.92 110.246 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 57.41 -91.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.68 0.612 . . . . 1.88 112.005 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -113.7 14.47 22.23 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.866 -0.683 . . . . 1.02 112.905 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -129.27 116.38 19.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.861 0.331 . . . . 1.95 111.201 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.21 129.85 57.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.071 0.462 . . . . 0.92 109.961 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m -144.03 -177.63 5.54 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.574 -0.528 . . . . 1.27 109.574 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.648 HG22 ' HG2' ' A' ' 139' ' ' LYS . 39.0 p -98.07 138.98 34.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.745 0.307 . . . . 1.45 110.284 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.829 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 58.6 t80 -79.57 135.44 36.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.996 -0.547 . . . . 0.47 109.966 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.7 t -132.17 102.31 5.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.526 0.679 . . . . 1.79 111.949 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.31 -68.46 2.91 Favored Glycine 0 CA--C 1.508 -0.344 0 CA-C-N 115.421 -0.809 . . . . 0.42 113.678 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -158.63 167.01 30.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.864 0.364 . . . . 1.23 110.452 -177.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.819 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 6.0 tt -80.92 127.55 32.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.539 -0.911 . . . . 1.17 108.539 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.762 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 5.7 p -112.45 102.9 10.98 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.346 -0.542 . . . . 1.35 112.333 -172.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 85' ' ' LEU . 97.1 t -91.72 109.35 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.783 -0.451 . . . . 0.42 109.783 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.581 ' HB2' ' HD2' ' A' ' 105' ' ' ARG . 39.9 mt-10 -120.3 112.05 18.55 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.533 -0.758 . . . . 1.98 109.609 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.672 ' CE1' ' HE1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -99.71 114.47 27.59 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 118.569 -1.253 . . . . 2.32 110.344 166.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 20.8 t -83.77 144.69 9.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 113.758 -1.565 . . . . 0.62 110.828 -169.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? . . . . . 0 C--O 1.234 0.256 0 CA-C-N 115.064 -0.971 . . . . 2.26 112.03 -172.002 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.878 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 2.4 t . . . . . 0 C--O 1.238 0.475 0 CA-C-O 119.727 -0.178 . . . . 1.19 110.699 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -129.95 74.42 1.59 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 119.623 -0.831 . . . . 1.36 113.133 -172.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 1.078 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -80.12 36.08 0.34 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.708 1.203 . . . . 0.31 113.576 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.733 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 18.9 tp -53.76 117.37 3.11 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.688 0.625 . . . . 0.69 112.688 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.75 ' HE1' HG23 ' A' ' 10' ' ' VAL . 8.4 t80 -123.89 127.79 48.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.963 0.505 . . . . 0.48 110.555 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.681 HG23 HG23 ' A' ' 11' ' ' ILE . 8.7 tt -119.13 131.65 71.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 121.811 0.815 . . . . 0.3 111.05 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 9.4 ptm -121.33 159.93 25.05 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.846 -0.616 . . . . 0.99 109.534 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 16.2 ptmt -113.18 149.98 32.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.424 1.107 . . . . 1.22 113.063 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' ' 176' ' ' THR . . . 103.58 -32.47 7.53 Favored Glycine 0 C--N 1.309 -0.917 0 CA-C-N 113.231 -1.804 . . . . 0.31 114.337 161.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.677 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.2 OUTLIER -177.49 162.22 1.82 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.052 0.926 . . . . 0.68 112.511 176.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.661 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -85.49 -10.36 56.18 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.22 -0.9 . . . . 0.86 109.891 168.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.677 ' H ' ' HB ' ' A' ' 176' ' ' THR . 22.2 m-20 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.416 -0.811 . . . . 2.16 111.616 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.704 ' HG ' HD11 ' A' ' 27' ' ' ILE . 47.6 tp . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 121.159 0.504 . . . . 0.72 110.111 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.502 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -61.23 -22.87 65.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.204 -0.907 . . . . 0.53 111.781 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -82.46 -34.3 28.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.41 -0.359 . . . . 2.18 111.373 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 57.8 mmtt -93.54 -15.39 25.52 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.59 -0.444 . . . . 1.79 112.02 -171.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.743 HG23 ' HE1' ' A' ' 171' ' ' PHE . 7.1 p -54.02 132.53 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.027 0.441 . . . . 0.33 111.775 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 pt -115.78 -32.28 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.226 -0.443 . . . . 0.92 110.705 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.72 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 42.0 t90 -159.63 133.0 7.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.046 -0.724 . . . . 0.36 109.046 -172.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.84 131.45 13.09 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.848 -0.341 . . . . 0.26 111.059 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.843 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 52.3 t -140.42 120.59 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.66 0.743 . . . . 0.79 111.357 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 51.4 t30 -98.15 101.63 13.15 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.109 -1.071 . . . . 1.49 108.109 167.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -60.36 95.7 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 116.051 -0.522 . . . . 0.48 110.036 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 175.94 -90.17 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 O-C-N 124.812 1.32 . . . . 0.76 113.068 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.37 -130.11 0.26 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.562 -0.352 . . . . 0.74 113.751 -172.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' HG3' ' HD3' ' A' ' 31' ' ' LYS . 31.6 tt0 -144.95 119.44 9.68 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.572 -0.369 . . . . 1.77 111.528 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.71 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 50.0 m 31.45 99.0 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.726 1.38 . . . . 1.29 114.726 172.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.862 ' HD2' ' HB2' ' A' ' 60' ' ' LEU . 76.2 t60 -135.33 134.97 40.4 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.786 -0.572 . . . . 0.42 111.855 -177.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 83.7 t -88.45 115.48 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.46 -0.791 . . . . 1.01 110.225 175.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.47 159.47 33.91 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.442 -0.577 . . . . 0.77 109.442 176.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 57' ' ' ASP . 28.8 m -66.2 -6.96 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.999 0.74 . . . . 0.62 112.999 -171.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -99.0 7.35 46.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.856 -0.794 . . . . 0.86 108.856 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 87.3 30.8 18.44 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.877 -1.056 . . . . 0.33 112.706 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.704 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.7 mm -104.45 106.27 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 0.31 111.34 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 30.3 t60 -86.33 109.43 18.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.289 0.566 . . . . 0.8 111.459 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.843 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -77.12 138.82 39.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.498 -0.774 . . . . 1.75 109.994 172.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -99.5 116.2 31.1 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.016 0.436 . . . . 2.94 110.677 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HG2' ' N ' ' A' ' 32' ' ' ASP . 8.9 ttpp -34.25 146.98 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.914 1.286 . . . . 2.78 114.371 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.54 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 7.7 p-10 -24.21 92.72 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 125.961 1.705 . . . . 2.41 114.639 -173.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.451 -1.015 0 C-N-CA 123.879 3.053 . . . . 1.87 113.507 176.138 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.539 HD13 ' HG3' ' A' ' 62' ' ' GLN . 1.5 mp . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 121.294 0.569 . . . . 1.59 110.389 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.89 -17.54 62.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 1.91 111.595 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HD3' ' HB ' ' A' ' 125' ' ' THR . 10.6 mpt_? -97.48 25.7 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.245 0.461 . . . . 3.17 112.245 -175.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -153.46 165.87 34.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 0.97 111.373 177.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.489 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 1.3 t30 -89.25 140.64 28.75 Favored Pre-proline 0 C--O 1.217 -0.655 0 CA-C-N 115.469 -0.787 . . . . 1.92 109.901 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.489 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 38.2 Cg_exo -37.78 -53.04 1.59 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 124.681 3.587 . . . . 0.7 117.339 -161.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -73.07 -45.97 54.27 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 119.419 1.008 . . . . 2.71 110.708 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.4 ' HB3' HG13 ' A' ' 24' ' ' VAL . 2.7 p30 -77.37 -20.8 54.24 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.004 -0.544 . . . . 1.63 109.563 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 24.5 tt0 -54.19 -48.07 71.38 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.563 -0.744 . . . . 1.58 109.378 169.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 63' ' ' THR . 61.4 t -54.79 -37.9 42.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.987 -0.551 . . . . 1.27 110.576 172.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.862 ' HB2' ' HD2' ' A' ' 21' ' ' HIS . 0.4 OUTLIER -74.92 -10.53 59.57 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.932 0.396 . . . . 1.18 111.758 178.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 169' ' ' ALA . 62.2 m-85 -115.78 12.66 15.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.276 1.036 . . . . 0.99 108.756 175.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.56 ' HG2' ' H ' ' A' ' 63' ' ' THR . 8.3 tt0 -126.88 -130.6 0.23 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.401 -1.727 . . . . 1.97 108.716 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.665 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 40.7 p 39.03 106.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.956 1.465 . . . . 1.27 114.956 -176.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.938 ' HB3' HG12 ' A' ' 167' ' ' VAL . 12.5 pt-20 -97.27 151.83 19.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.991 -1.114 . . . . 1.96 107.991 168.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.614 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 22.8 ptt180 . . . . . 0 C--N 1.328 -0.364 0 N-CA-C 112.353 0.501 . . . . 3.35 112.353 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.465 0.281 0 N-CA-C 109.308 -0.626 . . . . 1.41 109.308 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.857 ' HB2' ' HD1' ' A' ' 157' ' ' PHE . 15.3 m-85 -66.63 104.99 1.41 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.74 -0.664 . . . . 1.57 109.484 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.43 95.04 0.86 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 119.75 -1.214 . . . . 0.78 114.193 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.553 ' CE1' HG11 ' A' ' 14' ' ' VAL . 51.6 m-85 -84.4 148.33 26.66 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.305 -0.447 . . . . 1.21 110.77 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 1.9 p-10 -127.68 127.02 43.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.742 0.782 . . . . 2.47 109.934 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.912 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.0 mp -110.6 92.46 14.21 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 114.664 -1.153 . . . . 0.38 109.028 -176.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 34.5 Cg_exo -57.71 117.12 3.76 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.085 1.857 . . . . 0.59 111.609 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.767 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 56.4 mt -115.6 130.43 70.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.165 0.507 . . . . 0.49 111.634 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.52 -24.59 9.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.848 -0.615 . . . . 3.32 110.789 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.524 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 7.4 mm-40 -99.06 176.06 5.7 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.864 0.364 . . . . 2.16 110.575 -168.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 136' ' ' LYS . 2.3 tt0 -126.59 160.71 29.88 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.83 -0.623 . . . . 1.2 109.817 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.584 ' N ' ' HG2' ' A' ' 80' ' ' GLU . . . 139.45 -163.84 26.03 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 115.576 -0.738 . . . . 0.3 111.534 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 27.4 mt-10 -98.75 109.77 22.47 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 120.373 -0.531 . . . . 1.96 109.857 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.647 ' HB2' HG12 ' A' ' 133' ' ' ILE . 74.8 m-85 -94.34 124.66 38.5 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.583 -0.895 . . . . 0.71 108.583 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 177' ' ' ALA . 52.9 t -104.74 106.13 19.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-O 121.909 0.862 . . . . 0.26 109.902 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.738 HD11 HD11 ' A' ' 170' ' ' LEU . 10.9 tp -89.66 103.32 15.98 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.2 -1.364 . . . . 1.56 109.291 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.13 107.72 23.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.64 0.734 . . . . 1.14 109.364 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.612 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 1.3 pp -113.23 140.73 47.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.601 -0.727 . . . . 1.44 111.035 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.863 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 12.8 mptt -99.55 134.24 42.71 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.374 -0.53 . . . . 3.73 110.203 173.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CE2' HD13 ' A' ' 87' ' ' LEU . 11.3 m-85 -117.17 138.01 51.96 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.696 -0.684 . . . . 0.45 110.372 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.559 ' HB3' ' CG2' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.314 -0.977 0 C-N-CA 120.78 -0.368 . . . . 0.51 111.252 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.646 0 CA-C-O 121.26 0.552 . . . . 1.22 110.809 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 33.9 m-85 -77.36 158.19 30.24 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.532 -0.758 . . . . 0.99 109.804 176.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.734 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 50.9 m-20 -112.23 135.15 53.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.439 -0.949 . . . . 1.53 108.439 172.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.893 HG22 ' HD2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -125.79 119.81 55.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.164 0.506 . . . . 0.63 109.95 -177.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.712 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 79.6 mtt180 -116.83 141.87 47.66 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.017 -0.992 . . . . 1.95 111.456 -171.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 153' ' ' LEU . 41.8 t -116.5 102.25 13.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.663 -0.699 . . . . 1.44 109.153 174.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.896 ' HB2' HD12 ' A' ' 153' ' ' LEU . 23.3 t-20 57.26 46.45 18.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.227 1.013 . . . . 1.65 108.421 -170.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.79 -21.97 30.64 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.945 -1.025 . . . . 0.42 113.315 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 93.0 m-70 -78.12 108.57 11.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.268 0.47 . . . . 0.68 112.268 -173.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.51 ' CG2' ' HG2' ' A' ' 105' ' ' ARG . 5.9 p -69.35 87.81 0.45 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.779 0.323 . . . . 0.77 111.029 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.421 HG21 HG21 ' A' ' 131' ' ' ILE . 43.6 t -67.78 -55.55 16.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.154 -0.684 . . . . 0.94 109.154 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.597 HG21 ' HG2' ' A' ' 129' ' ' GLU . 17.3 t -112.53 90.52 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.874 -0.603 . . . . 0.35 109.72 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -107.9 73.25 0.89 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.757 0.789 . . . . 4.01 109.781 177.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 9.2 p-10 164.94 32.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.063 -1.426 . . . . 1.96 108.536 -172.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -78.11 71.08 4.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.217 -0.901 . . . . 1.18 112.042 -170.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 119' ' ' ASP . 31.0 m-20 -77.16 93.57 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.937 -1.134 . . . . 1.93 107.937 167.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.7 mt -54.01 -39.78 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.996 0.427 . . . . 0.82 110.211 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 56.7 t80 -64.71 -39.53 93.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.417 -0.81 . . . . 1.08 110.987 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 12.1 t70 -71.98 -36.41 69.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.987 0.422 . . . . 0.96 111.431 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -77.9 -49.56 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 1.69 111.807 -171.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 127' ' ' HIS . 15.9 m -110.5 -24.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.379 -0.529 . . . . 1.49 112.284 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 112.81 -142.86 17.54 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.423 -0.894 . . . . 1.4 111.961 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -89.14 110.29 21.04 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.173 -0.306 . . . . 4.11 110.173 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.4 t 68.15 -150.71 0.16 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.621 -0.718 . . . . 1.97 110.909 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.514 ' HB ' ' HD3' ' A' ' 52' ' ' ARG . 20.8 p 66.57 177.85 0.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.531 1.132 . . . . 0.85 111.176 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.49 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -91.94 119.1 31.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.826 0.346 . . . . 0.57 111.574 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.479 ' HA ' HG11 ' A' ' 121' ' ' VAL . 84.0 t60 -89.37 130.04 35.8 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.714 -0.847 . . . . 0.55 108.714 172.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -121.58 113.26 19.53 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.494 -0.321 . . . . 1.64 110.912 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.597 ' HG2' HG21 ' A' ' 112' ' ' VAL . 2.6 tp10 -116.53 113.62 23.02 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.696 -0.483 . . . . 1.12 109.696 177.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.4 mt -98.75 119.83 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.232 -0.44 . . . . 0.74 109.828 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.553 HG21 HG21 ' A' ' 106' ' ' VAL . 58.2 mt -125.23 89.58 52.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.233 -0.44 . . . . 1.25 110.63 -173.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -75.83 126.61 9.55 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.61 2.207 . . . . 0.29 112.019 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.647 HG12 ' HB2' ' A' ' 83' ' ' TYR . 6.0 pt -110.38 157.16 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.043 -0.725 . . . . 0.27 109.043 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 t -123.93 106.67 10.61 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.808 -0.442 . . . . 1.24 109.808 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.749 HG12 ' HG ' ' A' ' 140' ' ' LEU . 5.2 mt -104.73 137.14 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 109.021 -0.733 . . . . 0.34 109.021 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 53.1 mttm -152.77 131.13 12.08 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 123.699 0.625 . . . . 1.95 111.104 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.675 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER 56.22 27.66 12.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.147 -0.933 . . . . 3.13 111.239 177.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.62 13.62 62.75 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.792 -0.718 . . . . 0.41 113.085 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 59.2 mtpt -115.17 137.54 51.91 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.391 -0.476 . . . . 2.23 109.904 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.749 ' HG ' HG12 ' A' ' 135' ' ' ILE . 3.8 tt -115.51 121.44 42.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.314 -0.403 . . . . 0.41 110.185 -172.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -117.47 114.17 23.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.32 -0.4 . . . . 1.19 109.942 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 142' ' ' VAL . 5.5 m -90.73 111.07 23.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.97 -0.752 . . . . 0.92 108.97 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 63.55 -85.41 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.128 -0.487 . . . . 1.88 110.43 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -139.71 17.65 3.03 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.826 -0.625 . . . . 1.02 111.626 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -108.49 121.42 44.94 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.829 -0.804 . . . . 1.95 108.829 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.8 p -103.46 146.78 10.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.315 0.578 . . . . 0.92 111.943 -168.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.4 p -163.25 176.51 9.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.224 -0.898 . . . . 1.27 109.046 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 139' ' ' LYS . 70.3 p -100.27 138.13 37.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.711 0.291 . . . . 1.45 110.316 175.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.767 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 39.3 t80 -79.81 131.35 35.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.026 -0.361 . . . . 0.47 110.026 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.3 t -131.39 111.06 11.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.464 0.649 . . . . 1.79 111.473 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.37 -72.8 1.88 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.387 -0.824 . . . . 0.42 113.678 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -155.75 169.11 25.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.973 0.416 . . . . 1.23 110.62 -175.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.912 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 22.7 tp -80.99 150.72 28.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.707 -0.849 . . . . 1.17 108.707 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.6 t -132.53 104.11 6.51 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 118.994 -1.082 . . . . 1.35 110.353 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 15.5 t -92.91 96.44 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 108.401 -0.963 . . . . 0.42 108.401 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 105' ' ' ARG . 4.3 tt0 -107.7 121.82 45.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.495 -1.229 . . . . 1.98 109.582 -173.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.893 ' HD2' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -113.32 115.52 28.27 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.178 -0.609 . . . . 2.32 110.116 176.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 52.9 t -82.81 140.82 15.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.971 -1.013 . . . . 0.62 110.766 -173.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.3 pttm . . . . . 0 N--CA 1.454 -0.259 0 CA-C-N 114.999 -1.0 . . . . 2.26 112.336 -173.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.938 HG12 ' HB3' ' A' ' 64' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.244 0.802 0 N-CA-C 108.341 -0.985 . . . . 1.19 108.341 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 33.9 t -137.41 89.03 2.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.04 0.755 . . . . 1.36 113.04 -168.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.863 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -75.39 38.4 0.14 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 124.479 1.112 . . . . 0.31 113.273 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.738 HD11 HD11 ' A' ' 85' ' ' LEU . 40.7 tp -54.12 104.42 0.11 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.769 0.655 . . . . 0.69 112.769 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.782 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 4.3 t80 -117.99 124.62 48.62 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.489 -0.323 . . . . 0.48 110.925 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.664 ' HB ' HD12 ' A' ' 85' ' ' LEU . 5.0 tt -114.53 123.7 70.46 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-O 122.226 1.012 . . . . 0.3 111.359 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.782 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.6 ppp? -115.68 159.88 20.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.884 -1.053 . . . . 0.99 109.99 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 53.8 tttt -105.87 133.23 50.93 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 114.1 1.148 . . . . 1.22 114.1 -170.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 106.15 -28.87 12.28 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 113.832 -1.531 . . . . 0.31 116.226 157.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.99 158.09 1.98 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.036 1.418 . . . . 0.68 113.411 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.653 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -83.86 -9.58 58.65 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.206 -0.906 . . . . 0.86 111.356 174.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 30.6 t70 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 121.157 0.504 . . . . 2.16 111.215 -178.188 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.722 HD12 ' HE3' ' A' ' 173' ' ' MET . 50.2 tp . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.305 0.574 . . . . 0.72 110.141 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -69.89 -23.42 63.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.485 -0.78 . . . . 0.53 111.651 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.55 -16.54 53.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.026 -0.534 . . . . 2.18 111.009 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.454 ' HB2' ' HE2' ' A' ' 173' ' ' MET . 37.1 mtpt -126.22 2.77 7.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.438 -0.505 . . . . 1.79 111.785 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.522 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 11.6 p -58.78 136.91 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.508 -0.477 . . . . 0.33 110.176 169.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 174' ' ' LYS . 10.7 pt -115.76 -22.86 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.285 -0.416 . . . . 0.92 111.047 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.752 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 79.4 t90 -171.1 143.28 1.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.838 -0.431 . . . . 0.36 109.838 -173.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -162.18 137.58 7.28 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.207 -0.308 . . . . 0.26 111.553 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.402 HG11 ' CE2' ' A' ' 73' ' ' TYR . 45.2 t -142.02 125.72 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.02 -0.536 . . . . 0.79 110.885 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 28.5 t30 -101.77 104.87 15.68 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.793 -0.817 . . . . 1.49 108.793 167.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.602 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -65.52 89.11 0.1 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.245 -0.889 . . . . 0.48 110.247 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.617 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -174.36 -67.73 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 O-C-N 125.385 1.678 . . . . 0.76 112.249 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.85 -132.38 5.69 Favored Glycine 0 C--N 1.318 -0.441 0 C-N-CA 120.757 -0.735 . . . . 0.74 112.997 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 1.069 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 25.3 tt0 -138.33 119.37 14.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 111.243 0.09 . . . . 1.77 111.243 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.684 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 73.1 m 36.39 108.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.584 1.698 . . . . 1.29 115.584 170.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.614 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 82.6 t60 -137.76 128.37 26.74 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.928 -0.483 . . . . 0.42 111.42 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 86.1 t -87.8 113.15 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.209 -0.905 . . . . 1.01 109.074 171.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -78.38 161.33 27.24 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.333 -0.247 . . . . 0.77 110.333 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.32 -27.84 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 124.585 1.178 . . . . 0.62 113.232 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.441 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 87.6 m-70 -80.34 -6.55 58.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.312 0.577 . . . . 0.86 109.559 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 96.41 24.84 13.22 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.955 -1.021 . . . . 0.33 112.179 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.557 HD11 ' HG ' ' A' ' 6' ' ' LEU . 19.1 mm -99.36 109.18 23.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.178 0.513 . . . . 0.31 110.937 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 7.7 t60 -86.71 110.99 20.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.139 -0.482 . . . . 0.8 110.342 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.684 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -87.48 139.13 30.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.084 -0.339 . . . . 1.75 110.084 175.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.498 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 13.3 ptp180 -92.97 138.66 31.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.131 0.491 . . . . 2.94 110.664 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 1.069 ' HB3' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -73.9 136.91 43.38 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.939 1.088 . . . . 2.78 113.939 -173.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' CG ' ' HZ2' ' A' ' 31' ' ' LYS . 1.1 p30 28.54 54.67 0.5 Allowed Pre-proline 0 N--CA 1.484 1.246 0 CA-C-N 111.868 -2.424 . . . . 2.41 116.09 167.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 67.3 Cg_endo . . . . . 0 N--CA 1.455 -0.773 0 C-N-CA 122.503 2.135 . . . . 1.87 113.006 -175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' A' ' 62' ' ' GLN . 1.7 mp . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 121.863 0.84 . . . . 1.59 109.712 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.486 ' HB3' HG22 ' A' ' 125' ' ' THR . 2.8 tt -60.95 -35.51 76.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.592 -1.186 . . . . 1.91 110.962 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -88.09 33.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.951 0.722 . . . . 3.17 112.951 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -142.62 168.16 20.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.8 0.333 . . . . 0.97 110.878 172.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -90.21 141.42 27.69 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.958 -0.756 . . . . 1.92 108.958 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.425 ' O ' HG23 ' A' ' 59' ' ' VAL . 60.3 Cg_exo -39.67 -42.74 2.96 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 124.101 3.201 . . . . 0.7 115.947 -162.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -76.54 -44.37 35.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.248 0.476 . . . . 2.71 111.361 -177.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -81.2 -17.48 49.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.234 -0.654 . . . . 1.63 109.234 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -58.85 -45.69 89.52 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.174 -0.921 . . . . 1.58 109.135 167.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 55' ' ' PRO . 68.8 t -55.19 -44.6 75.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.487 0.66 . . . . 1.27 109.593 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 15' ' ' ASN . 35.0 tp -63.72 -18.94 64.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.644 -1.162 . . . . 1.18 112.141 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.614 ' CE2' ' HE2' ' A' ' 88' ' ' LYS . 13.6 m-30 -114.91 1.55 14.06 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 111.894 0.331 . . . . 0.99 111.894 -175.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.598 ' HA ' HD13 ' A' ' 50' ' ' ILE . 39.2 tt0 -124.3 -41.36 2.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.626 0.973 . . . . 1.97 113.626 -170.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.518 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 2.1 m -61.1 132.49 53.93 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 121.072 -0.251 . . . . 1.27 111.451 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 1.029 ' HB2' HG22 ' A' ' 167' ' ' VAL . 36.5 tt0 -120.33 147.75 44.62 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.123 0.569 . . . . 1.96 110.397 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.571 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 16.6 mtm-85 . . . . . 0 N--CA 1.463 0.184 0 O-C-N 123.232 0.333 . . . . 3.35 110.931 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.83 0.348 . . . . 1.41 110.437 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.737 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 8.4 p90 -107.28 126.61 52.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.132 -1.027 . . . . 1.57 110.838 -176.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -145.4 154.06 25.68 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.942 -1.027 . . . . 0.78 113.295 -173.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.602 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 53.5 m-85 -104.85 164.97 11.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.303 -0.448 . . . . 1.21 111.156 -175.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 8.0 p-10 -115.42 118.8 34.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.741 -0.663 . . . . 2.47 110.463 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.845 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.8 mp -104.5 90.88 3.59 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.333 -0.849 . . . . 0.38 109.302 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 38.4 Cg_exo -59.74 120.04 7.61 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.251 1.967 . . . . 0.59 112.405 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.775 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 72.4 mt -119.86 135.98 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.867 0.365 . . . . 0.49 111.236 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.484 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 32.6 mtpt -130.9 7.67 4.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 3.32 110.736 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.47 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 38.0 mt-10 -131.88 174.41 10.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.975 0.416 . . . . 2.16 110.882 -173.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 9.0 mt-10 -112.82 -172.99 2.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.778 -0.646 . . . . 1.2 110.112 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.33 -167.48 13.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.895 -0.669 . . . . 0.3 112.191 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.651 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 56.2 mt-10 -97.34 103.3 15.22 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 117.29 0.545 . . . . 1.96 109.747 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.666 ' HB2' HG12 ' A' ' 133' ' ' ILE . 10.9 m-30 -95.64 123.25 39.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 118.985 -1.086 . . . . 0.71 108.398 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.984 HG21 ' HA ' ' A' ' 177' ' ' ALA . 74.7 t -114.71 106.68 21.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.518 -0.764 . . . . 0.26 110.268 -172.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.1 mp -88.82 104.47 16.94 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.457 -1.247 . . . . 1.56 109.493 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.608 HG22 HG23 ' A' ' 130' ' ' ILE . 44.2 t -103.34 100.73 11.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 107.539 -1.282 . . . . 1.14 107.539 171.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.615 ' CB ' ' HA ' ' A' ' 170' ' ' LEU . 0.6 OUTLIER -109.23 132.24 54.31 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.106 -0.638 . . . . 1.44 109.803 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.994 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 13.8 mptt -89.09 122.61 32.58 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.129 -0.628 . . . . 3.73 110.393 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.14 135.21 48.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.227 -0.897 . . . . 0.45 108.645 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.843 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.312 -1.056 0 CA-C-O 121.095 0.474 . . . . 0.51 109.968 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.928 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 6.4 m . . . . . 0 N--CA 1.446 -0.671 0 CA-C-O 121.477 0.656 . . . . 1.22 110.356 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.711 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 23.5 m-85 -73.87 154.33 39.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.102 -0.954 . . . . 0.99 110.887 -175.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.681 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 12.5 m-20 -105.75 137.81 42.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.469 -0.567 . . . . 1.53 109.469 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 2.5 t -134.47 120.18 32.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.762 0.315 . . . . 0.63 110.682 -176.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 61.4 mtt180 -120.26 141.98 49.47 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.671 -0.695 . . . . 1.95 111.666 -174.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.872 HG23 HD21 ' A' ' 153' ' ' LEU . 2.8 p -118.43 102.78 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.75 -0.659 . . . . 1.44 109.845 172.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.415 ' HA ' ' H ' ' A' ' 154' ' ' SER . 64.7 t30 55.44 51.45 12.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.266 -0.879 . . . . 1.65 109.342 -172.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.31 -17.67 46.41 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.085 -0.961 . . . . 0.42 113.313 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 90.2 m-70 -85.49 105.45 16.11 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.098 0.407 . . . . 0.68 112.098 -172.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.575 ' HB ' ' HD2' ' A' ' 113' ' ' LYS . 1.9 p -69.91 94.3 0.83 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.043 0.449 . . . . 0.77 111.174 176.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.46 HG23 HG12 ' A' ' 106' ' ' VAL . 21.5 t -78.12 -49.62 21.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.643 0.735 . . . . 0.94 109.409 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.521 HG11 HD13 ' A' ' 115' ' ' LEU . 9.4 t -118.39 90.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.437 -0.801 . . . . 0.35 109.714 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.575 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 0.4 OUTLIER -109.45 71.66 0.78 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.906 -1.146 . . . . 4.01 107.906 176.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.928 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 6.6 p-10 168.86 19.29 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.026 -1.897 . . . . 1.96 109.698 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.711 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 11.5 tp -73.35 99.43 2.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.182 -0.463 . . . . 1.18 111.512 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 23.3 p-10 -110.59 91.08 3.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.161 0.981 . . . . 1.93 109.873 174.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.6 mm -52.9 -44.3 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 114.632 -1.167 . . . . 0.82 112.483 -170.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -56.96 -39.56 74.83 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 123.341 0.4 . . . . 1.08 111.755 -176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -73.18 -32.61 64.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.115 0.483 . . . . 0.96 110.849 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 8.6 mmt180 -71.5 -44.43 64.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.634 -0.712 . . . . 1.69 111.084 -173.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.77 -40.38 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.323 0.49 . . . . 1.49 112.323 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.25 -58.26 4.96 Favored Glycine 0 C--O 1.23 -0.137 0 C-N-CA 121.133 -0.556 . . . . 1.4 112.104 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -99.92 145.42 27.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.436 -0.579 . . . . 4.11 109.436 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.0 m -54.38 94.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 O-C-N 123.691 0.619 . . . . 1.97 111.03 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 51' ' ' LEU . 21.2 p -150.05 -174.9 4.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.217 -0.447 . . . . 0.85 109.872 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.567 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -79.92 124.14 28.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.563 -0.29 . . . . 0.57 111.007 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -104.87 145.15 30.79 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.723 -1.214 . . . . 0.55 107.723 168.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.73 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 23.8 p-10 -146.81 139.83 25.33 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.931 -0.708 . . . . 1.64 112.141 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -103.85 114.02 27.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.219 -0.901 . . . . 1.12 108.598 172.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.608 HG23 HG22 ' A' ' 86' ' ' VAL . 71.6 mt -95.73 110.05 23.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.997 -0.547 . . . . 0.74 109.629 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.8 mt -119.7 97.45 49.83 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.37 -0.377 . . . . 1.25 111.162 -173.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -78.68 123.75 6.01 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.717 2.278 . . . . 0.29 112.108 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.666 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.9 pt -110.03 154.05 11.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.727 -0.842 . . . . 0.27 108.727 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.9 p -123.78 109.42 13.64 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.852 0.358 . . . . 1.24 110.323 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.718 HG12 ' HG ' ' A' ' 140' ' ' LEU . 29.2 mt -98.82 125.11 52.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.049 -0.722 . . . . 0.34 109.049 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -151.0 135.57 17.1 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.71 0.631 . . . . 1.95 109.435 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 1.066 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 7.6 mmpt? 61.98 25.85 15.55 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.538 0.524 . . . . 3.13 111.316 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.25 9.98 85.96 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.731 -0.747 . . . . 0.41 112.167 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.746 ' HG2' HG22 ' A' ' 148' ' ' THR . 26.3 mtpp -110.83 137.48 48.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.406 -0.59 . . . . 2.23 109.406 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.718 ' HG ' HG12 ' A' ' 135' ' ' ILE . 4.9 tt -108.68 115.32 29.88 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.415 -0.587 . . . . 0.41 109.415 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 m -108.4 125.12 51.39 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.893 -0.594 . . . . 1.19 110.091 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.405 HG21 HG13 ' A' ' 106' ' ' VAL . 85.5 t -113.09 95.5 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.769 -0.456 . . . . 0.92 109.769 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 62.39 -91.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.427 -0.806 . . . . 1.88 111.132 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.3 -10.46 29.54 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.922 -0.656 . . . . 1.02 112.594 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -97.47 149.98 21.57 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.803 -0.234 . . . . 1.95 110.763 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.92 125.76 13.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.168 0.509 . . . . 0.92 110.865 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.0 m -155.42 141.72 18.53 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.626 -0.509 . . . . 1.27 109.626 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.746 HG22 ' HG2' ' A' ' 139' ' ' LYS . 25.1 p -59.09 140.93 55.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.2 0.524 . . . . 1.45 111.131 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.775 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 20.8 t80 -85.83 140.85 30.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.45 -0.795 . . . . 0.47 110.301 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 t -144.41 118.01 9.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.509 0.671 . . . . 1.79 110.923 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.21 -77.8 2.08 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.324 -0.853 . . . . 0.42 113.607 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -159.72 169.47 23.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.038 0.447 . . . . 1.23 110.975 -174.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.872 HD21 HG23 ' A' ' 106' ' ' VAL . 6.7 tt -84.34 135.35 34.34 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.778 -0.823 . . . . 1.17 108.778 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.475 ' N ' HD23 ' A' ' 153' ' ' LEU . 8.1 t -121.34 109.07 14.46 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.903 -0.719 . . . . 1.35 110.538 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 45.2 t -95.23 98.06 7.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.722 -0.473 . . . . 0.42 109.722 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -114.95 134.3 55.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.205 -0.452 . . . . 1.98 110.434 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.737 ' HE2' ' CE2' ' A' ' 71' ' ' PHE . 0.1 OUTLIER -123.5 136.76 54.74 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.621 0.724 . . . . 2.32 111.418 176.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 42.2 t -104.5 145.44 13.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 114.002 -1.454 . . . . 0.62 111.525 -170.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 N--CA 1.464 0.244 0 CA-C-N 113.973 -1.467 . . . . 2.26 113.338 -178.093 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 1.029 HG22 ' HB2' ' A' ' 64' ' ' GLU . 52.1 t . . . . . 0 C--O 1.237 0.399 0 N-CA-C 110.079 -0.341 . . . . 1.19 110.079 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 11.5 t -141.92 86.4 1.98 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 119.084 -1.046 . . . . 1.36 113.592 -175.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.994 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -75.68 37.02 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.718 1.207 . . . . 0.31 112.564 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.752 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 23.3 tp -50.5 101.97 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.659 0.784 . . . . 0.69 113.111 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.736 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 5.0 t80 -114.82 128.29 56.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.832 -0.622 . . . . 0.48 110.626 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.681 HG22 ' HE3' ' A' ' 12' ' ' TRP . 6.4 tt -121.15 124.82 72.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-O 121.529 0.68 . . . . 0.3 111.349 174.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.736 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 2.0 ppp? -115.32 166.06 12.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.801 -0.636 . . . . 0.99 109.395 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.445 ' HB3' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -120.14 148.73 43.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.4 1.095 . . . . 1.22 112.888 -170.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.52 -28.76 14.15 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 113.531 -1.668 . . . . 0.31 114.285 163.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.651 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.7 OUTLIER -166.62 152.24 8.19 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.545 0.943 . . . . 0.68 113.545 -174.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.984 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -85.1 -15.39 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.105 -0.952 . . . . 0.86 110.223 167.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.434 ' H ' ' HB ' ' A' ' 176' ' ' THR . 20.2 t70 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 114.965 -1.016 . . . . 2.16 112.002 -173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.661 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.5 tp . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.085 0.469 . . . . 0.72 110.557 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -71.01 -22.68 62.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.755 -0.657 . . . . 0.53 111.385 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.402 ' OD2' ' HG2' ' A' ' 9' ' ' LYS . 6.3 t70 -68.05 -42.13 80.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.207 0.527 . . . . 2.18 110.518 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 0.9 OUTLIER -103.29 -11.47 17.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.492 -0.776 . . . . 1.79 112.412 -168.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 12.4 p -59.96 131.25 24.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 120.401 -0.52 . . . . 0.33 111.015 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.509 HD11 HD13 ' A' ' 172' ' ' ILE . 22.7 pt -106.67 -22.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.952 -0.567 . . . . 0.92 110.071 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.741 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 34.9 t90 -168.81 142.13 2.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.775 -0.648 . . . . 0.36 109.595 -169.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -158.03 136.11 10.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.686 0.279 . . . . 0.26 111.195 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.801 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 18.8 t -146.71 125.18 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.418 0.627 . . . . 0.79 111.933 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 47.2 t30 -94.33 103.58 15.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.79 -1.189 . . . . 1.49 107.79 164.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -62.15 91.04 0.03 OUTLIER 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.881 -1.155 . . . . 0.48 107.881 171.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.781 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . 131.98 62.5 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.339 0 O-C-N 125.009 1.443 . . . . 0.76 113.169 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.92 -136.37 2.86 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 119.893 -1.146 . . . . 0.74 112.674 166.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.853 ' HG3' ' HD3' ' A' ' 31' ' ' LYS . 35.0 tt0 -161.64 118.12 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 119.724 -0.179 . . . . 1.77 110.952 171.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.731 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 60.1 p 31.36 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.567 1.167 . . . . 1.29 113.518 174.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.69 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 73.4 t60 -125.4 136.21 53.19 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.979 -0.688 . . . . 0.42 111.276 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.4 114.4 37.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.983 -0.553 . . . . 1.01 110.285 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.816 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -72.3 152.35 42.18 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.312 -0.625 . . . . 0.77 109.312 176.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG22 ' OD2' ' A' ' 57' ' ' ASP . 29.1 m -61.65 -10.83 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 113.594 0.961 . . . . 0.62 113.594 -170.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.484 ' HB2' HD23 ' A' ' 6' ' ' LEU . 65.5 m-70 -92.87 -3.44 54.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.972 -0.751 . . . . 0.86 108.972 176.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 97.89 30.77 6.96 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.991 -1.004 . . . . 0.33 112.679 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.661 HD11 ' HG ' ' A' ' 6' ' ' LEU . 29.8 mm -103.83 108.09 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.127 0.489 . . . . 0.31 110.689 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -94.42 113.22 25.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.8 111.229 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.801 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -80.99 132.5 35.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.149 -0.478 . . . . 1.75 110.631 175.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.847 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 5.2 ptm180 -90.74 113.51 25.64 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.451 0.47 . . . . 2.94 110.673 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.853 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 39.0 ttpt -32.95 109.54 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.401 1.63 . . . . 2.78 115.401 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 59.3 m-20 23.7 63.02 0.39 Allowed Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 126.352 1.861 . . . . 2.41 114.715 168.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.847 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 17.7 Cg_endo . . . . . 0 N--CA 1.455 -0.756 0 C-N-CA 123.47 2.78 . . . . 1.87 113.823 -172.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.1 tp . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 120.828 0.346 . . . . 1.59 111.699 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 125' ' ' THR . 9.1 mp 64.45 -67.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.503 0.721 . . . . 1.91 112.541 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -77.36 36.47 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.42 0.526 . . . . 3.17 112.42 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.2 t -157.23 143.82 18.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.082 -0.34 . . . . 0.97 110.082 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -65.71 145.35 99.04 Favored Pre-proline 0 C--O 1.223 -0.323 0 CA-C-N 115.659 -0.701 . . . . 1.92 109.737 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -41.12 -45.01 5.36 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.577 3.518 . . . . 0.7 115.462 -166.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.737 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.0 pt-20 -72.42 -46.91 52.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.019 0.914 . . . . 2.71 110.614 -176.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.816 ' OD1' ' HA ' ' A' ' 23' ' ' ASP . 68.3 m-20 -79.06 -14.63 59.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.553 -0.717 . . . . 1.63 109.56 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 33.2 tt0 -59.75 -49.55 77.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.136 -0.938 . . . . 1.58 109.269 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 56' ' ' GLU . 13.6 p -60.19 -35.27 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 119.726 -0.789 . . . . 1.27 110.055 176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.69 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 16.2 tp -69.34 -13.24 62.27 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.843 0.354 . . . . 1.18 111.763 176.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.537 ' CG ' ' HG2' ' A' ' 88' ' ' LYS . 15.8 m-30 -119.11 3.22 11.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.461 -0.336 . . . . 0.99 111.329 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.49 ' HA ' HD13 ' A' ' 50' ' ' ILE . 6.8 tt0 -121.25 -49.54 2.16 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.367 0.877 . . . . 1.97 113.367 -167.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.781 ' HB ' ' O ' ' A' ' 17' ' ' GLY . 20.8 m -74.05 133.17 42.89 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.766 -0.373 . . . . 1.27 111.221 -173.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' HB3' HG22 ' A' ' 167' ' ' VAL . 2.1 pm0 -93.32 162.25 14.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 1.96 109.889 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.45 ' HB2' ' C ' ' A' ' 16' ' ' ALA . 9.4 ttp180 . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.167 -0.679 . . . . 3.35 109.167 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 121.358 0.599 . . . . 1.41 110.336 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.519 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 24.5 p90 -125.3 134.54 52.21 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.611 -0.722 . . . . 1.57 109.541 -172.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.79 -151.76 5.78 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.243 -0.889 . . . . 0.78 112.522 -174.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.586 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -142.01 160.06 40.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.1 0.476 . . . . 1.21 111.334 -171.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.73 ' HB3' ' HG3' ' A' ' 152' ' ' LYS . 2.6 m-20 -110.23 117.5 33.85 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.495 -0.775 . . . . 2.47 109.511 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.486 HD12 HD22 ' A' ' 153' ' ' LEU . 5.9 mt -106.58 90.64 5.17 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.187 -0.671 . . . . 0.38 109.187 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HA ' ' CB ' ' A' ' 152' ' ' LYS . 37.1 Cg_endo -67.22 116.08 4.0 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.015 1.143 . . . . 0.59 111.96 -175.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.844 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 62.1 mt -107.52 130.99 58.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.948 -0.569 . . . . 0.49 110.418 -174.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -122.64 5.95 9.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.228 -0.442 . . . . 3.32 110.474 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -132.5 172.21 12.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.504 -0.317 . . . . 2.16 110.215 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.57 ' HG2' HG22 ' A' ' 135' ' ' ILE . 9.5 mt-10 -114.67 176.42 5.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.895 0.379 . . . . 1.2 110.753 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.72 -166.14 21.32 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.76 -0.936 . . . . 0.3 110.76 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 24.7 mt-10 -103.0 107.17 17.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.52 0.66 . . . . 1.96 109.587 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.653 ' HB2' HG12 ' A' ' 133' ' ' ILE . 93.3 m-85 -94.33 124.69 38.51 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 119.803 -0.759 . . . . 0.71 109.074 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.642 HG21 ' CA ' ' A' ' 177' ' ' ALA . 96.9 t -113.49 107.67 23.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.669 -0.696 . . . . 0.26 110.764 -171.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 85' ' ' LEU . 4.9 mp -90.12 104.78 17.32 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.475 -1.239 . . . . 1.56 109.146 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.65 105.12 17.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.224 -1.028 . . . . 1.14 108.224 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.576 ' HG ' HD13 ' A' ' 170' ' ' LEU . 3.7 mp -100.81 132.24 46.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.814 -0.81 . . . . 1.44 108.814 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.796 ' HD2' ' HB3' ' A' ' 128' ' ' ASP . 23.5 tptt -96.63 114.73 26.41 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.683 -0.858 . . . . 3.73 108.683 173.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -104.56 137.12 42.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.82 -0.627 . . . . 0.45 109.373 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.31 -1.119 0 CA-C-N 115.544 -0.753 . . . . 0.51 111.262 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.2 m . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.292 0.567 . . . . 1.22 110.261 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.615 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 18.4 m-85 -88.68 150.74 22.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.56 -0.745 . . . . 0.99 110.864 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 23.5 m-20 -104.51 134.74 47.19 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.165 -1.05 . . . . 1.53 108.165 169.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.404 HG21 HD12 ' A' ' 115' ' ' LEU . 4.8 t -134.89 115.52 19.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.088 0.471 . . . . 0.63 110.638 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.581 ' HB3' HG23 ' A' ' 110' ' ' THR . 23.2 ptt180 -124.42 126.41 45.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.664 -0.698 . . . . 1.95 111.889 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.681 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 32.1 m -102.86 131.72 50.54 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 108.982 -0.748 . . . . 1.44 108.982 173.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.577 HD22 ' HG ' ' A' ' 153' ' ' LEU . 1.6 p30 48.44 44.43 20.41 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.862 0.465 . . . . 1.65 111.553 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.24 -1.79 63.62 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.917 -0.583 . . . . 0.42 112.676 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.681 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 52.5 m-70 -101.73 103.18 13.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.274 0.629 . . . . 0.68 111.202 -173.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.581 HG23 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -69.23 98.61 1.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.377 0.608 . . . . 0.77 111.12 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.43 -52.0 15.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.631 -0.713 . . . . 0.94 109.71 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.56 HG11 ' HG ' ' A' ' 115' ' ' LEU . 3.8 t -117.68 94.33 3.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.714 -0.676 . . . . 0.35 109.811 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -111.86 73.26 0.81 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.566 0.698 . . . . 4.01 109.353 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.601 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 12.2 p-10 162.71 27.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.72 -1.582 . . . . 1.96 108.834 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -69.4 91.95 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.405 -0.816 . . . . 1.18 111.199 -172.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 24.0 p-10 -101.9 96.96 7.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.767 0.794 . . . . 1.93 109.275 171.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.7 mt -53.78 -35.76 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.979 -1.01 . . . . 0.82 111.954 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 84.7 t80 -56.12 -44.66 79.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 1.08 111.251 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.53 -35.71 68.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.34 -0.391 . . . . 0.96 111.525 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 5.3 mmt180 -75.62 -42.48 51.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.239 -0.437 . . . . 1.69 111.776 -170.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 p -117.37 -28.05 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.538 -0.465 . . . . 1.49 111.875 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 124.21 -151.46 17.17 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.851 -0.899 . . . . 1.4 110.851 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -92.39 122.92 35.31 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.263 -0.575 . . . . 4.11 109.972 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.0 m 65.27 -142.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.779 . . . . 1.97 110.39 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 59.2 p 58.13 -174.22 0.09 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.711 0.804 . . . . 0.85 111.865 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.3 131.57 53.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.385 . . . . 0.57 111.816 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 18.2 t60 -107.09 142.82 36.15 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 108.651 -0.87 . . . . 0.55 108.651 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.796 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 5.4 p-10 -129.54 123.87 32.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.524 0.678 . . . . 1.64 110.779 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -104.57 110.91 23.39 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.922 -1.035 . . . . 1.12 109.148 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.76 111.52 25.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.865 -0.607 . . . . 0.74 110.208 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.9 mt -118.81 95.71 49.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.242 -0.435 . . . . 1.25 110.751 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.443 ' HB3' HG22 ' A' ' 84' ' ' VAL . 5.9 Cg_exo -81.23 128.85 6.51 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.068 2.512 . . . . 0.29 112.202 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.705 ' HB ' HD21 ' A' ' 140' ' ' LEU . 3.5 pt -110.5 162.1 8.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.756 -0.831 . . . . 0.27 108.756 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.5 t -127.48 106.57 9.28 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.488 -0.324 . . . . 1.24 110.164 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.779 HG12 ' HG ' ' A' ' 140' ' ' LEU . 21.8 mt -101.05 124.04 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.236 -0.654 . . . . 0.34 109.236 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -148.16 125.12 11.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.824 -0.626 . . . . 1.95 109.395 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.2 OUTLIER 63.9 28.91 14.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.664 -0.698 . . . . 3.13 111.558 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.04 14.33 80.79 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.958 -0.639 . . . . 0.41 112.374 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.569 ' HG2' HG22 ' A' ' 148' ' ' THR . 55.0 mtpt -116.66 147.8 41.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.61 -0.515 . . . . 2.23 109.61 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.779 ' HG ' HG12 ' A' ' 135' ' ' ILE . 3.1 tt -118.06 127.46 53.82 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.07 -0.345 . . . . 0.41 110.07 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 15.0 m -114.6 125.29 53.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.053 -0.521 . . . . 1.19 110.203 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.42 HG23 HD22 ' A' ' 140' ' ' LEU . 85.6 t -118.62 98.5 6.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.672 0.272 . . . . 0.92 110.715 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 56.7 26.56 11.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.823 -0.626 . . . . 1.88 112.145 173.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.86 -39.6 1.8 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.767 -0.651 . . . . 1.02 112.343 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 141' ' ' SER . 39.9 mt-10 -68.78 114.17 6.88 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.075 -0.342 . . . . 1.95 110.075 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.2 p -108.53 115.9 50.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.307 0.575 . . . . 0.92 110.747 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 m -135.85 176.51 8.61 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.869 -0.789 . . . . 1.27 108.869 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.569 HG22 ' HG2' ' A' ' 139' ' ' LYS . 37.1 p -91.23 138.51 31.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.912 -0.403 . . . . 1.45 109.912 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.844 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 92.5 t80 -79.92 129.47 34.51 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.846 -0.427 . . . . 0.47 109.846 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.6 t -121.07 96.05 4.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.649 0.738 . . . . 1.79 112.062 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.93 -66.76 2.11 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.34 -0.845 . . . . 0.42 114.23 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.73 ' HG3' ' HB3' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -148.58 160.26 43.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.291 0.567 . . . . 1.23 111.014 -173.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.577 ' HG ' HD22 ' A' ' 107' ' ' ASN . 5.7 tt -90.76 117.94 29.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.402 -0.962 . . . . 1.17 108.402 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.535 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 3.6 t -107.37 111.69 24.15 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.91 -0.716 . . . . 1.35 110.559 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 22.7 t -98.94 98.6 7.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.13 -0.486 . . . . 0.42 110.134 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.541 ' HB2' ' HE ' ' A' ' 105' ' ' ARG . 12.8 mm-40 -105.22 146.89 28.66 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.705 -0.48 . . . . 1.98 109.705 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.519 ' HE2' ' CE2' ' A' ' 71' ' ' PHE . 2.9 p90 -127.81 134.09 49.44 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.134 0.492 . . . . 2.32 110.348 171.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 14.2 t -115.47 144.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.272 -0.876 . . . . 0.62 110.868 -170.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.6 pttp . . . . . 0 N--CA 1.447 -0.575 0 CA-C-N 115.915 -0.584 . . . . 2.26 111.473 -179.033 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.728 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 46.1 t . . . . . 0 C--O 1.239 0.501 0 N-CA-C 109.895 -0.409 . . . . 1.19 109.895 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 17.8 t -136.44 83.34 2.0 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.125 -0.63 . . . . 1.36 112.432 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.749 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -76.61 37.34 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.645 1.178 . . . . 0.31 112.715 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.741 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 6.8 tp -58.1 110.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.351 0.596 . . . . 0.69 111.834 -173.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.631 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -114.51 134.16 55.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.835 -0.621 . . . . 0.48 109.423 174.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.569 ' CG2' ' HB3' ' A' ' 12' ' ' TRP . 3.7 tt -124.58 127.01 72.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-O 122.268 1.032 . . . . 0.3 111.897 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.545 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 10.7 ptm -114.08 171.53 7.55 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.385 -1.28 . . . . 0.99 109.31 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 19.2 ptmt -118.35 146.05 44.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.914 0.864 . . . . 1.22 112.665 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 176' ' ' THR . . . 103.04 -30.0 11.31 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 113.913 -1.494 . . . . 0.31 114.747 162.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.4 OUTLIER -173.9 153.05 2.07 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.01 0.905 . . . . 0.68 112.744 -176.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.642 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -86.96 -14.24 42.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.013 -0.994 . . . . 0.86 110.2 169.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.37 -0.832 . . . . 2.16 111.415 -173.572 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.898 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 27.2 tp . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 121.0 0.428 . . . . 0.72 110.928 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 25' ' ' HIS . . . -62.45 -22.99 66.64 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.723 -0.671 . . . . 0.53 111.544 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.33 -40.95 17.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.096 -0.502 . . . . 2.18 110.952 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 173' ' ' MET . 66.9 mmtt -97.12 -4.62 38.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.414 0.524 . . . . 1.79 112.414 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 11.8 p -60.99 134.87 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.141 -0.624 . . . . 0.33 110.422 171.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.508 HD13 ' HE2' ' A' ' 83' ' ' TYR . 42.4 pt -113.86 -22.77 4.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.235 -0.439 . . . . 0.92 110.447 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.765 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 75.0 t90 -164.42 147.5 9.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.36 110.327 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -159.53 141.31 13.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.221 -0.289 . . . . 0.26 110.221 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.925 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 24.8 t -144.22 115.97 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.703 0.763 . . . . 0.79 112.584 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 1.9 t-20 -88.24 88.03 7.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.369 -1.345 . . . . 1.49 107.369 164.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.606 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -60.87 103.07 0.23 Allowed 'General case' 0 C--O 1.25 1.089 0 CA-C-N 115.768 -0.651 . . . . 0.48 109.982 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.427 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 160.44 -48.0 0.39 Allowed Glycine 0 N--CA 1.44 -1.064 0 O-C-N 125.127 1.517 . . . . 0.76 113.083 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.09 -131.32 6.47 Favored Glycine 0 C--O 1.229 -0.199 0 C-N-CA 120.74 -0.743 . . . . 0.74 113.627 -173.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 47.0 mt-10 -150.31 119.87 6.97 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 119.218 -0.42 . . . . 1.77 110.625 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 72.1 m 33.18 108.29 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 115.484 1.661 . . . . 1.29 115.484 170.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.746 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 71.1 t60 -147.87 131.19 16.56 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.733 -0.604 . . . . 0.42 110.861 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 1.1 p -96.79 124.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.235 -0.654 . . . . 1.01 109.235 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.41 ' OD1' ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -77.77 163.82 25.78 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.737 -0.665 . . . . 0.77 109.66 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 m -55.24 -29.59 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 113.14 0.792 . . . . 0.62 113.14 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 32.8 m-70 -70.02 -18.31 63.3 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.346 -0.613 . . . . 0.86 109.346 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 101.71 31.66 5.38 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.104 -0.953 . . . . 0.33 111.235 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.643 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.9 mm -102.63 110.97 30.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 0.31 110.861 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 3.3 t60 -97.44 111.7 23.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.21 -0.45 . . . . 0.8 111.23 -172.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.925 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -76.85 131.15 38.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.94 -0.573 . . . . 1.75 110.577 175.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.685 ' HD3' ' HG3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -88.36 107.05 18.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.805 -0.634 . . . . 2.94 110.693 177.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 33.4 ttmt -18.62 126.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 125.034 1.459 . . . . 2.78 113.094 174.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 16' ' ' ALA . 2.5 m-20 -35.77 101.26 0.21 Allowed Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 123.197 1.475 . . . . 2.41 114.046 -169.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.685 ' HG3' ' HD3' ' A' ' 30' ' ' ARG . 40.2 Cg_endo . . . . . 0 N--CA 1.449 -1.12 0 C-N-CA 125.174 3.916 . . . . 1.87 115.071 -166.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.714 HG12 ' HE3' ' A' ' 88' ' ' LYS . 1.7 mp . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 122.287 1.041 . . . . 1.59 109.91 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HB2' HG22 ' A' ' 125' ' ' THR . 87.9 mt -76.42 -2.3 31.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.18 -1.373 . . . . 1.91 113.171 -171.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.892 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 14.1 mmm180 -109.36 18.3 20.58 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.085 -0.646 . . . . 3.17 111.009 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB2' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -128.54 170.35 13.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.366 -0.379 . . . . 0.97 110.162 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.482 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -93.04 139.46 23.11 Favored Pre-proline 0 C--O 1.216 -0.708 0 N-CA-C 109.01 -0.737 . . . . 1.92 109.01 178.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 40.0 Cg_exo -38.63 -42.29 1.79 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 124.071 3.181 . . . . 0.7 116.617 -163.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.509 ' HG3' ' H ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -76.05 -46.41 29.38 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.51 -0.744 . . . . 2.71 110.516 -177.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 3.5 p30 -79.75 -17.43 53.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.177 -0.465 . . . . 1.63 110.119 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -57.89 -43.7 86.24 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 108.944 -0.762 . . . . 1.58 108.944 167.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.41 -45.76 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.788 -0.449 . . . . 1.27 109.788 172.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.746 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 24.3 tp -63.06 -15.24 55.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.458 -0.792 . . . . 1.18 111.489 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.54 ' CD2' ' HG3' ' A' ' 88' ' ' LYS . 4.2 m-30 -114.31 0.81 14.26 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.23 -0.441 . . . . 0.99 111.403 -177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.539 ' HA ' HD13 ' A' ' 50' ' ' ILE . 49.8 tt0 -122.07 -43.27 2.34 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.792 0.664 . . . . 1.97 112.792 -169.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.5 m -59.97 131.13 49.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.117 -0.492 . . . . 1.27 111.413 -175.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.851 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.9 pm0 -116.98 158.94 23.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.581 0.585 . . . . 1.96 112.581 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 3.2 ptm180 . . . . . 0 C--O 1.234 0.243 0 CA-C-N 115.616 -0.72 . . . . 3.35 110.182 172.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 32.1 t . . . . . 0 C--O 1.236 0.355 0 CA-C-O 120.98 0.419 . . . . 1.41 110.747 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -103.59 121.91 43.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.165 -0.614 . . . . 1.57 109.973 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 155' ' ' VAL . . . -108.17 174.47 19.03 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 114.934 -1.03 . . . . 0.78 113.808 -170.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.504 ' HB3' ' CZ2' ' A' ' 12' ' ' TRP . 52.4 m-85 -132.19 141.89 49.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.124 -0.538 . . . . 1.21 109.583 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 4.7 p-10 -106.0 114.42 28.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.192 0.52 . . . . 2.47 111.211 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.857 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.9 mp -106.91 91.34 6.19 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.662 -0.699 . . . . 0.38 109.347 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.701 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 32.1 Cg_exo -59.67 117.5 4.25 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 121.987 1.792 . . . . 0.59 111.892 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.795 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 60.6 mt -120.57 138.09 52.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.828 0.347 . . . . 0.49 111.02 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -136.82 7.3 2.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.132 -0.485 . . . . 3.32 110.709 173.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.447 ' HB2' ' HE3' ' A' ' 174' ' ' LYS . 6.6 mm-40 -121.87 -177.31 3.54 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.076 -0.342 . . . . 2.16 110.076 -173.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 5.0 mt-10 -128.05 -179.22 4.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.277 -0.419 . . . . 1.2 110.525 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.55 -172.65 15.44 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.637 -0.985 . . . . 0.3 110.637 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.25 108.78 20.2 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.099 -0.64 . . . . 1.96 109.463 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.706 ' HB2' HG12 ' A' ' 133' ' ' ILE . 61.8 m-85 -92.58 125.52 37.25 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.482 -0.933 . . . . 0.71 108.482 -177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.592 HG21 ' CA ' ' A' ' 177' ' ' ALA . 72.4 t -114.74 105.75 19.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.314 -0.857 . . . . 0.26 110.257 -173.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 170' ' ' LEU . 5.4 mp -89.21 104.4 16.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.495 -1.23 . . . . 1.56 108.82 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG23 HG12 ' A' ' 84' ' ' VAL . 80.4 t -103.47 102.17 13.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.068 -1.086 . . . . 1.14 108.068 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.703 ' CD2' ' HB3' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -103.95 132.98 49.67 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.033 -0.667 . . . . 1.44 110.216 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.714 ' HE3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -87.92 121.64 30.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.388 -0.968 . . . . 3.73 108.388 173.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 6.2 m-85 -107.05 141.25 38.57 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.119 0.485 . . . . 0.45 111.451 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.906 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . . . . . . 0 C--N 1.317 -0.832 0 CA-C-N 115.159 -0.928 . . . . 0.51 109.097 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.649 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 16.8 m . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 121.593 0.711 . . . . 1.22 110.611 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 73.2 m-85 -104.48 158.7 16.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.042 -0.981 . . . . 0.99 110.922 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.676 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 16.2 m-20 -108.88 137.64 46.49 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.718 -0.475 . . . . 1.53 109.718 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 110' ' ' THR . 0.3 OUTLIER -140.01 125.1 20.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.335 0.588 . . . . 0.63 110.945 -177.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.782 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 41.5 mtt180 -108.13 138.34 44.57 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.18 -0.918 . . . . 1.95 111.172 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.831 HG13 HD21 ' A' ' 153' ' ' LEU . 74.2 t -113.35 103.03 14.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.281 -0.637 . . . . 1.44 109.281 170.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.48 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.2 OUTLIER 64.18 39.26 7.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.202 -0.908 . . . . 1.65 108.949 -175.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.8 -22.37 34.19 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.3 -0.864 . . . . 0.42 112.452 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 83.6 m-70 -83.64 101.15 11.3 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.556 0.342 . . . . 0.68 111.857 -173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.686 HG23 ' HG2' ' A' ' 105' ' ' ARG . 3.3 p -62.88 93.05 0.05 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.331 0.586 . . . . 0.77 111.245 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.532 HG11 HG23 ' A' ' 131' ' ' ILE . 11.9 t -73.05 -47.59 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.559 -0.746 . . . . 0.94 109.742 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.702 HG11 ' HG ' ' A' ' 115' ' ' LEU . 11.7 t -117.62 90.19 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 109.245 -0.65 . . . . 0.35 109.245 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.36 71.67 0.76 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.901 0.858 . . . . 4.01 108.935 178.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.649 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.5 p30 164.18 24.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.686 -1.597 . . . . 1.96 108.601 -169.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.702 ' HG ' HG11 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -71.34 90.89 0.96 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.427 -0.806 . . . . 1.18 111.563 -170.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 14.0 p30 -104.88 94.57 5.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.676 0.75 . . . . 1.93 110.067 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 89' ' ' PHE . 83.2 mt -61.7 -37.11 77.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.125 -0.943 . . . . 0.82 111.653 -170.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -59.4 -38.56 80.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.08 110.873 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.73 -32.1 67.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.929 0.395 . . . . 0.96 110.969 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 12.0 mmt85 -76.36 -49.24 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.899 -0.591 . . . . 1.69 111.765 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 127' ' ' HIS . 60.0 t -107.52 -36.09 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.104 0.409 . . . . 1.49 112.104 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.08 -111.55 2.11 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.401 -0.904 . . . . 1.4 111.867 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -112.02 112.55 24.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.979 0.418 . . . . 4.11 111.198 -176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 125' ' ' THR . 33.0 p 53.03 -149.81 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.394 1.078 . . . . 1.97 112.277 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.892 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 29.1 p 64.85 -160.42 0.28 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.996 0.918 . . . . 0.85 110.932 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 50' ' ' ILE . . . -94.88 122.27 37.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.469 0.544 . . . . 0.57 112.469 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.673 ' HA ' HG21 ' A' ' 121' ' ' VAL . 13.6 t60 -92.44 130.65 38.05 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.466 -0.568 . . . . 0.55 109.466 167.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.81 121.67 42.21 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.16 -0.927 . . . . 1.64 109.572 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.703 ' HB3' ' CD2' ' A' ' 87' ' ' LEU . 4.5 tp10 -123.92 108.29 12.27 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.409 -0.96 . . . . 1.12 108.409 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.458 HG12 HG22 ' A' ' 86' ' ' VAL . 80.1 mt -94.1 118.21 39.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.889 -0.596 . . . . 0.74 110.166 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.532 HG23 HG11 ' A' ' 111' ' ' VAL . 68.2 mt -117.94 93.67 44.75 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.534 -0.303 . . . . 1.25 110.864 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.89 124.39 3.43 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.877 2.385 . . . . 0.29 112.797 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.706 HG12 ' HB2' ' A' ' 83' ' ' TYR . 3.5 pt -109.51 166.29 4.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.575 -1.269 . . . . 0.27 107.575 173.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.6 t -131.78 106.62 8.23 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.904 -0.406 . . . . 1.24 109.904 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 49.7 mt -99.27 122.99 51.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.291 -0.633 . . . . 0.34 109.291 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -150.78 136.62 18.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.86 -0.793 . . . . 1.95 108.86 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm 66.95 17.95 10.56 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.196 0.522 . . . . 3.13 110.544 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.15 12.08 77.18 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.815 -0.629 . . . . 0.41 112.383 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 94.5 mttt -112.72 140.15 47.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.97 0.385 . . . . 2.23 110.601 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.459 ' HG ' HD12 ' A' ' 133' ' ' ILE . 6.9 tt -103.27 115.67 31.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.518 -0.549 . . . . 0.41 109.518 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.0 m -110.87 107.15 16.53 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.599 -0.519 . . . . 1.19 109.599 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.436 HG21 HG22 ' A' ' 111' ' ' VAL . 4.0 p -90.72 106.99 18.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.369 -0.604 . . . . 0.92 109.369 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 63.69 -81.07 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.555 -0.748 . . . . 1.88 110.841 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.76 -0.56 3.55 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.851 -0.69 . . . . 1.02 112.046 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -95.66 113.96 25.65 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.522 -0.547 . . . . 1.95 109.522 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.31 132.47 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.13 0.49 . . . . 0.92 111.8 -171.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t -160.3 133.65 6.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.673 -0.694 . . . . 1.27 109.181 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.713 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 9.1 t -55.38 139.41 43.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.286 0.565 . . . . 1.45 111.081 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.795 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 25.9 t80 -80.0 133.87 36.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.34 -0.845 . . . . 0.47 110.536 -175.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 p -127.61 96.46 4.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.091 0.472 . . . . 1.79 112.229 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.17 -69.52 3.15 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.42 113.96 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.701 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -159.23 164.02 35.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.176 0.488 . . . . 1.23 110.552 -176.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.857 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 6.1 tt -81.81 142.84 32.22 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.131 -1.063 . . . . 1.17 108.131 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.585 ' N ' HD23 ' A' ' 153' ' ' LEU . 9.9 t -135.83 107.6 7.04 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.313 -0.555 . . . . 1.35 110.648 -172.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 59.4 t -97.08 99.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.389 -0.369 . . . . 0.42 111.141 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.16 123.76 42.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.725 -0.39 . . . . 1.98 110.457 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.454 ' HD2' HG23 ' A' ' 104' ' ' VAL . 49.0 t80 -102.65 118.03 35.95 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.461 -0.94 . . . . 2.32 108.461 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 21.9 t -103.67 144.25 14.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.558 -0.746 . . . . 0.62 110.422 -173.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.3 pttt . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 121.147 0.499 . . . . 2.26 112.205 -174.208 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.906 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 39.6 t . . . . . 0 C--O 1.241 0.616 0 CA-C-O 120.426 0.155 . . . . 1.19 111.066 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.7 t -132.15 141.16 49.02 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 120.228 -0.589 . . . . 1.36 110.974 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.693 ' HB3' ' CB ' ' A' ' 88' ' ' LYS . . . -131.35 35.06 3.91 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.428 -0.805 . . . . 0.31 109.311 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.765 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 14.4 tp -58.29 102.65 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.635 -1.166 . . . . 0.69 112.427 -175.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.898 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -111.21 132.63 54.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.698 -0.683 . . . . 0.48 109.659 176.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.713 HG22 ' HE3' ' A' ' 12' ' ' TRP . 5.3 tt -117.9 123.6 71.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.885 0.85 . . . . 0.3 111.577 176.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.68 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 2.5 ppp? -115.52 163.36 15.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.295 -1.002 . . . . 0.99 108.295 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 79' ' ' GLU . 11.6 ptmm? -119.3 147.91 43.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 122.629 1.204 . . . . 1.22 113.362 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 176' ' ' THR . . . 106.18 -29.64 10.83 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 112.863 -1.971 . . . . 0.31 114.84 167.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.6 OUTLIER -175.38 154.93 1.76 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.525 1.163 . . . . 0.68 112.478 -177.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.592 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -84.39 -17.85 38.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.886 -0.597 . . . . 0.86 110.465 169.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.766 -0.652 . . . . 2.16 111.302 -177.947 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 27' ' ' ILE . 24.7 tp . . . . . 0 C--O 1.235 0.318 0 CA-C-O 121.311 0.576 . . . . 0.72 110.589 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.528 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -60.92 -22.91 64.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.4 -0.818 . . . . 0.53 112.215 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.18 -21.6 59.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.536 -0.302 . . . . 2.18 110.63 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 59.8 mmtt -114.14 -16.59 12.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.649 -0.42 . . . . 1.79 111.799 -177.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.569 ' HB ' HD12 ' A' ' 27' ' ' ILE . 14.8 p -56.57 136.1 19.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.48 0.657 . . . . 0.33 111.729 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 174' ' ' LYS . 5.4 pt -115.27 -28.45 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.614 -0.721 . . . . 0.92 110.64 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.702 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 67.1 t90 -169.17 140.29 2.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.232 -0.44 . . . . 0.36 110.177 -170.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -162.42 147.21 12.27 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.317 -0.24 . . . . 0.26 111.224 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.69 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 2.2 p -151.16 125.6 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 113.197 0.814 . . . . 0.79 113.197 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.469 ' CB ' HD12 ' A' ' 60' ' ' LEU . 1.7 t-20 -94.05 95.79 9.25 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 114.956 -1.02 . . . . 1.49 108.65 170.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.687 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -58.54 103.21 0.14 Allowed 'General case' 0 C--O 1.246 0.907 0 CA-C-N 116.116 -0.493 . . . . 0.48 109.723 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.809 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 174.2 -42.26 0.14 Allowed Glycine 0 N--CA 1.438 -1.191 0 O-C-N 124.882 1.364 . . . . 0.76 113.98 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.24 -121.09 1.79 Allowed Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.001 -1.095 . . . . 0.74 113.072 -167.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . 46.1 mt-10 -148.59 119.52 7.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.847 0.323 . . . . 1.77 111.237 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 55.7 m 32.83 105.19 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.0 1.482 . . . . 1.29 115.0 170.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.739 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 71.9 t60 -133.68 122.49 23.48 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.686 -0.634 . . . . 0.42 111.244 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.38 116.1 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.815 -0.63 . . . . 1.01 109.712 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -83.57 162.75 20.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.002 -0.544 . . . . 0.77 110.715 -177.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.74 -24.95 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 113.001 0.741 . . . . 0.62 113.001 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.451 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 78.2 m-70 -80.52 1.17 30.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.426 -0.583 . . . . 0.86 109.426 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 82.84 28.5 37.95 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.061 -0.972 . . . . 0.33 111.508 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.646 HD11 ' HG ' ' A' ' 6' ' ' LEU . 11.8 mm -102.47 111.59 32.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.139 0.495 . . . . 0.31 111.015 -175.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -88.1 113.86 24.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.84 -0.618 . . . . 0.8 111.427 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.69 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -80.46 129.37 34.47 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.148 -0.478 . . . . 1.75 109.849 170.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.747 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 2.1 ptm180 -85.96 114.69 23.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 2.94 110.391 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 19' ' ' GLU . 37.0 ttmt -27.22 126.7 0.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.185 0.994 . . . . 2.78 112.032 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.683 ' OD2' ' HD3' ' A' ' 65' ' ' ARG . 1.4 m-20 -32.64 98.72 0.13 Allowed Pre-proline 0 N--CA 1.465 0.283 0 O-C-N 125.115 1.51 . . . . 2.41 114.342 -168.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.747 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 69.6 Cg_endo . . . . . 0 N--CA 1.446 -1.268 1 C-N-CA 125.454 4.103 . . . . 1.87 114.152 -169.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.695 HG12 ' HE3' ' A' ' 88' ' ' LYS . 1.7 mp . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.999 0.904 . . . . 1.59 109.947 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HB2' HG22 ' A' ' 125' ' ' THR . 85.7 mt -65.12 -18.2 65.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.336 -1.302 . . . . 1.91 112.977 -172.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -96.35 4.2 52.41 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.726 -0.39 . . . . 3.17 111.181 -173.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.516 ' HB2' HG22 ' A' ' 50' ' ' ILE . 3.2 m -125.28 145.25 50.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.903 -0.59 . . . . 0.97 111.156 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.465 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 2.1 p-10 -79.85 151.99 74.2 Favored Pre-proline 0 C--O 1.214 -0.776 0 N-CA-C 109.609 -0.515 . . . . 1.92 109.609 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 54' ' ' ASN . 3.5 Cg_exo -38.76 -46.67 2.66 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 124.307 3.338 . . . . 0.7 115.419 -164.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -69.94 -53.54 17.37 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 122.064 0.935 . . . . 2.71 110.483 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -22.21 55.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.437 -0.801 . . . . 1.63 109.711 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 5.7 tt0 -55.78 -45.15 78.22 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.688 -0.687 . . . . 1.58 109.651 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.3 t -57.29 -46.08 85.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.784 -0.45 . . . . 1.27 109.784 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.739 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 30.6 tp -60.14 -19.4 53.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.454 0.645 . . . . 1.18 111.138 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.507 ' HE1' HD23 ' A' ' 60' ' ' LEU . 2.9 m-30 -115.83 6.68 14.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.938 -0.573 . . . . 0.99 111.189 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.643 ' HA ' HD13 ' A' ' 50' ' ' ILE . 35.4 tt0 -122.02 -35.63 3.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.106 0.479 . . . . 1.97 111.821 -172.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 167' ' ' VAL . 1.0 OUTLIER -70.35 136.86 50.08 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.721 -0.672 . . . . 1.27 110.911 -176.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.809 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -120.76 149.46 42.5 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.089 0.556 . . . . 1.96 109.864 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.683 ' HD3' ' OD2' ' A' ' 32' ' ' ASP . 13.7 ttp-105 . . . . . 0 C--O 1.237 0.447 0 N-CA-C 112.524 0.564 . . . . 3.35 112.524 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.946 0.403 . . . . 1.41 111.107 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.486 ' HD2' HH22 ' A' ' 65' ' ' ARG . 0.1 OUTLIER -138.99 137.42 36.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 1.57 110.756 -175.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.762 ' HA3' ' HB3' ' A' ' 156' ' ' GLU . . . -151.43 -176.27 24.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.172 -1.013 . . . . 0.78 113.656 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.687 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 48.6 m-85 -128.62 169.41 14.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.014 -0.593 . . . . 1.21 111.777 -170.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -115.31 119.75 37.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.247 -0.888 . . . . 2.47 110.594 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.812 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.1 mp -107.34 90.31 5.66 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.977 -0.749 . . . . 0.38 108.977 171.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.62 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 43.6 Cg_endo -71.76 116.94 4.9 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.83 1.687 . . . . 0.59 111.631 -176.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.821 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 82.7 mt -116.4 141.45 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.853 -0.612 . . . . 0.49 110.872 -171.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 71.5 mmtt -139.31 20.95 2.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.746 0.308 . . . . 3.32 110.922 174.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.66 -175.93 4.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.227 0.537 . . . . 2.16 110.769 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 3.3 mt-10 -121.43 -172.62 2.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.266 -0.879 . . . . 1.2 109.771 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.56 -164.57 13.97 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.076 -0.81 . . . . 0.3 111.076 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 36.5 mt-10 -106.19 104.43 14.13 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.186 -0.606 . . . . 1.96 109.643 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.664 ' HB2' HG12 ' A' ' 133' ' ' ILE . 20.7 m-30 -94.06 122.73 36.88 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.411 -0.959 . . . . 0.71 108.411 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.674 HG21 ' CA ' ' A' ' 177' ' ' ALA . 88.0 t -107.18 106.5 20.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.866 0.841 . . . . 0.26 110.45 -172.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 170' ' ' LEU . 12.7 tp -89.66 103.94 16.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.362 -1.29 . . . . 1.56 109.88 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 43.7 t -108.24 111.37 35.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.357 -0.979 . . . . 1.14 108.357 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -114.23 134.96 54.57 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.093 -0.643 . . . . 1.44 110.423 178.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.816 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -93.57 122.91 36.5 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.073 -0.651 . . . . 3.73 109.903 177.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.656 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 8.8 m-85 -108.42 140.48 41.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.138 -0.483 . . . . 0.45 111.34 175.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.816 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 115.695 -0.684 . . . . 0.51 110.213 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 1.021 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 25.7 m . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.078 0.466 . . . . 1.22 111.011 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -128.06 164.41 22.47 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.993 -0.549 . . . . 0.99 112.017 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.733 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 1.8 m-20 -107.35 137.79 44.74 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.572 -0.529 . . . . 1.53 109.572 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.789 HG23 ' HD1' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -132.12 124.26 52.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 109.183 -0.673 . . . . 0.63 109.183 178.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.438 ' HE ' ' CG ' ' A' ' 156' ' ' GLU . 37.6 ptt180 -136.11 139.91 43.31 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.839 0.681 . . . . 1.95 112.839 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.909 ' HB ' HD11 ' A' ' 153' ' ' LEU . 16.1 m -109.47 114.28 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.093 -0.958 . . . . 1.44 111.195 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.704 ' HB2' HD12 ' A' ' 153' ' ' LEU . 65.7 t30 55.91 36.54 27.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.266 1.031 . . . . 1.65 108.875 -174.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.21 -17.63 58.93 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.393 -1.276 . . . . 0.42 112.803 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.503 ' ND1' ' HB3' ' A' ' 145' ' ' GLU . 90.4 m-70 -85.73 101.77 13.06 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.255 0.465 . . . . 0.68 112.255 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 20.1 p -63.44 113.15 3.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.192 0.52 . . . . 0.77 110.784 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 131' ' ' ILE . 17.5 t -91.92 -41.11 12.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.662 -0.699 . . . . 0.94 109.234 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.647 HG21 ' HG2' ' A' ' 129' ' ' GLU . 4.8 t -130.36 91.5 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.65 -0.704 . . . . 0.35 109.966 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -100.81 146.37 27.37 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.769 -1.197 . . . . 4.01 107.769 169.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 1.021 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 68.9 m-20 77.36 38.42 0.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.564 1.165 . . . . 1.96 108.823 -167.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.501 HD11 ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -69.58 86.69 0.46 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.032 -0.985 . . . . 1.18 110.031 175.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 11.6 t70 -102.23 106.02 16.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.522 -0.918 . . . . 1.93 108.522 172.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.97 -33.45 58.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.82 111.636 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -68.64 -37.98 80.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.992 0.425 . . . . 1.08 110.086 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.56 -28.66 67.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.068 0.461 . . . . 0.96 111.182 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 14.7 mmt180 -81.32 -45.52 16.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.359 0.503 . . . . 1.69 112.359 -173.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.655 HG11 ' HA ' ' A' ' 127' ' ' HIS . 15.6 m -128.34 0.34 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.207 0.817 . . . . 1.49 113.207 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.84 -97.54 1.86 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.136 -1.03 . . . . 1.4 112.648 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -113.17 108.78 17.76 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.558 -0.378 . . . . 4.11 111.553 -175.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.4 m 44.41 -122.4 0.88 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.412 1.07 . . . . 1.97 112.754 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 51' ' ' LEU . 70.0 p 51.12 -158.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.413 0.685 . . . . 0.85 111.124 -175.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.803 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . . . -99.12 110.08 22.7 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.484 -0.487 . . . . 0.57 111.63 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.655 ' HA ' HG11 ' A' ' 121' ' ' VAL . 12.9 t60 -83.35 126.18 32.44 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.106 -1.072 . . . . 0.55 108.106 167.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -123.56 108.19 12.36 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.486 0.66 . . . . 1.64 110.403 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.647 ' HG2' HG21 ' A' ' 112' ' ' VAL . 2.2 tp10 -102.03 108.95 20.54 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.962 -0.755 . . . . 1.12 108.962 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.409 HG23 HG22 ' A' ' 86' ' ' VAL . 64.9 mt -96.54 115.61 36.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.799 -0.637 . . . . 0.74 109.615 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.448 HG21 HG21 ' A' ' 111' ' ' VAL . 59.5 mt -122.43 93.16 48.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.251 -0.431 . . . . 1.25 110.777 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -74.46 123.01 7.84 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.662 2.241 . . . . 0.29 112.019 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.1 pt -109.86 146.57 15.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.61 -0.885 . . . . 0.27 108.61 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.3 p -115.9 106.98 14.42 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.899 0.381 . . . . 1.24 110.106 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.572 HG12 ' HG ' ' A' ' 140' ' ' LEU . 25.6 mt -98.74 120.69 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 107.761 -1.2 . . . . 0.34 107.761 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -144.33 122.63 12.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.118 0.485 . . . . 1.95 110.317 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 18.1 mmmt 57.24 35.24 25.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.79 -1.095 . . . . 3.13 111.5 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.37 7.15 69.96 Favored Glycine 0 C--O 1.227 -0.318 0 CA-C-N 115.597 -0.729 . . . . 0.41 113.18 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 99.6 mttt -109.22 145.6 35.58 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 122.649 -0.324 . . . . 2.23 110.168 174.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.663 HD12 ' HD1' ' A' ' 149' ' ' PHE . 5.9 tt -114.46 115.12 26.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.878 -0.786 . . . . 0.41 108.878 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.9 m -117.3 136.25 53.25 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.375 -0.375 . . . . 1.19 110.042 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.547 HG21 ' CG2' ' A' ' 106' ' ' VAL . 58.4 t -123.71 92.53 2.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.614 -0.513 . . . . 0.92 109.614 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 56.63 -87.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.105 -0.952 . . . . 1.88 111.632 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.49 -10.88 34.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 1.02 112.507 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.503 ' HB3' ' ND1' ' A' ' 109' ' ' HIS . 64.1 mm-40 -87.86 139.87 30.08 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.974 -0.38 . . . . 1.95 109.974 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.42 130.44 12.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.312 0.577 . . . . 0.92 111.728 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.6 m -159.9 166.86 29.34 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.631 -0.877 . . . . 1.27 108.631 174.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 66.6 p -74.71 147.04 41.78 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.125 -0.694 . . . . 1.45 109.125 173.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.821 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 65.3 t80 -79.07 128.2 32.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.801 0.334 . . . . 0.47 110.114 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 t -132.64 101.8 5.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.63 0.728 . . . . 1.79 111.515 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.96 -74.36 2.43 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.543 -0.753 . . . . 0.42 113.777 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -155.29 169.43 24.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.379 0.609 . . . . 1.23 111.13 -174.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.909 HD11 ' HB ' ' A' ' 106' ' ' VAL . 44.2 tp -90.83 127.52 36.39 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.092 -0.958 . . . . 1.17 109.23 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.732 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 97.0 p -97.01 142.51 28.88 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 119.373 -0.931 . . . . 1.35 109.553 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 106' ' ' VAL . 97.0 t -130.59 97.34 3.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.803 -0.814 . . . . 0.42 108.803 170.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.762 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 1.4 pm0 -126.78 141.85 51.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.188 -0.605 . . . . 1.98 111.279 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.789 ' HD1' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -102.65 122.24 44.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.235 -0.893 . . . . 2.32 108.789 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 26.1 t -84.13 127.65 39.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.35 -0.386 . . . . 0.62 110.282 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.331 -0.234 0 O-C-N 124.74 1.275 . . . . 2.26 111.723 -178.657 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.763 HG22 ' HB3' ' A' ' 64' ' ' GLU . 86.9 t . . . . . 0 CA--C 1.506 -0.747 0 N-CA-C 109.851 -0.426 . . . . 1.19 109.851 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -130.98 133.29 45.66 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 119.695 -0.802 . . . . 1.36 110.745 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -129.62 37.89 3.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.965 -0.561 . . . . 0.31 110.828 -175.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 85' ' ' LEU . 10.8 tp -41.92 126.96 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.615 -1.175 . . . . 0.69 112.018 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.69 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 7.5 t80 -144.84 119.22 9.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.79 -0.186 . . . . 0.48 110.577 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.63 HG22 ' HE3' ' A' ' 12' ' ' TRP . 9.3 tt -115.18 123.56 70.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.981 0.896 . . . . 0.3 110.699 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.69 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.0 ppp? -117.54 159.35 23.01 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.218 -0.901 . . . . 0.99 109.613 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 1.9 ptmm? -113.85 142.26 46.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 122.712 1.244 . . . . 1.22 114.218 -168.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.67 -30.25 10.09 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 112.708 -2.042 . . . . 0.31 114.264 162.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -176.99 158.16 1.52 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.002 0.901 . . . . 0.68 112.265 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.674 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -82.96 -9.93 59.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.965 -0.562 . . . . 0.86 110.375 172.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.515 ' H ' ' HB ' ' A' ' 176' ' ' THR . 5.0 m-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.694 -0.685 . . . . 2.16 111.357 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.141 0 CA-C-O 121.07 0.261 . . . . 1.48 112.916 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.583 ' HG ' HD11 ' A' ' 27' ' ' ILE . 25.8 tp -71.19 -29.37 65.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.241 0.543 . . . . 0.72 109.879 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -63.25 -23.02 67.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.204 -0.907 . . . . 0.53 111.686 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.595 ' HB3' ' HE3' ' A' ' 9' ' ' LYS . 22.6 t70 -83.0 -35.27 25.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.91 -0.587 . . . . 2.18 111.404 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.595 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 10.6 mmtp -94.26 -19.33 20.8 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.893 -0.323 . . . . 1.79 111.593 -171.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.523 ' HB ' HD12 ' A' ' 27' ' ' ILE . 7.2 p -56.01 134.78 19.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.018 0.437 . . . . 0.33 111.424 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 pt -110.88 -22.56 4.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.209 -0.45 . . . . 0.92 110.581 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.578 ' HE3' HG22 ' A' ' 172' ' ' ILE . 77.1 t90 -170.54 146.07 2.69 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.696 -0.483 . . . . 0.36 109.696 -173.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' HD3' ' A' ' 30' ' ' ARG . . . -163.01 138.28 6.71 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 122.32 -0.238 . . . . 0.26 111.003 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.775 HG22 ' HB2' ' A' ' 30' ' ' ARG . 84.4 t -146.84 121.78 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 122.574 0.35 . . . . 0.79 111.568 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 46.5 t30 -102.61 99.58 9.59 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.703 -0.48 . . . . 1.49 109.703 167.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -65.07 105.44 1.06 Allowed 'General case' 0 C--O 1.243 0.747 0 N-CA-C 109.414 -0.587 . . . . 0.48 109.414 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.567 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 158.24 -47.1 0.45 Allowed Glycine 0 N--CA 1.447 -0.601 0 O-C-N 124.248 0.968 . . . . 0.76 113.337 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -103.07 -132.77 7.76 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.853 -0.689 . . . . 0.74 112.727 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.444 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 16.9 mt-10 -156.87 120.27 4.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 119.679 -0.2 . . . . 1.77 111.237 174.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 4.0 p 35.31 90.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.644 1.215 . . . . 1.29 113.499 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.692 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 79.6 t60 -131.16 133.75 45.86 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.574 -0.851 . . . . 0.42 111.687 -174.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.9 t -95.17 116.22 36.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.724 -0.671 . . . . 1.01 110.038 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 0.8 OUTLIER -71.82 155.99 39.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.991 -0.55 . . . . 0.77 109.768 176.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.45 -13.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 113.422 0.897 . . . . 0.62 113.422 -172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -93.57 -0.66 56.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.421 0.629 . . . . 0.86 109.357 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.577 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 93.71 31.13 8.43 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 114.826 -1.079 . . . . 0.33 112.811 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.583 HD11 ' HG ' ' A' ' 6' ' ' LEU . 21.6 mm -103.93 109.3 26.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.14 0.495 . . . . 0.31 110.907 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -92.11 114.03 26.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.8 111.431 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.601 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -78.45 131.18 36.79 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.995 -0.548 . . . . 1.75 110.881 176.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.775 ' HB2' HG22 ' A' ' 14' ' ' VAL . 8.2 mpt_? -69.9 102.5 1.99 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 125.018 1.449 . . . . 2.94 111.565 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.646 ' HG2' ' HA3' ' A' ' 39' ' ' GLY . 14.7 ttmm -38.96 96.33 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.953 1.094 . . . . 2.78 113.953 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.956 ' HB2' ' HA2' ' A' ' 39' ' ' GLY . 75.0 m-20 30.22 78.25 0.29 Allowed Pre-proline 0 N--CA 1.476 0.859 0 C-N-CA 124.6 1.16 . . . . 2.41 113.297 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 16.4 Cg_endo -97.42 2.81 1.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.985 2.456 . . . . 1.87 114.347 -170.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.537 HD13 ' CD1' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -119.01 -24.41 6.55 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.208 1.188 . . . . 1.99 114.208 -173.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.94 86.47 4.66 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.681 0.673 . . . . 5.31 109.928 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' C ' ' HG2' ' A' ' 37' ' ' ARG . . . 73.85 -0.59 50.65 Favored Glycine 0 C--N 1.332 0.319 0 N-CA-C 109.972 -1.251 . . . . 2.64 109.972 -172.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.405 ' HG2' ' C ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 50.95 39.62 23.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 113.859 -1.171 . . . . 5.64 110.803 -171.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 m -122.51 137.05 57.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.938 -0.574 . . . . 3.96 110.394 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.956 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -99.89 135.4 12.12 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.929 -0.653 . . . . 2.56 113.373 -173.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.9 ' HE ' ' HA ' ' A' ' 40' ' ' ARG . 1.3 mmp_? -149.56 95.42 2.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.01 -0.367 . . . . 6.2 110.01 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.71 107.53 0.4 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.6 -0.727 . . . . 2.0 111.236 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.0 m -102.96 50.1 0.82 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.264 -0.88 . . . . 2.52 109.559 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.531 ' HA ' HG22 ' A' ' 63' ' ' THR . 0.3 OUTLIER -56.72 -74.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.359 -0.837 . . . . 2.52 110.923 178.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.6 t80 68.85 -63.2 0.37 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.288 0.635 . . . . 7.02 112.16 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -102.79 60.48 0.51 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.078 -0.582 . . . . 3.06 112.499 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.455 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 58.8 mtp -71.88 -0.37 11.14 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.629 0.728 . . . . 2.35 110.704 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -88.05 5.41 41.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.189 -0.914 . . . . 4.25 110.474 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.64 HD13 HG11 ' A' ' 92' ' ' VAL . 93.1 mt -116.51 79.54 9.44 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.696 -0.684 . . . . 2.56 110.102 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -57.76 144.45 93.3 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.935 2.423 . . . . 1.69 112.694 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.56 HG23 ' HB2' ' A' ' 126' ' ' ALA . 1.0 OUTLIER -81.04 -5.05 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.803 0.811 . . . . 1.59 109.407 178.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.423 ' HB3' HG22 ' A' ' 125' ' ' THR . 57.7 tp 69.26 -52.99 0.59 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.282 -1.326 . . . . 1.91 112.594 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -68.64 -21.88 64.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.449 -0.341 . . . . 3.17 111.764 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.436 ' HB3' ' CA ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -113.67 146.49 39.72 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.993 0.738 . . . . 0.97 112.993 -170.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.612 HD21 ' HG2' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -69.16 146.04 96.66 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 114.485 -1.234 . . . . 1.92 109.312 175.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.554 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 52.9 Cg_exo -38.24 -43.56 1.81 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.162 3.241 . . . . 0.7 116.161 -165.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.612 ' HG2' HD21 ' A' ' 54' ' ' ASN . 10.7 pt-20 -78.56 -50.1 12.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.203 0.525 . . . . 2.71 111.039 -173.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -74.88 -19.86 59.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.165 0.507 . . . . 1.63 109.695 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.436 ' CA ' ' HB3' ' A' ' 53' ' ' SER . 27.8 tt0 -59.69 -43.29 94.11 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.725 -0.67 . . . . 1.58 109.948 168.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 55' ' ' PRO . 91.4 t -54.18 -43.8 61.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.593 -0.521 . . . . 1.27 109.593 173.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.692 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 26.5 tp -67.53 -14.03 62.58 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 115.148 -0.933 . . . . 1.18 111.653 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.7 ' CE2' ' HE3' ' A' ' 88' ' ' LYS . 12.0 m-30 -118.39 7.74 12.0 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 111.833 0.309 . . . . 0.99 111.833 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.466 ' HB2' HD13 ' A' ' 50' ' ' ILE . 4.5 tt0 -127.2 -43.01 1.66 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.75 0.648 . . . . 1.97 112.75 -172.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.558 ' O ' HG13 ' A' ' 167' ' ' VAL . 18.7 p -67.37 130.82 44.27 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.276 0.473 . . . . 1.27 112.276 -174.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.814 ' HB3' HG22 ' A' ' 167' ' ' VAL . 8.7 pt-20 -114.94 156.65 24.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.048 0.452 . . . . 1.96 111.59 -178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.62 ' HD2' ' CG ' ' A' ' 32' ' ' ASP . 37.8 mtp85 -106.22 -157.54 0.62 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.948 -0.569 . . . . 3.35 111.461 173.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.497 ' H ' ' HB3' ' A' ' 65' ' ' ARG . 5.4 m-85 -96.85 99.19 10.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 4.71 111.384 -169.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.662 HD21 ' HG3' ' A' ' 166' ' ' LYS . 72.5 m-20 -68.22 132.64 47.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.339 -0.391 . . . . 4.38 110.468 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -143.31 -59.93 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.996 -0.547 . . . . 3.7 110.858 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -151.74 -163.69 1.81 Allowed 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.484 -0.562 . . . . 2.2 109.484 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.3 t -63.68 107.7 1.23 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.701 0.286 . . . . 1.41 110.345 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.552 ' CE1' ' CE2' ' A' ' 157' ' ' PHE . 11.5 p90 -124.52 140.18 53.19 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.116 -0.698 . . . . 1.57 109.116 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.508 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -136.77 161.81 25.12 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.133 -1.032 . . . . 0.78 114.8 -167.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.537 ' CD1' HD13 ' A' ' 34' ' ' LEU . 60.1 m-85 -100.43 152.85 19.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.854 -0.673 . . . . 1.21 111.847 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.574 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 9.4 t0 -116.24 103.61 10.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.067 -0.97 . . . . 2.47 108.646 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.879 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.7 mp -103.87 89.87 2.6 Favored Pre-proline 0 N--CA 1.464 0.246 0 N-CA-C 110.121 -0.325 . . . . 0.38 110.121 178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.644 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 38.6 Cg_exo -57.59 117.53 4.25 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.194 1.929 . . . . 0.59 112.733 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.667 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 67.9 mt -117.12 136.29 54.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.937 -0.574 . . . . 0.49 110.237 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -130.45 10.16 5.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.405 -0.361 . . . . 3.32 110.988 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.584 ' HG2' ' H ' ' A' ' 80' ' ' GLU . 23.3 tt0 -139.09 -176.89 4.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.148 -0.316 . . . . 2.16 110.148 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.646 ' HG3' ' O ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -130.32 157.51 42.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.559 -0.534 . . . . 1.2 109.559 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.08 -162.85 28.84 Favored Glycine 0 C--O 1.234 0.154 0 N-CA-C 110.354 -1.098 . . . . 0.3 110.354 -174.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 27.7 mt-10 -99.68 102.66 14.21 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 118.281 1.04 . . . . 1.96 110.198 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.634 ' HB2' HG12 ' A' ' 133' ' ' ILE . 79.1 m-85 -94.68 124.27 38.62 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.243 -1.021 . . . . 0.71 108.243 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.812 HG21 ' HA ' ' A' ' 177' ' ' ALA . 52.9 t -104.8 105.68 19.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.64 0.734 . . . . 0.26 109.902 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.791 HD12 ' HB ' ' A' ' 172' ' ' ILE . 7.5 tp -89.48 101.41 14.09 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 114.348 -1.297 . . . . 1.56 108.548 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.57 104.61 17.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.778 0.799 . . . . 1.14 108.848 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.649 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.3 OUTLIER -104.55 134.53 47.57 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.405 -0.816 . . . . 1.44 109.959 -178.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.838 ' HD2' ' HB1' ' A' ' 126' ' ' ALA . 10.9 tppt? -96.05 120.08 35.69 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.941 -0.703 . . . . 3.73 109.4 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.833 ' CE1' ' HB3' ' A' ' 165' ' ' PRO . 13.8 m-85 -106.26 141.81 36.99 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.781 -0.645 . . . . 0.45 110.374 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -136.44 148.38 47.72 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.72 -0.673 . . . . 0.51 109.661 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.608 ' HB2' HD12 ' A' ' 117' ' ' ILE . 38.6 tt0 -148.37 115.98 6.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.856 0.36 . . . . 2.62 110.791 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.64 HG11 HD13 ' A' ' 48' ' ' LEU . 18.6 t -137.33 80.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.076 -0.511 . . . . 3.77 109.651 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.793 ' HB2' ' HE2' ' A' ' 166' ' ' LYS . 18.4 t80 -150.37 -69.52 0.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.794 -0.362 . . . . 5.68 111.507 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.403 ' HB3' ' HE3' ' A' ' 100' ' ' LYS . 43.8 t80 -116.41 111.27 19.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.797 0.332 . . . . 4.65 110.25 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.96 91.11 1.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.914 -0.584 . . . . 1.39 111.656 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -156.25 140.44 16.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.061 -0.518 . . . . 2.75 110.217 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.697 ' HB3' ' HB2' ' A' ' 119' ' ' ASP . 15.0 m -114.32 152.25 31.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.258 -0.428 . . . . 1.4 110.402 -177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 53.03 32.84 13.58 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.541 0.526 . . . . 2.38 112.258 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -138.08 -50.52 0.58 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.941 -0.762 . . . . 2.89 108.941 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 161' ' ' TYR . 7.0 mtpm? -79.38 75.36 5.97 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.691 -0.855 . . . . 2.79 108.691 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.56 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.3 m -106.6 110.2 30.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 122.134 0.969 . . . . 1.22 110.316 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.829 ' HB3' ' HD3' ' A' ' 165' ' ' PRO . 11.8 m-85 -87.74 164.12 16.14 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.173 -1.376 . . . . 0.99 111.682 -173.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.65 137.8 41.94 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.566 -0.902 . . . . 1.53 108.566 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.652 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 2.5 t -131.91 113.09 21.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.902 -0.59 . . . . 0.63 109.51 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.724 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 62.9 mtt180 -122.6 130.15 52.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.108 0.48 . . . . 1.95 111.471 -173.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.867 HG12 HD11 ' A' ' 153' ' ' LEU . 21.8 t -105.62 99.88 9.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.154 -0.93 . . . . 1.44 109.413 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.827 ' HB2' HD12 ' A' ' 153' ' ' LEU . 4.1 t-20 57.87 51.81 8.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.219 1.009 . . . . 1.65 109.022 -170.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.5 -20.18 19.64 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 114.544 -1.207 . . . . 0.42 113.163 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.551 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 95.4 m-70 -79.25 107.33 11.94 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.01 0.374 . . . . 0.68 112.01 -172.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.531 HG22 ' HG2' ' A' ' 105' ' ' ARG . 3.1 p -68.52 96.61 0.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.19 0.519 . . . . 0.77 111.198 178.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.816 HG11 HD12 ' A' ' 131' ' ' ILE . 22.3 t -85.32 -46.14 17.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.832 -0.622 . . . . 0.94 109.568 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.652 ' HB ' ' HB ' ' A' ' 104' ' ' VAL . 10.2 t -119.2 88.35 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.441 0.639 . . . . 0.35 109.645 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 51.9 tptt -103.85 76.5 1.38 Allowed 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.211 -1.033 . . . . 4.01 108.211 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 4.8 p-10 162.43 14.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.154 -1.384 . . . . 1.96 110.457 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -66.47 98.29 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.867 0.365 . . . . 1.18 111.37 -169.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -112.87 94.58 4.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.066 0.936 . . . . 1.93 109.641 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 91' ' ' GLU . 56.2 mt -61.03 -46.8 95.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.713 -1.13 . . . . 0.82 111.829 -170.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -53.64 -37.17 62.85 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.092 0.404 . . . . 1.08 112.092 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.697 ' HB2' ' HB3' ' A' ' 97' ' ' SER . 16.4 t70 -71.73 -39.54 70.02 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.719 -0.392 . . . . 0.96 110.806 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -74.2 -43.72 56.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.89 -0.595 . . . . 1.69 111.607 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 117' ' ' ILE . 29.7 m -92.71 -32.66 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 120.87 -0.332 . . . . 1.49 111.829 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 85.1 -69.89 3.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 1.4 111.789 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -114.92 169.47 9.06 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.032 -0.359 . . . . 4.11 110.032 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.6 m -59.92 97.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.245 0.545 . . . . 1.97 112.142 -173.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 36.8 p -144.75 -166.44 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.391 -0.822 . . . . 0.85 109.004 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 88' ' ' LYS . . . -100.58 118.21 36.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.765 0.317 . . . . 0.57 111.69 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.461 ' HB2' ' CG1' ' A' ' 121' ' ' VAL . 83.8 t60 -95.57 136.98 35.26 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.206 -0.664 . . . . 0.55 109.206 175.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.2 132.31 43.01 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.871 -0.732 . . . . 1.64 112.167 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.644 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 77.0 mm-40 -110.95 114.09 27.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.12 -0.945 . . . . 1.12 108.673 170.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.464 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 46.0 mt -96.34 109.8 23.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.084 -0.71 . . . . 0.74 109.084 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.816 HD12 HG11 ' A' ' 111' ' ' VAL . 31.2 mm -118.43 88.14 32.8 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.612 -0.267 . . . . 1.25 110.908 -171.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 130' ' ' ILE . 8.3 Cg_exo -74.57 127.47 11.02 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.593 2.196 . . . . 0.29 111.796 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.634 HG12 ' HB2' ' A' ' 83' ' ' TYR . 3.4 pt -110.13 144.73 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.857 -0.794 . . . . 0.27 108.857 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 p -116.34 107.67 15.12 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.205 0.526 . . . . 1.24 110.44 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.646 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 3.9 mt -98.68 131.71 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.194 -0.669 . . . . 0.34 109.194 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.445 ' HD3' ' HG3' ' A' ' 80' ' ' GLU . 71.6 mmtt -148.38 129.73 14.74 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 123.641 0.588 . . . . 1.95 109.896 174.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 60.61 24.95 14.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.828 -0.624 . . . . 3.13 111.526 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 90.05 8.43 66.89 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.557 -0.83 . . . . 0.41 112.857 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.668 ' HG3' HG22 ' A' ' 148' ' ' THR . 8.9 mptt -111.69 139.65 46.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.682 -0.488 . . . . 2.23 109.682 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.4 tt -115.08 115.73 27.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.981 -0.554 . . . . 0.41 109.738 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.1 m -109.07 115.04 29.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 1.19 110.837 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.81 104.92 17.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 O-C-N 122.282 -0.261 . . . . 0.92 110.337 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 64.17 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.816 0.697 . . . . 1.88 110.928 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.51 1.68 5.66 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.944 -0.646 . . . . 1.02 112.27 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -99.14 112.8 24.85 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.0 -0.37 . . . . 1.95 110.0 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 p -115.02 119.23 61.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.385 0.612 . . . . 0.92 111.482 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.8 m -145.94 156.16 43.33 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.928 -0.767 . . . . 1.27 108.928 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.668 HG22 ' HG3' ' A' ' 139' ' ' LYS . 41.6 p -63.17 140.58 58.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.835 0.35 . . . . 1.45 110.536 176.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.667 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 18.0 t80 -79.48 142.8 35.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.839 -0.618 . . . . 0.47 109.489 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 t -137.95 102.71 4.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.274 0.559 . . . . 1.79 111.798 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.65 -64.27 3.31 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.693 -0.685 . . . . 0.42 113.979 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.697 ' HE2' ' HB3' ' A' ' 154' ' ' SER . 0.0 OUTLIER -155.92 170.65 21.62 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 117.137 0.469 . . . . 1.23 110.723 -178.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.879 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 22.7 tp -81.21 131.19 35.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.047 -1.094 . . . . 1.17 108.047 174.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.815 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 1.9 p -123.51 102.35 7.83 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.6 -0.84 . . . . 1.35 111.85 -171.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 48.4 t -93.01 95.97 5.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.231 -0.588 . . . . 0.42 110.146 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.406 ' OE2' ' HB2' ' A' ' 154' ' ' SER . 3.3 mp0 -98.72 119.83 38.12 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.203 -0.666 . . . . 1.98 109.203 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.552 ' CE2' ' CE1' ' A' ' 71' ' ' PHE . 1.9 p90 -115.92 126.57 54.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.047 0.927 . . . . 2.32 110.535 175.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.45 144.59 16.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.791 -1.549 . . . . 0.62 110.87 -168.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.626 ' HA ' ' HB3' ' A' ' 164' ' ' ASN . 24.8 pttm -68.02 137.11 54.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.593 -0.73 . . . . 2.26 111.364 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -101.85 -93.61 2.21 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.534 -1.026 . . . . 1.45 110.534 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.638 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 76.9 t80 -89.86 87.11 6.83 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.719 -0.845 . . . . 4.24 108.719 172.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 159' ' ' LYS . 88.6 t80 65.05 -71.58 0.08 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 124.027 0.83 . . . . 4.98 111.296 -173.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.04 151.96 45.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.55 0.69 . . . . 2.64 110.873 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.888 ' HB2' ' HD2' ' A' ' 165' ' ' PRO . 10.0 p30 -110.14 -165.11 0.06 OUTLIER Pre-proline 0 C--N 1.31 -1.138 0 N-CA-C 105.932 -1.877 . . . . 2.06 105.932 161.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.888 ' HD2' ' HB2' ' A' ' 164' ' ' ASN . 23.5 Cg_exo -42.1 96.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 121.588 1.525 . . . . 3.16 112.455 169.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.793 ' HE2' ' HB2' ' A' ' 93' ' ' TYR . 32.0 tttp -64.59 -62.61 1.48 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.745 -1.116 . . . . 3.18 110.829 -170.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.814 HG22 ' HB3' ' A' ' 64' ' ' GLU . 61.7 t -96.92 132.63 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 108.353 -0.981 . . . . 1.19 108.353 170.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 38.8 t -134.46 88.12 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.812 -0.755 . . . . 1.36 112.133 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.803 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -80.0 36.49 0.34 Allowed 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 124.466 1.106 . . . . 0.31 112.658 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -35.92 120.48 0.61 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.412 0.685 . . . . 0.69 111.507 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.677 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 4.1 t80 -136.18 109.7 7.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.497 -0.32 . . . . 0.48 110.317 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.791 ' HB ' HD12 ' A' ' 85' ' ' LEU . 6.7 tt -104.17 121.46 55.83 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 121.899 0.857 . . . . 0.3 110.583 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.677 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.2 ppp? -119.07 152.53 36.31 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.435 -0.802 . . . . 0.99 109.705 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.537 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 72.6 tttt -97.87 139.4 33.78 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 114.895 1.443 . . . . 1.22 114.895 -169.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.87 -28.89 12.97 Favored Glycine 0 C--N 1.317 -0.473 0 CA-C-N 113.196 -1.82 . . . . 0.31 115.61 155.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -171.81 155.0 3.77 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.28 1.04 . . . . 0.68 113.439 -174.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.812 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -84.78 -21.2 30.06 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.19 -0.914 . . . . 0.86 110.973 173.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.113 0.482 . . . . 2.16 111.582 -175.608 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 112.41 -0.276 . . . . 1.48 112.41 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.628 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.3 tp -58.67 -46.83 86.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.062 0.458 . . . . 0.72 110.618 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -63.03 -23.79 67.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.628 -0.714 . . . . 0.53 111.811 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -83.9 -43.94 14.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.285 -0.416 . . . . 2.18 110.885 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.71 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 32.2 mmtp -87.24 -10.74 51.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.489 0.552 . . . . 1.79 112.489 -172.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.577 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 14.1 p -57.28 135.77 20.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.323 0.583 . . . . 0.33 111.111 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.2 pt -119.35 -28.18 2.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.909 -0.587 . . . . 0.92 110.829 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.613 ' CH2' ' HB3' ' A' ' 73' ' ' TYR . 59.5 t90 -166.4 119.97 1.08 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.038 -0.528 . . . . 0.36 109.908 -170.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -135.49 140.1 44.53 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.114 -0.328 . . . . 0.26 110.114 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.897 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 55.0 t -140.5 105.71 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 112.615 0.598 . . . . 0.79 112.615 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 14.0 t-20 -81.53 89.3 6.17 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.082 -1.081 . . . . 1.49 108.082 164.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -64.52 101.14 0.42 Allowed 'General case' 0 C--O 1.248 1.026 0 N-CA-C 109.268 -0.642 . . . . 0.48 109.268 176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 155.17 -44.08 0.56 Allowed Glycine 0 N--CA 1.441 -1.018 0 O-C-N 125.66 1.85 . . . . 0.76 110.865 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.411 ' C ' ' HE2' ' A' ' 29' ' ' TYR . . . -102.42 -150.63 23.01 Favored Glycine 0 C--O 1.225 -0.409 0 CA-C-N 115.193 -0.504 . . . . 0.74 112.958 -172.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 1.032 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 3.9 tm-20 -149.34 121.06 8.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.929 0.365 . . . . 1.77 111.248 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.761 ' HB2' ' HB2' ' A' ' 31' ' ' LYS . 5.9 t 34.61 86.96 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.846 1.341 . . . . 1.29 112.839 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.883 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 67.4 t60 -129.42 132.01 46.9 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 119.75 -0.78 . . . . 0.42 111.541 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.4 120.75 45.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.597 -0.729 . . . . 1.01 110.338 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.86 154.36 31.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.754 -0.657 . . . . 0.77 109.383 175.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.1 m -61.52 -10.22 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 113.871 1.063 . . . . 0.62 113.871 -171.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.549 ' HB2' HD23 ' A' ' 6' ' ' LEU . 66.7 m-70 -95.35 -0.82 52.28 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.213 -0.662 . . . . 0.86 109.213 175.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 95.05 30.4 8.34 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.128 -0.942 . . . . 0.33 112.923 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.628 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.9 mm -104.08 115.46 46.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.08 0.466 . . . . 0.31 111.037 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -102.43 122.11 43.65 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.008 0.373 . . . . 0.8 112.008 -171.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.897 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -86.4 139.47 30.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.222 -0.444 . . . . 1.75 111.164 175.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.46 ' HG2' HG22 ' A' ' 14' ' ' VAL . 11.2 mmm180 -72.61 -7.89 52.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.527 1.677 . . . . 2.94 115.527 -161.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 1.032 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 25.3 ttmt 70.18 103.92 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.434 0.531 . . . . 2.78 112.434 -176.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 1.011 ' HB3' ' HA ' ' A' ' 38' ' ' VAL . 2.3 m-20 60.13 58.27 4.39 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.849 1.055 . . . . 2.41 113.849 165.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 30.0 Cg_endo -107.48 -153.23 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.639 2.893 . . . . 1.87 113.492 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.999 HD11 ' HB2' ' A' ' 71' ' ' PHE . 0.2 OUTLIER 84.18 -71.76 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.476 1.11 . . . . 1.99 112.775 169.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.79 ' HB2' ' HD3' ' A' ' 37' ' ' ARG . 14.2 mm-40 -126.1 28.85 5.98 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.322 -0.551 . . . . 5.31 111.457 -172.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.91 1.86 90.64 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.841 -1.171 . . . . 2.64 111.516 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.79 ' HD3' ' HB2' ' A' ' 35' ' ' GLU . 8.4 mpt_? -67.32 66.33 0.07 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.568 0.747 . . . . 5.64 111.386 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.011 ' HA ' ' HB3' ' A' ' 32' ' ' ASP . 16.9 t -105.21 117.42 50.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.896 -0.593 . . . . 3.96 109.694 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 166.33 -77.68 0.13 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.22 -0.991 . . . . 2.56 113.037 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -119.75 135.63 54.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.206 0.527 . . . . 6.2 112.048 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HA ' ' NH2' ' A' ' 65' ' ' ARG . . . -82.05 98.3 8.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.259 -0.882 . . . . 2.0 109.899 175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 65' ' ' ARG . 16.3 p -65.57 131.05 45.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.076 -0.511 . . . . 2.52 110.455 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 46' ' ' MET . 8.6 p-10 -139.74 36.9 2.0 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.91 0.862 . . . . 2.52 109.62 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -68.1 -25.92 65.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.892 -1.049 . . . . 7.02 110.374 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.3 34.32 4.74 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.68 -0.691 . . . . 3.06 111.607 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.553 ' HB2' ' HB2' ' A' ' 43' ' ' ASP . 24.3 ttt -72.13 -13.2 61.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.021 0.439 . . . . 2.35 110.577 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -83.58 57.52 4.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.426 0.631 . . . . 4.25 109.649 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.51 73.59 20.31 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.871 -0.788 . . . . 2.56 108.871 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.76 109.71 0.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.136 1.89 . . . . 1.69 112.588 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.583 HG22 ' HB3' ' A' ' 53' ' ' SER . 1.4 mp -68.49 111.92 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.676 -0.693 . . . . 1.59 110.087 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -68.17 -23.25 64.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.409 -0.814 . . . . 1.91 112.52 -171.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 126' ' ' ALA . 4.6 mpt_? -100.54 36.33 1.93 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.759 0.314 . . . . 3.17 111.331 -176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.583 ' HB3' HG22 ' A' ' 50' ' ' ILE . 42.2 t -154.36 153.54 31.79 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.172 -0.467 . . . . 0.97 111.142 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.9 140.93 50.54 Favored Pre-proline 0 C--O 1.219 -0.506 0 N-CA-C 109.087 -0.709 . . . . 1.92 109.087 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.491 ' O ' HG23 ' A' ' 59' ' ' VAL . 5.1 Cg_exo -39.22 -39.54 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.537 3.491 . . . . 0.7 115.992 -167.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.53 -55.09 6.78 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.484 1.135 . . . . 2.71 110.068 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.58 -15.11 60.4 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.048 -0.978 . . . . 1.63 109.655 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.413 ' HG3' ' HB ' ' A' ' 50' ' ' ILE . 27.4 tt0 -60.73 -43.09 98.34 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.464 -0.789 . . . . 1.58 109.294 170.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 55' ' ' PRO . 58.3 t -58.52 -40.86 80.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.154 -0.476 . . . . 1.27 109.848 174.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.883 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 23.6 tp -68.87 -22.78 64.18 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.583 -0.447 . . . . 1.18 111.573 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.451 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 9.1 m-30 -101.06 1.93 39.91 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.278 0.561 . . . . 0.99 109.667 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.533 ' O ' HG13 ' A' ' 167' ' ' VAL . 11.5 tt0 -124.44 -124.55 0.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.034 -0.984 . . . . 1.97 109.301 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.739 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.7 OUTLIER 29.04 104.05 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.751 1.22 . . . . 1.27 114.143 -173.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.436 ' HB2' ' HG2' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -81.82 148.16 29.0 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.086 0.469 . . . . 1.96 112.027 -178.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.727 ' NH2' ' HA ' ' A' ' 41' ' ' ALA . 2.1 ttm180 -109.86 91.33 3.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.533 -0.303 . . . . 3.35 111.433 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 57.45 -160.79 0.23 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.536 0.684 . . . . 4.71 111.913 173.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -123.21 75.02 1.27 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.452 -0.794 . . . . 4.38 109.395 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.419 ' CD ' ' HE ' ' A' ' 37' ' ' ARG . 1.7 tp10 -78.59 -164.29 0.56 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.895 -1.048 . . . . 3.7 111.919 -172.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -167.49 128.83 1.53 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.828 -1.078 . . . . 2.2 109.875 -173.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 m 52.08 55.34 9.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 124.007 0.817 . . . . 1.41 110.574 168.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.999 ' HB2' HD11 ' A' ' 34' ' ' LEU . 2.2 p90 -111.24 138.37 47.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.911 -1.041 . . . . 1.57 111.296 -167.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.536 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -129.57 146.37 17.19 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.661 -0.78 . . . . 0.78 113.658 -175.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.613 ' HB3' ' CH2' ' A' ' 12' ' ' TRP . 57.7 m-85 -103.44 136.43 43.2 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.42 -0.39 . . . . 1.21 110.769 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.418 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.4 p-10 -99.51 115.63 29.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.034 -0.53 . . . . 2.47 110.937 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.842 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.3 mp -110.01 89.86 8.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.602 -0.726 . . . . 0.38 109.358 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.681 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 21.8 Cg_exo -63.66 121.19 8.85 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 C-N-CA 121.992 1.795 . . . . 0.59 111.727 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.901 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 64.9 mt -121.47 143.05 35.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.715 0.293 . . . . 0.49 111.019 -174.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -127.05 -12.25 5.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.262 -0.426 . . . . 3.32 111.443 173.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -112.03 168.15 9.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 2.16 111.387 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -106.5 -178.37 3.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.799 -0.637 . . . . 1.2 110.6 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.36 -169.58 15.6 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 111.144 -0.782 . . . . 0.3 111.144 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 5.1 mm-40 -98.87 103.28 15.22 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.083 -0.71 . . . . 1.96 109.083 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.68 ' HB2' HG12 ' A' ' 133' ' ' ILE . 2.4 m-85 -92.37 124.37 36.37 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 119.225 -0.99 . . . . 0.71 108.8 -173.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.574 HG21 ' CA ' ' A' ' 177' ' ' ALA . 49.0 t -107.3 105.6 19.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.22 -0.9 . . . . 0.26 109.937 -174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 170' ' ' LEU . 17.0 tp -90.37 104.6 17.16 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.286 -1.325 . . . . 1.56 109.764 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 44.8 t -114.01 104.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.841 -0.8 . . . . 1.14 108.841 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.586 ' H ' HD13 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.38 135.68 46.32 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.968 -0.693 . . . . 1.44 110.616 178.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.758 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 16.2 tptt -98.7 120.63 39.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.302 -0.408 . . . . 3.73 110.494 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.456 ' CE2' HD11 ' A' ' 115' ' ' LEU . 26.4 m-85 -107.35 142.11 37.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.911 0.386 . . . . 0.45 111.253 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -139.33 135.14 33.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.424 -0.807 . . . . 0.51 110.387 178.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' A' ' 124' ' ' SER . 7.3 pt-20 -94.5 162.94 13.6 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 124.069 0.856 . . . . 2.62 110.91 -176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.538 HG21 ' HD2' ' A' ' 166' ' ' LYS . 25.9 m -139.41 -17.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.687 . . . . 3.77 110.813 173.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.449 ' HD2' HG23 ' A' ' 92' ' ' VAL . 10.4 m-85 -146.57 162.84 37.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 5.68 110.744 -175.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 64.02 56.3 1.44 Allowed 'General case' 0 N--CA 1.463 0.182 0 O-C-N 123.84 0.712 . . . . 4.65 111.253 173.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.24 87.2 3.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.403 -0.817 . . . . 1.39 111.103 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.606 HE21 ' HG2' ' A' ' 99' ' ' GLN . 16.5 pt20 -156.28 140.63 16.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.563 -0.744 . . . . 2.75 109.858 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 118' ' ' PHE . 5.9 p -100.43 146.93 26.43 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 112.86 0.689 . . . . 1.4 112.86 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 56.66 53.68 8.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.062 -0.972 . . . . 2.38 110.096 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.606 ' HG2' HE21 ' A' ' 96' ' ' GLN . 27.3 tp60 -148.63 -49.51 0.16 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.671 -0.695 . . . . 2.89 109.979 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -107.92 89.6 3.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.688 -0.687 . . . . 2.79 109.414 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.866 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 23.6 m -106.77 124.6 62.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.647 -0.706 . . . . 1.22 110.063 -173.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.498 ' HD1' ' HA ' ' A' ' 159' ' ' LYS . 61.7 m-85 -104.12 163.53 12.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.512 -0.767 . . . . 0.99 111.722 -173.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 24.6 m-20 -109.59 140.61 43.2 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.579 -0.282 . . . . 1.53 110.48 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.603 HG23 ' HD2' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -143.32 127.89 14.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.048 0.451 . . . . 0.63 110.735 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.659 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -121.39 144.89 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.676 -0.693 . . . . 1.95 112.189 -175.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.804 HG23 HD21 ' A' ' 153' ' ' LEU . 3.0 p -108.2 105.36 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.679 -0.691 . . . . 1.44 109.722 171.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.447 ' HA ' ' H ' ' A' ' 154' ' ' SER . 65.4 t30 57.67 44.22 21.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.882 0.848 . . . . 1.65 109.149 -174.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.95 -15.79 61.97 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 114.994 -1.003 . . . . 0.42 113.017 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 94.6 m-70 -89.39 98.86 12.01 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.564 0.579 . . . . 0.68 112.564 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 2.3 p -66.64 98.98 0.55 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.208 0.528 . . . . 0.77 111.706 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.688 HG21 HG21 ' A' ' 131' ' ' ILE . 6.4 t -80.47 -47.79 20.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.636 -0.711 . . . . 0.94 109.53 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.615 HG11 ' HG ' ' A' ' 115' ' ' LEU . 10.8 t -113.3 90.03 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.556 0.694 . . . . 0.35 109.364 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -113.16 71.74 0.75 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 122.332 1.063 . . . . 4.01 108.871 179.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.866 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.7 p30 162.66 30.2 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.186 -1.825 . . . . 1.96 107.218 -169.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.662 HD13 ' HE2' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -74.1 78.65 1.74 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.862 -1.063 . . . . 1.18 111.095 -172.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.531 ' HB2' HG12 ' A' ' 101' ' ' VAL . 10.9 t70 -101.95 103.74 14.4 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.727 -1.212 . . . . 1.93 107.727 172.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 165' ' ' PRO . 66.7 mt -55.0 -40.9 55.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.893 -0.594 . . . . 0.82 111.173 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.567 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 2.3 t80 -64.12 -45.61 87.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.7 -0.682 . . . . 1.08 110.558 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.8 -32.86 68.05 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.31 -0.405 . . . . 0.96 111.471 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HB3' ' CE1' ' A' ' 127' ' ' HIS . 15.4 mmt180 -77.03 -50.1 13.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.276 -0.42 . . . . 1.69 111.792 -173.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.9 p -118.79 -27.59 2.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.49 -0.484 . . . . 1.49 112.295 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 123.6 -161.49 17.91 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 110.316 -1.114 . . . . 1.4 110.316 -171.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -78.79 122.24 25.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.532 0.666 . . . . 4.11 111.027 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.7 ' HA ' ' HG2' ' A' ' 91' ' ' GLU . 78.2 p 51.77 -121.63 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.163 -0.926 . . . . 1.97 112.516 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.7 p 52.32 -161.41 0.1 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.469 0.707 . . . . 0.85 110.796 -173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.683 ' HB1' ' HE3' ' A' ' 88' ' ' LYS . . . -98.95 109.08 21.89 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.67 -0.412 . . . . 0.57 110.304 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 18.9 t60 -93.84 133.05 37.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.247 -0.649 . . . . 0.55 109.247 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.719 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.5 p30 -133.22 135.77 45.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.132 0.492 . . . . 1.64 111.108 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.448 ' HB2' HD21 ' A' ' 87' ' ' LEU . 17.1 mm-40 -112.25 111.78 22.9 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.211 -1.033 . . . . 1.12 108.211 171.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 86' ' ' VAL . 65.5 mt -96.04 113.48 30.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.934 -0.575 . . . . 0.74 109.668 -177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.688 HG21 HG21 ' A' ' 111' ' ' VAL . 47.2 mt -124.0 93.47 47.01 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.36 -0.382 . . . . 1.25 111.293 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -72.42 122.07 7.99 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.317 2.011 . . . . 0.29 112.648 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.68 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -109.74 160.61 8.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 106.959 -1.497 . . . . 0.27 106.959 174.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.5 p -127.29 111.99 14.55 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.036 0.446 . . . . 1.24 110.377 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 36.9 mt -99.87 122.41 51.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.191 -0.67 . . . . 0.34 109.191 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -149.06 135.32 19.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.87 -0.418 . . . . 1.95 109.87 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 61.28 25.04 15.07 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.606 0.566 . . . . 3.13 110.586 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.16 14.46 81.74 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.73 -0.668 . . . . 0.41 112.27 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.763 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 56.5 mtpt -111.9 150.53 30.33 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.583 -0.525 . . . . 2.23 109.583 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.0 tt -121.25 116.31 24.63 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.701 -0.481 . . . . 0.41 109.701 -175.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.9 t -116.65 111.04 19.28 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.61 -0.515 . . . . 1.19 109.61 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.685 HG21 HG11 ' A' ' 106' ' ' VAL . 5.5 p -100.76 113.95 38.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.175 -0.306 . . . . 0.92 110.175 -176.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 58.77 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.015 -0.539 . . . . 1.88 112.02 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -126.19 1.98 7.76 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.945 -0.645 . . . . 1.02 112.685 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -106.14 148.49 27.79 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.488 -0.56 . . . . 1.95 109.488 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.09 133.59 60.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.247 0.546 . . . . 0.92 111.616 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.8 m -152.94 179.06 9.01 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.897 -0.779 . . . . 1.27 108.897 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.763 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 7.9 t -99.36 143.05 30.06 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.847 -0.798 . . . . 1.45 108.847 168.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.901 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 51.6 t80 -79.62 121.98 25.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.264 -0.425 . . . . 0.47 110.46 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 p -118.46 95.59 4.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.248 0.546 . . . . 1.79 112.295 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.54 -71.6 2.87 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.42 114.167 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.681 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -151.5 156.75 41.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.355 0.577 . . . . 1.23 111.015 -176.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.842 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 7.0 tt -82.13 140.42 33.81 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.67 -0.863 . . . . 1.17 108.67 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.46 ' N ' HD23 ' A' ' 153' ' ' LEU . 5.5 t -124.29 109.17 13.04 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.876 -0.73 . . . . 1.35 110.241 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.729 HG11 HD21 ' A' ' 170' ' ' LEU . 49.1 t -91.51 96.03 5.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 108.029 -1.1 . . . . 0.42 108.029 174.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.596 ' HB3' ' HG3' ' A' ' 105' ' ' ARG . 4.5 tt0 -99.57 120.53 39.81 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.074 -0.966 . . . . 1.98 109.766 -175.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.662 ' HE2' HD13 ' A' ' 115' ' ' LEU . 62.1 t80 -108.36 116.38 31.86 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.332 0.587 . . . . 2.32 109.928 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 44.6 t -106.82 112.86 41.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.241 -0.89 . . . . 0.62 110.502 -176.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.766 ' HE3' ' HA ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -76.58 148.18 37.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.577 -0.738 . . . . 2.26 110.066 172.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -89.3 -57.05 1.82 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.584 -0.817 . . . . 1.45 112.01 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -68.41 -72.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.822 -0.436 . . . . 4.24 109.822 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.766 ' HA ' ' HE3' ' A' ' 159' ' ' LYS . 85.1 t80 -175.47 -48.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.276 -1.009 . . . . 4.98 108.276 174.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -66.62 147.04 53.82 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.364 -1.289 . . . . 2.64 110.362 172.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.644 ' HB2' ' HD2' ' A' ' 165' ' ' PRO . 0.9 OUTLIER -114.07 -175.06 0.29 Allowed Pre-proline 0 C--N 1.297 -1.681 0 CA-C-N 112.902 -1.954 . . . . 2.06 106.635 174.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.746 ' HB3' HD11 ' A' ' 117' ' ' ILE . 83.3 Cg_exo -49.63 -27.19 14.27 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 121.443 1.429 . . . . 3.16 110.788 170.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.538 ' HD2' HG21 ' A' ' 92' ' ' VAL . 32.2 tttm 88.42 -39.82 0.03 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 113.825 -1.534 . . . . 3.18 109.682 177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 62' ' ' GLN . 38.8 t -98.08 132.17 43.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 116.423 -0.353 . . . . 1.19 110.832 174.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 29.1 t -141.74 94.47 2.68 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 120.062 -0.655 . . . . 1.36 112.32 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -87.64 38.59 0.84 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.841 1.256 . . . . 0.31 113.473 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.729 HD21 HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -31.0 131.91 0.09 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.58 0.752 . . . . 0.69 112.137 177.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 5.4 t80 -144.97 115.65 7.71 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.242 -0.286 . . . . 0.48 110.449 171.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.568 HG21 HG21 ' A' ' 75' ' ' ILE . 7.0 tt -113.89 125.72 71.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 122.268 1.032 . . . . 0.3 111.007 172.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 9.7 ptm -117.58 163.55 16.27 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.58 -1.191 . . . . 0.99 109.099 176.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.71 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -120.74 149.62 42.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.131 0.967 . . . . 1.22 112.635 -174.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.15 -29.63 12.03 Favored Glycine 0 C--N 1.306 -1.099 0 CA-C-N 114.105 -1.407 . . . . 0.31 114.34 162.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.562 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.0 OUTLIER -176.31 160.06 2.09 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 118.253 1.027 . . . . 0.68 112.115 179.14 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.574 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -85.48 -9.64 57.18 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.496 -0.775 . . . . 0.86 110.048 168.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.562 ' H ' ' HB ' ' A' ' 176' ' ' THR . 2.4 m-20 . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.901 -0.59 . . . . 2.16 111.618 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 N-CA-C 112.116 -0.394 . . . . 1.48 112.116 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.765 ' HG ' HD11 ' A' ' 27' ' ' ILE . 27.2 tp -70.27 -36.84 74.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.113 0.482 . . . . 0.72 109.975 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.488 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -66.5 -24.91 66.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.487 -0.779 . . . . 0.53 111.288 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -75.33 -32.79 61.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.008 -0.542 . . . . 2.18 110.606 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.682 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 30.6 mmtp -93.4 -28.82 15.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.09 -0.504 . . . . 1.79 111.853 -171.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.612 ' HB ' HD12 ' A' ' 27' ' ' ILE . 9.6 p -57.63 119.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.627 0.727 . . . . 0.33 111.901 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.2 pt -101.82 -24.62 4.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.784 -0.644 . . . . 0.92 110.181 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.797 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 35.5 t90 -159.24 135.25 8.85 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.53 -0.759 . . . . 0.36 109.449 -172.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -154.76 131.34 10.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.722 0.296 . . . . 0.26 110.76 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.476 ' HB ' ' CH2' ' A' ' 12' ' ' TRP . 4.1 t -140.33 125.16 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.514 0.673 . . . . 0.79 111.598 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.742 ' HB2' HD23 ' A' ' 60' ' ' LEU . 3.2 t-20 -97.49 90.48 5.06 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.751 -1.203 . . . . 1.49 107.751 167.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.557 ' C ' ' HB2' ' A' ' 65' ' ' ARG . . . -62.38 102.2 0.29 Allowed 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 115.584 -0.734 . . . . 0.48 109.446 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 150.56 -20.12 1.03 Allowed Glycine 0 N--CA 1.442 -0.938 0 O-C-N 125.398 1.686 . . . . 0.76 112.333 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 43' ' ' ASP . . . -136.64 -166.08 10.72 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.036 -1.078 . . . . 0.74 112.924 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 31.7 tt0 -120.78 118.2 29.4 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.814 0.302 . . . . 1.77 111.814 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.756 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 18.4 m 36.31 109.27 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 115.639 1.718 . . . . 1.29 115.639 166.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.86 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 71.4 t60 -147.02 143.42 28.39 Favored 'General case' 0 C--O 1.221 -0.436 0 O-C-N 121.668 -0.645 . . . . 0.42 110.958 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.6 t -104.21 117.48 49.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.33 -0.85 . . . . 1.01 109.934 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.782 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -70.98 148.63 47.47 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.236 -0.653 . . . . 0.77 109.236 174.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.32 -17.38 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 114.219 1.192 . . . . 0.62 114.219 -173.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.532 ' HB2' HD23 ' A' ' 6' ' ' LEU . 63.9 m-70 -87.74 -11.52 47.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.255 -0.646 . . . . 0.86 109.255 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 108.64 33.89 2.77 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.053 -0.976 . . . . 0.33 113.246 175.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.765 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.5 mm -103.32 105.53 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.043 -0.663 . . . . 0.31 110.355 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -90.41 105.75 18.03 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.024 -0.534 . . . . 0.8 110.604 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.86 ' CE2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -83.7 138.77 33.14 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.686 -0.688 . . . . 1.75 109.269 175.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -95.23 149.29 21.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.861 0.362 . . . . 2.94 110.557 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 76.6 tttt -43.24 143.38 0.85 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.802 -1.09 . . . . 2.78 112.28 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.589 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 13.3 p-10 -45.8 106.09 0.53 Allowed Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 124.763 1.29 . . . . 2.41 113.387 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.509 ' HA ' HG12 ' A' ' 38' ' ' VAL . 33.8 Cg_endo -99.12 -72.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.967 3.111 . . . . 1.87 113.717 174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.58 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . 10.9 mp 65.63 -75.61 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.079 0.952 . . . . 1.99 111.078 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.588 ' HG3' ' HD2' ' A' ' 37' ' ' ARG . 4.1 pt-20 -156.02 62.32 0.58 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.893 -1.048 . . . . 5.31 111.369 -170.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.79 -0.49 89.5 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.522 -0.847 . . . . 2.64 112.449 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.588 ' HD2' ' HG3' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -91.99 58.4 3.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.957 0.408 . . . . 5.64 110.219 -175.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 33' ' ' PRO . 20.7 m -104.37 133.07 49.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.766 -0.652 . . . . 3.96 110.783 -174.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.82 14.12 10.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.428 -0.891 . . . . 2.56 112.633 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 40' ' ' ARG . 15.4 tpt180 -105.01 -67.96 0.88 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.872 0.336 . . . . 6.2 110.566 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 42' ' ' SER . . . 61.49 -86.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.173 0.589 . . . . 2.0 111.582 -177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.511 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 47.5 t 74.76 41.49 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.476 0.655 . . . . 2.52 109.312 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' HA2' ' A' ' 18' ' ' GLY . 11.5 p-10 -81.27 47.7 1.06 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.369 -0.832 . . . . 2.52 110.712 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -132.07 128.38 38.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.381 -0.827 . . . . 7.02 109.382 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.75 71.33 1.12 Allowed Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.511 -1.035 . . . . 3.06 110.511 -175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.486 ' O ' ' HB3' ' A' ' 47' ' ' LYS . 1.8 mpt? -61.21 -38.93 88.35 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 123.55 0.206 . . . . 2.35 110.672 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 46' ' ' MET . 24.3 ttpt 75.27 -51.08 0.66 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 113.695 0.998 . . . . 4.25 113.695 168.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 92' ' ' VAL . 27.8 tp -116.22 74.01 5.46 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 117.947 0.34 . . . . 2.56 110.834 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HD3' ' C ' ' A' ' 47' ' ' LYS . 52.6 Cg_exo -55.47 125.87 20.58 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.089 1.86 . . . . 1.69 112.665 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.679 ' CG2' ' HB2' ' A' ' 126' ' ' ALA . 1.4 mp -75.29 114.34 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.649 0.738 . . . . 1.59 110.335 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.547 ' HB2' HG22 ' A' ' 125' ' ' THR . 2.7 mm? -74.8 -2.83 28.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.389 -0.823 . . . . 1.91 112.744 -171.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 7.5 mmm180 -112.67 23.33 13.62 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.845 -0.342 . . . . 3.17 111.166 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.7 t -142.81 157.55 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.371 0.605 . . . . 0.97 112.346 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.447 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 22.6 t30 -63.75 129.25 93.66 Favored Pre-proline 0 C--O 1.213 -0.858 0 CA-C-N 114.983 -1.008 . . . . 1.92 109.258 172.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.534 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 3.2 Cg_exo -40.19 -44.75 4.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.192 3.261 . . . . 0.7 115.058 -170.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -64.31 -51.82 61.55 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 123.149 1.452 . . . . 2.71 109.407 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.782 ' OD1' ' HA ' ' A' ' 23' ' ' ASP . 31.6 m-20 -82.26 -6.87 59.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.231 -1.804 . . . . 1.63 109.645 -174.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.534 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 22.4 tt0 -67.41 -41.37 85.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 1.58 108.354 169.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.03 -50.4 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.311 -0.859 . . . . 1.27 109.064 170.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.751 ' HG ' ' HD2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -55.9 -34.41 65.52 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.484 -0.78 . . . . 1.18 110.39 178.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.601 ' HA ' ' CB ' ' A' ' 169' ' ' ALA . 10.9 m-30 -94.58 1.51 55.64 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.952 -0.567 . . . . 0.99 111.263 -174.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.733 ' HA ' HG21 ' A' ' 167' ' ' VAL . 2.1 tt0 -128.32 -110.05 0.28 Allowed 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 116.567 -0.288 . . . . 1.97 111.413 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.702 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 29.58 108.46 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.38 1.472 . . . . 1.27 114.584 -172.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.693 ' HB3' HG12 ' A' ' 167' ' ' VAL . 8.1 pt-20 -80.63 136.53 36.24 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.031 0.752 . . . . 1.96 113.031 -173.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.589 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -112.71 73.73 0.83 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.011 -0.54 . . . . 3.35 110.034 170.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -50.2 134.14 22.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.764 -0.653 . . . . 4.71 111.161 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -133.61 -85.53 0.44 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.849 -0.34 . . . . 4.38 110.882 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 178.81 -72.89 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.918 0.39 . . . . 3.7 110.445 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -166.45 156.02 11.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.422 -0.585 . . . . 2.2 109.422 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.3 t 49.68 65.25 1.46 Allowed 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.908 0.755 . . . . 1.41 110.741 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.637 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 1.5 p90 -126.77 137.41 53.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.836 -0.431 . . . . 1.57 109.836 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.08 -153.07 7.93 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.618 -0.801 . . . . 0.78 112.873 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -143.96 168.16 20.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.196 0.522 . . . . 1.21 111.589 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.451 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 5.6 m-20 -122.75 125.14 44.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.305 -0.861 . . . . 2.47 109.129 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.944 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.0 mp -104.69 95.96 9.66 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.439 -0.578 . . . . 0.38 109.439 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.616 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 32.0 Cg_exo -57.04 120.82 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.936 1.757 . . . . 0.59 112.013 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.783 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 66.3 mt -126.67 133.03 69.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.436 -0.347 . . . . 0.49 110.393 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -132.77 16.07 4.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.345 -0.389 . . . . 3.32 110.825 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -135.43 174.29 10.77 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.725 -0.39 . . . . 2.16 110.447 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.589 ' HG2' HG22 ' A' ' 135' ' ' ILE . 10.9 mt-10 -122.61 163.44 20.02 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.118 -0.492 . . . . 1.2 110.718 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.98 -173.99 21.89 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.644 -0.982 . . . . 0.3 110.644 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -92.4 104.74 17.04 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 117.878 0.839 . . . . 1.96 109.267 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.684 ' HB2' HG12 ' A' ' 133' ' ' ILE . 92.9 m-85 -92.59 123.4 35.86 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.491 -0.929 . . . . 0.71 108.491 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.508 HG21 ' CA ' ' A' ' 177' ' ' ALA . 88.8 t -116.14 106.65 20.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.633 -0.712 . . . . 0.26 110.268 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 172' ' ' ILE . 5.7 mp -86.77 104.69 16.38 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.955 -1.021 . . . . 1.56 109.302 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.42 HG22 HG23 ' A' ' 130' ' ' ILE . 53.3 t -102.87 102.64 13.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.694 -1.224 . . . . 1.14 107.694 172.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.5 OUTLIER -113.26 133.33 55.15 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.55 -0.46 . . . . 1.44 110.513 -176.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.763 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 5.3 mptp? -91.74 124.68 36.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.278 0.561 . . . . 3.73 110.097 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.75 ' CE1' ' HB3' ' A' ' 165' ' ' PRO . 2.8 m-85 -108.95 141.78 40.54 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.486 -0.779 . . . . 0.45 110.121 176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.602 ' HB3' ' CG2' ' A' ' 167' ' ' VAL . . . -149.3 114.6 5.51 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.736 -0.665 . . . . 0.51 109.901 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.727 ' HG3' ' HB3' ' A' ' 94' ' ' PHE . 10.5 pt-20 -92.44 129.42 38.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.387 -0.597 . . . . 2.62 109.387 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.465 ' HA ' HD22 ' A' ' 48' ' ' LEU . 40.2 t -82.73 -30.09 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.082 -0.508 . . . . 3.77 110.616 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -97.42 52.43 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.423 0.63 . . . . 5.68 109.471 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.727 ' HB3' ' HG3' ' A' ' 91' ' ' GLU . 22.9 p90 -77.09 101.03 5.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.488 -0.778 . . . . 4.65 110.894 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -153.42 14.27 0.5 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.335 0.495 . . . . 1.39 112.335 175.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.56 HE21 ' HB2' ' A' ' 100' ' ' LYS . 28.5 tt0 -161.71 139.36 8.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.977 -0.379 . . . . 2.75 109.977 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 119' ' ' ASP . 2.6 p -103.22 -78.3 0.55 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.074 -0.512 . . . . 1.4 110.618 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -65.15 142.12 58.45 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.533 -0.543 . . . . 2.38 109.533 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 77.24 -1.82 2.71 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.662 0.785 . . . . 2.89 110.238 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.56 ' HB2' HE21 ' A' ' 96' ' ' GLN . 62.7 tttm -126.95 51.49 1.87 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.674 -1.232 . . . . 2.79 107.674 169.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.854 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 13.3 m -107.57 118.8 56.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.038 -0.983 . . . . 1.22 110.273 -173.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.605 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 22.5 m-85 -90.41 156.96 17.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.133 -0.94 . . . . 0.99 111.469 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.667 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 6.7 t70 -107.57 136.33 47.51 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.507 -0.553 . . . . 1.53 109.507 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.68 122.41 23.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.099 0.476 . . . . 0.63 111.042 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.2 mtt180 -124.7 140.29 53.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.154 -0.93 . . . . 1.95 111.258 -174.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.624 HG22 HD11 ' A' ' 153' ' ' LEU . 7.7 p -117.59 104.93 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.327 0.584 . . . . 1.44 109.611 173.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.931 ' HB2' HD12 ' A' ' 153' ' ' LEU . 28.4 t-20 61.3 41.54 13.02 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.52 1.152 . . . . 1.65 108.193 -171.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.62 -21.29 26.78 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.747 -1.115 . . . . 0.42 112.698 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 78.1 m-70 -74.08 105.35 5.26 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 122.631 0.373 . . . . 0.68 111.717 -174.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.561 HG22 ' HG2' ' A' ' 105' ' ' ARG . 2.4 p -70.2 92.64 0.78 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.041 0.448 . . . . 0.77 111.511 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.416 HG23 HG12 ' A' ' 106' ' ' VAL . 21.4 t -76.62 -41.76 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.917 -0.583 . . . . 0.94 109.804 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.433 HG11 ' HG ' ' A' ' 115' ' ' LEU . 11.1 t -132.55 90.92 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.098 -0.501 . . . . 0.35 110.148 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -105.08 72.49 1.0 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.655 0.741 . . . . 4.01 109.777 175.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.854 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 7.8 p-10 161.24 32.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.587 -1.642 . . . . 1.96 108.226 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -69.65 85.43 0.46 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.91 -1.041 . . . . 1.18 111.093 -174.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 19.3 p-10 -98.0 88.69 4.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.574 -0.739 . . . . 1.93 109.52 172.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.611 ' HB ' ' OE2' ' A' ' 91' ' ' GLU . 56.8 mt -59.62 -39.86 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.578 -0.737 . . . . 0.82 111.166 -173.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.409 ' HD1' ' HB2' ' A' ' 94' ' ' PHE . 84.0 t80 -52.64 -37.15 57.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 1.08 111.585 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 97' ' ' SER . 24.9 t70 -73.88 -37.21 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.896 -0.503 . . . . 0.96 111.108 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 7.6 mmt180 -73.11 -51.91 16.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.721 -0.672 . . . . 1.69 110.945 -170.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -99.93 -23.18 4.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.351 -0.386 . . . . 1.49 111.813 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 86.78 -83.34 1.6 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.186 -1.006 . . . . 1.4 112.144 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -114.92 107.82 15.91 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.88 -0.328 . . . . 4.11 111.043 -176.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.6 p 44.71 -123.73 0.98 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.775 -0.648 . . . . 1.97 111.961 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.597 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 60.4 p 53.76 -169.27 0.06 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.859 0.863 . . . . 0.85 112.425 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.679 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -100.02 129.15 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.315 0.487 . . . . 0.57 112.315 -177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 38.4 t60 -101.82 147.41 26.53 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.584 -1.265 . . . . 0.55 107.584 169.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.602 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.5 p30 -142.78 127.65 18.29 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.145 -0.622 . . . . 1.64 111.911 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.95 115.27 28.52 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.895 -1.048 . . . . 1.12 108.793 172.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.42 HG23 HG22 ' A' ' 86' ' ' VAL . 64.2 mt -101.5 106.67 19.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.229 -0.656 . . . . 0.74 109.229 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 111' ' ' VAL . 54.3 mt -116.84 90.73 33.13 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.377 -0.374 . . . . 1.25 110.956 -173.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.452 ' HB3' HG22 ' A' ' 84' ' ' VAL . 8.9 Cg_exo -77.43 119.69 5.0 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.568 2.179 . . . . 0.29 112.237 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.684 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -109.68 144.59 17.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.875 -1.157 . . . . 0.27 107.875 175.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -113.92 107.33 15.54 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 120.34 -0.544 . . . . 1.24 110.503 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.589 HG22 ' HG2' ' A' ' 80' ' ' GLU . 33.5 mt -99.62 120.89 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.786 -0.45 . . . . 0.34 109.786 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -149.8 137.76 20.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.563 -0.532 . . . . 1.95 109.563 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 8.3 mptt 61.23 30.35 19.18 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.646 0.736 . . . . 3.13 110.185 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.31 11.44 84.18 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 114.805 -1.089 . . . . 0.41 112.607 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.769 ' HG2' HG22 ' A' ' 148' ' ' THR . 90.2 mttt -113.33 142.45 45.84 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.646 -0.326 . . . . 2.23 110.159 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 5.8 tt -112.61 119.46 38.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.037 -0.529 . . . . 0.41 110.096 -173.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 17.3 m -111.97 109.45 19.23 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.688 0.28 . . . . 1.19 110.94 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.44 HG23 ' CD2' ' A' ' 140' ' ' LEU . 66.9 t -94.24 94.58 4.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.563 -0.903 . . . . 0.92 108.563 176.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 59.27 -88.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.115 -0.948 . . . . 1.88 111.068 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -107.23 -13.0 22.33 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.541 -0.838 . . . . 1.02 113.091 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 141' ' ' SER . 51.6 mt-10 -90.14 112.88 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.535 -0.391 . . . . 1.95 110.863 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.8 p -105.65 113.48 42.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.418 0.627 . . . . 0.92 110.378 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.3 t -147.42 137.46 23.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.689 . . . . 1.27 109.19 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.769 HG22 ' HG2' ' A' ' 139' ' ' LYS . 41.0 p -56.81 139.36 51.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.116 0.484 . . . . 1.45 111.878 -175.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.783 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 22.8 t80 -79.91 129.09 34.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.497 -0.774 . . . . 0.47 109.785 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 t -122.64 99.19 6.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 1.79 111.971 -174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.37 -67.36 3.33 Favored Glycine 0 C--N 1.329 0.194 0 CA-C-N 115.742 -0.663 . . . . 0.42 113.939 171.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.616 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -158.83 167.55 29.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.205 0.526 . . . . 1.23 110.08 -177.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.944 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 14.5 tp -81.87 144.02 31.29 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.574 -0.899 . . . . 1.17 108.574 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.7 t -132.74 108.7 9.18 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.146 -1.022 . . . . 1.35 110.777 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 96.0 t -94.18 108.61 20.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.373 -0.376 . . . . 0.42 110.19 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -114.46 138.41 50.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.782 -0.644 . . . . 1.98 110.121 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.667 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -129.21 128.31 43.07 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.511 0.672 . . . . 2.32 110.705 168.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 103' ' ' ASP . 44.5 t -106.47 144.63 15.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 114.423 -1.262 . . . . 0.62 111.085 -172.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.54 ' HA ' ' OD1' ' A' ' 164' ' ' ASN . 36.0 ttpt -61.41 118.54 7.09 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.377 -0.828 . . . . 2.26 111.794 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 101' ' ' VAL . . . -99.33 0.23 57.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.93 -0.652 . . . . 1.45 111.671 175.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -175.43 -70.22 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.103 -1.073 . . . . 4.24 108.103 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.401 ' O ' ' HB3' ' A' ' 163' ' ' ASP . 2.5 t80 179.71 -178.77 0.41 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.237 -1.394 . . . . 4.98 107.237 170.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 162' ' ' TYR . 38.7 t70 74.55 -52.45 0.68 Allowed 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.792 0.682 . . . . 2.64 110.32 -178.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.726 ' HB3' ' HD2' ' A' ' 165' ' ' PRO . 80.1 m-20 63.61 -174.84 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 O-C-N 123.814 0.696 . . . . 2.06 109.88 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.75 ' HB3' ' CE1' ' A' ' 89' ' ' PHE . 80.4 Cg_exo -53.95 88.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 121.567 1.511 . . . . 3.16 111.171 165.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.473 ' HB2' ' HA ' ' A' ' 91' ' ' GLU . 1.1 mmtm -52.27 -57.97 8.08 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 115.711 -0.677 . . . . 3.18 111.085 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.733 HG21 ' HA ' ' A' ' 62' ' ' GLN . 1.0 OUTLIER -112.62 137.96 43.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.047 0 CA-C-N 115.918 -0.583 . . . . 1.19 109.516 176.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 38.3 t -132.53 101.61 5.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.725 0.774 . . . . 1.36 111.84 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.763 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -88.34 36.79 0.79 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.629 1.172 . . . . 0.31 112.094 -177.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.797 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 13.6 tp -61.64 116.59 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.798 0.666 . . . . 0.69 112.798 -170.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 173' ' ' MET . 0.1 OUTLIER -124.22 123.47 40.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.652 -0.703 . . . . 0.48 110.25 176.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.598 ' CG2' ' HB3' ' A' ' 12' ' ' TRP . 2.7 tt -113.0 123.41 68.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 CA-C-O 122.001 0.905 . . . . 0.3 111.366 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.61 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 12.3 ptm -111.4 164.57 12.79 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.997 -1.001 . . . . 0.99 109.914 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.682 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 19.2 ptmt -115.66 141.16 48.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.371 1.081 . . . . 1.22 112.726 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.71 -28.84 13.72 Favored Glycine 0 C--N 1.304 -1.227 0 CA-C-N 113.853 -1.521 . . . . 0.31 114.827 161.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.2 OUTLIER -169.52 153.67 5.25 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.642 1.221 . . . . 0.68 113.023 -178.081 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.508 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -86.43 -9.89 55.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.057 -0.974 . . . . 0.86 109.981 168.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.492 ' H ' ' HB ' ' A' ' 176' ' ' THR . 10.9 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.524 -0.762 . . . . 2.16 111.528 -177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 111.172 -0.771 . . . . 1.48 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.854 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 34.6 tp -56.06 -31.97 63.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.319 0.58 . . . . 0.72 110.789 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.525 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -55.23 -43.08 74.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.878 -1.055 . . . . 0.53 112.533 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.73 -17.76 34.99 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.441 -0.504 . . . . 2.18 112.256 -173.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 23.1 mmtm -91.55 -16.6 26.92 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 120.163 -0.615 . . . . 1.79 111.409 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 7' ' ' ALA . 12.3 p -55.2 128.57 15.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.546 0.689 . . . . 0.33 111.197 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.652 HG23 HG23 ' A' ' 172' ' ' ILE . 0.3 OUTLIER -96.63 -31.39 3.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.345 -0.843 . . . . 0.92 109.912 178.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.654 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 74.8 t90 -172.95 132.62 0.53 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.321 -0.854 . . . . 0.36 109.396 -169.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.57 137.82 18.41 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.864 -0.522 . . . . 0.26 110.827 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.681 HG21 ' CD ' ' A' ' 33' ' ' PRO . 7.3 p -148.37 138.86 16.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 122.196 0.998 . . . . 0.79 112.57 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.675 ' HB2' HD12 ' A' ' 60' ' ' LEU . 10.9 t-20 -98.35 104.12 16.12 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.403 -1.271 . . . . 1.49 107.623 167.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -66.3 89.14 0.13 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.002 -1.111 . . . . 0.48 108.002 172.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.876 ' HA2' ' N ' ' A' ' 65' ' ' ARG . . . 179.1 -41.24 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.56 0 O-C-N 125.059 1.474 . . . . 0.76 112.023 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -144.66 -157.55 7.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.18 -1.009 . . . . 0.74 112.937 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.858 ' HG3' ' HB2' ' A' ' 41' ' ' ALA . 44.1 mt-10 -119.35 120.09 35.88 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 111.528 0.196 . . . . 1.77 111.528 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.854 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 67.2 m 39.1 112.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 116.504 2.039 . . . . 1.29 116.504 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.998 ' HB3' ' CE2' ' A' ' 29' ' ' TYR . 8.4 t60 -145.94 130.07 17.48 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.252 0.549 . . . . 0.42 111.334 171.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.4 t -87.75 115.91 28.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.043 -0.981 . . . . 1.01 109.646 174.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -82.42 164.53 20.94 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.769 -0.456 . . . . 0.77 109.769 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 m -62.63 -17.32 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 O-C-N 124.16 0.913 . . . . 0.62 111.791 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.484 ' HB2' ' OD2' ' A' ' 23' ' ' ASP . 88.3 m-70 -84.64 -1.84 56.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.3 0.571 . . . . 0.86 109.966 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.511 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 86.48 25.94 34.51 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.166 -0.924 . . . . 0.33 111.81 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.626 HD11 ' HG ' ' A' ' 6' ' ' LEU . 26.1 mm -103.95 113.23 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.394 0.616 . . . . 0.31 111.145 -175.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -92.96 110.83 22.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.42 -0.809 . . . . 0.8 110.823 -173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.998 ' CE2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -85.7 145.4 27.3 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.5 0.191 . . . . 1.75 110.59 179.119 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.672 ' O ' HG23 ' A' ' 14' ' ' VAL . 66.2 mtt180 -94.97 170.19 9.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.979 -0.555 . . . . 2.94 111.689 -176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 61.1 mttp -84.7 82.49 8.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.017 0.747 . . . . 2.78 113.017 -169.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 1.029 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 39.45 45.9 1.05 Allowed Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 114.737 1.384 . . . . 2.41 114.737 167.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.681 ' CD ' HG21 ' A' ' 14' ' ' VAL . 28.0 Cg_endo -96.09 50.28 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.15 3.234 . . . . 1.87 113.76 -161.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.531 HD11 ' CE2' ' A' ' 73' ' ' TYR . 8.7 mp -81.82 -92.41 0.06 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.753 0.649 . . . . 1.99 112.753 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' O ' ' HD2' ' A' ' 37' ' ' ARG . 11.8 mm-40 -92.71 50.57 1.6 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.016 -0.538 . . . . 5.31 112.173 -167.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.3 -3.45 81.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.565 -0.826 . . . . 2.64 111.459 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 35' ' ' GLU . 4.9 mpt_? -87.67 72.94 9.45 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 109.05 -0.722 . . . . 5.64 109.05 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.9 t -102.64 116.83 47.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 120.487 -0.485 . . . . 3.96 110.163 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.91 33.8 9.49 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 111.266 -0.734 . . . . 2.56 111.266 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.476 ' HB3' ' OD2' ' A' ' 32' ' ' ASP . 5.0 tpm_? -98.45 -44.51 6.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.458 -0.571 . . . . 6.2 109.458 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.858 ' HB2' ' HG3' ' A' ' 19' ' ' GLU . . . 58.62 -81.96 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.612 -1.177 . . . . 2.0 112.149 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.3 m 58.7 63.81 1.59 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.416 0.627 . . . . 2.52 109.809 -170.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.49 63.18 0.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.147 -0.933 . . . . 2.52 111.397 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -111.26 15.5 21.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.606 -0.725 . . . . 7.02 109.906 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.692 ' HA3' ' HG3' ' A' ' 64' ' ' GLU . . . -100.02 7.53 58.86 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.758 -1.11 . . . . 3.06 111.154 171.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.432 ' SD ' HG23 ' A' ' 63' ' ' THR . 50.6 mmm -72.72 -12.66 61.1 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.659 0.743 . . . . 2.35 109.166 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -83.24 -0.71 50.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.848 -1.069 . . . . 4.25 110.787 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.6 mt -117.9 80.01 14.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.98 -0.554 . . . . 2.56 109.673 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.07 128.43 15.74 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.62 2.213 . . . . 1.69 112.254 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.889 HD13 ' HA ' ' A' ' 62' ' ' GLN . 1.7 mp -81.3 108.5 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.661 0.743 . . . . 1.59 109.811 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.556 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.6 mm? -65.29 -18.36 65.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.878 -1.055 . . . . 1.91 112.962 -173.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -91.91 -9.83 41.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.481 -0.487 . . . . 3.17 111.985 -175.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.501 ' OG ' ' HD2' ' A' ' 61' ' ' TYR . 57.9 m -108.83 160.06 16.29 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.285 0.564 . . . . 0.97 112.323 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.523 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.7 OUTLIER -90.88 143.44 28.71 Favored Pre-proline 0 C--O 1.214 -0.798 0 CA-C-N 115.305 -0.861 . . . . 1.92 109.26 -176.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 46.8 Cg_exo -37.48 -48.92 1.85 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.989 3.126 . . . . 0.7 115.841 -164.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HB3' ' HE1' ' A' ' 21' ' ' HIS . 25.5 mm-40 -64.22 -54.58 31.24 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.442 1.115 . . . . 2.71 109.659 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 3.3 p30 -77.85 -15.8 58.78 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.538 -1.21 . . . . 1.63 110.577 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.711 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 9.4 tt0 -58.12 -50.5 73.26 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.556 -0.535 . . . . 1.58 109.556 172.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.4 t -55.25 -47.94 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.445 0.641 . . . . 1.27 109.859 173.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.727 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 50.1 tp -56.78 -19.42 16.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.799 -1.091 . . . . 1.18 111.425 178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.62 ' HB3' ' HG3' ' A' ' 88' ' ' LYS . 23.1 m-30 -120.51 5.34 10.63 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.072 -0.513 . . . . 0.99 111.722 -173.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.889 ' HA ' HD13 ' A' ' 50' ' ' ILE . 0.7 OUTLIER -120.78 -38.25 2.88 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.812 -0.555 . . . . 1.97 112.453 -170.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.432 HG23 ' SD ' ' A' ' 46' ' ' MET . 0.2 OUTLIER -67.56 139.41 56.92 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.477 -0.783 . . . . 1.27 110.479 -175.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.975 ' HB3' HG12 ' A' ' 167' ' ' VAL . 0.0 OUTLIER -122.87 -4.01 8.62 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.298 1.592 . . . . 1.96 115.298 -166.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 1.029 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 2.1 mtp-105 70.64 -83.24 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.377 0.608 . . . . 3.35 112.179 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 34.0 t80 175.75 114.17 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.192 -0.913 . . . . 4.71 108.864 -166.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.528 ' HA ' ' HZ ' ' A' ' 71' ' ' PHE . 4.2 p-10 -64.82 135.29 55.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.069 -0.715 . . . . 4.38 109.069 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -142.52 -76.86 0.26 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.007 0.432 . . . . 3.7 111.655 -168.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -170.85 -162.51 0.27 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.427 -1.323 . . . . 2.2 107.427 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.7 t -48.77 104.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.076 0.465 . . . . 1.41 109.808 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.563 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . 71.4 m-85 -77.91 108.49 11.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.403 -0.962 . . . . 1.57 108.403 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -109.11 144.63 16.5 Favored Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 115.361 -0.836 . . . . 0.78 113.234 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.568 ' HE1' ' CE1' ' A' ' 157' ' ' PHE . 54.2 m-85 -132.42 129.26 39.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.344 -0.428 . . . . 1.21 110.487 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.555 ' OD2' ' HE2' ' A' ' 152' ' ' LYS . 10.3 t70 -100.6 102.34 13.47 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.151 -0.685 . . . . 2.47 109.151 177.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 6.1 mt -102.6 90.06 2.05 Favored Pre-proline 0 CA--C 1.513 -0.46 0 N-CA-C 109.158 -0.682 . . . . 0.38 109.158 174.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 33.4 Cg_endo -66.12 116.58 4.09 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.305 1.337 . . . . 0.59 111.751 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.843 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 43.6 mt -110.32 139.75 32.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.98 -0.554 . . . . 0.49 111.113 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.29 16.29 4.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 3.32 109.979 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.509 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 9.1 mm-40 -129.09 158.13 39.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.585 0.231 . . . . 2.16 110.891 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.519 ' HG2' HG22 ' A' ' 135' ' ' ILE . 4.5 mt-10 -111.64 170.6 8.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.062 -0.517 . . . . 1.2 110.374 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.26 -162.98 24.02 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.447 -1.061 . . . . 0.3 110.447 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 67.0 mt-10 -102.61 111.45 23.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.854 0.827 . . . . 1.96 109.83 176.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.674 ' HB2' HG12 ' A' ' 133' ' ' ILE . 73.6 m-85 -94.12 123.87 37.77 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 108.434 -0.95 . . . . 0.71 108.434 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.599 HG21 ' CA ' ' A' ' 177' ' ' ALA . 86.1 t -113.63 106.15 20.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 121.646 0.736 . . . . 0.26 110.289 -174.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.5 mp -87.37 104.0 16.02 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.602 -1.181 . . . . 1.56 109.127 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.525 HG22 HG23 ' A' ' 130' ' ' ILE . 50.3 t -106.02 103.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.754 -1.202 . . . . 1.14 107.754 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 1.1 pt? -116.0 132.01 56.77 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.076 -0.65 . . . . 1.44 110.18 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.672 ' HE3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -86.26 120.29 27.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.116 -0.698 . . . . 3.73 109.116 178.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.545 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -106.29 140.47 39.18 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.099 -0.955 . . . . 0.45 110.508 -179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.533 ' HB3' HG22 ' A' ' 167' ' ' VAL . . . -149.61 146.22 27.19 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.129 -0.693 . . . . 0.51 109.129 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.56 ' HB3' HD12 ' A' ' 117' ' ' ILE . 6.9 pt-20 -120.13 -177.81 3.51 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.791 -0.364 . . . . 2.62 111.023 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.703 HG22 ' CD2' ' A' ' 93' ' ' TYR . 14.2 p -80.99 -68.92 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 119.235 -0.412 . . . . 3.77 112.07 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.703 ' CD2' HG22 ' A' ' 92' ' ' VAL . 35.5 p90 -176.16 25.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.566 0.621 . . . . 5.68 112.53 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.599 ' CE2' ' HB3' ' A' ' 163' ' ' ASP . 29.1 m-85 -69.31 103.31 1.94 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.126 0.489 . . . . 4.65 110.585 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.69 67.24 5.39 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.251 0.834 . . . . 1.39 113.251 -168.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.468 ' HG2' ' HG2' ' A' ' 100' ' ' LYS . 18.4 pm0 -152.4 140.66 20.46 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.684 -0.488 . . . . 2.75 109.684 168.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' A' ' 119' ' ' ASP . 18.3 m -105.75 153.54 21.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.157 -0.474 . . . . 1.4 110.873 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 49.58 45.49 24.18 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.474 0.654 . . . . 2.38 111.834 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.61 -62.55 0.37 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.161 -1.052 . . . . 2.89 108.161 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HG2' ' HG2' ' A' ' 96' ' ' GLN . 0.7 OUTLIER -84.52 87.03 7.23 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.836 -1.075 . . . . 2.79 109.891 175.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.812 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.6 m -109.64 124.46 66.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.325 0.584 . . . . 1.22 111.0 -176.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.455 ' CD2' ' HD3' ' A' ' 165' ' ' PRO . 30.6 m-85 -96.79 165.49 12.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.172 -0.922 . . . . 0.99 110.727 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.621 ' OD2' ' HB ' ' A' ' 158' ' ' VAL . 0.0 OUTLIER -106.54 136.94 45.43 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.786 -0.766 . . . . 1.53 109.905 173.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 1.8 t -121.55 119.19 58.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.844 -0.616 . . . . 0.63 109.522 175.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.589 ' HG2' HG22 ' A' ' 110' ' ' THR . 24.5 mtt180 -121.38 139.42 53.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.088 0.471 . . . . 1.95 111.447 -173.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.899 HG13 HD11 ' A' ' 153' ' ' LEU . 79.9 t -122.39 100.07 7.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.24 -0.891 . . . . 1.44 109.469 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.858 ' HB2' HD22 ' A' ' 153' ' ' LEU . 29.1 t-20 63.28 43.66 6.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.46 1.124 . . . . 1.65 108.686 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.59 -5.4 78.32 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.941 -1.027 . . . . 0.42 112.704 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 92.9 m-70 -92.35 106.64 18.6 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 122.017 0.127 . . . . 0.68 111.15 -174.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.589 HG22 ' HG2' ' A' ' 105' ' ' ARG . 2.9 p -70.18 88.67 0.62 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.968 0.413 . . . . 0.77 111.362 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.539 HG22 HG11 ' A' ' 142' ' ' VAL . 37.2 t -69.01 -51.46 43.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.865 -0.607 . . . . 0.94 109.799 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.488 ' HB ' ' HB ' ' A' ' 104' ' ' VAL . 35.6 t -120.88 88.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.35 110.144 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.621 ' HG2' ' HB3' ' A' ' 103' ' ' ASP . 0.2 OUTLIER -102.57 76.88 1.57 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.515 -1.291 . . . . 4.01 107.515 173.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.812 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 9.2 p-10 166.05 26.79 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.99 -1.459 . . . . 1.96 109.634 -172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.73 101.11 3.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 1.18 111.499 -172.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 27.5 p-10 -118.16 85.88 2.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.288 1.042 . . . . 1.93 109.72 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 91' ' ' GLU . 60.0 mt -54.21 -37.43 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.84 -1.073 . . . . 0.82 112.167 -172.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -58.44 -38.63 77.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.691 0.282 . . . . 1.08 111.579 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.632 ' HB2' ' HB3' ' A' ' 97' ' ' SER . 9.4 t70 -70.15 -33.93 72.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.329 0.585 . . . . 0.96 110.422 177.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 7.4 mmt180 -74.42 -51.38 15.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.531 -0.759 . . . . 1.69 111.117 -173.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 m -115.18 -29.51 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 113.109 0.781 . . . . 1.49 113.109 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 84.1 -73.97 2.58 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.517 -0.849 . . . . 1.4 112.003 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -77.28 151.21 35.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.251 -0.277 . . . . 4.11 110.251 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.6 t -68.55 80.22 0.27 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.785 0.802 . . . . 1.97 109.762 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.556 HG22 ' HB2' ' A' ' 51' ' ' LEU . 41.5 p -125.38 -137.95 0.27 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.958 -1.019 . . . . 0.85 109.188 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.591 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . . . -102.5 116.54 32.82 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.492 -0.483 . . . . 0.57 111.427 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 89' ' ' PHE . 48.4 t60 -112.88 106.75 15.11 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 108.704 -0.85 . . . . 0.55 108.704 170.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.538 ' OD1' ' HG2' ' A' ' 88' ' ' LYS . 13.6 m-20 -105.03 117.12 33.2 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.319 -0.552 . . . . 1.64 111.384 -169.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -89.09 111.97 22.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.682 -0.69 . . . . 1.12 109.546 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.525 HG23 HG22 ' A' ' 86' ' ' VAL . 61.3 mt -103.18 110.15 28.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.411 -0.588 . . . . 0.74 109.411 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.481 HG21 HG21 ' A' ' 106' ' ' VAL . 65.5 mt -122.69 94.41 47.56 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.283 -0.417 . . . . 1.25 111.099 -173.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -80.83 121.81 4.19 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.728 2.285 . . . . 0.29 111.988 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' A' ' 83' ' ' TYR . 0.6 OUTLIER -110.58 155.62 11.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.646 -0.872 . . . . 0.27 108.646 177.057 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.528 ' OG ' ' HB2' ' A' ' 141' ' ' SER . 2.9 p -120.22 106.94 12.4 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.694 -0.402 . . . . 1.24 110.799 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 34.1 mt -100.66 119.6 49.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.326 -0.62 . . . . 0.34 109.326 176.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 27.5 mmtp -151.4 136.79 17.68 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.705 -0.48 . . . . 1.95 109.705 178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt 65.52 22.91 11.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.68 -0.691 . . . . 3.13 110.47 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.64 9.47 86.37 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.844 -0.693 . . . . 0.41 112.084 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 52.8 mtpt -106.61 166.51 10.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.687 -0.486 . . . . 2.23 109.687 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 6.2 tt -140.73 116.35 10.2 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.636 -0.505 . . . . 0.41 109.636 -174.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.528 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 40.6 m -110.73 131.07 55.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.26 -0.427 . . . . 1.19 111.041 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.539 HG11 HG22 ' A' ' 111' ' ' VAL . 74.6 t -129.37 109.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.92 111.136 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 50.79 37.5 17.13 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.82 -0.627 . . . . 1.88 112.665 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.97 -24.33 25.37 Favored Glycine 0 C--N 1.313 -0.71 0 C-N-CA 120.783 -0.723 . . . . 1.02 112.576 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -85.06 112.12 20.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.02 -0.733 . . . . 1.95 109.02 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.6 p -105.57 125.67 60.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.771 -0.65 . . . . 0.92 110.611 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.3 m -144.51 -166.65 2.44 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.926 -0.768 . . . . 1.27 108.926 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 59.8 p -98.75 148.39 23.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.001 0.429 . . . . 1.45 110.847 175.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.843 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 39.6 t80 -81.41 120.95 25.63 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.736 -1.209 . . . . 0.47 107.736 168.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 m -130.51 95.92 4.0 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.122 0.487 . . . . 1.79 110.75 -174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 92.13 -82.41 1.18 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.598 -0.728 . . . . 0.42 113.781 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.555 ' HE2' ' OD2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -145.04 158.69 43.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.331 0.565 . . . . 1.23 111.004 -175.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.899 HD11 HG13 ' A' ' 106' ' ' VAL . 1.4 tm? -80.96 118.56 22.54 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.174 -1.417 . . . . 1.17 107.174 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 5.3 t -114.23 107.06 15.1 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.951 -0.699 . . . . 1.35 110.161 -171.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.516 ' O ' ' HD1' ' A' ' 73' ' ' TYR . 38.2 t -92.62 108.02 19.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.98 -0.748 . . . . 0.42 108.98 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 25.4 mt-10 -130.33 108.91 10.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.174 -0.466 . . . . 1.98 110.156 -177.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 2.9 p90 -104.58 115.85 31.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.722 0.772 . . . . 2.32 110.676 174.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.621 ' HB ' ' OD2' ' A' ' 103' ' ' ASP . 59.3 t -87.63 143.43 11.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 114.347 -1.297 . . . . 0.62 111.01 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -68.0 136.01 53.21 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.739 -1.119 . . . . 2.26 111.585 -175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -86.61 -35.11 10.66 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.688 -0.768 . . . . 1.45 111.269 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -145.08 -97.71 0.1 Allowed 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.675 0.25 . . . . 4.24 111.675 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -112.0 -83.26 0.58 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.445 0.164 . . . . 4.98 111.203 -172.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.599 ' HB3' ' CE2' ' A' ' 94' ' ' PHE . 17.7 t70 -75.46 85.17 2.56 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.762 -0.829 . . . . 2.64 108.762 176.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.731 ' HB2' ' HD2' ' A' ' 165' ' ' PRO . 20.1 p-10 -78.68 161.43 69.29 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.152 -0.931 . . . . 2.06 109.692 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.731 ' HD2' ' HB2' ' A' ' 164' ' ' ASN . 32.6 Cg_exo -20.76 87.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 124.877 3.718 . . . . 3.16 114.155 -168.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.533 ' HD2' ' HB ' ' A' ' 92' ' ' VAL . 36.8 tttp -55.86 -61.28 2.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 113.926 -1.488 . . . . 3.18 112.44 -162.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.975 HG12 ' HB3' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -102.9 136.5 35.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 120.06 -0.656 . . . . 1.19 110.169 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.647 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 47.7 t -125.81 135.35 51.89 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.672 0.749 . . . . 1.36 110.313 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.6 ' HB1' ' HD1' ' A' ' 61' ' ' TYR . . . -123.05 36.76 4.57 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.615 -1.175 . . . . 0.31 109.869 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.654 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 9.9 tp -57.98 112.17 1.41 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.627 -1.17 . . . . 0.69 112.715 -170.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.854 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -122.27 120.45 34.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.619 -0.719 . . . . 0.48 110.243 176.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.652 HG23 HG23 ' A' ' 11' ' ' ILE . 6.9 tt -113.09 132.16 62.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.697 0.76 . . . . 0.3 110.357 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.618 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 4.1 ppp? -127.02 164.09 22.29 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.562 -0.744 . . . . 0.99 109.412 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.9 ptmt -112.61 142.16 45.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.565 1.174 . . . . 1.22 113.32 -173.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 176' ' ' THR . . . 105.37 -30.0 10.6 Favored Glycine 0 C--N 1.31 -0.865 0 CA-C-N 113.161 -1.836 . . . . 0.31 115.058 161.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.6 OUTLIER -176.75 153.07 1.04 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.467 1.133 . . . . 0.68 113.238 -177.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.599 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -84.59 -14.61 48.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.755 -0.657 . . . . 0.86 109.596 168.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.478 ' H ' ' HB ' ' A' ' 176' ' ' THR . 38.9 t70 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 114.937 -1.029 . . . . 2.16 111.807 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.026 0 N-CA-C 111.768 -0.533 . . . . 1.48 111.768 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.772 HD23 ' HB3' ' A' ' 25' ' ' HIS . 27.6 tp -66.14 -30.49 70.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.099 0.476 . . . . 0.72 110.425 -175.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.535 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -61.32 -25.86 67.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.368 -0.833 . . . . 0.53 111.91 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.73 -36.72 23.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.375 -0.375 . . . . 2.18 111.358 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.649 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -90.15 -11.04 42.35 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.542 -0.463 . . . . 1.79 111.582 -171.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.75 HG23 ' HE1' ' A' ' 171' ' ' PHE . 14.7 p -59.31 132.8 24.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.035 -0.666 . . . . 0.33 111.546 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.681 HG23 HG23 ' A' ' 172' ' ' ILE . 0.6 OUTLIER -107.79 -38.4 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.051 -0.522 . . . . 0.92 110.563 176.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.733 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 49.6 t90 -165.33 143.63 6.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.825 -0.625 . . . . 0.36 109.32 -172.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.85 135.75 11.76 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.66 -0.416 . . . . 0.26 111.347 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.0 t -137.15 106.58 4.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.686 0.755 . . . . 0.79 110.922 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 3.2 t-20 -81.25 86.55 6.21 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.265 -1.383 . . . . 1.49 107.265 163.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . . . -66.61 103.85 1.16 Allowed 'General case' 0 C--O 1.255 1.362 0 CA-C-N 115.386 -0.824 . . . . 0.48 109.813 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.629 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 172.93 -38.69 0.15 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 113.073 -1.876 . . . . 0.76 112.279 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.455 ' HA2' ' HB1' ' A' ' 41' ' ' ALA . . . -132.88 -141.26 4.58 Favored Glycine 0 N--CA 1.459 0.205 0 C-N-CA 120.702 -0.761 . . . . 0.74 112.427 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -118.17 157.63 26.58 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.589 -0.359 . . . . 1.77 110.893 175.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 23.2 m -19.03 122.44 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.307 1.595 . . . . 1.29 115.307 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.691 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 42.9 t60 -138.16 121.67 17.27 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.218 -0.901 . . . . 0.42 111.271 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 28' ' ' HIS . 64.1 t -85.3 123.3 39.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.077 -0.965 . . . . 1.01 109.019 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.76 ' HB3' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -101.7 171.26 7.65 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.525 -0.47 . . . . 0.77 110.715 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -56.53 -22.95 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 124.708 1.255 . . . . 0.62 112.808 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.772 ' HB3' HD23 ' A' ' 6' ' ' LEU . 34.0 m-70 -77.12 -10.61 59.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.35 0.595 . . . . 0.86 109.672 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.535 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 87.76 28.21 24.54 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.135 -0.939 . . . . 0.33 110.763 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.659 HD11 ' HG ' ' A' ' 6' ' ' LEU . 12.6 mm -102.14 112.49 35.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.136 0.493 . . . . 0.31 110.1 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.573 ' HB2' HG22 ' A' ' 22' ' ' VAL . 29.9 t60 -93.63 113.09 25.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.973 -0.558 . . . . 0.8 110.076 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.691 ' CD2' ' HB3' ' A' ' 21' ' ' HIS . 0.1 OUTLIER -90.5 142.38 27.8 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.643 -0.503 . . . . 1.75 109.643 175.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' H ' ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -100.78 69.29 1.35 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.012 0.745 . . . . 2.94 113.012 -169.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.746 ' HG2' ' H ' ' A' ' 32' ' ' ASP . 14.5 ttpp 60.83 -169.34 0.16 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.477 -0.783 . . . . 2.78 111.723 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.778 ' HB2' ' HD2' ' A' ' 65' ' ' ARG . 9.4 p-10 -103.09 88.93 1.71 Allowed Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-O 121.984 0.897 . . . . 2.41 110.106 173.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.638 ' HD3' ' O ' ' A' ' 31' ' ' LYS . 31.7 Cg_endo -86.57 -105.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.158 1.905 . . . . 1.87 112.313 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp 67.86 -40.35 0.41 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.145 0.578 . . . . 1.99 109.815 -170.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 33' ' ' PRO . 39.3 mt-10 78.53 149.29 0.1 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.216 -0.902 . . . . 5.31 112.466 166.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.57 -6.7 44.41 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.182 -0.917 . . . . 2.64 111.878 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -139.46 31.3 2.11 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.024 -0.362 . . . . 5.64 110.024 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.5 m -104.03 161.49 4.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.107 0.48 . . . . 3.96 111.591 -169.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.97 -54.57 0.73 Allowed Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.488 -0.778 . . . . 2.56 111.413 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -101.65 100.93 11.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.894 0.378 . . . . 6.2 111.587 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.455 ' HB1' ' HA2' ' A' ' 18' ' ' GLY . . . -89.81 -60.54 1.91 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.126 -0.694 . . . . 2.0 109.126 170.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.8 t 69.29 75.29 0.24 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.674 0.75 . . . . 2.52 110.883 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -89.39 -7.15 55.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.209 -0.905 . . . . 2.52 109.864 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -81.22 47.59 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.003 0.906 . . . . 7.02 110.124 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.13 50.39 0.19 Allowed Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 114.372 -1.286 . . . . 3.06 110.126 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.563 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 24.4 mmt -59.11 -62.74 1.65 Allowed 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.073 -0.563 . . . . 2.35 109.827 -176.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 46' ' ' MET . 22.7 pttm 48.8 -168.17 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.408 1.067 . . . . 4.25 112.448 171.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 30.4 66.5 0.82 Allowed Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 123.967 0.907 . . . . 2.56 113.119 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.77 105.78 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.41 2.073 . . . . 1.69 112.3 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 126' ' ' ALA . 1.3 mp -57.62 111.87 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 121.891 0.853 . . . . 1.59 110.462 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 51' ' ' LEU . 4.6 mp -68.86 -14.38 63.0 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.809 -1.087 . . . . 1.91 111.73 -172.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.641 ' HB2' ' HB3' ' A' ' 126' ' ' ALA . 27.4 mmm180 -98.97 23.01 9.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.22 -0.445 . . . . 3.17 111.423 -175.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -150.31 167.76 26.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 0.97 112.186 -176.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.403 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 3.0 t30 -95.51 139.17 21.84 Favored Pre-proline 0 C--O 1.215 -0.744 0 CA-C-N 115.013 -0.994 . . . . 1.92 108.83 177.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.481 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 3.7 Cg_exo -36.69 -54.7 0.94 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.512 3.475 . . . . 0.7 116.246 -162.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -77.08 -28.71 54.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.172 0.896 . . . . 2.71 112.012 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -10.98 43.8 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 120.912 -1.117 . . . . 1.63 109.026 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.481 ' HB3' ' O ' ' A' ' 55' ' ' PRO . 19.7 tt0 -67.07 -46.38 74.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.722 -1.126 . . . . 1.58 110.002 170.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.72 -39.98 86.83 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 N-CA-C 109.684 -0.487 . . . . 1.27 109.684 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.76 HD22 ' HB3' ' A' ' 23' ' ' ASP . 45.3 tp -60.69 -21.58 63.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.183 0.516 . . . . 1.18 111.153 173.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.577 ' CD2' ' HE3' ' A' ' 88' ' ' LYS . 8.6 m-30 -102.64 -2.21 28.75 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.937 -0.574 . . . . 0.99 111.542 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.829 ' HA ' HG11 ' A' ' 167' ' ' VAL . 4.1 tt0 -121.67 -110.4 0.33 Allowed 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.637 -0.425 . . . . 1.97 110.147 174.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.629 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.6 OUTLIER 35.01 102.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.446 0.906 . . . . 1.27 113.446 -173.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -88.84 136.98 32.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.465 -0.334 . . . . 1.96 111.824 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.778 ' HD2' ' HB2' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -92.74 178.79 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.379 . . . . 3.35 110.469 173.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -104.0 106.5 17.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.365 -0.38 . . . . 4.71 111.247 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -177.27 148.37 0.6 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.46 0.475 . . . . 4.38 110.071 174.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.578 ' HA ' ' HB2' ' A' ' 164' ' ' ASN . 1.5 pt-20 -131.53 35.8 3.81 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.934 -0.395 . . . . 3.7 109.934 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.662 ' HA ' ' HB3' ' A' ' 159' ' ' LYS . 26.8 t70 -142.34 -164.95 1.92 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.012 -0.675 . . . . 2.2 109.581 -165.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.512 ' H ' ' CG ' ' A' ' 69' ' ' ASP . 8.9 t -62.87 91.6 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.059 0.457 . . . . 1.41 109.884 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.49 ' CG ' ' CE2' ' A' ' 157' ' ' PHE . 38.2 m-85 -71.24 94.82 1.21 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.945 -1.132 . . . . 1.57 107.945 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.72 111.67 3.73 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.662 -0.78 . . . . 0.78 112.495 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.672 ' HE1' ' CE1' ' A' ' 157' ' ' PHE . 35.0 m-85 -102.59 151.29 22.51 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.568 0.347 . . . . 1.21 110.643 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.416 ' HB2' ' HG3' ' A' ' 152' ' ' LYS . 13.1 p-10 -115.28 112.97 23.23 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.342 0.591 . . . . 2.47 110.609 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.819 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.3 mp -103.55 93.42 4.97 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.611 -0.722 . . . . 0.38 110.067 178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 25.2 Cg_endo -65.8 119.33 6.34 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.683 1.588 . . . . 0.59 112.108 -175.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.829 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 69.3 mt -117.97 132.2 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.658 -0.701 . . . . 0.49 110.114 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.89 6.7 4.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.039 -0.528 . . . . 3.32 111.134 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -134.92 176.66 8.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.836 0.35 . . . . 2.16 110.625 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.597 ' HG2' HG22 ' A' ' 135' ' ' ILE . 5.5 mt-10 -122.12 159.06 27.94 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.807 -0.633 . . . . 1.2 110.108 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.97 -155.22 26.35 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.805 -0.918 . . . . 0.3 110.805 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 47.0 mt-10 -110.92 106.48 15.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.265 0.532 . . . . 1.96 109.781 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.672 ' HB2' HG12 ' A' ' 133' ' ' ILE . 88.8 m-85 -94.76 125.4 39.39 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 119.735 -0.786 . . . . 0.71 109.219 -176.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.661 HG21 ' CA ' ' A' ' 177' ' ' ALA . 52.8 t -108.67 106.02 19.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.165 0.983 . . . . 0.26 110.039 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 155' ' ' VAL . 9.1 tt -97.84 104.98 17.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 113.875 -1.511 . . . . 1.56 109.141 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 129' ' ' GLU . 2.2 p -115.01 105.94 19.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 109.013 -0.736 . . . . 1.14 109.013 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 87' ' ' LEU . 1.0 OUTLIER -101.48 134.94 43.81 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.115 0.483 . . . . 1.44 110.114 -177.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 1.078 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 10.9 tppt? -98.69 114.92 27.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.327 0.584 . . . . 3.73 109.873 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.465 ' CD2' HD11 ' A' ' 115' ' ' LEU . 4.0 m-85 -106.53 146.79 30.19 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.455 -0.793 . . . . 0.45 109.9 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.878 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -137.12 129.97 30.51 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.201 -0.454 . . . . 0.51 110.159 175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -121.63 118.14 28.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.723 -0.473 . . . . 2.62 109.723 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.5 m -136.4 30.51 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.069 0.462 . . . . 3.77 110.34 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -113.67 -46.27 3.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.135 -0.484 . . . . 5.68 111.105 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.8 ' HB3' ' HD2' ' A' ' 100' ' ' LYS . 42.2 t80 -137.8 109.02 6.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.061 0.458 . . . . 4.65 110.205 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.402 ' HB1' ' CE1' ' A' ' 118' ' ' PHE . . . -94.71 90.23 6.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.828 -0.624 . . . . 1.39 111.556 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -160.23 143.98 14.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.955 -0.566 . . . . 2.75 109.649 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.8 m -99.05 147.29 25.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.386 -0.37 . . . . 1.4 110.79 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 61.6 37.13 16.41 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.735 -0.666 . . . . 2.38 110.099 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -140.64 -47.05 0.41 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.727 -0.67 . . . . 2.89 110.423 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.8 ' HD2' ' HB3' ' A' ' 94' ' ' PHE . 33.4 tttm -102.31 75.81 1.51 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.185 -0.672 . . . . 2.79 109.185 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 116' ' ' ASP . 16.7 m -106.72 123.76 61.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.48 -0.782 . . . . 1.22 110.466 -173.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.566 ' CE2' ' HG2' ' A' ' 100' ' ' LYS . 80.5 m-85 -114.65 168.66 9.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.335 -0.848 . . . . 0.99 111.752 -173.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.635 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 11.3 m-20 -107.21 138.01 44.2 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 109.091 -0.707 . . . . 1.53 109.091 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 110' ' ' THR . 7.4 t -136.3 113.33 13.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 117.699 0.227 . . . . 0.63 111.525 -175.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.675 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 84.2 mtt180 -110.94 141.41 44.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.225 0.454 . . . . 1.95 112.225 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.426 HG23 ' HB2' ' A' ' 109' ' ' HIS . 12.0 m -110.65 96.71 4.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.44 -0.8 . . . . 1.44 109.662 168.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.762 ' HA ' ' OG ' ' A' ' 154' ' ' SER . 3.7 t-20 55.05 58.52 4.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.013 -0.994 . . . . 1.65 109.834 -172.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.25 -25.85 7.55 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 114.738 -1.119 . . . . 0.42 112.895 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.426 ' HB2' HG23 ' A' ' 106' ' ' VAL . 90.1 m-70 -83.71 95.04 8.27 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 111.915 0.339 . . . . 0.68 111.915 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -68.69 92.71 0.48 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.196 0.522 . . . . 0.77 111.063 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 112' ' ' VAL . 6.5 m -74.6 -37.58 43.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.978 -0.556 . . . . 0.94 110.904 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 111' ' ' VAL . 5.6 t -120.88 89.25 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.986 0.422 . . . . 0.35 109.963 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 11.6 tmtt? -106.98 73.9 0.96 Allowed 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.733 -1.21 . . . . 4.01 107.733 177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 7.2 p-10 161.16 28.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 113.441 -1.709 . . . . 1.96 108.807 -172.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -71.09 80.4 0.68 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.074 -0.512 . . . . 1.18 111.76 -170.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 100' ' ' LYS . 10.1 t70 -90.48 99.4 12.43 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.051 -1.092 . . . . 1.93 108.051 169.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.0 mt -63.64 -36.33 76.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.092 -0.504 . . . . 0.82 111.494 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.402 ' CE1' ' HB1' ' A' ' 95' ' ' ALA . 68.9 t80 -67.13 -34.94 78.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.056 0.455 . . . . 1.08 110.343 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -67.51 -37.9 83.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.001 0.429 . . . . 0.96 111.405 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 120' ' ' ARG . 14.1 mmt85 -77.15 -46.76 22.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.307 0.484 . . . . 1.69 112.307 -169.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.455 HG13 ' ND1' ' A' ' 127' ' ' HIS . 4.6 m -113.54 -17.02 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.484 0.549 . . . . 1.49 112.484 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 102.86 -146.66 16.71 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.261 -0.971 . . . . 1.4 111.723 -177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -80.24 116.1 20.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.676 0.274 . . . . 4.11 111.385 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.5 t 64.55 -146.74 0.27 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.792 -0.64 . . . . 1.97 110.693 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.402 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 42.6 p 63.06 178.87 0.15 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.48 1.112 . . . . 0.85 111.724 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.849 ' HB1' ' HD2' ' A' ' 88' ' ' LYS . . . -94.23 128.27 40.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.356 -0.384 . . . . 0.57 111.315 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.516 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 66.9 t60 -101.65 146.78 27.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.139 -0.689 . . . . 0.55 109.139 174.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 1.1 p30 -143.91 137.62 27.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.301 0.572 . . . . 1.64 111.305 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 81.6 mm-40 -110.03 114.63 28.31 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.267 -1.012 . . . . 1.12 108.267 172.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 61.4 mt -98.13 107.61 20.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.672 -0.492 . . . . 0.74 109.672 -178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 40.4 mm -116.47 101.06 53.81 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.394 -0.367 . . . . 1.25 111.017 -173.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.6 121.56 3.79 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.815 2.343 . . . . 0.29 111.616 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.672 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.2 pt -110.58 158.63 10.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.363 -0.606 . . . . 0.27 109.363 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.7 p -124.67 107.09 10.63 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.014 0.435 . . . . 1.24 110.773 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.597 HG22 ' HG2' ' A' ' 80' ' ' GLU . 35.0 mt -103.8 124.11 57.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.262 -0.426 . . . . 0.34 110.138 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 53.0 mmtt -151.46 138.49 19.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 123.646 0.592 . . . . 1.95 110.331 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 137' ' ' LYS . 63.5 mmtt 62.42 31.62 17.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.45 0.643 . . . . 3.13 110.507 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.09 22.01 77.15 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.015 -0.993 . . . . 0.41 111.923 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.648 ' HG2' HG22 ' A' ' 148' ' ' THR . 58.1 mtpt -118.71 137.58 53.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.014 -0.365 . . . . 2.23 110.014 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 149' ' ' PHE . 7.1 tt -113.91 116.32 29.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.178 -0.464 . . . . 0.41 109.777 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.6 t -111.26 132.95 53.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.407 -0.36 . . . . 1.19 110.375 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 88.7 t -125.66 103.97 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.298 -0.41 . . . . 0.92 110.246 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 57.41 -91.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.68 0.612 . . . . 1.88 112.005 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -113.7 14.47 22.23 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.866 -0.683 . . . . 1.02 112.905 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -129.27 116.38 19.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.861 0.331 . . . . 1.95 111.201 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.21 129.85 57.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.071 0.462 . . . . 0.92 109.961 174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.4 m -144.03 -177.63 5.54 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.574 -0.528 . . . . 1.27 109.574 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.648 HG22 ' HG2' ' A' ' 139' ' ' LYS . 39.0 p -98.07 138.98 34.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.745 0.307 . . . . 1.45 110.284 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.829 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 58.6 t80 -79.57 135.44 36.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.996 -0.547 . . . . 0.47 109.966 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.7 t -132.17 102.31 5.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.526 0.679 . . . . 1.79 111.949 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.31 -68.46 2.91 Favored Glycine 0 CA--C 1.508 -0.344 0 CA-C-N 115.421 -0.809 . . . . 0.42 113.678 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -158.63 167.01 30.69 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.864 0.364 . . . . 1.23 110.452 -177.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.819 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 6.0 tt -80.92 127.55 32.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.539 -0.911 . . . . 1.17 108.539 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.762 ' OG ' ' HA ' ' A' ' 107' ' ' ASN . 5.7 p -112.45 102.9 10.98 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.346 -0.542 . . . . 1.35 112.333 -172.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 85' ' ' LEU . 97.1 t -91.72 109.35 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.783 -0.451 . . . . 0.42 109.783 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.581 ' HB2' ' HD2' ' A' ' 105' ' ' ARG . 39.9 mt-10 -120.3 112.05 18.55 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.533 -0.758 . . . . 1.98 109.609 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.672 ' CE1' ' HE1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -99.71 114.47 27.59 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 118.569 -1.253 . . . . 2.32 110.344 166.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 20.8 t -83.77 144.69 9.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 113.758 -1.565 . . . . 0.62 110.828 -169.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.73 ' HA ' ' OD1' ' A' ' 164' ' ' ASN . 8.3 ptmm? -63.15 132.82 53.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.064 -0.971 . . . . 2.26 112.03 -172.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -113.86 -97.52 2.24 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.14 -0.936 . . . . 1.45 112.11 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -112.73 58.21 0.65 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.751 0.31 . . . . 4.24 111.468 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 68.83 155.48 0.12 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.514 -0.766 . . . . 4.98 112.497 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.534 ' OD1' ' HG2' ' A' ' 166' ' ' LYS . 7.0 t0 48.68 68.33 0.72 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.353 -0.839 . . . . 2.64 109.947 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.73 ' OD1' ' HA ' ' A' ' 159' ' ' LYS . 1.7 m-20 -57.56 135.09 82.26 Favored Pre-proline 0 CA--C 1.506 -0.734 0 CA-C-N 115.451 -0.795 . . . . 2.06 109.883 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.488 ' HD3' ' CD2' ' A' ' 102' ' ' PHE . 62.4 Cg_exo -17.3 73.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.057 1 C-N-CA 126.102 4.534 . . . . 3.16 114.681 -158.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.781 ' HA ' ' HE3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER 1.32 -77.48 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 O-C-N 125.936 2.022 . . . . 3.18 114.647 177.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.878 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 2.4 t -93.19 133.57 33.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.311 -0.404 . . . . 1.19 110.699 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -129.95 74.42 1.59 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 119.623 -0.831 . . . . 1.36 113.133 -172.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 1.078 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -80.12 36.08 0.34 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.708 1.203 . . . . 0.31 113.576 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.733 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 18.9 tp -53.76 117.37 3.11 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.688 0.625 . . . . 0.69 112.688 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.75 ' HE1' HG23 ' A' ' 10' ' ' VAL . 8.4 t80 -123.89 127.79 48.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.963 0.505 . . . . 0.48 110.555 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.681 HG23 HG23 ' A' ' 11' ' ' ILE . 8.7 tt -119.13 131.65 71.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 121.811 0.815 . . . . 0.3 111.05 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 9.4 ptm -121.33 159.93 25.05 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.846 -0.616 . . . . 0.99 109.534 177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 16.2 ptmt -113.18 149.98 32.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.424 1.107 . . . . 1.22 113.063 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' ' 176' ' ' THR . . . 103.58 -32.47 7.53 Favored Glycine 0 C--N 1.309 -0.917 0 CA-C-N 113.231 -1.804 . . . . 0.31 114.337 161.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.677 ' HB ' ' H ' ' A' ' 178' ' ' ASP . 0.2 OUTLIER -177.49 162.22 1.82 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.052 0.926 . . . . 0.68 112.511 176.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.661 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -85.49 -10.36 56.18 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.22 -0.9 . . . . 0.86 109.891 168.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.677 ' H ' ' HB ' ' A' ' 176' ' ' THR . 22.2 m-20 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.416 -0.811 . . . . 2.16 111.616 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 111.338 -0.705 . . . . 1.48 111.338 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.704 ' HG ' HD11 ' A' ' 27' ' ' ILE . 47.6 tp -76.12 -31.55 58.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.159 0.504 . . . . 0.72 110.111 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.502 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -61.23 -22.87 65.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.204 -0.907 . . . . 0.53 111.781 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -82.46 -34.3 28.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.41 -0.359 . . . . 2.18 111.373 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 57.8 mmtt -93.54 -15.39 25.52 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.59 -0.444 . . . . 1.79 112.02 -171.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.743 HG23 ' HE1' ' A' ' 171' ' ' PHE . 7.1 p -54.02 132.53 16.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.027 0.441 . . . . 0.33 111.775 177.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 pt -115.78 -32.28 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.226 -0.443 . . . . 0.92 110.705 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.72 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 42.0 t90 -159.63 133.0 7.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.046 -0.724 . . . . 0.36 109.046 -172.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.84 131.45 13.09 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.848 -0.341 . . . . 0.26 111.059 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.843 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 52.3 t -140.42 120.59 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.66 0.743 . . . . 0.79 111.357 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 51.4 t30 -98.15 101.63 13.15 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.109 -1.071 . . . . 1.49 108.109 167.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -60.36 95.7 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 116.051 -0.522 . . . . 0.48 110.036 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 175.94 -90.17 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.79 0 O-C-N 124.812 1.32 . . . . 0.76 113.068 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.37 -130.11 0.26 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.562 -0.352 . . . . 0.74 113.751 -172.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' HG3' ' HD3' ' A' ' 31' ' ' LYS . 31.6 tt0 -144.95 119.44 9.68 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.572 -0.369 . . . . 1.77 111.528 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.71 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 50.0 m 31.45 99.0 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.726 1.38 . . . . 1.29 114.726 172.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.862 ' HD2' ' HB2' ' A' ' 60' ' ' LEU . 76.2 t60 -135.33 134.97 40.4 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.786 -0.572 . . . . 0.42 111.855 -177.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 83.7 t -88.45 115.48 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.46 -0.791 . . . . 1.01 110.225 175.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.47 159.47 33.91 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.442 -0.577 . . . . 0.77 109.442 176.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 57' ' ' ASP . 28.8 m -66.2 -6.96 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.999 0.74 . . . . 0.62 112.999 -171.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -99.0 7.35 46.08 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.856 -0.794 . . . . 0.86 108.856 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 87.3 30.8 18.44 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.877 -1.056 . . . . 0.33 112.706 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.704 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.7 mm -104.45 106.27 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 0.31 111.34 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 30.3 t60 -86.33 109.43 18.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.289 0.566 . . . . 0.8 111.459 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.843 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -77.12 138.82 39.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.498 -0.774 . . . . 1.75 109.994 172.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -99.5 116.2 31.1 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.016 0.436 . . . . 2.94 110.677 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HG2' ' N ' ' A' ' 32' ' ' ASP . 8.9 ttpp -34.25 146.98 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.914 1.286 . . . . 2.78 114.371 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.54 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 7.7 p-10 -24.21 92.72 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 125.961 1.705 . . . . 2.41 114.639 -173.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -106.75 39.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.879 3.053 . . . . 1.87 113.507 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.598 ' HA ' ' HD2' ' A' ' 37' ' ' ARG . 19.7 tp -137.86 -66.1 0.51 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.971 0.73 . . . . 1.99 112.971 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -84.05 97.54 9.36 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.332 -0.855 . . . . 5.31 110.063 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 38' ' ' VAL . . . 92.81 -20.95 41.99 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.945 -1.262 . . . . 2.64 109.945 -168.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.598 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 16.3 mmm180 64.41 -7.19 0.25 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.674 1.19 . . . . 5.64 111.705 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.471 ' H ' ' C ' ' A' ' 36' ' ' GLY . 11.5 p -150.72 155.67 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.392 -0.596 . . . . 3.96 109.392 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.44 -143.36 9.27 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.863 -0.684 . . . . 2.56 112.025 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -132.18 -171.81 2.73 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.281 -0.266 . . . . 6.2 110.281 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.1 -60.13 2.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.644 -0.253 . . . . 2.0 111.261 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.7 m 55.27 50.84 14.16 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.647 -0.871 . . . . 2.52 108.647 -171.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.515 ' OD2' ' HB3' ' A' ' 46' ' ' MET . 43.9 t0 -78.2 81.4 4.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.603 -1.181 . . . . 2.52 111.748 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -96.76 9.11 42.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.724 -0.671 . . . . 7.02 109.661 171.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.878 ' HA3' ' HG2' ' A' ' 64' ' ' GLU . . . -104.89 -15.49 20.06 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.478 -0.783 . . . . 3.06 112.692 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.515 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 15.9 ptt? -66.07 0.63 1.83 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.356 0.502 . . . . 2.35 112.356 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.766 ' HG3' HD22 ' A' ' 48' ' ' LEU . 46.7 pttt -95.22 9.81 38.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.629 -0.26 . . . . 4.25 111.232 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD22 ' HG3' ' A' ' 47' ' ' LYS . 3.3 mm? -120.62 73.47 22.93 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.81 -0.177 . . . . 2.56 110.622 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.21 109.75 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.019 2.48 . . . . 1.69 113.489 -174.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.539 HD13 ' HG3' ' A' ' 62' ' ' GLN . 1.5 mp -61.82 116.15 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.765 -0.652 . . . . 1.59 110.389 174.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.89 -17.54 62.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 1.91 111.595 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HD3' ' HB ' ' A' ' 125' ' ' THR . 10.6 mpt_? -97.48 25.7 5.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.245 0.461 . . . . 3.17 112.245 -175.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -153.46 165.87 34.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 0.97 111.373 177.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.489 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 1.3 t30 -89.25 140.64 28.75 Favored Pre-proline 0 C--O 1.217 -0.655 0 CA-C-N 115.469 -0.787 . . . . 1.92 109.901 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.489 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 38.2 Cg_exo -37.78 -53.04 1.59 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 124.681 3.587 . . . . 0.7 117.339 -161.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -73.07 -45.97 54.27 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 119.419 1.008 . . . . 2.71 110.708 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' HB3' HG13 ' A' ' 24' ' ' VAL . 2.7 p30 -77.37 -20.8 54.24 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.004 -0.544 . . . . 1.63 109.563 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 24.5 tt0 -54.19 -48.07 71.38 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.563 -0.744 . . . . 1.58 109.378 169.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.427 HG13 HG23 ' A' ' 63' ' ' THR . 61.4 t -54.79 -37.9 42.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.987 -0.551 . . . . 1.27 110.576 172.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.862 ' HB2' ' HD2' ' A' ' 21' ' ' HIS . 0.4 OUTLIER -74.92 -10.53 59.57 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.932 0.396 . . . . 1.18 111.758 178.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 169' ' ' ALA . 62.2 m-85 -115.78 12.66 15.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.276 1.036 . . . . 0.99 108.756 175.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.56 ' HG2' ' H ' ' A' ' 63' ' ' THR . 8.3 tt0 -126.88 -130.6 0.23 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.401 -1.727 . . . . 1.97 108.716 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.665 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 40.7 p 39.03 106.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.956 1.465 . . . . 1.27 114.956 -176.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.938 ' HB3' HG12 ' A' ' 167' ' ' VAL . 12.5 pt-20 -97.27 151.83 19.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.991 -1.114 . . . . 1.96 107.991 168.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.614 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 22.8 ptt180 -123.23 -46.02 2.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.353 0.501 . . . . 3.35 112.353 -176.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -175.07 -175.93 0.9 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.142 -0.688 . . . . 4.71 109.142 -173.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 4.1 p30 -148.11 75.21 1.33 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.375 0.607 . . . . 4.38 110.597 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -54.7 -70.15 0.11 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.753 -0.658 . . . . 3.7 111.435 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -170.07 -161.25 0.26 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.277 -1.379 . . . . 2.2 107.277 -175.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 t -42.34 102.1 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.308 -0.626 . . . . 1.41 109.308 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.857 ' HB2' ' HD1' ' A' ' 157' ' ' PHE . 15.3 m-85 -66.63 104.99 1.41 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.74 -0.664 . . . . 1.57 109.484 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.487 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -109.43 95.04 0.86 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 119.75 -1.214 . . . . 0.78 114.193 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.553 ' CE1' HG11 ' A' ' 14' ' ' VAL . 51.6 m-85 -84.4 148.33 26.66 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.305 -0.447 . . . . 1.21 110.77 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 1.9 p-10 -127.68 127.02 43.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.742 0.782 . . . . 2.47 109.934 178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.912 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.0 mp -110.6 92.46 14.21 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 114.664 -1.153 . . . . 0.38 109.028 -176.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 34.5 Cg_exo -57.71 117.12 3.76 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.085 1.857 . . . . 0.59 111.609 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.767 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 56.4 mt -115.6 130.43 70.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.165 0.507 . . . . 0.49 111.634 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.52 -24.59 9.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.848 -0.615 . . . . 3.32 110.789 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.524 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 7.4 mm-40 -99.06 176.06 5.7 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.864 0.364 . . . . 2.16 110.575 -168.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.779 ' HG3' ' HA ' ' A' ' 136' ' ' LYS . 2.3 tt0 -126.59 160.71 29.88 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.83 -0.623 . . . . 1.2 109.817 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.584 ' N ' ' HG2' ' A' ' 80' ' ' GLU . . . 139.45 -163.84 26.03 Favored Glycine 0 C--N 1.314 -0.66 0 CA-C-N 115.576 -0.738 . . . . 0.3 111.534 -175.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 27.4 mt-10 -98.75 109.77 22.47 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 120.373 -0.531 . . . . 1.96 109.857 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.647 ' HB2' HG12 ' A' ' 133' ' ' ILE . 74.8 m-85 -94.34 124.66 38.5 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.583 -0.895 . . . . 0.71 108.583 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 177' ' ' ALA . 52.9 t -104.74 106.13 19.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-O 121.909 0.862 . . . . 0.26 109.902 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.738 HD11 HD11 ' A' ' 170' ' ' LEU . 10.9 tp -89.66 103.32 15.98 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.2 -1.364 . . . . 1.56 109.291 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 p -114.13 107.72 23.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.64 0.734 . . . . 1.14 109.364 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.612 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 1.3 pp -113.23 140.73 47.71 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.601 -0.727 . . . . 1.44 111.035 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.863 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 12.8 mptt -99.55 134.24 42.71 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.374 -0.53 . . . . 3.73 110.203 173.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' A' ' 165' ' ' PRO . 11.3 m-85 -117.17 138.01 51.96 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.696 -0.684 . . . . 0.45 110.372 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.559 ' HB3' ' CG2' ' A' ' 167' ' ' VAL . . . -147.36 161.75 40.37 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.78 -0.368 . . . . 0.51 111.252 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 166' ' ' LYS . 0.2 OUTLIER 70.61 108.03 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 124.407 1.067 . . . . 2.62 111.218 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 118' ' ' PHE . 5.0 p -120.47 82.61 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.705 0.764 . . . . 3.77 109.51 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -47.43 -49.0 26.2 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 114.901 -1.045 . . . . 5.68 111.954 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.963 ' HB2' ' HD2' ' A' ' 100' ' ' LYS . 99.2 m-85 -85.37 86.93 7.34 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.253 -0.647 . . . . 4.65 109.253 175.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.93 91.44 0.33 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.557 -0.747 . . . . 1.39 111.438 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . 5.9 tp60 -160.77 145.56 14.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.969 -0.56 . . . . 2.75 110.057 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.6 p -101.53 143.14 31.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 1.4 110.438 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 59.03 53.05 5.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.278 0.561 . . . . 2.38 109.867 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -162.99 -48.8 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.847 -0.615 . . . . 2.89 110.023 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.963 ' HD2' ' HB2' ' A' ' 94' ' ' PHE . 56.4 tttp -96.28 80.31 3.2 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.917 -0.771 . . . . 2.79 108.917 177.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.07 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.996 -1.002 . . . . 1.22 110.809 -171.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 33.9 m-85 -77.36 158.19 30.24 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.532 -0.758 . . . . 0.99 109.804 176.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.734 ' O ' ' HA ' ' A' ' 157' ' ' PHE . 50.9 m-20 -112.23 135.15 53.26 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.439 -0.949 . . . . 1.53 108.439 172.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.893 HG22 ' HD2' ' A' ' 157' ' ' PHE . 0.9 OUTLIER -125.79 119.81 55.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.164 0.506 . . . . 0.63 109.95 -177.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.712 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 79.6 mtt180 -116.83 141.87 47.66 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.017 -0.992 . . . . 1.95 111.456 -171.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 153' ' ' LEU . 41.8 t -116.5 102.25 13.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.663 -0.699 . . . . 1.44 109.153 174.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.896 ' HB2' HD12 ' A' ' 153' ' ' LEU . 23.3 t-20 57.26 46.45 18.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.227 1.013 . . . . 1.65 108.421 -170.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.79 -21.97 30.64 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.945 -1.025 . . . . 0.42 113.315 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.592 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 93.0 m-70 -78.12 108.57 11.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.268 0.47 . . . . 0.68 112.268 -173.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.51 ' CG2' ' HG2' ' A' ' 105' ' ' ARG . 5.9 p -69.35 87.81 0.45 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.779 0.323 . . . . 0.77 111.029 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.421 HG21 HG21 ' A' ' 131' ' ' ILE . 43.6 t -67.78 -55.55 16.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.154 -0.684 . . . . 0.94 109.154 175.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.597 HG21 ' HG2' ' A' ' 129' ' ' GLU . 17.3 t -112.53 90.52 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.874 -0.603 . . . . 0.35 109.72 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -107.9 73.25 0.89 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.757 0.789 . . . . 4.01 109.781 177.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 113' ' ' LYS . 9.2 p-10 164.94 32.84 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.063 -1.426 . . . . 1.96 108.536 -172.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -78.11 71.08 4.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.217 -0.901 . . . . 1.18 112.042 -170.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 119' ' ' ASP . 31.0 m-20 -77.16 93.57 3.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.937 -1.134 . . . . 1.93 107.937 167.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 61.7 mt -54.01 -39.78 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.996 0.427 . . . . 0.82 110.211 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 56.7 t80 -64.71 -39.53 93.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.417 -0.81 . . . . 1.08 110.987 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 12.1 t70 -71.98 -36.41 69.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.987 0.422 . . . . 0.96 111.431 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -77.9 -49.56 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 1.69 111.807 -171.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 127' ' ' HIS . 15.9 m -110.5 -24.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.379 -0.529 . . . . 1.49 112.284 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 112.81 -142.86 17.54 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.423 -0.894 . . . . 1.4 111.961 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -89.14 110.29 21.04 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 110.173 -0.306 . . . . 4.11 110.173 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.4 t 68.15 -150.71 0.16 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.621 -0.718 . . . . 1.97 110.909 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.514 ' HB ' ' HD3' ' A' ' 52' ' ' ARG . 20.8 p 66.57 177.85 0.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.531 1.132 . . . . 0.85 111.176 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.49 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -91.94 119.1 31.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.826 0.346 . . . . 0.57 111.574 -175.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.479 ' HA ' HG11 ' A' ' 121' ' ' VAL . 84.0 t60 -89.37 130.04 35.8 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.714 -0.847 . . . . 0.55 108.714 172.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -121.58 113.26 19.53 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.494 -0.321 . . . . 1.64 110.912 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.597 ' HG2' HG21 ' A' ' 112' ' ' VAL . 2.6 tp10 -116.53 113.62 23.02 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.696 -0.483 . . . . 1.12 109.696 177.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 65.4 mt -98.75 119.83 47.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.232 -0.44 . . . . 0.74 109.828 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.553 HG21 HG21 ' A' ' 106' ' ' VAL . 58.2 mt -125.23 89.58 52.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.233 -0.44 . . . . 1.25 110.63 -173.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -75.83 126.61 9.55 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.61 2.207 . . . . 0.29 112.019 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.647 HG12 ' HB2' ' A' ' 83' ' ' TYR . 6.0 pt -110.38 157.16 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.043 -0.725 . . . . 0.27 109.043 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 t -123.93 106.67 10.61 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.808 -0.442 . . . . 1.24 109.808 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.749 HG12 ' HG ' ' A' ' 140' ' ' LEU . 5.2 mt -104.73 137.14 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 109.021 -0.733 . . . . 0.34 109.021 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.779 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 53.1 mttm -152.77 131.13 12.08 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 123.699 0.625 . . . . 1.95 111.104 173.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.675 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 0.0 OUTLIER 56.22 27.66 12.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.147 -0.933 . . . . 3.13 111.239 177.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.62 13.62 62.75 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.792 -0.718 . . . . 0.41 113.085 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 59.2 mtpt -115.17 137.54 51.91 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.391 -0.476 . . . . 2.23 109.904 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.749 ' HG ' HG12 ' A' ' 135' ' ' ILE . 3.8 tt -115.51 121.44 42.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.314 -0.403 . . . . 0.41 110.185 -172.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.9 m -117.47 114.17 23.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.32 -0.4 . . . . 1.19 109.942 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 142' ' ' VAL . 5.5 m -90.73 111.07 23.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.97 -0.752 . . . . 0.92 108.97 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 63.55 -85.41 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.128 -0.487 . . . . 1.88 110.43 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -139.71 17.65 3.03 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.826 -0.625 . . . . 1.02 111.626 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -108.49 121.42 44.94 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.829 -0.804 . . . . 1.95 108.829 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 14.8 p -103.46 146.78 10.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.315 0.578 . . . . 0.92 111.943 -168.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.4 p -163.25 176.51 9.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.224 -0.898 . . . . 1.27 109.046 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 139' ' ' LYS . 70.3 p -100.27 138.13 37.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.711 0.291 . . . . 1.45 110.316 175.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.767 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 39.3 t80 -79.81 131.35 35.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.026 -0.361 . . . . 0.47 110.026 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.3 t -131.39 111.06 11.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.464 0.649 . . . . 1.79 111.473 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.37 -72.8 1.88 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.387 -0.824 . . . . 0.42 113.678 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -155.75 169.11 25.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.973 0.416 . . . . 1.23 110.62 -175.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.912 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 22.7 tp -80.99 150.72 28.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.707 -0.849 . . . . 1.17 108.707 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.6 t -132.53 104.11 6.51 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 118.994 -1.082 . . . . 1.35 110.353 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 15.5 t -92.91 96.44 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 108.401 -0.963 . . . . 0.42 108.401 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 105' ' ' ARG . 4.3 tt0 -107.7 121.82 45.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.495 -1.229 . . . . 1.98 109.582 -173.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.893 ' HD2' HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -113.32 115.52 28.27 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.178 -0.609 . . . . 2.32 110.116 176.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 52.9 t -82.81 140.82 15.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.971 -1.013 . . . . 0.62 110.766 -173.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.406 ' HB3' ' OD1' ' A' ' 164' ' ' ASN . 24.3 pttm -66.02 109.84 2.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.999 -1.0 . . . . 2.26 112.336 -173.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.548 ' H ' ' HD1' ' A' ' 102' ' ' PHE . . . -84.0 84.62 1.57 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.457 -0.792 . . . . 1.45 111.805 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.1 t80 63.52 63.67 0.86 Allowed 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.116 0.539 . . . . 4.24 110.81 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 16.9 t80 63.34 173.82 0.16 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.686 -0.688 . . . . 4.98 110.124 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 45.27 80.4 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.78 0.324 . . . . 2.64 110.922 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.639 ' HB3' ' HD2' ' A' ' 165' ' ' PRO . 3.4 m-20 -60.46 175.01 0.44 Allowed Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.632 -0.713 . . . . 2.06 109.711 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.639 ' HD2' ' HB3' ' A' ' 164' ' ' ASN . 73.0 Cg_exo -42.97 97.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.452 2.101 . . . . 3.16 111.989 172.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.656 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 12.9 tptm -55.62 -61.91 2.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.947 -1.024 . . . . 3.18 111.994 -162.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.938 HG12 ' HB3' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -109.77 136.87 44.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 108.341 -0.985 . . . . 1.19 108.341 171.123 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 33.9 t -137.41 89.03 2.39 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.04 0.755 . . . . 1.36 113.04 -168.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.863 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -75.39 38.4 0.14 Allowed 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 124.479 1.112 . . . . 0.31 113.273 -178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.738 HD11 HD11 ' A' ' 85' ' ' LEU . 40.7 tp -54.12 104.42 0.11 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.769 0.655 . . . . 0.69 112.769 -177.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.782 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 4.3 t80 -117.99 124.62 48.62 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.489 -0.323 . . . . 0.48 110.925 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.664 ' HB ' HD12 ' A' ' 85' ' ' LEU . 5.0 tt -114.53 123.7 70.46 Favored 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-O 122.226 1.012 . . . . 0.3 111.359 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.782 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.6 ppp? -115.68 159.88 20.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.884 -1.053 . . . . 0.99 109.99 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 53.8 tttt -105.87 133.23 50.93 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 114.1 1.148 . . . . 1.22 114.1 -170.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 106.15 -28.87 12.28 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 113.832 -1.531 . . . . 0.31 116.226 157.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.99 158.09 1.98 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.036 1.418 . . . . 0.68 113.411 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.653 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -83.86 -9.58 58.65 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.206 -0.906 . . . . 0.86 111.356 174.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 30.6 t70 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 121.157 0.504 . . . . 2.16 111.215 -178.188 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.402 ' HA2' ' OD2' ' A' ' 8' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 112.127 -0.389 . . . . 1.48 112.127 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.722 HD12 ' HE3' ' A' ' 173' ' ' MET . 50.2 tp -59.54 -36.83 76.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.305 0.574 . . . . 0.72 110.141 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -69.89 -23.42 63.24 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.485 -0.78 . . . . 0.53 111.651 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.402 ' OD2' ' HA2' ' A' ' 5' ' ' GLY . 10.8 m-20 -80.55 -16.54 53.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.026 -0.534 . . . . 2.18 111.009 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.454 ' HB2' ' HE2' ' A' ' 173' ' ' MET . 37.1 mtpt -126.22 2.77 7.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.438 -0.505 . . . . 1.79 111.785 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.522 ' HB ' ' CD1' ' A' ' 27' ' ' ILE . 11.6 p -58.78 136.91 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 120.508 -0.477 . . . . 0.33 110.176 169.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 174' ' ' LYS . 10.7 pt -115.76 -22.86 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.285 -0.416 . . . . 0.92 111.047 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.752 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 79.4 t90 -171.1 143.28 1.92 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.838 -0.431 . . . . 0.36 109.838 -173.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -162.18 137.58 7.28 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.207 -0.308 . . . . 0.26 111.553 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.402 HG11 ' CE2' ' A' ' 73' ' ' TYR . 45.2 t -142.02 125.72 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.02 -0.536 . . . . 0.79 110.885 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 28.5 t30 -101.77 104.87 15.68 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.793 -0.817 . . . . 1.49 108.793 167.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.602 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -65.52 89.11 0.1 Allowed 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.245 -0.889 . . . . 0.48 110.247 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.617 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -174.36 -67.73 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 O-C-N 125.385 1.678 . . . . 0.76 112.249 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.85 -132.38 5.69 Favored Glycine 0 C--N 1.318 -0.441 0 C-N-CA 120.757 -0.735 . . . . 0.74 112.997 -173.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 1.069 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 25.3 tt0 -138.33 119.37 14.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 111.243 0.09 . . . . 1.77 111.243 -174.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.684 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 73.1 m 36.39 108.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.584 1.698 . . . . 1.29 115.584 170.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.614 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 82.6 t60 -137.76 128.37 26.74 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.928 -0.483 . . . . 0.42 111.42 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 86.1 t -87.8 113.15 24.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.209 -0.905 . . . . 1.01 109.074 171.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -78.38 161.33 27.24 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.333 -0.247 . . . . 0.77 110.333 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 m -53.32 -27.84 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 124.585 1.178 . . . . 0.62 113.232 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.441 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 87.6 m-70 -80.34 -6.55 58.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.312 0.577 . . . . 0.86 109.559 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 96.41 24.84 13.22 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 114.955 -1.021 . . . . 0.33 112.179 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.557 HD11 ' HG ' ' A' ' 6' ' ' LEU . 19.1 mm -99.36 109.18 23.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.178 0.513 . . . . 0.31 110.937 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 7.7 t60 -86.71 110.99 20.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.139 -0.482 . . . . 0.8 110.342 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.684 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -87.48 139.13 30.85 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.084 -0.339 . . . . 1.75 110.084 175.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.498 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 13.3 ptp180 -92.97 138.66 31.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.131 0.491 . . . . 2.94 110.664 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 1.069 ' HB3' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -73.9 136.91 43.38 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.939 1.088 . . . . 2.78 113.939 -173.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' CG ' ' HZ2' ' A' ' 31' ' ' LYS . 1.1 p30 28.54 54.67 0.5 Allowed Pre-proline 0 N--CA 1.484 1.246 0 CA-C-N 111.868 -2.424 . . . . 2.41 116.09 167.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 67.3 Cg_endo -94.15 36.31 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.503 2.135 . . . . 1.87 113.006 -175.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.615 HD23 ' N ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -137.25 -54.93 0.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.477 0.547 . . . . 1.99 112.477 -178.037 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.615 ' N ' HD23 ' A' ' 34' ' ' LEU . 7.5 pt-20 -79.45 89.52 5.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.623 0.725 . . . . 5.31 110.159 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 38' ' ' VAL . . . 86.29 -10.11 67.72 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.414 -1.074 . . . . 2.64 110.414 -170.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 7.9 mmt180 67.13 -26.3 0.12 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.079 1.352 . . . . 5.64 112.301 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.466 ' H ' ' C ' ' A' ' 36' ' ' GLY . 28.6 t -127.58 116.64 44.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.777 -0.453 . . . . 3.96 109.777 177.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.75 -149.33 4.95 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.723 -0.751 . . . . 2.56 112.356 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -153.13 69.5 0.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.822 0.344 . . . . 6.2 110.639 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . . . 52.06 81.54 0.08 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.706 -0.679 . . . . 2.0 112.492 172.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.785 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 13.9 m -81.92 65.15 6.93 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.347 -0.388 . . . . 2.52 110.301 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -75.49 57.88 0.97 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.828 0.823 . . . . 2.52 111.452 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -110.39 125.84 53.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.467 -0.788 . . . . 7.02 109.044 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.29 8.02 60.3 Favored Glycine 0 C--O 1.227 -0.315 0 N-CA-C 110.741 -0.943 . . . . 3.06 110.741 -172.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.861 ' HG3' ' HA ' ' A' ' 63' ' ' THR . 23.9 ttt -70.59 -0.4 8.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.988 -0.606 . . . . 2.35 111.734 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HE2' ' HD3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -80.16 69.75 6.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.521 0.676 . . . . 4.25 110.628 -179.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.616 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 0.7 OUTLIER -153.81 74.03 6.43 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.225 -1.028 . . . . 2.56 108.225 176.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.438 ' HD3' ' HE2' ' A' ' 47' ' ' LYS . 14.5 Cg_endo -59.15 118.75 5.68 Favored 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.5 2.133 . . . . 1.69 112.788 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' A' ' 62' ' ' GLN . 1.7 mp -80.39 99.42 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.863 0.84 . . . . 1.59 109.712 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.486 ' HB3' HG22 ' A' ' 125' ' ' THR . 2.8 tt -60.95 -35.51 76.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.592 -1.186 . . . . 1.91 110.962 -178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -88.09 33.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.951 0.722 . . . . 3.17 112.951 -171.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.446 ' HB2' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -142.62 168.16 20.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.8 0.333 . . . . 0.97 110.878 172.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -90.21 141.42 27.69 Favored Pre-proline 0 C--O 1.219 -0.548 0 N-CA-C 108.958 -0.756 . . . . 1.92 108.958 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.425 ' O ' HG23 ' A' ' 59' ' ' VAL . 60.3 Cg_exo -39.67 -42.74 2.96 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 124.101 3.201 . . . . 0.7 115.947 -162.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -76.54 -44.37 35.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.248 0.476 . . . . 2.71 111.361 -177.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' N ' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -81.2 -17.48 49.48 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.234 -0.654 . . . . 1.63 109.234 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -58.85 -45.69 89.52 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.174 -0.921 . . . . 1.58 109.135 167.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 55' ' ' PRO . 68.8 t -55.19 -44.6 75.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.487 0.66 . . . . 1.27 109.593 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 15' ' ' ASN . 35.0 tp -63.72 -18.94 64.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.644 -1.162 . . . . 1.18 112.141 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.614 ' CE2' ' HE2' ' A' ' 88' ' ' LYS . 13.6 m-30 -114.91 1.55 14.06 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 111.894 0.331 . . . . 0.99 111.894 -175.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 39.2 tt0 -124.3 -41.36 2.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.626 0.973 . . . . 1.97 113.626 -170.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.861 ' HA ' ' HG3' ' A' ' 46' ' ' MET . 2.1 m -61.1 132.49 53.93 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 121.072 -0.251 . . . . 1.27 111.451 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 1.029 ' HB2' HG22 ' A' ' 167' ' ' VAL . 36.5 tt0 -120.33 147.75 44.62 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.123 0.569 . . . . 1.96 110.397 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.785 ' HA ' ' O ' ' A' ' 42' ' ' SER . 16.6 mtm-85 -103.83 -170.51 1.79 Allowed 'General case' 0 N--CA 1.463 0.184 0 O-C-N 123.232 0.333 . . . . 3.35 110.931 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.525 ' O ' ' HB3' ' A' ' 165' ' ' PRO . 51.2 t80 -79.23 -59.52 2.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.574 -0.284 . . . . 4.71 110.692 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 59.76 -164.66 0.21 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.583 -0.28 . . . . 4.38 111.212 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -160.35 -91.82 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.94 0.4 . . . . 3.7 111.82 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.968 ' HA ' HD22 ' A' ' 164' ' ' ASN . 19.2 t0 -149.36 142.22 24.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.575 -0.284 . . . . 2.2 110.283 -173.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.5 t 45.96 62.59 2.17 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 124.159 0.912 . . . . 1.41 110.437 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.813 ' HZ ' ' HA ' ' A' ' 165' ' ' PRO . 8.4 p90 -107.28 126.61 52.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.132 -1.027 . . . . 1.57 110.838 -176.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.467 ' O ' HD12 ' A' ' 34' ' ' LEU . . . -145.4 154.06 25.68 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.942 -1.027 . . . . 0.78 113.295 -173.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.602 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 53.5 m-85 -104.85 164.97 11.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.303 -0.448 . . . . 1.21 111.156 -175.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 8.0 p-10 -115.42 118.8 34.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.741 -0.663 . . . . 2.47 110.463 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.845 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.8 mp -104.5 90.88 3.59 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.333 -0.849 . . . . 0.38 109.302 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 38.4 Cg_exo -59.74 120.04 7.61 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.251 1.967 . . . . 0.59 112.405 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.775 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 72.4 mt -119.86 135.98 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.867 0.365 . . . . 0.49 111.236 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.484 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 32.6 mtpt -130.9 7.67 4.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 3.32 110.736 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.47 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 38.0 mt-10 -131.88 174.41 10.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.975 0.416 . . . . 2.16 110.882 -173.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 9.0 mt-10 -112.82 -172.99 2.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.778 -0.646 . . . . 1.2 110.112 176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.33 -167.48 13.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.895 -0.669 . . . . 0.3 112.191 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.651 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 56.2 mt-10 -97.34 103.3 15.22 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 117.29 0.545 . . . . 1.96 109.747 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.666 ' HB2' HG12 ' A' ' 133' ' ' ILE . 10.9 m-30 -95.64 123.25 39.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 118.985 -1.086 . . . . 0.71 108.398 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.984 HG21 ' HA ' ' A' ' 177' ' ' ALA . 74.7 t -114.71 106.68 21.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.518 -0.764 . . . . 0.26 110.268 -172.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 85' ' ' LEU . 5.1 mp -88.82 104.47 16.94 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.457 -1.247 . . . . 1.56 109.493 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.608 HG22 HG23 ' A' ' 130' ' ' ILE . 44.2 t -103.34 100.73 11.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 107.539 -1.282 . . . . 1.14 107.539 171.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.615 ' CB ' ' HA ' ' A' ' 170' ' ' LEU . 0.6 OUTLIER -109.23 132.24 54.31 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.106 -0.638 . . . . 1.44 109.803 -178.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.994 ' HB2' ' HB3' ' A' ' 169' ' ' ALA . 13.8 mptt -89.09 122.61 32.58 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.129 -0.628 . . . . 3.73 110.393 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.14 135.21 48.01 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.227 -0.897 . . . . 0.45 108.645 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.843 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -125.62 121.91 34.92 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.095 0.474 . . . . 0.51 109.968 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 92' ' ' VAL . 2.9 tp10 -165.88 143.48 5.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.817 -1.538 . . . . 2.62 108.374 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 91' ' ' GLU . 0.9 OUTLIER 171.91 -27.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 124.585 1.154 . . . . 3.77 108.253 -177.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -60.05 -32.76 71.22 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.294 -0.866 . . . . 5.68 110.675 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.503 ' HB2' ' NZ ' ' A' ' 100' ' ' LYS . 89.3 m-85 -96.86 85.36 3.77 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.599 -0.889 . . . . 4.65 108.599 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.45 102.57 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.669 -0.696 . . . . 1.39 112.578 -172.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -170.87 139.75 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.363 -0.835 . . . . 2.75 109.174 170.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.878 ' HB2' ' HB2' ' A' ' 119' ' ' ASP . 14.2 p -129.13 159.89 34.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.443 -0.344 . . . . 1.4 111.439 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.868 ' HA ' HE21 ' A' ' 98' ' ' GLN . 0.0 OUTLIER 48.0 44.19 18.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.436 0.694 . . . . 2.38 112.247 178.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -147.97 -61.52 0.26 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.872 -0.788 . . . . 2.89 108.872 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.663 ' HB3' ' HB2' ' A' ' 161' ' ' TYR . 50.2 pttt -86.99 98.15 11.11 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.6 -0.727 . . . . 2.79 109.234 172.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.928 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 6.4 m -108.96 109.82 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.477 0.656 . . . . 1.22 110.356 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.711 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 23.5 m-85 -73.87 154.33 39.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.102 -0.954 . . . . 0.99 110.887 -175.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.681 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 12.5 m-20 -105.75 137.81 42.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.469 -0.567 . . . . 1.53 109.469 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 112' ' ' VAL . 2.5 t -134.47 120.18 32.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.762 0.315 . . . . 0.63 110.682 -176.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 61.4 mtt180 -120.26 141.98 49.47 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.671 -0.695 . . . . 1.95 111.666 -174.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.872 HG23 HD21 ' A' ' 153' ' ' LEU . 2.8 p -118.43 102.78 13.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.75 -0.659 . . . . 1.44 109.845 172.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.415 ' HA ' ' H ' ' A' ' 154' ' ' SER . 64.7 t30 55.44 51.45 12.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.266 -0.879 . . . . 1.65 109.342 -172.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.31 -17.67 46.41 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.085 -0.961 . . . . 0.42 113.313 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 105' ' ' ARG . 90.2 m-70 -85.49 105.45 16.11 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.098 0.407 . . . . 0.68 112.098 -172.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.575 ' HB ' ' HD2' ' A' ' 113' ' ' LYS . 1.9 p -69.91 94.3 0.83 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.043 0.449 . . . . 0.77 111.174 176.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.46 HG23 HG12 ' A' ' 106' ' ' VAL . 21.5 t -78.12 -49.62 21.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.643 0.735 . . . . 0.94 109.409 176.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.521 HG11 HD13 ' A' ' 115' ' ' LEU . 9.4 t -118.39 90.08 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.437 -0.801 . . . . 0.35 109.714 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.575 ' HD2' ' HB ' ' A' ' 110' ' ' THR . 0.4 OUTLIER -109.45 71.66 0.78 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.906 -1.146 . . . . 4.01 107.906 176.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.928 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 6.6 p-10 168.86 19.29 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.026 -1.897 . . . . 1.96 109.698 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.711 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 11.5 tp -73.35 99.43 2.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.182 -0.463 . . . . 1.18 111.512 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.589 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 23.3 p-10 -110.59 91.08 3.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.161 0.981 . . . . 1.93 109.873 174.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.6 mm -52.9 -44.3 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 114.632 -1.167 . . . . 0.82 112.483 -170.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.53 ' HD1' HG22 ' A' ' 92' ' ' VAL . 69.5 t80 -56.96 -39.56 74.83 Favored 'General case' 0 C--O 1.222 -0.39 0 O-C-N 123.341 0.4 . . . . 1.08 111.755 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.878 ' HB2' ' HB2' ' A' ' 97' ' ' SER . 21.2 t70 -73.18 -32.61 64.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.115 0.483 . . . . 0.96 110.849 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 8.6 mmt180 -71.5 -44.43 64.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.634 -0.712 . . . . 1.69 111.084 -173.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.77 -40.38 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.323 0.49 . . . . 1.49 112.323 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.25 -58.26 4.96 Favored Glycine 0 C--O 1.23 -0.137 0 C-N-CA 121.133 -0.556 . . . . 1.4 112.104 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -99.92 145.42 27.84 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.436 -0.579 . . . . 4.11 109.436 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.419 ' OG ' HG11 ' A' ' 92' ' ' VAL . 3.0 m -54.38 94.06 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 O-C-N 123.691 0.619 . . . . 1.97 111.03 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 51' ' ' LEU . 21.2 p -150.05 -174.9 4.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.217 -0.447 . . . . 0.85 109.872 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.567 ' HB2' ' CG2' ' A' ' 50' ' ' ILE . . . -79.92 124.14 28.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.563 -0.29 . . . . 0.57 111.007 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -104.87 145.15 30.79 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.723 -1.214 . . . . 0.55 107.723 168.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.73 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 23.8 p-10 -146.81 139.83 25.33 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.931 -0.708 . . . . 1.64 112.141 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -103.85 114.02 27.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.219 -0.901 . . . . 1.12 108.598 172.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.608 HG23 HG22 ' A' ' 86' ' ' VAL . 71.6 mt -95.73 110.05 23.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.997 -0.547 . . . . 0.74 109.629 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.8 mt -119.7 97.45 49.83 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.37 -0.377 . . . . 1.25 111.162 -173.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -78.68 123.75 6.01 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.717 2.278 . . . . 0.29 112.108 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.666 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.9 pt -110.03 154.05 11.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 108.727 -0.842 . . . . 0.27 108.727 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.9 p -123.78 109.42 13.64 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.852 0.358 . . . . 1.24 110.323 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.718 HG12 ' HG ' ' A' ' 140' ' ' LEU . 29.2 mt -98.82 125.11 52.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.049 -0.722 . . . . 0.34 109.049 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -151.0 135.57 17.1 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.71 0.631 . . . . 1.95 109.435 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 1.066 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 7.6 mmpt? 61.98 25.85 15.55 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.538 0.524 . . . . 3.13 111.316 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.25 9.98 85.96 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.731 -0.747 . . . . 0.41 112.167 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.746 ' HG2' HG22 ' A' ' 148' ' ' THR . 26.3 mtpp -110.83 137.48 48.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.406 -0.59 . . . . 2.23 109.406 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.718 ' HG ' HG12 ' A' ' 135' ' ' ILE . 4.9 tt -108.68 115.32 29.88 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.415 -0.587 . . . . 0.41 109.415 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 m -108.4 125.12 51.39 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.893 -0.594 . . . . 1.19 110.091 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.405 HG21 HG13 ' A' ' 106' ' ' VAL . 85.5 t -113.09 95.5 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.769 -0.456 . . . . 0.92 109.769 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 62.39 -91.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.427 -0.806 . . . . 1.88 111.132 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -106.3 -10.46 29.54 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.922 -0.656 . . . . 1.02 112.594 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -97.47 149.98 21.57 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.803 -0.234 . . . . 1.95 110.763 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.92 125.76 13.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.168 0.509 . . . . 0.92 110.865 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.0 m -155.42 141.72 18.53 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.626 -0.509 . . . . 1.27 109.626 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.746 HG22 ' HG2' ' A' ' 139' ' ' LYS . 25.1 p -59.09 140.93 55.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.2 0.524 . . . . 1.45 111.131 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.775 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 20.8 t80 -85.83 140.85 30.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.45 -0.795 . . . . 0.47 110.301 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 t -144.41 118.01 9.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.509 0.671 . . . . 1.79 110.923 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.21 -77.8 2.08 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.324 -0.853 . . . . 0.42 113.607 174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -159.72 169.47 23.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.038 0.447 . . . . 1.23 110.975 -174.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.872 HD21 HG23 ' A' ' 106' ' ' VAL . 6.7 tt -84.34 135.35 34.34 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.778 -0.823 . . . . 1.17 108.778 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.475 ' N ' HD23 ' A' ' 153' ' ' LEU . 8.1 t -121.34 109.07 14.46 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.903 -0.719 . . . . 1.35 110.538 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 45.2 t -95.23 98.06 7.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.722 -0.473 . . . . 0.42 109.722 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -114.95 134.3 55.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.205 -0.452 . . . . 1.98 110.434 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.737 ' HE2' ' CE2' ' A' ' 71' ' ' PHE . 0.1 OUTLIER -123.5 136.76 54.74 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 121.621 0.724 . . . . 2.32 111.418 176.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 42.2 t -104.5 145.44 13.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 114.002 -1.454 . . . . 0.62 111.525 -170.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.844 ' HA ' ' HB2' ' A' ' 164' ' ' ASN . 85.7 tttt -46.88 129.28 11.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 113.973 -1.467 . . . . 2.26 113.338 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -97.54 -70.07 1.0 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.395 -0.821 . . . . 1.45 111.512 174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.663 ' HB2' ' HB3' ' A' ' 100' ' ' LYS . 38.3 t80 -123.86 -84.23 0.65 Allowed 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.592 -0.358 . . . . 4.24 110.404 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -126.67 -3.82 6.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.651 1.215 . . . . 4.98 108.281 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.71 37.98 3.76 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 113.298 -1.774 . . . . 2.64 110.779 -168.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.968 HD22 ' HA ' ' A' ' 69' ' ' ASP . 53.9 t30 -62.45 -49.91 81.39 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 107.801 -1.185 . . . . 2.06 107.801 164.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.813 ' HA ' ' HZ ' ' A' ' 71' ' ' PHE . 34.8 Cg_exo -62.35 108.59 0.71 Allowed 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 122.091 1.861 . . . . 3.16 111.108 169.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.503 ' HE3' ' CD2' ' A' ' 102' ' ' PHE . 14.0 pttm -147.89 177.16 9.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.296 -0.411 . . . . 3.18 110.347 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 1.029 HG22 ' HB2' ' A' ' 64' ' ' GLU . 52.1 t -69.45 135.44 28.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 120.646 -0.422 . . . . 1.19 110.079 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 11.5 t -141.92 86.4 1.98 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 119.084 -1.046 . . . . 1.36 113.592 -175.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.994 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . . . -75.68 37.02 0.14 Allowed 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.718 1.207 . . . . 0.31 112.564 177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.752 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 23.3 tp -50.5 101.97 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.659 0.784 . . . . 0.69 113.111 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.736 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 5.0 t80 -114.82 128.29 56.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.832 -0.622 . . . . 0.48 110.626 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.681 HG22 ' HE3' ' A' ' 12' ' ' TRP . 6.4 tt -121.15 124.82 72.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-O 121.529 0.68 . . . . 0.3 111.349 174.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.736 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 2.0 ppp? -115.32 166.06 12.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.801 -0.636 . . . . 0.99 109.395 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.445 ' HB3' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -120.14 148.73 43.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.4 1.095 . . . . 1.22 112.888 -170.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.52 -28.76 14.15 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-N 113.531 -1.668 . . . . 0.31 114.285 163.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.651 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.7 OUTLIER -166.62 152.24 8.19 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.545 0.943 . . . . 0.68 113.545 -174.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.984 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -85.1 -15.39 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.105 -0.952 . . . . 0.86 110.223 167.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.434 ' H ' ' HB ' ' A' ' 176' ' ' THR . 20.2 t70 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 114.965 -1.016 . . . . 2.16 112.002 -173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.73 0 N-CA-C 110.977 -0.849 . . . . 1.48 110.977 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.661 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.5 tp -65.27 -27.49 68.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.085 0.469 . . . . 0.72 110.557 -174.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -71.01 -22.68 62.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.755 -0.657 . . . . 0.53 111.385 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.402 ' OD2' ' HG2' ' A' ' 9' ' ' LYS . 6.3 t70 -68.05 -42.13 80.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.207 0.527 . . . . 2.18 110.518 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 0.9 OUTLIER -103.29 -11.47 17.92 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.492 -0.776 . . . . 1.79 112.412 -168.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 12.4 p -59.96 131.25 24.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 120.401 -0.52 . . . . 0.33 111.015 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.509 HD11 HD13 ' A' ' 172' ' ' ILE . 22.7 pt -106.67 -22.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.952 -0.567 . . . . 0.92 110.071 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.741 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 34.9 t90 -168.81 142.13 2.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.775 -0.648 . . . . 0.36 109.595 -169.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -158.03 136.11 10.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.686 0.279 . . . . 0.26 111.195 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.801 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 18.8 t -146.71 125.18 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.418 0.627 . . . . 0.79 111.933 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 47.2 t30 -94.33 103.58 15.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.79 -1.189 . . . . 1.49 107.79 164.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -62.15 91.04 0.03 OUTLIER 'General case' 0 C--O 1.245 0.828 0 N-CA-C 107.881 -1.155 . . . . 0.48 107.881 171.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.781 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . 131.98 62.5 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.339 0 O-C-N 125.009 1.443 . . . . 0.76 113.169 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.92 -136.37 2.86 Favored Glycine 0 C--N 1.315 -0.593 0 C-N-CA 119.893 -1.146 . . . . 0.74 112.674 166.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.853 ' HG3' ' HD3' ' A' ' 31' ' ' LYS . 35.0 tt0 -161.64 118.12 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 119.724 -0.179 . . . . 1.77 110.952 171.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.731 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 60.1 p 31.36 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.567 1.167 . . . . 1.29 113.518 174.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.69 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 73.4 t60 -125.4 136.21 53.19 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.979 -0.688 . . . . 0.42 111.276 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.4 114.4 37.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.983 -0.553 . . . . 1.01 110.285 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.816 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -72.3 152.35 42.18 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.312 -0.625 . . . . 0.77 109.312 176.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG22 ' OD2' ' A' ' 57' ' ' ASP . 29.1 m -61.65 -10.83 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 113.594 0.961 . . . . 0.62 113.594 -170.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.484 ' HB2' HD23 ' A' ' 6' ' ' LEU . 65.5 m-70 -92.87 -3.44 54.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.972 -0.751 . . . . 0.86 108.972 176.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 97.89 30.77 6.96 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.991 -1.004 . . . . 0.33 112.679 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.661 HD11 ' HG ' ' A' ' 6' ' ' LEU . 29.8 mm -103.83 108.09 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.127 0.489 . . . . 0.31 110.689 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -94.42 113.22 25.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 0.8 111.229 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.801 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -80.99 132.5 35.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.149 -0.478 . . . . 1.75 110.631 175.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.847 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 5.2 ptm180 -90.74 113.51 25.64 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.451 0.47 . . . . 2.94 110.673 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.853 ' HD3' ' HG3' ' A' ' 19' ' ' GLU . 39.0 ttpt -32.95 109.54 0.07 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.401 1.63 . . . . 2.78 115.401 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 59.3 m-20 23.7 63.02 0.39 Allowed Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 126.352 1.861 . . . . 2.41 114.715 168.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.847 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 17.7 Cg_endo -100.26 46.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.47 2.78 . . . . 1.87 113.823 -172.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.444 HD13 ' NH1' ' A' ' 65' ' ' ARG . 6.3 mp -82.2 -77.68 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.466 -0.494 . . . . 1.99 110.927 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.592 ' CD ' ' HD2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -132.83 32.73 3.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.993 -0.549 . . . . 5.31 111.967 -170.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.58 -14.65 50.17 Favored Glycine 0 C--N 1.322 -0.196 0 C-N-CA 120.595 -0.812 . . . . 2.64 113.284 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.592 ' HD2' ' CD ' ' A' ' 35' ' ' GLU . 52.6 mtt85 -79.43 65.5 4.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.613 -0.514 . . . . 5.64 109.613 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.802 HG12 ' HE3' ' A' ' 31' ' ' LYS . 22.1 t -105.2 118.57 52.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.309 -0.859 . . . . 3.96 110.787 -173.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA2' ' HD2' ' A' ' 31' ' ' LYS . . . 93.17 15.83 49.81 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 2.56 112.279 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.1 mtm180 -129.56 62.84 1.53 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.279 0.562 . . . . 6.2 110.122 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.77 -45.27 82.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.877 -1.056 . . . . 2.0 111.223 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.0 m 69.27 61.6 0.3 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.558 -0.904 . . . . 2.52 108.558 -171.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' HB2' ' CB ' ' A' ' 46' ' ' MET . 4.6 p-10 -72.04 60.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.182 -1.372 . . . . 2.52 112.708 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -86.35 -20.36 28.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.156 0.503 . . . . 7.02 109.678 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -98.59 1.04 58.29 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.724 -0.671 . . . . 3.06 111.954 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' A' ' 46' ' ' MET . 40.7 ttm -73.16 -0.42 14.17 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.445 0.641 . . . . 2.35 110.55 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 47' ' ' LYS . 10.7 ttpp -102.03 14.05 33.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.37 0.605 . . . . 4.25 110.017 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 48' ' ' LEU . 3.4 mm? -117.32 87.24 23.74 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.758 -0.655 . . . . 2.56 109.898 175.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -42.87 133.76 5.56 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.186 2.591 . . . . 1.69 112.157 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.1 tp -83.36 -7.09 10.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.05 -0.523 . . . . 1.59 111.699 -171.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 125' ' ' THR . 9.1 mp 64.45 -67.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.503 0.721 . . . . 1.91 112.541 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -77.36 36.47 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.42 0.526 . . . . 3.17 112.42 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.2 t -157.23 143.82 18.16 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.082 -0.34 . . . . 0.97 110.082 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -65.71 145.35 99.04 Favored Pre-proline 0 C--O 1.223 -0.323 0 CA-C-N 115.659 -0.701 . . . . 1.92 109.737 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -41.12 -45.01 5.36 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.577 3.518 . . . . 0.7 115.462 -166.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.737 ' O ' HG12 ' A' ' 59' ' ' VAL . 7.0 pt-20 -72.42 -46.91 52.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.019 0.914 . . . . 2.71 110.614 -176.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.816 ' OD1' ' HA ' ' A' ' 23' ' ' ASP . 68.3 m-20 -79.06 -14.63 59.04 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.553 -0.717 . . . . 1.63 109.56 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 33.2 tt0 -59.75 -49.55 77.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.136 -0.938 . . . . 1.58 109.269 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 56' ' ' GLU . 13.6 p -60.19 -35.27 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 119.726 -0.789 . . . . 1.27 110.055 176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.69 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 16.2 tp -69.34 -13.24 62.27 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.843 0.354 . . . . 1.18 111.763 176.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.537 ' CG ' ' HG2' ' A' ' 88' ' ' LYS . 15.8 m-30 -119.11 3.22 11.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.461 -0.336 . . . . 0.99 111.329 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.49 ' HA ' HD13 ' A' ' 50' ' ' ILE . 6.8 tt0 -121.25 -49.54 2.16 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.367 0.877 . . . . 1.97 113.367 -167.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.781 ' HB ' ' O ' ' A' ' 17' ' ' GLY . 20.8 m -74.05 133.17 42.89 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.766 -0.373 . . . . 1.27 111.221 -173.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' HB3' HG22 ' A' ' 167' ' ' VAL . 2.1 pm0 -93.32 162.25 14.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 1.96 109.889 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.55 ' NH1' ' HB2' ' A' ' 37' ' ' ARG . 9.4 ttp180 -103.12 168.79 8.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.167 -0.679 . . . . 3.35 109.167 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.513 ' H ' ' HG2' ' A' ' 65' ' ' ARG . 40.1 t80 -56.3 119.29 5.75 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.285 0.564 . . . . 4.71 110.312 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.45 HD21 ' N ' ' A' ' 164' ' ' ASN . 17.3 t-20 -83.83 142.54 30.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.316 -0.856 . . . . 4.38 110.239 -176.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -138.54 -94.07 0.19 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.774 -0.194 . . . . 3.7 110.82 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.655 ' HA ' HD21 ' A' ' 164' ' ' ASN . 12.1 t70 -171.04 126.31 0.68 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 122.353 0.261 . . . . 2.2 110.958 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t 44.49 68.07 0.6 Allowed 'General case' 0 N--CA 1.463 0.203 0 O-C-N 124.122 0.888 . . . . 1.41 110.336 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.519 ' CE2' ' HE2' ' A' ' 157' ' ' PHE . 24.5 p90 -125.3 134.54 52.21 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.611 -0.722 . . . . 1.57 109.541 -172.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.79 -151.76 5.78 Favored Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.243 -0.889 . . . . 0.78 112.522 -174.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.586 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -142.01 160.06 40.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.1 0.476 . . . . 1.21 111.334 -171.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.73 ' HB3' ' HG3' ' A' ' 152' ' ' LYS . 2.6 m-20 -110.23 117.5 33.85 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.495 -0.775 . . . . 2.47 109.511 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.486 HD12 HD22 ' A' ' 153' ' ' LEU . 5.9 mt -106.58 90.64 5.17 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.187 -0.671 . . . . 0.38 109.187 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HA ' ' CB ' ' A' ' 152' ' ' LYS . 37.1 Cg_endo -67.22 116.08 4.0 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.015 1.143 . . . . 0.59 111.96 -175.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.844 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 62.1 mt -107.52 130.99 58.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.948 -0.569 . . . . 0.49 110.418 -174.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -122.64 5.95 9.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.228 -0.442 . . . . 3.32 110.474 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -132.5 172.21 12.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.504 -0.317 . . . . 2.16 110.215 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.57 ' HG2' HG22 ' A' ' 135' ' ' ILE . 9.5 mt-10 -114.67 176.42 5.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.895 0.379 . . . . 1.2 110.753 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.72 -166.14 21.32 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.76 -0.936 . . . . 0.3 110.76 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 133' ' ' ILE . 24.7 mt-10 -103.0 107.17 17.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.52 0.66 . . . . 1.96 109.587 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.653 ' HB2' HG12 ' A' ' 133' ' ' ILE . 93.3 m-85 -94.33 124.69 38.51 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 119.803 -0.759 . . . . 0.71 109.074 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.642 HG21 ' CA ' ' A' ' 177' ' ' ALA . 96.9 t -113.49 107.67 23.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.669 -0.696 . . . . 0.26 110.764 -171.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 85' ' ' LEU . 4.9 mp -90.12 104.78 17.32 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.475 -1.239 . . . . 1.56 109.146 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.65 105.12 17.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.224 -1.028 . . . . 1.14 108.224 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.576 ' HG ' HD13 ' A' ' 170' ' ' LEU . 3.7 mp -100.81 132.24 46.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.814 -0.81 . . . . 1.44 108.814 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.796 ' HD2' ' HB3' ' A' ' 128' ' ' ASP . 23.5 tptt -96.63 114.73 26.41 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.683 -0.858 . . . . 3.73 108.683 173.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -104.56 137.12 42.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.82 -0.627 . . . . 0.45 109.373 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.728 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -133.09 133.64 43.24 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.544 -0.753 . . . . 0.51 111.262 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 124' ' ' SER . 8.3 tp10 -124.42 112.79 17.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.007 -0.997 . . . . 2.62 108.332 173.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.604 HG22 ' HE3' ' A' ' 166' ' ' LYS . 23.4 m -61.84 -40.69 87.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.536 -0.756 . . . . 3.77 112.133 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.67 95.84 0.04 OUTLIER 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.969 0.414 . . . . 5.68 111.854 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -140.77 92.46 2.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.219 -1.03 . . . . 4.65 108.219 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.484 ' HA ' ' CE1' ' A' ' 118' ' ' PHE . . . -80.87 61.52 4.53 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.826 -0.625 . . . . 1.39 112.32 -170.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -154.47 138.37 16.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.093 -0.336 . . . . 2.75 110.093 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 119' ' ' ASP . 31.3 t -102.77 151.47 22.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.049 -0.523 . . . . 1.4 110.334 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 54.13 35.19 21.77 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.835 -0.62 . . . . 2.38 111.696 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -124.4 -61.47 1.33 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.748 -0.834 . . . . 2.89 108.748 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -90.4 92.07 8.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.55 -0.907 . . . . 2.79 108.55 170.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 15.2 m -108.81 120.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.292 0.567 . . . . 1.22 110.261 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.724 ' HB3' ' HG3' ' A' ' 165' ' ' PRO . 18.4 m-85 -88.68 150.74 22.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.56 -0.745 . . . . 0.99 110.864 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 23.5 m-20 -104.51 134.74 47.19 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.165 -1.05 . . . . 1.53 108.165 169.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.404 HG21 HD12 ' A' ' 115' ' ' LEU . 4.8 t -134.89 115.52 19.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.088 0.471 . . . . 0.63 110.638 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.581 ' HB3' HG23 ' A' ' 110' ' ' THR . 23.2 ptt180 -124.42 126.41 45.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.664 -0.698 . . . . 1.95 111.889 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.681 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 32.1 m -102.86 131.72 50.54 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 N-CA-C 108.982 -0.748 . . . . 1.44 108.982 173.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.577 HD22 ' HG ' ' A' ' 153' ' ' LEU . 1.6 p30 48.44 44.43 20.41 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.862 0.465 . . . . 1.65 111.553 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.24 -1.79 63.62 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.917 -0.583 . . . . 0.42 112.676 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.681 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 52.5 m-70 -101.73 103.18 13.93 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.274 0.629 . . . . 0.68 111.202 -173.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.581 HG23 ' HB3' ' A' ' 105' ' ' ARG . 0.9 OUTLIER -69.23 98.61 1.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.377 0.608 . . . . 0.77 111.12 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.43 -52.0 15.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.631 -0.713 . . . . 0.94 109.71 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.56 HG11 ' HG ' ' A' ' 115' ' ' LEU . 3.8 t -117.68 94.33 3.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.714 -0.676 . . . . 0.35 109.811 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -111.86 73.26 0.81 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.566 0.698 . . . . 4.01 109.353 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.601 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 12.2 p-10 162.71 27.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 113.72 -1.582 . . . . 1.96 108.834 -178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -69.4 91.95 0.58 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.405 -0.816 . . . . 1.18 111.199 -172.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 24.0 p-10 -101.9 96.96 7.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.767 0.794 . . . . 1.93 109.275 171.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.7 mt -53.78 -35.76 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.979 -1.01 . . . . 0.82 111.954 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 122' ' ' GLY . 84.7 t80 -56.12 -44.66 79.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.25 -0.432 . . . . 1.08 111.251 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.465 ' HB2' ' OG ' ' A' ' 97' ' ' SER . 15.3 t70 -72.53 -35.71 68.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.34 -0.391 . . . . 0.96 111.525 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 5.3 mmt180 -75.62 -42.48 51.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.239 -0.437 . . . . 1.69 111.776 -170.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 p -117.37 -28.05 2.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.538 -0.465 . . . . 1.49 111.875 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 118' ' ' PHE . . . 124.21 -151.46 17.17 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.851 -0.899 . . . . 1.4 110.851 -175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -92.39 122.92 35.31 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.263 -0.575 . . . . 4.11 109.972 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 11.0 m 65.27 -142.6 0.21 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.779 . . . . 1.97 110.39 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 59.2 p 58.13 -174.22 0.09 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.711 0.804 . . . . 0.85 111.865 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.3 131.57 53.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.907 0.385 . . . . 0.57 111.816 -176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 18.2 t60 -107.09 142.82 36.15 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 108.651 -0.87 . . . . 0.55 108.651 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.796 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 5.4 p-10 -129.54 123.87 32.47 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.524 0.678 . . . . 1.64 110.779 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -104.57 110.91 23.39 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.922 -1.035 . . . . 1.12 109.148 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.76 111.52 25.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.865 -0.607 . . . . 0.74 110.208 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 59.9 mt -118.81 95.71 49.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.242 -0.435 . . . . 1.25 110.751 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.443 ' HB3' HG22 ' A' ' 84' ' ' VAL . 5.9 Cg_exo -81.23 128.85 6.51 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.068 2.512 . . . . 0.29 112.202 176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.705 ' HB ' HD21 ' A' ' 140' ' ' LEU . 3.5 pt -110.5 162.1 8.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.756 -0.831 . . . . 0.27 108.756 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.5 t -127.48 106.57 9.28 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.488 -0.324 . . . . 1.24 110.164 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.779 HG12 ' HG ' ' A' ' 140' ' ' LEU . 21.8 mt -101.05 124.04 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 109.236 -0.654 . . . . 0.34 109.236 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -148.16 125.12 11.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.824 -0.626 . . . . 1.95 109.395 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.2 OUTLIER 63.9 28.91 14.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.664 -0.698 . . . . 3.13 111.558 -178.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.04 14.33 80.79 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.958 -0.639 . . . . 0.41 112.374 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.569 ' HG2' HG22 ' A' ' 148' ' ' THR . 55.0 mtpt -116.66 147.8 41.6 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.61 -0.515 . . . . 2.23 109.61 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.779 ' HG ' HG12 ' A' ' 135' ' ' ILE . 3.1 tt -118.06 127.46 53.82 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.07 -0.345 . . . . 0.41 110.07 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 15.0 m -114.6 125.29 53.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.053 -0.521 . . . . 1.19 110.203 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.42 HG23 HD22 ' A' ' 140' ' ' LEU . 85.6 t -118.62 98.5 6.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.672 0.272 . . . . 0.92 110.715 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 56.7 26.56 11.45 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.823 -0.626 . . . . 1.88 112.145 173.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 129.86 -39.6 1.8 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.767 -0.651 . . . . 1.02 112.343 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 141' ' ' SER . 39.9 mt-10 -68.78 114.17 6.88 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.075 -0.342 . . . . 1.95 110.075 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.2 p -108.53 115.9 50.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.307 0.575 . . . . 0.92 110.747 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 m -135.85 176.51 8.61 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.869 -0.789 . . . . 1.27 108.869 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.569 HG22 ' HG2' ' A' ' 139' ' ' LYS . 37.1 p -91.23 138.51 31.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.912 -0.403 . . . . 1.45 109.912 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.844 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 92.5 t80 -79.92 129.47 34.51 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.846 -0.427 . . . . 0.47 109.846 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.6 t -121.07 96.05 4.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.649 0.738 . . . . 1.79 112.062 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.93 -66.76 2.11 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.34 -0.845 . . . . 0.42 114.23 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.73 ' HG3' ' HB3' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -148.58 160.26 43.29 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.291 0.567 . . . . 1.23 111.014 -173.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.577 ' HG ' HD22 ' A' ' 107' ' ' ASN . 5.7 tt -90.76 117.94 29.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.402 -0.962 . . . . 1.17 108.402 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.535 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 3.6 t -107.37 111.69 24.15 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 119.91 -0.716 . . . . 1.35 110.559 -175.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 22.7 t -98.94 98.6 7.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.13 -0.486 . . . . 0.42 110.134 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.541 ' HB2' ' HE ' ' A' ' 105' ' ' ARG . 12.8 mm-40 -105.22 146.89 28.66 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.705 -0.48 . . . . 1.98 109.705 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.827 ' HB2' ' HG2' ' A' ' 165' ' ' PRO . 2.9 p90 -127.81 134.09 49.44 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.134 0.492 . . . . 2.32 110.348 171.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 14.2 t -115.47 144.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.272 -0.876 . . . . 0.62 110.868 -170.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.593 ' HE3' ' HB2' ' A' ' 69' ' ' ASP . 16.6 pttp -77.83 112.68 14.95 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.915 -0.584 . . . . 2.26 111.473 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.95 -10.41 80.93 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.434 -0.889 . . . . 1.45 110.923 171.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -161.34 68.32 0.31 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.674 -0.263 . . . . 4.24 110.754 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' A' ' 159' ' ' LYS . 96.7 m-85 67.81 -67.06 0.19 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.588 0.755 . . . . 4.98 112.61 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.52 105.2 7.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.916 -0.584 . . . . 2.64 109.706 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.655 HD21 ' HA ' ' A' ' 69' ' ' ASP . 44.3 m-80 -60.68 164.16 7.9 Favored Pre-proline 0 N--CA 1.462 0.155 0 N-CA-C 107.573 -1.269 . . . . 2.06 107.573 168.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.827 ' HG2' ' HB2' ' A' ' 157' ' ' PHE . 64.8 Cg_exo -42.21 99.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.49 2.127 . . . . 3.16 112.031 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.604 ' HE3' HG22 ' A' ' 92' ' ' VAL . 20.1 ttmm -49.24 -68.1 0.21 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.732 -1.122 . . . . 3.18 112.084 -165.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.728 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 46.1 t -101.36 134.46 41.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.895 -0.409 . . . . 1.19 109.895 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 17.8 t -136.44 83.34 2.0 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 120.125 -0.63 . . . . 1.36 112.432 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.749 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -76.61 37.34 0.17 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 124.645 1.178 . . . . 0.31 112.715 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.741 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 6.8 tp -58.1 110.6 0.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.351 0.596 . . . . 0.69 111.834 -173.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.631 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -114.51 134.16 55.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.835 -0.621 . . . . 0.48 109.423 174.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.569 ' CG2' ' HB3' ' A' ' 12' ' ' TRP . 3.7 tt -124.58 127.01 72.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-O 122.268 1.032 . . . . 0.3 111.897 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.545 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 10.7 ptm -114.08 171.53 7.55 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.385 -1.28 . . . . 0.99 109.31 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 19.2 ptmt -118.35 146.05 44.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.914 0.864 . . . . 1.22 112.665 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 176' ' ' THR . . . 103.04 -30.0 11.31 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 113.913 -1.494 . . . . 0.31 114.747 162.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.4 OUTLIER -173.9 153.05 2.07 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.01 0.905 . . . . 0.68 112.744 -176.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.642 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -86.96 -14.24 42.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.013 -0.994 . . . . 0.86 110.2 169.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.37 -0.832 . . . . 2.16 111.415 -173.572 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.764 0 N-CA-C 111.737 -0.545 . . . . 1.48 111.737 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.898 HD11 ' HZ ' ' A' ' 171' ' ' PHE . 27.2 tp -60.02 -45.44 92.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.0 0.428 . . . . 0.72 110.928 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 25' ' ' HIS . . . -62.45 -22.99 66.64 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.723 -0.671 . . . . 0.53 111.544 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.33 -40.95 17.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.096 -0.502 . . . . 2.18 110.952 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 173' ' ' MET . 66.9 mmtt -97.12 -4.62 38.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.414 0.524 . . . . 1.79 112.414 -173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 173' ' ' MET . 11.8 p -60.99 134.87 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.141 -0.624 . . . . 0.33 110.422 171.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.508 HD13 ' HE2' ' A' ' 83' ' ' TYR . 42.4 pt -113.86 -22.77 4.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.235 -0.439 . . . . 0.92 110.447 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.765 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 75.0 t90 -164.42 147.5 9.08 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.36 110.327 -172.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -159.53 141.31 13.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.221 -0.289 . . . . 0.26 110.221 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.925 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 24.8 t -144.22 115.97 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.703 0.763 . . . . 0.79 112.584 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 169' ' ' ALA . 1.9 t-20 -88.24 88.03 7.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 107.369 -1.345 . . . . 1.49 107.369 164.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.606 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -60.87 103.07 0.23 Allowed 'General case' 0 C--O 1.25 1.089 0 CA-C-N 115.768 -0.651 . . . . 0.48 109.982 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.427 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 160.44 -48.0 0.39 Allowed Glycine 0 N--CA 1.44 -1.064 0 O-C-N 125.127 1.517 . . . . 0.76 113.083 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -108.09 -131.32 6.47 Favored Glycine 0 C--O 1.229 -0.199 0 C-N-CA 120.74 -0.743 . . . . 0.74 113.627 -173.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 47.0 mt-10 -150.31 119.87 6.97 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 119.218 -0.42 . . . . 1.77 110.625 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 72.1 m 33.18 108.29 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 115.484 1.661 . . . . 1.29 115.484 170.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.746 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 71.1 t60 -147.87 131.19 16.56 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.733 -0.604 . . . . 0.42 110.861 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 1.1 p -96.79 124.07 49.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.235 -0.654 . . . . 1.01 109.235 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' OD1' ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -77.77 163.82 25.78 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.737 -0.665 . . . . 0.77 109.66 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 m -55.24 -29.59 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 113.14 0.792 . . . . 0.62 113.14 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 32.8 m-70 -70.02 -18.31 63.3 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.346 -0.613 . . . . 0.86 109.346 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 101.71 31.66 5.38 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.104 -0.953 . . . . 0.33 111.235 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.643 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.9 mm -102.63 110.97 30.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 0.31 110.861 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 3.3 t60 -97.44 111.7 23.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.21 -0.45 . . . . 0.8 111.23 -172.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.925 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -76.85 131.15 38.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.94 -0.573 . . . . 1.75 110.577 175.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.685 ' HD3' ' HG3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -88.36 107.05 18.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.805 -0.634 . . . . 2.94 110.693 177.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.922 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 33.4 ttmt -18.62 126.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 125.034 1.459 . . . . 2.78 113.094 174.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 16' ' ' ALA . 2.5 m-20 -35.77 101.26 0.21 Allowed Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 123.197 1.475 . . . . 2.41 114.046 -169.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.685 ' HG3' ' HD3' ' A' ' 30' ' ' ARG . 40.2 Cg_endo -103.05 37.16 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 125.174 3.916 . . . . 1.87 115.071 -166.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.557 HD11 ' NH1' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -132.34 -35.32 1.17 Allowed 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.134 -1.026 . . . . 1.99 113.128 -179.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' N ' HD22 ' A' ' 34' ' ' LEU . 7.6 pt-20 -90.37 72.33 7.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.768 0.795 . . . . 5.31 110.338 176.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 80.78 -1.2 84.52 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.48 -0.782 . . . . 2.64 111.311 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.451 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER 46.21 53.61 9.22 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.432 0.693 . . . . 5.64 110.099 -176.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -106.91 156.18 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.074 -0.966 . . . . 3.96 109.779 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.922 ' HA2' ' HD3' ' A' ' 31' ' ' LYS . . . -75.58 72.92 1.69 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.763 -0.732 . . . . 2.56 111.511 174.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -115.12 76.66 1.01 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.776 0.322 . . . . 6.2 110.59 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.4 112.96 3.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.376 -0.601 . . . . 2.0 109.376 175.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 47.8 t -100.69 35.92 2.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.931 -0.577 . . . . 2.52 110.713 -171.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -73.84 56.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.651 0.738 . . . . 2.52 111.478 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -90.57 -25.42 20.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.766 -0.652 . . . . 7.02 110.243 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.57 44.31 1.39 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.208 -1.157 . . . . 3.06 110.208 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 46' ' ' MET . 37.8 ttm -62.03 -11.97 16.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.972 -0.614 . . . . 2.35 112.317 -172.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HD2' ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -69.45 100.09 1.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.404 0.621 . . . . 4.25 111.705 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER 170.27 66.8 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.948 0 CA-C-N 113.743 -1.571 . . . . 2.56 108.321 -178.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.94 113.55 2.42 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.26 1.973 . . . . 1.69 112.526 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.714 HG12 ' HE3' ' A' ' 88' ' ' LYS . 1.7 mp -71.06 100.77 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 122.287 1.041 . . . . 1.59 109.91 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.516 ' HB2' HG22 ' A' ' 125' ' ' THR . 87.9 mt -76.42 -2.3 31.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.18 -1.373 . . . . 1.91 113.171 -171.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.892 ' HG2' ' HB ' ' A' ' 125' ' ' THR . 14.1 mmm180 -109.36 18.3 20.58 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.085 -0.646 . . . . 3.17 111.009 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB2' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -128.54 170.35 13.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.366 -0.379 . . . . 0.97 110.162 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.482 ' OD1' ' HD2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -93.04 139.46 23.11 Favored Pre-proline 0 C--O 1.216 -0.708 0 N-CA-C 109.01 -0.737 . . . . 1.92 109.01 178.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 54' ' ' ASN . 40.0 Cg_exo -38.63 -42.29 1.79 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 124.071 3.181 . . . . 0.7 116.617 -163.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.509 ' HG3' ' H ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -76.05 -46.41 29.38 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.51 -0.744 . . . . 2.71 110.516 -177.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 3.5 p30 -79.75 -17.43 53.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.177 -0.465 . . . . 1.63 110.119 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -57.89 -43.7 86.24 Favored 'General case' 0 C--O 1.217 -0.625 0 N-CA-C 108.944 -0.762 . . . . 1.58 108.944 167.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.41 -45.76 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 109.788 -0.449 . . . . 1.27 109.788 172.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.746 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 24.3 tp -63.06 -15.24 55.87 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.458 -0.792 . . . . 1.18 111.489 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.54 ' CD2' ' HG3' ' A' ' 88' ' ' LYS . 4.2 m-30 -114.31 0.81 14.26 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 116.23 -0.441 . . . . 0.99 111.403 -177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.539 ' HA ' HD13 ' A' ' 50' ' ' ILE . 49.8 tt0 -122.07 -43.27 2.34 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.792 0.664 . . . . 1.97 112.792 -169.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.5 m -59.97 131.13 49.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.117 -0.492 . . . . 1.27 111.413 -175.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.851 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.9 pm0 -116.98 158.94 23.27 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.581 0.585 . . . . 1.96 112.581 -173.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.648 ' HA ' ' HB3' ' A' ' 42' ' ' SER . 3.2 ptm180 -139.29 156.19 47.21 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.616 -0.72 . . . . 3.35 110.182 172.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.445 ' HA ' ' CB ' ' A' ' 165' ' ' PRO . 44.9 p90 -121.8 144.6 48.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.382 -0.229 . . . . 4.71 110.382 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -165.87 64.14 0.11 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.072 0.463 . . . . 4.38 111.241 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.429 ' HG3' ' OD2' ' A' ' 69' ' ' ASP . 12.1 tp10 61.42 -93.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.206 -0.906 . . . . 3.7 112.854 173.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.825 ' HA ' ' ND2' ' A' ' 164' ' ' ASN . 2.9 p30 -164.87 153.26 12.14 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 122.209 -0.307 . . . . 2.2 111.302 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 32.1 t 54.16 61.52 3.01 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.164 -0.926 . . . . 1.41 110.747 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.825 ' CZ ' ' HA ' ' A' ' 165' ' ' PRO . 16.2 p90 -103.59 121.91 43.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.165 -0.614 . . . . 1.57 109.973 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 155' ' ' VAL . . . -108.17 174.47 19.03 Favored Glycine 0 N--CA 1.441 -0.973 0 CA-C-N 114.934 -1.03 . . . . 0.78 113.808 -170.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.504 ' HB3' ' CZ2' ' A' ' 12' ' ' TRP . 52.4 m-85 -132.19 141.89 49.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.124 -0.538 . . . . 1.21 109.583 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 4.7 p-10 -106.0 114.42 28.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.192 0.52 . . . . 2.47 111.211 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.857 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 3.9 mp -106.91 91.34 6.19 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.662 -0.699 . . . . 0.38 109.347 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.701 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 32.1 Cg_exo -59.67 117.5 4.25 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 121.987 1.792 . . . . 0.59 111.892 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.795 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 60.6 mt -120.57 138.09 52.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.828 0.347 . . . . 0.49 111.02 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -136.82 7.3 2.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.132 -0.485 . . . . 3.32 110.709 173.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.447 ' HB2' ' HE3' ' A' ' 174' ' ' LYS . 6.6 mm-40 -121.87 -177.31 3.54 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.076 -0.342 . . . . 2.16 110.076 -173.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 5.0 mt-10 -128.05 -179.22 4.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.277 -0.419 . . . . 1.2 110.525 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.55 -172.65 15.44 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.637 -0.985 . . . . 0.3 110.637 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -92.25 108.78 20.2 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.099 -0.64 . . . . 1.96 109.463 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.706 ' HB2' HG12 ' A' ' 133' ' ' ILE . 61.8 m-85 -92.58 125.52 37.25 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.482 -0.933 . . . . 0.71 108.482 -177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.592 HG21 ' CA ' ' A' ' 177' ' ' ALA . 72.4 t -114.74 105.75 19.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.314 -0.857 . . . . 0.26 110.257 -173.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 170' ' ' LEU . 5.4 mp -89.21 104.4 16.95 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.495 -1.23 . . . . 1.56 108.82 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG23 HG12 ' A' ' 84' ' ' VAL . 80.4 t -103.47 102.17 13.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.068 -1.086 . . . . 1.14 108.068 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.703 ' CD2' ' HB3' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -103.95 132.98 49.67 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.033 -0.667 . . . . 1.44 110.216 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.714 ' HE3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -87.92 121.64 30.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.388 -0.968 . . . . 3.73 108.388 173.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 6.2 m-85 -107.05 141.25 38.57 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.119 0.485 . . . . 0.45 111.451 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.906 ' HB3' ' HB ' ' A' ' 167' ' ' VAL . . . -134.08 113.8 12.48 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.159 -0.928 . . . . 0.51 109.097 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.818 ' HB2' HD12 ' A' ' 117' ' ' ILE . 29.6 tt0 -102.38 144.58 30.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 2.62 110.803 -173.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 p -108.14 107.39 22.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.628 0.727 . . . . 3.77 109.484 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.503 ' HD1' ' H ' ' A' ' 95' ' ' ALA . 0.7 OUTLIER -139.14 173.78 11.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.621 -0.718 . . . . 5.68 111.479 -171.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -105.87 41.81 1.34 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.521 -0.763 . . . . 4.65 109.624 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.503 ' H ' ' HD1' ' A' ' 93' ' ' TYR . . . 57.82 75.4 0.38 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.198 -0.91 . . . . 1.39 111.848 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -159.6 140.85 12.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.756 -0.656 . . . . 2.75 109.997 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.768 ' HB2' ' HB2' ' A' ' 119' ' ' ASP . 19.8 p -132.47 -177.03 4.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.551 -0.295 . . . . 1.4 111.003 -177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 54.36 36.76 26.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.378 0.609 . . . . 2.38 111.408 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -167.65 -37.9 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.14 -1.059 . . . . 2.89 108.14 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' ASP . 12.4 mmmm -75.7 67.65 2.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.207 -0.906 . . . . 2.79 109.377 168.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.649 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 16.8 m -108.25 120.54 59.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.593 0.711 . . . . 1.22 110.611 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . 73.2 m-85 -104.48 158.7 16.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.042 -0.981 . . . . 0.99 110.922 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.676 ' HA ' ' HA ' ' A' ' 113' ' ' LYS . 16.2 m-20 -108.88 137.64 46.49 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.718 -0.475 . . . . 1.53 109.718 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 110' ' ' THR . 0.3 OUTLIER -140.01 125.1 20.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.335 0.588 . . . . 0.63 110.945 -177.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.782 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 41.5 mtt180 -108.13 138.34 44.57 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.18 -0.918 . . . . 1.95 111.172 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.831 HG13 HD21 ' A' ' 153' ' ' LEU . 74.2 t -113.35 103.03 14.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.281 -0.637 . . . . 1.44 109.281 170.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.48 ' HA ' ' H ' ' A' ' 154' ' ' SER . 0.2 OUTLIER 64.18 39.26 7.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.202 -0.908 . . . . 1.65 108.949 -175.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.8 -22.37 34.19 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.3 -0.864 . . . . 0.42 112.452 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 83.6 m-70 -83.64 101.15 11.3 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.556 0.342 . . . . 0.68 111.857 -173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.686 HG23 ' HG2' ' A' ' 105' ' ' ARG . 3.3 p -62.88 93.05 0.05 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.331 0.586 . . . . 0.77 111.245 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.532 HG11 HG23 ' A' ' 131' ' ' ILE . 11.9 t -73.05 -47.59 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.559 -0.746 . . . . 0.94 109.742 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.702 HG11 ' HG ' ' A' ' 115' ' ' LEU . 11.7 t -117.62 90.19 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 109.245 -0.65 . . . . 0.35 109.245 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -110.36 71.67 0.76 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.901 0.858 . . . . 4.01 108.935 178.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.649 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.5 p30 164.18 24.9 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.686 -1.597 . . . . 1.96 108.601 -169.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.702 ' HG ' HG11 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -71.34 90.89 0.96 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.427 -0.806 . . . . 1.18 111.563 -170.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.604 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 14.0 p30 -104.88 94.57 5.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.676 0.75 . . . . 1.93 110.067 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.818 HD12 ' HB2' ' A' ' 91' ' ' GLU . 83.2 mt -61.7 -37.11 77.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.125 -0.943 . . . . 0.82 111.653 -170.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.503 ' HD2' ' HB3' ' A' ' 97' ' ' SER . 75.6 t80 -59.4 -38.56 80.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.08 110.873 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.768 ' HB2' ' HB2' ' A' ' 97' ' ' SER . 18.7 t70 -71.73 -32.1 67.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.929 0.395 . . . . 0.96 110.969 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 12.0 mmt85 -76.36 -49.24 17.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.899 -0.591 . . . . 1.69 111.765 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 127' ' ' HIS . 60.0 t -107.52 -36.09 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.104 0.409 . . . . 1.49 112.104 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 119.08 -111.55 2.11 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.401 -0.904 . . . . 1.4 111.867 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -112.02 112.55 24.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.979 0.418 . . . . 4.11 111.198 -176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.421 ' HB2' ' H ' ' A' ' 125' ' ' THR . 33.0 p 53.03 -149.81 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.394 1.078 . . . . 1.97 112.277 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.892 ' HB ' ' HG2' ' A' ' 52' ' ' ARG . 29.1 p 64.85 -160.42 0.28 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.996 0.918 . . . . 0.85 110.932 -178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.611 ' HB2' HG23 ' A' ' 50' ' ' ILE . . . -94.88 122.27 37.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.469 0.544 . . . . 0.57 112.469 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.673 ' HA ' HG21 ' A' ' 121' ' ' VAL . 13.6 t60 -92.44 130.65 38.05 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.466 -0.568 . . . . 0.55 109.466 167.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.81 121.67 42.21 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.16 -0.927 . . . . 1.64 109.572 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.703 ' HB3' ' CD2' ' A' ' 87' ' ' LEU . 4.5 tp10 -123.92 108.29 12.27 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.409 -0.96 . . . . 1.12 108.409 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.458 HG12 HG22 ' A' ' 86' ' ' VAL . 80.1 mt -94.1 118.21 39.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.889 -0.596 . . . . 0.74 110.166 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.532 HG23 HG11 ' A' ' 111' ' ' VAL . 68.2 mt -117.94 93.67 44.75 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.534 -0.303 . . . . 1.25 110.864 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.89 124.39 3.43 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.877 2.385 . . . . 0.29 112.797 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.706 HG12 ' HB2' ' A' ' 83' ' ' TYR . 3.5 pt -109.51 166.29 4.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.575 -1.269 . . . . 0.27 107.575 173.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.6 t -131.78 106.62 8.23 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.904 -0.406 . . . . 1.24 109.904 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 49.7 mt -99.27 122.99 51.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.291 -0.633 . . . . 0.34 109.291 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -150.78 136.62 18.21 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.86 -0.793 . . . . 1.95 108.86 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm 66.95 17.95 10.56 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.196 0.522 . . . . 3.13 110.544 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.15 12.08 77.18 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.815 -0.629 . . . . 0.41 112.383 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 148' ' ' THR . 94.5 mttt -112.72 140.15 47.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.97 0.385 . . . . 2.23 110.601 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.459 ' HG ' HD12 ' A' ' 133' ' ' ILE . 6.9 tt -103.27 115.67 31.0 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.518 -0.549 . . . . 0.41 109.518 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.0 m -110.87 107.15 16.53 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.599 -0.519 . . . . 1.19 109.599 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.436 HG21 HG22 ' A' ' 111' ' ' VAL . 4.0 p -90.72 106.99 18.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.369 -0.604 . . . . 0.92 109.369 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 63.69 -81.07 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.555 -0.748 . . . . 1.88 110.841 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.76 -0.56 3.55 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.851 -0.69 . . . . 1.02 112.046 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -95.66 113.96 25.65 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.522 -0.547 . . . . 1.95 109.522 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.31 132.47 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.13 0.49 . . . . 0.92 111.8 -171.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.4 t -160.3 133.65 6.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.673 -0.694 . . . . 1.27 109.181 175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.713 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 9.1 t -55.38 139.41 43.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.286 0.565 . . . . 1.45 111.081 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.795 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 25.9 t80 -80.0 133.87 36.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.34 -0.845 . . . . 0.47 110.536 -175.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 p -127.61 96.46 4.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.091 0.472 . . . . 1.79 112.229 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.17 -69.52 3.15 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.42 113.96 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.701 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -159.23 164.02 35.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.176 0.488 . . . . 1.23 110.552 -176.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.857 ' HB3' ' HB ' ' A' ' 75' ' ' ILE . 6.1 tt -81.81 142.84 32.22 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.131 -1.063 . . . . 1.17 108.131 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.585 ' N ' HD23 ' A' ' 153' ' ' LEU . 9.9 t -135.83 107.6 7.04 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.313 -0.555 . . . . 1.35 110.648 -172.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 59.4 t -97.08 99.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.389 -0.369 . . . . 0.42 111.141 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.16 123.76 42.37 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.725 -0.39 . . . . 1.98 110.457 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.508 ' HE1' ' HA ' ' A' ' 164' ' ' ASN . 49.0 t80 -102.65 118.03 35.95 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.461 -0.94 . . . . 2.32 108.461 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 21.9 t -103.67 144.25 14.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.558 -0.746 . . . . 0.62 110.422 -173.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.885 ' HA ' ' HB2' ' A' ' 164' ' ' ASN . 61.3 pttt -66.18 128.61 36.8 Favored 'General case' 0 N--CA 1.457 -0.096 0 CA-C-O 121.147 0.499 . . . . 2.26 112.205 -174.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.33 -31.4 5.88 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.433 -0.803 . . . . 1.45 111.981 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -138.35 -88.21 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.46 -0.57 . . . . 4.24 109.46 177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.514 ' O ' ' HD2' ' A' ' 165' ' ' PRO . 80.5 t80 -133.34 -48.17 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.791 -0.186 . . . . 4.98 110.526 174.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -74.65 49.34 0.39 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.903 0.858 . . . . 2.64 111.965 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.885 ' HB2' ' HA ' ' A' ' 159' ' ' LYS . 1.7 t30 -62.01 -45.28 91.52 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 114.388 -1.278 . . . . 2.06 109.023 162.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.825 ' HA ' ' CZ ' ' A' ' 71' ' ' PHE . 36.2 Cg_endo -69.08 65.85 1.38 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.046 1.83 . . . . 3.16 112.092 169.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.526 ' HE3' ' H ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -102.58 179.96 4.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.585 -0.734 . . . . 3.18 111.559 178.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.906 ' HB ' ' HB3' ' A' ' 90' ' ' ALA . 39.6 t -74.71 135.18 27.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 116.39 -0.368 . . . . 1.19 111.066 -175.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.606 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.7 t -132.15 141.16 49.02 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 120.228 -0.589 . . . . 1.36 110.974 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.693 ' HB3' ' CB ' ' A' ' 88' ' ' LYS . . . -131.35 35.06 3.91 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.428 -0.805 . . . . 0.31 109.311 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.765 ' HG ' ' HZ3' ' A' ' 12' ' ' TRP . 14.4 tp -58.29 102.65 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.635 -1.166 . . . . 0.69 112.427 -175.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.898 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -111.21 132.63 54.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.698 -0.683 . . . . 0.48 109.659 176.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.713 HG22 ' HE3' ' A' ' 12' ' ' TRP . 5.3 tt -117.9 123.6 71.9 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-O 121.885 0.85 . . . . 0.3 111.577 176.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.68 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 2.5 ppp? -115.52 163.36 15.88 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.295 -1.002 . . . . 0.99 108.295 175.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.447 ' HE3' ' HB2' ' A' ' 79' ' ' GLU . 11.6 ptmm? -119.3 147.91 43.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 122.629 1.204 . . . . 1.22 113.362 -174.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 176' ' ' THR . . . 106.18 -29.64 10.83 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 112.863 -1.971 . . . . 0.31 114.84 167.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 175' ' ' GLY . 0.6 OUTLIER -175.38 154.93 1.76 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.525 1.163 . . . . 0.68 112.478 -177.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.592 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -84.39 -17.85 38.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.886 -0.597 . . . . 0.86 110.465 169.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.766 -0.652 . . . . 2.16 111.302 -177.947 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 111.266 -0.734 . . . . 1.48 111.266 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 27' ' ' ILE . 24.7 tp -64.46 -25.34 67.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.926 -0.637 . . . . 0.72 110.589 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.528 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . . . -60.92 -22.91 64.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.4 -0.818 . . . . 0.53 112.215 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.18 -21.6 59.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.536 -0.302 . . . . 2.18 110.63 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 59.8 mmtt -114.14 -16.59 12.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.649 -0.42 . . . . 1.79 111.799 -177.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.569 ' HB ' HD12 ' A' ' 27' ' ' ILE . 14.8 p -56.57 136.1 19.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.48 0.657 . . . . 0.33 111.729 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 174' ' ' LYS . 5.4 pt -115.27 -28.45 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.614 -0.721 . . . . 0.92 110.64 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.702 ' HZ3' ' HG ' ' A' ' 170' ' ' LEU . 67.1 t90 -169.17 140.29 2.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.232 -0.44 . . . . 0.36 110.177 -170.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -162.42 147.21 12.27 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.317 -0.24 . . . . 0.26 111.224 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.69 ' HA ' ' HD1' ' A' ' 29' ' ' TYR . 2.2 p -151.16 125.6 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 113.197 0.814 . . . . 0.79 113.197 175.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.469 ' CB ' HD12 ' A' ' 60' ' ' LEU . 1.7 t-20 -94.05 95.79 9.25 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 114.956 -1.02 . . . . 1.49 108.65 170.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.687 ' HB2' ' OH ' ' A' ' 73' ' ' TYR . . . -58.54 103.21 0.14 Allowed 'General case' 0 C--O 1.246 0.907 0 CA-C-N 116.116 -0.493 . . . . 0.48 109.723 173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.809 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 174.2 -42.26 0.14 Allowed Glycine 0 N--CA 1.438 -1.191 0 O-C-N 124.882 1.364 . . . . 0.76 113.98 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.24 -121.09 1.79 Allowed Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.001 -1.095 . . . . 0.74 113.072 -167.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 31' ' ' LYS . 46.1 mt-10 -148.59 119.52 7.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.847 0.323 . . . . 1.77 111.237 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 55.7 m 32.83 105.19 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.0 1.482 . . . . 1.29 115.0 170.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.739 ' CD2' ' HB2' ' A' ' 60' ' ' LEU . 71.9 t60 -133.68 122.49 23.48 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.686 -0.634 . . . . 0.42 111.244 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.38 116.1 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.815 -0.63 . . . . 1.01 109.712 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -83.57 162.75 20.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.002 -0.544 . . . . 0.77 110.715 -177.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -56.74 -24.95 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 113.001 0.741 . . . . 0.62 113.001 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.451 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 78.2 m-70 -80.52 1.17 30.56 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.426 -0.583 . . . . 0.86 109.426 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 7' ' ' ALA . . . 82.84 28.5 37.95 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.061 -0.972 . . . . 0.33 111.508 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.646 HD11 ' HG ' ' A' ' 6' ' ' LEU . 11.8 mm -102.47 111.59 32.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.139 0.495 . . . . 0.31 111.015 -175.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -88.1 113.86 24.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.84 -0.618 . . . . 0.8 111.427 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.69 ' HD1' ' HA ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -80.46 129.37 34.47 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.148 -0.478 . . . . 1.75 109.849 170.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.747 ' HG3' ' HG3' ' A' ' 33' ' ' PRO . 2.1 ptm180 -85.96 114.69 23.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.92 -0.582 . . . . 2.94 110.391 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 19' ' ' GLU . 37.0 ttmt -27.22 126.7 0.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.185 0.994 . . . . 2.78 112.032 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.683 ' OD2' ' HD3' ' A' ' 65' ' ' ARG . 1.4 m-20 -32.64 98.72 0.13 Allowed Pre-proline 0 N--CA 1.465 0.283 0 O-C-N 125.115 1.51 . . . . 2.41 114.342 -168.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.747 ' HG3' ' HG3' ' A' ' 30' ' ' ARG . 69.6 Cg_endo -100.07 37.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.268 1 C-N-CA 125.454 4.103 . . . . 1.87 114.152 -169.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.563 HD11 ' CE2' ' A' ' 73' ' ' TYR . 3.6 mp -89.9 -88.35 0.17 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.276 -0.569 . . . . 1.99 110.036 178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.58 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 12.8 mm-40 -123.83 33.83 5.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.831 -0.622 . . . . 5.31 111.018 -172.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.17 1.34 68.71 Favored Glycine 0 CA--C 1.516 0.104 0 C-N-CA 120.013 -1.089 . . . . 2.64 112.186 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.58 ' HD2' ' HB2' ' A' ' 35' ' ' GLU . 26.1 mtt180 -72.08 45.22 0.12 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.725 0.81 . . . . 5.64 113.032 -172.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.09 117.44 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.183 0.516 . . . . 3.96 110.576 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.47 -60.46 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.801 -0.714 . . . . 2.56 111.656 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.7 mtm-85 -103.54 -4.94 23.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.417 -0.216 . . . . 6.2 110.417 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 17' ' ' GLY . . . 65.63 -171.28 0.19 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.853 0.721 . . . . 2.0 110.239 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.585 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 45.3 m -131.4 30.6 4.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.322 0.582 . . . . 2.52 110.151 176.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -86.92 -16.56 35.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 2.52 110.895 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -61.09 104.57 0.39 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.567 -0.288 . . . . 7.02 110.662 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.56 45.63 94.32 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.899 -0.667 . . . . 3.06 111.883 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -71.64 -36.28 70.66 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.819 0.303 . . . . 2.35 111.819 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 48' ' ' LEU . 49.6 mtpt 57.26 -161.68 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.243 0.34 . . . . 4.25 111.109 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.406 ' H ' ' HB3' ' A' ' 47' ' ' LYS . 89.7 mt 55.81 64.73 5.02 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.861 -0.608 . . . . 2.56 111.083 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.08 124.15 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.388 2.059 . . . . 1.69 112.047 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.695 HG12 ' HE3' ' A' ' 88' ' ' LYS . 1.7 mp -69.65 105.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.999 0.904 . . . . 1.59 109.947 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HB2' HG22 ' A' ' 125' ' ' THR . 85.7 mt -65.12 -18.2 65.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.336 -1.302 . . . . 1.91 112.977 -172.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -96.35 4.2 52.41 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.726 -0.39 . . . . 3.17 111.181 -173.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.516 ' HB2' HG22 ' A' ' 50' ' ' ILE . 3.2 m -125.28 145.25 50.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.903 -0.59 . . . . 0.97 111.156 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.465 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 2.1 p-10 -79.85 151.99 74.2 Favored Pre-proline 0 C--O 1.214 -0.776 0 N-CA-C 109.609 -0.515 . . . . 1.92 109.609 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 54' ' ' ASN . 3.5 Cg_exo -38.76 -46.67 2.66 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 124.307 3.338 . . . . 0.7 115.419 -164.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -69.94 -53.54 17.37 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-O 122.064 0.935 . . . . 2.71 110.483 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -22.21 55.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.437 -0.801 . . . . 1.63 109.711 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 53' ' ' SER . 5.7 tt0 -55.78 -45.15 78.22 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.688 -0.687 . . . . 1.58 109.651 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.3 t -57.29 -46.08 85.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.784 -0.45 . . . . 1.27 109.784 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.739 ' HB2' ' CD2' ' A' ' 21' ' ' HIS . 30.6 tp -60.14 -19.4 53.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.454 0.645 . . . . 1.18 111.138 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.507 ' HE1' HD23 ' A' ' 60' ' ' LEU . 2.9 m-30 -115.83 6.68 14.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.938 -0.573 . . . . 0.99 111.189 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.643 ' HA ' HD13 ' A' ' 50' ' ' ILE . 35.4 tt0 -122.02 -35.63 3.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.106 0.479 . . . . 1.97 111.821 -172.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.49 ' O ' HG13 ' A' ' 167' ' ' VAL . 1.0 OUTLIER -70.35 136.86 50.08 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.721 -0.672 . . . . 1.27 110.911 -176.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.809 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -120.76 149.46 42.5 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.089 0.556 . . . . 1.96 109.864 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.683 ' HD3' ' OD2' ' A' ' 32' ' ' ASP . 13.7 ttp-105 -114.76 72.96 0.81 Allowed 'General case' 0 C--O 1.237 0.447 0 N-CA-C 112.524 0.564 . . . . 3.35 112.524 -174.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.457 ' O ' ' HB2' ' A' ' 67' ' ' ASN . 67.4 t80 70.61 -69.21 0.18 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.481 0.548 . . . . 4.71 112.481 169.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 66' ' ' TYR . 38.1 m-80 73.51 123.26 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.476 0.71 . . . . 4.38 111.698 -177.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -137.91 -93.26 0.21 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.041 -0.527 . . . . 3.7 111.145 -174.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.613 ' HA ' ' HD2' ' A' ' 159' ' ' LYS . 0.6 OUTLIER -114.54 -169.45 1.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.541 -0.54 . . . . 2.2 109.541 179.543 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 p -45.18 114.71 0.78 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.946 0.403 . . . . 1.41 111.107 174.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.486 ' HD2' HH22 ' A' ' 65' ' ' ARG . 0.1 OUTLIER -138.99 137.42 36.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 1.57 110.756 -175.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.762 ' HA3' ' HB3' ' A' ' 156' ' ' GLU . . . -151.43 -176.27 24.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.172 -1.013 . . . . 0.78 113.656 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.687 ' OH ' ' HB2' ' A' ' 16' ' ' ALA . 48.6 m-85 -128.62 169.41 14.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.014 -0.593 . . . . 1.21 111.777 -170.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -115.31 119.75 37.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.247 -0.888 . . . . 2.47 110.594 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.812 ' HB ' ' HB3' ' A' ' 153' ' ' LEU . 4.1 mp -107.34 90.31 5.66 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.977 -0.749 . . . . 0.38 108.977 171.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.62 ' HA ' ' HB2' ' A' ' 152' ' ' LYS . 43.6 Cg_endo -71.76 116.94 4.9 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.83 1.687 . . . . 0.59 111.631 -176.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.821 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 82.7 mt -116.4 141.45 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.853 -0.612 . . . . 0.49 110.872 -171.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 78' ' ' LYS . 71.5 mmtt -139.31 20.95 2.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.746 0.308 . . . . 3.32 110.922 174.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -136.66 -175.93 4.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.227 0.537 . . . . 2.16 110.769 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 3.3 mt-10 -121.43 -172.62 2.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.266 -0.879 . . . . 1.2 109.771 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.56 -164.57 13.97 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.076 -0.81 . . . . 0.3 111.076 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 36.5 mt-10 -106.19 104.43 14.13 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.186 -0.606 . . . . 1.96 109.643 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.664 ' HB2' HG12 ' A' ' 133' ' ' ILE . 20.7 m-30 -94.06 122.73 36.88 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.411 -0.959 . . . . 0.71 108.411 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.674 HG21 ' CA ' ' A' ' 177' ' ' ALA . 88.0 t -107.18 106.5 20.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.866 0.841 . . . . 0.26 110.45 -172.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 170' ' ' LEU . 12.7 tp -89.66 103.94 16.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.362 -1.29 . . . . 1.56 109.88 -176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 43.7 t -108.24 111.37 35.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.357 -0.979 . . . . 1.14 108.357 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 170' ' ' LEU . 0.0 OUTLIER -114.23 134.96 54.57 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.093 -0.643 . . . . 1.44 110.423 178.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.816 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -93.57 122.91 36.5 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.073 -0.651 . . . . 3.73 109.903 177.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.656 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 8.8 m-85 -108.42 140.48 41.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.138 -0.483 . . . . 0.45 111.34 175.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.816 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -146.2 117.79 8.05 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.695 -0.684 . . . . 0.51 110.213 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.706 ' HB3' HD12 ' A' ' 117' ' ' ILE . 4.8 tm-20 -178.23 129.13 0.13 Allowed 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.027 0.204 . . . . 2.62 110.943 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.573 HG21 ' H ' ' A' ' 124' ' ' SER . 43.5 t -144.19 74.16 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 120.922 0.391 . . . . 3.77 110.169 175.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -91.15 -31.94 16.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.066 0.46 . . . . 5.68 110.3 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -114.11 105.78 13.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.721 -0.672 . . . . 4.65 109.425 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.96 64.64 5.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.951 -0.568 . . . . 1.39 111.845 -175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.668 ' HA ' HE21 ' A' ' 96' ' ' GLN . 0.0 OUTLIER -160.09 139.87 11.31 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.893 -0.78 . . . . 2.75 108.893 175.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 119' ' ' ASP . 6.8 m -85.7 141.06 30.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.17 0.509 . . . . 1.4 111.948 -172.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 59.91 49.84 7.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.77 -1.105 . . . . 2.38 109.819 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.419 HE21 ' HB2' ' A' ' 99' ' ' GLN . 4.0 tt0 -128.32 -38.31 1.78 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.759 -1.109 . . . . 2.89 109.893 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.7 ' HG3' ' HB2' ' A' ' 161' ' ' TYR . 27.8 ttpp -119.77 89.99 3.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.986 -0.746 . . . . 2.79 108.986 176.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.021 ' HB ' ' HA ' ' A' ' 114' ' ' ASP . 25.7 m -107.67 142.85 19.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.524 -0.762 . . . . 1.22 111.011 -169.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.636 ' CD2' ' HD3' ' A' ' 165' ' ' PRO . 75.1 m-85 -128.06 164.41 22.47 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.993 -0.549 . . . . 0.99 112.017 -174.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.733 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . 1.8 m-20 -107.35 137.79 44.74 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.572 -0.529 . . . . 1.53 109.572 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.789 HG23 ' HD1' ' A' ' 157' ' ' PHE . 0.3 OUTLIER -132.12 124.26 52.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 109.183 -0.673 . . . . 0.63 109.183 178.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.438 ' HE ' ' CG ' ' A' ' 156' ' ' GLU . 37.6 ptt180 -136.11 139.91 43.31 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.839 0.681 . . . . 1.95 112.839 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.909 ' HB ' HD11 ' A' ' 153' ' ' LEU . 16.1 m -109.47 114.28 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.093 -0.958 . . . . 1.44 111.195 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.704 ' HB2' HD12 ' A' ' 153' ' ' LEU . 65.7 t30 55.91 36.54 27.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.266 1.031 . . . . 1.65 108.875 -174.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.21 -17.63 58.93 Favored Glycine 0 N--CA 1.439 -1.165 0 CA-C-N 114.393 -1.276 . . . . 0.42 112.803 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.503 ' ND1' ' HB3' ' A' ' 145' ' ' GLU . 90.4 m-70 -85.73 101.77 13.06 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.255 0.465 . . . . 0.68 112.255 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 20.1 p -63.44 113.15 3.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.192 0.52 . . . . 0.77 110.784 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 131' ' ' ILE . 17.5 t -91.92 -41.11 12.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.662 -0.699 . . . . 0.94 109.234 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.647 HG21 ' HG2' ' A' ' 129' ' ' GLU . 4.8 t -130.36 91.5 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.65 -0.704 . . . . 0.35 109.966 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -100.81 146.37 27.37 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.769 -1.197 . . . . 4.01 107.769 169.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 1.021 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 68.9 m-20 77.36 38.42 0.22 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 124.564 1.165 . . . . 1.96 108.823 -167.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.501 HD11 ' CE2' ' A' ' 89' ' ' PHE . 0.5 OUTLIER -69.58 86.69 0.46 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.032 -0.985 . . . . 1.18 110.031 175.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 11.6 t70 -102.23 106.02 16.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.522 -0.918 . . . . 1.93 108.522 172.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.706 HD12 ' HB3' ' A' ' 91' ' ' GLU . 60.8 mt -61.97 -33.45 58.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 0.82 111.636 -171.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.478 ' HD2' HG13 ' A' ' 92' ' ' VAL . 32.7 t80 -68.64 -37.98 80.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.992 0.425 . . . . 1.08 110.086 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 97' ' ' SER . 20.0 t70 -68.56 -28.66 67.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.068 0.461 . . . . 0.96 111.182 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 14.7 mmt180 -81.32 -45.52 16.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.359 0.503 . . . . 1.69 112.359 -173.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.655 HG11 ' HA ' ' A' ' 127' ' ' HIS . 15.6 m -128.34 0.34 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 113.207 0.817 . . . . 1.49 113.207 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 81.84 -97.54 1.86 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.136 -1.03 . . . . 1.4 112.648 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -113.17 108.78 17.76 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.558 -0.378 . . . . 4.11 111.553 -175.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.573 ' H ' HG21 ' A' ' 92' ' ' VAL . 9.4 m 44.41 -122.4 0.88 Allowed 'General case' 0 CA--C 1.534 0.328 0 O-C-N 124.412 1.07 . . . . 1.97 112.754 175.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 51' ' ' LEU . 70.0 p 51.12 -158.9 0.1 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.413 0.685 . . . . 0.85 111.124 -175.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.803 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . . . -99.12 110.08 22.7 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.484 -0.487 . . . . 0.57 111.63 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.655 ' HA ' HG11 ' A' ' 121' ' ' VAL . 12.9 t60 -83.35 126.18 32.44 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.106 -1.072 . . . . 0.55 108.106 167.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -123.56 108.19 12.36 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.486 0.66 . . . . 1.64 110.403 -172.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.647 ' HG2' HG21 ' A' ' 112' ' ' VAL . 2.2 tp10 -102.03 108.95 20.54 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.962 -0.755 . . . . 1.12 108.962 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.409 HG23 HG22 ' A' ' 86' ' ' VAL . 64.9 mt -96.54 115.61 36.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.799 -0.637 . . . . 0.74 109.615 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.448 HG21 HG21 ' A' ' 111' ' ' VAL . 59.5 mt -122.43 93.16 48.68 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.251 -0.431 . . . . 1.25 110.777 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -74.46 123.01 7.84 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.662 2.241 . . . . 0.29 112.019 174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 83' ' ' TYR . 1.1 pt -109.86 146.57 15.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.61 -0.885 . . . . 0.27 108.61 177.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.3 p -115.9 106.98 14.42 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.899 0.381 . . . . 1.24 110.106 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.572 HG12 ' HG ' ' A' ' 140' ' ' LEU . 25.6 mt -98.74 120.69 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 107.761 -1.2 . . . . 0.34 107.761 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -144.33 122.63 12.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.118 0.485 . . . . 1.95 110.317 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 137' ' ' LYS . 18.1 mmmt 57.24 35.24 25.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.79 -1.095 . . . . 3.13 111.5 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.37 7.15 69.96 Favored Glycine 0 C--O 1.227 -0.318 0 CA-C-N 115.597 -0.729 . . . . 0.41 113.18 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 99.6 mttt -109.22 145.6 35.58 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 122.649 -0.324 . . . . 2.23 110.168 174.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.663 HD12 ' HD1' ' A' ' 149' ' ' PHE . 5.9 tt -114.46 115.12 26.75 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.878 -0.786 . . . . 0.41 108.878 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.9 m -117.3 136.25 53.25 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.375 -0.375 . . . . 1.19 110.042 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.547 HG21 ' CG2' ' A' ' 106' ' ' VAL . 58.4 t -123.71 92.53 2.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.614 -0.513 . . . . 0.92 109.614 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 56.63 -87.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.105 -0.952 . . . . 1.88 111.632 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -103.49 -10.88 34.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 1.02 112.507 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.503 ' HB3' ' ND1' ' A' ' 109' ' ' HIS . 64.1 mm-40 -87.86 139.87 30.08 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.974 -0.38 . . . . 1.95 109.974 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.7 p -145.42 130.44 12.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.312 0.577 . . . . 0.92 111.728 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 70.6 m -159.9 166.86 29.34 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.631 -0.877 . . . . 1.27 108.631 174.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 66.6 p -74.71 147.04 41.78 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.125 -0.694 . . . . 1.45 109.125 173.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.821 ' CZ ' ' HB ' ' A' ' 77' ' ' ILE . 65.3 t80 -79.07 128.2 32.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.801 0.334 . . . . 0.47 110.114 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 t -132.64 101.8 5.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.63 0.728 . . . . 1.79 111.515 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.96 -74.36 2.43 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.543 -0.753 . . . . 0.42 113.777 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -155.29 169.43 24.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.379 0.609 . . . . 1.23 111.13 -174.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.909 HD11 ' HB ' ' A' ' 106' ' ' VAL . 44.2 tp -90.83 127.52 36.39 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.092 -0.958 . . . . 1.17 109.23 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.732 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 97.0 p -97.01 142.51 28.88 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 119.373 -0.931 . . . . 1.35 109.553 176.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 106' ' ' VAL . 97.0 t -130.59 97.34 3.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.803 -0.814 . . . . 0.42 108.803 170.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.762 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 1.4 pm0 -126.78 141.85 51.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.188 -0.605 . . . . 1.98 111.279 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.789 ' HD1' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -102.65 122.24 44.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.235 -0.893 . . . . 2.32 108.789 178.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.733 ' HB ' ' HB2' ' A' ' 103' ' ' ASP . 26.1 t -84.13 127.65 39.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.35 -0.386 . . . . 0.62 110.282 -177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.613 ' HD2' ' HA ' ' A' ' 69' ' ' ASP . 86.8 tttt -53.28 123.9 13.15 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.74 1.275 . . . . 2.26 111.723 -178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -106.6 -90.71 2.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.891 -0.671 . . . . 1.45 112.353 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.7 ' HB2' ' HG3' ' A' ' 100' ' ' LYS . 85.7 m-85 -111.69 44.1 1.42 Allowed 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.82 -0.224 . . . . 4.24 110.622 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 68.46 160.34 0.18 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.868 -0.605 . . . . 4.98 111.534 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 51.12 65.3 1.52 Allowed 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 115.524 -0.762 . . . . 2.64 110.13 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 159' ' ' LYS . 50.5 m-20 -55.97 159.68 5.36 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.337 -1.301 . . . . 2.06 108.651 173.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.636 ' HD3' ' CD2' ' A' ' 102' ' ' PHE . 50.1 Cg_exo -34.66 94.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.854 3.036 . . . . 3.16 113.569 -172.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.615 ' HB2' ' HG3' ' A' ' 91' ' ' GLU . 10.9 tptp -52.49 -64.21 0.89 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 114.971 -1.013 . . . . 3.18 112.501 -163.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.763 HG22 ' HB3' ' A' ' 64' ' ' GLU . 86.9 t -87.24 132.22 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 C-N-CA 120.083 -0.647 . . . . 1.19 109.851 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -130.98 133.29 45.66 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 119.695 -0.802 . . . . 1.36 110.745 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -129.62 37.89 3.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.965 -0.561 . . . . 0.31 110.828 -175.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.749 HD11 HD11 ' A' ' 85' ' ' LEU . 10.8 tp -41.92 126.96 3.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.615 -1.175 . . . . 0.69 112.018 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.69 ' CZ ' ' HB3' ' A' ' 173' ' ' MET . 7.5 t80 -144.84 119.22 9.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.79 -0.186 . . . . 0.48 110.577 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.63 HG22 ' HE3' ' A' ' 12' ' ' TRP . 9.3 tt -115.18 123.56 70.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-O 121.981 0.896 . . . . 0.3 110.699 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.69 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 3.0 ppp? -117.54 159.35 23.01 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.218 -0.901 . . . . 0.99 109.613 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 83' ' ' TYR . 1.9 ptmm? -113.85 142.26 46.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 122.712 1.244 . . . . 1.22 114.218 -168.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.67 -30.25 10.09 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 112.708 -2.042 . . . . 0.31 114.264 162.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -176.99 158.16 1.52 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.002 0.901 . . . . 0.68 112.265 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.674 ' CA ' HG21 ' A' ' 84' ' ' VAL . . . -82.96 -9.93 59.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.965 -0.562 . . . . 0.86 110.375 172.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.515 ' H ' ' HB ' ' A' ' 176' ' ' THR . 5.0 m-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.694 -0.685 . . . . 2.16 111.357 -179.403 . . . . . . . . 1 1 . 1 stop_ save_